probeID;probesetid;sequencesourceid;GeneSymbol;GeneName;wilcox.pvalue;FoldChange;wilcox.pvalue.ubc;FoldChange.ubc;FDR.wilcox.ubc;wilcox.pvalue.grng;FoldChange.grng;FDR.wilcox.grng;X7_HighlyReproducedProbeSets_Bonferroni;X599_ReproducedProbeSets_FDR;Laval_clusters;UBC_clusters;GRNG_clusters
X100121622_TGI_at;100121622_TGI_at;NM_182607;VSIG1;V-set and immunoglobulin domain containing 1;0,00000017500000000000;2,202846201;0,000426117;1,664554882;0,002723432;0,07409907;1,56827324;0,161422649;0;0;NA;NA;NA
X100121623_TGI_at;100121623_TGI_at;NM_001031696;PLD3;phospholipase D family, member 3;0,00000011700000000000;1,323966301;0,047068664;1,132194487;0,077796053;0,001558392;1,472727354;0,012371173;0;0;NA;NA;NA
X100121633_TGI_at;100121633_TGI_at;NM_002115;HK3;hexokinase 3 (white cell);0,00000000000024400000;1,957412298;0,001712887;1,304317384;0,007188327;0,004654763;1,544492509;0,023927113;0;1;U1;U1;U1
X100121642_TGI_at;100121642_TGI_at;AK091834;;hypothetical gene supported by AK091834;0,00000000297000000000;0,643821433;0,117215198;0,818497835;0,159000245;0,552010088;0,967988727;0,680615346;0;0;NA;NA;NA
X100121644_TGI_at;100121644_TGI_at;AW974207;NFYB;nuclear transcription factor Y, beta;0,00000045700000000000;0,813561005;0,7099742;0,98154145;0,735623293;0,032088759;0,836036365;0,088319445;0;0;NA;NA;NA
X100121664_TGI_at;100121664_TGI_at;NM_016337;EVL;Enah/Vasp-like;0,00000000227000000000;1,340474256;0,01256159;1,148375722;0,029001436;0,000753789;1,252201145;0,007913552;0;1;U1;U1;U1
X100121691_TGI_at;100121691_TGI_at;NM_003279;TNNC2;troponin C type 2 (fast);0,00000077000000000000;0,780981731;0,06633218;0,921801728;0,102536506;0,402505519;0,97343944;0,542112532;0;0;NA;NA;NA
X100121696_TGI_at;100121696_TGI_at;NM_000181;GUSB;glucuronidase, beta;0,00000000047500000000;1,229422664;0,103401072;1,066072334;0,144582063;0,00256018;1,167514735;0,01677126;0;0;NA;NA;NA
X100121719_TGI_at;100121719_TGI_at;NM_001032394;GPR126;G protein-coupled receptor 126;0,00000000256000000000;0,733141017;0,103915228;0,926608639;0,14473586;0,823248705;1,035799814;0,88918585;0;0;NA;NA;NA
X100121739_TGI_at;100121739_TGI_at;BC009944;STX6;syntaxin 6;0,00000000000000047600;1,46277387;0,057592601;1,124325494;0,09125138;0,010330126;1,181966868;0,040961273;0;0;NA;NA;NA
X100121783_TGI_at;100121783_TGI_at;NM_004701;CCNB2;cyclin B2;0,00000004580000000000;1,693234265;0,013027084;1,249518141;0,029735334;0,137820448;1,279318867;0,249969219;0;0;NA;NA;NA
X100121791_TGI_at;100121791_TGI_at;NM_015277;NEDD4L;neural precursor cell expressed, developmentally down-regulated 4-like;0,00000000005220000000;0,765732673;0,258420049;0,936972258;0,307338678;0,039719764;1,285988945;0,101661999;0;0;NA;NA;NA
X100121797_TGI_at;100121797_TGI_at;NM_001029874;;Rab15 effector protein;0,00000000019300000000;0,720081041;6,67E-06;0,727939975;0,000217231;0,421327994;0,944162688;0,560904521;0;0;NA;NA;NA
X100121803_TGI_at;100121803_TGI_at;NM_006809;TOMM34;translocase of outer mitochondrial membrane 34;0,00000024800000000000;1,235732899;0,796209286;1,026417;0,815178694;0,431008093;0,927943695;0,568620174;0;0;NA;NA;NA
X100121822_TGI_at;100121822_TGI_at;AL834529;LRRK2;leucine-rich repeat kinase 2;0,00000000433000000000;1,473529866;0,009906539;1,146157282;0,024522868;9,98E-05;1,624929257;0,003183838;0;1;U2;U1;U1
X100121823_TGI_at;100121823_TGI_at;AF186252;SULT1C2;sulfotransferase family, cytosolic, 1C, member 2;0,00000000034900000000;1,98343661;0,007445908;1,347607711;0,019965193;0,001370872;1,889036542;0,011387427;0;1;U6;U1;U1
X100121830_TGI_at;100121830_TGI_at;AW117463;PKD1L1;polycystic kidney disease 1 like 1;0,00000002560000000000;1,270142405;4,59E-05;1,268792424;0,000649151;0,011420211;1,17871334;0,043251869;0;1;U2;U2;U1
X100121858_TGI_at;100121858_TGI_at;AK123835;C6orf138;chromosome 6 open reading frame 138;0,00000001280000000000;1,429967699;2,79E-05;1,400476572;0,000479188;0,27411466;1,138124021;0,411866186;0;0;NA;NA;NA
X100121861_TGI_at;100121861_TGI_at;NM_145918;CTSL1;cathepsin L1;0,00000040200000000000;1,251146767;0,029725907;1,120309661;0,054809267;0,039719764;1,124969715;0,101661999;0;0;NA;NA;NA
X100121871_TGI_at;100121871_TGI_at;NM_006646;WASF3;WAS protein family, member 3;0,00000000037100000000;0,666298283;0,234395156;0,930635833;0,283048178;0,648925345;0,964251048;0,755321916;0;0;NA;NA;NA
X100121873_TGI_at;100121873_TGI_at;U12778;ACADSB;acyl-Coenzyme A dehydrogenase, short/branched chain;0,00000000068900000000;1,505393327;6,84E-05;1,281988495;0,000819872;0,039719764;1,272761732;0,101661999;0;0;NA;NA;NA
X100121877_TGI_at;100121877_TGI_at;NM_001012507;C6orf173;chromosome 6 open reading frame 173;0,00000000001390000000;1,452940421;0,000104188;1,281814667;0,00106414;0,284058212;1,125085147;0,421122179;0;0;NA;NA;NA
X100121883_TGI_at;100121883_TGI_at;NM_198516;GALNTL4;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4;0,00000055800000000000;0,766365709;0,006385541;0,836035302;0,017849609;0,927501324;1,010841047;0,959350695;0;0;NA;NA;NA
X100121915_TGI_at;100121915_TGI_at;NM_018242;SLC47A1;solute carrier family 47, member 1;0,00000000459000000000;1,610829221;0,012772842;1,276966205;0,029342032;0,000276376;1,665057373;0,004763426;0;1;U2;U1;U1
X100121956_TGI_at;100121956_TGI_at;ENST00000319246;DDHD2;DDHD domain containing 2;0,00000000003670000000;0,8259284;0,858100505;0,995583001;0,870525001;0,026197762;0,926081793;0,076620133;0;0;NA;NA;NA
X100121973_TGI_at;100121973_TGI_at;NM_032814;RNFT2;ring finger protein, transmembrane 2;0,00000032800000000000;1,396780735;0,001175193;1,257743086;0,005372547;0,642406094;1,019321272;0,75262626;0;0;NA;NA;NA
X100121985_TGI_at;100121985_TGI_at;NM_033168;B3GALNT1;beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group);0,00000000012800000000;0,659224887;0,001930734;0,828235825;0,007817533;0,041415229;0,819764561;0,104282253;0;0;NA;NA;NA
X100121991_TGI_at;100121991_TGI_at;NM_001005377;PLAUR;plasminogen activator, urokinase receptor;0,00000000011300000000;1,75943243;0,000296404;1,44142522;0,002104205;0,012010459;1,518985625;0,044912263;0;1;U4;U3;U1
X100121996_TGI_at;100121996_TGI_at;AK093136;KIAA1919;KIAA1919;0,00000000248000000000;1,330902602;0,035970005;1,112558459;0,063109051;0,57904816;1,047005839;0,700552635;0;0;NA;NA;NA
X100122001_TGI_at;100122001_TGI_at;NM_002986;CCL11;chemokine (C-C motif) ligand 11;0,00000009750000000000;1,821136551;0,003561399;1,477275229;0,011857838;0,215347198;1,281206699;0,344448645;0;0;NA;NA;NA
X100122004_TGI_at;100122004_TGI_at;NM_014879;P2RY14;purinergic receptor P2Y, G-protein coupled, 14;0,00000030600000000000;0,787254698;0,298522576;0,948199718;0,347970438;0,452969134;0,983427644;0,589390197;0;0;NA;NA;NA
X100122019_TGI_at;100122019_TGI_at;NM_000399;EGR2;early growth response 2 (Krox-20 homolog, Drosophila);0,00000009190000000000;1,696474019;0,001172128;1,453255566;0,005372547;0,149505026;1,470593761;0,264174725;0;0;NA;NA;NA
X100122026_TGI_at;100122026_TGI_at;ENST00000357508;NCRNA00082;non-protein coding RNA 82;0,00000000003120000000;1,656750977;0,458867798;1,053300797;0,501502513;0,993400377;1,041092901;0,995253159;0;0;NA;NA;NA
X100122038_TGI_at;100122038_TGI_at;NM_001910;CTSE;cathepsin E;0,00000000296000000000;1,86954103;0,110091487;1,316442655;0,151053581;0,127027071;1,585441725;0,235834246;0;0;NA;NA;NA
X100122077_TGI_at;100122077_TGI_at;BC146799;EML4;echinoderm microtubule associated protein like 4;0,00000000000000855000;1,632138187;0,006011579;1,19529301;0,017070766;0,014643299;1,269819586;0,051467124;0;0;NA;NA;NA
X100122107_TGI_at;100122107_TGI_at;NM_144682;SLFN13;schlafen family member 13;0,00000028600000000000;0,819084294;0,011637059;0,869992144;0,027277267;0,118794011;0,856007707;0,224033409;0;0;NA;NA;NA
X100122114_TGI_at;100122114_TGI_at;ENST00000355167;EYA4;eyes absent homolog 4 (Drosophila);0,00000017700000000000;0,624041838;0,00514105;0,725823244;0,015413584;0,077689446;0,738987229;0,166153341;0;0;NA;NA;NA
X100122133_TGI_at;100122133_TGI_at;DQ890878;CYBB;cytochrome b-245, beta polypeptide;0,00000000000000208000;2,329672001;8,70E-06;1,603160137;0,000257344;0,000174604;1,821661194;0,004028419;0;1;U6;U2;U1
X100122178_TGI_at;100122178_TGI_at;NM_000715;C4BPA;complement component 4 binding protein, alpha;0,00000000006760000000;1,629087064;0,003688611;1,233527627;0,01215582;1,03E-06;1,901074089;0,00066272;0;1;U7;U2;U2
X100122215_TGI_at;100122215_TGI_at;NM_206900;RTN2;reticulon 2;0,00000000534000000000;1,41240264;0,204592141;1,079061731;0,253615565;0,000276376;1,570858011;0,004763426;0;0;NA;NA;NA
X100122237_TGI_at;100122237_TGI_at;NM_021871;FGA;fibrinogen alpha chain;0,00000000000141000000;5,680890806;4,77E-05;3,247005067;0,000659239;0,000703777;3,142712179;0,007741543;0;1;U6;U2;U1
X100122239_TGI_at;100122239_TGI_at;NM_014640;TTLL4;tubulin tyrosine ligase-like family, member 4;0,00000000863000000000;1,290194231;0,246441107;1,059794344;0,295271259;0,315219134;1,038967408;0,454361033;0;0;NA;NA;NA
X100122240_TGI_at;100122240_TGI_at;NM_004181;UCHL1;ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase);0,00000000006110000000;2,084638262;0,001199051;1,546321932;0,005450693;0,031930775;1,283571481;0,088319445;0;0;NA;NA;NA
X100122259_TGI_at;100122259_TGI_at;NM_015920;RPS27L;ribosomal protein S27-like;0,00000000000114000000;1,400620739;0,010443828;1,16209854;0,025365831;0,000371641;1,33010104;0,00537129;0;1;U3;U1;U1
X100122272_TGI_at;100122272_TGI_at;NM_001181;ASGR2;asialoglycoprotein receptor 2;0,00000030100000000000;1,552351613;0,42047434;1,115581226;0,466020907;0,033503156;1,294581662;0,091046096;0;0;NA;NA;NA
X100122276_TGI_at;100122276_TGI_at;NM_005539;INPP5A;inositol polyphosphate-5-phosphatase, 40kDa;0,00000000000134000000;0,801243047;0,000667146;0,878402864;0,003711391;0,012460483;0,891159496;0,046447382;0;1;D2;D1;D1
X100122296_TGI_at;100122296_TGI_at;NM_001003803;ATP5S;ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B);0,00000000028400000000;1,270065539;0,060672489;1,076988042;0,095249602;0,003371616;1,209170929;0,019650484;0;0;NA;NA;NA
X100122312_TGI_at;100122312_TGI_at;NM_001081976;ADORA3;adenosine A3 receptor;0,00000000000000045700;3,115615004;0,002325633;1,747834141;0,008756443;0,039719764;1,627299803;0,101661999;0;0;NA;NA;NA
X100122317_TGI_at;100122317_TGI_at;AY358204;TMEM92;transmembrane protein 92;0,00000000032800000000;1,483252197;0,000945553;1,25422772;0,004645604;7,19E-06;1,748489154;0,001159269;0;1;U2;U1;U2
X100122330_TGI_at;100122330_TGI_at;AI097119;RDH10;retinol dehydrogenase 10 (all-trans);0,00000002610000000000;1,447172306;0,000376562;1,291002658;0,002487007;0,284058212;1,162394839;0,421122179;0;0;NA;NA;NA
X100122332_TGI_at;100122332_TGI_at;NM_032552;DAB2IP;DAB2 interacting protein;0,00000000734000000000;0,829130728;0,000570407;0,876796318;0,003330477;0,083453505;1,124394899;0,17510994;0;0;NA;NA;NA
X100122336_TGI_at;100122336_TGI_at;NM_001531;MR1;major histocompatibility complex, class I-related;0,00000000000042600000;1,58100428;4,22E-06;1,287257338;0,00015806;2,28E-05;1,42569783;0,001749595;0;1;U2;U3;U1
X100122341_TGI_at;100122341_TGI_at;NM_144707;PROM2;prominin 2;0,00000000420000000000;1,302845336;0,588312588;1,061806985;0,622498841;0,635603663;0,995700557;0,747431382;0;0;NA;NA;NA
X100122375_TGI_at;100122375_TGI_at;NM_006832;FERMT2;fermitin family homolog 2 (Drosophila);0,00000000085600000000;0,829406942;0,000144442;0,897679217;0,001291564;0,064330368;0,909311944;0,144788251;0;0;NA;NA;NA
X100122391_TGI_at;100122391_TGI_at;NM_005949;MT1F;metallothionein 1F;0,00000000135000000000;1,440481796;1,98E-05;1,332264406;0,000387055;0,005143125;1,604938049;0,025423759;0;1;U5;U3;U1
X100122400_TGI_at;100122400_TGI_at;NM_133265;AMOT;angiomotin;0,00000001930000000000;0,784355212;0,020725238;0,875023054;0,042010971;0,028121921;0,805997276;0,080853658;0;0;NA;NA;NA
X100122413_TGI_at;100122413_TGI_at;CR738950;;;0,00000004450000000000;0,777120754;0,286177229;1,049941998;0,335399713;0,940656418;1,00875612;0,965520903;0;0;NA;NA;NA
X100122440_TGI_at;100122440_TGI_at;NM_001747;CAPG;capping protein (actin filament), gelsolin-like;0,00000000000062900000;1,592376559;0,00088411;1,213576137;0,004487371;0,00012425;1,498420473;0,003628771;0;1;U3;U1;U1
X100122450_TGI_at;100122450_TGI_at;BC018396;KIAA0408;KIAA0408;0,00000004960000000000;0,746677454;0,208657465;0,926588512;0,257879934;0,03650134;1,380638385;0,096439395;0;0;NA;NA;NA
X100122464_TGI_at;100122464_TGI_at;ENST00000312002;WDFY4;WDFY family member 4;0,00000014400000000000;1,289207707;0,007800348;1,137553147;0,020691786;0,000429707;1,27000628;0,005893387;0;1;U4;U1;U1
X100122466_TGI_at;100122466_TGI_at;AK055032;RAP1GDS1;RAP1, GTP-GDP dissociation stimulator 1;0,00000000010100000000;1,224565323;0,359317082;1,026041661;0,406628847;0,046244403;1,111117363;0,113775352;0;0;NA;NA;NA
X100122468_TGI_at;100122468_TGI_at;ENST00000290607;STARD9;StAR-related lipid transfer (START) domain containing 9;0,00000000000007880000;0,679241958;0,000613804;0,854012249;0,003505988;0,083615947;0,849675075;0,17510994;0;0;NA;NA;NA
X100122470_TGI_at;100122470_TGI_at;AK123325;RGS12;regulator of G-protein signaling 12;0,00000120000000000000;1,400894987;0,001379;1,240942779;0,006118008;0,502203015;1,123572985;0,637495201;0;0;NA;NA;NA
X100122494_TGI_at;100122494_TGI_at;BM991750;;;0,00000023600000000000;0,663765338;0,515477483;0,982907456;0,554501919;0,080609435;0,728646667;0,170587136;0;0;NA;NA;NA
X100122505_TGI_at;100122505_TGI_at;NM_052941;GBP4;guanylate binding protein 4;0,00000000009650000000;0,627683141;0,003969839;0,764415055;0,012743815;0,993400377;0,952614834;0,995253159;0;0;NA;NA;NA
X100122520_TGI_at;100122520_TGI_at;CN368271;UBE2F;ubiquitin-conjugating enzyme E2F (putative);0,00000000000000456000;1,346629682;0,504583157;1,022886208;0,544085485;0,08994195;1,099987806;0,184145191;0;0;NA;NA;NA
X100122557_TGI_at;100122557_TGI_at;NM_006449;CDC42EP3;CDC42 effector protein (Rho GTPase binding) 3;0,00000000055500000000;1,23756881;0,000791659;1,146003085;0,004196572;0,951948154;0,986753109;0,974385319;0;0;NA;NA;NA
X100122583_TGI_at;100122583_TGI_at;AK023660;;;0,00000001680000000000;1,361875823;0,033903593;1,118347335;0,059973261;0,980202899;1,022486423;0,987556719;0;0;NA;NA;NA
X100122603_TGI_at;100122603_TGI_at;NM_014848;SV2B;synaptic vesicle glycoprotein 2B;0,00000005400000000000;1,48836005;0,002000343;1,329504284;0,007988979;0,450742398;1,07173201;0,587204022;0;0;NA;NA;NA
X100122612_TGI_at;100122612_TGI_at;AB072905;FOXO3;forkhead box O3;0,00000031400000000000;0,825262216;0,013682879;0,896132903;0,030731651;0,534478464;1,036943842;0,664336324;0;0;NA;NA;NA
X100122613_TGI_at;100122613_TGI_at;NM_001001994;GPM6B;glycoprotein M6B;0,00000000010300000000;0,714131886;0,024715872;0,854286872;0,047757347;0,470967706;0,937426577;0,606928795;0;0;NA;NA;NA
X100122642_TGI_at;100122642_TGI_at;NM_020353;PLSCR4;phospholipid scramblase 4;0,00000046000000000000;0,768144238;0,299436944;0,951976228;0,348775163;0,221636126;0,896395221;0,351888292;0;0;NA;NA;NA
X100122687_TGI_at;100122687_TGI_at;BX647782;NUTF2;nuclear transport factor 2;0,00000000435000000000;0,772639116;0,00270207;0,869440353;0,00973047;0,91266668;1,029987748;0,951873502;0;0;NA;NA;NA
X100122693_TGI_at;100122693_TGI_at;NM_024709;C1orf115;chromosome 1 open reading frame 115;0,00000000778000000000;0,742931639;0,002460776;0,824650334;0,00913719;0,924555569;0,986997235;0,959350695;0;0;NA;NA;NA
X100122703_TGI_at;100122703_TGI_at;NM_198859;PRICKLE2;prickle homolog 2 (Drosophila);0,00000000092800000000;0,774817736;0,00030297;0,86237325;0,002128165;0,823248705;0,984838701;0,88918585;0;0;NA;NA;NA
X100122806_TGI_at;100122806_TGI_at;AI862445;TNFAIP2;tumor necrosis factor, alpha-induced protein 2;0,00000005100000000000;1,324426859;0,20250426;1,095616347;0,251403866;0,01262694;1,307775528;0,046447382;0;0;NA;NA;NA
X100122813_TGI_at;100122813_TGI_at;NM_002754;MAPK13;mitogen-activated protein kinase 13;0,00000000006790000000;1,411928048;0,190768785;1,085630255;0,239054352;3,28E-05;1,521223618;0,001805101;0;0;NA;NA;NA
X100122823_TGI_at;100122823_TGI_at;NM_004573;PLCB2;phospholipase C, beta 2;0,00000000089200000000;1,394924289;0,004189615;1,158782996;0,013225397;0,026896706;1,226496635;0,078167794;0;0;NA;NA;NA
X100122831_TGI_at;100122831_TGI_at;AY305384;ASAH1;N-acylsphingosine amidohydrolase (acid ceramidase) 1;0,00000021300000000000;1,315771134;0,001815764;1,188562292;0,007499003;0,001221875;1,556758877;0,010701369;0;1;U1;U1;U1
X100122838_TGI_at;100122838_TGI_at;CF553052;;;0,00000000000000037200;1,767348582;3,66E-05;1,304740838;0,000569809;0,006617028;1,209323466;0,030122431;0;1;U2;U1;U1
X100122843_TGI_at;100122843_TGI_at;NM_004612;TGFBR1;transforming growth factor, beta receptor 1;0,00000014400000000000;1,329612085;0,008237955;1,119629561;0,021498728;0,228052747;1,121133499;0,35942005;0;0;NA;NA;NA
X100122844_TGI_at;100122844_TGI_at;BM671447;;;0,00000017200000000000;0,828040861;0,33002996;0,955367171;0,378132443;0,221636126;0,879587511;0,351888292;0;0;NA;NA;NA
X100122883_TGI_at;100122883_TGI_at;NM_002350;LYN;v-yes-1 Yamaguchi sarcoma viral related oncogene homolog;0,00000000202000000000;1,284997402;0,009815311;1,129851376;0,024390708;0,00023763;1,401095753;0,004452797;0;1;U5;U2;U1
X100122908_TGI_at;100122908_TGI_at;BC036424;;;0,00000000271000000000;1,229706442;0,000765107;1,144665593;0,004123647;0,052890615;1,1335375;0,126177982;0;0;NA;NA;NA
X100122909_TGI_at;100122909_TGI_at;ENST00000372244;TMEM53;transmembrane protein 53;0,00000000030700000000;1,350871048;0,1850597;1,083657608;0,23298727;0,001003293;1,342482372;0,009400035;0;0;NA;NA;NA
X100122923_TGI_at;100122923_TGI_at;NM_198474;OLFML1;olfactomedin-like 1;0,00000064600000000000;0,815995612;0,344634911;0,952606133;0,39221692;0,734410047;1,0399178;0,82359206;0;0;NA;NA;NA
X100122954_TGI_at;100122954_TGI_at;BC047481;;hypothetical LOC401022;0,00000085000000000000;1,21465638;0,026629163;1,146166602;0,050455025;0,000146987;1,708320476;0,003847048;0;0;NA;NA;NA
X100122967_TGI_at;100122967_TGI_at;NM_001002901;FCRLB;Fc receptor-like B;0,00000000005690000000;1,905700964;1,56E-05;1,50784343;0,000343627;0,086693301;1,224258751;0,179491513;0;0;NA;NA;NA
X100122975_TGI_at;100122975_TGI_at;AJ238994;ADAP2;ArfGAP with dual PH domains 2;0,00000126000000000000;1,306843657;0,739593162;1,013523363;0,762298932;0,020452962;1,313540247;0,064249412;0;0;NA;NA;NA
X100123033_TGI_at;100123033_TGI_at;NM_000923;PDE4C;phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila);0,00000022600000000000;1,61860764;0,030190519;1,297709533;0,055254992;0,007886168;1,551029241;0,034341403;0;0;NA;NA;NA
X100123038_TGI_at;100123038_TGI_at;NM_000459;TEK;TEK tyrosine kinase, endothelial;0,00000000000554000000;0,700221438;0,003020068;0,860933011;0,0105686;0,348497017;0,907703605;0,486868611;0;0;NA;NA;NA
X100123040_TGI_at;100123040_TGI_at;NM_001098497;SGSM1;small G protein signaling modulator 1;0,00000005380000000000;0,77144379;0,260366709;0,933766081;0,309539618;0,357146031;0,930901676;0,494450884;0;0;NA;NA;NA
X100123064_TGI_at;100123064_TGI_at;L26985;CYP3A5;cytochrome P450, family 3, subfamily A, polypeptide 5;0,00000109000000000000;0,709765634;0,074246935;0,839988966;0,111406886;0,849099163;1,021965559;0,906474529;0;0;NA;NA;NA
X100123070_TGI_at;100123070_TGI_at;NM_005392;PHF2;PHD finger protein 2;0,00000000002890000000;0,830051289;0,091972423;0,972839447;0,131862597;0,939476698;1,00788582;0,965520903;0;0;NA;NA;NA
X100123110_TGI_at;100123110_TGI_at;NM_002627;PFKP;phosphofructokinase, platelet;0,00000063200000000000;1,294895129;0,635540939;1,036322984;0,66895769;0,276598639;0,918775591;0,413486741;0;0;NA;NA;NA
X100123115_TGI_at;100123115_TGI_at;NM_003601;SMARCA5;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5;0,00000000660000000000;1,298755693;0,004146518;1,096574121;0,013127926;0,03650134;1,214514976;0,096439395;0;0;NA;NA;NA
X100123132_TGI_at;100123132_TGI_at;NM_004673;ANGPTL1;angiopoietin-like 1;0,00000000055400000000;0,679862574;0,001381914;0,792186432;0,006118008;0,093170847;0,852187316;0,188856657;0;0;NA;NA;NA
X100123138_TGI_at;100123138_TGI_at;NM_203304;MEX3D;mex-3 homolog D (C. elegans);0,00000003860000000000;0,820235156;0,664135402;0,978782136;0,694294;0,63704437;0,93706541;0,747431382;0;0;NA;NA;NA
X100123145_TGI_at;100123145_TGI_at;ENST00000369579;BCL2L15;BCL2-like 15;0,00000001650000000000;1,318151611;0,511926975;1,035193716;0,551450749;0,967010726;0,916755436;0,980394958;0;0;NA;NA;NA
X100123150_TGI_at;100123150_TGI_at;NM_001013836;MAD1L1;MAD1 mitotic arrest deficient-like 1 (yeast);0,00000126000000000000;1,285684313;0,325938151;1,025744548;0,373976027;0,00053236;1,35518893;0,006649296;0;0;NA;NA;NA
X100123156_TGI_at;100123156_TGI_at;NM_004049;BCL2A1;BCL2-related protein A1;0,00000000000009760000;1,842250497;0,000786994;1,282784159;0,004185615;0,010244574;1,362396117;0,040961273;0;1;U2;U2;U1
X100123193_TGI_at;100123193_TGI_at;NM_021021;SNTB1;syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1);0,00000000000000391000;1,609217856;0,040030079;1,135991372;0,068553105;2,18E-05;1,479037083;0,001749595;0;0;NA;NA;NA
X100123204_TGI_at;100123204_TGI_at;NM_013267;GLS2;glutaminase 2 (liver, mitochondrial);0,00000000000246000000;1,536589194;0,000289567;1,301562334;0,002072229;0,021756187;1,39451915;0,067164932;0;0;NA;NA;NA
X100123296_TGI_at;100123296_TGI_at;AK055335;;;0,00000000128000000000;0,756307516;0,000709947;0,830968063;0,003904708;0,328995653;0,900497193;0,470431672;0;0;NA;NA;NA
X100123301_TGI_at;100123301_TGI_at;CA314541;GPR110;G protein-coupled receptor 110;0,00000000000000035700;2,735338906;1,69E-06;1,998149527;9,22E-05;0,004862758;1,841786688;0,024374289;0;1;U7;U1;U1
X100123323_TGI_at;100123323_TGI_at;NM_000299;PKP1;plakophilin 1 (ectodermal dysplasia/skin fragility syndrome);0,00000005320000000000;0,608673435;1,68E-05;0,657054483;0,000356071;0,002687123;0,609319771;0,017251748;0;1;D2;D2;D1
X100123362_TGI_at;100123362_TGI_at;NM_030760;S1PR5;sphingosine-1-phosphate receptor 5;0,00000025400000000000;0,632213648;0,070638801;0,801315927;0,107492378;0,127936269;0,796217181;0,236568327;0;0;NA;NA;NA
X100123369_TGI_at;100123369_TGI_at;NM_023068;SIGLEC1;sialic acid binding Ig-like lectin 1, sialoadhesin;0,00000000158000000000;1,621440635;0,001886216;1,304274606;0,007662265;0,004386492;1,531370667;0,022988073;0;1;U4;U1;U1
X100123380_TGI_at;100123380_TGI_at;NM_031286;SH3BGRL3;SH3 domain binding glutamic acid-rich protein like 3;0,00000042300000000000;1,205445895;0,143862073;1,044718446;0,187795651;0,007170261;1,217424593;0,031919548;0;0;NA;NA;NA
X100123410_TGI_at;100123410_TGI_at;N92876;;;0,00000000014600000000;0,628647595;0,056843276;0,846460213;0,09060627;0,613556941;0,888866495;0,727019861;0;0;NA;NA;NA
X100123417_TGI_at;100123417_TGI_at;NM_015346;ZFYVE26;zinc finger, FYVE domain containing 26;0,00000002210000000000;1,251863078;0,033014488;1,098175764;0,058873378;0,20948725;1,095222877;0,337419993;0;0;NA;NA;NA
X100123437_TGI_at;100123437_TGI_at;NM_016931;NOX4;NADPH oxidase 4;0,00000000924000000000;0,741335623;0,739856397;1,059951773;0,76232646;0,053765992;0,777647193;0,127699182;0;0;NA;NA;NA
X100123443_TGI_at;100123443_TGI_at;BF432251;CDH13;cadherin 13, H-cadherin (heart);0,00000004560000000000;0,691424292;0,314781435;0,916939796;0,364026036;0,142561501;0,771621672;0,256260858;0;0;NA;NA;NA
X100123446_TGI_at;100123446_TGI_at;NM_032206;NLRC5;NLR family, CARD domain containing 5;0,00000040400000000000;0,773020988;0,000393156;0,805646326;0,002575494;0,154336744;0,894116922;0,270635106;0;0;NA;NA;NA
X100123464_TGI_at;100123464_TGI_at;ENST00000296289;TKT;transketolase;0,00000001080000000000;1,419695761;0,366983454;1,055667585;0,414141342;0,002131763;1,409372647;0,014968787;0;0;NA;NA;NA
X100123493_TGI_at;100123493_TGI_at;NM_198212;CAV2;caveolin 2;0,00000000000055800000;0,761892588;0,106155966;0,935366032;0,147347407;0,323340368;1,132495373;0,462755775;0;0;NA;NA;NA
X100123614_TGI_at;100123614_TGI_at;NM_181784;SPRED2;sprouty-related, EVH1 domain containing 2;0,00000000202000000000;0,79447343;0,22136805;0,943205573;0,270566211;0,980202899;1,011317644;0,987556719;0;0;NA;NA;NA
X100123618_TGI_at;100123618_TGI_at;BC041400;;;0,00000000306000000000;0,767701136;0,008807054;0,817737009;0,022492182;0,746919855;1,076580113;0,832983631;0;0;NA;NA;NA
X100123640_TGI_at;100123640_TGI_at;NM_014266;HCST;hematopoietic cell signal transducer;0,00000000009960000000;1,437732597;0,002377754;1,184058616;0,008880071;0,000320802;1,42861708;0,005118537;0;1;U2;U1;U1
X100123645_TGI_at;100123645_TGI_at;NM_006774;INMT;indolethylamine N-methyltransferase;0,00000000172000000000;0,801074117;0,000147817;0,811423229;0,001312437;0,079431373;0,921078429;0,169766123;0;0;NA;NA;NA
X100123667_TGI_at;100123667_TGI_at;NM_144580;C1orf85;chromosome 1 open reading frame 85;0,00000000000021600000;1,490934262;0,105425446;1,089519783;0,146522731;0,003063783;1,368786538;0,018596182;0;0;NA;NA;NA
X100123681_TGI_at;100123681_TGI_at;NM_015981;CAMK2A;calcium/calmodulin-dependent protein kinase (CaM kinase) II alpha;0,00000001480000000000;0,764943549;0,048777784;0,92337642;0,0799648;0,203035049;0,900636405;0,330514884;0;0;NA;NA;NA
X100123700_TGI_at;100123700_TGI_at;DQ893266;ACSL5;acyl-CoA synthetase long-chain family member 5;0,00000000000066600000;1,337127716;0,020508088;1,121583037;0,041649382;1,45E-06;1,468895133;0,000668695;0;1;U6;U1;U4
X100123705_TGI_at;100123705_TGI_at;NM_018425;PI4K2A;phosphatidylinositol 4-kinase type 2 alpha;0,00000000000318000000;1,432349073;1,51E-05;1,224347859;0,000343266;7,19E-06;1,394504516;0,001159269;1;1;U2;U2;U3
X100123706_TGI_at;100123706_TGI_at;NM_020828;ZFP28;zinc finger protein 28 homolog (mouse);0,00000024800000000000;0,790344594;0,049873966;0,896487092;0,081389261;0,043170182;0,800155893;0,107774978;0;0;NA;NA;NA
X100123718_TGI_at;100123718_TGI_at;ENST00000266517;ETNK1;ethanolamine kinase 1;0,00000000693000000000;1,408113871;0,001175193;1,168897394;0,005372547;0,888166261;1,023930706;0,935477078;0;0;NA;NA;NA
X100123723_TGI_at;100123723_TGI_at;M81592;GGCX;gamma-glutamyl carboxylase;0,00000013300000000000;1,233241811;0,264710888;1,04971922;0,314009273;0,039719764;1,183856046;0,101661999;0;0;NA;NA;NA
X100123730_TGI_at;100123730_TGI_at;NM_005532;IFI27;interferon, alpha-inducible protein 27;0,00000000006990000000;0,7917528;0,032873206;0,889807415;0,058795973;0,53491626;1,06702194;0,664624174;0;0;NA;NA;NA
X100123803_TGI_at;100123803_TGI_at;NM_013314;BLNK;B-cell linker;0,00000012300000000000;1,325285832;0,001522442;1,240898893;0,006576612;0,144787165;1,222647383;0,25853132;0;0;NA;NA;NA
X100123807_TGI_at;100123807_TGI_at;NM_016580;PCDH12;protocadherin 12;0,00000004450000000000;0,709966991;0,008928786;0,820815946;0,022785018;0,797584764;0,939042116;0,871690639;0;0;NA;NA;NA
X100123838_TGI_at;100123838_TGI_at;NM_017438;SETD4;SET domain containing 4;0,00000003110000000000;0,813253216;0,09349449;0,933946191;0,133569477;0,008831116;0,851565727;0,036964527;0;0;NA;NA;NA
X100123846_TGI_at;100123846_TGI_at;AF165531;GGA2;golgi associated, gamma adaptin ear containing, ARF binding protein 2;0,00000000816000000000;1,340652053;0,004662592;1,155972272;0,01433925;0,039901467;1,186694602;0,101661999;0;0;NA;NA;NA
X100123853_TGI_at;100123853_TGI_at;AF017635;STK39;serine threonine kinase 39 (STE20/SPS1 homolog, yeast);0,00000007750000000000;1,244895172;0,017262702;1,149913216;0,036531641;0,901252766;1,01929007;0,944937432;0;0;NA;NA;NA
X100123860_TGI_at;100123860_TGI_at;AK025100;;;0,00000000001120000000;1,290101401;0,000803306;1,133404159;0,004223584;4,28E-05;1,359195787;0,001969095;0;1;U2;U1;U1
X100123873_TGI_at;100123873_TGI_at;BF526220;TNS1;tensin 1;0,00000000345000000000;0,805243883;0,538062749;0,963923043;0,575755724;0,91266668;1,019200098;0,951873502;0;0;NA;NA;NA
X100123912_TGI_at;100123912_TGI_at;NM_017734;PALMD;palmdelphin;0,00000000000236000000;0,69996895;0,004662592;0,835485093;0,01433925;0,043170182;0,845076556;0,107774978;0;0;NA;NA;NA
X100123973_TGI_at;100123973_TGI_at;BT007214;MYOZ2;myozenin 2;0,00000058700000000000;0,805916851;0,047744551;0,867661214;0,078550632;0,81616847;1,012399943;0,885097907;0;0;NA;NA;NA
X100123982_TGI_at;100123982_TGI_at;NM_170743;IL28RA;interleukin 28 receptor, alpha (interferon, lambda receptor);0,00000000052900000000;1,410141134;0,00691763;1,262997722;0,018980446;3,28E-05;1,660336051;0,001805101;0;1;U1;U1;U1
X100124023_TGI_at;100124023_TGI_at;NM_203371;;fin bud initiation factor;0,00000000104000000000;0,493850447;0,004299091;0,737632982;0,01351802;0,083615947;0,772788147;0,17510994;0;0;NA;NA;NA
X100124040_TGI_at;100124040_TGI_at;NM_021648;TSPYL4;TSPY-like 4;0,00000001950000000000;0,830361316;0,85364584;1,001213533;0,867097555;0,001073561;0,787679665;0,009774253;0;0;NA;NA;NA
X100124045_TGI_at;100124045_TGI_at;ENST00000369709;RAP1A;RAP1A, member of RAS oncogene family;0,00000000044600000000;0,759924268;0,029927107;0,890802735;0,05498277;0,034779818;0,865111804;0,093703947;0;0;NA;NA;NA
X100124088_TGI_at;100124088_TGI_at;NM_021732;AVPI1;arginine vasopressin-induced 1;0,00000000160000000000;1,335378275;0,013833329;1,171012295;0,031000594;0,299373904;1,108762828;0,437985516;0;0;NA;NA;NA
X100124092_TGI_at;100124092_TGI_at;AK000215;PGPEP1;pyroglutamyl-peptidase I;0,00000000000000163000;1,479585506;0,200482866;1,050986787;0,249288687;0,191451954;1,127756809;0,318230865;0;0;NA;NA;NA
X100124107_TGI_at;100124107_TGI_at;BC002457;DERL1;Der1-like domain family, member 1;0,00000000000007290000;1,318294879;0,006276536;1,116998046;0,017652074;0,007948708;1,225632423;0,034341403;0;1;U6;U1;U1
X100124113_TGI_at;100124113_TGI_at;NM_020856;TSHZ3;teashirt zinc finger homeobox 3;0,00000000280000000000;0,778199385;0,000352894;0,840701879;0,002369537;0,005235058;0,796332422;0,025720413;0;1;D1;D1;D1
X100124137_TGI_at;100124137_TGI_at;NM_138437;GPRASP2;G protein-coupled receptor associated sorting protein 2;0,00000000158000000000;0,813885316;0,180635617;0,95270545;0,228130327;0,09653965;0,902645412;0,193392487;0;0;NA;NA;NA
X100124179_TGI_at;100124179_TGI_at;NM_005308;GRK5;G protein-coupled receptor kinase 5;0,00000000003370000000;0,774999714;0,000447131;0,836944284;0,002792833;0,031192857;0,819227349;0,087269599;0;0;NA;NA;NA
X100124186_TGI_at;100124186_TGI_at;ENST00000292392;FCRL3;Fc receptor-like 3;0,00000061400000000000;0,588667483;0,363087998;0,853289874;0,409888833;0,072102527;0,665510087;0,157336794;0;0;NA;NA;NA
X100124248_TGI_at;100124248_TGI_at;ENST00000361972;SFMBT2;Scm-like with four mbt domains 2;0,00000000021900000000;1,416854245;0,000248471;1,244115412;0,001888732;0,159283623;1,115648042;0,276600817;0;0;NA;NA;NA
X100124256_TGI_at;100124256_TGI_at;NM_199194;BRE;brain and reproductive organ-expressed (TNFRSF1A modulator);0,00000001700000000000;1,213194815;0,017425747;1,048528837;0,036664064;0,16275398;1,079920057;0,281112582;0;0;NA;NA;NA
X100124261_TGI_at;100124261_TGI_at;NM_078467;CDKN1A;cyclin-dependent kinase inhibitor 1A (p21, Cip1);0,00000061600000000000;1,742106293;0,010591601;1,266481972;0,02564743;0,927501324;0,964924138;0,959350695;0;0;NA;NA;NA
X100124265_TGI_at;100124265_TGI_at;NM_001040630;NCALD;neurocalcin delta;0,00000000102000000000;0,781427188;0,000348984;0,826512052;0,00235309;0,04591269;0,867122926;0,113218515;0;0;NA;NA;NA
X100124274_TGI_at;100124274_TGI_at;NM_198834;ACACA;acetyl-Coenzyme A carboxylase alpha;0,00000000009040000000;1,20594706;0,002239351;1,114831121;0,008591489;0,005437653;1,282276713;0,026196646;0;1;U1;U1;U1
X100124309_TGI_at;100124309_TGI_at;CA841412;SH3TC1;SH3 domain and tetratricopeptide repeats 1;0,00000050500000000000;1,328556878;0,238891819;1,042882981;0,287837906;0,045429645;1,154849348;0,112199038;0;0;NA;NA;NA
X100124329_TGI_at;100124329_TGI_at;NM_018420;SLC22A15;solute carrier family 22, member 15;0,00000000100000000000;1,483038944;0,005004235;1,213940819;0,015130065;0,033503156;1,228812817;0,091046096;0;0;NA;NA;NA
X100124330_TGI_at;100124330_TGI_at;NM_080717;TBX5;T-box 5;0,00000000609000000000;0,782371815;0,027446409;0,88464729;0,051460022;0,307230301;0,892102045;0,446439703;0;0;NA;NA;NA
X100124343_TGI_at;100124343_TGI_at;NM_001671;ASGR1;asialoglycoprotein receptor 1;0,00000000008210000000;1,400767842;0,085983342;1,08533318;0,125169065;0,000276376;1,287465582;0,004763426;0;0;NA;NA;NA
X100124392_TGI_at;100124392_TGI_at;CN307838;KIAA0355;KIAA0355;0,00000003020000000000;0,786865278;0,01500958;0,86665514;0,032976056;0,030713739;0,830027168;0,086003807;0;0;NA;NA;NA
X100124394_TGI_at;100124394_TGI_at;NM_003120;SPI1;spleen focus forming virus (SFFV) proviral integration oncogene spi1;0,00000000562000000000;1,505957431;0,01344048;1,176480404;0,030302638;0,00236704;1,694136653;0,016094875;0;1;U1;U1;U1
X100124425_TGI_at;100124425_TGI_at;ENST00000331920;PTCH1;patched homolog 1 (Drosophila);0,00000000459000000000;0,745471224;0,076106704;0,901443464;0,113351158;0,81616847;0,940491266;0,885097907;0;0;NA;NA;NA
X100124441_TGI_at;100124441_TGI_at;AB219936;MARVELD2;MARVEL domain containing 2;0,00000014500000000000;0,806559528;0,007934042;0,850940487;0,020960178;0,567746993;1,169771139;0,6918142;0;0;NA;NA;NA
X100124455_TGI_at;100124455_TGI_at;NM_031498;GNGT2;guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2;0,00000000000000531000;1,824012698;0,001088806;1,286771352;0,005115482;0,000292732;1,577536314;0,004872704;0;1;U5;U1;U1
X100124471_TGI_at;100124471_TGI_at;NM_020760;HECW2;HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2;0,00000004580000000000;0,704654715;0,000577323;0,755556673;0,003352635;0,57904816;0,979340578;0,700552635;0;0;NA;NA;NA
X100124473_TGI_at;100124473_TGI_at;AL037701;DENND2A;DENN/MADD domain containing 2A;0,00000000155000000000;0,617840968;0,000231545;0,776309591;0,001809564;0,885953667;0,99456683;0,935477078;0;0;NA;NA;NA
X100124490_TGI_at;100124490_TGI_at;NM_001995;ACSL1;acyl-CoA synthetase long-chain family member 1;0,00000000000069900000;1,387458556;0,020112876;1,107185693;0,041020393;0,020452962;1,227914916;0,064249412;0;0;NA;NA;NA
X100124518_TGI_at;100124518_TGI_at;NM_002090;CXCL3;chemokine (C-X-C motif) ligand 3;0,00000025400000000000;2,153423754;3,22E-05;1,874757697;0,000510526;0,00057123;2,00829429;0,006879298;0;1;U1;U3;U1
X100124563_TGI_at;100124563_TGI_at;NM_006770;MARCO;macrophage receptor with collagenous structure;0,00000000005780000000;1,583253938;0,010183485;1,284158555;0,024967324;0,000992908;1,967593809;0,009357144;0;1;U2;U1;U1
X100124616_TGI_at;100124616_TGI_at;AB073386;;Src homology 3 domain-containing guanine nucleotide exchange factor;0,00000000263000000000;0,722080353;0,101985231;0,892859071;0,142912348;0,315219134;1,127043724;0,454361033;0;0;NA;NA;NA
X100124646_TGI_at;100124646_TGI_at;BX647313;PBX1;pre-B-cell leukemia homeobox 1;0,00000021800000000000;0,787105096;0,118560965;0,935022923;0,160488026;0,096917017;0,895816105;0,193653778;0;0;NA;NA;NA
X100124701_TGI_at;100124701_TGI_at;NM_014298;QPRT;quinolinate phosphoribosyltransferase;0,00000000214000000000;1,342650315;0,002325633;1,152843704;0,008756443;0,006224908;1,234473997;0,028702256;0;1;U1;U1;U1
X100124713_TGI_at;100124713_TGI_at;T68445;;;0,00000000000010100000;0,695212133;0,003020068;0,777980755;0,0105686;0,039719764;0,848220217;0,101661999;0;0;NA;NA;NA
X100124737_TGI_at;100124737_TGI_at;NM_014232;VAMP2;vesicle-associated membrane protein 2 (synaptobrevin 2);0,00000000553000000000;0,830964598;0,10924462;0,954624949;0,150284122;0,858977898;1,041223854;0,915504552;0;0;NA;NA;NA
X100124755_TGI_at;100124755_TGI_at;NM_152451;GCOM1;GRINL1A complex locus;0,00000000060700000000;0,649263033;0,121288819;0,864354128;0,163493879;0,721968894;1,13052307;0,81331903;0;0;NA;NA;NA
X100124771_TGI_at;100124771_TGI_at;BC041906;;;0,00000009910000000000;0,774043937;0,319186712;0,938055898;0,368063962;0,131303184;0,906970157;0,240585653;0;0;NA;NA;NA
X100124798_TGI_at;100124798_TGI_at;NM_030948;PHACTR1;phosphatase and actin regulator 1;0,00000000000202000000;1,558321394;0,010906918;1,174616768;0,02611664;0,000173465;1,592005844;0,004028419;0;1;U4;U1;U1
X100124815_TGI_at;100124815_TGI_at;BC037909;;hypothetical protein LOC642924;0,00000001180000000000;0,729183236;0,047465782;0,847513436;0,078171801;0,279853683;0,882449096;0,417964977;0;0;NA;NA;NA
X100124818_TGI_at;100124818_TGI_at;AK131463;PREPL;prolyl endopeptidase-like;0,00000040200000000000;1,291283219;0,080922752;1,072626327;0,119038808;0,052890615;1,207844349;0,126177982;0;0;NA;NA;NA
X100124841_TGI_at;100124841_TGI_at;BC016153;TMEM45B;transmembrane protein 45B;0,00000000001320000000;1,516686514;0,08392924;1,129605766;0,122844659;0,110976585;1,2069703;0,212903293;0;0;NA;NA;NA
X100124853_TGI_at;100124853_TGI_at;AK098285;CHCHD7;coiled-coil-helix-coiled-coil-helix domain containing 7;0,00000012200000000000;1,204929138;0,095734617;1,074695305;0,135719763;0,009802261;1,184645581;0,039467969;0;0;NA;NA;NA
X100124874_TGI_at;100124874_TGI_at;AK090985;CBFA2T3;"core-binding factor, runt domain, alpha subunit 2; translocated to, 3";0,00000012600000000000;0,773703773;0,011047817;0,885856864;0,026395193;0,449193241;0,924199732;0,587204022;0;0;NA;NA;NA
X100124914_TGI_at;100124914_TGI_at;AB046856;TANC2;tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2;0,00000000000281000000;1,281968267;0,103678413;1,072101532;0,14471872;0,00256018;1,338198194;0,01677126;0;0;NA;NA;NA
X100124986_TGI_at;100124986_TGI_at;NM_003374;VDAC1;voltage-dependent anion channel 1;0,00000000011100000000;1,200858139;0,031138172;1,065185123;0,056571775;0,411774001;1,046079385;0,552978168;0;0;NA;NA;NA
X100125024_TGI_at;100125024_TGI_at;DQ891897;LEPROTL1;leptin receptor overlapping transcript-like 1;0,00000000241000000000;1,224103455;0,021357694;1,123841119;0,042923852;0,004342204;1,189092751;0,022867523;0;1;U2;U1;U1
X100125041_TGI_at;100125041_TGI_at;NM_001032998;KYNU;kynureninase (L-kynurenine hydrolase);0,00000000044700000000;1,759483558;0,000889677;1,444974395;0,004487371;0,005143125;1,520302368;0,025423759;0;1;U2;U1;U1
X100125045_TGI_at;100125045_TGI_at;U83460;SLC31A1;solute carrier family 31 (copper transporters), member 1;0,00000000000000011500;2,020980444;3,14E-05;1,315944125;0,000508004;0,000343576;1,431450478;0,005300617;0;1;U2;U1;U1
X100125046_TGI_at;100125046_TGI_at;NM_024989;PGAP1;post-GPI attachment to proteins 1;0,00000005680000000000;0,733359047;0,458209165;0,987712674;0,500952558;0,034975442;0,794224171;0,093703947;0;0;NA;NA;NA
X100125080_TGI_at;100125080_TGI_at;AK090989;;;0,00000000178000000000;1,522025126;4,06E-07;1,677787302;3,96E-05;0,063921148;1,288243036;0,144788251;0;0;NA;NA;NA
X100125089_TGI_at;100125089_TGI_at;BX649145;;hypothetical protein LOC157562;0,00000004040000000000;0,727827367;0,140775035;0,907893874;0,184663386;0,491673531;0,93293093;0,627589621;0;0;NA;NA;NA
X100125122_TGI_at;100125122_TGI_at;NM_152687;GAPT;GRB2-binding adaptor protein, transmembrane;0,00000000400000000000;1,551332279;0,012813633;1,261918855;0,029356114;0,136822082;1,294276535;0,248858674;0;0;NA;NA;NA
X100125149_TGI_at;100125149_TGI_at;CA307526;;;0,00000000000128000000;2,074278407;0,002287756;1,46590534;0,008696308;0,001558392;1,726948989;0,012371173;0;1;U3;U1;U1
X100125150_TGI_at;100125150_TGI_at;NM_194450;CLEC4A;C-type lectin domain family 4, member A;0,00000000001910000000;1,487547157;0,008807054;1,186196074;0,022492182;0,086710607;1,18148808;0,179491513;0;0;NA;NA;NA
X100125155_TGI_at;100125155_TGI_at;BC015328;;;0,00000007040000000000;0,741322959;0,000889677;0,784729259;0,004487371;0,025716846;0,819204176;0,075487609;0;0;NA;NA;NA
X100125185_TGI_at;100125185_TGI_at;NM_001039538;MAP2;microtubule-associated protein 2;0,00000000006080000000;0,729648354;0,00155273;0,797794206;0,006643984;0,03340833;0,87622295;0,091046096;0;0;NA;NA;NA
X100125189_TGI_at;100125189_TGI_at;ENST00000320985;ZEB1;zinc finger E-box binding homeobox 1;0,00000000365000000000;0,801597618;0,063070935;0,899791922;0,097870787;0,002195888;0,787727561;0,015318934;0;0;NA;NA;NA
X100125197_TGI_at;100125197_TGI_at;NM_178865;SERINC2;serine incorporator 2;0,00000002650000000000;1,378477386;0,910249139;1,021408725;0,918801432;0,331593893;1,108760243;0,472261209;0;0;NA;NA;NA
X100125217_TGI_at;100125217_TGI_at;N33393;;;0,00000123000000000000;1,337400283;0,019371351;1,165221571;0,039944892;0,131303184;1,242669789;0,240585653;0;0;NA;NA;NA
X100125225_TGI_at;100125225_TGI_at;NM_016582;SLC15A3;solute carrier family 15, member 3;0,00000000000220000000;1,551917423;0,008207603;1,21427899;0,021454262;0,001826926;1,435315582;0,013920055;0;1;U2;U1;U1
X100125228_TGI_at;100125228_TGI_at;NM_170601;SIAE;sialic acid acetylesterase;0,00000002740000000000;1,258254607;0,008661579;1,153446075;0,022279544;0,000220177;1,383627887;0,004272984;0;1;U1;U1;U2
X100125249_TGI_at;100125249_TGI_at;AL161982;;;0,00000002130000000000;0,671057836;0,006140409;0,781906313;0,017344905;0,993400377;1,02142373;0,995253159;0;0;NA;NA;NA
X100125255_TGI_at;100125255_TGI_at;NM_002736;PRKAR2B;protein kinase, cAMP-dependent, regulatory, type II, beta;0,00000000408000000000;0,766119729;0,000921772;0,860217703;0,004620326;0,22530743;0,902200149;0,356838254;0;0;NA;NA;NA
X100125256_TGI_at;100125256_TGI_at;NM_014053;FLVCR1;feline leukemia virus subgroup C cellular receptor 1;0,00000000297000000000;1,473609048;0,106876436;1,140742532;0,148028686;0,029393816;1,226950385;0,083541684;0;0;NA;NA;NA
X100125272_TGI_at;100125272_TGI_at;CK004354;;;0,00000001640000000000;0,819836903;0,325938151;0,940840121;0,373976027;0,209185181;0,90573859;0,337324278;0;0;NA;NA;NA
X100125279_TGI_at;100125279_TGI_at;ENST00000375138;C1orf151;chromosome 1 open reading frame 151;0,00000000967000000000;0,781138936;0,002554823;0,856430868;0,009367686;0,691575598;0,977993933;0,790968117;0;0;NA;NA;NA
X100125280_TGI_at;100125280_TGI_at;AK055468;;;0,00000003760000000000;0,773753764;0,025303994;0,884681329;0,048602367;0,083615947;1,243648156;0,17510994;0;0;NA;NA;NA
X100125286_TGI_at;100125286_TGI_at;AK128527;BCAT1;branched chain aminotransferase 1, cytosolic;0,00000000000000022300;2,339931155;0,000407219;1,428295571;0,002646102;0,015374349;1,425724401;0,052959853;0;0;NA;NA;NA
X100125293_TGI_at;100125293_TGI_at;NM_002543;OLR1;oxidized low density lipoprotein (lectin-like) receptor 1;0,00000000000000067900;1,513413527;4,90E-05;1,267411993;0,000675058;0,000355178;1,489911846;0,00537129;0;1;U2;U2;U1
X100125301_TGI_at;100125301_TGI_at;NM_001080433;CCDC85A;coiled-coil domain containing 85A;0,00000000422000000000;0,660361322;0,10635186;0,857653776;0,147428836;0,993400377;1,016550241;0,995253159;0;0;NA;NA;NA
X100125321_TGI_at;100125321_TGI_at;NM_032562;PLA2G12B;phospholipase A2, group XIIB;0,00000126000000000000;1,540234455;0,032598151;1,303027419;0,058433727;0,018860805;1,426675884;0,060869395;0;0;NA;NA;NA
X100125335_TGI_at;100125335_TGI_at;NM_014048;MKL2;MKL/myocardin-like 2;0,00000000873000000000;0,797603897;0,002119201;0,900238233;0,00829913;0,197238472;0,933763118;0,324667823;0;0;NA;NA;NA
X100125340_TGI_at;100125340_TGI_at;AM392668;CTSZ;cathepsin Z;0,00000005380000000000;1,324817293;0,031041531;1,119371156;0,056428006;0,003371616;1,467907142;0,019650484;0;0;NA;NA;NA
X100125367_TGI_at;100125367_TGI_at;NM_020223;FAM20C;family with sequence similarity 20, member C;0,00000002370000000000;1,356948191;0,027429566;1,105816538;0,051460022;0,299373904;1,05193225;0,437985516;0;0;NA;NA;NA
X100125374_TGI_at;100125374_TGI_at;NM_005700;DPP3;dipeptidyl-peptidase 3;0,00000000011700000000;1,284044301;0,150191537;1,055636629;0,194717347;0,440813265;1,068481532;0,5787133;0;0;NA;NA;NA
X100125377_TGI_at;100125377_TGI_at;NM_002371;MAL;mal, T-cell differentiation protein;0,00000027200000000000;0,734454085;0,046032072;0,86802788;0,076356855;0,120037886;0,839155937;0,225850617;0;0;NA;NA;NA
X100125379_TGI_at;100125379_TGI_at;DQ893078;TKT;transketolase;0,00000000000020100000;1,283425775;0,020725238;1,114969146;0,042010971;0,000259767;1,332445122;0,004600156;0;1;U2;U1;U1
X100125394_TGI_at;100125394_TGI_at;AK074557;TMED4;transmembrane emp24 protein transport domain containing 4;0,00000000012000000000;0,822357377;0,970300741;1,01411902;0,972715175;0,374422782;0,944804935;0,511473085;0;0;NA;NA;NA
X100125397_TGI_at;100125397_TGI_at;NM_152318;C12orf45;chromosome 12 open reading frame 45;0,00000000064500000000;1,260641521;0,016268394;1,108326021;0,035002026;0,481261259;1,015110688;0,617970134;0;0;NA;NA;NA
X100125405_TGI_at;100125405_TGI_at;AK124913;;;0,00000000464000000000;0,740285465;0,006956535;0,840097251;0,019033032;0,209323164;0,886318077;0,337324278;0;0;NA;NA;NA
X100125423_TGI_at;100125423_TGI_at;NM_001430;EPAS1;endothelial PAS domain protein 1;0,00000000000086300000;0,83213427;0,000422686;0,919608606;0,002708384;0,474091728;0,966187612;0,610566891;0;0;NA;NA;NA
X100125425_TGI_at;100125425_TGI_at;NM_005849;IGSF6;immunoglobulin superfamily, member 6;0,00000000000005240000;1,964949587;1,32E-05;1,451968372;0,000318541;0,000345371;1,608246193;0,005300617;0;1;U2;U2;U1
X100125441_TGI_at;100125441_TGI_at;NM_014844;KIAA0329;KIAA0329;0,00000034300000000000;0,808135401;0,07705074;0,903164811;0,114387165;0,066842161;1,139504905;0,148369342;0;0;NA;NA;NA
X100125468_TGI_at;100125468_TGI_at;NM_002118;HLA-DMB;major histocompatibility complex, class II, DM beta;0,00000000013700000000;1,305246183;0,047390757;1,092826488;0,078088145;0,000747797;1,286210286;0,007913552;0;0;NA;NA;NA
X100125476_TGI_at;100125476_TGI_at;BC047548;KIAA1462;KIAA1462;0,00000000043300000000;0,693943898;0,059125914;0,885155633;0,093139209;0,339979528;0,923297463;0,480593868;0;0;NA;NA;NA
X100125482_TGI_at;100125482_TGI_at;NM_012335;MYO1F;myosin IF;0,00000000995000000000;1,373359575;0,370033643;1,063857963;0,417145307;0,089796347;1,214870588;0,184145191;0;0;NA;NA;NA
X100125483_TGI_at;100125483_TGI_at;BC015852;;;0,00000117000000000000;0,773998125;0,139681718;0,920606227;0,183652827;0,648925345;0,966011682;0,755321916;0;0;NA;NA;NA
X100125484_TGI_at;100125484_TGI_at;NM_000104;CYP1B1;cytochrome P450, family 1, subfamily B, polypeptide 1;0,00000000000000000011;4,526129938;3,33E-10;2,384760502;1,67E-07;0,002812489;1,617255176;0,017739047;0;1;U8;U4;U1
X100125530_TGI_at;100125530_TGI_at;NM_004079;CTSS;cathepsin S;0,00000002240000000000;1,300944185;0,005326341;1,088437206;0,015749355;0,000806993;1,298799982;0,008256949;0;1;U2;U1;U1
X100125536_TGI_at;100125536_TGI_at;NM_032423;ZNF528;zinc finger protein 528;0,00000123000000000000;0,801554342;0,270796715;0,946776254;0,319933216;0,255009933;0,882035123;0,38934013;0;0;NA;NA;NA
X100125547_TGI_at;100125547_TGI_at;BC021982;ZNF780A;zinc finger protein 780A;0,00000000040600000000;1,439859135;0,010859876;1,132699293;0,02611664;0,044349835;1,160558078;0,110207801;0;0;NA;NA;NA
X100125552_TGI_at;100125552_TGI_at;NM_001736;C5AR1;complement component 5a receptor 1;0,00000000000437000000;1,421905726;0,001712667;1,177419794;0,007188327;0,046864607;1,252736677;0,114688405;0;0;NA;NA;NA
X100125568_TGI_at;100125568_TGI_at;NM_002686;PNMT;phenylethanolamine N-methyltransferase;0,00000000002450000000;0,51453933;2,94E-05;0,614479697;0,000491632;0,526346389;0,797732289;0,659403342;0;0;NA;NA;NA
X100125595_TGI_at;100125595_TGI_at;NM_001422;ELF5;E74-like factor 5 (ets domain transcription factor);0,00000000000046600000;2,650147135;0,000261549;1,498478864;0,001951324;0,007144385;1,953260521;0,031892454;0;1;U6;U1;U1
X100125604_TGI_at;100125604_TGI_at;DQ891254;LMAN1;lectin, mannose-binding, 1;0,00000109000000000000;1,288745126;0,027837492;1,207364592;0,052102344;0,927501324;1,015294034;0,959350695;0;0;NA;NA;NA
X100125605_TGI_at;100125605_TGI_at;NM_001793;CDH3;cadherin 3, type 1, P-cadherin (placental);0,00000000595000000000;1,605958938;0,147000756;1,153763796;0,191195899;0,118794011;0,748446072;0,224033409;0;0;NA;NA;NA
X100125608_TGI_at;100125608_TGI_at;NM_053064;GNG2;guanine nucleotide binding protein (G protein), gamma 2;0,00000002560000000000;0,784819332;0,02172816;0,906208192;0,043496808;0,291649909;0,9033268;0,430200301;0;0;NA;NA;NA
X100125612_TGI_at;100125612_TGI_at;AY562243;REEP5;receptor accessory protein 5;0,00000000000082400000;1,280888319;0,000518817;1,13892218;0,003113871;1,18E-05;1,2262631;0,001323039;0;1;U1;U1;U1
X100125626_TGI_at;100125626_TGI_at;AK021874;;;0,00000004570000000000;0,78416916;0,724640666;0,979949038;0,748563098;0,57904816;0,922373134;0,700552635;0;0;NA;NA;NA
X100125641_TGI_at;100125641_TGI_at;ENST00000367554;NPL;N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase);0,00000000001280000000;1,884471607;0,000535197;1,338689083;0,003176686;0,000188734;1,749084027;0,004028419;0;1;U5;U1;U1
X100125654_TGI_at;100125654_TGI_at;NM_080676;MACROD2;MACRO domain containing 2;0,00000007230000000000;1,714000224;0,033532736;1,330317582;0,059447749;0,000203903;1,955774632;0,004159363;0;0;NA;NA;NA
X100125682_TGI_at;100125682_TGI_at;NM_181523;PIK3R1;phosphoinositide-3-kinase, regulatory subunit 1 (alpha);0,00000000168000000000;0,775481591;0,05610208;0,907969265;0,089602083;0,460794302;0,903558963;0,597401462;0;0;NA;NA;NA
X100125698_TGI_at;100125698_TGI_at;AF052941;DAPK2;death-associated protein kinase 2;0,00000009240000000000;0,785689707;0,041724775;0,858076685;0,0706297;0,303779418;1,102211197;0,443625313;0;0;NA;NA;NA
X100125706_TGI_at;100125706_TGI_at;NM_003248;THBS4;thrombospondin 4;0,00000083000000000000;1,560511239;0,00012759;1,494810959;0,001204762;0,967010726;1,04157448;0,980394958;0;0;NA;NA;NA
X100125715_TGI_at;100125715_TGI_at;NM_003122;SPINK1;serine peptidase inhibitor, Kazal type 1;0,00000009910000000000;2,039126014;0,00382748;1,506768437;0,012485798;0,088361143;1,406117603;0,182790733;0;0;NA;NA;NA
X100125723_TGI_at;100125723_TGI_at;ENST00000379842;NEO1;neogenin homolog 1 (chicken);0,00000000422000000000;0,772721414;0,002630126;0,887265161;0,009524601;0,526346389;0,910232852;0,659403342;0;0;NA;NA;NA
X100125740_TGI_at;100125740_TGI_at;NM_015994;ATP6V1D;ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D;0,00000000006570000000;1,273151317;0,166579462;1,03143295;0,212375635;0,08994195;1,067066795;0,184145191;0;0;NA;NA;NA
X100125753_TGI_at;100125753_TGI_at;NM_001937;DPT;dermatopontin;0,00000000000002340000;0,55812193;0,009684986;0,749030955;0,024122649;0,252599303;0,890974435;0,387495266;0;0;NA;NA;NA
X100125792_TGI_at;100125792_TGI_at;NM_007364;TMED3;transmembrane emp24 protein transport domain containing 3;0,00000000000192000000;1,357721611;0,196606479;1,069273869;0,24503584;0,077689446;1,178986244;0,166153341;0;0;NA;NA;NA
X100125798_TGI_at;100125798_TGI_at;NM_002291;LAMB1;laminin, beta 1;0,00000000184000000000;0,763642923;0,000964889;0,8130546;0,004711873;0,026896706;0,79422637;0,078167794;0;0;NA;NA;NA
X100125872_TGI_at;100125872_TGI_at;NM_015035;ZHX3;zinc fingers and homeoboxes 3;0,00000069600000000000;0,829351212;0,020109172;0,909373981;0,041020393;0,089895036;1,108954145;0,184145191;0;0;NA;NA;NA
X100125890_TGI_at;100125890_TGI_at;BQ001967;PSD3;pleckstrin and Sec7 domain containing 3;0,00000005680000000000;1,395228245;0,008207603;1,291637204;0,021454262;0,716662803;1,060196632;0,809321729;0;0;NA;NA;NA
X100125892_TGI_at;100125892_TGI_at;NM_021637;TMEM35;transmembrane protein 35;0,00000017000000000000;0,738785086;0,319186712;0,957371969;0,368063962;0,248075799;0,877847229;0,381463883;0;0;NA;NA;NA
X100125903_TGI_at;100125903_TGI_at;NM_001039960;SLC4A8;solute carrier family 4, sodium bicarbonate cotransporter, member 8;0,00000018200000000000;1,397227429;0,221265922;1,135460226;0,270566211;0,967010726;0,980864746;0,980394958;0;0;NA;NA;NA
X100125915_TGI_at;100125915_TGI_at;AA854847;;;0,00000000000271000000;2,2134609;0,042303005;1,220651926;0,071383552;0,185788694;1,219260618;0,311548887;0;0;NA;NA;NA
X100125955_TGI_at;100125955_TGI_at;NM_020415;RETN;resistin;0,00000000000065700000;1,987164578;0,000570407;1,412845348;0,003330477;0,002409533;1,9097805;0,016145377;0;1;U2;U1;U1
X100125969_TGI_at;100125969_TGI_at;NM_144724;MARVELD2;MARVEL domain containing 2;0,00000029700000000000;0,828258698;0,401327741;0,949131993;0,447336566;0,91436561;1,050423629;0,951873502;0;0;NA;NA;NA
X100126009_TGI_at;100126009_TGI_at;NM_013258;PYCARD;PYD and CARD domain containing;0,00000000042000000000;1,401071275;0,027446409;1,128083957;0,051460022;0,00010495;1,524670044;0,003284032;0;0;NA;NA;NA
X100126021_TGI_at;100126021_TGI_at;DA034095;MCFD2;multiple coagulation factor deficiency 2;0,00000000001020000000;1,333671939;0,012318601;1,138743166;0,028542669;0,793641573;0,962425823;0,870332355;0;0;NA;NA;NA
X100126040_TGI_at;100126040_TGI_at;BE466108;STYX;serine/threonine/tyrosine interacting protein;0,00000000005970000000;1,263312342;2,15E-05;1,175642619;0,000410363;0,045603439;1,084061158;0,112542025;0;0;NA;NA;NA
X100126085_TGI_at;100126085_TGI_at;AK090811;;;0,00000032600000000000;0,832057696;0,752749773;0,983498074;0,774126522;3,58E-05;0,76467136;0,001805101;0;0;NA;NA;NA
X100126092_TGI_at;100126092_TGI_at;NM_182639;HPS1;Hermansky-Pudlak syndrome 1;0,00000000000613000000;1,516331136;0,005320199;1,166831494;0,015749355;0,012656854;1,22302856;0,046447382;0;1;U4;U1;U1
X100126118_TGI_at;100126118_TGI_at;BC072423;SLC1A4;solute carrier family 1 (glutamate/neutral amino acid transporter), member 4;0,00000000815000000000;1,332385104;0,50120118;1,03704905;0,540800603;0,107219939;0,88394751;0,208174617;0;0;NA;NA;NA
X100126132_TGI_at;100126132_TGI_at;AK097371;PTPRB;protein tyrosine phosphatase, receptor type, B;0,00000008800000000000;0,739601023;0,002119201;0,798578075;0,00829913;0,81616847;1,049347916;0,885097907;0;0;NA;NA;NA
X100126133_TGI_at;100126133_TGI_at;ENST00000378092;KCNAB2;potassium voltage-gated channel, shaker-related subfamily, beta member 2;0,00000001560000000000;1,701960804;0,232800597;1,063475743;0,281438981;0,196882599;1,181838937;0,324667823;0;0;NA;NA;NA
X100126137_TGI_at;100126137_TGI_at;NM_014431;KIAA1274;KIAA1274;0,00000004700000000000;0,787450014;0,019807176;0,887465381;0,040583935;0,57904816;0,960479996;0,700552635;0;0;NA;NA;NA
X100126144_TGI_at;100126144_TGI_at;NM_016001;UTP18;UTP18, small subunit (SSU) processome component, homolog (yeast);0,00000000031700000000;1,239049752;0,441064201;1,022765359;0,485336265;0,330381396;1,04576968;0,47157628;0;0;NA;NA;NA
X100126168_TGI_at;100126168_TGI_at;NM_201536;NDRG2;NDRG family member 2;0,00000014900000000000;0,791624335;0,011075532;0,871327367;0,026402691;0,047406807;0,89970495;0,115927269;0;0;NA;NA;NA
X100126186_TGI_at;100126186_TGI_at;NM_014629;ARHGEF10;Rho guanine nucleotide exchange factor (GEF) 10;0,00000000000213000000;0,745958773;0,000291349;0,848012448;0,002077476;0,144787165;0,890655905;0,25853132;0;0;NA;NA;NA
X100126203_TGI_at;100126203_TGI_at;NM_005160;ADRBK2;adrenergic, beta, receptor kinase 2;0,00000029400000000000;1,235515993;0,393848913;1,040545472;0,43999135;0,001127468;1,314559776;0,010122083;0;0;NA;NA;NA
X100126232_TGI_at;100126232_TGI_at;CR936700;VGLL3;vestigial like 3 (Drosophila);0,00000027200000000000;0,728176426;0,009545933;0,85115425;0,023813114;0,086710607;0,802235299;0,179491513;0;0;NA;NA;NA
X100126234_TGI_at;100126234_TGI_at;AI087792;;;0,00000010500000000000;0,648017861;0,277060727;0,867894338;0,326138321;0,556550302;1,034640987;0,68359818;0;0;NA;NA;NA
X100126242_TGI_at;100126242_TGI_at;NM_002747;MAPK4;mitogen-activated protein kinase 4;0,00000000011700000000;0,646938835;0,00080841;0,725146671;0,004236593;0,648925345;1,071982333;0,755321916;0;0;NA;NA;NA
X100126245_TGI_at;100126245_TGI_at;NM_001173;ARHGAP5;Rho GTPase activating protein 5;0,00000032900000000000;0,767961443;0,392976666;0,970091439;0,439169138;0,069432339;0,875200908;0,153169355;0;0;NA;NA;NA
X100126265_TGI_at;100126265_TGI_at;NM_206938;MS4A7;membrane-spanning 4-domains, subfamily A, member 7;0,00000000027400000000;1,381709193;2,83E-06;1,293158443;0,000115604;0,001203889;1,583170485;0,010630505;0;1;U2;U2;U1
X100126281_TGI_at;100126281_TGI_at;NM_001044385;ALS2CR4;amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4;0,00000000000008750000;0,687598673;0,062262892;0,90435929;0,097084325;0,191451954;0,873316685;0,318230865;0;0;NA;NA;NA
X100126295_TGI_at;100126295_TGI_at;NM_004758;BZRAP1;benzodiazapine receptor (peripheral) associated protein 1;0,00000046700000000000;0,782749986;0,008802152;0,862391749;0,022492182;0,018620907;0,796283762;0,060256208;0;0;NA;NA;NA
X100126332_TGI_at;100126332_TGI_at;NM_002863;PYGL;phosphorylase, glycogen, liver;0,00000000021900000000;1,272367153;0,061474491;1,07742299;0,096087432;0,032083057;1,122575578;0,088319445;0;0;NA;NA;NA
X100126342_TGI_at;100126342_TGI_at;NM_001718;BMP6;bone morphogenetic protein 6;0,00000126000000000000;0,666051745;0,134754056;0,866357735;0,17836235;0,601955364;1,083839076;0,718556347;0;0;NA;NA;NA
X100126362_TGI_at;100126362_TGI_at;AJ133133;ENTPD1;ectonucleoside triphosphate diphosphohydrolase 1;0,00000096100000000000;1,316479035;0,011249501;1,175958053;0,026680893;0,26927095;1,106481166;0,405163526;0;0;NA;NA;NA
X100126425_TGI_at;100126425_TGI_at;NM_182925;FLT4;fms-related tyrosine kinase 4;0,00000000054600000000;0,701134122;0,010906918;0,848324247;0,02611664;0,556550302;0,931311774;0,68359818;0;0;NA;NA;NA
X100126476_TGI_at;100126476_TGI_at;NM_181720;ARHGAP30;Rho GTPase activating protein 30;0,00000018800000000000;1,253001621;0,947956231;1,018435835;0,953255133;0,029139344;1,258338141;0,083541684;0;0;NA;NA;NA
X100126501_TGI_at;100126501_TGI_at;NM_032512;PDZD4;PDZ domain containing 4;0,00000000190000000000;0,724186143;0,005906185;0,851436244;0,01680109;0,034281134;0,825773607;0,09276918;0;0;NA;NA;NA
X100126535_TGI_at;100126535_TGI_at;ENST00000238570;PCNX;pecanex homolog (Drosophila);0,00000000004020000000;1,262111654;0,239295578;1,038099927;0,287887139;0,606496763;1,023414259;0,723709391;0;0;NA;NA;NA
X100126546_TGI_at;100126546_TGI_at;NM_032331;ECE2;endothelin converting enzyme 2;0,00000000809000000000;1,337246625;0,223632634;1,075155578;0,272849094;0,059535454;1,19155299;0,137945916;0;0;NA;NA;NA
X100126558_TGI_at;100126558_TGI_at;NM_014899;RHOBTB3;Rho-related BTB domain containing 3;0,00000023000000000000;0,770201237;0,412115853;0,947691745;0,457543711;0,010855277;0,778462594;0,041904859;0;0;NA;NA;NA
X100126576_TGI_at;100126576_TGI_at;BC042008;;hypothetical protein LOC220930;0,00000017000000000000;0,762567529;0,223663452;0,914536269;0,272849094;0,001768621;0,729768182;0,013507735;0;0;NA;NA;NA
X100126584_TGI_at;100126584_TGI_at;NM_020925;CACHD1;cache domain containing 1;0,00000000005420000000;1,276099118;1,55E-05;1,21129624;0,000343627;0,511433257;1,044615176;0,646425302;0;0;NA;NA;NA
X100126595_TGI_at;100126595_TGI_at;AL360134;TRIM22;tripartite motif-containing 22;0,00000000060900000000;1,267388367;0,090581812;1,08904377;0,13033267;0,491673531;1,045693881;0,627589621;0;0;NA;NA;NA
X100126597_TGI_at;100126597_TGI_at;AF498925;GRB2;growth factor receptor-bound protein 2;0,00000106000000000000;1,218882333;0,03877072;1,115325443;0,06685823;0,028121921;1,204552233;0,080853658;0;0;NA;NA;NA
X100126608_TGI_at;100126608_TGI_at;NM_030788;TM7SF4;transmembrane 7 superfamily member 4;0,00000000000000062700;4,147624582;6,61E-08;2,749774492;9,69E-06;0,00023763;2,751740922;0,004452797;0;1;U2;U2;U1
X100126638_TGI_at;100126638_TGI_at;BC013942;;;0,00000063000000000000;1,578607446;0,004595721;1,350820743;0,014256025;0,000371641;1,819945111;0,00537129;0;1;U1;U1;U1
X100126640_TGI_at;100126640_TGI_at;NM_005917;MDH1;malate dehydrogenase 1, NAD (soluble);0,00000034300000000000;1,200523206;0,000165838;1,139568459;0,00141401;0,096726246;1,11564812;0,193392487;0;0;NA;NA;NA
X100126652_TGI_at;100126652_TGI_at;NM_080809;COL13A1;collagen, type XIII, alpha 1;0,00000001320000000000;0,725677224;0,13925074;0,929829027;0,183335431;0,185788694;0,871220183;0,311548887;0;0;NA;NA;NA
X100126696_TGI_at;100126696_TGI_at;AI341167;CD163;CD163 molecule;0,00000001480000000000;1,795221188;0,532147746;1,053638833;0,570373191;0,601955364;1,086548586;0,718556347;0;0;NA;NA;NA
X100126761_TGI_at;100126761_TGI_at;NM_020452;ATP8B2;ATPase, class I, type 8B, member 2;0,00000005380000000000;0,767410451;0,217196261;0,910254022;0,266472611;0,204001167;0,887175096;0,331733482;0;0;NA;NA;NA
X100126838_TGI_at;100126838_TGI_at;NM_001083;PDE5A;phosphodiesterase 5A, cGMP-specific;0,00000000050500000000;0,756744035;0,961520477;1,028461844;0,965414485;0,276598639;0,862443598;0,413486741;0;0;NA;NA;NA
X100126852_TGI_at;100126852_TGI_at;NM_173359;EIF4E3;eukaryotic translation initiation factor 4E family member 3;0,00000001620000000000;0,78902995;0,000940185;0,884674129;0,004645604;0,529200325;1,060958463;0,660834037;0;0;NA;NA;NA
X100126911_TGI_at;100126911_TGI_at;NM_021785;RAI2;retinoic acid induced 2;0,00000000031200000000;0,766987152;0,001041015;0,889407248;0,004941373;0,862086046;0,988829095;0,916392918;0;0;NA;NA;NA
X100126932_TGI_at;100126932_TGI_at;AL080186;SFRS18;splicing factor, arginine/serine-rich 18;0,00000002010000000000;0,752835625;0,687859962;0,99002076;0,716076439;0,069432339;0,868535266;0,153169355;0;0;NA;NA;NA
X100126983_TGI_at;100126983_TGI_at;BQ005994;LAMB1;laminin, beta 1;0,00000069500000000000;0,745023912;0,01145057;0,836851982;0,026977475;0,039719764;0,698468536;0,101661999;0;0;NA;NA;NA
X100126991_TGI_at;100126991_TGI_at;BT007051;CAV2;caveolin 2;0,00000006350000000000;0,765501258;0,979436501;0,998054607;0,98126324;0,114834098;1,192521374;0,21874131;0;0;NA;NA;NA
X100127006_TGI_at;100127006_TGI_at;AY344091;TXNRD1;thioredoxin reductase 1;0,00000000003580000000;1,487096023;0,011237529;1,157792399;0,026680893;0,001660524;1,429034808;0,012896073;0;1;U2;U1;U1
X100127023_TGI_at;100127023_TGI_at;NM_178140;PDZD2;PDZ domain containing 2;0,00000004960000000000;0,787828556;0,81210893;0,979043532;0,829875422;0,033503156;1,165594733;0,091046096;0;0;NA;NA;NA
X100127025_TGI_at;100127025_TGI_at;BX649155;PSIP1;PC4 and SFRS1 interacting protein 1;0,00000000190000000000;0,785583277;0,318678863;0,964340647;0,367741487;0,00200392;0,818669382;0,01464543;0;0;NA;NA;NA
X100127039_TGI_at;100127039_TGI_at;NM_003332;TYROBP;TYRO protein tyrosine kinase binding protein;0,00000000000777000000;1,374608562;0,001194874;1,143942873;0,005447071;1,09E-05;1,457441249;0,001306304;0;1;U5;U2;U1
X100127045_TGI_at;100127045_TGI_at;NM_000167;GK;glycerol kinase;0,00000003040000000000;1,448271126;0,005857073;1,195815895;0,016676101;0,122857837;1,216394588;0,229149774;0;0;NA;NA;NA
X100127090_TGI_at;100127090_TGI_at;ENST00000370361;;hypothetical protein LOC203547;0,00000000343000000000;1,344508121;0,263322834;1,07246656;0,312596318;0,120226931;1,16405129;0,226074328;0;0;NA;NA;NA
X100127124_TGI_at;100127124_TGI_at;NM_207481;;Nck-associated protein 5;0,00000000667000000000;0,678358782;0,655404503;0,919267138;0,68672585;0,039046711;1,515274179;0,101245011;0;0;NA;NA;NA
X100127178_TGI_at;100127178_TGI_at;BX644237;;;0,00000010200000000000;0,748099518;0,158399335;0,876062;0,203638236;0,623344939;0,895925492;0,736451884;0;0;NA;NA;NA
X100127179_TGI_at;100127179_TGI_at;NM_005787;ALG3;asparagine-linked glycosylation 3 homolog (S. cerevisiae, alpha-1,3-mannosyltransferase);0,00000008490000000000;1,270074691;0,160750194;1,045538295;0,206249154;0,526346389;1,057388185;0,659403342;0;0;NA;NA;NA
X100127198_TGI_at;100127198_TGI_at;NM_020381;PDSS2;prenyl (decaprenyl) diphosphate synthase, subunit 2;0,00000000037600000000;1,255740607;0,002764239;1,0826183;0,009844355;0,506743264;1,006822303;0,641830435;0;0;NA;NA;NA
X100127265_TGI_at;100127265_TGI_at;NM_153702;ELMOD2;ELMO/CED-12 domain containing 2;0,00000026800000000000;1,38560562;0,076106704;1,118353433;0,113351158;0,819786989;1,001056866;0,887827105;0;0;NA;NA;NA
X100127301_TGI_at;100127301_TGI_at;AI128130;;;0,00000000792000000000;0,596835911;0,042887999;0,780682642;0,07214406;0,348497017;0,881952696;0,486868611;0;0;NA;NA;NA
X100127305_TGI_at;100127305_TGI_at;AK022042;SLC28A3;solute carrier family 28 (sodium-coupled nucleoside transporter), member 3;0,00000000001100000000;2,221996912;6,43E-08;2,378791754;9,69E-06;0,979808692;0,992503134;0,987556719;0;0;NA;NA;NA
X100127321_TGI_at;100127321_TGI_at;NM_016588;NRN1;neuritin 1;0,00000000000087500000;0,656540939;0,027216682;0,881420254;0,051218159;0,784830893;1,017611449;0,861549716;0;0;NA;NA;NA
X100127385_TGI_at;100127385_TGI_at;BM705209;;;0,00000076900000000000;1,321128134;0,306580596;1,095087842;0,355562886;0,034281134;1,360717439;0,09276918;0;0;NA;NA;NA
X100127386_TGI_at;100127386_TGI_at;NM_002725;PRELP;proline/arginine-rich end leucine-rich repeat protein;0,00000028600000000000;0,705113735;0,447887452;0,919742577;0,490666641;0,493698061;0,996017968;0,628679909;0;0;NA;NA;NA
X100127463_TGI_at;100127463_TGI_at;AF063657;FLT1;fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);0,00000000069800000000;0,754908757;4,43E-05;0,771083147;0,000631699;0,350421333;0,927512844;0,489132939;0;0;NA;NA;NA
X100127469_TGI_at;100127469_TGI_at;NM_003238;TGFB2;transforming growth factor, beta 2;0,00000001950000000000;0,747349354;0,035393331;0,872545075;0,062368892;0,402347064;0,901070484;0,542112532;0;0;NA;NA;NA
X100127479_TGI_at;100127479_TGI_at;DC343925;MRPS15;mitochondrial ribosomal protein S15;0,00000003040000000000;1,302877689;0,024931798;1,082079173;0,048059321;0,002886902;1,227808596;0,017893238;0;1;U4;U1;U1
X100127490_TGI_at;100127490_TGI_at;NM_018992;KCTD5;potassium channel tetramerisation domain containing 5;0,00000000004700000000;1,268127856;0,00020789;1,175292131;0,001666738;0,055034692;1,171060619;0,12937769;0;0;NA;NA;NA
X100127506_TGI_at;100127506_TGI_at;AF131214;SNX9;sorting nexin 9;0,00000120000000000000;1,316962993;0,13209773;1,082340692;0,175784882;0,91436561;1,019721895;0,951873502;0;0;NA;NA;NA
X100127543_TGI_at;100127543_TGI_at;AK091057;;hypothetical protein LOC285535;0,00000062800000000000;0,791372574;0,680711217;0,993071225;0,709092518;0,043170182;0,837609391;0,107774978;0;0;NA;NA;NA
X100127552_TGI_at;100127552_TGI_at;ENST00000254898;MATN2;matrilin 2;0,00000001150000000000;0,695505801;0,370033643;0,914363054;0,417145307;0,660894461;0,894059004;0,764285198;0;0;NA;NA;NA
X100127559_TGI_at;100127559_TGI_at;AY344083;TXNRD1;thioredoxin reductase 1;0,00000000004520000000;1,45509599;0,018405177;1,132724819;0,038246218;0,000495904;1,319927404;0,006356879;0;1;U2;U1;U1
X100127560_TGI_at;100127560_TGI_at;BG498372;;;0,00000000000000013800;2,065206943;6,93E-07;1,693970218;5,20E-05;0,005306726;1,419292526;0,025993282;0;1;U5;U2;U1
X100127567_TGI_at;100127567_TGI_at;NM_001080410;FBXO41;F-box protein 41;0,00000075200000000000;1,257705803;0,067309469;1,131444804;0,103451797;0,648925345;1,044497639;0,755321916;0;0;NA;NA;NA
X100127581_TGI_at;100127581_TGI_at;AF086441;C21orf71;chromosome 21 open reading frame 71;0,00000029400000000000;0,800865771;0,000836876;0,862030543;0,004336418;0,856524137;0,953351242;0,913191298;0;0;NA;NA;NA
X100127614_TGI_at;100127614_TGI_at;NM_000521;HEXB;hexosaminidase B (beta polypeptide);0,00000000000011800000;1,442905037;2,64E-06;1,210556893;0,000115604;0,000137814;1,336553853;0,003701458;0;1;U2;U2;U1
X100127618_TGI_at;100127618_TGI_at;BC053553;NET1;neuroepithelial cell transforming 1;0,00000016100000000000;0,799120144;0,599565062;0,963499703;0,633780975;0,011395566;0,778298932;0,043251869;0;0;NA;NA;NA
X100127633_TGI_at;100127633_TGI_at;ENST00000378047;FGF1;fibroblast growth factor 1 (acidic);0,00000000448000000000;0,624438251;0,044206554;0,843001222;0,073860924;0,006670412;0,660555865;0,030279914;0;0;NA;NA;NA
X100127645_TGI_at;100127645_TGI_at;NM_004172;SLC1A3;solute carrier family 1 (glial high affinity glutamate transporter), member 3;0,00000000028100000000;1,744993844;0,248432889;1,10114887;0,297436554;0,209185181;1,189910627;0,337324278;0;0;NA;NA;NA
X100127703_TGI_at;100127703_TGI_at;ENST00000368682;FYN;FYN oncogene related to SRC, FGR, YES;0,00000000037600000000;0,719327136;0,091631188;0,903854396;0,131431829;0,512848122;1,084166418;0,646425302;0;0;NA;NA;NA
X100127714_TGI_at;100127714_TGI_at;NM_031426;AIF1L;allograft inflammatory factor 1-like;0,00000000000950000000;0,666593874;4,77E-05;0,772563516;0,000659239;0,235851277;0,822352035;0,368289083;0;0;NA;NA;NA
X100127746_TGI_at;100127746_TGI_at;AK023435;GVIN1;GTPase, very large interferon inducible 1;0,00000001800000000000;0,757440151;0,074386478;0,90054254;0,111406886;0,611187453;1,044652678;0,727019861;0;0;NA;NA;NA
X100127800_TGI_at;100127800_TGI_at;NM_020465;NDRG4;NDRG family member 4;0,00000002250000000000;0,699503366;0,000878456;0,742832343;0,004481384;0,772133359;1,015386405;0,852547385;0;0;NA;NA;NA
X100127826_TGI_at;100127826_TGI_at;AK025611;CCDC93;coiled-coil domain containing 93;0,00000000017700000000;1,67830811;0,005599921;1,167573551;0,016290801;0,331593893;0,893771095;0,472261209;0;0;NA;NA;NA
X100127847_TGI_at;100127847_TGI_at;NM_002020;FLT4;fms-related tyrosine kinase 4;0,00000012400000000000;0,693463817;0,026841265;0,830880346;0,050619894;0,888166261;1,000740912;0,935477078;0;0;NA;NA;NA
X100127892_TGI_at;100127892_TGI_at;ENST00000371276;TTC22;tetratricopeptide repeat domain 22;0,00000047700000000000;0,807971878;0,103678413;0,933273458;0,14471872;0,552010088;0,982128344;0,680615346;0;0;NA;NA;NA
X100127902_TGI_at;100127902_TGI_at;NM_001001290;SLC2A9;solute carrier family 2 (facilitated glucose transporter), member 9;0,00000000000021300000;1,792066587;2,40E-07;1,358818791;2,75E-05;0,001003293;1,380482697;0,009400035;0;1;U4;U1;U1
X100127955_TGI_at;100127955_TGI_at;N94992;ABI2;abl interactor 2;0,00000013500000000000;0,766311172;0,929255278;0,967881778;0,9359343;0,704079782;1,079438254;0,801288537;0;0;NA;NA;NA
X100127992_TGI_at;100127992_TGI_at;NM_032539;SLITRK2;SLIT and NTRK-like family, member 2;0,00000000000000051500;0,338937077;7,59E-06;0,554533678;0,000239953;0,052890615;0,661705521;0,126177982;0;0;NA;NA;NA
X100128015_TGI_at;100128015_TGI_at;NM_020957;PCDHB16;protocadherin beta 16;0,00000035200000000000;0,737896392;0,861315541;0,977928716;0,873236863;0,159283623;0,787755431;0,276600817;0;0;NA;NA;NA
X100128031_TGI_at;100128031_TGI_at;NM_003099;SNX1;sorting nexin 1;0,00000000000088500000;0,767902685;0,279577061;0,969461271;0,328380783;0,422282974;0,961004255;0,560904521;0;0;NA;NA;NA
X100128053_TGI_at;100128053_TGI_at;NM_021998;ZNF711;zinc finger protein 711;0,00000000420000000000;0,685599552;0,130370441;0,909588833;0,17406128;0,003250241;0,639340252;0,019115922;0;0;NA;NA;NA
X100128073_TGI_at;100128073_TGI_at;NM_003649;DDO;D-aspartate oxidase;0,00000000227000000000;1,520638907;0,019487139;1,205708449;0,04012637;0,001127468;1,408275695;0,010122083;0;1;U1;U1;U1
X100128088_TGI_at;100128088_TGI_at;NM_032918;RERG;RAS-like, estrogen-regulated, growth inhibitor;0,00000000848000000000;0,746460486;0,327348403;0,950617936;0,375326896;0,235851277;0,925361708;0,368289083;0;0;NA;NA;NA
X100128092_TGI_at;100128092_TGI_at;BC002326;MAPKAP1;mitogen-activated protein kinase associated protein 1;0,00000000005590000000;1,298395008;0,042303005;1,079929569;0,071383552;0,001710443;1,250334207;0,013125611;0;0;NA;NA;NA
X100128096_TGI_at;100128096_TGI_at;NM_000434;NEU1;sialidase 1 (lysosomal sialidase);0,00000000002500000000;1,290846887;0,00260307;1,144983372;0,009458504;5,09E-05;1,36339626;0,002079933;0;1;U1;U1;U2
X100128113_TGI_at;100128113_TGI_at;AW975990;ZNF704;zinc finger protein 704;0,00000123000000000000;0,769294622;0,772184822;0,992513539;0,792596077;0,402475181;1,115495855;0,542112532;0;0;NA;NA;NA
X100128132_TGI_at;100128132_TGI_at;NM_020190;OLFML3;olfactomedin-like 3;0,00000063000000000000;0,810446798;0,427597909;0,962609213;0,472615934;0,875109546;0,987596079;0,925961283;0;0;NA;NA;NA
X100128138_TGI_at;100128138_TGI_at;NM_058164;OLFM2;olfactomedin 2;0,00000000693000000000;1,628586024;5,38E-05;1,437405047;0,000715495;0,003446716;1,505893473;0,019661534;0;1;U1;U2;U1
X100128142_TGI_at;100128142_TGI_at;BC007710;SSR1;signal sequence receptor, alpha;0,00000000034900000000;1,318539592;0,070567589;1,062000706;0,107492378;0,709599351;1,041352701;0,803597578;0;0;NA;NA;NA
X100128157_TGI_at;100128157_TGI_at;NM_020421;ADCK1;aarF domain containing kinase 1;0,00000000505000000000;1,354674715;0,239165346;1,071999171;0,287837906;0,940656418;1,032787066;0,965520903;0;0;NA;NA;NA
X100128161_TGI_at;100128161_TGI_at;NM_005041;PRF1;perforin 1 (pore forming protein);0,00000032000000000000;0,724898342;0,263325785;0,923946084;0,312596318;0,611187453;0,97936268;0,727019861;0;0;NA;NA;NA
X100128192_TGI_at;100128192_TGI_at;NM_001100912;BEND7;BEN domain containing 7;0,00000001800000000000;0,799364592;0,066390252;0,913452739;0,102577076;0,291649909;0,93433457;0,430200301;0;0;NA;NA;NA
X100128198_TGI_at;100128198_TGI_at;NM_019055;ROBO4;roundabout homolog 4, magic roundabout (Drosophila);0,00000038300000000000;0,768066848;0,004916765;0,826491062;0,01494975;0,059459202;0,794792031;0,137945916;0;0;NA;NA;NA
X100128206_TGI_at;100128206_TGI_at;ENST00000333209;GPRIN3;GPRIN family member 3;0,00000000000000287000;1,861253018;2,58E-05;1,414748582;0,000460173;0,002195888;1,389198591;0,015318934;0;1;U8;U2;U1
X100128220_TGI_at;100128220_TGI_at;AK094703;LPHN3;latrophilin 3;0,00000050500000000000;0,639688378;0,347540305;0,902219711;0,394826366;0,534478464;0,910808294;0,664336324;0;0;NA;NA;NA
X100128223_TGI_at;100128223_TGI_at;NM_182947;;RhoA/RAC/CDC42 exchange factor;0,00000000164000000000;0,735572621;0,026274021;0,865468132;0,049929935;0,075602991;0,838211349;0,163426183;0;0;NA;NA;NA
X100128228_TGI_at;100128228_TGI_at;NM_004271;LY86;lymphocyte antigen 86;0,00000000006570000000;1,588822862;4,21E-05;1,375664875;0,000609621;3,34E-06;1,717171832;0,000832852;0;1;U3;U1;U1
X100128246_TGI_at;100128246_TGI_at;NM_177444;PPFIBP1;PTPRF interacting protein, binding protein 1 (liprin beta 1);0,00000007230000000000;0,745132312;0,002206741;0,873103089;0,008517757;0,203149235;0,905690938;0,330514884;0;0;NA;NA;NA
X100128247_TGI_at;100128247_TGI_at;AY426759;CLEC12A;C-type lectin domain family 12, member A;0,00000000001540000000;2,007200019;0,002115417;1,428412543;0,00829913;0,01262694;1,514882836;0,046447382;0;1;U2;U1;U1
X100128252_TGI_at;100128252_TGI_at;AL109691;;;0,00000091500000000000;1,296825148;0,015166146;1,199885842;0,033184309;0,093170847;1,269207317;0,188856657;0;0;NA;NA;NA
X100128253_TGI_at;100128253_TGI_at;NM_001039847;GPX4;glutathione peroxidase 4 (phospholipid hydroperoxidase);0,00000000234000000000;1,232988607;0,05989;1,058119936;0,094117683;0,00919586;1,248735691;0,038004115;0;0;NA;NA;NA
X100128259_TGI_at;100128259_TGI_at;AK075203;UBASH3B;ubiquitin associated and SH3 domain containing, B;0,00000000000162000000;2,237374356;9,17E-06;1,699732198;0,000259388;2,53E-06;2,285708709;0,000740535;1;1;U4;U2;U1
X100128300_TGI_at;100128300_TGI_at;NM_152637;METTL7B;methyltransferase like 7B;0,00000001780000000000;1,706409331;0,022744481;1,241982742;0,04508331;0,083615947;1,360401532;0,17510994;0;0;NA;NA;NA
X100128312_TGI_at;100128312_TGI_at;NM_005720;ARPC1B;actin related protein 2/3 complex, subunit 1B, 41kDa;0,00000040200000000000;1,204256627;0,680700863;1,015407058;0,709092518;0,004654763;1,213255096;0,023927113;0;0;NA;NA;NA
X100128316_TGI_at;100128316_TGI_at;AL579340;VPS33A;vacuolar protein sorting 33 homolog A (S. cerevisiae);0,00000003580000000000;1,229139622;0,023012864;1,111123931;0,045364196;0,023487994;1,204257488;0,070485851;0;0;NA;NA;NA
X100128320_TGI_at;100128320_TGI_at;NM_018099;FAR2;fatty acyl CoA reductase 2;0,00000000567000000000;1,519560226;0,015307647;1,218258189;0,033425844;0,021756187;1,394912766;0,067164932;0;0;NA;NA;NA
X100128350_TGI_at;100128350_TGI_at;N66243;;;0,00000013900000000000;0,727784706;0,067175755;0,874726107;0,103447061;0,132322651;0,84589285;0,242040809;0;0;NA;NA;NA
X100128370_TGI_at;100128370_TGI_at;NM_017923;01/mar;membrane-associated ring finger (C3HC4) 1;0,00000001510000000000;1,512393787;0,00389894;1,281998447;0,012604096;0,011420211;1,403014697;0,043251869;0;1;U2;U1;U1
X100128379_TGI_at;100128379_TGI_at;BU571191;;;0,00000004330000000000;0,738004502;0,484590791;0,925895425;0,525693746;0,057249107;0,790135762;0,133608886;0;0;NA;NA;NA
X100128400_TGI_at;100128400_TGI_at;NM_032683;;hypothetical protein MGC12972;0,00000006100000000000;1,276247231;0,857414887;0,996107552;0,870103332;0,365926162;1,071302087;0,503363219;0;0;NA;NA;NA
X100128411_TGI_at;100128411_TGI_at;NM_004104;FASN;fatty acid synthase;0,00000000000635000000;1,37347446;0,028051873;1,136957412;0,052351584;0,001558392;1,453229018;0,012371173;0;0;NA;NA;NA
X100128418_TGI_at;100128418_TGI_at;AL833212;;hypothetical protein LOC286191;0,00000024500000000000;0,747283754;0,004342205;0,843735503;0,013640279;0,009303521;0,740834098;0,038004115;0;1;D2;D1;D1
X100128435_TGI_at;100128435_TGI_at;BC026299;;;0,00000000549000000000;1,365655196;0,091296611;1,105731249;0,131185456;0,003797214;1,478497867;0,021100725;0;0;NA;NA;NA
X100128438_TGI_at;100128438_TGI_at;AK223417;ME1;malic enzyme 1, NADP(+)-dependent, cytosolic;0,00000001350000000000;1,392692888;0,002352669;1,258617657;0,008827302;0,083538037;1,260994972;0,17510994;0;0;NA;NA;NA
X100128449_TGI_at;100128449_TGI_at;NM_023926;ZSCAN18;zinc finger and SCAN domain containing 18;0,00000001810000000000;0,788725128;0,00478784;0,874650018;0,014585264;0,152409103;0,913141672;0,268716924;0;0;NA;NA;NA
X100128458_TGI_at;100128458_TGI_at;NM_001085423;C17orf60;chromosome 17 open reading frame 60;0,00000000008210000000;1,576106061;0,265249548;1,091231184;0,314532485;0,010855277;1,322418794;0,041904859;0;0;NA;NA;NA
X100128523_TGI_at;100128523_TGI_at;AK225124;GALNT6;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6);0,00000000397000000000;1,581405117;0,155076368;1,161085978;0,200084522;0,149505026;1,175628667;0,264174725;0;0;NA;NA;NA
X100128527_TGI_at;100128527_TGI_at;AK024964;NFIA;nuclear factor I/A;0,00000000021500000000;0,832318328;0,090534847;0,93043563;0,13033267;0,870075594;0,977635687;0,924580824;0;0;NA;NA;NA
X100128592_TGI_at;100128592_TGI_at;NM_015144;ZCCHC14;zinc finger, CCHC domain containing 14;0,00000000003020000000;0,819248151;0,327348403;0,975485965;0,375326896;0,299373904;0,937544596;0,437985516;0;0;NA;NA;NA
X100128601_TGI_at;100128601_TGI_at;NM_018125;ARHGEF10L;Rho guanine nucleotide exchange factor (GEF) 10-like;0,00000000030900000000;1,368477373;0,10333299;1,092615033;0,144549578;0,37483693;1,099890618;0,511473085;0;0;NA;NA;NA
X100128635_TGI_at;100128635_TGI_at;NM_001003792;RBMS3;RNA binding motif, single stranded interacting protein;0,00000001180000000000;0,785418296;0,00542123;0,87617537;0,015927644;0,149505026;0,900186907;0,264174725;0;0;NA;NA;NA
X100128639_TGI_at;100128639_TGI_at;BG716691;MACF1;microtubule-actin crosslinking factor 1;0,00000000000410000000;0,775027553;0,013452035;0,918766636;0,030302638;0,823248705;0,997177476;0,88918585;0;0;NA;NA;NA
X100128644_TGI_at;100128644_TGI_at;NM_002423;MMP7;matrix metallopeptidase 7 (matrilysin, uterine);0,00000106000000000000;1,66655458;0,000836876;1,57975112;0,004336418;0,036535061;1,613543761;0,096439395;0;0;NA;NA;NA
X100128713_TGI_at;100128713_TGI_at;NM_004957;FPGS;folylpolyglutamate synthase;0,00000000089200000000;1,249774826;0,344915099;1,040102882;0,392397233;0,144787165;1,093436019;0,25853132;0;0;NA;NA;NA
X100128729_TGI_at;100128729_TGI_at;NM_001042472;ABHD12;abhydrolase domain containing 12;0,00000000000005640000;1,504635811;0,00097408;1,164947714;0,004742384;0,002645386;1,327635675;0,017224404;0;1;U5;U1;U1
X100128750_TGI_at;100128750_TGI_at;ENST00000323669;DDHD1;DDHD domain containing 1;0,00000000008220000000;1,452525396;2,60E-06;1,328892207;0,000115604;0,038082294;1,335852781;0,099545202;0;0;NA;NA;NA
X100128767_TGI_at;100128767_TGI_at;NM_000066;C8B;complement component 8, beta polypeptide;0,00000000995000000000;0,446808401;0,025892963;0,688190419;0,049468299;0,590451681;0,911604985;0,709819384;0;0;NA;NA;NA
X100128782_TGI_at;100128782_TGI_at;BM981759;OTUD7B;OTU domain containing 7B;0,00000000214000000000;0,81687973;0,05989;0,917798145;0,094117683;0,583057317;0,999883468;0,704873868;0;0;NA;NA;NA
X100128791_TGI_at;100128791_TGI_at;BC014528;ASB1;ankyrin repeat and SOCS box-containing 1;0,00000000995000000000;1,250766481;0,489692738;1,040671559;0,530335919;0,221636126;1,059449806;0,351888292;0;0;NA;NA;NA
X100128795_TGI_at;100128795_TGI_at;NM_018660;ZNF395;zinc finger protein 395;0,00000000297000000000;0,821254966;0,023356949;0,91335164;0,045707011;0,122857837;0,913684139;0,229149774;0;0;NA;NA;NA
X100128796_TGI_at;100128796_TGI_at;NM_020335;VANGL2;vang-like 2 (van gogh, Drosophila);0,00000001360000000000;0,74819871;0,584873976;0,973981138;0,619267025;0,029393816;0,826046757;0,083541684;0;0;NA;NA;NA
X100128799_TGI_at;100128799_TGI_at;NM_031471;FERMT3;fermitin family homolog 3 (Drosophila);0,00000000008480000000;1,479184499;0,004102979;1,152274712;0,013054196;0,000446526;1,348907433;0,006049403;0;1;U1;U1;U1
X100128852_TGI_at;100128852_TGI_at;NM_006675;TSPAN9;tetraspanin 9;0,00000000002710000000;0,761151249;0,001850312;0,863439772;0,007561703;0,200000657;0,928131027;0,328951158;0;0;NA;NA;NA
X100128891_TGI_at;100128891_TGI_at;NM_003304;TRPC1;transient receptor potential cation channel, subfamily C, member 1;0,00000000025000000000;0,713615132;0,221471345;0,961857541;0,270584588;0,032083057;0,767327455;0,088319445;0;0;NA;NA;NA
X100128911_TGI_at;100128911_TGI_at;AA772427;GRK5;G protein-coupled receptor kinase 5;0,00000040000000000000;0,786133305;0,103915228;0,918641904;0,14473586;0,054500465;1,254560226;0,128784177;0;0;NA;NA;NA
X100128941_TGI_at;100128941_TGI_at;NM_173502;PRSS36;protease, serine, 36;0,00000000115000000000;1,341318802;0,424269133;1,038055393;0,46925855;0,01262694;1,220928328;0,046447382;0;0;NA;NA;NA
X100128943_TGI_at;100128943_TGI_at;NM_031941;USHBP1;Usher syndrome 1C binding protein 1;0,00000001230000000000;0,682146241;0,001151774;0,766922222;0,005338446;0,772133359;0,996969179;0,852547385;0;0;NA;NA;NA
X100128959_TGI_at;100128959_TGI_at;DQ892055;DPT;dermatopontin;0,00000000010300000000;0,594628193;0,373099534;0,837905659;0,420307514;0,515167818;0,906151179;0,649064713;0;0;NA;NA;NA
X100128990_TGI_at;100128990_TGI_at;NM_002560;P2RX4;purinergic receptor P2X, ligand-gated ion channel, 4;0,00000000033900000000;1,360342609;0,584873976;1,039293013;0,619267025;0,023487994;1,233324021;0,070485851;0;0;NA;NA;NA
X100129003_TGI_at;100129003_TGI_at;NM_198471;KANK3;KN motif and ankyrin repeat domains 3;0,00000000000792000000;0,670528153;0,000169682;0,789782006;0,001435503;0,039901467;0,823016539;0,101661999;0;0;NA;NA;NA
X100129016_TGI_at;100129016_TGI_at;NM_004846;EIF4E2;eukaryotic translation initiation factor 4E family member 2;0,00000000133000000000;1,228942602;0,013019646;1,072777975;0,029735334;0,015517157;1,143009079;0,052959853;0;0;NA;NA;NA
X100129043_TGI_at;100129043_TGI_at;NM_002990;CCL22;chemokine (C-C motif) ligand 22;0,00000000000117000000;2,0156428;0,002156011;1,457876777;0,008418916;0,011460375;1,466396606;0,04335304;0;1;U2;U1;U1
X100129078_TGI_at;100129078_TGI_at;NM_001449;FHL1;four and a half LIM domains 1;0,00000027900000000000;0,81409521;0,341639607;0,966707747;0,389948125;0,096726005;0,920521122;0,193392487;0;0;NA;NA;NA
X100129095_TGI_at;100129095_TGI_at;NM_148957;TNFRSF19;tumor necrosis factor receptor superfamily, member 19;0,00000000288000000000;0,668452027;0,013452035;0,830962395;0,030302638;0,016136566;0,769073972;0,054745423;0;0;NA;NA;NA
X100129120_TGI_at;100129120_TGI_at;NM_003234;TFRC;transferrin receptor (p90, CD71);0,00000001610000000000;1,418223423;1,55E-05;1,266386941;0,000343627;0,010806794;1,342552048;0,041904859;0;1;U2;U3;U1
X100129132_TGI_at;100129132_TGI_at;BM679607;TRMT6;tRNA methyltransferase 6 homolog (S. cerevisiae);0,00000026000000000000;1,297588459;0,13209773;1,091118683;0,175784882;0,159283623;1,195079324;0,276600817;0;0;NA;NA;NA
X100129151_TGI_at;100129151_TGI_at;NM_012484;HMMR;hyaluronan-mediated motility receptor (RHAMM);0,00000101000000000000;1,585454667;0,038556734;1,284966711;0,066524815;0,16275398;1,095890241;0,281112582;0;0;NA;NA;NA
X100129173_TGI_at;100129173_TGI_at;NM_014614;PSME4;proteasome (prosome, macropain) activator subunit 4;0,00000000076500000000;1,241698172;0,009104568;1,079113064;0,023054415;0,440813265;1,046003864;0,5787133;0;0;NA;NA;NA
X100129176_TGI_at;100129176_TGI_at;AK226124;CTNND2;catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein);0,00000000000558000000;0,586486528;0,151032647;0,844246056;0,19565041;0,096726246;1,368513497;0,193392487;0;0;NA;NA;NA
X100129180_TGI_at;100129180_TGI_at;NM_145871;GSTZ1;glutathione transferase zeta 1;0,00000002580000000000;1,249155514;0,167985773;1,07814039;0,213745814;0,011420211;1,17868752;0,043251869;0;0;NA;NA;NA
X100129197_TGI_at;100129197_TGI_at;NM_052839;PANX2;pannexin 2;0,00000000006140000000;1,645807795;0,00314995;1,252370646;0,010858063;0,010855277;1,226222463;0,041904859;0;1;U1;U1;U1
X100129200_TGI_at;100129200_TGI_at;NM_021146;ANGPTL7;angiopoietin-like 7;0,00000000000753000000;0,563296749;0,004961603;0,759285007;0,015057672;0,115439964;0,85793138;0,219635776;0;0;NA;NA;NA
X100129230_TGI_at;100129230_TGI_at;NM_018212;ENAH;enabled homolog (Drosophila);0,00000000002400000000;0,753429813;0,002804499;0,850743859;0,009954736;0,57904816;0,929512577;0,700552635;0;0;NA;NA;NA
X100129234_TGI_at;100129234_TGI_at;AI822141;CCBE1;collagen and calcium binding EGF domains 1;0,00000016400000000000;0,731571451;0,041724775;0,792521167;0,0706297;0,093170847;1,290836838;0,188856657;0;0;NA;NA;NA
X100129242_TGI_at;100129242_TGI_at;BC111089;;;0,00000000016000000000;1,514668238;0,024347842;1,148543463;0,047301444;0,009303521;1,288321066;0,038004115;0;1;U2;U1;U1
X100129257_TGI_at;100129257_TGI_at;NM_080725;SRXN1;sulfiredoxin 1 homolog (S. cerevisiae);0,00000005160000000000;1,35514969;0,002033673;1,192009438;0,008096077;0,001284943;1,32701812;0,011043654;0;1;U1;U1;U1
X100129261_TGI_at;100129261_TGI_at;ENST00000375250;ARHGAP12;Rho GTPase activating protein 12;0,00000120000000000000;0,799138675;0,716067694;0,978743834;0,740656668;0,031382101;0,882731226;0,087495254;0;0;NA;NA;NA
X100129264_TGI_at;100129264_TGI_at;CN292360;FAM89A;family with sequence similarity 89, member A;0,00000000054200000000;1,461475867;0,012813633;1,195602484;0,029356114;0,017119128;1,333406183;0,056940092;0;0;NA;NA;NA
X100129269_TGI_at;100129269_TGI_at;BC101550;TPRG1;tumor protein p63 regulated 1;0,00000000003440000000;1,398526183;1,36E-06;1,345290135;7,66E-05;0,106626206;1,12170542;0,208174617;0;0;NA;NA;NA
X100129292_TGI_at;100129292_TGI_at;NM_007113;TCHH;trichohyalin;0,00000007660000000000;1,531243716;1,05E-06;1,511201601;6,67E-05;0,780651618;1,032542044;0,859890692;0;0;NA;NA;NA
X100129302_TGI_at;100129302_TGI_at;AK023266;MOBKL2B;MOB1, Mps One Binder kinase activator-like 2B (yeast);0,00000000000562000000;1,429270552;0,003717817;1,234331266;0,012227066;0,010855277;1,236864214;0,041904859;0;1;U2;U1;U1
X100129312_TGI_at;100129312_TGI_at;NM_003637;ITGA10;integrin, alpha 10;0,00000000000536000000;0,60461502;0,000589932;0,738463656;0,003413558;0,039046711;0,673012737;0,101245011;0;0;NA;NA;NA
X100129324_TGI_at;100129324_TGI_at;NM_053054;CATSPER1;cation channel, sperm associated 1;0,00000000000015800000;1,747893139;0,000316514;1,335277853;0,002193817;0,002062001;1,457472367;0,014968787;0;1;U1;U1;U1
X100129328_TGI_at;100129328_TGI_at;NM_031301;APH1B;anterior pharynx defective 1 homolog B (C. elegans);0,00000000000002790000;1,395866428;0,013921454;1,08218492;0,031051104;7,79E-05;1,274342597;0,002727399;0;1;U6;U1;U1
X100129335_TGI_at;100129335_TGI_at;BX103595;ITPR2;inositol 1,4,5-triphosphate receptor, type 2;0,00000000000038800000;3,546514912;2,39E-08;2,785108277;5,14E-06;0,005891727;1,624916883;0,027802396;0;1;U1;U2;U1
X100129344_TGI_at;100129344_TGI_at;NM_000577;IL1RN;interleukin 1 receptor antagonist;0,00000000296000000000;1,763554911;0,087025521;1,215680742;0,126286922;0,003446716;1,651056834;0,019661534;0;0;NA;NA;NA
X100129357_TGI_at;100129357_TGI_at;NM_003982;SLC7A7;solute carrier family 7 (cationic amino acid transporter, y+ system), member 7;0,00000000000258000000;1,356462749;0,069359792;1,103150767;0,10594626;0,001950454;1,362520322;0,014451293;0;0;NA;NA;NA
X100129366_TGI_at;100129366_TGI_at;NM_020813;ZNF471;zinc finger protein 471;0,00000007230000000000;0,763974373;0,006722851;0,857022859;0,01856705;0,032083057;0,837232886;0,088319445;0;0;NA;NA;NA
X100129372_TGI_at;100129372_TGI_at;NM_197948;CLEC7A;C-type lectin domain family 7, member A;0,00000000000262000000;1,351983423;0,030634664;1,120772581;0,05590913;0,010855277;1,266393266;0,041904859;0;0;NA;NA;NA
X100129373_TGI_at;100129373_TGI_at;NM_000499;CYP1A1;cytochrome P450, family 1, subfamily A, polypeptide 1;0,00000000000002430000;2,335691956;0,000640844;1,877952045;0,003626088;0,053887745;1,214994219;0,12789411;0;0;NA;NA;NA
X100129382_TGI_at;100129382_TGI_at;CA429938;;;0,00000000084800000000;0,69889425;0,005190221;0,803939197;0,015488965;0,450742398;0,926246973;0,587204022;0;0;NA;NA;NA
X100129386_TGI_at;100129386_TGI_at;BC017327;FERMT2;fermitin family homolog 2 (Drosophila);0,00000000083900000000;0,773816281;0,128323273;0,914740284;0,17161241;0,119496494;0,900134536;0,225094798;0;0;NA;NA;NA
X100129397_TGI_at;100129397_TGI_at;NM_013449;BAZ2A;bromodomain adjacent to zinc finger domain, 2A;0,00000002010000000000;0,812443037;0,026236583;0,893648529;0,049929935;0,164346936;1,13118536;0,282652175;0;0;NA;NA;NA
X100129421_TGI_at;100129421_TGI_at;NM_001098797;TOX2;TOX high mobility group box family member 2;0,00000044200000000000;0,715956572;2,84E-05;0,780858008;0,000484115;0,307230301;0,83019893;0,446439703;0;0;NA;NA;NA
X100129425_TGI_at;100129425_TGI_at;BC009467;;hypothetical protein BC009467;0,00000000006140000000;1,306715561;0,324732812;1,057232758;0,372858515;0,122857837;1,170131816;0,229149774;0;0;NA;NA;NA
X100129464_TGI_at;100129464_TGI_at;J05593;TIMP2;TIMP metallopeptidase inhibitor 2;0,00000000105000000000;1,541915214;0,029956483;1,141442686;0,05498277;0,00023763;1,410950586;0,004452797;0;0;NA;NA;NA
X100129540_TGI_at;100129540_TGI_at;BF115745;;;0,00000001390000000000;0,815181522;0,025145164;0,922601703;0,048383799;0,635603663;0,985951416;0,747431382;0;0;NA;NA;NA
X100129548_TGI_at;100129548_TGI_at;NM_001080779;MYO1C;myosin IC;0,00000087100000000000;0,805905579;0,000428415;0,846410418;0,002723432;0,086456258;1,103031739;0,179491513;0;0;NA;NA;NA
X100129555_TGI_at;100129555_TGI_at;NM_175610;TJP1;tight junction protein 1 (zona occludens 1);0,00000000051300000000;0,814491357;0,077393505;0,959875861;0,114737473;0,502203015;0,97618586;0,637495201;0;0;NA;NA;NA
X100129596_TGI_at;100129596_TGI_at;NM_001085451;LNP1;leukemia NUP98 fusion partner 1;0,00000031200000000000;0,7667823;0,119221309;0,894181508;0,161314139;0,234597793;0,923540616;0,367043051;0;0;NA;NA;NA
X100129602_TGI_at;100129602_TGI_at;NM_001033044;GLUL;glutamate-ammonia ligase (glutamine synthetase);0,00000000040700000000;1,448065265;0,136866188;1,155405261;0,18071271;0,038082294;1,298625512;0,099545202;0;0;NA;NA;NA
X100129656_TGI_at;100129656_TGI_at;NM_020166;MCCC1;methylcrotonoyl-Coenzyme A carboxylase 1 (alpha);0,00000000000350000000;1,315704934;4,43E-05;1,222141545;0,000631699;0,002886902;1,291706402;0,017893238;0;1;U2;U1;U1
X100129670_TGI_at;100129670_TGI_at;ENST00000352732;ABHD2;abhydrolase domain containing 2;0,00000000001540000000;1,462128474;0,011631769;1,165936553;0,027277267;0,001660524;1,342876119;0,012896073;0;1;U1;U1;U1
X100129691_TGI_at;100129691_TGI_at;NM_018129;PNPO;"pyridoxamine 5';-phosphate oxidase";0,00000074700000000000;1,27916938;0,024564352;1,106148586;0,047578669;0,066842161;1,150943951;0,148369342;0;0;NA;NA;NA
X100129742_TGI_at;100129742_TGI_at;NM_032866;CGNL1;cingulin-like 1;0,00000000297000000000;0,829152094;0,035495257;0,914483464;0,062446077;0,203149235;1,193254271;0,330514884;0;0;NA;NA;NA
X100129744_TGI_at;100129744_TGI_at;NM_153326;AKR1A1;aldo-keto reductase family 1, member A1 (aldehyde reductase);0,00000000001770000000;1,227442154;0,104408088;1,044601596;0,14535951;0,003653668;1,130997997;0,020560753;0;0;NA;NA;NA
X100129781_TGI_at;100129781_TGI_at;ENST00000381322;CLOCK;clock homolog (mouse);0,00000021800000000000;1,232433184;0,41110641;1,02336777;0,456580276;0,004595971;1,173900567;0,023853166;0;0;NA;NA;NA
X100129784_TGI_at;100129784_TGI_at;NM_014992;DAAM1;dishevelled associated activator of morphogenesis 1;0,00000011100000000000;0,792263974;0,000404769;0,892939248;0,002635498;0,462143696;0,941966648;0,598428739;0;0;NA;NA;NA
X100129867_TGI_at;100129867_TGI_at;NM_181785;SLC46A3;solute carrier family 46, member 3;0,00000000002920000000;1,339240161;9,66E-07;1,232046275;6,63E-05;0,274492264;1,086390747;0,411866186;0;0;NA;NA;NA
X100129877_TGI_at;100129877_TGI_at;ENST00000222690;H2AFV;H2A histone family, member V;0,00000000378000000000;0,810408887;0,601941484;0,962323973;0,63587591;0,57904816;0,973885693;0,700552635;0;0;NA;NA;NA
X100129909_TGI_at;100129909_TGI_at;AF151858;TMED5;transmembrane emp24 protein transport domain containing 5;0,00000000061700000000;1,340259583;0,016881957;1,106056919;0,035962027;0,000656787;1,310925745;0,007427454;0;1;U2;U1;U1
X100129915_TGI_at;100129915_TGI_at;NM_001033047;NPNT;nephronectin;0,00000000000016800000;0,740484044;0,074819269;0,934846534;0,11200302;0,843026037;0,996948947;0,905389176;0;0;NA;NA;NA
X100129925_TGI_at;100129925_TGI_at;NM_005399;PRKAB2;protein kinase, AMP-activated, beta 2 non-catalytic subunit;0,00000041300000000000;0,793790082;0,379278337;0,955010227;0,426522708;0,173607521;0,901318993;0,296679236;0;0;NA;NA;NA
X100129931_TGI_at;100129931_TGI_at;ENST00000377058;CXorf24;chromosome X open reading frame 24;0,00000006000000000000;0,808859669;0,238891819;0,940390989;0,287837906;0,442606018;0,936867012;0,579650222;0;0;NA;NA;NA
X100129938_TGI_at;100129938_TGI_at;NM_013231;FLRT2;fibronectin leucine rich transmembrane protein 2;0,00000005840000000000;0,670321972;0,214902634;0,839244899;0,263911579;0,024581037;0,740230642;0,072950903;0;0;NA;NA;NA
X100129969_TGI_at;100129969_TGI_at;NM_021097;SLC8A1;solute carrier family 8 (sodium/calcium exchanger), member 1;0,00000031200000000000;1,249444099;0,021463156;1,123733108;0,04307332;0,348497017;1,088227381;0,486868611;0;0;NA;NA;NA
X100129979_TGI_at;100129979_TGI_at;NM_005471;GNPDA1;glucosamine-6-phosphate deaminase 1;0,00000000002080000000;1,294932276;0,026443224;1,092381817;0,05016275;0,089895036;1,143211234;0,184145191;0;0;NA;NA;NA
X100129997_TGI_at;100129997_TGI_at;NM_006994;BTN3A3;butyrophilin, subfamily 3, member A3;0,00000001080000000000;0,777584641;0,133280366;0,934455124;0,17692005;0,883640065;0,998749543;0,933455238;0;0;NA;NA;NA
X100130009_TGI_at;100130009_TGI_at;NM_014038;BZW2;basic leucine zipper and W2 domains 2;0,00000000009340000000;1,251287556;0,003371859;1,110104334;0,011403465;0,107219939;1,175062591;0,208174617;0;0;NA;NA;NA
X100130024_TGI_at;100130024_TGI_at;NM_005964;MYH10;myosin, heavy chain 10, non-muscle;0,00000000004660000000;0,789908574;0,576525867;1,000011497;0,611633598;0,048807143;0,890943897;0,118721072;0;0;NA;NA;NA
X100130034_TGI_at;100130034_TGI_at;NM_016310;POLR3K;polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa;0,00000014800000000000;1,222619836;0,016785068;1,106923718;0,035826671;0,41805304;1,069223619;0,560243222;0;0;NA;NA;NA
X100130036_TGI_at;100130036_TGI_at;BC021675;TSPAN2;tetraspanin 2;0,00000007060000000000;0,719865064;0,0630447;0,83838934;0,097870787;0,008831116;0,742952414;0,036964527;0;0;NA;NA;NA
X100130054_TGI_at;100130054_TGI_at;NM_001080545;PPP1R1C;protein phosphatase 1, regulatory (inhibitor) subunit 1C;0,00000000000003540000;2,377196691;1,16E-05;1,861726726;0,000294785;0,000297835;1,970596899;0,004872704;0;1;U4;U2;U1
X100130055_TGI_at;100130055_TGI_at;DA393531;LIPA;lipase A, lysosomal acid, cholesterol esterase;0,00000000000140000000;2,159390879;0,000122768;1,577757674;0,001188283;0,000429707;2,181062122;0,005893387;0;1;U5;U1;U1
X100130076_TGI_at;100130076_TGI_at;NM_000837;GRINA;glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding);0,00000000003790000000;1,314347204;0,493672452;1,013285862;0,533570192;0,003653668;1,212990237;0,020560753;0;0;NA;NA;NA
X100130080_TGI_at;100130080_TGI_at;NM_021734;SLC25A19;solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19;0,00000000006500000000;1,469502492;1,43E-05;1,253239138;0,000331475;0,01269629;1,274741153;0,046447382;0;1;U1;U2;U1
X100130092_TGI_at;100130092_TGI_at;NM_000609;CXCL12;chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1);0,00000000226000000000;0,622306712;0,492987169;0,927956304;0,533187129;0,024581037;0,696727471;0,072950903;0;0;NA;NA;NA
X100130110_TGI_at;100130110_TGI_at;AF038185;;;0,00000001900000000000;0,671001099;0,004499816;0,799183369;0,014039599;0,01554453;0,765877882;0,052959853;0;0;NA;NA;NA
X100130123_TGI_at;100130123_TGI_at;ENST00000253707;SLC6A6;solute carrier family 6 (neurotransmitter transporter, taurine), member 6;0,00000000044700000000;1,373856871;0,026436227;1,133886903;0,05016275;0,33768758;1,119569586;0,479456859;0;0;NA;NA;NA
X100130150_TGI_at;100130150_TGI_at;U48296;PTP4A1;protein tyrosine phosphatase type IVA, member 1;0,00000006860000000000;1,302067528;0,00770199;1,114747157;0,020498359;0,18024766;1,10929093;0,304954439;0;0;NA;NA;NA
X100130164_TGI_at;100130164_TGI_at;NM_001040409;MTHFD2;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase;0,00000000022100000000;1,556938624;0,057616059;1,138513588;0,09125138;0,849099163;1,02859888;0,906474529;0;0;NA;NA;NA
X100130174_TGI_at;100130174_TGI_at;BC039435;UBE2F;ubiquitin-conjugating enzyme E2F (putative);0,00000000000000188000;1,385141402;0,468713109;1,024692103;0,510703972;0,22530743;1,066611765;0,356838254;0;0;NA;NA;NA
X100130182_TGI_at;100130182_TGI_at;ENST00000381414;TMC5;transmembrane channel-like 5;0,00000035500000000000;1,378914415;0,255546423;1,075222954;0,304370333;0,086710607;1,162302654;0,179491513;0;0;NA;NA;NA
X100130186_TGI_at;100130186_TGI_at;NM_032857;LACTB;lactamase, beta;0,00000101000000000000;1,371190033;0,006237006;1,179016707;0,017556218;0,002719171;1,407317907;0,017251748;0;1;U1;U1;U1
X100130192_TGI_at;100130192_TGI_at;NM_001188;BAK1;BCL2-antagonist/killer 1;0,00000074700000000000;1,201057704;0,693227388;0,99656659;0,720786836;0,000446526;1,292208449;0,006049403;0;0;NA;NA;NA
X100130232_TGI_at;100130232_TGI_at;NM_138957;MAPK1;mitogen-activated protein kinase 1;0,00000083400000000000;1,328599363;0,9307231;0,998697214;0,936827155;0,00919586;1,275810814;0,038004115;0;0;NA;NA;NA
X100130258_TGI_at;100130258_TGI_at;NM_001337;CX3CR1;chemokine (C-X3-C motif) receptor 1;0,00000000001050000000;0,516611485;0,088394549;0,85701348;0,127813203;0,57904816;1,141918916;0,700552635;0;0;NA;NA;NA
X100130266_TGI_at;100130266_TGI_at;NM_001859;SLC31A1;solute carrier family 31 (copper transporters), member 1;0,00000000000000040600;1,707121772;0,001746334;1,218866421;0,007300763;0,000345371;1,46602123;0,005300617;0;1;U2;U1;U1
X100130282_TGI_at;100130282_TGI_at;NM_025074;FRAS1;Fraser syndrome 1;0,00000000178000000000;0,700437624;0,09349449;0,850382913;0,133569477;0,320446876;0,8906524;0,461483593;0;0;NA;NA;NA
X100130288_TGI_at;100130288_TGI_at;NM_005202;COL8A2;collagen, type VIII, alpha 2;0,00000000000000058200;2,004041336;1,75E-06;1,511710713;9,27E-05;0,006224908;1,369001394;0,028702256;0;1;U1;U1;U1
X100130305_TGI_at;100130305_TGI_at;NM_025144;ALPK1;alpha-kinase 1;0,00000000000044200000;1,420914862;0,000169682;1,162312497;0,001435503;0,849099163;1,025205074;0,906474529;0;0;NA;NA;NA
X100130312_TGI_at;100130312_TGI_at;NM_004095;EIF4EBP1;eukaryotic translation initiation factor 4E binding protein 1;0,00000000000007580000;1,53633929;0,038037942;1,11163345;0,065911982;0,149505026;1,133581106;0,264174725;0;0;NA;NA;NA
X100130334_TGI_at;100130334_TGI_at;NM_020809;ARHGAP20;Rho GTPase activating protein 20;0,00000009640000000000;0,769936158;0,22136805;0,93191869;0,270566211;0,709599351;0,954947719;0,803597578;0;0;NA;NA;NA
X100130349_TGI_at;100130349_TGI_at;ENST00000313060;;FP2025;0,00000001730000000000;0,683442609;0,000203273;0,73023667;0,001640436;0,940656418;1,021857552;0,965520903;0;0;NA;NA;NA
X100130355_TGI_at;100130355_TGI_at;AI417595;;;0,00000002350000000000;0,588970505;0,032598151;0,808944178;0,058433727;0,927501324;0,877419963;0,959350695;0;0;NA;NA;NA
X100130393_TGI_at;100130393_TGI_at;NM_199331;HOMER2;homer homolog 2 (Drosophila);0,00000015700000000000;1,458490183;0,056168997;1,148606435;0,089634839;0,013942384;1,303023742;0,049653374;0;0;NA;NA;NA
X100130396_TGI_at;100130396_TGI_at;AK126467;PDE1C;phosphodiesterase 1C, calmodulin-dependent 70kDa;0,00000000016100000000;0,713463761;0,048564501;0,896988472;0,079696226;0,940656418;1,008027861;0,965520903;0;0;NA;NA;NA
X100130406_TGI_at;100130406_TGI_at;NM_007195;POLI;polymerase (DNA directed) iota;0,00000016700000000000;0,746761584;0,441838545;0,949926023;0,485690869;0,926061411;0,9695301;0,959350695;0;0;NA;NA;NA
X100130415_TGI_at;100130415_TGI_at;NM_016500;CXorf26;chromosome X open reading frame 26;0,00000000025400000000;1,218721178;0,051212907;1,05427861;0,083153249;0,004027359;1,178949491;0,021963076;0;0;NA;NA;NA
X100130496_TGI_at;100130496_TGI_at;BC110332;ZNF507;zinc finger protein 507;0,00000071300000000000;0,823345052;0,028252839;0,90770573;0,052635203;0,241271938;0,868688485;0,374575845;0;0;NA;NA;NA
X100130520_TGI_at;100130520_TGI_at;NM_000509;FGG;fibrinogen gamma chain;0,00000000000004740000;9,506954282;0,000124125;2,601879775;0,001194195;0,001064102;2,539577616;0,009747097;0;1;U8;U1;U1
X100130524_TGI_at;100130524_TGI_at;AK056826;;;0,00000000000000033200;3,393041728;1,62E-12;3,54538848;2,61E-09;3,44E-06;2,75081346;0,000832852;1;1;U7;U4;U3
X100130545_TGI_at;100130545_TGI_at;BC009478;DCUN1D1;DCN1, defective in cullin neddylation 1, domain containing 1 (S. cerevisiae);0,00000000227000000000;1,302023098;0,000626754;1,177431227;0,003556386;0,33768758;1,076369399;0,479456859;0;0;NA;NA;NA
X100130551_TGI_at;100130551_TGI_at;AF506757;AIFM2;apoptosis-inducing factor, mitochondrion-associated, 2;0,00000000008220000000;1,423170621;0,000437317;1,211137391;0,002760548;0,015374349;1,172142342;0,052959853;0;0;NA;NA;NA
X100130566_TGI_at;100130566_TGI_at;BC047374;SLC36A4;solute carrier family 36 (proton/amino acid symporter), member 4;0,00000000263000000000;1,420207185;0,004431732;1,178468677;0,013867448;0,234597793;1,133606465;0,367043051;0;0;NA;NA;NA
X100130580_TGI_at;100130580_TGI_at;NM_058195;CDKN2A;cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4);0,00000000026400000000;1,648931046;6,51E-08;1,676145359;9,69E-06;0,032083057;1,345533043;0,088319445;0;0;NA;NA;NA
X100130599_TGI_at;100130599_TGI_at;NM_005128;DOPEY2;dopey family member 2;0,00000000202000000000;1,282257138;0,022796678;1,117172981;0,045131261;0,348497017;1,070684889;0,486868611;0;0;NA;NA;NA
X100130604_TGI_at;100130604_TGI_at;AB089319;NIPA1;non imprinted in Prader-Willi/Angelman syndrome 1;0,00000017900000000000;1,356686555;0,29919023;1,05733139;0,3486226;0,055034692;1,143881812;0,12937769;0;0;NA;NA;NA
X100130626_TGI_at;100130626_TGI_at;BX538111;;hypothetical protein LOC283904;0,00000013500000000000;0,688112063;0,030597543;0,802234857;0,055904694;0,924555569;0,987945204;0,959350695;0;0;NA;NA;NA
X100130660_TGI_at;100130660_TGI_at;BC020911;;;0,00000000001980000000;0,733944572;0,404616994;0,956057561;0,450304065;0,754854076;1,102260809;0,840087944;0;0;NA;NA;NA
X100130675_TGI_at;100130675_TGI_at;NM_003263;TLR1;toll-like receptor 1;0,00000000042000000000;1,38883481;0,023141098;1,127997433;0,045422509;0,299373904;1,164787431;0,437985516;0;0;NA;NA;NA
X100130701_TGI_at;100130701_TGI_at;BC002480;SRD5A3;steroid 5 alpha-reductase 3;0,00000000002920000000;1,427146969;0,030358762;1,112683018;0,055499882;0,234597793;1,12966482;0,367043051;0;0;NA;NA;NA
X100130704_TGI_at;100130704_TGI_at;AF010236;;;0,00000000037600000000;0,690163802;0,017530499;0,803239608;0,036808338;0,470967706;0,927869487;0,606928795;0;0;NA;NA;NA
X100130706_TGI_at;100130706_TGI_at;H51497;MAPRE2;microtubule-associated protein, RP/EB family, member 2;0,00000000024800000000;0,78348698;0,013228583;0,855375373;0,030047513;0,979396399;0,987122389;0,987556719;0;0;NA;NA;NA
X100130725_TGI_at;100130725_TGI_at;NM_080548;PTPN6;protein tyrosine phosphatase, non-receptor type 6;0,00000000017600000000;1,375763526;0,01776739;1,117252811;0,037208576;0,021964693;1,249739638;0,067549815;0;0;NA;NA;NA
X100130728_TGI_at;100130728_TGI_at;ENST00000359203;RRAGD;Ras-related GTP binding D;0,00000000000000006120;1,610310501;1,76E-05;1,301234916;0,000366485;0,008379773;1,359257484;0,035724879;0;1;U6;U1;U1
X100130731_TGI_at;100130731_TGI_at;AK000969;KLF7;Kruppel-like factor 7 (ubiquitous);0,00000000169000000000;0,79597231;0,015730028;0,904093106;0,034117012;0,784830893;0,982244028;0,861549716;0;0;NA;NA;NA
X100130756_TGI_at;100130756_TGI_at;NM_170692;RASAL2;RAS protein activator like 2;0,00000010600000000000;1,264398306;0,001616049;1,191357499;0,006865836;0,074175285;1,162878745;0,161422649;0;0;NA;NA;NA
X100130761_TGI_at;100130761_TGI_at;AF062481;DHCR7;7-dehydrocholesterol reductase;0,00000000027400000000;1,430730969;0,22801032;1,089980202;0,276581581;0,000806993;1,559051637;0,008256949;0;0;NA;NA;NA
X100130766_TGI_at;100130766_TGI_at;AF230393;TRIM27;tripartite motif-containing 27;0,00000000648000000000;1,285427286;0,188470656;1,045972514;0,236634563;0,013270593;1,160694473;0,048111498;0;0;NA;NA;NA
X100130774_TGI_at;100130774_TGI_at;NM_013343;LOH3CR2A;loss of heterozygosity, 3, chromosomal region 2, gene A;0,00000046500000000000;0,666223945;0,010730868;0,81633288;0,025848719;0,759495311;1,033229132;0,842344593;0;0;NA;NA;NA
X100130832_TGI_at;100130832_TGI_at;NM_138804;C2orf65;chromosome 2 open reading frame 65;0,00000000000002400000;2,37650304;5,98E-07;1,804792656;4,70E-05;3,00E-05;1,903845107;0,001805101;0;1;U5;U2;U1
X100130854_TGI_at;100130854_TGI_at;ENST00000362010;VEPH1;ventricular zone expressed PH domain homolog 1 (zebrafish);0,00000014100000000000;1,234987395;0,013873289;1,172271829;0,031000594;0,016349104;1,506812643;0,055233924;0;0;NA;NA;NA
X100130907_TGI_at;100130907_TGI_at;DQ457059;;;0,00000000064500000000;1,2278144;0,007934042;1,10103276;0,020960178;0,255009933;1,058834576;0,38934013;0;0;NA;NA;NA
X100130932_TGI_at;100130932_TGI_at;L25259;CD86;CD86 molecule;0,00000000000006290000;1,755735769;0,000109657;1,383726283;0,001094198;0,008707469;1,476311979;0,036926544;0;1;U6;U3;U1
X100130993_TGI_at;100130993_TGI_at;NM_024829;;hypothetical protein FLJ22662;0,00000000000290000000;1,541482937;2,34E-05;1,310286274;0,000435318;0,000256336;1,634630349;0,004600156;0;1;U2;U2;U1
X100130995_TGI_at;100130995_TGI_at;BC000049;TMEM38B;transmembrane protein 38B;0,00000000139000000000;1,392115527;0,003268833;1,240192246;0,011184127;0,289772413;1,108075143;0,428607841;0;0;NA;NA;NA
X100131018_TGI_at;100131018_TGI_at;ENST00000367853;MPZL1;myelin protein zero-like 1;0,00000013100000000000;1,22447872;0,055428835;1,074000497;0,08861465;0,080609435;1,115805655;0,170587136;0;0;NA;NA;NA
X100131077_TGI_at;100131077_TGI_at;NM_016245;HSD17B11;hydroxysteroid (17-beta) dehydrogenase 11;0,00000000023700000000;1,256085428;2,86E-05;1,152360044;0,000484849;0,007500138;1,220344282;0,03302315;0;1;U3;U2;U1
X100131087_TGI_at;100131087_TGI_at;AB208946;ALOX5;arachidonate 5-lipoxygenase;0,00000000000994000000;1,731010953;0,002244503;1,281355777;0,008591489;0,000371641;1,757728165;0,00537129;0;1;U2;U1;U1
X100131098_TGI_at;100131098_TGI_at;NM_019063;EML4;echinoderm microtubule associated protein like 4;0,00000000004460000000;1,262403737;0,00260307;1,146595773;0,009458504;0,007948708;1,176073101;0,034341403;0;1;U2;U1;U1
X100131136_TGI_at;100131136_TGI_at;AK091196;ARHGAP24;Rho GTPase activating protein 24;0,00000000002480000000;0,798327286;0,009726645;0,915336236;0,024189026;0,806687836;1,041767768;0,879551723;0;0;NA;NA;NA
X100131143_TGI_at;100131143_TGI_at;BC012049;CYP1B1;cytochrome P450, family 1, subfamily B, polypeptide 1;0,00000000000000000006;4,006838212;3,30E-11;2,565330203;2,13E-08;0,003371616;1,611062172;0,019650484;0;1;U8;U4;U1
X100131149_TGI_at;100131149_TGI_at;NM_024901;DENND2D;DENN/MADD domain containing 2D;0,00000000032800000000;1,323167938;0,038133346;1,089097806;0,066006324;0,030508302;1,218665273;0,086003807;0;0;NA;NA;NA
X100131156_TGI_at;100131156_TGI_at;BX119451;;;0,00000019200000000000;1,844221759;0,140775035;1,288120683;0,184663386;1,72E-05;2,225427816;0,001749595;0;0;NA;NA;NA
X100131174_TGI_at;100131174_TGI_at;ENST00000179259;C12orf5;chromosome 12 open reading frame 5;0,00000000000017000000;1,655889706;3,46E-05;1,338717906;0,000541936;0,000469144;1,348910794;0,006121661;0;1;U2;U2;U1
X100131211_TGI_at;100131211_TGI_at;AK001074;;;0,00000000179000000000;0,655754186;0,148589606;0,812618853;0,193028739;0,284058212;1,1565084;0,421122179;0;0;NA;NA;NA
X100131212_TGI_at;100131212_TGI_at;NM_012396;PHLDA3;pleckstrin homology-like domain, family A, member 3;0,00000000000065200000;1,546410065;0,009105886;1,198502029;0,023054415;0,002337491;1,411735268;0,016063395;0;1;U4;U1;U1
X100131218_TGI_at;100131218_TGI_at;NM_003370;VASP;vasodilator-stimulated phosphoprotein;0,00000003040000000000;1,384614815;0,279577061;1,0847604;0,328380783;0,107895631;1,198053258;0,208857428;0;0;NA;NA;NA
X100131223_TGI_at;100131223_TGI_at;NM_006344;CLEC10A;C-type lectin domain family 10, member A;0,00000000012500000000;1,4638499;0,023141098;1,228870347;0,045422509;0,005437653;1,360770594;0,026196646;0;1;U1;U1;U1
X100131228_TGI_at;100131228_TGI_at;NM_020779;WDR35;WD repeat domain 35;0,00000041100000000000;0,821267669;0,0380271;0,898252798;0,065911982;0,00053236;0,770762969;0,006649296;0;0;NA;NA;NA
X100131287_TGI_at;100131287_TGI_at;NM_032463;LAT2;linker for activation of T cells family, member 2;0,00000000000577000000;1,433979822;0,114559664;1,081400337;0,155791476;0,020928503;1,246313675;0,065424408;0;0;NA;NA;NA
X100131294_TGI_at;100131294_TGI_at;NM_144956;PRSS21;protease, serine, 21 (testisin);0,00000000002830000000;2,913532377;0,0001118;1,877805887;0,001109637;0,01647292;1,736262892;0,055593949;0;0;NA;NA;NA
X100131298_TGI_at;100131298_TGI_at;BC000948;TMEM33;transmembrane protein 33;0,00000000017700000000;1,477996417;0,007376088;1,190898994;0,019844017;0,021756187;1,27182143;0,067164932;0;0;NA;NA;NA
X100131312_TGI_at;100131312_TGI_at;NM_000397;CYBB;cytochrome b-245, beta polypeptide;0,00000000000000807000;2,131934538;0,000233003;1,441508503;0,001809564;7,79E-05;2,008964849;0,002727399;0;1;U8;U2;U1
X100131328_TGI_at;100131328_TGI_at;NM_207309;UAP1L1;UDP-N-acteylglucosamine pyrophosphorylase 1-like 1;0,00000000196000000000;1,378007987;0,995375748;1,001768263;0,995993802;0,09653965;1,193652648;0,193392487;0;0;NA;NA;NA
X100131330_TGI_at;100131330_TGI_at;NM_018231;SLC38A7;solute carrier family 38, member 7;0,00000049200000000000;1,30183789;0,226232596;1,06609562;0,275150059;0,066842161;1,193176911;0,148369342;0;0;NA;NA;NA
X100131355_TGI_at;100131355_TGI_at;AL532155;FAM13C1;family with sequence similarity 13, member C1;0,00000002780000000000;0,739058967;0,006846809;0,82090345;0,018828725;0,37483693;0,924034813;0,511473085;0;0;NA;NA;NA
X100131375_TGI_at;100131375_TGI_at;NM_153211;TTC39C;tetratricopeptide repeat domain 39C;0,00000000015800000000;1,360808783;0,010717959;1,110784937;0,025848719;0,357146031;1,100474753;0,494450884;0;0;NA;NA;NA
X100131378_TGI_at;100131378_TGI_at;NM_017872;THG1L;tRNA-histidine guanylyltransferase 1-like (S. cerevisiae);0,00000000006380000000;1,216378757;0,008489575;1,09418875;0,02197743;0,005635154;1,21049822;0,026986777;0;1;U1;U1;U1
X100131379_TGI_at;100131379_TGI_at;AK056079;JAM2;junctional adhesion molecule 2;0,00000000020200000000;0,734194555;0,042442521;0,937167703;0,071469302;0,003883416;0,778439166;0,021358785;0;0;NA;NA;NA
X100131387_TGI_at;100131387_TGI_at;NM_005601;NKG7;natural killer cell group 7 sequence;0,00000001480000000000;0,650405875;0,022062453;0,809411595;0,044056559;0,993131469;1,004784311;0,995253159;0;0;NA;NA;NA
X100131403_TGI_at;100131403_TGI_at;BQ441651;;;0,00000000008490000000;1,474395416;0,112641765;1,078385319;0,15370212;0,422375201;1,111595425;0,560904521;0;0;NA;NA;NA
X100131417_TGI_at;100131417_TGI_at;NM_002522;NPTX1;neuronal pentraxin I;0,00000000000026200000;2,092911435;2,27E-05;1,90445996;0,000427646;0,032055212;1,603327335;0,088319445;0;0;NA;NA;NA
X100131453_TGI_at;100131453_TGI_at;NM_001031679;MSRB3;methionine sulfoxide reductase B3;0,00000000101000000000;0,738534311;0,255546423;0,934168255;0,304370333;0,05081529;0,817780968;0,122313429;0;0;NA;NA;NA
X100131473_TGI_at;100131473_TGI_at;NM_153026;PRICKLE1;prickle homolog 1 (Drosophila);0,00000052600000000000;0,762782924;0,208672314;0,909664983;0,257879934;0,660413637;0,894111712;0,764285198;0;0;NA;NA;NA
X100131488_TGI_at;100131488_TGI_at;NM_203308;;ribosomal protein L13A pseudogene;0,00000000007710000000;2,572739133;1,10E-05;2,326556768;0,000288889;3,49E-05;2,851404765;0,001805101;0;1;U6;U1;U2
X100131490_TGI_at;100131490_TGI_at;NM_022003;FXYD6;FXYD domain containing ion transport regulator 6;0,00000000128000000000;0,783535666;0,018047863;0,915615209;0,037625007;0,545460135;0,95224627;0,674086662;0;0;NA;NA;NA
X100131505_TGI_at;100131505_TGI_at;BC025246;ME1;malic enzyme 1, NADP(+)-dependent, cytosolic;0,00000004640000000000;1,346199191;0,00030308;1,259509009;0,002128165;0,01806578;1,282775531;0,05881415;0;0;NA;NA;NA
X100131522_TGI_at;100131522_TGI_at;AK095776;THRB;thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian);0,00000077000000000000;0,818970198;0,07705074;0,927593964;0,114387165;0,235851277;0,848425664;0,368289083;0;0;NA;NA;NA
X100131545_TGI_at;100131545_TGI_at;BC012204;FNDC3B;fibronectin type III domain containing 3B;0,00000002350000000000;1,475241681;0,139435432;1,124244357;0,183428734;0,089895036;1,177349967;0,184145191;0;0;NA;NA;NA
X100131560_TGI_at;100131560_TGI_at;NM_199328;CLDN8;claudin 8;0,00000069800000000000;0,644421389;0,002369906;0,509773869;0,008871322;0,001882981;0,48657713;0,014113602;0;1;D5;D2;D1
X100131565_TGI_at;100131565_TGI_at;NM_004951;GPR183;G protein-coupled receptor 183;0,00000058600000000000;1,646644431;0,002369906;1,346058314;0,008871322;0,460794302;1,056907141;0,597401462;0;0;NA;NA;NA
X100131587_TGI_at;100131587_TGI_at;NM_000180;GUCY2D;guanylate cyclase 2D, membrane (retina-specific);0,00000000029900000000;1,456766694;0,13333503;1,137670015;0,17692005;0,003063783;1,621069554;0,018596182;0;0;NA;NA;NA
X100131620_TGI_at;100131620_TGI_at;AK000787;;;0,00000030900000000000;0,66340645;0,362864328;0,898502518;0,409888833;0,648925345;1,012756241;0,755321916;0;0;NA;NA;NA
X100131626_TGI_at;100131626_TGI_at;ENST00000300187;MS4A14;membrane-spanning 4-domains, subfamily A, member 14;0,00000000839000000000;1,816026228;0,000626754;1,536316741;0,003556386;0,002719171;2,138166451;0,017251748;0;1;U1;U1;U1
X100131669_TGI_at;100131669_TGI_at;NM_030938;TMEM49;transmembrane protein 49;0,00000102000000000000;1,460418908;0,016078086;1,193559473;0,03470842;0,221636126;0,818593512;0,351888292;0;0;NA;NA;NA
X100131676_TGI_at;100131676_TGI_at;AK056140;;;0,00000001440000000000;0,792318152;0,383612482;0,95296498;0,430495484;0,460794302;0,95429686;0,597401462;0;0;NA;NA;NA
X100131685_TGI_at;100131685_TGI_at;BC029891;TFEC;transcription factor EC;0,00000000002080000000;1,81829144;0,028663655;1,202296348;0,053185353;0,001461933;1,504785605;0,011898514;0;0;NA;NA;NA
X100131712_TGI_at;100131712_TGI_at;BC051373;NES;nestin;0,00000066200000000000;0,74475765;0,019807176;0,824452533;0,040583935;0,291649909;0,883351924;0,430200301;0;0;NA;NA;NA
X100131732_TGI_at;100131732_TGI_at;ENST00000367629;ANGPTL1;angiopoietin-like 1;0,00000000004460000000;0,581014215;0,004041906;0,739110907;0,012891901;0,144787165;0,854589284;0,25853132;0;0;NA;NA;NA
X100131741_TGI_at;100131741_TGI_at;NM_145246;C10orf4;chromosome 10 open reading frame 4;0,00000000297000000000;0,764987557;0,285409472;0,935729153;0,334743351;0,118794011;0,880466216;0,224033409;0;0;NA;NA;NA
X100131748_TGI_at;100131748_TGI_at;NM_182983;HPN;hepsin (transmembrane protease, serine 1);0,00000000002040000000;1,449561692;0,001299028;1,240269572;0,005806891;1,45E-06;1,961428355;0,000668695;0;1;U6;U1;U2
X100131772_TGI_at;100131772_TGI_at;NM_001042482;TPK1;thiamin pyrophosphokinase 1;0,00000001900000000000;1,325906566;0,010217779;1,130816712;0,024967324;0,0064123;1,311501053;0,029273149;0;1;U1;U1;U1
X100131801_TGI_at;100131801_TGI_at;NM_013252;CLEC5A;C-type lectin domain family 5, member A;0,00000000000000000915;3,313175611;9,67E-06;1,810434146;0,000266398;0,136822082;1,333997095;0,248858674;0;0;NA;NA;NA
X100131820_TGI_at;100131820_TGI_at;NM_002398;MEIS1;Meis homeobox 1;0,00000000020400000000;0,773013093;0,009388181;0,902139546;0,023512966;0,001055444;0,793572787;0,009719131;0;1;D1;D1;D1
X100131822_TGI_at;100131822_TGI_at;NM_014839;;plasticity related gene 1;0,00000013900000000000;1,532520255;1,39E-05;1,572119261;0,000327735;0,255009933;1,278496925;0,38934013;0;0;NA;NA;NA
X100131829_TGI_at;100131829_TGI_at;BC032472;;hypothetical LOC643733;0,00000000000371000000;0,734204461;0,01145057;0,892456357;0,026977475;0,357146031;0,94071473;0,494450884;0;0;NA;NA;NA
X100131868_TGI_at;100131868_TGI_at;AK022777;IVD;isovaleryl Coenzyme A dehydrogenase;0,00000039200000000000;1,231271651;0,324494185;1,030190426;0,372858515;0,041415229;1,190394288;0,104282253;0;0;NA;NA;NA
X100131875_TGI_at;100131875_TGI_at;AL162075;;;0,00000000256000000000;0,798157236;0,002325633;0,877925416;0,008756443;0,09653965;0,888939136;0,193392487;0;0;NA;NA;NA
X100131878_TGI_at;100131878_TGI_at;AK027248;;;0,00000000000301000000;0,77048247;0,016227066;0,914283895;0,034983166;0,888166261;0,968046259;0,935477078;0;0;NA;NA;NA
X100131890_TGI_at;100131890_TGI_at;AW969033;CYBB;cytochrome b-245, beta polypeptide;0,00000000000008130000;2,202935523;0,000138179;1,521646839;0,0012652;0,000399716;2,197734061;0,005625698;0;1;U4;U1;U1
X100131911_TGI_at;100131911_TGI_at;NM_012244;SLC7A8;solute carrier family 7 (cationic amino acid transporter, y+ system), member 8;0,00000000063300000000;1,363658993;0,04579876;1,119225381;0,076165843;0,009303521;1,261856163;0,038004115;0;0;NA;NA;NA
X100131940_TGI_at;100131940_TGI_at;NM_001042693;FAM159A;family with sequence similarity 159, member A;0,00000044800000000000;1,221895317;0,441064201;1,024781192;0,485336265;0,660894461;1,031200315;0,764285198;0;0;NA;NA;NA
X100131949_TGI_at;100131949_TGI_at;BC031250;KLF17;Kruppel-like factor 17;0,00000001140000000000;0,765863196;0,0169985;0,861179896;0,036091018;0,357146031;1,066656948;0,494450884;0;0;NA;NA;NA
X100131959_TGI_at;100131959_TGI_at;NM_173558;FGD2;FYVE, RhoGEF and PH domain containing 2;0,00000000271000000000;1,228891381;0,541752218;1,01244561;0,579511251;0,045429645;1,133299917;0,112199038;0;0;NA;NA;NA
X100131960_TGI_at;100131960_TGI_at;NM_004044;ATIC;5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase;0,00000000000005420000;1,296831239;0,000819932;1,114386275;0,004269209;0,034975442;1,11856767;0,093703947;0;0;NA;NA;NA
X100131985_TGI_at;100131985_TGI_at;NM_000061;BTK;Bruton agammaglobulinemia tyrosine kinase;0,00000000001700000000;1,443531234;1,32E-05;1,255041493;0,000318541;0,003446716;1,422021686;0,019661534;0;1;U2;U1;U1
X100131991_TGI_at;100131991_TGI_at;AI867675;NFIB;nuclear factor I/B;0,00000000307000000000;0,829330072;0,008347524;0,887110061;0,021714342;0,039046711;0,866940314;0,101245011;0;0;NA;NA;NA
X100132051_TGI_at;100132051_TGI_at;NM_016013;NDUFAF1;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1;0,00000000374000000000;1,220160795;0,002460776;1,141415562;0,00913719;0,086481142;1,105292317;0,179491513;0;0;NA;NA;NA
X100132059_TGI_at;100132059_TGI_at;NM_016240;SCARA3;scavenger receptor class A, member 3;0,00000000000593000000;0,657082886;0,011826238;0,830265312;0,027580294;0,000297835;0,634147863;0,004872704;0;1;D3;D1;D1
X100132099_TGI_at;100132099_TGI_at;NM_007148;RNF112;ring finger protein 112;0,00000001150000000000;0,796333774;0,001886216;0,869052586;0,007662265;0,01806578;0,7939303;0,05881415;0;0;NA;NA;NA
X100132114_TGI_at;100132114_TGI_at;AW873072;DSC2;desmocollin 2;0,00000000985000000000;1,394873031;0,002239351;1,259662657;0,008591489;0,100265293;1,229404392;0,198776243;0;0;NA;NA;NA
X100132116_TGI_at;100132116_TGI_at;AJ272065;RAB20;RAB20, member RAS oncogene family;0,00000023900000000000;1,255740985;0,166942325;1,077913586;0,212670005;0,010314762;1,304437747;0,040961273;0;0;NA;NA;NA
X100132157_TGI_at;100132157_TGI_at;NM_000878;IL2RB;interleukin 2 receptor, beta;0,00000000190000000000;0,683161584;0,122932283;0,896447986;0,165501566;0,37483693;1,076717433;0,511473085;0;0;NA;NA;NA
X100132205_TGI_at;100132205_TGI_at;NM_015147;CEP68;centrosomal protein 68kDa;0,00000002880000000000;0,808626547;0,150625107;0,946539567;0,195200932;0,122857837;0,872636585;0,229149774;0;0;NA;NA;NA
X100132237_TGI_at;100132237_TGI_at;NM_018843;SLC25A40;solute carrier family 25, member 40;0,00000000006310000000;1,471399314;0,000104664;1,274496179;0,00106414;0,039046711;1,182328686;0,101245011;0;0;NA;NA;NA
X100132242_TGI_at;100132242_TGI_at;NM_005412;SHMT2;serine hydroxymethyltransferase 2 (mitochondrial);0,00000000000054500000;1,283790561;0,190961296;1,033998518;0,239202587;0,007777056;1,154549346;0,034055789;0;0;NA;NA;NA
X100132253_TGI_at;100132253_TGI_at;NM_019089;HES2;hairy and enhancer of split 2 (Drosophila);0,00000000065000000000;1,554423257;0,002712805;1,25797668;0,009736492;0,215747939;1,137979984;0,344576615;0;0;NA;NA;NA
X100132265_TGI_at;100132265_TGI_at;NM_001511;CXCL1;chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha);0,00000033700000000000;2,261386425;0,003133427;1,611383423;0,010847514;0,234597793;1,267765719;0,367043051;0;0;NA;NA;NA
X100132318_TGI_at;100132318_TGI_at;NM_002087;GRN;granulin;0,00000000049000000000;1,391793702;0,005326341;1,166118495;0,015749355;0,001600651;1,422595992;0,012613442;0;1;U2;U1;U1
X100132328_TGI_at;100132328_TGI_at;AL514294;SENP3;SUMO1/sentrin/SMT3 specific peptidase 3;0,00000006620000000000;1,267522063;0,073315274;1,096623565;0,110338959;0,039901467;1,157004575;0,101661999;0;0;NA;NA;NA
X100132353_TGI_at;100132353_TGI_at;AK024722;CLIP4;CAP-GLY domain containing linker protein family, member 4;0,00000000000000070600;1,712236514;4,37E-06;1,342962006;0,000158381;0,000320802;1,401564868;0,005118537;0;1;U8;U3;U1
X100132362_TGI_at;100132362_TGI_at;NM_016027;LACTB2;lactamase, beta 2;0,00000026500000000000;1,398243889;0,067035975;1,159513206;0,10337653;0,154336744;1,248569023;0,270635106;0;0;NA;NA;NA
X100132368_TGI_at;100132368_TGI_at;NM_015252;EHBP1;EH domain binding protein 1;0,00000000008490000000;0,824304218;0,482889321;0,974665925;0,524200836;0,203149235;0,926670801;0,330514884;0;0;NA;NA;NA
X100132379_TGI_at;100132379_TGI_at;ENST00000369303;EPHA7;EPH receptor A7;0,00000002250000000000;0,605772324;0,168691726;0,867186736;0,214474727;9,98E-05;0,517876682;0,003183838;0;0;NA;NA;NA
X100132386_TGI_at;100132386_TGI_at;NM_002941;ROBO1;roundabout, axon guidance receptor, homolog 1 (Drosophila);0,00000001320000000000;0,812704484;0,009079637;0,913336439;0,023054415;0,000803319;0,850201607;0,008256949;0;1;D2;D1;D1
X100132388_TGI_at;100132388_TGI_at;BC015818;LGALS8;lectin, galactoside-binding, soluble, 8;0,00000000367000000000;1,224382346;0,014112434;1,088523986;0,031411861;0,784830893;0,981126777;0,861549716;0;0;NA;NA;NA
X100132406_TGI_at;100132406_TGI_at;NM_024015;HOXB4;homeobox B4;0,00000074800000000000;0,782123694;0,001110836;0,834121729;0,00521139;3,92E-05;0,744737687;0,001884006;0;1;D1;D1;D1
X100132426_TGI_at;100132426_TGI_at;AF468213;LGALS8;lectin, galactoside-binding, soluble, 8;0,00000000003520000000;1,281082719;0,023843515;1,07871165;0,046517947;0,357146031;1,032097782;0,494450884;0;0;NA;NA;NA
X100132434_TGI_at;100132434_TGI_at;NM_006291;TNFAIP2;tumor necrosis factor, alpha-induced protein 2;0,00000000023000000000;1,313884051;0,005673448;1,145153999;0,016384876;0,006071612;1,255308676;0,028156556;0;1;U2;U1;U1
X100132468_TGI_at;100132468_TGI_at;BC007029;PCYOX1;prenylcysteine oxidase 1;0,00000039200000000000;0,798688868;0,852322817;1,020461585;0,86602662;0,016931008;1,409770341;0,056430856;0;0;NA;NA;NA
X100132477_TGI_at;100132477_TGI_at;NM_007249;KLF12;Kruppel-like factor 12;0,00000098600000000000;0,822771848;0,061309086;0,928050431;0,096087432;0,034975442;0,803773479;0,093703947;0;0;NA;NA;NA
X100132509_TGI_at;100132509_TGI_at;NM_030915;LBH;limb bud and heart development homolog (mouse);0,00000003550000000000;0,813186013;0,640628148;0,981193279;0,673432655;0,276598639;0,926572205;0,413486741;0;0;NA;NA;NA
X100132511_TGI_at;100132511_TGI_at;AW853954;EML4;echinoderm microtubule associated protein like 4;0,00000067900000000000;1,244606891;0,032598151;1,092191598;0,058433727;0,03650134;1,168637789;0,096439395;0;0;NA;NA;NA
X100132530_TGI_at;100132530_TGI_at;NM_000540;RYR1;ryanodine receptor 1 (skeletal);0,00000000002150000000;1,671289243;0,000101761;1,341558462;0,001063056;0,080609435;1,266005972;0,170587136;0;0;NA;NA;NA
X100132561_TGI_at;100132561_TGI_at;NM_024307;GDPD3;glycerophosphodiester phosphodiesterase domain containing 3;0,00000000898000000000;0,682295501;0,024416133;0,85122013;0,047377;0,484848197;0,87786633;0,621585418;0;0;NA;NA;NA
X100132603_TGI_at;100132603_TGI_at;ENST00000373304;CYSLTR1;cysteinyl leukotriene receptor 1;0,00000006330000000000;1,335615339;0,001038089;1,152736247;0,004941373;0,200146826;1,213600261;0,328951158;0;0;NA;NA;NA
X100132619_TGI_at;100132619_TGI_at;ENST00000379035;CDC42EP3;CDC42 effector protein (Rho GTPase binding) 3;0,00000061400000000000;1,243061788;0,002239351;1,120268894;0,008591489;0,897250228;1,006556184;0,944437642;0;0;NA;NA;NA
X100132634_TGI_at;100132634_TGI_at;NM_001795;CDH5;cadherin 5, type 2 (vascular endothelium);0,00000000000102000000;0,738254373;0,132693749;0,917548314;0,176359568;0,967010726;1,041088045;0,980394958;0;0;NA;NA;NA
X100132672_TGI_at;100132672_TGI_at;NM_138463;TLCD1;TLC domain containing 1;0,00000000000322000000;1,574736247;0,44529919;1,013569533;0,488661657;0,013270593;1,37571412;0,048111498;0;0;NA;NA;NA
X100132699_TGI_at;100132699_TGI_at;NM_000107;DDB2;damage-specific DNA binding protein 2, 48kDa;0,00000000037100000000;1,421772074;5,13E-05;1,226333107;0,000697125;0,284058212;1,103475268;0,421122179;0;0;NA;NA;NA
X100132703_TGI_at;100132703_TGI_at;AF131837;ST6GALNAC5;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5;0,00000000000301000000;0,625689038;0,05251581;0,819129431;0,084820412;0,267057988;1,286508059;0,403399161;0;0;NA;NA;NA
X100132705_TGI_at;100132705_TGI_at;NM_153029;N4BP1;NEDD4 binding protein 1;0,00000127000000000000;0,817824695;0,013873289;0,833363853;0,031000594;0,197238472;1,157734119;0,324667823;0;0;NA;NA;NA
X100132722_TGI_at;100132722_TGI_at;NM_030965;ST6GALNAC5;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5;0,00000000002860000000;0,674063589;0,085983342;0,827553979;0,125169065;0,392990225;1,265091991;0,532042792;0;0;NA;NA;NA
X100132759_TGI_at;100132759_TGI_at;ENST00000260058;CREBZF;CREB/ATF bZIP transcription factor;0,00000002650000000000;0,798607299;0,414374158;0,998080113;0,459734221;0,004342204;0,827949766;0,022867523;0;0;NA;NA;NA
X100132760_TGI_at;100132760_TGI_at;AL133627;;;0,00000004330000000000;0,744585797;0,59791149;0,96311925;0,632240398;0,215347198;0,853217998;0,344448645;0;0;NA;NA;NA
X100132785_TGI_at;100132785_TGI_at;NM_001375;DNASE2;deoxyribonuclease II, lysosomal;0,00000000060700000000;1,275767382;0,204592141;1,090044068;0,253615565;0,038082294;1,239567217;0,099545202;0;0;NA;NA;NA
X100132821_TGI_at;100132821_TGI_at;NM_015697;COQ2;coenzyme Q2 homolog, prenyltransferase (yeast);0,00000000011000000000;1,353347418;0,000926576;1,14262093;0,004637197;0,010345168;1,192280986;0,040961273;0;1;U2;U1;U1
X100132826_TGI_at;100132826_TGI_at;AU121404;LMCD1;LIM and cysteine-rich domains 1;0,00000000435000000000;0,673518198;0,13925074;0,870688991;0,183335431;0,780651618;1,066193763;0,859890692;0;0;NA;NA;NA
X100132841_TGI_at;100132841_TGI_at;NM_015589;SAMD4A;sterile alpha motif domain containing 4A;0,00000023300000000000;1,373465198;0,724093479;1,026326006;0,74847764;0,009797793;1,249048333;0,039467969;0;0;NA;NA;NA
X100132869_TGI_at;100132869_TGI_at;AL136909;CLPB;ClpB caseinolytic peptidase B homolog (E. coli);0,00000000137000000000;1,434034487;0,053570912;1,064115692;0,08607131;0,066842161;1,14517617;0,148369342;0;0;NA;NA;NA
X100132896_TGI_at;100132896_TGI_at;NM_001024594;C1orf53;chromosome 1 open reading frame 53;0,00000000003050000000;1,500203314;0,000283668;1,258995576;0,002045332;0,003250241;1,3326645;0,019115922;0;1;U3;U1;U1
X100132898_TGI_at;100132898_TGI_at;NM_002456;MUC1;mucin 1, cell surface associated;0,00000000000395000000;1,242793132;0,028046529;1,076419265;0,052351584;0,000461729;1,377664577;0,006049403;0;0;NA;NA;NA
X100132927_TGI_at;100132927_TGI_at;NM_016086;STYXL1;serine/threonine/tyrosine interacting-like 1;0,00000018700000000000;1,202709122;0,568383551;0,996207001;0,604388051;0,797584764;0,95866088;0,871690639;0;0;NA;NA;NA
X100132932_TGI_at;100132932_TGI_at;NM_018040;GPATCH2;G patch domain containing 2;0,00000010200000000000;1,231699954;0,000277495;1,204951586;0,002018582;0,323340368;0,950101837;0,462755775;0;0;NA;NA;NA
X100132938_TGI_at;100132938_TGI_at;NM_001085347;TOR2A;torsin family 2, member A;0,00000008720000000000;1,245867235;0,997714917;0,989652248;0,997735624;0,039046711;1,16213982;0,101245011;0;0;NA;NA;NA
X100132946_TGI_at;100132946_TGI_at;NM_003608;GPR65;G protein-coupled receptor 65;0,00000000027900000000;1,364788618;0,004662592;1,194366745;0,01433925;0,004342204;1,436764825;0,022867523;0;1;U7;U2;U1
X100132988_TGI_at;100132988_TGI_at;NM_004227;CYTH3;cytohesin 3;0,00000000410000000000;0,80990123;0,06802814;0,951221976;0,10445674;0,221636126;0,920652999;0,351888292;0;0;NA;NA;NA
X100132994_TGI_at;100132994_TGI_at;NM_030984;TBXAS1;thromboxane A synthase 1 (platelet);0,00000000000017400000;1,506157576;0,0150656;1,139017955;0,032986703;0,000988854;1,470208307;0,009357144;0;1;U6;U1;U1
X100133022_TGI_at;100133022_TGI_at;NM_022126;;phospholysine phosphohistidine inorganic pyrophosphate phosphatase;0,00000117000000000000;1,241491643;0,271640547;1,046698032;0,320812562;0,005437653;1,233728836;0,026196646;0;0;NA;NA;NA
X100133026_TGI_at;100133026_TGI_at;BC041480;;hypothetical protein LOC286189;0,00000000002990000000;1,701434366;0,000120247;1,472170453;0,001174417;0,016349104;1,415287337;0,055233924;0;0;NA;NA;NA
X100133071_TGI_at;100133071_TGI_at;ENST00000344427;;;0,00000000234000000000;1,427435518;4,77E-05;1,284174968;0,000659239;0,00125244;1,422187816;0,010880359;0;1;U1;U2;U1
X100133086_TGI_at;100133086_TGI_at;NM_016209;TRAPPC2L;trafficking protein particle complex 2-like;0,00000000365000000000;1,240455206;0,074386478;1,06628682;0,111406886;0,002081391;1,229860967;0,014968787;0;0;NA;NA;NA
X100133091_TGI_at;100133091_TGI_at;NM_001040033;CD53;CD53 molecule;0,00000000208000000000;1,269296528;0,014775974;1,093688632;0,03261847;0,004131968;1,225868288;0,022121815;0;1;U2;U1;U1
X100133097_TGI_at;100133097_TGI_at;NM_014373;GPR160;G protein-coupled receptor 160;0,00000000000027800000;1,715449997;0,000217614;1,26767783;0,001729115;0,002988929;1,465000958;0,018419346;0;1;U3;U1;U1
X100133099_TGI_at;100133099_TGI_at;NM_001083910;SIRPB1;signal-regulatory protein beta 1;0,00000008270000000000;1,520750004;0,007800348;1,230056237;0,020691786;0,071328394;1,280239743;0,157136987;0;0;NA;NA;NA
X100133101_TGI_at;100133101_TGI_at;ENST00000274335;PIK3R1;phosphoinositide-3-kinase, regulatory subunit 1 (alpha);0,00000038000000000000;0,758374702;0,085210471;0,891282269;0,124324738;0,492644299;0,934818864;0,6285798;0;0;NA;NA;NA
X100133124_TGI_at;100133124_TGI_at;DQ891643;CDS2;CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2;0,00000004700000000000;1,251073016;0,007767151;1,152708419;0,020654725;0,004862758;1,236072189;0,024374289;0;1;U1;U1;U1
X100133130_TGI_at;100133130_TGI_at;BE219210;TUSC3;tumor suppressor candidate 3;0,00000010200000000000;0,778839288;0,001490572;0,838181848;0,00650083;0,050233572;0,795622598;0,121639972;0;0;NA;NA;NA
X100133134_TGI_at;100133134_TGI_at;NM_016267;VGLL1;vestigial like 1 (Drosophila);0,00000085000000000000;0,75923047;0,005463048;0,851616688;0,01600673;0,484848197;1,072536638;0,621585418;0;0;NA;NA;NA
X100133144_TGI_at;100133144_TGI_at;NM_000316;PTHR1;parathyroid hormone receptor 1;0,00000058400000000000;0,734491671;1,99E-05;0,730275772;0,000387055;0,228052747;0,847756475;0,35942005;0;0;NA;NA;NA
X100133158_TGI_at;100133158_TGI_at;NM_001079692;MS4A14;membrane-spanning 4-domains, subfamily A, member 14;0,00000000070700000000;1,665109229;0,000419333;1,463045549;0,002692253;0,004100912;1,691549525;0,022065509;0;1;U1;U1;U1
X100133199_TGI_at;100133199_TGI_at;CK429529;SLC5A8;solute carrier family 5 (iodide transporter), member 8;0,00000008270000000000;2,375640133;0,006385541;1,969295213;0,017849609;0,107219939;1,427197223;0,208174617;0;0;NA;NA;NA
X100133215_TGI_at;100133215_TGI_at;NM_004795;KL;klotho;0,00000001800000000000;0,620983206;0,000507959;0,74115248;0,003065826;0,836152269;1,0396936;0,898605789;0;0;NA;NA;NA
X100133230_TGI_at;100133230_TGI_at;T92996;;;0,00000011100000000000;1,327951478;0,075321601;1,134323381;0,112389593;0,450742398;1,119582365;0,587204022;0;0;NA;NA;NA
X100133255_TGI_at;100133255_TGI_at;NM_002421;MMP1;matrix metallopeptidase 1 (interstitial collagenase);0,00000000000000105000;7,554590102;5,63E-07;3,857168596;4,70E-05;0,5291358;1,179028071;0,660834037;0;0;NA;NA;NA
X100133262_TGI_at;100133262_TGI_at;NM_015595;;Src homology 3 domain-containing guanine nucleotide exchange factor;0,00000003570000000000;0,773985302;0,048467276;0,827679149;0,079617753;0,257214424;1,273118934;0,391963163;0;0;NA;NA;NA
X100133273_TGI_at;100133273_TGI_at;NM_213649;SFXN4;sideroflexin 4;0,00000089300000000000;1,245899527;0,818187906;0,992101361;0,834235881;0,806687836;0,989374108;0,879551723;0;0;NA;NA;NA
X100133288_TGI_at;100133288_TGI_at;NM_022054;KCNK13;potassium channel, subfamily K, member 13;0,00000000271000000000;1,508971346;0,042105435;1,185778555;0,071161939;0,545437832;1,090376115;0,674086662;0;0;NA;NA;NA
X100133298_TGI_at;100133298_TGI_at;NM_002468;MYD88;myeloid differentiation primary response gene (88);0,00000000046100000000;1,292395394;0,00098459;1,160071753;0,004757623;0,025338248;1,187089124;0,074853504;0;0;NA;NA;NA
X100133326_TGI_at;100133326_TGI_at;NM_006100;ST3GAL6;ST3 beta-galactoside alpha-2,3-sialyltransferase 6;0,00000000595000000000;1,305114198;0,03123814;1,08346536;0,056657583;0,137820448;1,168514612;0,249969219;0;0;NA;NA;NA
X100133335_TGI_at;100133335_TGI_at;NM_000185;SERPIND1;serpin peptidase inhibitor, clade D (heparin cofactor), member 1;0,00000000000000005200;13,25693513;9,60E-10;5,647876289;3,44E-07;1,82E-06;5,660269053;0,000730441;1;1;U8;U3;U3
X100133344_TGI_at;100133344_TGI_at;NM_031442;TMEM47;transmembrane protein 47;0,00000000002080000000;0,701277756;0,004265291;0,863290745;0,013424838;0,140181821;0,86770778;0,252829328;0;0;NA;NA;NA
X100133355_TGI_at;100133355_TGI_at;NM_007274;ACOT7;acyl-CoA thioesterase 7;0,00000003580000000000;1,411716636;0,02245672;1,160648159;0,044622694;0,017971918;1,213478578;0,058805575;0;0;NA;NA;NA
X100133375_TGI_at;100133375_TGI_at;NM_007199;IRAK3;interleukin-1 receptor-associated kinase 3;0,00000039000000000000;1,424378495;0,199203783;1,121911524;0,247889495;0,784830893;1,008837216;0,861549716;0;0;NA;NA;NA
X100133379_TGI_at;100133379_TGI_at;ENST00000330692;ZNF829;zinc finger protein 829;0,00000052800000000000;0,821483658;0,359317082;0,951924239;0,406628847;0,829572899;1,0175803;0,894817086;0;0;NA;NA;NA
X100133427_TGI_at;100133427_TGI_at;ENST00000357783;PHTF1;putative homeodomain transcription factor 1;0,00000003390000000000;1,348302525;0,733248303;1,013727722;0,75696966;0,567746993;1,006761104;0,6918142;0;0;NA;NA;NA
X100133460_TGI_at;100133460_TGI_at;BC108284;TRMT5;TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae);0,00000031200000000000;1,207078585;0,265798147;1,038072332;0,315067094;0,284058212;1,054709887;0,421122179;0;0;NA;NA;NA
X100133547_TGI_at;100133547_TGI_at;NM_022082;C20orf59;chromosome 20 open reading frame 59;0,00000000017000000000;1,537266035;0,001522442;1,246049556;0,006576612;0,196882599;1,16624522;0,324667823;0;0;NA;NA;NA
X100133551_TGI_at;100133551_TGI_at;AF033095;TMBIM6;transmembrane BAX inhibitor motif containing 6;0,00000000000000719000;1,256721402;0,002115417;1,166806038;0,00829913;0,004100912;1,184163053;0,022065509;0;1;U1;U1;U1
X100133559_TGI_at;100133559_TGI_at;AK128040;TMEM136;transmembrane protein 136;0,00000000000050900000;0,743424773;0,014591598;0,896040754;0,032299946;0,021425185;0,815055629;0,066397472;0;0;NA;NA;NA
X100133588_TGI_at;100133588_TGI_at;ENST00000374465;PARD3B;par-3 partitioning defective 3 homolog B (C. elegans);0,00000000000888000000;0,755653142;0,033014488;0,896256607;0,058873378;0,421327994;0,956039753;0,560904521;0;0;NA;NA;NA
X100133649_TGI_at;100133649_TGI_at;NM_000685;AGTR1;angiotensin II receptor, type 1;0,00000011700000000000;0,753805442;0,06554722;0,896142462;0,101371732;0,63704437;0,988410011;0,747431382;0;0;NA;NA;NA
X100133673_TGI_at;100133673_TGI_at;NM_181745;GPR120;G protein-coupled receptor 120;0,00000000000124000000;1,7564222;0,00155383;1,456038496;0,006643984;0,000826708;1,598739256;0,008431896;0;1;U2;U1;U1
X100133675_TGI_at;100133675_TGI_at;NM_172069;PLEKHH2;pleckstrin homology domain containing, family H (with MyTH4 domain) member 2;0,00000000000002300000;0,6723832;0,272790044;0,937236351;0,321816366;0,038082294;0,826907442;0,099545202;0;0;NA;NA;NA
X100133715_TGI_at;100133715_TGI_at;NM_002225;IVD;isovaleryl Coenzyme A dehydrogenase;0,00000003780000000000;1,285633057;0,827020574;1,00242767;0,84244226;0,000149203;1,367642894;0,003847048;0;0;NA;NA;NA
X100133718_TGI_at;100133718_TGI_at;AA772087;SGPP2;sphingosine-1-phosphate phosphotase 2;0,00000025800000000000;1,532571416;0,241760217;1,098925904;0,290202302;0,001370872;1,768060432;0,011387427;0;0;NA;NA;NA
X100133720_TGI_at;100133720_TGI_at;NM_030806;C1orf21;chromosome 1 open reading frame 21;0,00000000635000000000;0,783908666;0,0688894;0,945326092;0,10547769;0,018620907;1,228227642;0,060256208;0;0;NA;NA;NA
X100133738_TGI_at;100133738_TGI_at;NM_001645;APOC1;apolipoprotein C-I;0,00000000000634000000;1,359268241;0,036531194;1,096837713;0,063884991;7,39E-05;1,454293164;0,002647619;0;0;NA;NA;NA
X100133742_TGI_at;100133742_TGI_at;NM_004946;DOCK2;dedicator of cytokinesis 2;0,00000010800000000000;1,306285022;0,009411023;1,153045096;0,023512966;7,94E-06;1,42960903;0,001170948;0;1;U4;U1;U1
X100133783_TGI_at;100133783_TGI_at;NM_024786;ZDHHC11;zinc finger, DHHC-type containing 11;0,00000127000000000000;0,621446615;0,002563706;0,711069572;0,009378915;0,209185181;1,2295394;0,337324278;0;0;NA;NA;NA
X100133793_TGI_at;100133793_TGI_at;NM_198393;TEX14;testis expressed 14;0,00000000001020000000;1,867042117;1,05E-05;1,568163848;0,000281013;0,001340028;1,642652803;0,011387427;0;1;U2;U2;U1
X100133799_TGI_at;100133799_TGI_at;NM_000101;CYBA;cytochrome b-245, alpha polypeptide;0,00000000068600000000;1,472355931;0,010183485;1,147126351;0,024967324;0,004654763;1,467847049;0,023927113;0;1;U1;U1;U1
X100133844_TGI_at;100133844_TGI_at;CR457348;TMEM53;transmembrane protein 53;0,00000000043400000000;1,461066323;0,135092127;1,077897692;0,178736423;0,000574164;1,463085854;0,006879298;0;0;NA;NA;NA
X100133867_TGI_at;100133867_TGI_at;AK025495;SASH1;SAM and SH3 domain containing 1;0,00000012400000000000;0,80080416;0,000114452;0,811710499;0,00112807;0,107219939;1,15608608;0,208174617;0;0;NA;NA;NA
X100133883_TGI_at;100133883_TGI_at;BC051306;CCR1;chemokine (C-C motif) receptor 1;0,00000000084800000000;1,56305682;0,008469659;1,228816874;0,02197743;0,010855277;1,56278182;0,041904859;0;1;U2;U1;U1
X100133900_TGI_at;100133900_TGI_at;NM_004484;GPC3;glypican 3;0,00000000000001400000;0,645349116;7,84E-05;0,760752607;0,000892421;0,086481142;0,883944336;0,179491513;0;0;NA;NA;NA
X100133912_TGI_at;100133912_TGI_at;AW072050;MYO9B;myosin IXB;0,00000001080000000000;1,397298186;0,004102979;1,131896827;0,013054196;0,06589724;1,20151321;0,147695969;0;0;NA;NA;NA
X100133917_TGI_at;100133917_TGI_at;NM_001004303;C1orf168;chromosome 1 open reading frame 168;0,00000006510000000000;0,589163679;0,092738173;0,758025865;0,132783266;0,048807143;0,628505682;0,118721072;0;0;NA;NA;NA
X100133958_TGI_at;100133958_TGI_at;NM_018840;C20orf24;chromosome 20 open reading frame 24;0,00000000004540000000;1,271667242;0,288796926;1,034266949;0,337855714;0,161066496;1,089264136;0,279095331;0;0;NA;NA;NA
X100133964_TGI_at;100133964_TGI_at;CR933682;PEG3;paternally expressed 3;0,00000000083000000000;0,710139376;0,001025116;0,818506976;0,004894737;0,022436456;0,734550783;0,06841315;0;0;NA;NA;NA
X100133983_TGI_at;100133983_TGI_at;NM_053279;FAM167A;family with sequence similarity 167, member A;0,00000000002290000000;0,578332834;0,079940239;0,825695464;0,117862484;0,033503156;1,413076224;0,091046096;0;0;NA;NA;NA
X100133985_TGI_at;100133985_TGI_at;NM_001333;CTSL2;cathepsin L2;0,00000009960000000000;0,641531513;0,546674998;0,921249246;0,584195464;0,044986133;0,722601717;0,111445279;0;0;NA;NA;NA
X100133997_TGI_at;100133997_TGI_at;NM_153236;GIMAP7;GTPase, IMAP family member 7;0,00000000075600000000;0,71158318;0,0150656;0,88045177;0,032986703;0,810391779;0,989584911;0,881205366;0;0;NA;NA;NA
X100134020_TGI_at;100134020_TGI_at;ENST00000296858;ATXN1;ataxin 1;0,00000002090000000000;1,233034199;0,004662592;1,103090013;0,01433925;0,022436456;1,139739082;0,06841315;0;0;NA;NA;NA
X100134027_TGI_at;100134027_TGI_at;NM_001138;AGRP;agouti related protein homolog (mouse);0,00000000091900000000;1,479900229;0,068103114;1,170540621;0,104472317;0,003720657;1,395762773;0,020759189;0;0;NA;NA;NA
X100134049_TGI_at;100134049_TGI_at;AK124702;;;0,00000096900000000000;0,809906389;0,392976666;0,924627059;0,439169138;0,059535454;0,793675751;0,137945916;0;0;NA;NA;NA
X100134055_TGI_at;100134055_TGI_at;NM_000784;CYP27A1;cytochrome P450, family 27, subfamily A, polypeptide 1;0,00000000000000012700;1,7757864;9,26E-05;1,299259605;0,001014885;9,68E-06;1,656457459;0,001248259;0;1;U4;U2;U1
X100134072_TGI_at;100134072_TGI_at;NM_001428;ENO1;enolase 1, (alpha);0,00000064800000000000;1,277358233;0,306580596;1,032711189;0,355562886;0,003871569;1,257410823;0,021358785;0;0;NA;NA;NA
X100134077_TGI_at;100134077_TGI_at;NM_002094;GSPT1;G1 to S phase transition 1;0,00000000256000000000;1,250248113;0,02245672;1,090467842;0,044622694;0,016136566;1,149074028;0,054745423;0;0;NA;NA;NA
X100134109_TGI_at;100134109_TGI_at;DQ893643;PDE1C;phosphodiesterase 1C, calmodulin-dependent 70kDa;0,00000066400000000000;0,78086604;0,031041531;0,869813279;0,056428006;0,613556941;1,036406341;0,727019861;0;0;NA;NA;NA
X100134122_TGI_at;100134122_TGI_at;NM_078483;SLC36A1;solute carrier family 36 (proton/amino acid symporter), member 1;0,00000001810000000000;1,422324476;0,023984572;1,130065152;0,046764837;0,190864759;1,118734915;0,318230865;0;0;NA;NA;NA
X100134141_TGI_at;100134141_TGI_at;NM_018413;CHST11;carbohydrate (chondroitin 4) sulfotransferase 11;0,00000000011300000000;1,454517214;0,011258261;1,121515566;0,026680893;0,093170847;1,1232693;0,188856657;0;0;NA;NA;NA
X100134144_TGI_at;100134144_TGI_at;CA429631;STK32A;serine/threonine kinase 32A;0,00000025200000000000;1,377437929;0,662513641;1,017295935;0,692823317;0,698315981;0,934320528;0,796134562;0;0;NA;NA;NA
X100134151_TGI_at;100134151_TGI_at;ENST00000372725;MYST4;MYST histone acetyltransferase (monocytic leukemia) 4;0,00000000000504000000;0,814197361;0,856816856;0,993575632;0,869770307;0,383877774;0,95622502;0,520942343;0;0;NA;NA;NA
X100134167_TGI_at;100134167_TGI_at;ENST00000312785;PLAC2;placenta-specific 2 (non-protein coding);0,00000017900000000000;0,669998479;0,093855869;0,856897781;0,133848436;0,545460135;1,122868415;0,674086662;0;0;NA;NA;NA
X100134188_TGI_at;100134188_TGI_at;ENST00000369697;KCND3;potassium voltage-gated channel, Shal-related subfamily, member 3;0,00000001560000000000;1,408678754;0,007415148;1,217575149;0,019932462;0,534478464;1,05559069;0,664336324;0;0;NA;NA;NA
X100134205_TGI_at;100134205_TGI_at;NM_021804;ACE2;angiotensin I converting enzyme (peptidyl-dipeptidase A) 2;0,00000002370000000000;1,422155192;0,153434863;1,115181607;0,198284107;0,026896706;1,156175496;0,078167794;0;0;NA;NA;NA
X100134212_TGI_at;100134212_TGI_at;NM_000034;ALDOA;aldolase A, fructose-bisphosphate;0,00000000070700000000;1,212666024;0,010386329;1,07283984;0,025245201;0,017758754;1,18426544;0,058404554;0;0;NA;NA;NA
X100134219_TGI_at;100134219_TGI_at;NM_032901;C12orf62;chromosome 12 open reading frame 62;0,00000000007700000000;1,200826119;0,045378774;1,046377837;0,075584387;0,000185312;1,212877505;0,004028419;0;0;NA;NA;NA
X100134239_TGI_at;100134239_TGI_at;NM_130847;AMOTL1;angiomotin like 1;0,00000000000554000000;0,818086779;0,006838796;0,902531127;0,018822749;0,255009933;1,045930481;0,38934013;0;0;NA;NA;NA
X100134259_TGI_at;100134259_TGI_at;BC018435;;damage-regulated autophagy modulator;0,00000019900000000000;1,297112405;0,023012864;1,124238319;0,045364196;0,000173465;1,581851373;0,004028419;0;1;U4;U1;U1
X100134262_TGI_at;100134262_TGI_at;AK074637;PTGFRN;prostaglandin F2 receptor negative regulator;0,00000000000751000000;1,538254049;0,006418168;1,204753769;0,017925266;0,26927095;1,164179026;0,405163526;0;0;NA;NA;NA
X100134288_TGI_at;100134288_TGI_at;NM_001091;ABP1;amiloride binding protein 1 (amine oxidase (copper-containing));0,00000000022600000000;1,458170683;0,000669041;1,235584454;0,003711391;0,04205485;1,192220942;0,105810133;0;0;NA;NA;NA
X100134303_TGI_at;100134303_TGI_at;BC090942;;;0,00000000022100000000;1,427151205;0,000355184;1,194768245;0,002379956;0,03016913;1,241789683;0,085594282;0;0;NA;NA;NA
X100134334_TGI_at;100134334_TGI_at;NM_145064;STAC3;SH3 and cysteine rich domain 3;0,00000000220000000000;1,433791073;0,049215579;1,112454077;0,080518686;0,004937402;1,36771393;0,024633511;0;0;NA;NA;NA
X100134346_TGI_at;100134346_TGI_at;NM_001005473;PLCXD3;phosphatidylinositol-specific phospholipase C, X domain containing 3;0,00000000000002210000;0,449971168;1,30E-06;0,646437752;7,52E-05;0,023487994;0,703303294;0,070485851;0;0;NA;NA;NA
X100134356_TGI_at;100134356_TGI_at;BQ446588;;;0,00000007250000000000;0,825606561;0,703275376;0,983161398;0,730472619;0,069102179;1,107988929;0,153169355;0;0;NA;NA;NA
X100134381_TGI_at;100134381_TGI_at;AK074775;LONP2;lon peptidase 2, peroxisomal;0,00000000000271000000;1,321233584;7,92E-05;1,138588448;0,000898638;0,019786991;1,132615164;0,062769164;0;0;NA;NA;NA
X100134409_TGI_at;100134409_TGI_at;NM_033105;DNAJC5B;DnaJ (Hsp40) homolog, subfamily C, member 5 beta;0,00000000000002320000;2,820615033;2,17E-06;2,020292107;0,000101523;4,67E-05;2,027553095;0,002060556;0;1;U6;U3;U1
X100134410_TGI_at;100134410_TGI_at;AF227905;UGCGL1;UDP-glucose ceramide glucosyltransferase-like 1;0,00000000000042600000;1,322458098;0,009388181;1,102898769;0,023512966;0,331593893;1,064854324;0,472261209;0;0;NA;NA;NA
X100134442_TGI_at;100134442_TGI_at;AK095500;;;0,00000000013300000000;1,782435323;0,001429592;1,450869681;0,006303114;0,563622584;0,926838555;0,691231198;0;0;NA;NA;NA
X100134457_TGI_at;100134457_TGI_at;NM_152414;BHLHB5;basic helix-loop-helix domain containing, class B, 5;0,00000057900000000000;1,641348997;0,012735628;1,278230928;0,02927741;0,411774001;0,800764187;0,552978168;0;0;NA;NA;NA
X100134477_TGI_at;100134477_TGI_at;AF237916;MS4A7;membrane-spanning 4-domains, subfamily A, member 7;0,00000000002480000000;1,71386531;0,000185772;1,336318691;0,001548298;5,16E-05;1,835752388;0,002079933;0;1;U2;U2;U1
X100134493_TGI_at;100134493_TGI_at;NM_018648;NOP10;NOP10 ribonucleoprotein homolog (yeast);0,00000000030700000000;1,257538925;0,001458714;1,106804984;0,006396509;3,09E-05;1,270330513;0,001805101;0;1;U1;U1;U1
X100134508_TGI_at;100134508_TGI_at;NM_000404;GLB1;galactosidase, beta 1;0,00000000016700000000;1,276582837;0,000570407;1,14727854;0,003330477;8,46E-05;1,342498966;0,002840678;0;1;U2;U1;U1
X100134529_TGI_at;100134529_TGI_at;ENST00000373965;PCDH15;protocadherin 15;0,00000000106000000000;0,651276776;0,072424474;0,864626429;0,109485966;0,299373904;0,888116253;0,437985516;0;0;NA;NA;NA
X100134532_TGI_at;100134532_TGI_at;AI762077;;hypothetical protein LOC283875;0,00000007230000000000;1,305288643;0,152507196;1,093675297;0,197243456;0,107219939;1,126124345;0,208174617;0;0;NA;NA;NA
X100134592_TGI_at;100134592_TGI_at;DQ891713;CDH13;cadherin 13, H-cadherin (heart);0,00000000024700000000;0,630567987;0,071527072;0,871291207;0,10858773;0,174827775;0,828895187;0,298290058;0;0;NA;NA;NA
X100134611_TGI_at;100134611_TGI_at;CR936651;SIPA1L1;signal-induced proliferation-associated 1 like 1;0,00000000107000000000;0,813005684;0,043023798;0,920841236;0,072259354;0,883640065;1,006129295;0,933455238;0;0;NA;NA;NA
X100134624_TGI_at;100134624_TGI_at;NM_016615;SLC6A13;solute carrier family 6 (neurotransmitter transporter, GABA), member 13;0,00000013400000000000;1,279101367;0,123311312;1,0798208;0,165873271;0,004100912;1,308892271;0,022065509;0;0;NA;NA;NA
X100134628_TGI_at;100134628_TGI_at;NM_002381;MATN3;matrilin 3;0,00000000004050000000;0,553881079;0,232169449;0,855298487;0,281097721;0,69730432;0,945849596;0,795825717;0;0;NA;NA;NA
X100134631_TGI_at;100134631_TGI_at;AI681842;RBM9;RNA binding motif protein 9;0,00000001360000000000;0,831376479;0,83587518;0,993210581;0,850421991;0,849099163;0,954935144;0,906474529;0;0;NA;NA;NA
X100134643_TGI_at;100134643_TGI_at;NM_001045;SLC6A4;solute carrier family 6 (neurotransmitter transporter, serotonin), member 4;0,00000000159000000000;0,425936817;0,002168837;0,627173484;0,008436864;0,829572899;0,985465738;0,894817086;0;0;NA;NA;NA
X100134671_TGI_at;100134671_TGI_at;NM_007256;SLCO2B1;solute carrier organic anion transporter family, member 2B1;0,00000000502000000000;1,255484372;0,00127124;1,16882914;0,005706417;0,093036384;1,204974951;0,188856657;0;0;NA;NA;NA
X100134706_TGI_at;100134706_TGI_at;NM_005771;DHRS9;dehydrogenase/reductase (SDR family) member 9;0,00000003380000000000;1,699439926;0,441838545;1,126456513;0,485690869;0,862086046;0,923939574;0,916392918;0;0;NA;NA;NA
X100134746_TGI_at;100134746_TGI_at;NM_001001555;GRB10;growth factor receptor-bound protein 10;0,00000020500000000000;0,796965646;0,000669041;0,844854479;0,003711391;0,567746993;1,043458535;0,6918142;0;0;NA;NA;NA
X100134766_TGI_at;100134766_TGI_at;BC038440;GALNT1;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1);0,00000092200000000000;1,235845827;0,133321827;1,042589604;0,17692005;0,215747939;1,161991823;0,344576615;0;0;NA;NA;NA
X100134770_TGI_at;100134770_TGI_at;BC073171;SNX5;sorting nexin 5;0,00000002440000000000;1,606460796;0,074246935;1,169281378;0,111406886;0,784830893;0,984548273;0,861549716;0;0;NA;NA;NA
X100134827_TGI_at;100134827_TGI_at;NM_001037738;NPM1;nucleophosmin (nucleolar phosphoprotein B23, numatrin);0,00000000000000096700;1,338235784;0,000121772;1,140225448;0,001185712;0,086710607;1,092866316;0,179491513;0;0;NA;NA;NA
X100134851_TGI_at;100134851_TGI_at;NM_015488;PNKD;paroxysmal nonkinesigenic dyskinesia;0,00000000000199000000;1,447926363;0,027050695;1,149736715;0,050955225;0,001064529;1,369313318;0,009747097;0;0;NA;NA;NA
X100134858_TGI_at;100134858_TGI_at;BC037549;GK;glycerol kinase;0,00000000000056600000;1,991369303;0,005403783;1,274267509;0,015905381;0,007101333;1,342522929;0,031892454;0;1;U2;U1;U1
X100134936_TGI_at;100134936_TGI_at;NM_198488;FAM83H;family with sequence similarity 83, member H;0,00000008950000000000;1,203486996;0,230332759;1,046384467;0,279293635;0,001882981;1,314921905;0,014113602;0;0;NA;NA;NA
X100134997_TGI_at;100134997_TGI_at;AA129758;EIF4E3;eukaryotic translation initiation factor 4E family member 3;0,00000000017200000000;0,791399894;0,000162156;0,84935778;0,001397404;0,421327994;0,968146885;0,560904521;0;0;NA;NA;NA
X100135002_TGI_at;100135002_TGI_at;NM_031950;FGFBP2;fibroblast growth factor binding protein 2;0,00000000220000000000;0,537015664;0,01950916;0,694684182;0,04012637;0,289772413;0,865054839;0,428607841;0;0;NA;NA;NA
X100135009_TGI_at;100135009_TGI_at;BC064492;UBE2I;ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast);0,00000000001820000000;0,773751057;0,080146196;0,935649558;0,118004197;0,481261259;0,9416683;0,617970134;0;0;NA;NA;NA
X100135028_TGI_at;100135028_TGI_at;NM_001112;ADARB1;adenosine deaminase, RNA-specific, B1 (RED1 homolog rat);0,00000000003730000000;0,679163797;0,000278706;0,823516079;0,002018582;0,036535061;0,805773115;0,096439395;0;0;NA;NA;NA
X100135032_TGI_at;100135032_TGI_at;NM_000584;IL8;interleukin 8;0,00000069800000000000;2,533004292;0,002483526;1,549819868;0,009168847;0,556550302;1,084002708;0,68359818;0;0;NA;NA;NA
X100135068_TGI_at;100135068_TGI_at;NM_006633;IQGAP2;IQ motif containing GTPase activating protein 2;0,00000019200000000000;1,320908244;0,000749376;1,183308021;0,004066058;0,020452962;1,204142878;0,064249412;0;0;NA;NA;NA
X100135088_TGI_at;100135088_TGI_at;NM_003081;SNAP25;synaptosomal-associated protein, 25kDa;0,00000000256000000000;2,098925345;0,001062346;1,544600631;0,005013089;0,411774001;1,142586874;0,552978168;0;0;NA;NA;NA
X100135102_TGI_at;100135102_TGI_at;AI363185;;;0,00000006350000000000;1,390835121;0,030190519;1,145805054;0,055254992;0,284058212;1,151968203;0,421122179;0;0;NA;NA;NA
X100135144_TGI_at;100135144_TGI_at;NM_001033578;SGK3;serum/glucocorticoid regulated kinase family, member 3;0,00000000018200000000;1,351895546;1,32E-05;1,195096818;0,000318541;0,140181821;1,118103068;0,252829328;0;0;NA;NA;NA
X100135186_TGI_at;100135186_TGI_at;NM_004497;FOXA3;forkhead box A3;0,00000012700000000000;1,336735349;0,091296611;1,145503136;0,131185456;0,203149235;1,166517978;0,330514884;0;0;NA;NA;NA
X100135215_TGI_at;100135215_TGI_at;AK095461;VNN1;vanin 1;0,00000020100000000000;1,554760536;0,079940239;1,238141604;0,117862484;0,155979894;1,2254449;0,273070722;0;0;NA;NA;NA
X100135298_TGI_at;100135298_TGI_at;NM_003679;KMO;kynurenine 3-monooxygenase (kynurenine 3-hydroxylase);0,00000000000018100000;1,875346578;1,17E-06;1,598985117;6,95E-05;0,000276376;1,705304497;0,004763426;0;1;U2;U2;U1
X100135319_TGI_at;100135319_TGI_at;NM_138370;;protein kinase-like protein SgK493;0,00000005840000000000;0,718397063;0,00616921;0,832800224;0,017411;0,57904816;0,967705302;0,700552635;0;0;NA;NA;NA
X100135342_TGI_at;100135342_TGI_at;NM_002742;PRKD1;protein kinase D1;0,00000000001060000000;0,74368053;0,001062346;0,855784389;0,005013089;0,110976585;0,892115075;0,212903293;0;0;NA;NA;NA
X100135350_TGI_at;100135350_TGI_at;BC036485;;;0,00000001060000000000;1,332758809;9,65E-06;1,239302565;0,000266398;0,179079095;1,151753995;0,304576213;0;0;NA;NA;NA
X100135351_TGI_at;100135351_TGI_at;BC066363;SDK2;sidekick homolog 2 (chicken);0,00000106000000000000;1,268980092;0,000941238;1,21369302;0,004645604;0,215347198;0,888766403;0,344448645;0;0;NA;NA;NA
X100135383_TGI_at;100135383_TGI_at;NM_004556;NFKBIE;nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon;0,00000025800000000000;1,456041314;0,192544541;1,127530214;0,240998469;0,01262694;1,305487467;0,046447382;0;0;NA;NA;NA
X100135436_TGI_at;100135436_TGI_at;NM_014475;DHDH;dihydrodiol dehydrogenase (dimeric);0,00000000068600000000;1,51123432;0,003674662;1,192399376;0,012122249;0,01269629;1,325881094;0,046447382;0;1;U2;U2;U1
X100135447_TGI_at;100135447_TGI_at;NM_001001974;PLEKHA1;pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1;0,00000050500000000000;0,830869257;0,920876849;0,992470036;0,928075698;0,91266668;0,992001686;0,951873502;0;0;NA;NA;NA
X100135453_TGI_at;100135453_TGI_at;NM_001007224;GIMAP6;GTPase, IMAP family member 6;0,00000000000003100000;0,647956581;8,62E-05;0,818924238;0,000964198;0,810391779;1,041755478;0,881205366;0;0;NA;NA;NA
X100135454_TGI_at;100135454_TGI_at;CF552990;PALLD;palladin, cytoskeletal associated protein;0,00000003860000000000;0,783140892;0,572238526;0,945669782;0,607885553;0,323340368;0,884649301;0,462755775;0;0;NA;NA;NA
X100135471_TGI_at;100135471_TGI_at;NM_001005914;SEMA3B;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B;0,00000000000026200000;0,647725251;0,002325633;0,753679559;0,008756443;0,802816453;0,998103937;0,876241102;0;0;NA;NA;NA
X100135481_TGI_at;100135481_TGI_at;NM_020548;DBI;diazepam binding inhibitor (GABA receptor modulator, acyl-Coenzyme A binding protein);0,00000026800000000000;1,26551188;0,120572663;1,08233074;0,162664585;0,000863569;1,321641662;0,008670668;0;0;NA;NA;NA
X100135501_TGI_at;100135501_TGI_at;NM_003177;SYK;spleen tyrosine kinase;0,00000000000000871000;1,539384599;0,08442861;1,107681209;0,123463435;0,001660524;1,308024884;0,012896073;0;0;NA;NA;NA
X100135507_TGI_at;100135507_TGI_at;NM_001099658;LRRN3;leucine rich repeat neuronal 3;0,00000010900000000000;0,705764543;0,038133346;0,849132879;0,066006324;0,567746993;0,910610017;0,6918142;0;0;NA;NA;NA
X100135521_TGI_at;100135521_TGI_at;NM_031280;MRPS15;mitochondrial ribosomal protein S15;0,00000000000281000000;1,290901464;0,021039396;1,090941683;0,042487451;0,001370872;1,195383046;0,011387427;0;1;U6;U1;U1
X100135523_TGI_at;100135523_TGI_at;NM_194284;CLDN23;claudin 23;0,00000000815000000000;1,249270423;0,091527578;1,069023088;0,131431829;0,229011154;1,137975799;0,360577895;0;0;NA;NA;NA
X100135529_TGI_at;100135529_TGI_at;NM_175629;DNMT3A;DNA (cytosine-5-)-methyltransferase 3 alpha;0,00000027200000000000;1,267061877;0,009079637;1,091700724;0,023054415;0,953827391;0,998833118;0,974385319;0;0;NA;NA;NA
X100135540_TGI_at;100135540_TGI_at;AK024050;UBE2W;ubiquitin-conjugating enzyme E2W (putative);0,00000000364000000000;1,387152748;0,003620908;1,168438162;0,01198171;0,276598639;1,115972932;0,413486741;0;0;NA;NA;NA
X100135554_TGI_at;100135554_TGI_at;BX641069;LPCAT2;lysophosphatidylcholine acyltransferase 2;0,00000002370000000000;1,474456842;0,000260942;1,25476577;0,001951317;0,262074839;1,202640252;0,39749045;0;0;NA;NA;NA
X100135568_TGI_at;100135568_TGI_at;ENST00000360121;SPN;sialophorin;0,00000000159000000000;1,495058779;0,465781141;1,082941733;0,507852712;0,005235058;1,590241427;0,025720413;0;0;NA;NA;NA
X100135603_TGI_at;100135603_TGI_at;NM_017686;GDAP2;ganglioside induced differentiation associated protein 2;0,00000003480000000000;1,219879953;0,005857073;1,130262624;0,016676101;0,131303184;1,110451561;0,240585653;0;0;NA;NA;NA
X100135617_TGI_at;100135617_TGI_at;ENST00000308894;;;0,00000000344000000000;0,640134446;0,000595067;0,735289777;0,003430948;0,299373904;1,205185239;0,437985516;0;0;NA;NA;NA
X100135634_TGI_at;100135634_TGI_at;NM_005544;IRS1;insulin receptor substrate 1;0,00000000027500000000;0,740308965;6,64E-06;0,794094387;0,000217231;0,000295359;0,780554509;0,004872704;0;1;D2;D3;D1
X100135660_TGI_at;100135660_TGI_at;NM_175834;KRT79;keratin 79;0,00000000000000062200;4,053099707;1,89E-08;2,61412424;4,82E-06;0,007460982;1,937991565;0,032940745;0;1;U1;U2;U1
X100135716_TGI_at;100135716_TGI_at;NM_030769;NPL;N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase);0,00000000001360000000;1,837008074;0,001432237;1,306456578;0,006306148;7,16E-05;1,683190573;0,002622099;0;1;U5;U1;U1
X100135727_TGI_at;100135727_TGI_at;NM_001763;CD1A;CD1a molecule;0,00000000000000000073;5,586806736;5,20E-08;3,055024523;8,82E-06;0,000899478;2,127469101;0,008947581;0;1;U2;U2;U1
X100135737_TGI_at;100135737_TGI_at;NM_202000;ACSM3;acyl-CoA synthetase medium-chain family member 3;0,00000000840000000000;1,474746218;0,001679516;1,320482153;0,007096641;0,000753789;1,407754266;0,007913552;0;1;U2;U1;U1
X100135740_TGI_at;100135740_TGI_at;AA904425;;;0,00000020400000000000;0,734785077;0,112555401;0,928286265;0,15370212;0,993400377;1,102772158;0,995253159;0;0;NA;NA;NA
X100135755_TGI_at;100135755_TGI_at;ENST00000260010;TLR2;toll-like receptor 2;0,00000000364000000000;1,29433009;0,772184822;1,034348499;0,792596077;0,039901467;1,177708671;0,101661999;0;0;NA;NA;NA
X100135806_TGI_at;100135806_TGI_at;BC042197;MFSD1;major facilitator superfamily domain containing 1;0,00000000364000000000;1,268815394;0,004028585;1,127102966;0,012868315;0,036535061;1,229414717;0,096439395;0;0;NA;NA;NA
X100135813_TGI_at;100135813_TGI_at;NM_003974;DOK2;docking protein 2, 56kDa;0,00000000202000000000;1,383256581;0,253580906;1,099758102;0,302588397;0,003045158;1,371291175;0,018596182;0;0;NA;NA;NA
X100135818_TGI_at;100135818_TGI_at;NM_018473;THEM2;thioesterase superfamily member 2;0,00000000008760000000;1,322852085;3,36E-05;1,200491299;0,000528049;2,50E-05;1,338279893;0,001789912;0;1;U2;U3;U1
X100135832_TGI_at;100135832_TGI_at;NM_031924;RSPH3;radial spoke 3 homolog (Chlamydomonas);0,00000001280000000000;1,237697908;0,052581813;1,101532517;0,084820412;0,315016309;1,084885824;0,454361033;0;0;NA;NA;NA
X100135836_TGI_at;100135836_TGI_at;NM_000044;AR;androgen receptor;0,00000000000069900000;0,721161604;0,015730028;0,842459188;0,034117012;0,032083057;0,84300447;0,088319445;0;0;NA;NA;NA
X100135885_TGI_at;100135885_TGI_at;NM_016445;PLEK2;pleckstrin 2;0,00000000567000000000;1,654759013;0,001175193;1,289371883;0,005372547;0,846130083;1,018305782;0,906474529;0;0;NA;NA;NA
X100135909_TGI_at;100135909_TGI_at;NM_005276;GPD1;glycerol-3-phosphate dehydrogenase 1 (soluble);0,00000000000122000000;2,072576896;0,000712771;1,77757235;0,003906904;0,000137814;2,677684865;0,003701458;0;1;U2;U1;U1
X100135921_TGI_at;100135921_TGI_at;NM_032108;SEMA6B;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B;0,00000000105000000000;2,141303266;0,002036323;1,361606453;0,008096077;0,086710607;1,397576021;0,179491513;0;0;NA;NA;NA
X100135929_TGI_at;100135929_TGI_at;NM_000262;NAGA;N-acetylgalactosaminidase, alpha-;0,00000000078200000000;1,27974339;0,005475486;1,094715637;0,016028604;0,000256336;1,273029258;0,004600156;0;1;U1;U1;U1
X100135932_TGI_at;100135932_TGI_at;NM_007048;BTN3A1;butyrophilin, subfamily 3, member A1;0,00000000102000000000;0,734014962;0,140775035;0,91890444;0,184663386;0,063309309;0,878414318;0,144202051;0;0;NA;NA;NA
X100135947_TGI_at;100135947_TGI_at;NM_005745;BCAP31;B-cell receptor-associated protein 31;0,00000000001260000000;1,213063125;0,436858759;1,019719255;0,481037164;0,007537159;1,240757593;0,0330507;0;0;NA;NA;NA
X100135979_TGI_at;100135979_TGI_at;NM_018643;TREM1;triggering receptor expressed on myeloid cells 1;0,00000002240000000000;1,411421023;0,088373832;1,170775082;0,127813203;0,000647022;1,665380495;0,007421185;0;0;NA;NA;NA
X100135981_TGI_at;100135981_TGI_at;NM_002416;CXCL9;chemokine (C-X-C motif) ligand 9;0,00000004220000000000;0,450076722;0,030795756;0,683067751;0,056139549;0,209185181;0,661707942;0,337324278;0;0;NA;NA;NA
X100135985_TGI_at;100135985_TGI_at;NM_018043;ANO1;anoctamin 1, calcium activated chloride channel;0,00000000000004840000;0,553268217;0,03123814;0,851176984;0,056657583;0,023889612;0,814694866;0,071425065;0;0;NA;NA;NA
X100136005_TGI_at;100136005_TGI_at;X60502;SPN;sialophorin;0,00000000000099300000;1,490706554;0,075321601;1,179700023;0,112389593;6,19E-05;1,576288287;0,002345748;0;0;NA;NA;NA
X100136008_TGI_at;100136008_TGI_at;L32185;SLC11A1;solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1;0,00000000014600000000;1,79000371;0,029079604;1,219953447;0,053771407;0,012010459;1,577849492;0,044912263;0;0;NA;NA;NA
X100136015_TGI_at;100136015_TGI_at;ENST00000376438;FRMD3;FERM domain containing 3;0,00000091600000000000;0,74435312;0,825464116;0,976090912;0,84112262;0,484848197;0,950704154;0,621585418;0;0;NA;NA;NA
X100136016_TGI_at;100136016_TGI_at;NM_177433;MAGED2;melanoma antigen family D, 2;0,00000013300000000000;0,823112305;0,118560965;0,935843605;0,160488026;0,276598639;0,924713295;0,413486741;0;0;NA;NA;NA
X100136024_TGI_at;100136024_TGI_at;NM_021233;DNASE2B;deoxyribonuclease II beta;0,00000000000000256000;4,305525545;6,92E-07;2,497434244;5,20E-05;3,83E-06;3,117093058;0,000832852;1;1;U2;U2;U1
X100136031_TGI_at;100136031_TGI_at;ENST00000379287;GFOD1;glucose-fructose oxidoreductase domain containing 1;0,00000007270000000000;0,737260106;9,31E-05;0,765669698;0,00101719;0,365926162;0,88478374;0,503363219;0;0;NA;NA;NA
X100136034_TGI_at;100136034_TGI_at;ENST00000339561;CLIC5;chloride intracellular channel 5;0,00000028300000000000;0,756790243;0,774391154;0,981437308;0,794354771;0,411774001;1,155189962;0,552978168;0;0;NA;NA;NA
X100136102_TGI_at;100136102_TGI_at;NM_002854;PVALB;parvalbumin;0,00000000014900000000;2,041691315;1,08E-06;1,615330073;6,67E-05;0,03938351;1,304455298;0,101661999;0;0;NA;NA;NA
X100136114_TGI_at;100136114_TGI_at;U09197;;;0,00000000000499000000;0,652496949;0,003454833;0,813651125;0,011610977;0,836152269;1,018958466;0,898605789;0;0;NA;NA;NA
X100136140_TGI_at;100136140_TGI_at;ENST00000381961;IL7R;interleukin 7 receptor;0,00000101000000000000;0,758672982;0,249184084;0,96204977;0,298003822;0,856524137;0,999667532;0,913191298;0;0;NA;NA;NA
X100136143_TGI_at;100136143_TGI_at;BC018093;TNIK;TRAF2 and NCK interacting kinase;0,00000013700000000000;1,220425341;0,160750194;1,065439556;0,206249154;0,021365663;1,199589496;0,066397472;0;0;NA;NA;NA
X100136145_TGI_at;100136145_TGI_at;NM_153705;KDELC2;KDEL (Lys-Asp-Glu-Leu) containing 2;0,00000058400000000000;0,832212364;0,049786634;0,914737099;0,081287904;0,028121921;0,847006285;0,080853658;0;0;NA;NA;NA
X100136163_TGI_at;100136163_TGI_at;NM_033222;PSIP1;PC4 and SFRS1 interacting protein 1;0,00000000015000000000;0,78791194;0,110665403;0,951405689;0,151776422;0,003446716;0,820612713;0,019661534;0;0;NA;NA;NA
X100136168_TGI_at;100136168_TGI_at;CB243049;NFIB;nuclear factor I/B;0,00000000003780000000;0,804441874;0,461095912;0,957914155;0,503766822;0,560040474;0,995008535;0,687361176;0;0;NA;NA;NA
X100136182_TGI_at;100136182_TGI_at;AK001590;C14orf132;chromosome 14 open reading frame 132;0,00000000041300000000;0,725507198;0,00542123;0,805429864;0,015927644;0,089895036;1,215794291;0,184145191;0;0;NA;NA;NA
X100136196_TGI_at;100136196_TGI_at;NM_052820;CORO2A;coronin, actin binding protein, 2A;0,00000000000593000000;1,407524551;0,232169449;1,055724297;0,281097721;0,018620907;1,262855538;0,060256208;0;0;NA;NA;NA
X100136226_TGI_at;100136226_TGI_at;ENST00000354181;SLC12A6;solute carrier family 12 (potassium/chloride transporters), member 6;0,00000015200000000000;1,275053495;0,008710537;1,171726704;0,022387609;0,776306806;1,018360887;0,85627544;0;0;NA;NA;NA
X100136241_TGI_at;100136241_TGI_at;AI921300;CAPN8;calpain 8;0,00000000003090000000;1,645558875;0,26715;1,101244376;0,316436769;0,000429707;1,759394001;0,005893387;0;0;NA;NA;NA
X100136258_TGI_at;100136258_TGI_at;BC039603;MLL;myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila);0,00000000088300000000;0,790242208;0,081135749;0,958108913;0,119243283;0,545460135;0,952379334;0,674086662;0;0;NA;NA;NA
X100136265_TGI_at;100136265_TGI_at;NM_012302;LPHN2;latrophilin 2;0,00000000000014100000;0,69953412;0,000323497;0,826764725;0,002227841;0,023487994;0,833439961;0,070485851;0;0;NA;NA;NA
X100136272_TGI_at;100136272_TGI_at;BC010527;;;0,00000000067700000000;0,609929307;0,056873236;0,853048738;0,090609213;0,470967706;1,120382057;0,606928795;0;0;NA;NA;NA
X100136307_TGI_at;100136307_TGI_at;NM_018447;TMEM111;transmembrane protein 111;0,00000000000030300000;1,204905722;0,078368269;1,045264497;0,115862812;2,27E-06;1,227519632;0,000730441;0;0;NA;NA;NA
X100136314_TGI_at;100136314_TGI_at;NM_018221;MOBKL1B;MOB1, Mps One Binder kinase activator-like 1B (yeast);0,00000000012500000000;1,531771259;0,00149306;1,234262371;0,006502883;0,127936269;1,16219874;0,236568327;0;0;NA;NA;NA
X100136337_TGI_at;100136337_TGI_at;AK022020;;;0,00000063200000000000;0,800792592;0,000819932;0,831111555;0,004269209;0,888166261;0,96469149;0,935477078;0;0;NA;NA;NA
X100136343_TGI_at;100136343_TGI_at;ENST00000375377;KIAA1462;KIAA1462;0,00000000005780000000;0,684490818;0,000940185;0,802054046;0,004645604;0,784830893;1,008794699;0,861549716;0;0;NA;NA;NA
X100136348_TGI_at;100136348_TGI_at;NM_018659;CYTL1;cytokine-like 1;0,00000000000071500000;3,152505883;3,96E-05;2,022568043;0,000591038;0,215347198;1,174354548;0,344448645;0;0;NA;NA;NA
X100136363_TGI_at;100136363_TGI_at;NM_001042508;C6orf124;chromosome 6 open reading frame 124;0,00000100000000000000;0,754514819;0,018803442;0,810219254;0,038973308;0,080609435;0,805085027;0,170587136;0;0;NA;NA;NA
X100136400_TGI_at;100136400_TGI_at;NM_172246;CSF2RA;colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage);0,00000000000024100000;1,760268238;0,05989;1,205382542;0,094117683;0,004131968;1,435027085;0,022121815;0;0;NA;NA;NA
X100136403_TGI_at;100136403_TGI_at;NM_001005910;IHPK2;inositol hexaphosphate kinase 2;0,00000033400000000000;0,786436773;0,101247036;0,91920522;0,142125085;0,004595971;0,734414906;0,023853166;0;0;NA;NA;NA
X100136418_TGI_at;100136418_TGI_at;NM_015600;ABHD12;abhydrolase domain containing 12;0,00000000001880000000;1,329625402;0,104911384;1,095086762;0,145871178;6,19E-05;1,473445981;0,002345748;0;0;NA;NA;NA
X100136433_TGI_at;100136433_TGI_at;NM_014210;EVI2A;ecotropic viral integration site 2A;0,00000005870000000000;1,463563844;0,003133427;1,155378971;0,010847514;0,008831116;1,361329667;0,036964527;0;1;U3;U1;U1
X100136438_TGI_at;100136438_TGI_at;BC029358;GPR110;G protein-coupled receptor 110;0,00000000000000000362;2,93134115;1,07E-06;1,934637736;6,67E-05;0,001370872;1,822973627;0,011387427;0;1;U8;U3;U1
X100136479_TGI_at;100136479_TGI_at;AJ227890;AGPAT4;1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta);0,00000064200000000000;1,283084388;0,028458518;1,131277629;0,052926602;0,330381396;1,118898407;0,47157628;0;0;NA;NA;NA
X100136515_TGI_at;100136515_TGI_at;NM_021155;CD209;CD209 molecule;0,00000037000000000000;1,532397301;0,005131254;1,480671485;0,015412891;0,491673531;1,110402158;0,627589621;0;0;NA;NA;NA
X100136523_TGI_at;100136523_TGI_at;AK122891;ABLIM1;actin binding LIM protein 1;0,00000000035800000000;0,801868279;0,010883635;0,90557931;0,02611664;0,672949117;1,053712283;0,774063003;0;0;NA;NA;NA
X100136563_TGI_at;100136563_TGI_at;BC005020;PPIF;peptidylprolyl isomerase F (cyclophilin F);0,00000000033900000000;1,464407223;0,040588371;1,112272491;0,069251625;0,203149235;1,116225945;0,330514884;0;0;NA;NA;NA
X100136609_TGI_at;100136609_TGI_at;BC003167;PI4K2A;phosphatidylinositol 4-kinase type 2 alpha;0,00000000638000000000;1,326340367;0,044557843;1,110057129;0,074332261;0,003239583;1,351141707;0,019115922;0;0;NA;NA;NA
X100136610_TGI_at;100136610_TGI_at;NM_003282;TNNI2;troponin I type 2 (skeletal, fast);0,00000075200000000000;1,419531488;0,056843276;1,178519155;0,09060627;0,177060975;1,188281302;0,301461976;0;0;NA;NA;NA
X100136619_TGI_at;100136619_TGI_at;ENST00000337189;FADS1;fatty acid desaturase 1;0,00000000010400000000;1,355719655;0,044206554;1,167106596;0,073860924;0,000219748;1,53151823;0,004272984;0;0;NA;NA;NA
X100136626_TGI_at;100136626_TGI_at;BU754208;SLC6A4;solute carrier family 6 (neurotransmitter transporter, serotonin), member 4;0,00000000133000000000;0,413850426;0,007249714;0,640396273;0,019602206;0,601955364;1,261752042;0,718556347;0;0;NA;NA;NA
X100136654_TGI_at;100136654_TGI_at;NM_005194;CEBPB;CCAAT/enhancer binding protein (C/EBP), beta;0,00000001080000000000;1,230400464;0,049215579;1,089899813;0,080518686;0,901252766;0,996528612;0,944937432;0;0;NA;NA;NA
X100136682_TGI_at;100136682_TGI_at;NM_001017923;C14orf28;chromosome 14 open reading frame 28;0,00000036700000000000;0,731600268;0,553089088;0,963410154;0,589897988;0,742053091;0,952130724;0,830717996;0;0;NA;NA;NA
X100136695_TGI_at;100136695_TGI_at;NM_006735;HOXA2;homeobox A2;0,00000003990000000000;0,735960062;0,08495127;0,894896668;0,124046493;0,262074839;0,881839825;0,39749045;0;0;NA;NA;NA
X100136721_TGI_at;100136721_TGI_at;CD370215;;hypothetical protein LOC100128501;0,00000003210000000000;1,405001441;0,65181757;1,016399561;0,683634243;0,590451681;0,994616644;0,709819384;0;0;NA;NA;NA
X100136728_TGI_at;100136728_TGI_at;NM_002064;GLRX;glutaredoxin (thioltransferase);0,00000000003220000000;1,312048275;0,005717051;1,079057009;0,016466538;0,136822082;1,085728143;0,248858674;0;0;NA;NA;NA
X100136733_TGI_at;100136733_TGI_at;NM_133459;CCBE1;collagen and calcium binding EGF domains 1;0,00000030400000000000;0,704086033;0,210741641;0,844050072;0,259679814;0,039901467;1,427593079;0,101661999;0;0;NA;NA;NA
X100136757_TGI_at;100136757_TGI_at;ENST00000346874;PARD3;par-3 partitioning defective 3 homolog (C. elegans);0,00000000005940000000;0,742119723;9,83E-05;0,805183497;0,001053705;0,721968894;0,922035594;0,81331903;0;0;NA;NA;NA
X100136768_TGI_at;100136768_TGI_at;NM_001039457;ATP6V0B;ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b;0,00000000000012700000;1,405790192;0,003812693;1,120155651;0,012480854;0,000221405;1,358300778;0,004272984;0;1;U2;U1;U1
X100136822_TGI_at;100136822_TGI_at;NM_023940;RASL11B;RAS-like, family 11, member B;0,00000082900000000000;0,666148414;0,112641765;0,842119212;0,15370212;0,060804037;0,716124314;0,140481298;0;0;NA;NA;NA
X100136858_TGI_at;100136858_TGI_at;BC070495;;;0,00000000003500000000;1,866334722;3,37E-07;1,851901618;3,39E-05;0,267057988;1,147353114;0,403399161;0;0;NA;NA;NA
X100136862_TGI_at;100136862_TGI_at;DQ890647;CAV1;caveolin 1, caveolae protein, 22kDa;0,00000000000023500000;0,746377536;0,227927448;0,948773597;0,276581581;0,043170182;1,260997428;0,107774978;0;0;NA;NA;NA
X100136866_TGI_at;100136866_TGI_at;NM_006557;DMRT2;doublesex and mab-3 related transcription factor 2;0,00000001240000000000;0,577244871;0,143862073;0,868196251;0,187795651;0,63704437;0,961534494;0,747431382;0;0;NA;NA;NA
X100136878_TGI_at;100136878_TGI_at;NM_019605;SERTAD4;SERTA domain containing 4;0,00000000018300000000;0,739025162;0,002471725;0,822719143;0,009146232;0,070303136;0,751069145;0,154984274;0;0;NA;NA;NA
X100136926_TGI_at;100136926_TGI_at;NM_003826;NAPG;N-ethylmaleimide-sensitive factor attachment protein, gamma;0,00000000003410000000;1,32753694;0,10457726;1,075325374;0,145532172;0,76311125;0,987744609;0,846063832;0;0;NA;NA;NA
X100136933_TGI_at;100136933_TGI_at;NM_006144;GZMA;granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3);0,00000005530000000000;0,647636821;0,072389816;0,873769468;0,109484925;0,721968894;1,039989836;0,81331903;0;0;NA;NA;NA
X100136959_TGI_at;100136959_TGI_at;AY044655;SNX24;sorting nexin 24;0,00000000002040000000;1,339966014;0,002160237;1,158866753;0,008418916;0,093285696;1,191292023;0,188856657;0;0;NA;NA;NA
X100136963_TGI_at;100136963_TGI_at;BU622441;FKBP7;FK506 binding protein 7;0,00000003110000000000;0,728889085;0,093855869;0,880094612;0,133848436;0,048807143;0,776590226;0,118721072;0;0;NA;NA;NA
X100136969_TGI_at;100136969_TGI_at;ENST00000378518;RER1;RER1 retention in endoplasmic reticulum 1 homolog (S. cerevisiae);0,00000000007710000000;1,214381907;0,001856505;1,10039844;0,007564495;0,000863569;1,147880166;0,008670668;0;1;U5;U1;U1
X100137013_TGI_at;100137013_TGI_at;NM_016112;PKD2L1;polycystic kidney disease 2-like 1;0,00000114000000000000;1,390659764;0,144390383;1,183860743;0,188256555;0,001976212;1,467101348;0,014608557;0;0;NA;NA;NA
X100137058_TGI_at;100137058_TGI_at;NM_004347;CASP5;caspase 5, apoptosis-related cysteine peptidase;0,00000018200000000000;1,563328293;0,053230526;1,254035932;0,085642836;0,026704649;1,403939247;0,077961127;0;0;NA;NA;NA
X100137103_TGI_at;100137103_TGI_at;NM_173505;ANKRD29;ankyrin repeat domain 29;0,00000085000000000000;0,799866627;0,107587048;0,910016084;0,148629685;0,323340368;1,263415589;0,462755775;0;0;NA;NA;NA
X100137126_TGI_at;100137126_TGI_at;AM393174;;DKFZP564O0823 protein;0,00000000387000000000;1,40633373;0,000935197;1,211469816;0,004645604;0,020452962;1,427068353;0,064249412;0;0;NA;NA;NA
X100137144_TGI_at;100137144_TGI_at;AI263926;;;0,00000000306000000000;0,704135501;0,017490744;0,86674509;0,036772777;0,110976585;0,863428581;0,212903293;0;0;NA;NA;NA
X100137153_TGI_at;100137153_TGI_at;NM_152913;TMEM130;transmembrane protein 130;0,00000000323000000000;1,822176375;2,38E-05;1,499899639;0,000441117;0,107219939;1,261498371;0,208174617;0;0;NA;NA;NA
X100137174_TGI_at;100137174_TGI_at;NM_001803;CD52;CD52 molecule;0,00000000037100000000;1,294306267;0,013450431;1,145764024;0,030302638;0,000221405;1,665313207;0,004272984;0;1;U1;U1;U1
X100137190_TGI_at;100137190_TGI_at;BC008968;MYH10;myosin, heavy chain 10, non-muscle;0,00000000037400000000;0,775563978;0,447887452;0,977158216;0,490666641;0,618369026;0,940967658;0,731645878;0;0;NA;NA;NA
X100137227_TGI_at;100137227_TGI_at;NM_000761;CYP1A2;cytochrome P450, family 1, subfamily A, polypeptide 2;0,00000000000002560000;2,461417488;4,28E-07;2,093071541;3,99E-05;0,000163845;2,082094689;0,004028419;0;1;U1;U2;U1
X100137230_TGI_at;100137230_TGI_at;ENST00000336687;TMEM97;transmembrane protein 97;0,00000000630000000000;1,333745669;0,013247552;1,132946569;0,030047513;8,46E-05;1,532958056;0,002840678;0;1;U1;U1;U1
X100137243_TGI_at;100137243_TGI_at;NM_022136;SAMSN1;SAM domain, SH3 domain and nuclear localization signals 1;0,00000004830000000000;1,542664502;0,029927107;1,17773899;0,05498277;0,613556941;1,011277905;0,727019861;0;0;NA;NA;NA
X100137261_TGI_at;100137261_TGI_at;ENST00000371489;FER1L3;fer-1-like 3, myoferlin (C. elegans);0,00000005840000000000;1,261169377;0,09349449;1,049692495;0,133569477;0,072102527;1,206783986;0,157336794;0;0;NA;NA;NA
X100137293_TGI_at;100137293_TGI_at;AK025806;;;0,00000077000000000000;0,810747031;0,000125665;0,83770573;0,001194742;0,567746993;0,985927264;0,6918142;0;0;NA;NA;NA
X100137321_TGI_at;100137321_TGI_at;NM_030762;BHLHB3;basic helix-loop-helix domain containing, class B, 3;0,00000000000000102000;2,105869404;1,62E-05;1,539156047;0,000349371;0,006359107;1,38791328;0,029237377;0;1;U2;U2;U1
X100137323_TGI_at;100137323_TGI_at;AF123757;CLN8;ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation);0,00000022400000000000;1,232511592;0,006801407;1,156613962;0,018767923;7,39E-05;1,276788395;0,002647619;0;1;U1;U3;U1
X100137333_TGI_at;100137333_TGI_at;NM_145728;SYNM;synemin, intermediate filament protein;0,00000000867000000000;0,773577261;0,068103114;0,886487681;0,104472317;0,039719764;0,805122063;0,101661999;0;0;NA;NA;NA
X100137382_TGI_at;100137382_TGI_at;BU783420;CALM3;calmodulin 3 (phosphorylase kinase, delta);0,00000058700000000000;1,232826448;0,485655952;1,035053177;0,526671983;0,032083057;1,175327004;0,088319445;0;0;NA;NA;NA
X100137392_TGI_at;100137392_TGI_at;BC040195;;;0,00000000025600000000;0,58788024;0,002036323;0,71098805;0,008096077;0,157518655;0,88633538;0,275315957;0;0;NA;NA;NA
X100137393_TGI_at;100137393_TGI_at;NM_002095;GTF2E2;general transcription factor IIE, polypeptide 2, beta 34kDa;0,00000000003330000000;1,204560446;0,435129476;1,021751279;0,479460616;0,259760472;0,940792711;0,395282342;0;0;NA;NA;NA
X100137404_TGI_at;100137404_TGI_at;AK098193;ARHGAP24;Rho GTPase activating protein 24;0,00000000000140000000;0,789383146;0,022006892;0,90274326;0,043972854;0,339979528;1,05114605;0,480593868;0;0;NA;NA;NA
X100137417_TGI_at;100137417_TGI_at;NM_004845;PCYT1B;phosphate cytidylyltransferase 1, choline, beta;0,00000000020600000000;0,595986519;1,22E-05;0,596292778;0,000305875;0,002719171;0,634127662;0,017251748;0;1;D6;D3;D1
X100137440_TGI_at;100137440_TGI_at;CB321733;KAL1;Kallmann syndrome 1 sequence;0,00000000006790000000;1,390978976;0,004595721;1,257374578;0,014256025;0,016931008;1,420099104;0,056430856;0;0;NA;NA;NA
X100137456_TGI_at;100137456_TGI_at;NM_198552;FAM89A;family with sequence similarity 89, member A;0,00000000006340000000;1,351616952;0,061452158;1,118718534;0,096087432;0,056742235;1,175675485;0,133003799;0;0;NA;NA;NA
X100137470_TGI_at;100137470_TGI_at;BC062303;SCD;stearoyl-CoA desaturase (delta-9-desaturase);0,00000000092000000000;1,411858672;0,007249714;1,239614657;0,019602206;0,00163372;1,574372969;0,012842631;0;1;U6;U1;U1
X100137479_TGI_at;100137479_TGI_at;ENST00000298635;KIAA1462;KIAA1462;0,00000045700000000000;0,737851782;0,035470814;0,875543253;0,062437156;0,393048057;0,892845093;0,532042792;0;0;NA;NA;NA
X100137484_TGI_at;100137484_TGI_at;AK054863;ABI2;abl interactor 2;0,00000000000131000000;0,738235726;0,748338702;0,992275382;0,770573685;0,203149235;0,884580951;0,330514884;0;0;NA;NA;NA
X100137488_TGI_at;100137488_TGI_at;BC036296;;;0,00000001380000000000;0,786556584;0,284656215;0,941967136;0,333981428;0,953827391;1,014070815;0,974385319;0;0;NA;NA;NA
X100137544_TGI_at;100137544_TGI_at;NM_000137;FAH;fumarylacetoacetate hydrolase (fumarylacetoacetase);0,00000006680000000000;1,245398761;0,688121323;0,99198556;0,716117218;0,002988929;1,218744033;0,018419346;0;0;NA;NA;NA
X100137554_TGI_at;100137554_TGI_at;NM_001031740;MANEAL;mannosidase, endo-alpha-like;0,00000030900000000000;1,300434369;0,002752849;1,177327248;0,009825507;0,100003042;1,195811738;0,198466629;0;0;NA;NA;NA
X100137557_TGI_at;100137557_TGI_at;NM_001532;SLC29A2;solute carrier family 29 (nucleoside transporters), member 2;0,00000039000000000000;1,28839243;0,964249928;1,018750106;0,967853478;0,209323164;1,151820081;0,337324278;0;0;NA;NA;NA
X100137573_TGI_at;100137573_TGI_at;NM_001399;EDA;ectodysplasin A;0,00000000940000000000;0,762154552;0,009411023;0,87841572;0,023512966;0,481261259;0,943200495;0,617970134;0;0;NA;NA;NA
X100137574_TGI_at;100137574_TGI_at;NM_001543;NDST1;N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 1;0,00000005090000000000;0,823160881;0,046032072;0,906642424;0,076356855;0,034975442;1,252843005;0,093703947;0;0;NA;NA;NA
X100137591_TGI_at;100137591_TGI_at;BC027588;RP5-1022P6.2;hypothetical protein KIAA1434;0,00000000420000000000;1,483050861;0,002483526;1,223986821;0,009168847;0,093170847;1,154156526;0,188856657;0;0;NA;NA;NA
X100137598_TGI_at;100137598_TGI_at;NM_000098;CPT2;carnitine palmitoyltransferase II;0,00000000002020000000;1,249328893;0,122671034;1,096198118;0,165218864;0,010314762;1,276820982;0,040961273;0;0;NA;NA;NA
X100137613_TGI_at;100137613_TGI_at;ENST00000368870;RFX5;regulatory factor X, 5 (influences HLA class II expression);0,00000038300000000000;1,282656284;0,359537778;1,062098068;0,406735788;0,010314762;1,23384813;0,040961273;0;0;NA;NA;NA
X100137640_TGI_at;100137640_TGI_at;BC042629;TYSND1;trypsin domain containing 1;0,00000027500000000000;1,247479184;0,110978562;1,047963186;0,15207649;0,197238472;1,115508183;0,324667823;0;0;NA;NA;NA
X100137653_TGI_at;100137653_TGI_at;NM_024630;ZDHHC14;zinc finger, DHHC-type containing 14;0,00000010300000000000;0,787481973;0,10635186;0,93448746;0,147428836;0,736968995;0,989662623;0,825599955;0;0;NA;NA;NA
X100137655_TGI_at;100137655_TGI_at;NM_033380;COL4A5;collagen, type IV, alpha 5;0,00000001040000000000;0,737269305;0,089449084;0,915036932;0,129106314;0,064330368;0,838400593;0,144788251;0;0;NA;NA;NA
X100137720_TGI_at;100137720_TGI_at;NM_002815;PSMD11;proteasome (prosome, macropain) 26S subunit, non-ATPase, 11;0,00000000095700000000;1,213546716;0,028922097;1,070850365;0,053541595;0,018980373;1,136381602;0,060869395;0;0;NA;NA;NA
X100137745_TGI_at;100137745_TGI_at;NM_005920;MEF2D;myocyte enhancer factor 2D;0,00000003770000000000;0,832754567;0,246092788;0,966297435;0,294963576;0,411774001;0,950695227;0,552978168;0;0;NA;NA;NA
X100137755_TGI_at;100137755_TGI_at;AB050194;ATXN3;ataxin 3;0,00000000000141000000;1,440282401;0,07705074;1,092352463;0,114387165;0,140181821;1,144746971;0,252829328;0;0;NA;NA;NA
X100137809_TGI_at;100137809_TGI_at;NM_014186;COMMD9;COMM domain containing 9;0,00000000000145000000;1,266426434;0,166579462;1,069450361;0,212375635;0,002812489;1,243516896;0,017739047;0;0;NA;NA;NA
X100137814_TGI_at;100137814_TGI_at;NM_002965;S100A9;S100 calcium binding protein A9;0,00000030100000000000;1,472678751;0,83587518;0,972571531;0,850421991;0,100344073;1,31140348;0,198776243;0;0;NA;NA;NA
X100137819_TGI_at;100137819_TGI_at;BX118690;;;0,00000023000000000000;1,375118756;0,010370688;1,207844494;0,025245201;0,431008093;1,076770883;0,568620174;0;0;NA;NA;NA
X100137821_TGI_at;100137821_TGI_at;NM_022052;NXF3;nuclear RNA export factor 3;0,00000001590000000000;0,609895943;0,109390801;0,853439375;0,150284122;0,993400377;1,000464839;0,995253159;0;0;NA;NA;NA
X100137870_TGI_at;100137870_TGI_at;AF173378;MRTO4;mRNA turnover 4 homolog (S. cerevisiae);0,00000007500000000000;1,25566855;0,098435093;1,066870073;0,138721602;0,365926162;1,076230063;0,503363219;0;0;NA;NA;NA
X100137882_TGI_at;100137882_TGI_at;BM547919;EFHD2;EF-hand domain family, member D2;0,00000007190000000000;1,480176299;0,009906539;1,178495618;0,024522868;0,000253386;1,460273173;0,004600156;0;1;U2;U1;U1
X100137939_TGI_at;100137939_TGI_at;NM_024875;SYNPO2L;synaptopodin 2-like;0,00000001280000000000;0,687562996;0,116269207;0,873494293;0,158049622;0,618369026;1,073071407;0,731645878;0;0;NA;NA;NA
X100137941_TGI_at;100137941_TGI_at;NM_002223.1;ITPR2;inositol 1,4,5-triphosphate receptor, type 2;0,00000000278000000000;1,302370635;0,000128626;1,184283453;0,001204762;0,01262694;1,193844007;0,046447382;0;1;U7;U2;U1
X100137945_TGI_at;100137945_TGI_at;BC101645;GCOM1;GRINL1A complex locus;0,00000000019900000000;0,635519004;0,386718587;0,901510577;0,43337761;0,26927095;1,185099547;0,405163526;0;0;NA;NA;NA
X100137980_TGI_at;100137980_TGI_at;AK096761;;hypothetical protein LOC284080;0,00000000759000000000;0,632643029;0,000145381;0,71325573;0,001294369;0,276598639;0,868906163;0,413486741;0;0;NA;NA;NA
X100137990_TGI_at;100137990_TGI_at;NM_004567;PFKFB4;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4;0,00000001700000000000;1,345959445;0,037503666;1,148821871;0,065302169;0,365926162;1,128997456;0,503363219;0;0;NA;NA;NA
X100138029_TGI_at;100138029_TGI_at;ENST00000313875;LIMCH1;LIM and calponin homology domains 1;0,00000001440000000000;0,811162369;0,892924387;0,976244139;0,902444434;0,185788694;1,185840578;0,311548887;0;0;NA;NA;NA
X100138035_TGI_at;100138035_TGI_at;AL832168;;;0,00000004450000000000;1,241811149;0,016503034;1,147856247;0,035341712;0,18024766;1,108475472;0,304954439;0;0;NA;NA;NA
X100138058_TGI_at;100138058_TGI_at;AK125235;LRCH3;leucine-rich repeats and calponin homology (CH) domain containing 3;0,00000000003190000000;0,802259199;0,090534847;0,940322183;0,13033267;0,91436561;1,02091406;0,951873502;0;0;NA;NA;NA
X100138082_TGI_at;100138082_TGI_at;NM_015364;LY96;lymphocyte antigen 96;0,00000000000011700000;1,693050826;0,000368513;1,206161873;0,002453959;0,016301258;1,263386338;0,055233924;0;0;NA;NA;NA
X100138094_TGI_at;100138094_TGI_at;AK125718;ATAD2B;ATPase family, AAA domain containing 2B;0,00000118000000000000;1,213017075;0,000144665;1,158564504;0,001291564;0,590451681;1,041056499;0,709819384;0;0;NA;NA;NA
X100138098_TGI_at;100138098_TGI_at;ENST00000370721;LPHN2;latrophilin 2;0,00000000009050000000;0,667465026;0,018422499;0,839903734;0,038257549;0,491673531;0,91732332;0,627589621;0;0;NA;NA;NA
X100138129_TGI_at;100138129_TGI_at;ENST00000302728;SVEP1;sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1;0,00000001590000000000;0,75510233;0,302922556;0,918434025;0,352207575;0,152409103;0,883604333;0,268716924;0;0;NA;NA;NA
X100138166_TGI_at;100138166_TGI_at;AK001912;CPSF2;cleavage and polyadenylation specific factor 2, 100kDa;0,00000000296000000000;1,278551071;0,017801931;1,13194524;0,037208576;0,357146031;1,120948314;0,494450884;0;0;NA;NA;NA
X100138168_TGI_at;100138168_TGI_at;AI963994;TACC1;transforming, acidic coiled-coil containing protein 1;0,00000040200000000000;0,812675882;0,813780137;0,99693454;0,830529886;0,618314835;1,049952122;0,731645878;0;0;NA;NA;NA
X100138170_TGI_at;100138170_TGI_at;NM_018930;PCDHB10;protocadherin beta 10;0,00000053100000000000;0,65193668;0,445215162;0,9259865;0,488661657;0,093170847;0,756711298;0,188856657;0;0;NA;NA;NA
X100138175_TGI_at;100138175_TGI_at;NM_004848;C1orf38;chromosome 1 open reading frame 38;0,00000000002650000000;1,451932804;0,002979003;1,164813373;0,010458963;0,001221875;1,347691067;0,010701369;0;1;U5;U1;U1
X100138180_TGI_at;100138180_TGI_at;AK056245;;;0,00000000003230000000;1,459191456;2,16E-05;1,246204779;0,000410363;0,244066946;1,099032186;0,378004693;0;0;NA;NA;NA
X100138219_TGI_at;100138219_TGI_at;DC354601;FGA;fibrinogen alpha chain;0,00000000103000000000;1,74772274;2,78E-05;2,053394251;0,000479188;0,002645386;1,464892069;0,017224404;0;1;U2;U2;U1
X100138248_TGI_at;100138248_TGI_at;AK123079;;hypothetical protein LOC100128893;0,00000037300000000000;0,832324674;0,051805827;0,901779101;0,083973089;0,772133359;1,002977207;0,852547385;0;0;NA;NA;NA
X100138306_TGI_at;100138306_TGI_at;NM_004805;POLR2D;polymerase (RNA) II (DNA directed) polypeptide D;0,00000038000000000000;1,201052828;0,306580596;1,057223987;0,355562886;0,393048057;1,06554403;0,532042792;0;0;NA;NA;NA
X100138311_TGI_at;100138311_TGI_at;NM_014293;NPTXR;neuronal pentraxin receptor;0,00000079000000000000;0,791263016;0,008661579;0,87029504;0,022279544;0,002886902;0,804526551;0,017893238;0;1;D1;D1;D1
X100138331_TGI_at;100138331_TGI_at;NM_015090;NFASC;neurofascin homolog (chicken);0,00000000018700000000;0,710280167;0,017705979;0,876167576;0,037152586;0,504461526;0,929746771;0,639606411;0;0;NA;NA;NA
X100138336_TGI_at;100138336_TGI_at;NM_006573;TNFSF13B;tumor necrosis factor (ligand) superfamily, member 13b;0,00000000045300000000;1,422942733;0,162486577;1,107468792;0,208228325;0,01554453;1,309783562;0,052959853;0;0;NA;NA;NA
X100138360_TGI_at;100138360_TGI_at;NM_032995;ARHGEF4;Rho guanine nucleotide exchange factor (GEF) 4;0,00000040000000000000;0,749669329;0,016268394;0,837588794;0,035002026;0,810391779;0,982684459;0,881205366;0;0;NA;NA;NA
X100138368_TGI_at;100138368_TGI_at;NM_004878;PTGES;prostaglandin E synthase;0,00000000105000000000;1,571369114;0,710337995;1,067306207;0,7356746;0,836152269;1,032828072;0,898605789;0;0;NA;NA;NA
X100138388_TGI_at;100138388_TGI_at;NM_012304;FBXL7;F-box and leucine-rich repeat protein 7;0,00000002050000000000;0,779860433;0,062262892;0,898891969;0,097084325;0,005685907;0,832904644;0,027149152;0;0;NA;NA;NA
X100138450_TGI_at;100138450_TGI_at;NM_001238;CCNE1;cyclin E1;0,00000002120000000000;1,390672528;0,000437679;1,321863955;0,002760548;0,013270593;1,227131037;0,048111498;0;1;U1;U1;U1
X100138457_TGI_at;100138457_TGI_at;NM_001005376;PLAUR;plasminogen activator, urokinase receptor;0,00000000000000552000;2,101398345;1,80E-05;1,469294024;0,0003666;0,000137814;1,539263153;0,003701458;0;1;U5;U3;U1
X100138461_TGI_at;100138461_TGI_at;AA810907;;;0,00000000012600000000;1,578169394;0,020109172;1,208140342;0,041020393;0,197238472;1,176765771;0,324667823;0;0;NA;NA;NA
X100138479_TGI_at;100138479_TGI_at;NM_005393;PLXNB3;plexin B3;0,00000001500000000000;0,733873474;0,005213869;0,821568915;0,015545142;0,046864607;0,780860176;0,114688405;0;0;NA;NA;NA
X100138492_TGI_at;100138492_TGI_at;BX370011;LDB2;LIM domain binding 2;0,00000000002950000000;0,652197776;0,003650418;0,819396406;0,012066971;0,648925345;1,047156399;0,755321916;0;0;NA;NA;NA
X100138521_TGI_at;100138521_TGI_at;NM_006005;WFS1;Wolfram syndrome 1 (wolframin);0,00000001520000000000;0,812977298;0,004189615;0,862848581;0,013225397;0,347587896;1,058018149;0,486868611;0;0;NA;NA;NA
X100138535_TGI_at;100138535_TGI_at;BG251250;DST;dystonin;0,00000000013800000000;0,790779397;0,08392924;0,939741149;0,122844659;0,754854076;0,990700811;0,840087944;0;0;NA;NA;NA
X100138594_TGI_at;100138594_TGI_at;NM_015326;SRGAP2;SLIT-ROBO Rho GTPase activating protein 2;0,00000001180000000000;0,792929976;3,35E-06;0,832085238;0,000134812;0,953827391;0,994554466;0,974385319;0;0;NA;NA;NA
X100138605_TGI_at;100138605_TGI_at;NM_001080479;;Rho-guanine nucleotide exchange factor;0,00000001560000000000;1,387973169;0,724586041;1,057920157;0,748563098;0,248075799;1,120760313;0,381463883;0;0;NA;NA;NA
X100138606_TGI_at;100138606_TGI_at;BC040168;ERG;v-ets erythroblastosis virus E26 oncogene homolog (avian);0,00000000041700000000;0,740245552;0,000620715;0,858057434;0,003534568;0,91436561;0,966106009;0,951873502;0;0;NA;NA;NA
X100138611_TGI_at;100138611_TGI_at;M90656;GCLC;glutamate-cysteine ligase, catalytic subunit;0,00000001440000000000;1,345478527;0,022922823;1,184312357;0,045353136;0,940656418;1,001093301;0,965520903;0;0;NA;NA;NA
X100138620_TGI_at;100138620_TGI_at;NM_015060;AVL9;AVL9 homolog (S. cerevisiase);0,00000000004050000000;1,398782244;0,004580549;1,142404624;0,014236364;0,716662803;0,955114959;0,809321729;0;0;NA;NA;NA
X100138623_TGI_at;100138623_TGI_at;NM_020717;SHROOM4;shroom family member 4;0,00000008490000000000;0,735964509;0,159247024;0,899356184;0,204646395;0,587186896;0,976777583;0,708272218;0;0;NA;NA;NA
X100138671_TGI_at;100138671_TGI_at;ENST00000367623;ABL2;v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene);0,00000055300000000000;1,406293031;0,045916534;1,179999885;0,076282984;0,194183373;0,828853794;0,322272406;0;0;NA;NA;NA
X100138709_TGI_at;100138709_TGI_at;NM_001039618;CREBZF;CREB/ATF bZIP transcription factor;0,00000002140000000000;0,762858364;0,612987125;0,973703235;0,646908154;0,020452962;0,864326254;0,064249412;0;0;NA;NA;NA
X100138738_TGI_at;100138738_TGI_at;NM_004336;BUB1;BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast);0,00000012900000000000;1,476880999;0,0056156;1,368962721;0,016290801;0,060804037;1,215339007;0,140481298;0;0;NA;NA;NA
X100138743_TGI_at;100138743_TGI_at;BM981427;ZNRF2;zinc and ring finger 2;0,00000071800000000000;1,348989641;0,120454058;1,084104713;0,162664585;0,939476698;0,980337691;0,965520903;0;0;NA;NA;NA
X100138752_TGI_at;100138752_TGI_at;BC050439;VPS36;vacuolar protein sorting 36 homolog (S. cerevisiae);0,00000016800000000000;1,216623429;0,025680989;1,092972336;0,04912156;0,926061411;1,002957478;0,959350695;0;0;NA;NA;NA
X100138774_TGI_at;100138774_TGI_at;NM_002631;PGD;phosphogluconate dehydrogenase;0,00000000000000006370;1,650488217;0,001219327;1,193075647;0,005518227;0,000370278;1,338240239;0,00537129;0;1;U6;U1;U1
X100138777_TGI_at;100138777_TGI_at;NM_130852;PLUNC;palate, lung and nasal epithelium associated;0,00000000000025900000;13,74827066;0,001712887;3,269093018;0,007188327;0,556550302;0,793937455;0,68359818;0;0;NA;NA;NA
X100138781_TGI_at;100138781_TGI_at;NM_014790;JAKMIP2;janus kinase and microtubule interacting protein 2;0,00000000444000000000;1,607067783;0,00195995;1,498148904;0,007904827;0,152591154;1,271331464;0,26889081;0;0;NA;NA;NA
X100138801_TGI_at;100138801_TGI_at;NM_000820;GAS6;growth arrest-specific 6;0,00000000008210000000;0,80558424;0,287219061;0,958065879;0,336131821;0,284058212;1,107547123;0,421122179;0;0;NA;NA;NA
X100138809_TGI_at;100138809_TGI_at;NM_002001;FCER1A;"Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide";0,00000000000003900000;1,979476913;0,000972843;1,703846618;0,004742384;0,077689446;1,524861119;0,166153341;0;0;NA;NA;NA
X100138825_TGI_at;100138825_TGI_at;ENST00000368918;GABPB2;GA binding protein transcription factor, beta subunit 2;0,00000000422000000000;0,784803875;0,447155122;0,965041509;0,490197605;0,222469843;0,907486558;0,352690755;0;0;NA;NA;NA
X100138838_TGI_at;100138838_TGI_at;AF533230;USP32;ubiquitin specific peptidase 32;0,00000000072900000000;1,288723535;0,444468355;1,006197353;0,48824864;0,57904816;1,060916666;0,700552635;0;0;NA;NA;NA
X100138861_TGI_at;100138861_TGI_at;ENST00000373985;PRKG1;protein kinase, cGMP-dependent, type I;0,00000034900000000000;0,794479981;0,053277656;0,916557026;0,085642836;0,127027071;0,873935639;0,235834246;0;0;NA;NA;NA
X100138878_TGI_at;100138878_TGI_at;BM714521;;;0,00000000066500000000;0,69059727;0,000416916;0,7625399;0,002687443;0,721968894;1,068762542;0,81331903;0;0;NA;NA;NA
X100138880_TGI_at;100138880_TGI_at;NM_001628;AKR1B1;aldo-keto reductase family 1, member B1 (aldose reductase);0,00000000010300000000;1,256924025;0,007213298;1,104445195;0,01953652;2,74E-05;1,272544836;0,001805101;0;1;U3;U1;U1
X100138892_TGI_at;100138892_TGI_at;NM_001040708;HEY1;hairy/enhancer-of-split related with YRPW motif 1;0,00000001880000000000;0,635777075;0,057616059;0,815005209;0,09125138;0,131303184;0,796267555;0,240585653;0;0;NA;NA;NA
X100138903_TGI_at;100138903_TGI_at;NM_000507;FBP1;fructose-1,6-bisphosphatase 1;0,00000000000003620000;1,5516086;0,000117411;1,335733015;0,001151763;0,000992908;1,484866949;0,009357144;0;1;U2;U1;U1
X100138908_TGI_at;100138908_TGI_at;AL161983;EIF4E3;eukaryotic translation initiation factor 4E family member 3;0,00000000089200000000;0,75680557;0,000413637;0,881574804;0,002682399;0,137820448;0,894949223;0,249969219;0;0;NA;NA;NA
X100138918_TGI_at;100138918_TGI_at;NM_002147;HOXB5;homeobox B5;0,00000000003410000000;0,634511403;7,18E-05;0,797482547;0,000853589;0,057249107;0,809735945;0,133608886;0;0;NA;NA;NA
X100138919_TGI_at;100138919_TGI_at;BF001669;TBC1D30;TBC1 domain family, member 30;0,00000000008280000000;1,41909301;0,069057932;1,086999478;0,10553519;0,026197762;1,187137847;0,076620133;0;0;NA;NA;NA
X100138947_TGI_at;100138947_TGI_at;NM_032385;C5orf4;chromosome 5 open reading frame 4;0,00000000019300000000;0,692196683;0,000233003;0,757462919;0,001809564;0,924555569;0,988016299;0,959350695;0;0;NA;NA;NA
X100138993_TGI_at;100138993_TGI_at;AF410885;ADCY2;adenylate cyclase 2 (brain);0,00000018200000000000;0,720446931;0,001004664;0,722489729;0,004818499;7,16E-05;0,518180504;0,002622099;0;1;D3;D2;D2
X100138998_TGI_at;100138998_TGI_at;NM_001031615;ALDH3B2;aldehyde dehydrogenase 3 family, member B2;0,00000000000083400000;2,090118486;0,000667146;1,526013168;0,003711391;0,967010726;0,861106632;0,980394958;0;0;NA;NA;NA
X100138999_TGI_at;100138999_TGI_at;DB356513;MAPRE2;microtubule-associated protein, RP/EB family, member 2;0,00000000000253000000;0,72719059;0,219129992;0,96947835;0,268638061;0,491673531;0,928223569;0,627589621;0;0;NA;NA;NA
X100139007_TGI_at;100139007_TGI_at;NM_014634;PPM1F;protein phosphatase 1F (PP2C domain containing);0,00000004570000000000;0,768685837;5,25E-05;0,806924026;0,000708252;0,357146031;1,097829988;0,494450884;0;0;NA;NA;NA
X100139031_TGI_at;100139031_TGI_at;AL831999;;;0,00000000019500000000;0,790083629;0,360930256;0,974769534;0,408024629;0,502203015;0,967182289;0,637495201;0;0;NA;NA;NA
X100139034_TGI_at;100139034_TGI_at;NM_001312;CRIP2;cysteine-rich protein 2;0,00000000000640000000;0,716792311;1,90E-05;0,786674366;0,000379493;0,191451954;0,957447574;0,318230865;0;0;NA;NA;NA
X100139056_TGI_at;100139056_TGI_at;NM_002197;ACO1;aconitase 1, soluble;0,00000000271000000000;1,207629772;0,856816856;1,033540189;0,869770307;0,027420742;1,151800824;0,079475766;0;0;NA;NA;NA
X100139058_TGI_at;100139058_TGI_at;AK098050;DOCK4;dedicator of cytokinesis 4;0,00000000027800000000;0,759090452;0,280274939;0,944442477;0,329080557;0,648001878;1,118085872;0,755321916;0;0;NA;NA;NA
X100139068_TGI_at;100139068_TGI_at;NM_000204;CFI;complement factor I;0,00000000049300000000;1,328850335;0,007039731;1,183377754;0,019195477;0,257214424;1,157985568;0,391963163;0;0;NA;NA;NA
X100139077_TGI_at;100139077_TGI_at;NM_018066;GPN2;GPN-loop GTPase 2;0,00000000459000000000;1,285561424;0,052581813;1,072320148;0,084820412;0,008831116;1,161506983;0,036964527;0;0;NA;NA;NA
X100139153_TGI_at;100139153_TGI_at;NM_001562;IL18;interleukin 18 (interferon-gamma-inducing factor);0,00000000022600000000;1,415753103;0,295000807;1,079148726;0,344363492;0,053765992;1,24170823;0,127699182;0;0;NA;NA;NA
X100139176_TGI_at;100139176_TGI_at;NM_032340;C6orf125;chromosome 6 open reading frame 125;0,00000000033900000000;1,364538058;0,04480815;1,078684072;0,074672527;0,014643299;1,212572483;0,051467124;0;0;NA;NA;NA
X100139182_TGI_at;100139182_TGI_at;BQ225423;;;0,00000000002340000000;2,254228186;1,22E-05;2,183415546;0,000305875;3,49E-05;2,497390411;0,001805101;0;1;U4;U3;U1
X100139214_TGI_at;100139214_TGI_at;BX640727;KLHL8;kelch-like 8 (Drosophila);0,00000091500000000000;1,232833521;0,172231739;1,132181394;0,21845844;0,015374349;1,215282682;0,052959853;0;0;NA;NA;NA
X100139230_TGI_at;100139230_TGI_at;NM_032160;DSEL;dermatan sulfate epimerase-like;0,00000000002480000000;0,695423897;0,001815037;0,808340074;0,007499003;0,63704437;0,929178595;0,747431382;0;0;NA;NA;NA
X100139232_TGI_at;100139232_TGI_at;NM_000235;LIPA;lipase A, lysosomal acid, cholesterol esterase;0,00000000000011700000;1,642913994;0,000141387;1,251198334;0,001280027;3,58E-05;1,447476737;0,001805101;0;1;U3;U1;U1
X100139264_TGI_at;100139264_TGI_at;NM_017793;RPP25;ribonuclease P/MRP 25kDa subunit;0,00000000464000000000;1,333712865;0,180818305;1,101688227;0,228271601;0,034975442;1,220935367;0,093703947;0;0;NA;NA;NA
X100139295_TGI_at;100139295_TGI_at;NM_000895;LTA4H;leukotriene A4 hydrolase;0,00000000000033200000;1,494577208;0,000123142;1,263062603;0,001188283;0,000612657;1,470969214;0,007180335;0;1;U2;U2;U1
X100139314_TGI_at;100139314_TGI_at;NM_014312;VSIG2;V-set and immunoglobulin domain containing 2;0,00000034300000000000;0,827577905;0,301192721;0,936238454;0,350449148;0,011395566;1,340299919;0,043251869;0;0;NA;NA;NA
X100139356_TGI_at;100139356_TGI_at;NM_001097641;FUT3;fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group);0,00000003970000000000;1,40321579;0,811502009;0,994542886;0,829781401;0,348497017;1,10356994;0,486868611;0;0;NA;NA;NA
X100139367_TGI_at;100139367_TGI_at;M86553;CTSS;cathepsin S;0,00000001560000000000;1,630677051;0,136608863;1,137693522;0,180446871;0,003250241;1,63943365;0,019115922;0;0;NA;NA;NA
X100139388_TGI_at;100139388_TGI_at;H10348;HECW2;HECT, C2 and WW domain containing E3 ubiquitin protein ligase 2;0,00000001210000000000;0,69447266;0,078184688;0,833145034;0,115644446;0,875109546;1,05543584;0,925961283;0;0;NA;NA;NA
X100139404_TGI_at;100139404_TGI_at;NM_001257;CDH13;cadherin 13, H-cadherin (heart);0,00000000004360000000;0,661842207;0,099607341;0,907051662;0,140128529;0,023487994;0,77353392;0,070485851;0;0;NA;NA;NA
X100139417_TGI_at;100139417_TGI_at;BX417717;TIMP3;TIMP metallopeptidase inhibitor 3;0,00000000047400000000;0,747954758;0,113934251;0,906173682;0,155071829;0,897259715;1,014200414;0,944437642;0;0;NA;NA;NA
X100139433_TGI_at;100139433_TGI_at;BC096336;IDE;insulin-degrading enzyme;0,00000018700000000000;1,241810313;0,000934729;1,163318844;0,004645604;0,203149235;1,082190481;0,330514884;0;0;NA;NA;NA
X100139467_TGI_at;100139467_TGI_at;NM_016495;TBC1D7;TBC1 domain family, member 7;0,00000000365000000000;1,284865541;5,51E-05;1,216232953;0,00072813;0,967010726;0,974044187;0,980394958;0;0;NA;NA;NA
X100139477_TGI_at;100139477_TGI_at;NM_001079670;CAB39L;calcium binding protein 39-like;0,00000010200000000000;0,718599533;0,121288819;0,893904585;0,163493879;0,348497017;1,182143133;0,486868611;0;0;NA;NA;NA
X100139550_TGI_at;100139550_TGI_at;ENST00000340619;C6orf123;chromosome 6 open reading frame 123;0,00000000518000000000;0,674459789;0,047177407;0,830111471;0,077856008;0,14616607;0,853152264;0,260560422;0;0;NA;NA;NA
X100139566_TGI_at;100139566_TGI_at;NM_001822;CHN1;chimerin (chimaerin) 1;0,00000036700000000000;0,797333703;0,710060212;0,991687565;0,735623293;0,033568153;0,851764073;0,091069156;0;0;NA;NA;NA
X100139568_TGI_at;100139568_TGI_at;NM_001042351;G6PD;glucose-6-phosphate dehydrogenase;0,00000000000033200000;1,547069538;0,02678245;1,117137429;0,050619894;0,00020055;1,490001342;0,004159363;0;0;NA;NA;NA
X100139571_TGI_at;100139571_TGI_at;NM_001083963;TDRKH;tudor and KH domain containing;0,00000007190000000000;1,348067343;0,120572663;1,098694061;0,162664585;0,103562613;1,209458661;0,203277894;0;0;NA;NA;NA
X100139575_TGI_at;100139575_TGI_at;NM_003272;GPR137B;G protein-coupled receptor 137B;0,00000000000150000000;1,41539511;9,90E-06;1,221433949;0,000268799;0,001284943;1,280016321;0,011043654;0;1;U2;U2;U1
X100139578_TGI_at;100139578_TGI_at;BC025294;TLR4;toll-like receptor 4;0,00000001360000000000;1,38285689;0,486864302;1,065590661;0,527449965;0,431724615;1,072321829;0,569099564;0;0;NA;NA;NA
X100139580_TGI_at;100139580_TGI_at;AK096717;PTPRB;protein tyrosine phosphatase, receptor type, B;0,00000017300000000000;0,721780234;0,519432012;0,941895914;0,558043125;0,647960846;1,078797268;0,755321916;0;0;NA;NA;NA
X100139584_TGI_at;100139584_TGI_at;ENST00000382823;;hypothetical protein LOC286161;0,00000096300000000000;0,811028468;0,350461231;1,051140085;0,397864229;0,412093198;0,953233188;0,553027493;0;0;NA;NA;NA
X100139595_TGI_at;100139595_TGI_at;NM_175709;CBX7;chromobox homolog 7;0,00000000005910000000;0,759504266;0,083260462;0,934033281;0,122032046;0,137820448;0,888361656;0,249969219;0;0;NA;NA;NA
X100139604_TGI_at;100139604_TGI_at;AF329839;C1QTNF7;C1q and tumor necrosis factor related protein 7;0,00000080900000000000;0,750749198;0,59658263;0,996123913;0,631042276;0,709599351;0,974756619;0,803597578;0;0;NA;NA;NA
X100139609_TGI_at;100139609_TGI_at;DB304486;PPAP2B;phosphatidic acid phosphatase type 2B;0,00000000792000000000;0,702860066;0,05536895;0,894280248;0,088606816;0,512848122;0,971554072;0,646425302;0;0;NA;NA;NA
X100139613_TGI_at;100139613_TGI_at;AL582126;PDK3;pyruvate dehydrogenase kinase, isozyme 3;0,00000010200000000000;1,374742016;0,131819181;1,106563909;0,175631757;0,118794011;1,150865108;0,224033409;0;0;NA;NA;NA
X100139662_TGI_at;100139662_TGI_at;NM_053067;UBQLN1;ubiquilin 1;0,00000000248000000000;1,220197953;0,041299878;1,073403878;0,070131458;0,672959103;1,044605612;0,774063003;0;0;NA;NA;NA
X100139699_TGI_at;100139699_TGI_at;NM_025214;CCDC68;coiled-coil domain containing 68;0,00000000707000000000;0,696680427;0,0765938;0,88407162;0,113866152;0,648925345;1,019642801;0,755321916;0;0;NA;NA;NA
X100139703_TGI_at;100139703_TGI_at;AW976243;BACH2;BTB and CNC homology 1, basic leucine zipper transcription factor 2;0,00000023900000000000;0,804827825;0,000154792;0,851377796;0,001355693;0,648925345;0,955162044;0,755321916;0;0;NA;NA;NA
X100139723_TGI_at;100139723_TGI_at;ENST00000380934;NFIB;nuclear factor I/B;0,00000049400000000000;0,831383365;0,085836562;0,918973762;0,125124938;0,161066496;0,898920894;0,279095331;0;0;NA;NA;NA
X100139749_TGI_at;100139749_TGI_at;NM_001098272;HMGCS1;3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble);0,00000073300000000000;1,333807468;0,025274159;1,151028283;0,048602367;0,002131763;1,433127826;0,014968787;0;1;U2;U1;U1
X100139759_TGI_at;100139759_TGI_at;NM_002442;MSI1;musashi homolog 1 (Drosophila);0,00000003990000000000;0,756887991;2,83E-06;0,759943262;0,000115604;0,127687215;0,880565341;0,236568327;0;0;NA;NA;NA
X100139778_TGI_at;100139778_TGI_at;NM_015464;SOSTDC1;sclerostin domain containing 1;0,00000000000000067900;0,253809924;0,000137043;0,52401992;0,0012652;0,026896706;0,601231159;0,078167794;0;0;NA;NA;NA
X100139780_TGI_at;100139780_TGI_at;NM_005854;RAMP2;receptor (G protein-coupled) activity modifying protein 2;0,00000000000007560000;0,620694209;0,010200837;0,832387595;0,024967324;0,540513764;0,959308478;0,670621847;0;0;NA;NA;NA
X100139794_TGI_at;100139794_TGI_at;NM_005891;ACAT2;acetyl-Coenzyme A acetyltransferase 2;0,00000000315000000000;1,336085977;0,007544439;1,215221008;0,020162294;0,001127468;1,323492815;0,010122083;0;1;U2;U1;U1
X100139796_TGI_at;100139796_TGI_at;AI148004;SPATA12;spermatogenesis associated 12;0,00000000128000000000;1,379838662;0,000979379;1,180375611;0,004753824;0,724035966;1,027556454;0,815362655;0;0;NA;NA;NA
X100139822_TGI_at;100139822_TGI_at;NM_153692;HTRA4;HtrA serine peptidase 4;0,00000000000506000000;2,327013691;1,36E-05;1,674163031;0,000322623;0,000127227;1,819075413;0,003628771;0;1;U2;U3;U1
X100139855_TGI_at;100139855_TGI_at;NM_153840;GPR110;G protein-coupled receptor 110;0,00000000000000004600;3,233509323;4,33E-07;1,866049586;3,99E-05;0,022436456;1,592909186;0,06841315;0;0;NA;NA;NA
X100139882_TGI_at;100139882_TGI_at;BX538036;C13orf31;chromosome 13 open reading frame 31;0,00000000010300000000;1,38865355;0,000243791;1,199982643;0,001875273;0,021425185;1,180924219;0,066397472;0;0;NA;NA;NA
X100139890_TGI_at;100139890_TGI_at;ENST00000379510;CNKSR2;connector enhancer of kinase suppressor of Ras 2;0,00000002180000000000;0,738191314;0,003822092;0,844515154;0,012480854;0,14742388;0,881843913;0,262512245;0;0;NA;NA;NA
X100139923_TGI_at;100139923_TGI_at;NM_152459;C16orf89;chromosome 16 open reading frame 89;0,00000104000000000000;1,278530115;0,708769693;1,030736161;0,734758674;7,19E-06;1,802184922;0,001159269;0;0;NA;NA;NA
X100139944_TGI_at;100139944_TGI_at;NM_005391;PDK3;pyruvate dehydrogenase kinase, isozyme 3;0,00000009170000000000;1,249560435;0,008082051;1,120319241;0,02122938;0,077689446;1,100790897;0,166153341;0;0;NA;NA;NA
X100139952_TGI_at;100139952_TGI_at;NM_016569;TBX3;T-box 3;0,00000000002560000000;0,694459633;0,000595067;0,81504699;0,003430948;0,069432339;0,875133051;0,153169355;0;0;NA;NA;NA
X100139953_TGI_at;100139953_TGI_at;NM_014584;ERO1L;ERO1-like (S. cerevisiae);0,00000000031200000000;1,27614494;0,008518256;1,114691514;0,021998668;0,034942555;1,129539581;0,093703947;0;0;NA;NA;NA
X100139961_TGI_at;100139961_TGI_at;NM_018414;ST6GALNAC1;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1;0,00000014000000000000;1,603554435;0,583877372;1,133280643;0,618618267;0,523607186;0,855792642;0,657671847;0;0;NA;NA;NA
X100139963_TGI_at;100139963_TGI_at;BC063666;CREB3L2;cAMP responsive element binding protein 3-like 2;0,00000000001560000000;1,568697303;2,68E-06;1,262166957;0,000115604;0,979396399;0,998778829;0,987556719;0;0;NA;NA;NA
X100139989_TGI_at;100139989_TGI_at;NM_024656;GLT25D1;glycosyltransferase 25 domain containing 1;0,00000000023300000000;1,463992553;0,035970005;1,096993097;0,063109051;0,01262417;1,264681407;0,046447382;0;0;NA;NA;NA
X100140003_TGI_at;100140003_TGI_at;BC028284;MARCKS;myristoylated alanine-rich protein kinase C substrate;0,00000005680000000000;0,804645909;0,190420542;0,890028444;0,23880366;0,759495311;0,995721128;0,842344593;0;0;NA;NA;NA
X100140015_TGI_at;100140015_TGI_at;NM_016113;TRPV2;transient receptor potential cation channel, subfamily V, member 2;0,00000000000395000000;1,480321973;0,000248471;1,237043933;0,001888732;0,000558686;1,385610331;0,006820628;0;1;U2;U2;U1
X100140048_TGI_at;100140048_TGI_at;NM_015656;KIF26A;kinesin family member 26A;0,00000000000758000000;0,708252607;0,001328486;0,817602733;0,005922144;0,672949117;0,953746984;0,774063003;0;0;NA;NA;NA
X100140068_TGI_at;100140068_TGI_at;BC015467;ZDHHC3;zinc finger, DHHC-type containing 3;0,00000002630000000000;1,302149269;0,239165346;1,063036576;0,287837906;0,00139981;1,337423741;0,011509154;0;0;NA;NA;NA
X100140071_TGI_at;100140071_TGI_at;NM_001431;EPB41L2;erythrocyte membrane protein band 4.1-like 2;0,00000000000000014100;0,769037717;0,090053638;0,946937275;0,129920714;0,096726246;0,920351057;0,193392487;0;0;NA;NA;NA
X100140088_TGI_at;100140088_TGI_at;NM_000310;PPT1;palmitoyl-protein thioesterase 1;0,00000000001300000000;1,218417149;0,057592601;1,068303995;0,09125138;0,005143125;1,212949892;0,025423759;0;0;NA;NA;NA
X100140111_TGI_at;100140111_TGI_at;NM_014175;MRPL15;mitochondrial ribosomal protein L15;0,00000000042200000000;1,217800694;0,150191537;1,055534275;0,194717347;0,054500465;1,122714846;0,128784177;0;0;NA;NA;NA
X100140168_TGI_at;100140168_TGI_at;NM_005250;FOXL1;forkhead box L1;0,00000049000000000000;0,781020359;0,075172124;0,889392902;0,112389593;0,009303521;0,72999631;0,038004115;0;0;NA;NA;NA
X100140172_TGI_at;100140172_TGI_at;NM_052970;HSPA12B;heat shock 70kD protein 12B;0,00000000344000000000;0,698610252;0,00077099;0,795466964;0,004127742;0,334904546;0,898136032;0,476134694;0;0;NA;NA;NA
X100140176_TGI_at;100140176_TGI_at;NM_019604;CRTAM;cytotoxic and regulatory T cell molecule;0,00000000000001030000;2,013374155;0,000194066;1,464198879;0,00159156;0,000461729;1,628928475;0,006049403;0;1;U5;U1;U1
X100140186_TGI_at;100140186_TGI_at;AK023947;;;0,00000096100000000000;0,644410004;0,000363033;0,725638817;0,002427502;0,57904816;0,965853648;0,700552635;0;0;NA;NA;NA
X100140196_TGI_at;100140196_TGI_at;NM_016428;ABI3;ABI family, member 3;0,00000001850000000000;1,376644261;0,008633784;1,143488552;0,022279171;0,036535061;1,223047511;0,096439395;0;0;NA;NA;NA
X100140216_TGI_at;100140216_TGI_at;NM_178588;PPP2R5C;"protein phosphatase 2, regulatory subunit B'; gamma isoform";0,00000000024800000000;1,213100315;0,016737853;1,095967621;0,035749569;0,030508302;1,1066684;0,086003807;0;0;NA;NA;NA
X100140230_TGI_at;100140230_TGI_at;NM_004512;IL11RA;interleukin 11 receptor, alpha;0,00000064600000000000;0,794238498;0,030634664;0,907088371;0,05590913;0,940656418;0,964484718;0,965520903;0;0;NA;NA;NA
X100140231_TGI_at;100140231_TGI_at;NM_015157;PHLDB1;pleckstrin homology-like domain, family B, member 1;0,00000000089200000000;0,724653102;0,000207884;0,830291313;0,001666738;0,16775574;0,847968047;0,288360932;0;0;NA;NA;NA
X100140262_TGI_at;100140262_TGI_at;AW444868;IGSF2;immunoglobulin superfamily, member 2;0,00000000000007040000;2,545759924;4,16E-05;1,700460776;0,000607007;0,000231241;2,089786864;0,004436256;0;1;U1;U1;U1
X100140273_TGI_at;100140273_TGI_at;NM_000637;GSR;glutathione reductase;0,00000051800000000000;1,246900554;0,533348342;1,008658888;0,571469982;0,154336744;1,096733712;0,270635106;0;0;NA;NA;NA
X100140280_TGI_at;100140280_TGI_at;BQ000894;ASPH;aspartate beta-hydroxylase;0,00000003440000000000;1,314789463;0,018140248;1,129933878;0,037793161;0,013356329;1,200070071;0,048313634;0;1;U1;U1;U1
X100140285_TGI_at;100140285_TGI_at;ENST00000225573;PNPO;"pyridoxamine 5';-phosphate oxidase";0,00000010800000000000;1,220872459;0,225582458;1,052217496;0,274637279;0,013942384;1,223294404;0,049653374;0;0;NA;NA;NA
X100140291_TGI_at;100140291_TGI_at;ENST00000380763;HCCS;holocytochrome c synthase (cytochrome c heme-lyase);0,00000000009430000000;1,325464655;0,01261405;1,078457378;0,029018619;0,16275398;1,093394643;0,281112582;0;0;NA;NA;NA
X100140293_TGI_at;100140293_TGI_at;NM_032048;EMILIN2;elastin microfibril interfacer 2;0,00000000000155000000;1,476854267;0,005004235;1,174923161;0,015130065;0,00236704;1,343783092;0,016094875;0;1;U5;U1;U1
X100140352_TGI_at;100140352_TGI_at;NM_002110;HCK;hemopoietic cell kinase;0,00000000472000000000;1,401638885;0,073331074;1,095931796;0,110338959;0,008241833;1,317087094;0,035370744;0;0;NA;NA;NA
X100140370_TGI_at;100140370_TGI_at;NM_015030;FRYL;FRY-like;0,00000000040700000000;0,787977375;0,05536895;0,947481184;0,088606816;0,215347198;0,959976301;0,344448645;0;0;NA;NA;NA
X100140384_TGI_at;100140384_TGI_at;M97347;GCNT1;glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase);0,00000000279000000000;1,413844359;0,001520553;1,178120262;0,006576612;0,383281963;1,079378715;0,520942343;0;0;NA;NA;NA
X100140407_TGI_at;100140407_TGI_at;AK023635;;hypothetical protein LOC90246;0,00000000687000000000;0,759720855;0,002000343;0,808716684;0,007988979;0,502203015;1,114690558;0,637495201;0;0;NA;NA;NA
X100140424_TGI_at;100140424_TGI_at;NM_005130;FGFBP1;fibroblast growth factor binding protein 1;0,00000000050500000000;2,516510163;0,029927107;1,502108929;0,05498277;0,248075799;1,56643837;0,381463883;0;0;NA;NA;NA
X100140429_TGI_at;100140429_TGI_at;NM_147187;TNFRSF10B;tumor necrosis factor receptor superfamily, member 10b;0,00000000007230000000;1,297953678;0,014143657;1,10485774;0,031437935;0,009797793;1,142897731;0,039467969;0;1;U3;U1;U1
X100140443_TGI_at;100140443_TGI_at;NM_001082618;CD33;CD33 molecule;0,00000000000271000000;1,573565204;0,026659915;1,136157923;0,050455025;0,039901467;1,26232988;0,101661999;0;0;NA;NA;NA
X100140451_TGI_at;100140451_TGI_at;AL137566;PGR;progesterone receptor;0,00000075000000000000;0,747334965;0,212834192;0,921925949;0,261918519;0,810391779;0,862687569;0,881205366;0;0;NA;NA;NA
X100140486_TGI_at;100140486_TGI_at;ENST00000312943;DOK3;docking protein 3;0,00000000010600000000;1,574366763;0,074916395;1,096033561;0,112096352;0,111832653;1,12082453;0,21403601;0;0;NA;NA;NA
X100140507_TGI_at;100140507_TGI_at;NM_005792;MPHOSPH6;M-phase phosphoprotein 6;0,00000000000156000000;1,367997614;0,003299043;1,128402394;0,011227894;0,967010726;1,02222387;0,980394958;0;0;NA;NA;NA
X100140555_TGI_at;100140555_TGI_at;CR749357;PIK3CB;phosphoinositide-3-kinase, catalytic, beta polypeptide;0,00000000000003330000;1,254426405;0,037058751;1,049599997;0,06466722;0,221636126;1,092159789;0,351888292;0;0;NA;NA;NA
X100140595_TGI_at;100140595_TGI_at;NM_019106;03/set;septin 3;0,00000016000000000000;1,927164443;0,000217875;1,422205485;0,001729115;0,042519769;1,364630934;0,106896423;0;0;NA;NA;NA
X100140613_TGI_at;100140613_TGI_at;BG336957;SLC16A3;solute carrier family 16, member 3 (monocarboxylic acid transporter 4);0,00000039700000000000;1,301163966;0,09460924;1,09842982;0,134565569;0,013942384;1,244912207;0,049653374;0;0;NA;NA;NA
X100140630_TGI_at;100140630_TGI_at;ENST00000253934;TMEM204;transmembrane protein 204;0,00000002350000000000;0,687204322;0,000181722;0,783132906;0,001525236;0,299373904;0,833017508;0,437985516;0;0;NA;NA;NA
X100140639_TGI_at;100140639_TGI_at;NM_002290;LAMA4;laminin, alpha 4;0,00000089400000000000;0,829125712;0,010051668;0,899839131;0,024730173;0,711121171;0,953687584;0,803908641;0;0;NA;NA;NA
X100140664_TGI_at;100140664_TGI_at;AF246665;BCL2L13;BCL2-like 13 (apoptosis facilitator);0,00000001320000000000;1,288912067;0,099607341;1,094916323;0,140128529;0,022436456;1,147995378;0,06841315;0;0;NA;NA;NA
X100140677_TGI_at;100140677_TGI_at;NM_006441;MTHFS;5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase);0,00000091600000000000;1,230835289;0,033498413;1,099489545;0,059447749;0,000188734;1,395284478;0,004028419;0;0;NA;NA;NA
X100140678_TGI_at;100140678_TGI_at;NM_004935;CDK5;cyclin-dependent kinase 5;0,00000000002920000000;1,405387654;0,041724775;1,102712289;0,0706297;0,006721236;1,257738234;0,030467711;0;0;NA;NA;NA
X100140717_TGI_at;100140717_TGI_at;AK091010;GRB2;growth factor receptor-bound protein 2;0,00000046800000000000;1,220662419;0,036986376;1,116559923;0,064575888;0,026896706;1,273348927;0,078167794;0;0;NA;NA;NA
X100140738_TGI_at;100140738_TGI_at;NM_032024;C10orf11;chromosome 10 open reading frame 11;0,00000000000012400000;1,402120825;0,003299043;1,147426211;0,011227894;0,011420211;1,229014597;0,043251869;0;1;U6;U2;U1
X100140744_TGI_at;100140744_TGI_at;AK094937;C22orf9;chromosome 22 open reading frame 9;0,00000000050500000000;1,373888587;0,021790006;1,115825072;0,043566494;0,291649909;1,069086713;0,430200301;0;0;NA;NA;NA
X100140806_TGI_at;100140806_TGI_at;NM_020686;ABAT;4-aminobutyrate aminotransferase;0,00000000000047400000;1,496550465;7,35E-05;1,260984213;0,00086144;0,103562613;1,185475325;0,203277894;0;0;NA;NA;NA
X100140829_TGI_at;100140829_TGI_at;NM_000169;GLA;galactosidase, alpha;0,00000000000001530000;1,519215575;0,000607765;1,193912228;0,003485457;0,011420211;1,18797514;0,043251869;0;1;U4;U2;U1
X100140843_TGI_at;100140843_TGI_at;AK091292;FAT4;FAT tumor suppressor homolog 4 (Drosophila);0,00000000003950000000;0,642173442;0,03893302;0,872671807;0,067102204;0,191451954;0,871658509;0,318230865;0;0;NA;NA;NA
X100140854_TGI_at;100140854_TGI_at;NM_130386;COLEC12;collectin sub-family member 12;0,00000008930000000000;1,213782301;0,001373205;1,18755109;0,00611304;0,024581037;1,254600078;0,072950903;0;0;NA;NA;NA
X100140863_TGI_at;100140863_TGI_at;AF131817;;;0,00000104000000000000;0,786337109;0,01605445;0,88812816;0,034680626;0,402347064;0,876861019;0,542112532;0;0;NA;NA;NA
X100140872_TGI_at;100140872_TGI_at;NM_003026;SH3GL2;SH3-domain GRB2-like 2;0,00000051800000000000;0,639720264;0,010386329;0,682256621;0,025245201;0,512848122;1,145007774;0,646425302;0;0;NA;NA;NA
X100140893_TGI_at;100140893_TGI_at;BC008349;AHCYL2;S-adenosylhomocysteine hydrolase-like 2;0,00000000325000000000;1,426927103;0,037693376;1,170002096;0,065561658;0,001461933;1,40991462;0,011898514;0;0;NA;NA;NA
X100140896_TGI_at;100140896_TGI_at;NM_022141;PARVG;parvin, gamma;0,00000000000206000000;1,546052959;0,000889677;1,201343489;0,004487371;0,003444946;1,287019234;0,019661534;0;1;U2;U1;U1
X100140899_TGI_at;100140899_TGI_at;NM_018934;PCDHB14;protocadherin beta 14;0,00000007230000000000;0,771435411;0,350461231;0,934596345;0,397864229;0,002719171;0,768876122;0,017251748;0;0;NA;NA;NA
X100140912_TGI_at;100140912_TGI_at;NM_014686;KIAA0355;KIAA0355;0,00000000002580000000;0,801965708;0,086254592;0,933041281;0,125394023;0,063309309;0,91007406;0,144202051;0;0;NA;NA;NA
X100140943_TGI_at;100140943_TGI_at;NM_002837;PTPRB;protein tyrosine phosphatase, receptor type, B;0,00000001250000000000;0,714201977;0,396128587;0,919922331;0,441925384;0,440813265;1,138922442;0,5787133;0;0;NA;NA;NA
X100140993_TGI_at;100140993_TGI_at;NM_152219;GJD3;gap junction protein, delta 3, 31.9kDa;0,00000017500000000000;0,712648763;0,023356949;0,852865699;0,045707011;0,721968894;0,955079585;0,81331903;0;0;NA;NA;NA
X100141016_TGI_at;100141016_TGI_at;ENST00000375077;CORO2A;coronin, actin binding protein, 2A;0,00000000018200000000;1,382845622;0,0056156;1,146723307;0,016290801;0,014643299;1,281692093;0,051467124;0;0;NA;NA;NA
X100141048_TGI_at;100141048_TGI_at;ENST00000339788;DAB2;disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila);0,00000005530000000000;1,276621387;0,20250426;1,067875658;0,251403866;0,00200392;1,320035271;0,01464543;0;0;NA;NA;NA
X100141057_TGI_at;100141057_TGI_at;NM_144569;SPOCD1;SPOC domain containing 1;0,00000000000097400000;2,011518343;8,43E-06;1,58921706;0,000251644;0,039046711;1,419278014;0,101245011;0;0;NA;NA;NA
X100141077_TGI_at;100141077_TGI_at;BI857441;GFPT1;glutamine-fructose-6-phosphate transaminase 1;0,00000051800000000000;1,240401854;0,012148345;1,150964979;0,028249724;0,460794302;1,052095789;0,597401462;0;0;NA;NA;NA
X100141079_TGI_at;100141079_TGI_at;NM_002396;ME2;malic enzyme 2, NAD(+)-dependent, mitochondrial;0,00000060100000000000;1,24323999;0,001128787;1,146491232;0,005272578;0,050233572;1,120786139;0,121639972;0;0;NA;NA;NA
X100141185_TGI_at;100141185_TGI_at;AA489463;SLIT2;slit homolog 2 (Drosophila);0,00000000117000000000;0,709661354;0,109390801;0,88517163;0,150284122;0,673192242;0,996424933;0,774063003;0;0;NA;NA;NA
X100141220_TGI_at;100141220_TGI_at;BC002682;DUSP3;dual specificity phosphatase 3;0,00000004450000000000;1,208746054;0,140775035;1,054890732;0,184663386;0,007144385;1,219376687;0,031892454;0;0;NA;NA;NA
X100141230_TGI_at;100141230_TGI_at;AW263638;PRKD1;protein kinase D1;0,00000003770000000000;0,79484838;0,07163789;0,889514877;0,108653609;0,466095876;0,938307853;0,603061826;0;0;NA;NA;NA
X100141234_TGI_at;100141234_TGI_at;BC020494;BLOC1S2;biogenesis of lysosomal organelles complex-1, subunit 2;0,00000000005240000000;1,261873994;0,01051333;1,070681286;0,025515409;0,001311767;1,143780779;0,011184726;0;1;U3;U1;U1
X100141272_TGI_at;100141272_TGI_at;NM_006579;EBP;emopamil binding protein (sterol isomerase);0,00000003780000000000;1,230902692;0,014925456;1,123951732;0,032836003;0,000647022;1,398871569;0,007421185;0;1;U1;U1;U1
X100141275_TGI_at;100141275_TGI_at;NM_182487;OLFML2A;olfactomedin-like 2A;0,00000001500000000000;0,645634993;0,338870761;0,967441816;0,387298037;0,26927095;0,874971887;0,405163526;0;0;NA;NA;NA
X100141276_TGI_at;100141276_TGI_at;NM_004403;DFNA5;deafness, autosomal dominant 5;0,00000000025800000000;1,563788488;0,001194874;1,292648819;0,005447071;0,862086046;1,007008347;0,916392918;0;0;NA;NA;NA
X100141286_TGI_at;100141286_TGI_at;CA422831;TEP1;telomerase-associated protein 1;0,00000000090100000000;1,37569384;0,032406821;1,127689195;0,058382999;0,041415229;1,147036723;0,104282253;0;0;NA;NA;NA
X100141303_TGI_at;100141303_TGI_at;ENST00000372403;KCNMA1;potassium large conductance calcium-activated channel, subfamily M, alpha member 1;0,00000003110000000000;1,531088719;0,005050606;1,26710267;0,015227412;0,862086046;0,993628455;0,916392918;0;0;NA;NA;NA
X100141305_TGI_at;100141305_TGI_at;NM_004615;TSPAN7;tetraspanin 7;0,00000000104000000000;0,795964833;0,033345326;0,940044571;0,059245858;0,711121171;1,037324498;0,803908641;0;0;NA;NA;NA
X100141312_TGI_at;100141312_TGI_at;AB209094;GRIA1;glutamate receptor, ionotropic, AMPA 1;0,00000000002860000000;0,596680955;0,036475174;0,798528926;0,063821653;0,215747939;0,889340461;0,344576615;0;0;NA;NA;NA
X100141330_TGI_at;100141330_TGI_at;BC032453;SCFD2;sec1 family domain containing 2;0,00000069200000000000;1,255360943;0,020391221;1,110435914;0,041490471;0,849099163;0,989401096;0,906474529;0;0;NA;NA;NA
X100141332_TGI_at;100141332_TGI_at;NM_017988;SCYL2;SCY1-like 2 (S. cerevisiae);0,00000001880000000000;1,20355985;0,153944667;1,048605575;0,198863191;0,526346389;0,981078875;0,659403342;0;0;NA;NA;NA
X100141342_TGI_at;100141342_TGI_at;NM_005397;PODXL;podocalyxin-like;0,00000000635000000000;0,818271837;0,0150656;0,897332546;0,032986703;0,431008093;0,919748886;0,568620174;0;0;NA;NA;NA
X100141362_TGI_at;100141362_TGI_at;NM_175898;C15orf37;chromosome 15 open reading frame 37;0,00000001200000000000;1,395877696;0,010014837;1,16618373;0,024730173;0,009797793;1,387188302;0,039467969;0;1;U2;U1;U1
X100141376_TGI_at;100141376_TGI_at;NM_182797;PLCB4;phospholipase C, beta 4;0,00000000334000000000;0,724339229;0,032598151;0,854649077;0,058433727;0,033503156;0,773407136;0,091046096;0;0;NA;NA;NA
X100141378_TGI_at;100141378_TGI_at;NM_000532;PCCB;propionyl Coenzyme A carboxylase, beta polypeptide;0,00000000000007580000;1,465855883;0,00292393;1,124543017;0,010299264;0,031382101;1,168357984;0,087495254;0;0;NA;NA;NA
X100141389_TGI_at;100141389_TGI_at;AK075533;C1QTNF3;C1q and tumor necrosis factor related protein 3;0,00000087100000000000;0,713213557;0,472751961;0,92525731;0,514409037;0,127027071;0,83377888;0,235834246;0;0;NA;NA;NA
X100141502_TGI_at;100141502_TGI_at;NM_152331;ACOT4;acyl-CoA thioesterase 4;0,00000000000149000000;1,815702882;0,000101264;1,466488938;0,001063056;0,000497032;1,64124449;0,006356879;0;1;U2;U1;U1
X100141520_TGI_at;100141520_TGI_at;BC036848;;;0,00000043400000000000;0,595057438;0,0169985;0,744158966;0,036091018;0,823248705;1,028958301;0,88918585;0;0;NA;NA;NA
X100141545_TGI_at;100141545_TGI_at;CB242128;;;0,00000008490000000000;1,339152813;0,008780178;1,195323032;0,022492182;0,242831425;1,110503255;0,376271963;0;0;NA;NA;NA
X100141556_TGI_at;100141556_TGI_at;NM_001040107;HVCN1;hydrogen voltage-gated channel 1;0,00000000000002770000;1,723521439;6,25E-05;1,330307387;0,000783836;0,000656787;1,469093618;0,007427454;0;1;U4;U1;U1
X100141623_TGI_at;100141623_TGI_at;NM_181844;BCL6B;B-cell CLL/lymphoma 6, member B (zinc finger protein);0,00000046500000000000;0,713965702;0,202432565;0,899642394;0,251403866;0,888166261;1,009861372;0,935477078;0;0;NA;NA;NA
X100141627_TGI_at;100141627_TGI_at;NM_013322;SNX10;sorting nexin 10;0,00000011100000000000;1,537448724;0,041517401;1,154250023;0,070463709;0,004862758;1,508866907;0,024374289;0;0;NA;NA;NA
X100141663_TGI_at;100141663_TGI_at;X62852;GRB2;growth factor receptor-bound protein 2;0,00000000001850000000;1,317406704;0,005774829;1,142680083;0,016573709;0,004100912;1,251790492;0,022065509;0;1;U2;U1;U1
X100141669_TGI_at;100141669_TGI_at;NM_007191;WIF1;WNT inhibitory factor 1;0,00000010600000000000;0,672237611;0,001852432;0,798663273;0,007561703;0,856524137;1,133036767;0,913191298;0;0;NA;NA;NA
X100141684_TGI_at;100141684_TGI_at;NM_016543;SIGLEC7;sialic acid binding Ig-like lectin 7;0,00000000000018100000;1,863785717;2,52E-05;1,326583438;0,000456611;2,95E-05;1,59804029;0,001805101;0;1;U2;U1;U1
X100141702_TGI_at;100141702_TGI_at;BX648284;ITGA1;integrin, alpha 1;0,00000000000012300000;0,704021328;0,000158506;0,804891327;0,001373293;0,37483693;0,928237724;0,511473085;0;0;NA;NA;NA
X100141730_TGI_at;100141730_TGI_at;BU852892;IQGAP2;IQ motif containing GTPase activating protein 2;0,00000000374000000000;1,313257026;0,004619603;1,133925995;0,014302575;0,025716846;1,174899576;0,075487609;0;0;NA;NA;NA
X100141737_TGI_at;100141737_TGI_at;NM_031915;SETDB2;SET domain, bifurcated 2;0,00000025100000000000;1,2121405;0,028252839;1,093587118;0,052635203;0,601955364;1,016859355;0,718556347;0;0;NA;NA;NA
X100141747_TGI_at;100141747_TGI_at;NM_000887;ITGAX;integrin, alpha X (complement component 3 receptor 4 subunit);0,00000000000000807000;1,899614243;0,000601103;1,2947337;0,00345956;0,000558686;1,495783344;0,006820628;0;1;U2;U1;U1
X100141781_TGI_at;100141781_TGI_at;DQ892977;ADFP;adipose differentiation-related protein;0,00000000136000000000;1,391936343;0,096240748;1,13583843;0,136284679;0,015374349;1,401396565;0,052959853;0;0;NA;NA;NA
X100141783_TGI_at;100141783_TGI_at;NM_018689;KIAA1199;KIAA1199;0,00000003270000000000;1,805026896;0,01261051;1,372262612;0,029018619;0,567746993;1,051464694;0,6918142;0;0;NA;NA;NA
X100141812_TGI_at;100141812_TGI_at;NM_014600;EHD3;EH-domain containing 3;0,00000003110000000000;0,729724802;0,000517351;0,836795893;0,003113871;0,061895338;0,849954414;0,141481329;0;0;NA;NA;NA
X100141820_TGI_at;100141820_TGI_at;ENST00000371481;GPR120;G protein-coupled receptor 120;0,00000000169000000000;1,7228077;0,006919647;1,4325595;0,018980446;0,007101333;1,613026224;0,031892454;0;1;U1;U1;U1
X100141827_TGI_at;100141827_TGI_at;NM_020826;SYT13;synaptotagmin XIII;0,00000036400000000000;0,643710616;5,80E-06;0,599977122;0,000198818;0,043170182;0,700650055;0,107774978;0;0;NA;NA;NA
X100141831_TGI_at;100141831_TGI_at;AK074440;;;0,00000000001020000000;1,677654202;1,63E-05;1,415812442;0,000349371;0,017758754;1,324439609;0,058404554;0;0;NA;NA;NA
X100141854_TGI_at;100141854_TGI_at;H79011;ROD1;ROD1 regulator of differentiation 1 (S. pombe);0,00000000145000000000;1,31859316;0,053981174;1,083603792;0,086600958;0,431008093;0,955015987;0,568620174;0;0;NA;NA;NA
X100141864_TGI_at;100141864_TGI_at;NM_014441;SIGLEC9;sialic acid binding Ig-like lectin 9;0,00000000000241000000;1,864721387;0,000372231;1,300279563;0,002473608;0,000159725;1,614920505;0,004028419;0;1;U5;U1;U1
X100141897_TGI_at;100141897_TGI_at;NM_152574;TTC39B;tetratricopeptide repeat domain 39B;0,00000000000322000000;1,827114411;6,68E-05;1,332583225;0,000812592;0,016931008;1,388528057;0,056430856;0;0;NA;NA;NA
X100141909_TGI_at;100141909_TGI_at;NM_005424;TIE1;tyrosine kinase with immunoglobulin-like and EGF-like domains 1;0,00000000139000000000;0,713027749;0,010033466;0,872455455;0,024730173;0,545460135;0,951986498;0,674086662;0;0;NA;NA;NA
X100141945_TGI_at;100141945_TGI_at;NM_001038603;MARVELD2;MARVEL domain containing 2;0,00000041300000000000;0,785409606;0,032406821;0,874321741;0,058382999;0,009802261;1,24109315;0,039467969;0;0;NA;NA;NA
X100141950_TGI_at;100141950_TGI_at;NM_018836;AJAP1;adherens junctions associated protein 1;0,00000012300000000000;0,647408612;0,054692429;0,865966365;0,087654748;0,534478464;0,910151341;0,664336324;0;0;NA;NA;NA
X100141979_TGI_at;100141979_TGI_at;NM_003683;RRP1;ribosomal RNA processing 1 homolog (S. cerevisiae);0,00000022400000000000;1,22400574;0,600209448;0,97604586;0,634254115;0,066842161;1,110308368;0,148369342;0;0;NA;NA;NA
X100141995_TGI_at;100141995_TGI_at;NM_000211;ITGB2;integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);0,00000000839000000000;1,38629959;0,005093109;1,183535087;0,015312584;0,004654763;1,251034288;0,023927113;0;1;U5;U1;U1
X100142003_TGI_at;100142003_TGI_at;NM_032038;SPNS1;spinster homolog 1 (Drosophila);0,00000000000322000000;1,390419421;0,008237955;1,130141631;0,021498728;0,001703037;1,350166266;0,013125611;0;1;U2;U1;U1
X100142007_TGI_at;100142007_TGI_at;NM_213720;CHCHD10;coiled-coil-helix-coiled-coil-helix domain containing 10;0,00000000040700000000;1,299861142;0,002532714;1,116101852;0,009297196;0,018620907;1,160427807;0,060256208;0;0;NA;NA;NA
X100142017_TGI_at;100142017_TGI_at;AL832945;;hypothetical protein LOC284262;0,00000038000000000000;0,812108785;0,287219061;0,941598365;0,336131821;0,009303521;0,820808532;0,038004115;0;0;NA;NA;NA
X100142018_TGI_at;100142018_TGI_at;NM_001400;S1PR1;sphingosine-1-phosphate receptor 1;0,00000000006570000000;0,774854823;0,007934042;0,904323835;0,020960178;0,299373904;0,918372566;0,437985516;0;0;NA;NA;NA
X100142022_TGI_at;100142022_TGI_at;NM_172037;RDH10;retinol dehydrogenase 10 (all-trans);0,00000004450000000000;1,404268895;0,000576431;1,271060885;0,003352635;0,421327994;1,088491362;0,560904521;0;0;NA;NA;NA
X100142025_TGI_at;100142025_TGI_at;NM_006963;ZNF22;zinc finger protein 22 (KOX 15);0,00000012300000000000;0,829569945;0,000137907;0,900882821;0,0012652;0,37483693;0,926664741;0,511473085;0;0;NA;NA;NA
X100142027_TGI_at;100142027_TGI_at;NM_004684;SPARCL1;SPARC-like 1 (hevin);0,00000000003980000000;0,769857542;0,000808306;0,884892948;0,004236593;0,011420211;0,872077049;0,043251869;0;1;D1;D1;D1
X100142028_TGI_at;100142028_TGI_at;BC013166;TRIM44;tripartite motif-containing 44;0,00000000116000000000;1,262837481;9,19E-05;1,127071799;0,001010589;0,5291358;1,014345769;0,660834037;0;0;NA;NA;NA
X100142055_TGI_at;100142055_TGI_at;NM_021996;GBGT1;globoside alpha-1,3-N-acetylgalactosaminyltransferase 1;0,00000000000863000000;1,562753567;0,387467266;1,028868773;0,434065692;0,016931008;1,282691578;0,056430856;0;0;NA;NA;NA
X100142058_TGI_at;100142058_TGI_at;BX097614;;;0,00000126000000000000;0,635129539;0,399295725;0,83938743;0,44530454;0,008379773;0,650453115;0,035724879;0;0;NA;NA;NA
X100142117_TGI_at;100142117_TGI_at;XM_001133772;;hypothetical LOC731724;0,00000051800000000000;1,283288206;0,081915046;1,101741675;0,120333725;0,002812489;1,246361479;0,017739047;0;0;NA;NA;NA
X100142135_TGI_at;100142135_TGI_at;NM_017882;CLN6;ceroid-lipofuscinosis, neuronal 6, late infantile, variant;0,00000001610000000000;1,366619463;0,214945049;1,084236615;0,263911579;0,012010459;1,274125332;0,044912263;0;0;NA;NA;NA
X100142157_TGI_at;100142157_TGI_at;NM_022072;NSUN3;NOL1/NOP2/Sun domain family, member 3;0,00000000097000000000;1,238093409;0,000454233;1,16432591;0,002813909;0,980202899;0,982225076;0,987556719;0;0;NA;NA;NA
X100142202_TGI_at;100142202_TGI_at;NM_001764;CD1B;CD1b molecule;0,00000000344000000000;2,052734036;0,022337881;1,423819704;0,044441352;0,025226781;1,390084461;0,074729702;0;0;NA;NA;NA
X100142212_TGI_at;100142212_TGI_at;NM_001013642;C1orf225;chromosome 1 open reading frame 225;0,00000000000062100000;0,660013404;5,93E-05;0,746097447;0,000754915;0,284058212;0,928050206;0,421122179;0;0;NA;NA;NA
X100142241_TGI_at;100142241_TGI_at;NM_030949;PPP1R14C;protein phosphatase 1, regulatory (inhibitor) subunit 14C;0,00000035500000000000;1,364104125;0,544942264;1,050495554;0,582536954;0,209185181;1,335963335;0,337324278;0;0;NA;NA;NA
X100142242_TGI_at;100142242_TGI_at;BC044884;KLHDC10;kelch domain containing 10;0,00000024500000000000;1,209940829;0,227763131;1,039798869;0,276581581;0,248075799;1,049245164;0,381463883;0;0;NA;NA;NA
X100142264_TGI_at;100142264_TGI_at;NM_022470;ZMAT3;zinc finger, matrin type 3;0,00000051200000000000;1,371425761;0,020029603;1,204978185;0,041013602;0,025319643;1,313742931;0,074853504;0;0;NA;NA;NA
X100142267_TGI_at;100142267_TGI_at;BC054028;CTSC;cathepsin C;0,00000001080000000000;1,26082032;0,997735624;1,005805689;0,997735624;0,077689446;1,143485246;0,166153341;0;0;NA;NA;NA
X100142287_TGI_at;100142287_TGI_at;NM_205548;FAM151B;family with sequence similarity 151, member B;0,00000041000000000000;1,332383195;0,248805218;1,062249352;0,297661179;0,704079782;0,985287683;0,801288537;0;0;NA;NA;NA
X100142316_TGI_at;100142316_TGI_at;NM_004947;DOCK3;dedicator of cytokinesis 3;0,00000000000281000000;2,015345151;1,80E-05;1,600210986;0,0003666;0,979398256;1,020035924;0,987556719;0;0;NA;NA;NA
X100142391_TGI_at;100142391_TGI_at;BC111464;GNA12;guanine nucleotide binding protein (G protein) alpha 12;0,00000001950000000000;1,350843049;0,070843535;1,088567738;0,107702224;0,003871569;1,2726219;0,021358785;0;0;NA;NA;NA
X100142421_TGI_at;100142421_TGI_at;NM_199166;ALAS1;aminolevulinate, delta-, synthase 1;0,00000000009960000000;1,374837326;0,000712771;1,174865363;0,003906904;6,04E-05;1,404903854;0,002345748;0;1;U1;U2;U1
X100142473_TGI_at;100142473_TGI_at;NM_024571;C16orf33;chromosome 16 open reading frame 33;0,00000040200000000000;1,224280023;0,813780137;1,032860141;0,830529886;0,255009933;1,082470503;0,38934013;0;0;NA;NA;NA
X100142478_TGI_at;100142478_TGI_at;U66563;LIFR;leukemia inhibitory factor receptor alpha;0,00000001680000000000;0,738586398;0,227927448;0,885865691;0,276581581;0,339979528;0,961144588;0,480593868;0;0;NA;NA;NA
X100142482_TGI_at;100142482_TGI_at;AK124571;;;0,00000002860000000000;0,80925287;0,046654517;0,931763212;0,077190713;0,901252766;0,979535331;0,944937432;0;0;NA;NA;NA
X100142497_TGI_at;100142497_TGI_at;AK129526;;;0,00000093800000000000;1,200681067;0,020508088;1,079712604;0,041649382;0,31372464;1,070983261;0,454361033;0;0;NA;NA;NA
X100142525_TGI_at;100142525_TGI_at;NM_003890;FCGBP;Fc fragment of IgG binding protein;0,00000001700000000000;2,083063997;0,107587048;1,294469874;0,148629685;0,940656418;0,994555572;0,965520903;0;0;NA;NA;NA
X100142526_TGI_at;100142526_TGI_at;BC001671;HDDC2;HD domain containing 2;0,00000000043300000000;1,221266444;0,017370431;1,075233538;0,036591438;0,57011803;1,043420603;0,69444082;0;0;NA;NA;NA
X100142537_TGI_at;100142537_TGI_at;ENST00000370399;TGFBR3;transforming growth factor, beta receptor III;0,00000000000114000000;0,651914253;4,58E-06;0,782686289;0,000162666;0,836152269;0,979085921;0,898605789;0;0;NA;NA;NA
X100142549_TGI_at;100142549_TGI_at;ENST00000379837;NUDT21;nudix (nucleoside diphosphate linked moiety X)-type motif 21;0,00000000001940000000;1,36364817;0,040738397;1,110088728;0,06937601;0,001660524;1,226694457;0,012896073;0;0;NA;NA;NA
X100142552_TGI_at;100142552_TGI_at;NM_152793;C7orf41;chromosome 7 open reading frame 41;0,00000000001440000000;0,764093526;0,01290632;0,912239846;0,029522405;0,348497017;0,953917808;0,486868611;0;0;NA;NA;NA
X100142616_TGI_at;100142616_TGI_at;ENST00000370704;TTLL7;tubulin tyrosine ligase-like family, member 7;0,00000000002150000000;0,648831062;0,204592141;0,896413727;0,253615565;0,772133359;0,857339274;0,852547385;0;0;NA;NA;NA
X100142621_TGI_at;100142621_TGI_at;NM_152547;BTNL9;butyrophilin-like 9;0,00000067600000000000;0,666723289;0,003541191;0,77001168;0,011814966;0,41805304;0,865401496;0,560243222;0;0;NA;NA;NA
X100142646_TGI_at;100142646_TGI_at;AF109362;SCD;stearoyl-CoA desaturase (delta-9-desaturase);0,00000000782000000000;1,357322064;0,004513052;1,187330062;0,014053687;0,003643829;1,655203475;0,020560753;0;1;U1;U1;U1
X100142653_TGI_at;100142653_TGI_at;BX648950;;;0,00000000002250000000;0,744120556;0,069057932;0,930636618;0,10553519;0,797584764;1,02510011;0,871690639;0;0;NA;NA;NA
X100142655_TGI_at;100142655_TGI_at;BC030115;;;0,00000053100000000000;0,805549527;0,477310023;0,975322793;0,519018287;0,901252766;1,022326259;0,944937432;0;0;NA;NA;NA
X100142710_TGI_at;100142710_TGI_at;BX105647;;;0,00000010800000000000;1,51042492;0,04115325;1,233705097;0,0699931;0,029393816;1,348844941;0,083541684;0;0;NA;NA;NA
X100142717_TGI_at;100142717_TGI_at;BC007541;UBASH3B;ubiquitin associated and SH3 domain containing, B;0,00000000013200000000;1,709858462;6,52E-05;1,551150598;0,000805535;3,28E-05;2,000515923;0,001805101;0;1;U2;U2;U1
X100142719_TGI_at;100142719_TGI_at;NM_001251;CD68;CD68 molecule;0,00000000007470000000;1,840105115;0,004028585;1,307967359;0,012868315;0,000399716;1,753536013;0,005625698;0;1;U2;U1;U1
X100142804_TGI_at;100142804_TGI_at;NM_003436;ZNF135;zinc finger protein 135;0,00000001160000000000;0,744594109;0,000437679;0,822590305;0,002760548;0,107219939;0,843624682;0,208174617;0;0;NA;NA;NA
X100142819_TGI_at;100142819_TGI_at;BC013304;SESN2;sestrin 2;0,00000000057700000000;1,342921959;0,039641612;1,078342216;0,067923932;0,002409533;1,267579898;0,016145377;0;0;NA;NA;NA
X100142834_TGI_at;100142834_TGI_at;NM_000358;TGFBI;transforming growth factor, beta-induced, 68kDa;0,00000003680000000000;1,284732618;0,077114356;1,117347384;0,114395359;0,274492264;1,07624332;0,411866186;0;0;NA;NA;NA
X100142862_TGI_at;100142862_TGI_at;NM_016359;NUSAP1;nucleolar and spindle associated protein 1;0,00000021500000000000;1,457190036;0,163484482;1,179801779;0,208925648;0,036535061;1,216930763;0,096439395;0;0;NA;NA;NA
X100142874_TGI_at;100142874_TGI_at;BT019481;HUS1;HUS1 checkpoint homolog (S. pombe);0,00000000000570000000;1,28488543;0,000541187;1,158979606;0,003206334;0,021964693;1,158248071;0,067549815;0;0;NA;NA;NA
X100142914_TGI_at;100142914_TGI_at;CA449365;EPB41L2;erythrocyte membrane protein band 4.1-like 2;0,00000000713000000000;0,755546232;0,620275428;0,979579624;0,653743527;0,940656418;0,959324742;0,965520903;0;0;NA;NA;NA
X100142922_TGI_at;100142922_TGI_at;NM_002294;LAMP2;lysosomal-associated membrane protein 2;0,00000000000043900000;1,465046779;9,71E-05;1,184373092;0,001049817;0,001311767;1,327205611;0,011184726;0;1;U2;U1;U1
X100142942_TGI_at;100142942_TGI_at;ENST00000381015;MPDZ;multiple PDZ domain protein;0,00000002700000000000;0,790653852;0,652972105;0,98094206;0,684622346;0,266380968;0,902495983;0,403399161;0;0;NA;NA;NA
X100142950_TGI_at;100142950_TGI_at;NM_020716;GRAMD1B;GRAM domain containing 1B;0,00000069600000000000;1,336394521;0,011631769;1,163338846;0,027277267;0,039719764;1,160489527;0,101661999;0;0;NA;NA;NA
X100142961_TGI_at;100142961_TGI_at;BC040985;;;0,00000001390000000000;0,696321454;0,03896799;0,848921737;0,06712658;0,072654801;0,802280571;0,158434658;0;0;NA;NA;NA
X100143007_TGI_at;100143007_TGI_at;NM_153619;SEMA6D;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D;0,00000013000000000000;0,715844293;0,124698729;0,890972969;0,167529806;0,967010726;0,960658823;0,980394958;0;0;NA;NA;NA
X100143016_TGI_at;100143016_TGI_at;NM_001077188;HS6ST2;heparan sulfate 6-O-sulfotransferase 2;0,00000001480000000000;1,536539864;0,032598151;1,32368523;0,058433727;0,924555569;0,987951429;0,959350695;0;0;NA;NA;NA
X100143051_TGI_at;100143051_TGI_at;ENST00000324868;YARS2;tyrosyl-tRNA synthetase 2, mitochondrial;0,00000000011800000000;1,237259142;0,007161683;1,113504473;0,01943163;0,248075799;1,086199992;0,381463883;0;0;NA;NA;NA
X100143058_TGI_at;100143058_TGI_at;NM_018593;SLC16A10;solute carrier family 16, member 10 (aromatic amino acid transporter);0,00000000000245000000;2,392684427;5,25E-05;1,726873615;0,000708252;0,016931008;1,65040284;0,056430856;0;0;NA;NA;NA
X100143066_TGI_at;100143066_TGI_at;NM_005905;SMAD9;SMAD family member 9;0,00000109000000000000;0,797654935;0,096870685;0,877234492;0,136996146;0,660413637;0,955187622;0,764285198;0;0;NA;NA;NA
X100143074_TGI_at;100143074_TGI_at;NM_000129;F13A1;coagulation factor XIII, A1 polypeptide;0,00000000297000000000;1,38435392;0,059893071;1,220632345;0,094117683;0,567746993;1,065090535;0,6918142;0;0;NA;NA;NA
X100143094_TGI_at;100143094_TGI_at;NM_152996;ST6GALNAC3;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3;0,00000126000000000000;0,689123876;3,16E-05;0,707107572;0,000509476;0,901252766;1,019506695;0,944937432;0;0;NA;NA;NA
X100143106_TGI_at;100143106_TGI_at;NM_000961;PTGIS;prostaglandin I2 (prostacyclin) synthase;0,00000036700000000000;0,759444761;0,47977983;0,926646616;0,521352121;0,613556941;0,944517759;0,727019861;0;0;NA;NA;NA
X100143134_TGI_at;100143134_TGI_at;NM_014964;EPN2;epsin 2;0,00000000190000000000;0,820945052;0,000140883;0,887079737;0,00127906;0,91436561;1,019924616;0,951873502;0;0;NA;NA;NA
X100143173_TGI_at;100143173_TGI_at;NM_012232;PTRF;polymerase I and transcript release factor;0,00000009490000000000;0,738285072;0,001147322;0,865168939;0,005335959;0,250101923;1,125907845;0,384396041;0;0;NA;NA;NA
X100143178_TGI_at;100143178_TGI_at;NM_001003704;;mitochondrial protein 18 kDa;0,00000002180000000000;1,397459292;0,749906972;1,002729364;0,771695457;0,089895036;1,209096262;0,184145191;0;0;NA;NA;NA
X100143185_TGI_at;100143185_TGI_at;BU681386;;;0,00000000344000000000;0,729481326;0,007800348;0,864469255;0,020691786;0,100003042;0,888585012;0,198466629;0;0;NA;NA;NA
X100143192_TGI_at;100143192_TGI_at;NM_001017373;SAMD3;sterile alpha motif domain containing 3;0,00000123000000000000;0,723306165;0,155625162;0,967885292;0,200631958;0,672949117;0,944554755;0,774063003;0;0;NA;NA;NA
X100143200_TGI_at;100143200_TGI_at;AK023508;;;0,00000000032800000000;0,5716596;0,000940185;0,675839338;0,004645604;0,030713739;0,748283123;0,086003807;0;0;NA;NA;NA
X100143217_TGI_at;100143217_TGI_at;AK127156;;hypothetical LOC100131662;0,00000030400000000000;0,761430009;0,01480128;0,868778469;0,032629635;0,567746993;0,942686853;0,6918142;0;0;NA;NA;NA
X100143232_TGI_at;100143232_TGI_at;NM_020753;CASKIN2;CASK interacting protein 2;0,00000019100000000000;0,703521636;0,001780381;0,812893617;0,007423245;0,291649909;0,884315633;0,430200301;0;0;NA;NA;NA
X100143270_TGI_at;100143270_TGI_at;BU622650;BHLHB3;basic helix-loop-helix domain containing, class B, 3;0,00000000000003680000;1,998522966;7,53E-05;1,487809872;0,000869522;0,005373466;1,403264671;0,026121691;0;1;U4;U1;U1
X100143282_TGI_at;100143282_TGI_at;NM_182972;IRF2BP2;interferon regulatory factor 2 binding protein 2;0,00000004850000000000;0,829605065;0,403539846;0,981903084;0,449260423;0,450742398;0,953936401;0,587204022;0;0;NA;NA;NA
X100143316_TGI_at;100143316_TGI_at;NM_007267;TMC6;transmembrane channel-like 6;0,00000000185000000000;1,32245996;0,043023798;1,110947138;0,072259354;0,039719764;1,250754458;0,101661999;0;0;NA;NA;NA
X100143321_TGI_at;100143321_TGI_at;AK055438;;;0,00000012700000000000;0,825526671;0,031491038;0,902182765;0,056987993;0,197238472;0,887222982;0,324667823;0;0;NA;NA;NA
X100143351_TGI_at;100143351_TGI_at;NM_172115;CAMK2D;calcium/calmodulin-dependent protein kinase (CaM kinase) II delta;0,00000014700000000000;1,218818559;0,572472174;1,004488163;0,607892045;0,421843348;1,029518328;0,560904521;0;0;NA;NA;NA
X100143376_TGI_at;100143376_TGI_at;NM_000175;GPI;glucose phosphate isomerase;0,00000008270000000000;1,2389177;0,454770284;1,011245504;0,497361597;0,746919855;1,040570103;0,832983631;0;0;NA;NA;NA
X100143411_TGI_at;100143411_TGI_at;BX537985;CCDC88A;coiled-coil domain containing 88A;0,00000000000173000000;1,728648413;3,82E-05;1,380799391;0,000578519;0,003063783;1,419167816;0,018596182;0;1;U2;U2;U1
X100143423_TGI_at;100143423_TGI_at;NM_006262;PRPH;peripherin;0,00000000256000000000;0,633637109;0,000501762;0,71721194;0,003035671;0,287685654;0,85013861;0,426107933;0;0;NA;NA;NA
X100143433_TGI_at;100143433_TGI_at;NM_145641;APOL3;apolipoprotein L, 3;0,00000000005780000000;0,704344157;6,84E-05;0,781284168;0,000819872;0,534478464;0,937735143;0,664336324;0;0;NA;NA;NA
X100143443_TGI_at;100143443_TGI_at;NM_007365;PADI2;peptidyl arginine deiminase, type II;0,00000000002080000000;2,017244494;0,012410242;1,281753621;0,028676416;0,05081529;1,359989195;0,122313429;0;0;NA;NA;NA
X100143444_TGI_at;100143444_TGI_at;AF147343;;;0,00000021300000000000;1,483024185;0,424269133;1,060238373;0,46925855;0,118794011;1,355032008;0,224033409;0;0;NA;NA;NA
X100143470_TGI_at;100143470_TGI_at;NM_031911;C1QTNF7;C1q and tumor necrosis factor related protein 7;0,00000000385000000000;0,645910146;0,053611892;0,833958121;0,086094234;0,392990225;0,964759993;0,532042792;0;0;NA;NA;NA
X100143476_TGI_at;100143476_TGI_at;M63013;PON1;paraoxonase 1;0,00000004090000000000;1,571420553;1,16E-05;1,645083638;0,000294785;0,001370872;1,472165988;0,011387427;0;1;U6;U3;U1
X100143486_TGI_at;100143486_TGI_at;NM_130759;GIMAP1;GTPase, IMAP family member 1;0,00000089300000000000;0,756146519;0,050457527;0,887523031;0,082175144;0,431008093;1,109152797;0,568620174;0;0;NA;NA;NA
X100143570_TGI_at;100143570_TGI_at;NM_006639;CYSLTR1;cysteinyl leukotriene receptor 1;0,00000000064500000000;1,400691389;0,000682553;1,250759308;0,003779842;0,005076254;1,459754608;0,025287121;0;1;U1;U1;U1
X100143578_TGI_at;100143578_TGI_at;AA021440;;;0,00000000888000000000;0,706202428;0,232376611;0,947560976;0,281137319;0,262074839;0,8336709;0,39749045;0;0;NA;NA;NA
X100143617_TGI_at;100143617_TGI_at;ENST00000371581;IDE;insulin-degrading enzyme;0,00000007630000000000;1,232030806;0,006063538;1,06530663;0,01717292;0,69730432;0,970158273;0,795825717;0;0;NA;NA;NA
X100143658_TGI_at;100143658_TGI_at;NM_138410;CMTM7;CKLF-like MARVEL transmembrane domain containing 7;0,00000000000656000000;1,441969401;0,00045487;1,14623897;0,002813909;0,012010459;1,179243458;0,044912263;0;1;U5;U1;U1
X100143662_TGI_at;100143662_TGI_at;NM_025227;BPIL1;bactericidal/permeability-increasing protein-like 1;0,00000007590000000000;1,56441787;0,011733341;1,480037462;0,027463005;0,910890029;0,57541536;0,951873502;0;0;NA;NA;NA
X100143667_TGI_at;100143667_TGI_at;NM_002300;LDHB;lactate dehydrogenase B;0,00000000012500000000;1,211835458;0,006684985;1,066217724;0,018541916;0,041415229;1,112146685;0,104282253;0;0;NA;NA;NA
X100143673_TGI_at;100143673_TGI_at;NM_015296;DOCK9;dedicator of cytokinesis 9;0,00000068100000000000;0,817396779;0,07163789;0,924956534;0,108653609;0,980202899;1,005564731;0,987556719;0;0;NA;NA;NA
X100143687_TGI_at;100143687_TGI_at;ENST00000307465;CDKL2;cyclin-dependent kinase-like 2 (CDC2-related kinase);0,00000012100000000000;1,257540719;0,038556734;1,138533055;0,066524815;0,000203903;1,324162904;0,004159363;0;0;NA;NA;NA
X100143702_TGI_at;100143702_TGI_at;NM_002436;MPP1;membrane protein, palmitoylated 1, 55kDa;0,00000000109000000000;1,29530599;0,453407663;1,024373308;0,496208115;0,023044114;1,155606001;0,069935199;0;0;NA;NA;NA
X100143705_TGI_at;100143705_TGI_at;CA429926;LTBP1;latent transforming growth factor beta binding protein 1;0,00000000515000000000;0,702970792;0,380521699;0,904752396;0,427324542;0,474169695;0,882041119;0,610566891;0;0;NA;NA;NA
X100143736_TGI_at;100143736_TGI_at;NM_003661;APOL1;apolipoprotein L, 1;0,00000014800000000000;0,831858591;0,00030297;0,834453267;0,002128165;0,141760286;0,877654035;0,25524771;0;0;NA;NA;NA
X100143750_TGI_at;100143750_TGI_at;ENST00000361080;SLC44A1;solute carrier family 44, member 1;0,00000000000982000000;0,784157668;0,008807054;0,92233373;0,022492182;0,118794011;0,923724457;0,224033409;0;0;NA;NA;NA
X100143762_TGI_at;100143762_TGI_at;NM_022743;SMYD3;SET and MYND domain containing 3;0,00000000307000000000;1,202620529;0,075473611;1,074989199;0,112564298;0,114834098;1,095785696;0,21874131;0;0;NA;NA;NA
X100143766_TGI_at;100143766_TGI_at;BC020624;;hypothetical protein LOC641518;0,00000085000000000000;0,777075676;0,504583157;0,962332614;0,544085485;0,096707538;0,879014968;0,193392487;0;0;NA;NA;NA
X100143776_TGI_at;100143776_TGI_at;NM_000632;ITGAM;integrin, alpha M (complement component 3 receptor 3 subunit);0,00000000005220000000;1,70525894;0,005093109;1,241092419;0,015312584;0,002645386;1,413680377;0,017224404;0;1;U1;U1;U1
X100143779_TGI_at;100143779_TGI_at;NM_172197;AGER;advanced glycosylation end product-specific receptor;0,00000000000001470000;0,790047637;0,113871062;0,928865761;0,155071829;0,334904546;1,075496797;0,476134694;0;0;NA;NA;NA
X100143806_TGI_at;100143806_TGI_at;NM_021209;NLRC4;NLR family, CARD domain containing 4;0,00000000000018400000;1,664539512;0,001156139;1,294510928;0,005338446;0,004342204;1,610144594;0,022867523;0;1;U2;U1;U1
X100143809_TGI_at;100143809_TGI_at;NM_015717;CD207;CD207 molecule, langerin;0,00000000000000000114;4,141511651;2,11E-06;2,457939012;0,000101523;0,05175184;1,600886597;0,124289255;0;0;NA;NA;NA
X100143810_TGI_at;100143810_TGI_at;AF070618;;;0,00000000008770000000;0,819586961;0,009256664;0,919001083;0,023326213;0,685086646;0,970398827;0,784939303;0;0;NA;NA;NA
X100143828_TGI_at;100143828_TGI_at;NM_003505;FZD1;frizzled homolog 1 (Drosophila);0,00000000011700000000;0,671293419;0,117890784;0,925839894;0,159782169;0,127936269;0,858569048;0,236568327;0;0;NA;NA;NA
X100143838_TGI_at;100143838_TGI_at;NM_181716;PRR6;proline rich 6;0,00000054400000000000;1,296121795;0,005673448;1,127566575;0,016384876;0,875109546;1,002287325;0,925961283;0;0;NA;NA;NA
X100143851_TGI_at;100143851_TGI_at;CR749205;LIMCH1;LIM and calponin homology domains 1;0,00000000000536000000;0,809549306;0,37988552;0,970658096;0,427056515;0,517878297;0,981735408;0,651746096;0;0;NA;NA;NA
X100143865_TGI_at;100143865_TGI_at;AK027107;;;0,00000000000012700000;1,744618135;0,101523164;1,149330407;0,142326732;0,000220177;1,568020757;0,004272984;0;0;NA;NA;NA
X100143866_TGI_at;100143866_TGI_at;NM_024778;LONRF3;LON peptidase N-terminal domain and ring finger 3;0,00000028300000000000;1,395072701;0,074386478;1,142065066;0,111406886;0,002081391;1,549310713;0,014968787;0;0;NA;NA;NA
X100143876_TGI_at;100143876_TGI_at;AK123774;;;0,00000000016500000000;0,724305711;0,049028973;0,902435334;0,080335729;0,451876019;0,953170579;0,588442994;0;0;NA;NA;NA
X100143880_TGI_at;100143880_TGI_at;NM_198436;AURKA;aurora kinase A;0,00000027200000000000;1,358410938;0,304969755;1,064533287;0,354076916;0,018980373;1,280919198;0,060869395;0;0;NA;NA;NA
X100143890_TGI_at;100143890_TGI_at;BC060868;BMPER;BMP binding endothelial regulator;0,00000029500000000000;0,720033521;0,003969839;0,782710794;0,012743815;0,523607186;0,957084648;0,657671847;0;0;NA;NA;NA
X100143893_TGI_at;100143893_TGI_at;AF086027;;;0,00000071500000000000;0,676346232;3,68E-05;0,619568065;0,00057068;0,552010088;0,943570007;0,680615346;0;0;NA;NA;NA
X100143894_TGI_at;100143894_TGI_at;NM_053281;DACH2;dachshund homolog 2 (Drosophila);0,00000095600000000000;0,776363432;0,002563706;0,86739656;0,009378915;0,209180841;0,915381602;0,337324278;0;0;NA;NA;NA
X100143910_TGI_at;100143910_TGI_at;NM_005595;NFIA;nuclear factor I/A;0,00000000486000000000;0,827866171;0,304853815;0,95805481;0,354069854;0,504461526;0,931961343;0,639606411;0;0;NA;NA;NA
X100143982_TGI_at;100143982_TGI_at;NM_016929;CLIC5;chloride intracellular channel 5;0,00000000006310000000;0,745551016;0,353766783;0,92341158;0,401192942;0,5291358;1,096873011;0,660834037;0;0;NA;NA;NA
X100143991_TGI_at;100143991_TGI_at;BC040549;CAMSAP1;calmodulin regulated spectrin-associated protein 1;0,00000001200000000000;1,238047714;0,191138436;1,043342036;0,23933146;0,030713739;1,120143138;0,086003807;0;0;NA;NA;NA
X100144018_TGI_at;100144018_TGI_at;NM_153046;TDRD9;tudor domain containing 9;0,00000004700000000000;1,480128547;0,014775974;1,25481404;0,03261847;0,030713739;1,264092489;0,086003807;0;0;NA;NA;NA
X100144062_TGI_at;100144062_TGI_at;NM_000883;IMPDH1;IMP (inosine monophosphate) dehydrogenase 1;0,00000111000000000000;1,213332707;0,693227388;0,990099761;0,720786836;0,672949117;1,105062594;0,774063003;0;0;NA;NA;NA
X100144137_TGI_at;100144137_TGI_at;NM_001963;EGF;epidermal growth factor (beta-urogastrone);0,00000006890000000000;1,512358347;0,003133427;1,376420211;0,010847514;0,284058212;1,143993023;0,421122179;0;0;NA;NA;NA
X100144166_TGI_at;100144166_TGI_at;AB017016;TPPP;tubulin polymerization promoting protein;0,00000001900000000000;0,729780786;0,003299043;0,816859241;0,011227894;0,229011154;1,259873329;0,360577895;0;0;NA;NA;NA
X100144174_TGI_at;100144174_TGI_at;AW794113;FDFT1;farnesyl-diphosphate farnesyltransferase 1;0,00000070100000000000;1,2541222;0,071527072;1,110473681;0,10858773;0,093210697;1,139774471;0,188856657;0;0;NA;NA;NA
X100144181_TGI_at;100144181_TGI_at;AK125283;;hypothetical LOC255167;0,00000002860000000000;0,640212574;0,701625498;1,036453452;0,728993869;0,020452962;0,750715376;0,064249412;0;0;NA;NA;NA
X100144185_TGI_at;100144185_TGI_at;NM_174918;C19orf59;chromosome 19 open reading frame 59;0,00000000021900000000;1,637040702;0,046543377;1,235188977;0,077046381;0,000461729;2,210913542;0,006049403;0;0;NA;NA;NA
X100144186_TGI_at;100144186_TGI_at;NM_001005339;RGS10;regulator of G-protein signaling 10;0,00000000004760000000;1,292934382;0,025658322;1,099513583;0,04912156;0,025716846;1,172699774;0,075487609;0;0;NA;NA;NA
X100144191_TGI_at;100144191_TGI_at;ENST00000372045;CHRDL1;chordin-like 1;0,00000003680000000000;0,778830418;0,212811135;0,894482967;0,261918519;0,190948014;0,890897317;0,318230865;0;0;NA;NA;NA
X100144196_TGI_at;100144196_TGI_at;NM_014275;MGAT4B;mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B;0,00000060100000000000;0,803179172;0,000311326;0,886099036;0,00217658;0,567746993;0,971121049;0,6918142;0;0;NA;NA;NA
X100144202_TGI_at;100144202_TGI_at;AL136660;SPCS3;signal peptidase complex subunit 3 homolog (S. cerevisiae);0,00000002780000000000;1,303880419;0,032961973;1,094209355;0,058873378;0,587186896;1,032790157;0,708272218;0;0;NA;NA;NA
X100144215_TGI_at;100144215_TGI_at;NM_006019;TCIRG1;T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3;0,00000014800000000000;1,250498946;0,776771239;1,014777102;0,796542699;0,672949117;1,079220843;0,774063003;0;0;NA;NA;NA
X100144219_TGI_at;100144219_TGI_at;NM_001025077;CUGBP2;CUG triplet repeat, RNA binding protein 2;0,00000000006550000000;0,824682172;0,234395156;0,976944298;0,283048178;0,014643299;1,280137585;0,051467124;0;0;NA;NA;NA
X100144242_TGI_at;100144242_TGI_at;NM_052954;CYYR1;cysteine/tyrosine-rich 1;0,00000006340000000000;0,760935925;0,006237006;0,869676912;0,017556218;0,030508302;0,831482496;0,086003807;0;0;NA;NA;NA
X100144255_TGI_at;100144255_TGI_at;AF131784;;;0,00000011500000000000;1,488718703;0,00106718;1,302504194;0,005021199;0,228052747;1,233360814;0,35942005;0;0;NA;NA;NA
X100144256_TGI_at;100144256_TGI_at;NM_020980;AQP9;aquaporin 9;0,00000001560000000000;1,765400312;0,52311882;1,048185647;0,561629566;0,06589724;1,34140842;0,147695969;0;0;NA;NA;NA
X100144264_TGI_at;100144264_TGI_at;NM_153022;C12orf59;chromosome 12 open reading frame 59;0,00000000000000003050;2,395002728;0,004745963;1,351060476;0,014553986;0,000188734;1,744708178;0,004028419;0;1;U2;U1;U1
X100144268_TGI_at;100144268_TGI_at;AK124227;;;0,00000003780000000000;0,748085005;0,279577061;0,964166458;0,328380783;0,017971918;0,7937559;0,058805575;0;0;NA;NA;NA
X100144297_TGI_at;100144297_TGI_at;NM_015180;SYNE2;spectrin repeat containing, nuclear envelope 2;0,00000000000000317000;0,722701146;3,71E-05;0,831271714;0,000572823;0,013851111;0,840506656;0,049653374;0;1;D6;D1;D1
X100144305_TGI_at;100144305_TGI_at;ENST00000273695;TM4SF19;transmembrane 4 L six family member 19;0,00000001250000000000;1,63875419;0,217070954;1,116372286;0,266420291;0,003720657;1,293830517;0,020759189;0;0;NA;NA;NA
X100144312_TGI_at;100144312_TGI_at;Z48579;ADAM10;ADAM metallopeptidase domain 10;0,00000000012000000000;1,359151319;0,001522442;1,144668135;0,006576612;0,013851111;1,236025294;0,049653374;0;1;U2;U1;U1
X100144361_TGI_at;100144361_TGI_at;BC035683;PIK3CG;phosphoinositide-3-kinase, catalytic, gamma polypeptide;0,00000000255000000000;1,426556003;0,074386478;1,154601925;0,111406886;0,184980417;1,234195624;0,311548887;0;0;NA;NA;NA
X100144372_TGI_at;100144372_TGI_at;NM_021992;TMSL8;thymosin-like 8;0,00000000000000006640;0,238282783;1,19E-09;0,351373303;3,83E-07;0,000345371;0,39995353;0,005300617;0;1;D6;D3;D1
X100144384_TGI_at;100144384_TGI_at;AL834241;NLN;neurolysin (metallopeptidase M3 family);0,00000002560000000000;1,396342579;0,001816474;1,186219248;0,007499003;0,348497017;1,09387346;0,486868611;0;0;NA;NA;NA
X100144415_TGI_at;100144415_TGI_at;AI050752;SGCB;sarcoglycan, beta (43kDa dystrophin-associated glycoprotein);0,00000082900000000000;0,783452536;0,902872813;0,977805603;0,911927006;0,338916048;0,88217396;0,480593868;0;0;NA;NA;NA
X100144445_TGI_at;100144445_TGI_at;ENST00000257414;SEMA6A;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A;0,00000000000017300000;0,588041789;0,012212797;0,798558018;0,028317874;0,115879498;0,814017897;0,220212042;0;0;NA;NA;NA
X100144489_TGI_at;100144489_TGI_at;NM_133168;OSCAR;osteoclast associated, immunoglobulin-like receptor;0,00000000000019400000;1,881891377;0,000502021;1,340416068;0,003035671;0,000259767;1,844859364;0,004600156;0;1;U2;U1;U1
X100144500_TGI_at;100144500_TGI_at;NM_006142;SFN;stratifin;0,00000000067700000000;2,12453695;0,000441341;1,527793092;0,002767398;0,002409533;1,665719652;0,016145377;0;1;U6;U3;U1
X100144528_TGI_at;100144528_TGI_at;NM_198568;GJB7;gap junction protein, beta 7, 25kDa;0,00000038700000000000;0,703009969;0,002732209;0,648971546;0,009762649;0,004100912;0,705450222;0,022065509;0;1;D5;D1;D1
X100144553_TGI_at;100144553_TGI_at;NM_020297;ABCC9;ATP-binding cassette, sub-family C (CFTR/MRP), member 9;0,00000032900000000000;0,767836153;0,423824994;0,928776615;0,46908927;0,567746993;0,965008202;0,6918142;0;0;NA;NA;NA
X100144556_TGI_at;100144556_TGI_at;AK026189;;hypothetical locus LOC401237;0,00000000734000000000;0,75396856;0,001478597;0,823112802;0,006466102;0,096707538;0,849994796;0,193392487;0;0;NA;NA;NA
X100144563_TGI_at;100144563_TGI_at;BC005850;RUNX1T1;"runt-related transcription factor 1; translocated to, 1 (cyclin D-related)";0,00000117000000000000;0,765871852;0,034612927;0,890146827;0,061093901;0,348497017;0,884597874;0,486868611;0;0;NA;NA;NA
X100144575_TGI_at;100144575_TGI_at;NM_000491;C1QB;complement component 1, q subcomponent, B chain;0,00000007430000000000;1,292031427;0,017922749;1,140722492;0,037388363;0,001950454;1,512099943;0,014451293;0;1;U2;U1;U1
X100144578_TGI_at;100144578_TGI_at;AK055915;CDC42EP3;CDC42 effector protein (Rho GTPase binding) 3;0,00000000000000002690;1,349748369;0,000447122;1,132230899;0,002792833;0,412325494;1,033353722;0,553027493;0;0;NA;NA;NA
X100144607_TGI_at;100144607_TGI_at;NM_002926;RGS12;regulator of G-protein signaling 12;0,00000000000618000000;1,567027353;0,000266578;1,266520364;0,001979679;0,029393816;1,256895874;0,083541684;0;0;NA;NA;NA
X100144624_TGI_at;100144624_TGI_at;NM_032905;RBM17;RNA binding motif protein 17;0,00000000000000012500;0,765151713;2,08E-06;0,889285707;0,000101523;0,038082294;0,915186013;0,099545202;0;0;NA;NA;NA
X100144628_TGI_at;100144628_TGI_at;AK125979;KALRN;kalirin, RhoGEF kinase;0,00000000009050000000;0,777662799;0,011826238;0,865018103;0,027580294;0,000703777;0,71244372;0,007741543;0;1;D3;D1;D1
X100144634_TGI_at;100144634_TGI_at;NM_001017995;SH3PXD2B;SH3 and PX domains 2B;0,00000014500000000000;1,425619252;0,210734374;1,07316725;0,259679814;0,228052747;1,110226071;0,35942005;0;0;NA;NA;NA
X100144690_TGI_at;100144690_TGI_at;NM_007311;TSPO;translocator protein (18kDa);0,00000032200000000000;1,266096567;0,214945049;1,069586367;0,263911579;0,001203889;1,420595217;0,010630505;0;0;NA;NA;NA
X100144749_TGI_at;100144749_TGI_at;BC035985;PGP;phosphoglycolate phosphatase;0,00000007250000000000;1,254349836;0,792532576;1,018917786;0,812188392;0,140181821;1,138281126;0,252829328;0;0;NA;NA;NA
X100144755_TGI_at;100144755_TGI_at;ENST00000373367;ZDHHC15;zinc finger, DHHC-type containing 15;0,00000079000000000000;0,820322448;0,040738397;0,942897824;0,06937601;0,836152269;0,947675136;0,898605789;0;0;NA;NA;NA
X100144764_TGI_at;100144764_TGI_at;ENST00000370535;RP1-177G6.2;hypothetical protein LOC286411;0,00000001690000000000;0,771104403;0,000165838;0,816274757;0,00141401;0,307230301;0,882867115;0,446439703;0;0;NA;NA;NA
X100144778_TGI_at;100144778_TGI_at;NM_182566;VMO1;vitelline membrane outer layer 1 homolog (chicken);0,00000000001670000000;1,517504207;0,032467798;1,150831739;0,058433727;0,142561501;1,177351912;0,256260858;0;0;NA;NA;NA
X100144806_TGI_at;100144806_TGI_at;NM_014184;CNIH4;cornichon homolog 4 (Drosophila);0,00000000000412000000;1,259042934;0,001406002;1,135885573;0,006207597;0,001073561;1,246547654;0,009774253;0;1;U7;U1;U1
X100144807_TGI_at;100144807_TGI_at;BM919267;LDB2;LIM domain binding 2;0,00000000000236000000;0,664877222;0,000194562;0,811648179;0,00159156;0,832935571;0,980029265;0,897243096;0;0;NA;NA;NA
X100144809_TGI_at;100144809_TGI_at;NM_001393;ECM2;extracellular matrix protein 2, female organ and adipocyte specific;0,00000000026400000000;0,660103165;0,04565745;0,862332022;0,076005373;0,038187481;0,762710312;0,099577872;0;0;NA;NA;NA
X100144851_TGI_at;100144851_TGI_at;NM_018256;WDR12;WD repeat domain 12;0,00000000908000000000;1,266190681;7,73E-05;1,154745751;0,000883245;0,69730432;0,994648156;0,795825717;0;0;NA;NA;NA
X100144865_TGI_at;100144865_TGI_at;BC040991;;;0,00000000125000000000;0,796876165;0,032716224;0,931875405;0,058612779;0,131303184;0,927776685;0,240585653;0;0;NA;NA;NA
X100144871_TGI_at;100144871_TGI_at;ENST00000374872;ARHGEF9;Cdc42 guanine nucleotide exchange factor (GEF) 9;0,00000000047600000000;1,277418724;0,003998875;1,125028589;0,012811505;0,709599351;1,026167832;0,803597578;0;0;NA;NA;NA
X100144891_TGI_at;100144891_TGI_at;NM_001234;CAV3;caveolin 3;0,00000000038300000000;0,634877555;9,17E-06;0,702256798;0,000259388;0,502203015;0,9341604;0,637495201;0;0;NA;NA;NA
X100144896_TGI_at;100144896_TGI_at;AB013805;CTNND2;catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein);0,00000000001120000000;0,513110211;0,099670688;0,814844662;0,140156469;0,299373904;1,175813965;0,437985516;0;0;NA;NA;NA
X100144914_TGI_at;100144914_TGI_at;NM_018488;TBX4;T-box 4;0,00000053100000000000;0,751624372;0,107587048;0,879187284;0,148629685;0,759495311;0,996880608;0,842344593;0;0;NA;NA;NA
X100145054_TGI_at;100145054_TGI_at;X69151;ATP6V1C1;ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1;0,00000000888000000000;1,410633326;0,012176346;1,141325872;0,028294423;0,077500779;1,117339182;0,166153341;0;0;NA;NA;NA
X100145061_TGI_at;100145061_TGI_at;NM_178859;;organic solute transporter beta;0,00000000037600000000;0,655865594;0,026436227;0,854342722;0,05016275;0,526346389;0,931155133;0,659403342;0;0;NA;NA;NA
X100145066_TGI_at;100145066_TGI_at;NM_014474;SMPDL3B;sphingomyelin phosphodiesterase, acid-like 3B;0,00000000149000000000;1,511638278;0,073331074;1,164964861;0,110338959;0,365341727;1,171701326;0,503363219;0;0;NA;NA;NA
X100145117_TGI_at;100145117_TGI_at;CK821117;RNF145;ring finger protein 145;0,00000000010300000000;1,406961294;0,047920672;1,156534625;0,078759982;0,051573216;1,239453695;0,12395263;0;0;NA;NA;NA
X100145147_TGI_at;100145147_TGI_at;NM_025219;DNAJC5;DnaJ (Hsp40) homolog, subfamily C, member 5;0,00000001360000000000;1,250389419;0,296475984;1,030328834;0,345834997;0,008241833;1,186815078;0,035370744;0;0;NA;NA;NA
X100145172_TGI_at;100145172_TGI_at;NM_021199;SQRDL;sulfide quinone reductase-like (yeast);0,00000000000470000000;1,308587076;0,034796643;1,083212844;0,061384554;2,13E-05;1,293191803;0,001749595;0;0;NA;NA;NA
X100145179_TGI_at;100145179_TGI_at;NM_015305;ANGEL1;angel homolog 1 (Drosophila);0,00000000748000000000;1,208021597;6,68E-05;1,180268073;0,000812592;0,000923705;1,22872952;0,008967168;0;1;U1;U1;U1
X100145204_TGI_at;100145204_TGI_at;BC148409;GALNT12;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12);0,00000000005750000000;1,667305397;1,90E-06;1,446741187;9,71E-05;0,033503156;1,402874358;0,091046096;0;0;NA;NA;NA
X100145227_TGI_at;100145227_TGI_at;NM_014251;SLC25A13;solute carrier family 25, member 13 (citrin);0,00000000000009070000;1,28589649;0,032406821;1,054535917;0,058382999;0,780651618;0,985290486;0,859890692;0;0;NA;NA;NA
X100145228_TGI_at;100145228_TGI_at;NM_013342;TFPT;TCF3 (E2A) fusion partner (in childhood Leukemia);0,00000000024800000000;1,356847383;0,000272579;1,138673339;0,002005756;0,021425185;1,219860047;0,066397472;0;0;NA;NA;NA
X100145234_TGI_at;100145234_TGI_at;NM_052906;ELFN2;extracellular leucine-rich repeat and fibronectin type III domain containing 2;0,00000000549000000000;1,549182716;0,010386329;1,221562573;0,025245201;0,155979894;1,270561729;0,273070722;0;0;NA;NA;NA
X100145249_TGI_at;100145249_TGI_at;NM_004694;SLC16A6;solute carrier family 16, member 6 (monocarboxylic acid transporter 7);0,00000000050500000000;1,502271312;0,000203273;1,51031912;0,001640436;0,005746943;1,380428863;0,02719882;0;1;U2;U2;U1
X100145254_TGI_at;100145254_TGI_at;NM_001103;ACTN2;actinin, alpha 2;0,00000011400000000000;0,713801379;0,357927282;0,961688094;0,405340699;0,089796347;0,790538521;0,184145191;0;0;NA;NA;NA
X100145267_TGI_at;100145267_TGI_at;NM_006211;PENK;proenkephalin;0,00000008530000000000;0,642963685;0,001524272;0,723875316;0,006576612;0,823248705;0,917278439;0,88918585;0;0;NA;NA;NA
X100145309_TGI_at;100145309_TGI_at;AL832285;GBP5;guanylate binding protein 5;0,00000001210000000000;0,578470813;0,243449004;0,880419012;0,292011962;0,940656418;0,94422236;0,965520903;0;0;NA;NA;NA
X100145332_TGI_at;100145332_TGI_at;NM_015508;TIPARP;TCDD-inducible poly(ADP-ribose) polymerase;0,00000058600000000000;1,505339116;0,000803306;1,307202823;0,004223584;0,440813265;1,110830616;0,5787133;0;0;NA;NA;NA
X100145337_TGI_at;100145337_TGI_at;NM_005337;NCKAP1L;NCK-associated protein 1-like;0,00000000000034100000;1,543005313;0,00514105;1,189682824;0,015413584;0,000695763;1,402314466;0,007705996;0;1;U6;U1;U1
X100145339_TGI_at;100145339_TGI_at;NM_003680;YARS;tyrosyl-tRNA synthetase;0,00000000050500000000;1,231859952;0,040764302;1,056639019;0,06937601;0,066842161;1,107757429;0,148369342;0;0;NA;NA;NA
X100145433_TGI_at;100145433_TGI_at;NM_018092;NETO2;neuropilin (NRP) and tolloid (TLL)-like 2;0,00000018400000000000;0,69749927;6,12E-06;0,694430471;0,0002034;0,029393816;0,81224191;0,083541684;0;0;NA;NA;NA
X100145440_TGI_at;100145440_TGI_at;AK130162;GPD1;glycerol-3-phosphate dehydrogenase 1 (soluble);0,00000000000053800000;1,911923704;0,000697907;1,582590205;0,003851635;0,00023763;2,130888779;0,004452797;0;1;U2;U1;U1
X100145450_TGI_at;100145450_TGI_at;AL833633;DARS2;aspartyl-tRNA synthetase 2, mitochondrial;0,00000010200000000000;1,216239711;0,011631769;1,103103562;0,027277267;0,026197762;1,116881286;0,076620133;0;0;NA;NA;NA
X100145464_TGI_at;100145464_TGI_at;BX640843;;similar to hCG2041270;0,00000000000000552000;2,365506621;1,10E-07;1,933831513;1,54E-05;0,007460982;1,374256502;0,032940745;0;1;U2;U2;U1
X100145469_TGI_at;100145469_TGI_at;NM_004751;GCNT3;glucosaminyl (N-acetyl) transferase 3, mucin type;0,00000000001270000000;2,095071482;0,001955111;1,39049166;0,007904827;0,279853683;1,013908919;0,417964977;0;0;NA;NA;NA
X100145480_TGI_at;100145480_TGI_at;DB317311;GIMAP1;GTPase, IMAP family member 1;0,00000000124000000000;0,643507637;0,007320753;0,782256617;0,019739332;0,534478464;1,081725083;0,664336324;0;0;NA;NA;NA
X100145538_TGI_at;100145538_TGI_at;NM_001080420;SHANK3;SH3 and multiple ankyrin repeat domains 3;0,00000000003980000000;0,697876721;5,73E-05;0,791529599;0,000744162;0,491673531;0,899317332;0,627589621;0;0;NA;NA;NA
X100145541_TGI_at;100145541_TGI_at;DA634014;TBXAS1;thromboxane A synthase 1 (platelet);0,00000000079800000000;1,442878449;0,125472351;1,179305257;0,168498912;0,002546598;1,589757291;0,01677126;0;0;NA;NA;NA
X100145547_TGI_at;100145547_TGI_at;BU753528;PTPLA;protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A;0,00000005840000000000;1,306896791;0,29953759;1,091778829;0,348775163;0,365341727;1,107121445;0,503363219;0;0;NA;NA;NA
X100145549_TGI_at;100145549_TGI_at;BC075849;SIRPA;signal-regulatory protein alpha;0,00000000000077700000;1,492530333;0,021570816;1,11305306;0,04326244;0,000328732;1,306711603;0,005193636;0;1;U1;U1;U1
X100145551_TGI_at;100145551_TGI_at;NM_006042;HS3ST3A1;heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1;0,00000026200000000000;0,693104911;0,022796678;0,807748876;0,045131261;0,003045158;0,692214052;0,018596182;0;1;D2;D1;D1
X100145563_TGI_at;100145563_TGI_at;NM_000478;ALPL;alkaline phosphatase, liver/bone/kidney;0,00000000271000000000;1,386564669;0,112283064;1,116530421;0,153537681;0,000135182;1,603369789;0,003701458;0;0;NA;NA;NA
X100145575_TGI_at;100145575_TGI_at;NM_002848;PTPRO;protein tyrosine phosphatase, receptor type, O;0,00000000027700000000;1,562765434;0,000743319;1,343525888;0,004046817;0,003446716;1,678049732;0,019661534;0;1;U2;U1;U1
X100145578_TGI_at;100145578_TGI_at;AF147316;;;0,00000000006570000000;0,621806353;0,013873289;0,781982137;0,031000594;0,951948154;1,059028425;0,974385319;0;0;NA;NA;NA
X100145635_TGI_at;100145635_TGI_at;NM_019556;MOSPD1;motile sperm domain containing 1;0,00000000004180000000;1,388392206;0,000475034;1,181547196;0,002905189;0,951952506;0,969888453;0,974385319;0;0;NA;NA;NA
X100145649_TGI_at;100145649_TGI_at;NM_000924;PDE1B;phosphodiesterase 1B, calmodulin-dependent;0,00000126000000000000;1,340827802;0,243768181;1,084033641;0,29228603;0,357146031;1,077954477;0,494450884;0;0;NA;NA;NA
X100145658_TGI_at;100145658_TGI_at;NM_005488;TOM1;target of myb1 (chicken);0,00000028900000000000;1,246273096;0,572621858;1,029403831;0,607892045;0,023044114;1,188843273;0,069935199;0;0;NA;NA;NA
X100145744_TGI_at;100145744_TGI_at;AF086222;;;0,00000006350000000000;1,238875422;0,560985751;1,029066672;0,596915508;0,197238472;1,111579786;0,324667823;0;0;NA;NA;NA
X100145749_TGI_at;100145749_TGI_at;BC001880;INSIG1;insulin induced gene 1;0,00000000000079600000;1,516153367;0,001616869;1,237655213;0,006865836;0,001284943;1,412686133;0,011043654;0;1;U4;U1;U1
X100145795_TGI_at;100145795_TGI_at;U07361;SORD;sorbitol dehydrogenase;0,00000077000000000000;1,228346437;0,395305085;1,062804659;0,441312188;0,953827391;0,962387662;0,974385319;0;0;NA;NA;NA
X100145868_TGI_at;100145868_TGI_at;AF007137;;;0,00000000530000000000;0,579640309;0,078004298;0,829119968;0,115483626;0,37483693;0,835138326;0,511473085;0;0;NA;NA;NA
X100145896_TGI_at;100145896_TGI_at;NM_001025242;IRAK1;interleukin-1 receptor-associated kinase 1;0,00000000397000000000;1,282776054;0,056178212;1,048462245;0,089634839;0,421327994;1,066652958;0,560904521;0;0;NA;NA;NA
X100145904_TGI_at;100145904_TGI_at;DB370515;ADD2;adducin 2 (beta);0,00000055400000000000;0,799550217;0,00282885;0,855560287;0,009997133;0,242831425;0,878514059;0,376271963;0;0;NA;NA;NA
X100145913_TGI_at;100145913_TGI_at;NM_016563;RASL12;RAS-like, family 12;0,00000000122000000000;0,70808876;0,008100924;0,845785689;0,021261627;0,066842161;0,836934099;0,148369342;0;0;NA;NA;NA
X100145927_TGI_at;100145927_TGI_at;NM_001629;ALOX5AP;arachidonate 5-lipoxygenase-activating protein;0,00000000000000030700;1,57087991;0,006919647;1,16467752;0,018980446;4,67E-05;1,542371218;0,002060556;0;1;U2;U1;U1
X100145957_TGI_at;100145957_TGI_at;NM_203315;BDH1;3-hydroxybutyrate dehydrogenase, type 1;0,00000004210000000000;1,417987167;0,017861791;1,133589941;0,037285332;0,010855277;1,214872519;0,041904859;0;1;U1;U1;U1
X100145963_TGI_at;100145963_TGI_at;NM_000232;SGCB;sarcoglycan, beta (43kDa dystrophin-associated glycoprotein);0,00000000029000000000;0,766276334;0,00478784;0,903822532;0,014585264;0,103562613;0,876185963;0,203277894;0;0;NA;NA;NA
X100145976_TGI_at;100145976_TGI_at;AL133642;EVL;Enah/Vasp-like;0,00000000132000000000;1,490294624;0,01145057;1,220992323;0,026977475;0,122857837;1,256855188;0,229149774;0;0;NA;NA;NA
X100145992_TGI_at;100145992_TGI_at;NM_000508;FGA;fibrinogen alpha chain;0,00000002490000000000;1,81471708;0,000277495;2,250375233;0,002018582;0,023889612;1,59537262;0,071425065;0;0;NA;NA;NA
X100145998_TGI_at;100145998_TGI_at;NM_080422;PTPN2;protein tyrosine phosphatase, non-receptor type 2;0,00000000029800000000;1,229008153;0,303878726;1,041263266;0,353064577;0,064330368;1,119823511;0,144788251;0;0;NA;NA;NA
X100146019_TGI_at;100146019_TGI_at;NM_001042521;;hypothetical protein MGC13057;0,00000118000000000000;0,650275758;0,11454;0,856089653;0,155791476;0,030713739;0,735457811;0,086003807;0;0;NA;NA;NA
X100146023_TGI_at;100146023_TGI_at;U78165;RIT1;Ras-like without CAAX 1;0,00000000026400000000;1,345716007;0,009411023;1,111440613;0,023512966;0,046864607;1,191060846;0,114688405;0;0;NA;NA;NA
X100146061_TGI_at;100146061_TGI_at;NM_006949;STXBP2;syntaxin binding protein 2;0,00000001200000000000;1,323474659;0,758713458;1,015898772;0,77976195;0,007375314;1,344964561;0,032696886;0;0;NA;NA;NA
X100146063_TGI_at;100146063_TGI_at;NM_001040716;PC;pyruvate carboxylase;0,00000000000127000000;1,557129947;0,003050272;1,168055317;0,010651167;0,080609435;1,18155596;0,170587136;0;0;NA;NA;NA
X100146074_TGI_at;100146074_TGI_at;NM_024872;DOK3;docking protein 3;0,00000000007960000000;1,619112509;0,177079764;1,069113088;0,224254649;0,000753789;1,447023718;0,007913552;0;0;NA;NA;NA
X100146078_TGI_at;100146078_TGI_at;BF921458;;;0,00000020700000000000;0,750394901;0,961520477;0,99632695;0,965414485;0,018980373;0,805169802;0,060869395;0;0;NA;NA;NA
X100146125_TGI_at;100146125_TGI_at;NM_025193;HSD3B7;hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7;0,00000000000011300000;1,688576955;0,003584132;1,241661869;0,011906754;0,004937402;1,334023519;0,024633511;0;1;U2;U1;U1
X100146153_TGI_at;100146153_TGI_at;BC032541;EML1;echinoderm microtubule associated protein like 1;0,00000000133000000000;0,713473273;0,009232759;0,881724435;0,023320675;0,140181821;0,816053063;0,252829328;0;0;NA;NA;NA
X100146203_TGI_at;100146203_TGI_at;NM_004113;FGF12;fibroblast growth factor 12;0,00000073300000000000;0,684027142;0,017262702;0,7953734;0,036531641;0,0064123;0,726250475;0,029273149;0;1;D1;D1;D1
X100146213_TGI_at;100146213_TGI_at;NM_005908;MANBA;mannosidase, beta A, lysosomal;0,00000000002390000000;1,244859317;4,18E-06;1,168166171;0,00015806;0,017758754;1,159663068;0,058404554;0;0;NA;NA;NA
X100146214_TGI_at;100146214_TGI_at;NM_007023;RAPGEF4;Rap guanine nucleotide exchange factor (GEF) 4;0,00000007080000000000;0,676912695;0,374894512;0,935063049;0,422182044;0,759495311;1,010167946;0,842344593;0;0;NA;NA;NA
X100146217_TGI_at;100146217_TGI_at;NM_021077;NMB;neuromedin B;0,00000000008740000000;1,74315452;0,015037392;1,221064096;0,032986703;0,141436063;1,204572532;0,254806278;0;0;NA;NA;NA
X100146264_TGI_at;100146264_TGI_at;NM_005472;KCNE3;potassium voltage-gated channel, Isk-related family, member 3;0,00000000084700000000;1,440059519;0,19847624;1,082985708;0,247079537;0,228052747;1,168217202;0,35942005;0;0;NA;NA;NA
X100146282_TGI_at;100146282_TGI_at;NM_032452;JPH4;junctophilin 4;0,00000046500000000000;1,315815777;0,002344438;1,18741941;0,00880667;0,010855277;1,368182701;0,041904859;0;1;U3;U1;U1
X100146308_TGI_at;100146308_TGI_at;ENST00000366558;KMO;kynurenine 3-monooxygenase (kynurenine 3-hydroxylase);0,00000000000000026200;2,278072144;4,33E-06;1,562361247;0,000158381;0,000149203;1,829307986;0,003847048;0;1;U8;U2;U1
X100146335_TGI_at;100146335_TGI_at;AL575089;LAPTM5;lysosomal multispanning membrane protein 5;0,00000000000001550000;1,536502592;0,000419333;1,208361323;0,002692253;0,00012425;1,459062773;0,003628771;0;1;U6;U1;U1
X100146347_TGI_at;100146347_TGI_at;NM_000676;ADORA2B;adenosine A2b receptor;0,00000000008480000000;1,456683778;0,12609829;1,095182401;0,169128085;0,059535454;1,185114696;0,137945916;0;0;NA;NA;NA
X100146372_TGI_at;100146372_TGI_at;NM_018181;ZNF532;zinc finger protein 532;0,00000000190000000000;0,820828205;0,037164325;0,938779268;0,064816353;0,007375314;0,865079233;0,032696886;0;0;NA;NA;NA
X100146464_TGI_at;100146464_TGI_at;AF131740;KCMF1;potassium channel modulatory factor 1;0,00000025400000000000;0,812449246;0,078088783;0,918539928;0,115555623;0,297618761;0,89947035;0,437985516;0;0;NA;NA;NA
X100146480_TGI_at;100146480_TGI_at;BM923209;RERG;RAS-like, estrogen-regulated, growth inhibitor;0,00000120000000000000;0,784027861;0,765712494;1,00267614;0,786453591;0,965667301;1,032220819;0,980394958;0;0;NA;NA;NA
X100146488_TGI_at;100146488_TGI_at;BX111056;;;0,00000000000536000000;0,596363278;0,005326341;0,798563396;0,015749355;0,284058212;0,886569425;0,421122179;0;0;NA;NA;NA
X100146552_TGI_at;100146552_TGI_at;BM683298;;;0,00000044500000000000;1,594515854;0,13925074;1,160623793;0,183335431;0,00256018;1,50658334;0,01677126;0;0;NA;NA;NA
X100146578_TGI_at;100146578_TGI_at;NM_005896;IDH1;isocitrate dehydrogenase 1 (NADP+), soluble;0,00000000000052700000;1,517002916;4,00E-05;1,22181015;0,000593747;0,03650134;1,260603787;0,096439395;0;0;NA;NA;NA
X100146669_TGI_at;100146669_TGI_at;NM_006332;IFI30;interferon, gamma-inducible protein 30;0,00000000000300000000;1,299907188;0,004420374;1,133300394;0,013845349;0,00012425;1,338160593;0,003628771;0;1;U2;U1;U1
X100146709_TGI_at;100146709_TGI_at;AW592486;FLT1;fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);0,00000013400000000000;0,763450983;0,000254038;0,760397455;0,001917479;0,248075799;0,893039258;0,381463883;0;0;NA;NA;NA
X100146716_TGI_at;100146716_TGI_at;R38526;LIFR;leukemia inhibitory factor receptor alpha;0,00000101000000000000;0,624795281;0,645826129;0,961708066;0,677791473;0,709599351;0,970746204;0,803597578;0;0;NA;NA;NA
X100146739_TGI_at;100146739_TGI_at;BC008299;C14orf139;chromosome 14 open reading frame 139;0,00000000006500000000;0,715805401;0,010014837;0,871561018;0,024730173;0,746919855;1,0277138;0,832983631;0;0;NA;NA;NA
X100146751_TGI_at;100146751_TGI_at;NM_001013659;ZNF793;zinc finger protein 793;0,00000007920000000000;0,751053833;0,002042231;0,813575023;0,008096077;0,000987594;0,684882898;0,009357144;0;1;D2;D1;D1
X100146758_TGI_at;100146758_TGI_at;NM_173623;TTLL6;tubulin tyrosine ligase-like family, member 6;0,00000071500000000000;0,628475633;0,000177562;0,590320503;0,001494212;0,006071612;0,600549108;0,028156556;0;1;D3;D2;D1
X100146767_TGI_at;100146767_TGI_at;BC050073;ACSL1;acyl-CoA synthetase long-chain family member 1;0,00000000017100000000;1,559448631;0,015584608;1,251195547;0,033852683;0,072102527;1,313610565;0,157336794;0;0;NA;NA;NA
X100146785_TGI_at;100146785_TGI_at;NM_015481;ZNF385A;zinc finger protein 385A;0,00000000214000000000;1,553933992;0,018559576;1,149318067;0,038517395;0,000753789;1,256166708;0,007913552;0;1;U1;U1;U1
X100146794_TGI_at;100146794_TGI_at;BE463692;;;0,00000016100000000000;0,764399996;0,038489268;0,895148293;0,066524815;0,122857837;1,184474768;0,229149774;0;0;NA;NA;NA
X100146818_TGI_at;100146818_TGI_at;NM_178006;STARD13;StAR-related lipid transfer (START) domain containing 13;0,00000000004890000000;0,788669459;0,000765107;0,869179498;0,004123647;0,470967706;1,073252867;0,606928795;0;0;NA;NA;NA
X100146857_TGI_at;100146857_TGI_at;NM_021922;FANCE;Fanconi anemia, complementation group E;0,00000000008440000000;1,298687903;0,084981277;1,072078473;0,124046493;0,074854353;1,136899901;0,161916497;0;0;NA;NA;NA
X100146868_TGI_at;100146868_TGI_at;U33936;ADK;adenosine kinase;0,00000000364000000000;1,284028302;7,60E-05;1,174375261;0,000874545;0,002719171;1,230488153;0,017251748;0;1;U2;U2;U1
X100146870_TGI_at;100146870_TGI_at;NM_000691;ALDH3A1;aldehyde dehydrogenase 3 family, memberA1;0,00000000000000711000;3,962513529;9,89E-05;2,352320057;0,001053705;0,127027071;1,450545481;0,235834246;0;0;NA;NA;NA
X100146871_TGI_at;100146871_TGI_at;NM_016350;NIN;ninein (GSK3B interacting protein);0,00000000530000000000;1,55301114;0,171909147;1,093951406;0,218135111;0,491673531;1,172338986;0,627589621;0;0;NA;NA;NA
X100146878_TGI_at;100146878_TGI_at;NM_207517;ADAMTSL3;ADAMTS-like 3;0,00000000000015200000;0,636278964;0,05989;0,867215297;0,094117683;0,18024766;0,859592281;0,304954439;0;0;NA;NA;NA
X100146903_TGI_at;100146903_TGI_at;NM_014178;STXBP6;syntaxin binding protein 6 (amisyn);0,00000000037600000000;0,65243218;0,0034759;0,82054684;0,011669609;0,601955364;1,10456741;0,718556347;0;0;NA;NA;NA
X100146932_TGI_at;100146932_TGI_at;AV652595;HSDL2;hydroxysteroid dehydrogenase like 2;0,00000117000000000000;1,224112809;0,00385602;1,150415574;0,012528179;0,008707469;1,303102364;0,036926544;0;1;U1;U1;U1
X100146943_TGI_at;100146943_TGI_at;DB298383;CDKL2;cyclin-dependent kinase-like 2 (CDC2-related kinase);0,00000000008200000000;1,511547435;0,028663655;1,189950983;0,053185353;0,00125244;1,470371738;0,010880359;0;0;NA;NA;NA
X100146956_TGI_at;100146956_TGI_at;AK093229;;;0,00000005100000000000;1,528872966;0,018780069;1,239739087;0,038949911;0,093210697;1,216843625;0,188856657;0;0;NA;NA;NA
X100146961_TGI_at;100146961_TGI_at;NM_004265;FADS2;fatty acid desaturase 2;0,00000022100000000000;1,307629151;0,087316992;1,098609812;0,126652865;0,016931008;1,351272413;0,056430856;0;0;NA;NA;NA
X100147004_TGI_at;100147004_TGI_at;NM_014945;ABLIM3;actin binding LIM protein family, member 3;0,00000000031200000000;0,741976003;0,001962104;0,851336563;0,007904827;0,043948888;0,851356952;0,109380128;0;0;NA;NA;NA
X100147013_TGI_at;100147013_TGI_at;ENST00000346401;LILRB3;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3;0,00000000002370000000;1,614685905;0,044078519;1,148906371;0,073761717;0,008707469;1,298236451;0,036926544;0;0;NA;NA;NA
X100147056_TGI_at;100147056_TGI_at;NM_003047;SLC9A1;solute carrier family 9 (sodium/hydrogen exchanger), member 1;0,00000000007470000000;1,324892935;0,008207603;1,097361168;0,021454262;0,018980373;1,165129793;0,060869395;0;0;NA;NA;NA
X100147073_TGI_at;100147073_TGI_at;NM_005084;PLA2G7;phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma);0,00000000000382000000;3,446907995;0,000185772;1,568962213;0,001548298;0,002131763;1,979701878;0,014968787;0;1;U6;U1;U1
X100147096_TGI_at;100147096_TGI_at;BX361168;ATAD1;ATPase family, AAA domain containing 1;0,00000001850000000000;1,231587064;0,000945553;1,132093229;0,004645604;0,039719764;1,159231963;0,101661999;0;0;NA;NA;NA
X100147102_TGI_at;100147102_TGI_at;NM_004370;COL12A1;collagen, type XII, alpha 1;0,00000000000007040000;0,592811633;0,015486569;0,857081504;0,033702371;0,432376875;0,941156222;0,56949353;0;0;NA;NA;NA
X100147111_TGI_at;100147111_TGI_at;AF200193;BACE1;beta-site APP-cleaving enzyme 1;0,00000000043300000000;1,312905991;0,067175755;1,081602848;0,103447061;0,013942384;1,214746548;0,049653374;0;0;NA;NA;NA
X100147114_TGI_at;100147114_TGI_at;NM_032575;GLIS2;GLIS family zinc finger 2;0,00000000034700000000;0,748326999;4,54E-05;0,820431389;0,000644465;0,185788694;0,863598661;0,311548887;0;0;NA;NA;NA
X100147116_TGI_at;100147116_TGI_at;ENST00000358431;CTA-221G9.4;KIAA1671 protein;0,00000021800000000000;0,833271727;0,148097263;0,955900044;0,192466726;0,164346936;0,901215524;0,282652175;0;0;NA;NA;NA
X100147118_TGI_at;100147118_TGI_at;AK023271;LPCAT2;lysophosphatidylcholine acyltransferase 2;0,00000000000022700000;1,731607347;2,80E-05;1,319206977;0,000479188;0,248075799;1,152628894;0,381463883;0;0;NA;NA;NA
X100147140_TGI_at;100147140_TGI_at;NM_015689;DENND2A;DENN/MADD domain containing 2A;0,00000002610000000000;0,712117398;0,000153972;0,819314783;0,001355693;0,980202899;0,997668644;0,987556719;0;0;NA;NA;NA
X100147158_TGI_at;100147158_TGI_at;NM_004186;SEMA3F;sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F;0,00000058200000000000;0,767658036;2,79E-06;0,739681445;0,000115604;0,393048057;0,903763106;0,532042792;0;0;NA;NA;NA
X100147160_TGI_at;100147160_TGI_at;NM_016297;PCYOX1;prenylcysteine oxidase 1;0,00000080900000000000;0,792295995;0,707530368;0,951769194;0,733709902;0,003250241;1,392321361;0,019115922;0;0;NA;NA;NA
X100147167_TGI_at;100147167_TGI_at;NM_005258;GCHFR;GTP cyclohydrolase I feedback regulator;0,00000000018200000000;1,761615654;0,171580367;1,162011129;0,217889489;0,00317515;1,77353601;0,019115922;0;0;NA;NA;NA
X100147171_TGI_at;100147171_TGI_at;NM_016246;HSD17B14;hydroxysteroid (17-beta) dehydrogenase 14;0,00000000000151000000;1,694337987;0,000842704;1,220215424;0,004353649;0,000806993;1,440157161;0,008256949;0;1;U4;U2;U1
X100147179_TGI_at;100147179_TGI_at;NM_014921;LPHN1;latrophilin 1;0,00000015300000000000;0,829397915;0,027237954;0,920905694;0,051218159;0,512848122;1,060012666;0,646425302;0;0;NA;NA;NA
X100147201_TGI_at;100147201_TGI_at;NM_002250;KCNN4;potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4;0,00000000014200000000;1,622554296;0,043479817;1,146113814;0,072911264;0,545460135;1,041839515;0,674086662;0;0;NA;NA;NA
X100147215_TGI_at;100147215_TGI_at;NM_002208;ITGAE;"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)";0,00000000000005840000;1,602173302;3,76E-08;1,296627;6,74E-06;0,00595432;1,254857229;0,028056686;0;1;U1;U1;U1
X100147246_TGI_at;100147246_TGI_at;ENST00000256969;C12orf39;chromosome 12 open reading frame 39;0,00000073300000000000;0,64097441;0,583877372;0,929690713;0,618618267;1;1,006440721;1;0;0;NA;NA;NA
X100147293_TGI_at;100147293_TGI_at;ENST00000323944;STXBP6;syntaxin binding protein 6 (amisyn);0,00000000000898000000;0,605356863;0,009232759;0,776334763;0,023320675;0,746919855;1,018178715;0,832983631;0;0;NA;NA;NA
X100147315_TGI_at;100147315_TGI_at;BC028609;CCDC93;coiled-coil domain containing 93;0,00000004960000000000;1,338516341;0,007287848;1,124104004;0,019688796;0,096726246;1,108954549;0,193392487;0;0;NA;NA;NA
X100147317_TGI_at;100147317_TGI_at;BX111043;;;0,00000066400000000000;0,813294335;0,490063816;0,987037618;0,530381356;0,241271938;0,884737715;0,374575845;0;0;NA;NA;NA
X100147331_TGI_at;100147331_TGI_at;NM_013321;SNX8;sorting nexin 8;0,00000000081400000000;1,437131831;0,087598007;1,072766973;0,127003318;0,00057123;1,272963662;0,006879298;0;0;NA;NA;NA
X100147332_TGI_at;100147332_TGI_at;ENST00000263816;LRP2;low density lipoprotein-related protein 2;0,00000000283000000000;1,772892505;0,036323065;1,269478544;0,063693819;0,000518747;1,9891694;0,006582364;0;0;NA;NA;NA
X100147336_TGI_at;100147336_TGI_at;AK025665;PNPLA3;patatin-like phospholipase domain containing 3;0,00000000000075000000;2,342516306;2,57E-07;1,982269362;2,77E-05;0,001127468;1,902818263;0,010122083;0;1;U2;U2;U1
X100147362_TGI_at;100147362_TGI_at;AB002330;;U2-associated SR140 protein;0,00000000388000000000;0,808075264;0,240918096;0,967039506;0,28962291;0,267057988;0,953137585;0,403399161;0;0;NA;NA;NA
X100147383_TGI_at;100147383_TGI_at;BI914249;ADFP;adipose differentiation-related protein;0,00000000069800000000;1,51005179;0,09460924;1,138851989;0,134565569;0,127027071;1,237177192;0,235834246;0;0;NA;NA;NA
X100147393_TGI_at;100147393_TGI_at;BQ440490;CEP27;centrosomal protein 27kDa;0,00000010800000000000;1,345005901;0,174022453;1,091573386;0,220642945;0,212463914;1,168554056;0,341531768;0;0;NA;NA;NA
X100147438_TGI_at;100147438_TGI_at;NM_012294;RAPGEF5;Rap guanine nucleotide exchange factor (GEF) 5;0,00000111000000000000;0,809464902;0,335802487;0,939574753;0,384303319;0,709599351;1,001028995;0,803597578;0;0;NA;NA;NA
X100147440_TGI_at;100147440_TGI_at;NM_145753;PHLDB2;pleckstrin homology-like domain, family B, member 2;0,00000063000000000000;0,769123283;0,067242194;0,90735451;0,103447061;0,307230301;0,895309399;0,446439703;0;0;NA;NA;NA
X100147493_TGI_at;100147493_TGI_at;NM_144584;C1orf59;chromosome 1 open reading frame 59;0,00000120000000000000;1,236894334;0,001245762;1,183239666;0,005607668;0,061895338;1,179287359;0,141481329;0;0;NA;NA;NA
X100147504_TGI_at;100147504_TGI_at;AK023631;;;0,00000010800000000000;0,686152025;0,028250638;0,877633064;0,052635203;0,323340368;0,937181958;0,462755775;0;0;NA;NA;NA
X100147509_TGI_at;100147509_TGI_at;NM_025154;UNC84A;unc-84 homolog A (C. elegans);0,00000000001050000000;0,804119525;0,128323273;0,960661658;0,17161241;0,015374349;0,890106055;0,052959853;0;0;NA;NA;NA
X100147607_TGI_at;100147607_TGI_at;AK056217;;;0,00000000011300000000;0,719770846;0,040738397;0,899575253;0,06937601;0,284058212;0,858151715;0,421122179;0;0;NA;NA;NA
X100147647_TGI_at;100147647_TGI_at;NM_003811;TNFSF9;tumor necrosis factor (ligand) superfamily, member 9;0,00000000000001780000;1,798655304;4,61E-05;1,425918745;0,000649405;0,002409533;1,418365055;0,016145377;0;1;U4;U2;U1
X100147653_TGI_at;100147653_TGI_at;NM_012212;PTGR1;prostaglandin reductase 1;0,00000000667000000000;1,233760532;0,149326566;1,085240829;0,193829852;0,967010726;0,988333347;0,980394958;0;0;NA;NA;NA
X100147674_TGI_at;100147674_TGI_at;NM_002133;HMOX1;heme oxygenase (decycling) 1;0,00000104000000000000;1,449306183;0,1451755;1,08700329;0,189127177;0,004342204;1,649371707;0,022867523;0;0;NA;NA;NA
X100147679_TGI_at;100147679_TGI_at;NM_018326;GIMAP4;GTPase, IMAP family member 4;0,00000037700000000000;0,810705407;0,031491038;0,928788918;0,056987993;0,746919855;1,036743427;0,832983631;0;0;NA;NA;NA
X100147680_TGI_at;100147680_TGI_at;AF086914;SRPRB;signal recognition particle receptor, B subunit;0,00000000009040000000;1,353497586;0,965010898;0,982671727;0,96831573;0,257214424;1,08042838;0,391963163;0;0;NA;NA;NA
X100147684_TGI_at;100147684_TGI_at;NM_012329;MMD;monocyte to macrophage differentiation-associated;0,00000034900000000000;1,221763508;0,000441341;1,144813968;0,002767398;0,111832653;1,097897036;0,21403601;0;0;NA;NA;NA
X100147699_TGI_at;100147699_TGI_at;NM_006097;MYL9;myosin, light chain 9, regulatory;0,00000038000000000000;0,82938472;0,020109172;0,888003065;0,041020393;0,599183733;1,03007382;0,718556347;0;0;NA;NA;NA
X100147707_TGI_at;100147707_TGI_at;NM_002980;SCTR;secretin receptor;0,00000000000016800000;2,101438635;3,18E-05;1,537524623;0,000509476;1,09E-05;2,02841809;0,001306304;0;1;U6;U2;U1
X100147740_TGI_at;100147740_TGI_at;NM_024556;FAM118B;family with sequence similarity 118, member B;0,00000000957000000000;1,239959413;0,020751596;1,082381593;0,04203796;0,000149203;1,344370232;0,003847048;0;1;U2;U1;U1
X100147756_TGI_at;100147756_TGI_at;ENST00000354442;MBOAT2;membrane bound O-acyltransferase domain containing 2;0,00000000515000000000;0,782193253;0,317546799;0,952146959;0,36656638;0,215347198;0,918320174;0,344448645;0;0;NA;NA;NA
X100147776_TGI_at;100147776_TGI_at;BC032361;KIAA0040;KIAA0040;0,00000000026400000000;0,741711153;0,010859876;0,874647218;0,02611664;0,209185181;0,90037984;0,337324278;0;0;NA;NA;NA
X100147780_TGI_at;100147780_TGI_at;AF068836;CYTIP;cytohesin 1 interacting protein;0,00000000578000000000;1,514385211;0,002115417;1,262500725;0,00829913;0,648925345;1,041107068;0,755321916;0;0;NA;NA;NA
X100147804_TGI_at;100147804_TGI_at;NM_138418;C16orf14;chromosome 16 open reading frame 14;0,00000000101000000000;1,278744689;0,57746322;1,027505859;0,612426443;0,035812533;1,205289591;0,09578738;0;0;NA;NA;NA
X100147805_TGI_at;100147805_TGI_at;BC018929;PHLDA1;pleckstrin homology-like domain, family A, member 1;0,00000053100000000000;1,664631881;0,000401707;1,517860168;0,002620856;0,967010726;0,988869805;0,980394958;0;0;NA;NA;NA
X100147820_TGI_at;100147820_TGI_at;NM_000231;SGCG;sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein);0,00000034300000000000;0,68833252;0,93892153;1,0152048;0,944489417;0,307230301;1,263664824;0,446439703;0;0;NA;NA;NA
X100147825_TGI_at;100147825_TGI_at;ENST00000313038;LAIR1;leukocyte-associated immunoglobulin-like receptor 1;0,00000000002900000000;1,613712837;0,136240309;1,105214631;0,180033832;0,001600651;1,343181307;0,012613442;0;0;NA;NA;NA
X100147831_TGI_at;100147831_TGI_at;NM_014405;CACNG4;calcium channel, voltage-dependent, gamma subunit 4;0,00000000000685000000;0,63529101;0,029872805;0,774783937;0,05498277;0,402347064;1,149707939;0,542112532;0;0;NA;NA;NA
X100147839_TGI_at;100147839_TGI_at;NM_145792;MGST1;microsomal glutathione S-transferase 1;0,00000000863000000000;1,385457785;0,000156022;1,202434921;0,001362759;0,003883416;1,320943171;0,021358785;0;1;U2;U1;U1
X100147852_TGI_at;100147852_TGI_at;NM_030766;BCL2L14;BCL2-like 14 (apoptosis facilitator);0,00000002510000000000;1,431427512;0,152975069;1,0853022;0,197769212;0,685594243;1,023170575;0,784962787;0;0;NA;NA;NA
X100147865_TGI_at;100147865_TGI_at;NM_001001995;GPM6B;glycoprotein M6B;0,00000000648000000000;0,698855084;0,014130794;0,832510244;0,03143102;0,159283623;0,882943195;0,276600817;0;0;NA;NA;NA
X100147884_TGI_at;100147884_TGI_at;T90396;;;0,00000000001300000000;0,622892525;0,000277495;0,712202583;0,002018582;0,672949117;0,976325272;0,774063003;0;0;NA;NA;NA
X100147891_TGI_at;100147891_TGI_at;BC020784;ZC3HAV1L;zinc finger CCCH-type, antiviral 1-like;0,00000003040000000000;0,7117256;0,06554722;0,916207375;0,101371732;0,028121921;0,791897351;0,080853658;0;0;NA;NA;NA
X100147909_TGI_at;100147909_TGI_at;NM_030583;MATN2;matrilin 2;0,00000021300000000000;0,711038096;0,069852151;0,849969302;0,106597292;0,140181821;0,841429;0,252829328;0;0;NA;NA;NA
X100147948_TGI_at;100147948_TGI_at;AK056836;;hypothetical protein LOC150166;0,00000005240000000000;1,496516074;0,221372354;1,108305692;0,270566211;0,008831116;1,445250283;0,036964527;0;0;NA;NA;NA
X100147978_TGI_at;100147978_TGI_at;AF161529;COPZ1;coatomer protein complex, subunit zeta 1;0,00000000049300000000;1,224611235;0,003250652;1,095145394;0,011157456;0,057249107;1,164013895;0,133608886;0;0;NA;NA;NA
X100148022_TGI_at;100148022_TGI_at;NM_174896;C1orf162;chromosome 1 open reading frame 162;0,00000000000000807000;1,527904736;0,000866119;1,186345956;0,004445065;0,003239583;1,358712247;0,019115922;0;1;U6;U1;U1
X100148030_TGI_at;100148030_TGI_at;NM_173728;ARHGEF15;Rho guanine nucleotide exchange factor (GEF) 15;0,00000000184000000000;0,679082043;0,001997802;0,761799089;0,007988979;0,083263264;0,821482085;0,17510994;0;0;NA;NA;NA
X100148083_TGI_at;100148083_TGI_at;NM_001584;MPPED2;metallophosphoesterase domain containing 2;0,00000001900000000000;0,622573034;0,619438503;0,959038802;0,653288709;0,001203889;0,553270416;0,010630505;0;0;NA;NA;NA
X100148087_TGI_at;100148087_TGI_at;NM_004258;IGSF2;immunoglobulin superfamily, member 2;0,00000000000000155000;2,407237221;2,52E-05;1,677018332;0,000456611;0,000289945;2,01614637;0,004872704;0;1;U1;U1;U1
X100148116_TGI_at;100148116_TGI_at;NM_194250;ZNF804A;zinc finger protein 804A;0,00000011700000000000;1,34172247;0,001219327;1,243444397;0,005518227;0,093285696;1,145113917;0,188856657;0;0;NA;NA;NA
X100148135_TGI_at;100148135_TGI_at;NM_002885;RAP1GAP;RAP1 GTPase activating protein;0,00000028900000000000;1,287303201;0,337348803;1,082189285;0,38569535;0,004862758;1,557191493;0,024374289;0;0;NA;NA;NA
X100148151_TGI_at;100148151_TGI_at;BC002660;TMOD1;tropomodulin 1;0,00000000800000000000;0,742435334;0,016480721;0,84970666;0,035317396;0,315219134;0,916340897;0,454361033;0;0;NA;NA;NA
X100148172_TGI_at;100148172_TGI_at;NM_020188;C16orf61;chromosome 16 open reading frame 61;0,00000000001510000000;1,23597509;0,005093109;1,112071071;0,015312584;0,194183373;1,040037732;0,322272406;0;0;NA;NA;NA
X100148175_TGI_at;100148175_TGI_at;NM_032229;SLITRK6;SLIT and NTRK-like family, member 6;0,00000000000013100000;0,459714779;0,000964889;0,557994942;0,004711873;0,000188734;0,432933384;0,004028419;0;1;D5;D1;D1
X100148181_TGI_at;100148181_TGI_at;NM_006511;RSC1A1;regulatory solute carrier protein, family 1, member 1;0,00000039200000000000;1,256614228;0,808674872;1,029175537;0,827153003;0,061895338;1,093503485;0,141481329;0;0;NA;NA;NA
X100148193_TGI_at;100148193_TGI_at;NM_001018073;PCK2;phosphoenolpyruvate carboxykinase 2 (mitochondrial);0,00000058200000000000;1,322688027;0,004499816;1,210919112;0,014039599;0,000863569;1,510635984;0,008670668;0;1;U1;U1;U1
X100148200_TGI_at;100148200_TGI_at;BQ014745;ATP2B4;ATPase, Ca++ transporting, plasma membrane 4;0,00000000001790000000;0,795339576;0,00064739;0,845410255;0,003647791;0,552010088;1,035629799;0,680615346;0;0;NA;NA;NA
X100148216_TGI_at;100148216_TGI_at;BC020257;NF2;neurofibromin 2 (merlin);0,00000028200000000000;1,275586116;0,961520477;0,999747593;0,965414485;0,203149235;1,118391285;0,330514884;0;0;NA;NA;NA
X100148226_TGI_at;100148226_TGI_at;D85181;SC5DL;sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like;0,00000087100000000000;1,252274452;0,000289487;1,131015981;0,002072229;0,013942384;1,184044017;0,049653374;0;1;U2;U1;U1
X100148283_TGI_at;100148283_TGI_at;NM_006103;WFDC2;WAP four-disulfide core domain 2;0,00000000048200000000;1,57247944;0,26715;1,13724574;0,316436769;0,625254079;0,934957504;0,737895971;0;0;NA;NA;NA
X100148302_TGI_at;100148302_TGI_at;BC063428;NCALD;neurocalcin delta;0,00000000007470000000;0,7636058;0,118560965;0,926605539;0,160488026;0,967010726;0,995172979;0,980394958;0;0;NA;NA;NA
X100148303_TGI_at;100148303_TGI_at;NM_000934;SERPINF2;serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2;0,00000010100000000000;1,501340418;0,072389816;1,178646894;0,109484925;0,013270593;1,354977674;0,048111498;0;0;NA;NA;NA
X100148308_TGI_at;100148308_TGI_at;BI759100;;;0,00000001180000000000;1,376599202;0,043345414;1,165434152;0,072761598;0,583057317;1,123600471;0,704873868;0;0;NA;NA;NA
X100148313_TGI_at;100148313_TGI_at;BC000123;PDXK;pyridoxal (pyridoxine, vitamin B6) kinase;0,00000000001530000000;1,425230762;0,344634911;1,058696699;0,39221692;0,003446716;1,283461139;0,019661534;0;0;NA;NA;NA
X100148334_TGI_at;100148334_TGI_at;NM_005213;CSTA;cystatin A (stefin A);0,00000000000318000000;1,376079783;0,111951704;1,078247446;0,153149551;0,032804824;1,189980461;0,090213266;0;0;NA;NA;NA
X100148366_TGI_at;100148366_TGI_at;NM_017909;RMND1;required for meiotic nuclear division 1 homolog (S. cerevisiae);0,00000117000000000000;1,203054223;0,966044564;0,992398725;0,969051238;0,100003042;1,139539794;0,198466629;0;0;NA;NA;NA
X100148374_TGI_at;100148374_TGI_at;ENST00000264167;AGPS;alkylglycerone phosphate synthase;0,00000000000007560000;1,570886586;2,93E-05;1,281357416;0,000491632;0,259760472;1,078493472;0,395282342;0;0;NA;NA;NA
X100148388_TGI_at;100148388_TGI_at;BX103476;;;0,00000004900000000000;0,780739109;0,835909671;0,998321401;0,850421991;0,746919855;1,064699813;0,832983631;0;0;NA;NA;NA
X100148396_TGI_at;100148396_TGI_at;NM_003278;CLEC3B;C-type lectin domain family 3, member B;0,00000000007430000000;0,695606572;0,021694474;0,854746784;0,043456363;0,038187481;1,439839231;0,099577872;0;0;NA;NA;NA
X100148441_TGI_at;100148441_TGI_at;NM_022842;CDCP1;CUB domain containing protein 1;0,00000000000040900000;1,661020327;0,002000343;1,201914467;0,007988979;0,017758754;1,269228673;0,058404554;0;0;NA;NA;NA
X100148443_TGI_at;100148443_TGI_at;NM_021980;OPTN;optineurin;0,00000000046100000000;0,734826876;0,55713264;0,970456698;0,593403338;0,238684003;0,935855235;0,372171524;0;0;NA;NA;NA
X100148492_TGI_at;100148492_TGI_at;NM_001098416;HDAC7;histone deacetylase 7;0,00000003270000000000;0,779218602;0,002816562;0,888875804;0,00997558;0,315219134;0,952674363;0,454361033;0;0;NA;NA;NA
X100148503_TGI_at;100148503_TGI_at;BM716528;;;0,00000041300000000000;1,395136857;0,044429116;1,196710966;0,074194322;0,590451681;1,123223459;0,709819384;0;0;NA;NA;NA
X100148507_TGI_at;100148507_TGI_at;AL390971;PALMD;palmdelphin;0,00000003110000000000;0,704746308;0,128934085;0,890023641;0,172357759;0,421327994;0,922112828;0,560904521;0;0;NA;NA;NA
X100148531_TGI_at;100148531_TGI_at;AF035284;FADS1;fatty acid desaturase 1;0,00000000000236000000;1,391485097;0,46169996;1,072171698;0,504255836;0,000239889;1,543507733;0,004469137;0;0;NA;NA;NA
X100148546_TGI_at;100148546_TGI_at;NM_000845;GRM8;glutamate receptor, metabotropic 8;0,00000000000924000000;0,516023405;0,000126232;0,687964544;0,001196607;0,012011905;0,759971346;0,044912263;0;1;D6;D1;D1
X100148573_TGI_at;100148573_TGI_at;AK056696;ZNF606;zinc finger protein 606;0,00000069600000000000;0,767452663;0,648846671;0,976354846;0,68073985;0,431008093;0,925067551;0,568620174;0;0;NA;NA;NA
X100148607_TGI_at;100148607_TGI_at;ENST00000336173;PDE4C;phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila);0,00000073300000000000;1,505256208;0,023012864;1,277369845;0,045364196;0,003446716;1,601127661;0,019661534;0;1;U1;U1;U2
X100148613_TGI_at;100148613_TGI_at;NM_173204;IL1F7;interleukin 1 family, member 7 (zeta);0,00000000000000002810;2,05345981;1,10E-05;1,536499425;0,000288889;0,014643299;1,357414155;0,051467124;0;0;NA;NA;NA
X100148614_TGI_at;100148614_TGI_at;NM_016006;ABHD5;abhydrolase domain containing 5;0,00000000000290000000;1,50445076;0,007039731;1,177291714;0,019195477;0,004027359;1,394697653;0,021963076;0;1;U2;U1;U1
X100148669_TGI_at;100148669_TGI_at;NM_020365;EIF2B3;eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa;0,00000000003920000000;1,205038834;0,255992533;1,037044224;0,304789041;0,013942384;1,112730445;0,049653374;0;0;NA;NA;NA
X100148685_TGI_at;100148685_TGI_at;NM_198477;CXCL17;chemokine (C-X-C motif) ligand 17;0,00000000012000000000;1,226900302;0,003483477;1,137095091;0,01168288;0,011420211;1,346146938;0,043251869;0;1;U4;U1;U1
X100148697_TGI_at;100148697_TGI_at;DQ893069;ABAT;4-aminobutyrate aminotransferase;0,00000010300000000000;1,267817402;0,000327237;1,146995825;0,002244011;0,312041432;1,071944417;0,452818341;0;0;NA;NA;NA
X100148703_TGI_at;100148703_TGI_at;BC070102;;hypothetical LOC729111;0,00000000202000000000;0,753060563;0,022121178;0,841345573;0,044091872;0,185788694;0,876213194;0,311548887;0;0;NA;NA;NA
X100148717_TGI_at;100148717_TGI_at;NM_001243;TNFRSF8;tumor necrosis factor receptor superfamily, member 8;0,00000001880000000000;0,704822117;0,000842903;0,828004998;0,004353649;0,431008093;0,875128797;0,568620174;0;0;NA;NA;NA
X100148733_TGI_at;100148733_TGI_at;NM_000452;SLC10A2;solute carrier family 10 (sodium/bile acid cotransporter family), member 2;0,00000001050000000000;1,742168518;0,000131652;1,897185452;0,001222808;0,252599303;1,067715218;0,387495266;0;0;NA;NA;NA
X100148735_TGI_at;100148735_TGI_at;NM_032293;GARNL3;GTPase activating Rap/RanGAP domain-like 3;0,00000000510000000000;0,755692465;0,069759599;0,913153855;0,106506484;0,05081529;0,830820867;0,122313429;0;0;NA;NA;NA
X100148773_TGI_at;100148773_TGI_at;AK125858;;;0,00000000985000000000;0,665597214;0,030190519;0,844831605;0,055254992;0,255009933;0,849056396;0,38934013;0;0;NA;NA;NA
X100148778_TGI_at;100148778_TGI_at;ENST00000360514;;hypothetical LOC339483;0,00000004820000000000;0,74215786;0,086531045;0,908005414;0,125739205;0,599133899;0,879299421;0,718556347;0;0;NA;NA;NA
X100148781_TGI_at;100148781_TGI_at;AK025590;KCTD15;potassium channel tetramerisation domain containing 15;0,00000008080000000000;0,734345423;0,010033466;0,86615869;0,024730173;0,043170182;0,833788643;0,107774978;0;0;NA;NA;NA
X100148799_TGI_at;100148799_TGI_at;AK057653;;;0,00000000000000082600;1,82253183;2,58E-05;1,372489954;0,000460173;0,110976585;1,202799805;0,212903293;0;0;NA;NA;NA
X100148816_TGI_at;100148816_TGI_at;NM_000903;NQO1;NAD(P)H dehydrogenase, quinone 1;0,00000000000000001170;1,908371219;3,19E-05;1,405871962;0,000509476;0,004862758;1,251424901;0,024374289;0;1;U2;U1;U1
X100148821_TGI_at;100148821_TGI_at;BC039741;TMEM106B;transmembrane protein 106B;0,00000046400000000000;1,217314808;0,061463432;1,069468337;0,096087432;0,993268938;0,977920046;0,995253159;0;0;NA;NA;NA
X100148822_TGI_at;100148822_TGI_at;NM_004557;NOTCH4;Notch homolog 4 (Drosophila);0,00000000635000000000;0,715024709;0,006023311;0,821739845;0,017089025;0,315219134;0,904621962;0,454361033;0;0;NA;NA;NA
X100148867_TGI_at;100148867_TGI_at;NM_138570;SLC38A10;solute carrier family 38, member 10;0,00000027500000000000;1,348409799;0,497712237;1,025329777;0,537395825;0,168116482;1,105178728;0,288673107;0;0;NA;NA;NA
X100148868_TGI_at;100148868_TGI_at;BX437624;GALNT2;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2);0,00000002490000000000;1,310784856;0,27459638;1,032058384;0,323710364;0,021964693;1,174180574;0,067549815;0;0;NA;NA;NA
X100148899_TGI_at;100148899_TGI_at;CN358662;;hypothetical protein DKFZp434H1419;0,00000021800000000000;0,767956867;0,462317258;0,95158884;0,504588054;0,491673531;1,053568772;0,627589621;0;0;NA;NA;NA
X100148902_TGI_at;100148902_TGI_at;CR936609;;;0,00000002120000000000;0,618344623;0,033062617;0,879952655;0,058873378;0,064330368;0,85813909;0,144788251;0;0;NA;NA;NA
X100148916_TGI_at;100148916_TGI_at;NM_198336;INSIG1;insulin induced gene 1;0,00000098600000000000;1,210115581;0,011698265;1,084119349;0,027400806;0,01806578;1,199599712;0,05881415;0;0;NA;NA;NA
X100148920_TGI_at;100148920_TGI_at;BC018104;RNF141;ring finger protein 141;0,00000000006790000000;1,304771254;0,113249769;1,090887825;0,154335732;0,151013543;1,138172836;0,266548001;0;0;NA;NA;NA
X100148927_TGI_at;100148927_TGI_at;NM_005139;ANXA3;annexin A3;0,00000008560000000000;0,745123946;0,328767016;0,903352442;0,376819379;0,305602819;1,171003242;0,445682301;0;0;NA;NA;NA
X100148934_TGI_at;100148934_TGI_at;NM_022127;SLC28A3;solute carrier family 28 (sodium-coupled nucleoside transporter), member 3;0,00000000003160000000;1,499086154;2,09E-08;1,542289126;4,82E-06;0,849099163;0,999066601;0,906474529;0;0;NA;NA;NA
X100148935_TGI_at;100148935_TGI_at;NM_004311;ARL3;ADP-ribosylation factor-like 3;0,00000006890000000000;0,787506474;0,02267319;0,902595439;0,044997347;0,315219134;0,933380817;0,454361033;0;0;NA;NA;NA
X100148954_TGI_at;100148954_TGI_at;NM_021626;SCPEP1;serine carboxypeptidase 1;0,00000000162000000000;1,384495292;2,05E-05;1,19228604;0,000394874;0,083263264;1,170043375;0,17510994;0;0;NA;NA;NA
X100148958_TGI_at;100148958_TGI_at;AK056155;;;0,00000015700000000000;1,232667922;0,024778326;1,126693627;0,047792068;0,002409533;1,408325969;0,016145377;0;1;U1;U1;U1
X100148986_TGI_at;100148986_TGI_at;NM_182915;STEAP3;STEAP family member 3;0,00000000017900000000;1,53440179;0,421271466;1,054964195;0,466743876;0,241271938;1,091263924;0,374575845;0;0;NA;NA;NA
X100149015_TGI_at;100149015_TGI_at;AK226075;SEH1L;SEH1-like (S. cerevisiae);0,00000010000000000000;1,271753821;0,0688894;1,119659246;0,10547769;0,069432339;1,186996251;0,153169355;0;0;NA;NA;NA
X100149017_TGI_at;100149017_TGI_at;CR740475;;;0,00000009440000000000;1,837547169;0,293229835;1,105235793;0,342544312;0,100003042;1,323670308;0,198466629;0;0;NA;NA;NA
X100149024_TGI_at;100149024_TGI_at;BC037213;;;0,00000024200000000000;0,780794624;0,344634911;0,927422558;0,39221692;0,421327994;0,917021749;0,560904521;0;0;NA;NA;NA
X100149027_TGI_at;100149027_TGI_at;NM_030773;TUBB1;tubulin, beta 1;0,00000049200000000000;0,587191692;0,516263782;0,910872913;0,555009396;0,685086646;0,821824101;0,784939303;0;0;NA;NA;NA
X100149031_TGI_at;100149031_TGI_at;AJ224117;RNASEH1;ribonuclease H1;0,00000000001460000000;1,267523146;0,0070728;1,112561949;0,019245774;0,013270593;1,162497448;0,048111498;0;1;U2;U1;U1
X100149043_TGI_at;100149043_TGI_at;NM_014603;CDR2L;cerebellar degeneration-related protein 2-like;0,00000007680000000000;0,800241497;0,004662592;0,843471049;0,01433925;0,587186896;0,960750742;0,708272218;0;0;NA;NA;NA
X100149044_TGI_at;100149044_TGI_at;NM_001099691;TGFA;transforming growth factor, alpha;0,00000000280000000000;1,253535724;0,021357694;1,092857104;0,042923852;0,534478464;1,059228043;0,664336324;0;0;NA;NA;NA
X100149087_TGI_at;100149087_TGI_at;AL133090;ADAM22;ADAM metallopeptidase domain 22;0,00000002630000000000;0,685690282;0,004765188;0,798534523;0,014571347;0,122857837;0,826737694;0,229149774;0;0;NA;NA;NA
X100149119_TGI_at;100149119_TGI_at;NM_001040274;SYCP2L;synaptonemal complex protein 2-like;0,00000000727000000000;0,631099626;0,085983342;0,848040219;0,125169065;0,567746993;0,945121352;0,6918142;0;0;NA;NA;NA
X100149122_TGI_at;100149122_TGI_at;BC007333;ETV5;ets variant 5;0,00000064600000000000;0,703490022;0,603516607;0,914294714;0,637330939;0,953827391;1,137128402;0,974385319;0;0;NA;NA;NA
X100149136_TGI_at;100149136_TGI_at;ENST00000339360;RAP1GDS1;RAP1, GTP-GDP dissociation stimulator 1;0,00000009900000000000;1,212017842;0,14256512;1,047246959;0,186480269;0,077500779;1,107518555;0,166153341;0;0;NA;NA;NA
X100149140_TGI_at;100149140_TGI_at;NM_173626;SLC26A11;solute carrier family 26, member 11;0,00000000010300000000;1,385779607;0,000313011;1,186283572;0,002183624;0,012010459;1,18341754;0,044912263;0;1;U2;U1;U1
X100149156_TGI_at;100149156_TGI_at;NM_001801;CDO1;cysteine dioxygenase, type I;0,00000000000002650000;0,601450683;0,017316091;0,855950889;0,036572583;0,077689446;0,813090082;0,166153341;0;0;NA;NA;NA
X100149164_TGI_at;100149164_TGI_at;NM_000898;MAOB;monoamine oxidase B;0,00000000001360000000;0,751681119;0,001647754;0,878659356;0,006987777;0,107895631;0,893895201;0,208857428;0;0;NA;NA;NA
X100149234_TGI_at;100149234_TGI_at;NM_000405;GM2A;GM2 ganglioside activator;0,00000000000000905000;1,699221336;6,46E-05;1,252834349;0,000804433;1,41E-07;1,58290148;0,00013516;0;1;U4;U1;U1
X100149268_TGI_at;100149268_TGI_at;NM_002437;MPV17;MpV17 mitochondrial inner membrane protein;0,00000000000003760000;1,268613174;0,000222313;1,122679796;0,001751873;0,01262694;1,149002226;0,046447382;0;1;U4;U1;U1
X100149293_TGI_at;100149293_TGI_at;U52840;SEMA5A;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A;0,00000000007010000000;0,71029653;0,113934251;0,897977621;0,155071829;0,159283623;1,047807887;0,276600817;0;0;NA;NA;NA
X100149296_TGI_at;100149296_TGI_at;BI668583;SH3BGRL;SH3 domain binding glutamic acid-rich protein like;0,00000000198000000000;1,217029657;1,10E-05;1,22692295;0,000288889;0,002886902;1,29838738;0,017893238;0;1;U1;U1;U1
X100149300_TGI_at;100149300_TGI_at;NM_024841;;protor-2;0,00000017400000000000;0,719295744;0,14114991;0,912820715;0,185079804;0,052890615;0,824261304;0,126177982;0;0;NA;NA;NA
X100149313_TGI_at;100149313_TGI_at;NM_007161;LST1;leukocyte specific transcript 1;0,00000000102000000000;1,347190364;0,132046703;1,090131278;0,175784882;0,004100912;1,405576675;0,022065509;0;0;NA;NA;NA
X100149337_TGI_at;100149337_TGI_at;NM_020909;EPB41L5;erythrocyte membrane protein band 4.1 like 5;0,00000001900000000000;0,747417109;0,431797112;0,939858347;0,476114298;0,967010726;1,016947366;0,980394958;0;0;NA;NA;NA
X100149338_TGI_at;100149338_TGI_at;NM_014583;LMCD1;LIM and cysteine-rich domains 1;0,00000000006520000000;0,714071186;0,000203591;0,846559343;0,001640436;0,767721344;0,967939691;0,850005459;0;0;NA;NA;NA
X100149339_TGI_at;100149339_TGI_at;DQ891837;ATP6V1B2;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2;0,00000000000206000000;1,450000844;0,002376561;1,189638749;0,008880071;0,000923705;1,340405592;0,008967168;0;1;U2;U1;U1
X100149360_TGI_at;100149360_TGI_at;ENST00000333132;TRPC2;transient receptor potential cation channel, subfamily C, member 2 (pseudogene);0,00000016100000000000;1,373945364;0,002804499;1,180678779;0,009954736;0,010855277;1,328296236;0,041904859;0;1;U1;U1;U1
X100149363_TGI_at;100149363_TGI_at;BQ008553;FKBP15;FK506 binding protein 15, 133kDa;0,00000000000075000000;1,509114775;0,008489575;1,193263865;0,02197743;0,015517157;1,239712613;0,052959853;0;0;NA;NA;NA
X100149367_TGI_at;100149367_TGI_at;NM_016523;KLRF1;killer cell lectin-like receptor subfamily F, member 1;0,00000091600000000000;0,6064662;0,272074473;0,912334356;0,32108972;0,940656418;0,970359278;0,965520903;0;0;NA;NA;NA
X100149391_TGI_at;100149391_TGI_at;NM_004004;GJB2;gap junction protein, beta 2, 26kDa;0,00000120000000000000;1,789290462;0,063070935;1,380445833;0,097870787;0,736968995;1,052533279;0,825599955;0;0;NA;NA;NA
X100149426_TGI_at;100149426_TGI_at;NM_145018;C11orf82;chromosome 11 open reading frame 82;0,00000003480000000000;1,670304798;0,000428415;1,456855329;0,002723432;0,039719764;1,361241413;0,101661999;0;0;NA;NA;NA
X100149429_TGI_at;100149429_TGI_at;NM_003385;VSNL1;visinin-like 1;0,00000006160000000000;0,771902013;0,553292466;1,050972367;0,589897988;0,660413637;0,906522524;0,764285198;0;0;NA;NA;NA
X100149448_TGI_at;100149448_TGI_at;BX537989;HEXA;hexosaminidase A (alpha polypeptide);0,00000000012900000000;1,363347883;0,001403866;1,164064441;0,006206666;0,000753789;1,414233408;0,007913552;0;1;U2;U2;U1
X100149465_TGI_at;100149465_TGI_at;NM_021244;RRAGD;Ras-related GTP binding D;0,00000000000000005410;1,890283366;0,000645;1,236726192;0,003640689;0,00317515;1,337904287;0,019115922;0;1;U6;U1;U1
X100149468_TGI_at;100149468_TGI_at;NM_000147;FUCA1;fucosidase, alpha-L- 1, tissue;0,00000000000000101000;1,693411147;5,74E-09;1,4348502;1,68E-06;7,99E-06;1,501768154;0,001170948;1;1;U6;U2;U1
X100149539_TGI_at;100149539_TGI_at;NM_052813;CARD9;caspase recruitment domain family, member 9;0,00000000000536000000;1,584534615;0,168691726;1,104553474;0,214474727;0,004793639;1,383002216;0,024374289;0;0;NA;NA;NA
X100149542_TGI_at;100149542_TGI_at;NM_014505;KCNMB4;potassium large conductance calcium-activated channel, subfamily M, beta member 4;0,00000000000146000000;0,575941105;3,82E-05;0,72273465;0,000578519;0,307230301;0,879939754;0,446439703;0;0;NA;NA;NA
X100149568_TGI_at;100149568_TGI_at;NM_018211;RAVER2;ribonucleoprotein, PTB-binding 2;0,00000000009650000000;0,762061606;0,009545933;0,894180065;0,023813114;0,018980373;0,825167933;0,060869395;0;0;NA;NA;NA
X100149616_TGI_at;100149616_TGI_at;ENST00000358356;RUNX1;runt-related transcription factor 1;0,00000091600000000000;1,741914824;0,010217779;1,384472709;0,024967324;0,248075799;0,746365169;0,381463883;0;0;NA;NA;NA
X100149634_TGI_at;100149634_TGI_at;NM_001025356;ANO6;anoctamin 6;0,00000002220000000000;0,787403548;0,155076368;0,953927722;0,200084522;0,299373904;0,93443799;0,437985516;0;0;NA;NA;NA
X100149639_TGI_at;100149639_TGI_at;NM_001150;ANPEP;alanyl (membrane) aminopeptidase;0,00000007430000000000;1,696924005;0,206624915;1,132431793;0,255938548;0,021065089;1,401441887;0,06578758;0;0;NA;NA;NA
X100149643_TGI_at;100149643_TGI_at;NM_000095;COMP;cartilage oligomeric matrix protein;0,00000000000000462000;2,43983526;0,000218352;1,411466285;0,001729115;0,149505026;1,291202133;0,264174725;0;0;NA;NA;NA
X100149645_TGI_at;100149645_TGI_at;NM_001018109;PIR;pirin (iron-binding nuclear protein);0,00000000227000000000;1,378230842;0,017336076;1,132284466;0,036590814;0,033503156;1,150701595;0,091046096;0;0;NA;NA;NA
X100149649_TGI_at;100149649_TGI_at;U24152;PAK1;p21 protein (Cdc42/Rac)-activated kinase 1;0,00000036100000000000;1,297490813;0,530527587;1,031450941;0,569015112;0,797584764;0,986757877;0,871690639;0;0;NA;NA;NA
X100149661_TGI_at;100149661_TGI_at;AK095651;ENY2;enhancer of yellow 2 homolog (Drosophila);0,00000003990000000000;0,811052675;0,451321445;0,978341554;0,494092736;0,348497017;0,949055357;0,486868611;0;0;NA;NA;NA
X100149722_TGI_at;100149722_TGI_at;NM_199451;ZNF365;zinc finger protein 365;0,00000000000000065200;3,096274748;4,65E-05;1,828315981;0,000651765;0,002050555;1,866258642;0,014952351;0;1;U2;U1;U1
X100149731_TGI_at;100149731_TGI_at;BG548689;;;0,00000000000271000000;0,696975744;0,476258791;0,97432968;0,518049978;0,299373904;0,87769109;0,437985516;0;0;NA;NA;NA
X100149745_TGI_at;100149745_TGI_at;ENST00000311224;CD84;CD84 molecule;0,00000000214000000000;1,400020043;0,319833915;1,090241225;0,368678365;0,000312251;1,33522974;0,005082755;0;0;NA;NA;NA
X100149771_TGI_at;100149771_TGI_at;NM_013261;PPARGC1A;peroxisome proliferator-activated receptor gamma, coactivator 1 alpha;0,00000000003920000000;0,7095712;0,00077099;0,778631614;0,004127742;0,064330368;0,853355263;0,144788251;0;0;NA;NA;NA
X100149777_TGI_at;100149777_TGI_at;CR936721;SMURF2;SMAD specific E3 ubiquitin protein ligase 2;0,00000000001150000000;0,789677736;0,237079803;0,946897504;0,286075703;0,660894461;1,048531315;0,764285198;0;0;NA;NA;NA
X100149815_TGI_at;100149815_TGI_at;NM_144988;ALG14;asparagine-linked glycosylation 14 homolog (S. cerevisiae);0,00000000878000000000;1,247037764;0,001784906;1,094001918;0,007432495;0,526622464;1,021867957;0,659403342;0;0;NA;NA;NA
X100149817_TGI_at;100149817_TGI_at;NM_001079803;GAA;"glucosidase, alpha; acid";0,00000024200000000000;1,366322917;0,255108164;1,061641002;0,304185576;0,014036883;1,289704162;0,049746761;0;0;NA;NA;NA
X100149829_TGI_at;100149829_TGI_at;ENST00000367012;SERTAD4;SERTA domain containing 4;0,00000000108000000000;0,761518208;0,141779497;0,928712569;0,185678715;0,018980373;0,742654146;0,060869395;0;0;NA;NA;NA
X100149840_TGI_at;100149840_TGI_at;NM_016206;VGLL3;vestigial like 3 (Drosophila);0,00000000125000000000;0,688101643;0,004189615;0,814571829;0,013225397;0,066842161;0,845292303;0,148369342;0;0;NA;NA;NA
X100149842_TGI_at;100149842_TGI_at;BG677853;LAMC2;laminin, gamma 2;0,00000050500000000000;0,802375888;0,130619943;0,877067502;0,174250032;0,383639173;1,127365671;0,520942343;0;0;NA;NA;NA
X100149849_TGI_at;100149849_TGI_at;NM_004816;C9orf61;chromosome 9 open reading frame 61;0,00000001130000000000;0,779041286;0,020994476;0,854928767;0,042476583;0,450742398;1,09015199;0,587204022;0;0;NA;NA;NA
X100149896_TGI_at;100149896_TGI_at;AW959468;;;0,00000126000000000000;0,757924164;0,0169985;0,823864814;0,036091018;0,709599351;0,865209038;0,803597578;0;0;NA;NA;NA
X100149897_TGI_at;100149897_TGI_at;NM_013302;EEF2K;eukaryotic elongation factor-2 kinase;0,00000000202000000000;0,782180858;0,051822052;0,906496077;0,083973089;0,049454079;0,866166462;0,12011341;0;0;NA;NA;NA
X100149902_TGI_at;100149902_TGI_at;NM_001100829;TMEM170B;transmembrane protein 170B;0,00000091500000000000;1,356739361;0,000979379;1,210101019;0,004753824;0,131303184;1,216987039;0,240585653;0;0;NA;NA;NA
X100149904_TGI_at;100149904_TGI_at;NM_007039;PTPN21;protein tyrosine phosphatase, non-receptor type 21;0,00000000000023500000;0,690594634;0,057616059;0,879852956;0,09125138;0,231928706;1,066433506;0,36481514;0;0;NA;NA;NA
X100149910_TGI_at;100149910_TGI_at;NM_147161;ACOT11;acyl-CoA thioesterase 11;0,00000009850000000000;1,279937369;0,640972737;1,015943684;0,673575198;0,734410047;0,952686911;0,82359206;0;0;NA;NA;NA
X100149922_TGI_at;100149922_TGI_at;ENST00000369936;KIAA1324;KIAA1324;0,00000009440000000000;1,625840321;0,078004298;1,208213861;0,115483626;0,215347198;1,196317321;0,344448645;0;0;NA;NA;NA
X100149944_TGI_at;100149944_TGI_at;NM_001014444;CRYM;crystallin, mu;0,00000000059900000000;1,773089447;0,001172128;1,503511174;0,005372547;0,028121921;1,494409234;0,080853658;0;0;NA;NA;NA
X100149948_TGI_at;100149948_TGI_at;AK095844;;;0,00000047300000000000;0,713176294;0,422083546;0,892941778;0,467322319;0,061450873;0,855075692;0,141367712;0;0;NA;NA;NA
X100149953_TGI_at;100149953_TGI_at;AF007149;C2orf72;chromosome 2 open reading frame 72;0,00000071500000000000;0,827919156;0,23258697;0,950767813;0,28128623;0,938242924;0,956981575;0,965520903;0;0;NA;NA;NA
X100149973_TGI_at;100149973_TGI_at;NM_004851;NAPSA;napsin A aspartic peptidase;0,00000002690000000000;1,216414668;0,136240309;1,073448154;0,180033832;0,000392315;1,707319752;0,005619687;0;0;NA;NA;NA
X100150000_TGI_at;100150000_TGI_at;AF456765;RDH10;retinol dehydrogenase 10 (all-trans);0,00000000435000000000;1,551731713;0,001554317;1,363019364;0,006643984;0,685086646;0,945638591;0,784939303;0;0;NA;NA;NA
X100150018_TGI_at;100150018_TGI_at;NM_018003;UACA;uveal autoantigen with coiled-coil domains and ankyrin repeats;0,00000000687000000000;0,697660974;0,01950916;0,863679313;0,04012637;0,203035049;0,893303054;0,330514884;0;0;NA;NA;NA
X100150035_TGI_at;100150035_TGI_at;NM_005504;BCAT1;branched chain aminotransferase 1, cytosolic;0,00000000000000012200;2,235579031;1,29E-05;1,524697519;0,000318541;0,003871569;1,449404744;0,021358785;0;1;U8;U2;U1
X100150083_TGI_at;100150083_TGI_at;NM_007210;GALNT6;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6);0,00000000000613000000;1,640783361;0,166209819;1,107278786;0,212324315;0,159283623;1,056313438;0,276600817;0;0;NA;NA;NA
X100150108_TGI_at;100150108_TGI_at;BC004174;NEK6;NIMA (never in mitosis gene a)-related kinase 6;0,00000000000000012700;2,047693106;7,83E-06;1,366803695;0,000244969;0,000656787;1,391298715;0,007427454;0;1;U6;U1;U1
X100150125_TGI_at;100150125_TGI_at;NM_207578;PRKACB;protein kinase, cAMP-dependent, catalytic, beta;0,00000003120000000000;1,55629955;2,14E-06;1,437401212;0,000101523;0,872642718;0,992494502;0,925961283;0;0;NA;NA;NA
X100150136_TGI_at;100150136_TGI_at;AW073340;BEST1;bestrophin 1;0,00000032000000000000;1,697508767;0,007965937;1,35348444;0,020975665;0,339979528;0,822266491;0,480593868;0;0;NA;NA;NA
X100150142_TGI_at;100150142_TGI_at;AI093876;;;0,00000126000000000000;0,77042899;0,354940079;1,041031753;0,402240463;0,672949117;0,973047798;0,774063003;0;0;NA;NA;NA
X100150209_TGI_at;100150209_TGI_at;NM_001100812;CXCL16;chemokine (C-X-C motif) ligand 16;0,00000000000000022300;1,632084341;7,35E-05;1,327718076;0,00086144;2,21E-05;1,593169137;0,001749595;0;1;U2;U2;U1
X100150223_TGI_at;100150223_TGI_at;BX538233;;;0,00000000014100000000;1,93413949;0,023012864;1,38549238;0,045364196;0,169527921;1,332064231;0,290015121;0;0;NA;NA;NA
X100150224_TGI_at;100150224_TGI_at;NM_000115;EDNRB;endothelin receptor type B;0,00000000000311000000;0,604800373;0,001045952;0,796539354;0,004957505;0,364619131;0,960216286;0,503363219;0;0;NA;NA;NA
X100150240_TGI_at;100150240_TGI_at;NM_019012;PLEKHA5;pleckstrin homology domain containing, family A member 5;0,00000006000000000000;0,787211207;0,248771274;0,948133527;0,297661179;0,007144385;0,817317702;0,031892454;0;0;NA;NA;NA
X100150244_TGI_at;100150244_TGI_at;NM_014845;FIG4;FIG4 homolog (S. cerevisiae);0,00000000000063500000;1,340606283;0,000109206;1,196385292;0,001094198;0,027420742;1,189460297;0,079475766;0;0;NA;NA;NA
X100150258_TGI_at;100150258_TGI_at;BX648370;KLHL6;kelch-like 6 (Drosophila);0,00000000000164000000;1,680950073;0,003287393;1,238590955;0,011223801;0,019518593;1,427659046;0,062162477;0;0;NA;NA;NA
X100150278_TGI_at;100150278_TGI_at;NM_005776;CNIH;cornichon homolog (Drosophila);0,00000000546000000000;1,21895022;0,061463432;1,071958565;0,096087432;0,066842161;1,113705305;0,148369342;0;0;NA;NA;NA
X100150279_TGI_at;100150279_TGI_at;BC032683;CCDC88A;coiled-coil domain containing 88A;0,00000000007470000000;1,478628149;0,000298613;1,223644784;0,002110593;0,006027045;1,265200665;0,028156556;0;1;U2;U1;U1
X100150286_TGI_at;100150286_TGI_at;NM_006755;TALDO1;transaldolase 1;0,00000000000106000000;1,296401723;0,002039265;1,108981979;0,008096077;3,28E-05;1,287142912;0,001805101;0;1;U1;U1;U1
X100150289_TGI_at;100150289_TGI_at;NM_182734;PLCB1;phospholipase C, beta 1 (phosphoinositide-specific);0,00000007060000000000;0,773742125;0,515619687;0,962459874;0,554501919;0,007918414;0,785308331;0,034341403;0;0;NA;NA;NA
X100150297_TGI_at;100150297_TGI_at;NM_004566;PFKFB3;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3;0,00000050200000000000;0,827342887;0,284656215;0,948251138;0,333981428;0,100003042;0,910782921;0,198466629;0;0;NA;NA;NA
X100150310_TGI_at;100150310_TGI_at;NM_003118;SPARC;secreted protein, acidic, cysteine-rich (osteonectin);0,00000000002890000000;0,773634584;0,052581813;0,919551274;0,084820412;0,660394247;1,012276401;0,764285198;0;0;NA;NA;NA
X100150318_TGI_at;100150318_TGI_at;AK057721;;;0,00000000000702000000;0,766979232;0,272074473;0,950807394;0,32108972;0,75371136;1,03591812;0,83968604;0;0;NA;NA;NA
X100150321_TGI_at;100150321_TGI_at;NM_018371;CSGALNACT1;chondroitin sulfate N-acetylgalactosaminyltransferase 1;0,00000059900000000000;0,777032549;0,103678413;0,899716552;0,14471872;0,421327994;0,912407892;0,560904521;0;0;NA;NA;NA
X100150331_TGI_at;100150331_TGI_at;ENST00000329809;;hypothetical protein LOC100132684;0,00000000001850000000;0,71583267;0,010051668;0,839185295;0,024730173;0,169527921;1,124458413;0,290015121;0;0;NA;NA;NA
X100150345_TGI_at;100150345_TGI_at;NM_001387;DPYSL3;dihydropyrimidinase-like 3;0,00000000000253000000;0,698693507;0,120572663;0,899854066;0,162664585;0,33242117;0,944371598;0,473230314;0;0;NA;NA;NA
X100150384_TGI_at;100150384_TGI_at;AK024702;MRPS25;mitochondrial ribosomal protein S25;0,00000000005690000000;1,355675299;0,010217779;1,111232398;0,024967324;0,083263264;1,214337007;0,17510994;0;0;NA;NA;NA
X100150389_TGI_at;100150389_TGI_at;BC002477;DHTKD1;dehydrogenase E1 and transketolase domain containing 1;0,00000080900000000000;1,200483946;0,230794563;0,949307929;0,279748355;0,032083057;1,169268515;0,088319445;0;0;NA;NA;NA
X100150426_TGI_at;100150426_TGI_at;NM_020533;MCOLN1;mucolipin 1;0,00000000000045800000;1,531557908;0,003587173;1,158902803;0,011906754;0,000203903;1,517016499;0,004159363;0;1;U4;U1;U1
X100150499_TGI_at;100150499_TGI_at;NM_002253;KDR;kinase insert domain receptor (a type III receptor tyrosine kinase);0,00000000145000000000;0,716392727;0,163095975;0,918242352;0,208751891;0,967010726;0,973520849;0,980394958;0;0;NA;NA;NA
X100150521_TGI_at;100150521_TGI_at;AI702438;;;0,00000017800000000000;1,652005069;0,036475174;1,274260027;0,063821653;0,01554453;1,536740255;0,052959853;0;0;NA;NA;NA
X100150522_TGI_at;100150522_TGI_at;NM_006678;CD300C;CD300c molecule;0,00000000584000000000;1,593883198;0,046422148;1,195390055;0,076898291;0,000790925;1,580573785;0,008249677;0;0;NA;NA;NA
X100150534_TGI_at;100150534_TGI_at;BX106402;;;0,00000005840000000000;0,77383676;0,04944512;0,890514951;0,080812181;0,030713739;0,872655422;0,086003807;0;0;NA;NA;NA
X100150549_TGI_at;100150549_TGI_at;NM_001287;CLCN7;chloride channel 7;0,00000018700000000000;1,276986023;0,669579135;1,012748178;0,698851539;0,110976585;1,131498789;0,212903293;0;0;NA;NA;NA
X100150554_TGI_at;100150554_TGI_at;NM_001097634;GCNT1;glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase);0,00000058600000000000;1,358353429;0,333051744;1,072270733;0,381323542;0,875109546;0,99593176;0,925961283;0;0;NA;NA;NA
X100150557_TGI_at;100150557_TGI_at;NM_001432;EREG;epiregulin;0,00000057200000000000;2,102720159;0,003497168;1,835857105;0,011704437;0,103562613;1,549759501;0,203277894;0;0;NA;NA;NA
X100150587_TGI_at;100150587_TGI_at;BQ016416;RCSD1;RCSD domain containing 1;0,00000025500000000000;0,807048634;0,137178612;0,904859726;0,18097694;0,556550302;1,032065956;0,68359818;0;0;NA;NA;NA
X100150607_TGI_at;100150607_TGI_at;NM_016256;NAGPA;N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase;0,00000000095700000000;1,370127441;0,063070935;1,089464204;0,097870787;0,004862758;1,260547528;0,024374289;0;0;NA;NA;NA
X100150611_TGI_at;100150611_TGI_at;NM_198531;ATP9B;ATPase, class II, type 9B;0,00000000000006530000;1,289013971;6,08E-06;1,158985353;0,0002034;0,05081529;1,105190535;0,122313429;0;0;NA;NA;NA
X100150622_TGI_at;100150622_TGI_at;NM_018946;NANS;N-acetylneuraminic acid synthase;0,00000000000162000000;1,330602972;0,225582458;1,044837067;0,274637279;0,18024766;1,072392938;0,304954439;0;0;NA;NA;NA
X100150704_TGI_at;100150704_TGI_at;NM_213589;RAPH1;Ras association (RalGDS/AF-6) and pleckstrin homology domains 1;0,00000000014100000000;0,812507083;0,238891819;0,953358452;0,287837906;0,241271938;0,948618387;0,374575845;0;0;NA;NA;NA
X100150715_TGI_at;100150715_TGI_at;ENST00000360629;ARGLU1;arginine and glutamate rich 1;0,00000006170000000000;0,722760628;0,21919078;0,944919755;0,268638061;0,721968894;1,030948426;0,81331903;0;0;NA;NA;NA
X100150730_TGI_at;100150730_TGI_at;BC026930;TRIM38;tripartite motif-containing 38;0,00000000256000000000;1,217931842;0,001041015;1,146819476;0,004941373;0,033503156;1,137365946;0,091046096;0;0;NA;NA;NA
X100150753_TGI_at;100150753_TGI_at;NM_181882;PRX;periaxin;0,00000000213000000000;0,64206579;6,95E-05;0,683229973;0,000829593;0,924555569;0,993099486;0,959350695;0;0;NA;NA;NA
X100150793_TGI_at;100150793_TGI_at;DQ893537;PI4K2A;phosphatidylinositol 4-kinase type 2 alpha;0,00000000500000000000;1,354760797;0,198258426;1,077594085;0,246999191;0,011395566;1,274562807;0,043251869;0;0;NA;NA;NA
X100150831_TGI_at;100150831_TGI_at;ENST00000328681;PBX1;pre-B-cell leukemia homeobox 1;0,00000000003300000000;0,759805553;0,482889321;0,955957173;0,524200836;0,110976585;0,87293875;0,212903293;0;0;NA;NA;NA
X100150856_TGI_at;100150856_TGI_at;NM_006219;PIK3CB;phosphoinositide-3-kinase, catalytic, beta polypeptide;0,00000017500000000000;1,222003839;0,003076272;1,146640163;0,010707153;0,055034692;1,15202383;0,12937769;0;0;NA;NA;NA
X100150882_TGI_at;100150882_TGI_at;NM_005574;LMO2;LIM domain only 2 (rhombotin-like 1);0,00000071000000000000;0,821171535;0,063070935;0,935552839;0,097870787;0,951948154;0,962867436;0,974385319;0;0;NA;NA;NA
X100150912_TGI_at;100150912_TGI_at;NM_173652;C2orf58;chromosome 2 open reading frame 58;0,00000000000000003480;2,679633661;3,63E-10;2,037523961;1,67E-07;1,89E-05;1,70770117;0,001749595;0;1;U8;U3;U2
X100150913_TGI_at;100150913_TGI_at;NM_003720;PSMG1;proteasome (prosome, macropain) assembly chaperone 1;0,00000000696000000000;1,204996503;0,032000921;1,069680781;0,057813322;0,502203015;1,056621168;0,637495201;0;0;NA;NA;NA
X100150919_TGI_at;100150919_TGI_at;BC004287;;;0,00000002060000000000;0,798320464;0,090581812;0,962233792;0,13033267;0,734410047;1,016141869;0,82359206;0;0;NA;NA;NA
X100150938_TGI_at;100150938_TGI_at;BC043443;OPA1;optic atrophy 1 (autosomal dominant);0,00000000001120000000;1,397337246;0,039478314;1,096729635;0,067788283;0,338916048;1,060711918;0,480593868;0;0;NA;NA;NA
X100150944_TGI_at;100150944_TGI_at;NM_032591;SLC9A7;solute carrier family 9 (sodium/hydrogen exchanger), member 7;0,00000000078900000000;1,362044362;0,00101496;1,18185112;0,004860647;0,033568153;1,168967729;0,091069156;0;0;NA;NA;NA
X100150962_TGI_at;100150962_TGI_at;NM_018938;PCDHB4;protocadherin beta 4;0,00000000042600000000;0,639983943;0,028046529;0,863912432;0,052351584;0,191451954;0,802731729;0,318230865;0;0;NA;NA;NA
X100150963_TGI_at;100150963_TGI_at;NM_002426;MMP12;matrix metallopeptidase 12 (macrophage elastase);0,00000000000012800000;3,946254281;5,65E-05;2,777741691;0,000739861;0,061768971;1,597194282;0,141481329;0;0;NA;NA;NA
X100150977_TGI_at;100150977_TGI_at;NM_170600;SH2D3C;SH2 domain containing 3C;0,00000000005080000000;0,694977433;0,003391789;0,811275098;0,011458842;0,063309309;0,823961217;0,144202051;0;0;NA;NA;NA
X100151008_TGI_at;100151008_TGI_at;NM_006395;ATG7;ATG7 autophagy related 7 homolog (S. cerevisiae);0,00000000000026200000;1,413951698;0,000416916;1,134775301;0,002687443;0,000495904;1,263428896;0,006356879;0;1;U5;U1;U1
X100151009_TGI_at;100151009_TGI_at;NM_178181;CDCP1;CUB domain containing protein 1;0,00000000000044200000;1,742643778;0,000485426;1,273704862;0,002957517;0,003250241;1,426832551;0,019115922;0;1;U4;U1;U1
X100151045_TGI_at;100151045_TGI_at;NM_018344;SLC29A3;solute carrier family 29 (nucleoside transporters), member 3;0,00000000005600000000;1,672553936;0,002293473;1,317436747;0,008696308;0,003250241;1,374646326;0,019115922;0;1;U1;U1;U1
X100151046_TGI_at;100151046_TGI_at;NM_181597;UPP1;uridine phosphorylase 1;0,00000000000228000000;1,64360679;0,013889189;1,225082787;0,031000594;0,07711217;1,210004236;0,166153341;0;0;NA;NA;NA
X100151051_TGI_at;100151051_TGI_at;NM_152280;SYT11;synaptotagmin XI;0,00000000208000000000;0,795137086;0,007965937;0,874880645;0,020975665;0,071816378;0,86938043;0,157336794;0;0;NA;NA;NA
X100151083_TGI_at;100151083_TGI_at;AK095741;GREM1;gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis);0,00000002430000000000;1,555304754;0,017370431;1,636931229;0,036591438;0,829572899;1,109946941;0,894817086;0;0;NA;NA;NA
X100151085_TGI_at;100151085_TGI_at;AY358502;TPP1;tripeptidyl peptidase I;0,00000000102000000000;1,324448279;0,000775214;1,218492736;0,004136613;0,014045781;1,251257534;0,049746761;0;1;U4;U1;U1
X100151094_TGI_at;100151094_TGI_at;AK001134;PCDH17;protocadherin 17;0,00000000867000000000;0,673705412;0,000173587;0,757394356;0,001464581;0,089895036;0,737256769;0,184145191;0;0;NA;NA;NA
X100151103_TGI_at;100151103_TGI_at;NM_012320;PLA2G15;phospholipase A2, group XV;0,00000000002320000000;1,559376211;0,083152891;1,165307273;0,121929831;0,000320802;1,508728614;0,005118537;0;0;NA;NA;NA
X100151110_TGI_at;100151110_TGI_at;AL832793;LACE1;lactation elevated 1;0,00000008050000000000;1,319229754;0,002712805;1,130157671;0,009736492;0,642406094;1,048525935;0,75262626;0;0;NA;NA;NA
X100151112_TGI_at;100151112_TGI_at;BC094869;hCG_20426;hCG20426;0,00000114000000000000;1,250057928;0,097339389;1,112353524;0,137598619;0,599133899;1,036015838;0,718556347;0;0;NA;NA;NA
X100151126_TGI_at;100151126_TGI_at;NM_138636;TLR8;toll-like receptor 8;0,00000000002560000000;1,935907941;0,011637059;1,267655772;0,027277267;0,000398855;1,811624276;0,005625698;0;1;U2;U1;U1
X100151132_TGI_at;100151132_TGI_at;AL359559;AGPS;alkylglycerone phosphate synthase;0,00000000047600000000;1,360668914;0,000314729;1,184210208;0,002190865;0,267057988;1,058216504;0,403399161;0;0;NA;NA;NA
X100151133_TGI_at;100151133_TGI_at;NM_007324;ZFYVE9;zinc finger, FYVE domain containing 9;0,00000000000017800000;0,721902322;0,000523918;0,833862559;0,003132814;0,647692683;0,965377336;0,755321916;0;0;NA;NA;NA
X100151148_TGI_at;100151148_TGI_at;NM_020663;RHOJ;ras homolog gene family, member J;0,00000007470000000000;0,777871374;0,270195104;0,939045204;0,319393163;0,132322651;0,892332956;0,242040809;0;0;NA;NA;NA
X100151151_TGI_at;100151151_TGI_at;NM_015426;WDR51A;WD repeat domain 51A;0,00000096300000000000;1,288734356;0,143862073;0,944675006;0,187795651;0,967010726;0,996812144;0,980394958;0;0;NA;NA;NA
X100151205_TGI_at;100151205_TGI_at;ENST00000330165;RBM8A;RNA binding motif protein 8A;0,00000000256000000000;0,820208962;0,035793874;0,916311169;0,062902756;0,328995653;0,933090022;0,470431672;0;0;NA;NA;NA
X100151228_TGI_at;100151228_TGI_at;ENST00000372234;ANXA11;annexin A11;0,00000000097700000000;0,777264554;0,005633972;0,884238071;0,016314727;0,072102527;1,102374118;0,157336794;0;0;NA;NA;NA
X100151247_TGI_at;100151247_TGI_at;M29276;NAGA;N-acetylgalactosaminidase, alpha-;0,00000000031800000000;1,391187574;0,006457501;1,126197768;0,018019504;0,005306726;1,166654659;0,025993282;0;1;U1;U1;U1
X100151274_TGI_at;100151274_TGI_at;NM_032105;PPP1R12B;protein phosphatase 1, regulatory (inhibitor) subunit 12B;0,00000064800000000000;0,797383675;0,166942325;0,921751198;0,212670005;0,347587896;0,886209071;0,486868611;0;0;NA;NA;NA
X100151277_TGI_at;100151277_TGI_at;NM_145013;C11orf45;chromosome 11 open reading frame 45;0,00000040400000000000;1,381412063;0,039087961;1,168243622;0,067233473;0,016931008;1,286839152;0,056430856;0;0;NA;NA;NA
X100151293_TGI_at;100151293_TGI_at;ENST00000367390;LHX9;LIM homeobox 9;0,00000000000002770000;2,698908859;4,50E-13;4,317058817;1,45E-09;5,09E-05;2,240955524;0,002079933;0;1;U3;U4;U2
X100151298_TGI_at;100151298_TGI_at;NM_000687;AHCY;S-adenosylhomocysteine hydrolase;0,00000000173000000000;1,226418616;0,061452158;1,055614636;0,096087432;0,066842161;1,132014138;0,148369342;0;0;NA;NA;NA
X100151345_TGI_at;100151345_TGI_at;DQ891810;MTCH2;mitochondrial carrier homolog 2 (C. elegans);0,00000000001420000000;1,216625939;0,039478314;1,062000081;0,067788283;0,284058212;1,057989131;0,421122179;0;0;NA;NA;NA
X100151378_TGI_at;100151378_TGI_at;AK093872;;;0,00000020200000000000;0,663855843;0,389839991;0,922218828;0,436420385;0,927501324;1,002589922;0,959350695;0;0;NA;NA;NA
X100151383_TGI_at;100151383_TGI_at;NM_000492;CFTR;cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7);0,00000000001370000000;1,88021234;0,000450954;1,376359196;0,002805841;4,28E-05;2,036394933;0,001969095;0;1;U2;U1;U2
X100151404_TGI_at;100151404_TGI_at;NM_032219;MFSD7;major facilitator superfamily domain containing 7;0,00000007430000000000;1,412413785;0,011258261;1,12633511;0,026680893;0,006071612;1,285364258;0,028156556;0;1;U1;U1;U1
X100151438_TGI_at;100151438_TGI_at;NM_013279;C11orf9;chromosome 11 open reading frame 9;0,00000000001260000000;0,636817331;0,006570358;0,741682718;0,018302734;0,635603663;1,104101871;0,747431382;0;0;NA;NA;NA
X100151440_TGI_at;100151440_TGI_at;AK095147;;;0,00000021800000000000;0,753543791;0,314781435;0,955305715;0,364026036;0,654565662;0,944942861;0,76161196;0;0;NA;NA;NA
X100151456_TGI_at;100151456_TGI_at;NM_033197;C20orf114;chromosome 20 open reading frame 114;0,00000003240000000000;3,469419743;0,119918818;1,596689591;0,162121791;0,810391779;1,136076633;0,881205366;0;0;NA;NA;NA
X100151461_TGI_at;100151461_TGI_at;U38545;PLD1;phospholipase D1, phosphatidylcholine-specific;0,00000000207000000000;1,313216932;0,000128281;1,164076559;0,001204762;0,746919855;1,03897551;0,832983631;0;0;NA;NA;NA
X100151468_TGI_at;100151468_TGI_at;NM_020792;AADACL1;arylacetamide deacetylase-like 1;0,00000000000001920000;1,675660175;1,85E-05;1,390274015;0,00037225;5,78E-05;1,6585691;0,002271113;0;1;U2;U2;U1
X100151470_TGI_at;100151470_TGI_at;X51602;FLT1;fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);0,00000021800000000000;0,736186761;0,192700334;0,89259087;0,241099836;0,348497017;0,887739486;0,486868611;0;0;NA;NA;NA
X100151495_TGI_at;100151495_TGI_at;BC026873;;fin bud initiation factor;0,00000000005540000000;0,534791933;0,005004235;0,76259088;0,015130065;0,033503156;0,7582197;0,091046096;0;0;NA;NA;NA
X100151497_TGI_at;100151497_TGI_at;AK001903;;;0,00000000208000000000;1,458392107;0,002313893;1,319167972;0,008756443;0,122857837;1,223316464;0,229149774;0;0;NA;NA;NA
X100151549_TGI_at;100151549_TGI_at;NM_000189;HK2;hexokinase 2;0,00000000000043900000;1,513945548;1,94E-05;1,290419105;0,000384507;0,000753789;1,408131645;0,007913552;0;1;U2;U1;U1
X100151568_TGI_at;100151568_TGI_at;BF791901;TMEM38B;transmembrane protein 38B;0,00000005690000000000;1,336731414;0,239165346;1,07421114;0,287837906;0,074615336;1,126138255;0,161916497;0;0;NA;NA;NA
X100151582_TGI_at;100151582_TGI_at;NM_022343;GLIPR2;GLI pathogenesis-related 2;0,00000014400000000000;1,262090577;0,428057748;1,029725808;0,472961989;0,000710321;1,345457609;0,007786952;0;0;NA;NA;NA
X100151641_TGI_at;100151641_TGI_at;AK056723;;hypothetical LOC158376;0,00000001560000000000;0,729657494;0,001851378;0,822756211;0,007561703;0,110976585;0,868053063;0,212903293;0;0;NA;NA;NA
X100151752_TGI_at;100151752_TGI_at;NM_001010924;FAM171A1;family with sequence similarity 171, member A1;0,00000000072000000000;0,752487654;0,069057932;0,905235245;0,10553519;0,140181821;0,872348944;0,252829328;0;0;NA;NA;NA
X100151754_TGI_at;100151754_TGI_at;M13230;CTSB;cathepsin B;0,00000000001560000000;1,550930505;0,01480128;1,180441354;0,032629635;0,000923705;1,470564996;0,008967168;0;1;U5;U1;U1
X100151777_TGI_at;100151777_TGI_at;BF513724;RAB30;RAB30, member RAS oncogene family;0,00000047500000000000;0,741289873;0,666712249;1,032248824;0,696084735;0,052890615;0,810079877;0,126177982;0;0;NA;NA;NA
X100151791_TGI_at;100151791_TGI_at;BC036592;GABRB2;gamma-aminobutyric acid (GABA) A receptor, beta 2;0,00000032000000000000;0,677034667;0,059125914;0,870170646;0,093139209;0,776284254;1,052603677;0,85627544;0;0;NA;NA;NA
X100151855_TGI_at;100151855_TGI_at;NM_182826;SCARA3;scavenger receptor class A, member 3;0,00000000000146000000;0,589839137;0,034977546;0,83213981;0,061669929;0,0064123;0,676094414;0,029273149;0;0;NA;NA;NA
X100151868_TGI_at;100151868_TGI_at;AX748273;;;0,00000042000000000000;0,751948162;0,103915228;0,879940506;0,14473586;0,255009933;1,010195114;0,38934013;0;0;NA;NA;NA
X100151872_TGI_at;100151872_TGI_at;ENST00000231909;ACTR8;ARP8 actin-related protein 8 homolog (yeast);0,00000000436000000000;1,268588431;0,005715124;1,091383414;0,016466538;0,711121171;1,018181663;0,803908641;0;0;NA;NA;NA
X100151876_TGI_at;100151876_TGI_at;NM_178862;STT3B;STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae);0,00000016400000000000;1,218578213;0,029079604;1,13027581;0,053771407;0,144787165;1,127849058;0,25853132;0;0;NA;NA;NA
X100151884_TGI_at;100151884_TGI_at;NM_018845;RAG1AP1;recombination activating gene 1 activating protein 1;0,00000000009640000000;1,229554075;0,970300741;0,980758191;0,972715175;0,023487994;1,215471437;0,070485851;0;0;NA;NA;NA
X100151899_TGI_at;100151899_TGI_at;AK055806;WDFY3;WD repeat and FYVE domain containing 3;0,00000003480000000000;1,293713861;0,004119507;1,122214293;0,013055233;0,660894461;0,976555984;0,764285198;0;0;NA;NA;NA
X100151902_TGI_at;100151902_TGI_at;BC037331;;hypothetical protein LOC285758;0,00000049000000000000;0,652989161;0,079940239;0,836318973;0,117862484;0,901252766;0,953073553;0,944937432;0;0;NA;NA;NA
X100151923_TGI_at;100151923_TGI_at;ENST00000389041;CSPP1;centrosome and spindle pole associated protein 1;0,00000014400000000000;0,813767901;0,043479817;0,887058472;0,072911264;0,772133359;0,956340605;0,852547385;0;0;NA;NA;NA
X100151938_TGI_at;100151938_TGI_at;NM_001093771;TXNRD1;thioredoxin reductase 1;0,00000000020900000000;1,34608598;0,000945553;1,136653942;0,004645604;0,024581037;1,177855965;0,072950903;0;0;NA;NA;NA
X100151963_TGI_at;100151963_TGI_at;NM_024873;TNIP3;TNFAIP3 interacting protein 3;0,00000000052900000000;1,944605791;0,000255868;1,645921901;0,001922292;0,000167556;1,789563263;0,004028419;0;1;U2;U3;U1
X100151991_TGI_at;100151991_TGI_at;ENST00000356492;MPP3;membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3);0,00000040000000000000;0,763164245;0,108833569;0,870249175;0,149837929;0,625254079;0,97890595;0,737895971;0;0;NA;NA;NA
X100152041_TGI_at;100152041_TGI_at;NM_015032;PDS5B;PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae);0,00000036100000000000;0,810949234;0,013228583;0,931730349;0,030047513;0,072102527;0,877346958;0,157336794;0;0;NA;NA;NA
X100152105_TGI_at;100152105_TGI_at;NM_018103;LRRC8D;leucine rich repeat containing 8 family, member D;0,00000003150000000000;1,258291618;0,038394136;1,087867795;0,066422062;0,048807143;1,13607562;0,118721072;0;0;NA;NA;NA
X100152106_TGI_at;100152106_TGI_at;DQ891034;CD164;CD164 molecule, sialomucin;0,00000000000008460000;1,614648214;0,000232972;1,292420373;0,001809564;0,016136566;1,381433561;0,054745423;0;0;NA;NA;NA
X100152121_TGI_at;100152121_TGI_at;DB355827;;;0,00000120000000000000;0,788747232;0,344634911;0,962385712;0,39221692;0,460794302;0,946261679;0,597401462;0;0;NA;NA;NA
X100152123_TGI_at;100152123_TGI_at;NM_025240;CD276;CD276 molecule;0,00000007860000000000;1,353249861;0,000819932;1,165922752;0,004269209;0,002719171;1,357157153;0,017251748;0;1;U1;U1;U1
X100152157_TGI_at;100152157_TGI_at;NM_198570;VWC2;von Willebrand factor C domain containing 2;0,00000000090100000000;1,42175451;9,38E-06;1,249639277;0,00026296;0,000770124;1,367754456;0,008058794;0;1;U2;U2;U2
X100152174_TGI_at;100152174_TGI_at;NM_002310;LIFR;leukemia inhibitory factor receptor alpha;0,00000000155000000000;0,664637428;0,311393181;0,947694941;0,360884654;0,323340368;0,96138993;0,462755775;0;0;NA;NA;NA
X100152211_TGI_at;100152211_TGI_at;NM_001005340;GPNMB;glycoprotein (transmembrane) nmb;0,00000000003550000000;1,35822938;0,002232295;1,111574406;0,008591489;0,006224908;1,280871968;0,028702256;0;1;U2;U1;U1
X100152229_TGI_at;100152229_TGI_at;ENST00000367555;NPL;N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase);0,00000000018400000000;1,790057825;0,000278706;1,360727209;0,002018582;0,000108253;1,75426625;0,003322844;0;1;U2;U1;U1
X100152235_TGI_at;100152235_TGI_at;X77690;;;0,00000000991000000000;0,759737248;0,017530499;0,89441192;0,036808338;0,481261259;0,905570152;0,617970134;0;0;NA;NA;NA
X100152238_TGI_at;100152238_TGI_at;DQ892572;SSR3;signal sequence receptor, gamma (translocon-associated protein gamma);0,00000000000003200000;1,291901987;0,002436346;1,131392;0,00906737;0,083615947;1,17529451;0,17510994;0;0;NA;NA;NA
X100152246_TGI_at;100152246_TGI_at;BU934659;TMEM127;transmembrane protein 127;0,00000015600000000000;1,363090811;0,382391206;1,041269157;0,429274419;0,029393816;1,199707657;0,083541684;0;0;NA;NA;NA
X100152256_TGI_at;100152256_TGI_at;NM_005956;MTHFD1;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase;0,00000000000124000000;1,23756069;0,059115899;1,052016072;0,093139209;0,064330368;1,075348206;0,144788251;0;0;NA;NA;NA
X100152276_TGI_at;100152276_TGI_at;NM_030637;DDHD1;DDHD domain containing 1;0,00000000000751000000;1,350344995;9,94E-05;1,217852582;0,001053705;0,009298025;1,207838531;0,038004115;0;1;U1;U2;U1
X100152289_TGI_at;100152289_TGI_at;NM_000190;HMBS;hydroxymethylbilane synthase;0,00000005140000000000;1,282961204;0,239386474;1,04910493;0,287889032;0,118794011;1,136533465;0,224033409;0;0;NA;NA;NA
X100152297_TGI_at;100152297_TGI_at;NM_153225;;RPE-spondin;0,00000104000000000000;0,754578676;0,024201607;0,844007619;0,047045705;0,005635154;0,80076288;0,026986777;0;1;D3;D1;D1
X100152308_TGI_at;100152308_TGI_at;AB067490;C14orf106;chromosome 14 open reading frame 106;0,00000013000000000000;1,335313399;1,58E-05;1,248524574;0,000345112;0,980202899;0,992044209;0,987556719;0;0;NA;NA;NA
X100152332_TGI_at;100152332_TGI_at;ENST00000335464;TMEM104;transmembrane protein 104;0,00000000343000000000;1,314446951;0,036475174;1,111281251;0,063821653;0,060804037;1,168932655;0,140481298;0;0;NA;NA;NA
X100152336_TGI_at;100152336_TGI_at;NM_004543;NEB;nebulin;0,00000118000000000000;0,695469078;0,149709819;0,921051736;0,194249092;0,339979528;0,817728823;0,480593868;0;0;NA;NA;NA
X100152340_TGI_at;100152340_TGI_at;BC034319;;;0,00000000000000076400;1,648197597;0,00770199;1,169340856;0,020498359;0,004027359;1,476917017;0,021963076;0;1;U8;U1;U1
X100152354_TGI_at;100152354_TGI_at;ENST00000375751;SYK;spleen tyrosine kinase;0,00000000000062900000;1,444042246;0,031041531;1,122194979;0,056428006;0,000461729;1,366595108;0,006049403;0;0;NA;NA;NA
X100152364_TGI_at;100152364_TGI_at;NM_178033;CYP4X1;cytochrome P450, family 4, subfamily X, polypeptide 1;0,00000013700000000000;0,754617124;0,098017509;0,847783315;0,13831455;0,010855277;0,694216064;0,041904859;0;0;NA;NA;NA
X100152388_TGI_at;100152388_TGI_at;AK128814;;;0,00000005380000000000;0,805268053;0,004265291;0,866718401;0,013424838;0,100003042;0,90794524;0,198466629;0;0;NA;NA;NA
X100152439_TGI_at;100152439_TGI_at;NM_024993;LRRTM4;leucine rich repeat transmembrane neuronal 4;0,00000015900000000000;0,690499014;0,611454601;0,944456805;0,645502188;0,545460135;0,970068882;0,674086662;0;0;NA;NA;NA
X100152523_TGI_at;100152523_TGI_at;NM_032505;KBTBD8;kelch repeat and BTB (POZ) domain containing 8;0,00000000297000000000;1,609698313;0,000107133;1,339526064;0,001082416;0,131303184;1,247798027;0,240585653;0;0;NA;NA;NA
X100152525_TGI_at;100152525_TGI_at;NM_014017;ROBLD3;roadblock domain containing 3;0,00000000007960000000;1,211419206;0,134175912;1,057479943;0,177889332;0,000461729;1,244271276;0,006049403;0;0;NA;NA;NA
X100152530_TGI_at;100152530_TGI_at;BC040700;;;0,00000022700000000000;0,789246146;0,001244241;0,806100502;0,005607668;0,575348974;1,128510601;0,700018778;0;0;NA;NA;NA
X100152539_TGI_at;100152539_TGI_at;NM_001099401;SGCE;sarcoglycan, epsilon;0,00000024800000000000;0,761795562;0,139719743;0,947562528;0,183652827;0,846130083;1,002327473;0,906474529;0;0;NA;NA;NA
X100152570_TGI_at;100152570_TGI_at;BE082842;TGFB2;transforming growth factor, beta 2;0,00000000234000000000;0,734952488;0,91106659;1,006846731;0,919338641;0,734410047;0,983274599;0,82359206;0;0;NA;NA;NA
X100152580_TGI_at;100152580_TGI_at;NM_024582;FAT4;FAT tumor suppressor homolog 4 (Drosophila);0,00000050000000000000;0,815727177;0,316437048;0,938613752;0,365678238;0,63704437;1,05216049;0,747431382;0;0;NA;NA;NA
X100152601_TGI_at;100152601_TGI_at;NM_022124;CDH23;cadherin-like 23;0,00000000935000000000;0,658731449;0,000104664;0,731351427;0,00106414;0,110976585;0,822348414;0,212903293;0;0;NA;NA;NA
X100152633_TGI_at;100152633_TGI_at;NM_032630;;cyclin-dependent kinase 2-interacting protein;0,00000001310000000000;1,213566645;0,208672314;1,036406667;0,257879934;0,000188734;1,326677704;0,004028419;0;0;NA;NA;NA
X100152641_TGI_at;100152641_TGI_at;AI640147;NPC1;Niemann-Pick disease, type C1;0,00000009170000000000;1,351984695;0,268305342;1,073618273;0,317338759;0,003444946;1,400702685;0,019661534;0;0;NA;NA;NA
X100152651_TGI_at;100152651_TGI_at;BC000284;GGA2;golgi associated, gamma adaptin ear containing, ARF binding protein 2;0,00000000046500000000;1,402128504;0,017801931;1,153682293;0,037208576;0,008831116;1,290950907;0,036964527;0;1;U1;U1;U1
X100152698_TGI_at;100152698_TGI_at;NM_017424;CECR1;cat eye syndrome chromosome region, candidate 1;0,00000000019300000000;1,361607312;0,009256664;1,150705798;0,023326213;0,019518593;1,235495546;0,062162477;0;0;NA;NA;NA
X100152777_TGI_at;100152777_TGI_at;DB503292;APOE;apolipoprotein E;0,00000000334000000000;2,178050496;0,025516694;1,364059043;0,048923441;0,00200392;2,254927694;0,01464543;0;1;U4;U1;U1
X100152788_TGI_at;100152788_TGI_at;NM_004069;AP2S1;adaptor-related protein complex 2, sigma 1 subunit;0,00000000164000000000;1,306987762;0,186744185;1,039272258;0,234741227;0,021425185;1,282023342;0,066397472;0;0;NA;NA;NA
X100152789_TGI_at;100152789_TGI_at;AK125370;;;0,00000008010000000000;0,801300992;0,007324927;0,854275163;0,019739332;0,901252766;0,965840577;0,944937432;0;0;NA;NA;NA
X100152796_TGI_at;100152796_TGI_at;AK023406;MACF1;microtubule-actin crosslinking factor 1;0,00000000000212000000;0,781549349;0,081072349;0,93466298;0,119204461;0,709599351;1,021313766;0,803597578;0;0;NA;NA;NA
X100152803_TGI_at;100152803_TGI_at;NM_005564;LCN2;lipocalin 2;0,00000001560000000000;2,183943301;0,163484482;1,294991627;0,208925648;0,069432339;1,699843664;0,153169355;0;0;NA;NA;NA
X100152816_TGI_at;100152816_TGI_at;NM_006495;EVI2B;ecotropic viral integration site 2B;0,00000000000330000000;1,413694741;0,0380271;1,123591861;0,065911982;0,000355178;1,481176218;0,00537129;0;0;NA;NA;NA
X100152827_TGI_at;100152827_TGI_at;BC000297;HMGCS1;3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble);0,00000049000000000000;1,500653791;0,00389894;1,326435567;0,012604096;0,001370872;1,56914105;0,011387427;0;1;U2;U1;U1
X100152837_TGI_at;100152837_TGI_at;AW291937;SPTBN1;spectrin, beta, non-erythrocytic 1;0,00000014000000000000;0,754266019;0,015765749;0,826076441;0,034171492;0,635603663;1,067160553;0,747431382;0;0;NA;NA;NA
X100152897_TGI_at;100152897_TGI_at;AK021543;;similar to hCG2041313;0,00000000503000000000;0,686899602;0,303878726;0,941335794;0,353064577;0,611187453;0,970697078;0,727019861;0;0;NA;NA;NA
X100152941_TGI_at;100152941_TGI_at;AY303972;PDXK;pyridoxal (pyridoxine, vitamin B6) kinase;0,00000000000253000000;1,437454178;0,214902634;1,070214184;0,263911579;0,010855277;1,233134159;0,041904859;0;0;NA;NA;NA
X100152960_TGI_at;100152960_TGI_at;NM_001457;FLNB;filamin B, beta (actin binding protein 278);0,00000000043200000000;0,807775959;0,00024801;0,868021087;0,001888732;0,007500138;0,861838803;0,03302315;0;1;D2;D3;D1
X100153031_TGI_at;100153031_TGI_at;AK094995;;;0,00000009940000000000;0,767601263;0,73756481;0,961970214;0,760451498;0,103562613;0,896757154;0,203277894;0;0;NA;NA;NA
X100153035_TGI_at;100153035_TGI_at;NM_024776;;NKF3 kinase family member;0,00000001130000000000;0,820835043;0,313702974;0,962823366;0,363169787;0,797584764;0,994609216;0,871690639;0;0;NA;NA;NA
X100153079_TGI_at;100153079_TGI_at;NM_015004;EXOSC7;exosome component 7;0,00000000129000000000;1,218949173;0,000297871;1,107376484;0,002109973;0,059535454;1,070259301;0,137945916;0;0;NA;NA;NA
X100153090_TGI_at;100153090_TGI_at;NM_003597;KLF11;Kruppel-like factor 11;0,00000005780000000000;0,818205802;0,324732812;0,958975785;0,372858515;0,685594243;0,981074022;0,784962787;0;0;NA;NA;NA
X100153140_TGI_at;100153140_TGI_at;NM_020871;LRCH2;leucine-rich repeats and calponin homology (CH) domain containing 2;0,00000003210000000000;0,779369937;0,170118588;0,947557317;0,216118333;0,185788694;0,944979184;0,311548887;0;0;NA;NA;NA
X100153150_TGI_at;100153150_TGI_at;AL833266;;;0,00000000815000000000;1,435133522;0,013463661;1,154684688;0,030302638;0,173607521;1,186853802;0,296679236;0;0;NA;NA;NA
X100153160_TGI_at;100153160_TGI_at;NM_001029839;C3orf23;chromosome 3 open reading frame 23;0,00000000002620000000;1,295070706;0,001524272;1,129000184;0,006576612;4,28E-05;1,392307454;0,001969095;0;1;U3;U1;U1
X100153171_TGI_at;100153171_TGI_at;NM_198053;CD247;CD247 molecule;0,00000001650000000000;0,691123242;0,105879824;0,883163598;0,147027434;0,495732622;0,929540463;0,631021422;0;0;NA;NA;NA
X100153179_TGI_at;100153179_TGI_at;NM_003243;TGFBR3;transforming growth factor, beta receptor III;0,00000000003020000000;0,666630457;2,51E-05;0,728984836;0,000456611;0,993400377;0,997752633;0,995253159;0;0;NA;NA;NA
X100153247_TGI_at;100153247_TGI_at;NM_001001395;LMO3;LIM domain only 3 (rhombotin-like 2);0,00000000004750000000;1,353502017;0,001381914;1,181605064;0,006118008;0,004753151;1,304880076;0,024374289;0;1;U3;U1;U1
X100153254_TGI_at;100153254_TGI_at;ENST00000381048;TNFRSF10B;tumor necrosis factor receptor superfamily, member 10b;0,00000000000001160000;1,803408759;0,006338004;1,201742825;0,017809404;0,003063783;1,416635668;0,018596182;0;1;U6;U1;U1
X100153260_TGI_at;100153260_TGI_at;NM_000297;PKD2;polycystic kidney disease 2 (autosomal dominant);0,00000000001160000000;0,771660446;0,179478009;0,948976901;0,226757202;0,018620907;0,845732974;0,060256208;0;0;NA;NA;NA
X100153327_TGI_at;100153327_TGI_at;AK091766;;hypothetical protein LOC255480;0,00000000002450000000;0,670546421;7,53E-05;0,763259509;0,000869522;0,164346936;0,88548772;0,282652175;0;0;NA;NA;NA
X100153333_TGI_at;100153333_TGI_at;AK123772;SLC25A16;"solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16";0,00000000002800000000;1,309933102;0,083112321;1,105436398;0,121925813;0,005746943;1,303597003;0,02719882;0;0;NA;NA;NA
X100153341_TGI_at;100153341_TGI_at;NM_016341;PLCE1;phospholipase C, epsilon 1;0,00000000000018300000;0,701489311;0,024201607;0,891068774;0,047045705;0,980202899;1,010026276;0,987556719;0;0;NA;NA;NA
X100153378_TGI_at;100153378_TGI_at;NM_174941;CD163L1;CD163 molecule-like 1;0,00000000000002230000;2,158871485;2,72E-06;1,707627103;0,000115604;0,006071612;1,544282117;0,028156556;0;1;U6;U3;U1
X100153412_TGI_at;100153412_TGI_at;NM_004388;CTBS;chitobiase, di-N-acetyl-;0,00000000031800000000;1,418092705;0,002287756;1,143102127;0,008696308;0,282063648;1,092213974;0,421070467;0;0;NA;NA;NA
X100153417_TGI_at;100153417_TGI_at;NM_021259;TMEM8;transmembrane protein 8 (five membrane-spanning domains);0,00000008270000000000;1,321428129;0,666712249;0,981733551;0,696084735;0,016136566;1,264687376;0,054745423;0;0;NA;NA;NA
X100153456_TGI_at;100153456_TGI_at;NM_000057;BLM;Bloom syndrome;0,00000017700000000000;1,348881994;0,053217315;1,126263413;0,085642836;0,836152269;0,95437153;0,898605789;0;0;NA;NA;NA
X100153461_TGI_at;100153461_TGI_at;NM_016008;DYNC2LI1;dynein, cytoplasmic 2, light intermediate chain 1;0,00000000486000000000;0,759793072;0,074246935;0,938065821;0,111406886;0,034975442;0,817717741;0,093703947;0;0;NA;NA;NA
X100153568_TGI_at;100153568_TGI_at;AK074450;;;0,00000012600000000000;1,260802228;0,277938352;1,061646462;0,326932594;0,05081529;1,231115461;0,122313429;0;0;NA;NA;NA
X100153574_TGI_at;100153574_TGI_at;NM_004429;EFNB1;ephrin-B1;0,00000001360000000000;0,730401877;0,003003449;0,853751614;0,010533314;0,635603663;0,939514886;0,747431382;0;0;NA;NA;NA
X100153577_TGI_at;100153577_TGI_at;BF573028;MAPK1;mitogen-activated protein kinase 1;0,00000077000000000000;1,276921569;0,155076368;1,062782016;0,200084522;0,066842161;1,156206066;0,148369342;0;0;NA;NA;NA
X100153638_TGI_at;100153638_TGI_at;NM_000362;TIMP3;TIMP metallopeptidase inhibitor 3;0,00000000000077700000;0,815952166;0,005368356;0,924794748;0,015830021;0,642406094;0,981942558;0,75262626;0;0;NA;NA;NA
X100153680_TGI_at;100153680_TGI_at;NM_000573;CR1;complement component (3b/4b) receptor 1 (Knops blood group);0,00000000000733000000;1,780137028;0,026841265;1,240188037;0,050619894;0,228052747;1,2284455;0,35942005;0;0;NA;NA;NA
X100153712_TGI_at;100153712_TGI_at;NM_014002;IKBKE;inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon;0,00000089900000000000;1,434212712;0,472751961;1,071479931;0,514409037;0,357146031;1,091335568;0,494450884;0;0;NA;NA;NA
X100153769_TGI_at;100153769_TGI_at;NM_003198;TCEB3;transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A);0,00000000003220000000;1,282426697;0,030795756;1,089496991;0,056139549;0,018980373;1,199524694;0,060869395;0;0;NA;NA;NA
X100153770_TGI_at;100153770_TGI_at;NM_000827;GRIA1;glutamate receptor, ionotropic, AMPA 1;0,00000000027200000000;0,680600799;0,047177407;0,845354649;0,077856008;0,81616847;0,960101098;0,885097907;0;0;NA;NA;NA
X100153805_TGI_at;100153805_TGI_at;BC036406;;;0,00000032000000000000;0,714801708;0,380521699;0,912017072;0,427324542;0,421327994;0,930118296;0,560904521;0;0;NA;NA;NA
X100153808_TGI_at;100153808_TGI_at;NM_018249;CDK5RAP2;CDK5 regulatory subunit associated protein 2;0,00000027500000000000;1,204763565;0,097905729;1,05427297;0,13821733;0,182641544;1,080629687;0,308842443;0;0;NA;NA;NA
X100153819_TGI_at;100153819_TGI_at;NM_033512;TSPYL5;TSPY-like 5;0,00000000220000000000;0,809243856;0,277060727;0,95318939;0,326138321;0,967010726;0,98698549;0,980394958;0;0;NA;NA;NA
X100153837_TGI_at;100153837_TGI_at;NM_001037582;SCD5;stearoyl-CoA desaturase 5;0,00000000098600000000;0,741521817;0,50120118;0,951002898;0,540800603;0,365341727;0,936074973;0,503363219;0;0;NA;NA;NA
X100153853_TGI_at;100153853_TGI_at;NM_005582;CD180;CD180 molecule;0,00000001660000000000;1,586165218;0,219211942;1,144024687;0,268638061;0,074854353;1,270369662;0,161916497;0;0;NA;NA;NA
X100153877_TGI_at;100153877_TGI_at;BC062555;GPT2;glutamic pyruvate transaminase (alanine aminotransferase) 2;0,00000029400000000000;1,269456118;0,07194242;1,085539687;0,108910484;0,197238472;0,820178848;0,324667823;0;0;NA;NA;NA
X100153881_TGI_at;100153881_TGI_at;DB308377;;;0,00000002980000000000;0,786100663;0,10211703;0,909340128;0,143034849;0,759495311;1,056811078;0,842344593;0;0;NA;NA;NA
X100153900_TGI_at;100153900_TGI_at;NM_006270;RRAS;related RAS viral (r-ras) oncogene homolog;0,00000000738000000000;0,769792808;0,000765107;0,827136131;0,004123647;0,517878297;1,081711961;0,651746096;0;0;NA;NA;NA
X100153921_TGI_at;100153921_TGI_at;ENST00000311127;HEG1;HEG homolog 1 (zebrafish);0,00000002700000000000;0,78543989;0,000889677;0,854991112;0,004487371;0,235851277;1,116375239;0,368289083;0;0;NA;NA;NA
X100153946_TGI_at;100153946_TGI_at;ENST00000371110;PIK3AP1;phosphoinositide-3-kinase adaptor protein 1;0,00000043400000000000;1,381651871;0,006227465;1,300788707;0,017556218;0,019518593;1,358332904;0,062162477;0;0;NA;NA;NA
X100153953_TGI_at;100153953_TGI_at;NM_017966;VPS37C;vacuolar protein sorting 37 homolog C (S. cerevisiae);0,00000002120000000000;1,292057335;0,156294214;1,053904396;0,201333434;0,015374349;1,16043554;0,052959853;0;0;NA;NA;NA
X100153973_TGI_at;100153973_TGI_at;NM_002658;PLAU;plasminogen activator, urokinase;0,00000003350000000000;1,351287286;0,000337896;1,306302431;0,002297553;0,37483693;1,039552367;0,511473085;0;0;NA;NA;NA
X100153979_TGI_at;100153979_TGI_at;NM_001033564;C6orf225;chromosome 6 open reading frame 225;0,00000114000000000000;0,745092599;0,000854145;0,721449081;0,004397617;0,14616607;0,815551581;0,260560422;0;0;NA;NA;NA
X100153984_TGI_at;100153984_TGI_at;NM_003835;RGS9;regulator of G-protein signaling 9;0,00000096100000000000;0,65709831;0,005183407;0,779175281;0,015488965;0,567746993;1,079497545;0,6918142;0;0;NA;NA;NA
X100154002_TGI_at;100154002_TGI_at;NM_030751;ZEB1;zinc finger E-box binding homeobox 1;0,00000001630000000000;0,778926313;0,082139299;0,899203886;0,120608182;0,064330368;0,819629167;0,144788251;0;0;NA;NA;NA
X100154005_TGI_at;100154005_TGI_at;NM_001496;GFRA3;GDNF family receptor alpha 3;0,00000000000655000000;2,066755408;9,76E-05;1,607605181;0,001051784;0,161066496;1,269315147;0,279095331;0;0;NA;NA;NA
X100154024_TGI_at;100154024_TGI_at;NM_139018;CD300LF;CD300 molecule-like family member f;0,00000000000001050000;1,762266004;0,000185911;1,357798902;0,001548298;0,002886902;1,558876884;0,017893238;0;1;U6;U1;U1
X100154029_TGI_at;100154029_TGI_at;NM_175862;CD86;CD86 molecule;0,00000000000083400000;1,589215342;0,000255115;1,295107007;0,00192111;0,003890586;1,394485627;0,021361772;0;1;U5;U1;U1
X100154041_TGI_at;100154041_TGI_at;AK123676;CHST11;carbohydrate (chondroitin 4) sulfotransferase 11;0,00000039200000000000;1,300719156;0,111951704;1,076869199;0,153149551;0,017758754;1,216223329;0,058404554;0;0;NA;NA;NA
X100154083_TGI_at;100154083_TGI_at;NM_213606;SLC16A12;solute carrier family 16, member 12 (monocarboxylic acid transporter 12);0,00000000002110000000;0,612949619;0,00089721;0,729221965;0,004518293;0,320446876;0,863593377;0,461483593;0;0;NA;NA;NA
X100154092_TGI_at;100154092_TGI_at;ENST00000369769;KCNA3;potassium voltage-gated channel, shaker-related subfamily, member 3;0,00000018200000000000;1,460380929;0,007162512;1,236685312;0,01943163;0,002522564;1,626444103;0,016763349;0;1;U5;U2;U1
X100154097_TGI_at;100154097_TGI_at;NM_002194;INPP1;inositol polyphosphate-1-phosphatase;0,00000023000000000000;0,809773336;0,001602472;0,88483117;0,006831703;0,203149235;0,908175936;0,330514884;0;0;NA;NA;NA
X100154168_TGI_at;100154168_TGI_at;BC046126;ABCC3;ATP-binding cassette, sub-family C (CFTR/MRP), member 3;0,00000000000080500000;1,590347602;0,069950746;1,088588926;0,106697234;0,305602819;1,118001529;0,445682301;0;0;NA;NA;NA
X100154172_TGI_at;100154172_TGI_at;AL133118;MAPKSP1;MAPK scaffold protein 1;0,00000000000000085800;0,557544403;3,10E-08;0,705265582;6,24E-06;0,009707916;0,769145218;0,039467969;0;1;D6;D3;D1
X100154195_TGI_at;100154195_TGI_at;NM_198472;C10orf125;chromosome 10 open reading frame 125;0,00000000000437000000;1,471024686;0,02132498;1,148104961;0,042923852;0,001055444;1,42098537;0,009719131;0;1;U1;U1;U1
X100154198_TGI_at;100154198_TGI_at;NM_014142;NUDT5;nudix (nucleoside diphosphate linked moiety X)-type motif 5;0,00000000000173000000;1,218257354;0,225582458;1,025158265;0,274637279;0,061450873;1,068367745;0,141367712;0;0;NA;NA;NA
X100154228_TGI_at;100154228_TGI_at;DQ892427;STAM2;signal transducing adaptor molecule (SH3 domain and ITAM motif) 2;0,00000038000000000000;1,261922365;0,55713264;1,037330429;0,593403338;0,284058212;1,074841476;0,421122179;0;0;NA;NA;NA
X100154270_TGI_at;100154270_TGI_at;NM_001012978;BEX5;BEX family member 5;0,00000000000005640000;0,494893506;1,85E-07;0,654609225;2,37E-05;0,191451954;0,866276494;0,318230865;0;0;NA;NA;NA
X100154274_TGI_at;100154274_TGI_at;BC035116;;;0,00000000000470000000;0,728485908;0,00411516;0,864667167;0,013055233;0,203149235;0,927277935;0,330514884;0;0;NA;NA;NA
X100154300_TGI_at;100154300_TGI_at;AK023055;;hypothetical LOC441027;0,00000008530000000000;0,780042471;0,009208355;0,854207882;0,023295549;0,177060975;0,898954087;0,301461976;0;0;NA;NA;NA
X100154315_TGI_at;100154315_TGI_at;BC035518;;;0,00000000014600000000;0,817333663;0,044557843;0,933622332;0,074332261;0,493698061;0,941925806;0,628679909;0;0;NA;NA;NA
X100154320_TGI_at;100154320_TGI_at;DB357058;SGCD;sarcoglycan, delta (35kDa dystrophin-associated glycoprotein);0,00000009190000000000;0,7301652;0,255108164;0,88439117;0,304185576;0,18024766;0,887998997;0,304954439;0;0;NA;NA;NA
X100154342_TGI_at;100154342_TGI_at;NM_017944;USP47;ubiquitin specific peptidase 47;0,00000000635000000000;0,817113736;0,030190519;0,902088013;0,055254992;0,284058212;0,959476805;0,421122179;0;0;NA;NA;NA
X100154353_TGI_at;100154353_TGI_at;ENST00000378076;ITGA8;integrin, alpha 8;0,00000003210000000000;0,784718531;0,287219061;0,940035993;0,336131821;0,127027071;0,820783419;0,235834246;0;0;NA;NA;NA
X100154454_TGI_at;100154454_TGI_at;BC036074;IMPACT;Impact homolog (mouse);0,00000000011400000000;1,435209951;0,018858583;1,116771157;0,039062477;0,832935571;0,973865956;0,897243096;0;0;NA;NA;NA
X100154475_TGI_at;100154475_TGI_at;ENST00000372142;NRG3;neuregulin 3;0,00000000080600000000;0,548095002;0,000384776;0,657763263;0,002530881;0,37483693;0,888723845;0,511473085;0;0;NA;NA;NA
X100154488_TGI_at;100154488_TGI_at;AL080094;;RPE-spondin;0,00000000000708000000;0,649572853;0,00763478;0,830013355;0,020369946;0,206634;0,880865487;0,335845377;0;0;NA;NA;NA
X100154531_TGI_at;100154531_TGI_at;ENST00000313966;;PRO2055;0,00000017500000000000;1,252233477;0,350875674;1,065718059;0,398054311;0,086710607;1,199411607;0,179491513;0;0;NA;NA;NA
X100154635_TGI_at;100154635_TGI_at;NM_003149;STAC;SH3 and cysteine rich domain;0,00000000000751000000;1,61268687;0,01261405;1,308735487;0,029018619;0,012010459;1,46251034;0,044912263;0;1;U1;U1;U1
X100154639_TGI_at;100154639_TGI_at;NM_001079846;CREBBP;CREB binding protein;0,00000052800000000000;0,821104909;0,001616049;0,915724761;0,006865836;0,672949117;0,99975277;0,774063003;0;0;NA;NA;NA
X100154689_TGI_at;100154689_TGI_at;ENST00000361490;HPS1;Hermansky-Pudlak syndrome 1;0,00000080900000000000;1,266994926;0,314190285;1,045510925;0,363603335;0,022436456;1,199406199;0,06841315;0;0;NA;NA;NA
X100154706_TGI_at;100154706_TGI_at;NM_003638;ITGA8;integrin, alpha 8;0,00000047700000000000;0,80999656;0,232169449;0,934789149;0,281097721;0,711121171;0,9271957;0,803908641;0;0;NA;NA;NA
X100154724_TGI_at;100154724_TGI_at;NM_005428;VAV1;vav 1 guanine nucleotide exchange factor;0,00000006500000000000;1,303404067;0,121935977;1,089370504;0,164297514;0,010314762;1,210532398;0,040961273;0;0;NA;NA;NA
X100154729_TGI_at;100154729_TGI_at;AK027726;SLC35B4;solute carrier family 35, member B4;0,00000000000067600000;1,305613781;0,002816562;1,10342257;0,00997558;0,01806578;1,222075291;0,05881415;0;0;NA;NA;NA
X100154748_TGI_at;100154748_TGI_at;NM_080869;WFDC12;WAP four-disulfide core domain 12;0,00000015900000000000;1,50426075;0,009388181;1,332453104;0,023512966;0,00200392;1,847029669;0,01464543;0;1;U2;U1;U2
X100154760_TGI_at;100154760_TGI_at;AA504757;;;0,00000075200000000000;0,767717318;0,615440861;0,938346523;0,649285072;0,567746993;0,913059166;0,6918142;0;0;NA;NA;NA
X100154774_TGI_at;100154774_TGI_at;NM_053035;MRPS33;mitochondrial ribosomal protein S33;0,00000000052300000000;1,213029857;0,00047664;1,129305844;0,002909492;0,107219939;1,120092563;0,208174617;0;0;NA;NA;NA
X100154796_TGI_at;100154796_TGI_at;ENST00000356289;AMICA1;adhesion molecule, interacts with CXADR antigen 1;0,00000000000000454000;1,60958303;2,02E-06;1,409974374;0,000101523;0,006224908;1,45376192;0,028702256;0;1;U6;U3;U1
X100154875_TGI_at;100154875_TGI_at;AF135593;VPS41;vacuolar protein sorting 41 homolog (S. cerevisiae);0,00000000000114000000;1,229514237;0,008038078;1,072711031;0,021148348;0,000582582;1,204826834;0,006928637;0;1;U2;U1;U1
X100154897_TGI_at;100154897_TGI_at;ENST00000378204;EXT1;exostoses (multiple) 1;0,00000061200000000000;0,81462325;0,221372354;0,938977943;0,270566211;0,089895036;0,899714158;0,184145191;0;0;NA;NA;NA
X100154904_TGI_at;100154904_TGI_at;AK056075;;;0,00000044500000000000;0,808894308;0,666712249;0,982071799;0,696084735;0,685086646;0,988851207;0,784939303;0;0;NA;NA;NA
X100154905_TGI_at;100154905_TGI_at;NM_002339;LSP1;lymphocyte-specific protein 1;0,00000018700000000000;1,363184573;0,006680295;1,155011731;0,018541916;0,432376875;1,109023569;0,56949353;0;0;NA;NA;NA
X100154918_TGI_at;100154918_TGI_at;NM_002146;HOXB3;homeobox B3;0,00000000256000000000;0,687769048;0,19847624;0,923684919;0,247079537;0,000345371;0,696432034;0,005300617;0;0;NA;NA;NA
X100154927_TGI_at;100154927_TGI_at;CF551948;PALLD;palladin, cytoskeletal associated protein;0,00000058600000000000;0,829797706;0,783098099;0,993872939;0,802775182;0,776306806;0,992917682;0,85627544;0;0;NA;NA;NA
X100154930_TGI_at;100154930_TGI_at;NM_001080471;PEAR1;platelet endothelial aggregation receptor 1;0,00000000001090000000;0,697917705;0,024564352;0,896167852;0,047578669;0,431008093;0,926708427;0,568620174;0;0;NA;NA;NA
X100154959_TGI_at;100154959_TGI_at;ENST00000240587;TSHZ3;teashirt zinc finger homeobox 3;0,00000078700000000000;0,795264511;0,031041531;0,900799885;0,056428006;0,063309309;0,841916658;0,144202051;0;0;NA;NA;NA
X100154966_TGI_at;100154966_TGI_at;BQ185142;IRS1;insulin receptor substrate 1;0,00000000087400000000;0,756509797;0,02267319;0,83792585;0,044997347;0,103562613;0,832567508;0,203277894;0;0;NA;NA;NA
X100154981_TGI_at;100154981_TGI_at;BC073798;PTPMT1;protein tyrosine phosphatase, mitochondrial 1;0,00000000000009050000;1,361761797;0,08495127;1,105007628;0,124046493;0,017971918;1,260397753;0,058805575;0;0;NA;NA;NA
X100154989_TGI_at;100154989_TGI_at;CD672190;PLCE1;phospholipase C, epsilon 1;0,00000012200000000000;0,744295943;0,156731174;0,932397244;0,201735054;0,601955364;0,987412803;0,718556347;0;0;NA;NA;NA
X100154997_TGI_at;100154997_TGI_at;AF151890;MRPS16;mitochondrial ribosomal protein S16;0,00000000000536000000;1,250149886;0,024071007;1,063880467;0,046904991;0,041156692;1,091053406;0,104282253;0;0;NA;NA;NA
X100154998_TGI_at;100154998_TGI_at;NM_020156;C1GALT1;core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1;0,00000000459000000000;1,428341853;0,002325633;1,184386659;0,008756443;0,064330368;1,257360419;0,144788251;0;0;NA;NA;NA
X100155006_TGI_at;100155006_TGI_at;NM_006669;LILRB1;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1;0,00000021800000000000;1,319848498;0,566122331;1,028545956;0,602182268;0,100344073;1,215957091;0,198776243;0;0;NA;NA;NA
X100155026_TGI_at;100155026_TGI_at;NM_032208;ANTXR1;anthrax toxin receptor 1;0,00000001630000000000;0,8251356;0,975095871;1,000160789;0,977218281;0,052890615;0,866673741;0,126177982;0;0;NA;NA;NA
X100155035_TGI_at;100155035_TGI_at;NM_020726;NLN;neurolysin (metallopeptidase M3 family);0,00000000334000000000;1,405358836;0,013463661;1,14689784;0,030302638;0,259760472;1,061703436;0,395282342;0;0;NA;NA;NA
X100155039_TGI_at;100155039_TGI_at;DN914603;BLVRA;biliverdin reductase A;0,00000008950000000000;1,25975151;0,107587048;1,089799798;0,148629685;0,000161447;1,364283625;0,004028419;0;0;NA;NA;NA
X100155047_TGI_at;100155047_TGI_at;AA258154;PHCA;phytoceramidase, alkaline;0,00000000000000174000;1,769182936;0,000570407;1,228644145;0,003330477;0,023889612;1,252819299;0,071425065;0;0;NA;NA;NA
X100155053_TGI_at;100155053_TGI_at;AK097116;;;0,00000000679000000000;1,353321926;0,002622199;1,196595193;0,009506578;0,009808825;1,191902558;0,039467969;0;1;U1;U1;U1
X100155055_TGI_at;100155055_TGI_at;BC020209;AGPAT4;1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta);0,00000001300000000000;1,24550148;0,032873206;1,094824921;0,058795973;0,004937402;1,293440771;0,024633511;0;0;NA;NA;NA
X100155056_TGI_at;100155056_TGI_at;AK001890;GNB4;guanine nucleotide binding protein (G protein), beta polypeptide 4;0,00000046800000000000;1,3176388;0,029956483;1,097257962;0,05498277;0,299373904;1,131685512;0,437985516;0;0;NA;NA;NA
X100155060_TGI_at;100155060_TGI_at;NM_005400;PRKCE;protein kinase C, epsilon;0,00000000343000000000;0,711187131;0,000104664;0,767462478;0,00106414;0,862086046;1,066312559;0,916392918;0;0;NA;NA;NA
X100155075_TGI_at;100155075_TGI_at;NM_003273;TM7SF2;transmembrane 7 superfamily member 2;0,00000000376000000000;1,377811482;0,05610208;1,130662023;0,089602083;0,003653668;1,400475202;0,020560753;0;0;NA;NA;NA
X100155085_TGI_at;100155085_TGI_at;NM_020796;SEMA6A;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A;0,00000000000001630000;0,619878248;0,009868546;0,863108202;0,024466402;0,611187453;0,972234016;0,727019861;0;0;NA;NA;NA
X100155094_TGI_at;100155094_TGI_at;AF163254;DAPP1;dual adaptor of phosphotyrosine and 3-phosphoinositides;0,00000007430000000000;1,34801979;0,194208031;1,102484378;0,242797705;0,144787165;1,177850058;0,25853132;0;0;NA;NA;NA
X100155107_TGI_at;100155107_TGI_at;NM_133373;PLCD3;phospholipase C, delta 3;0,00000003990000000000;0,818466271;0,021357694;0,907977038;0,042923852;0,072102527;0,897319114;0,157336794;0;0;NA;NA;NA
X100155126_TGI_at;100155126_TGI_at;AW976724;PHCA;phytoceramidase, alkaline;0,00000000000007300000;1,516974317;4,32E-05;1,212662421;0,000621028;0,003616259;1,306916087;0,020560753;0;1;U2;U2;U1
X100155154_TGI_at;100155154_TGI_at;NM_017671;FERMT1;fermitin family homolog 1 (Drosophila);0,00000008950000000000;1,541180299;0,001437318;1,317078753;0,006319886;0,556550302;0,837249067;0,68359818;0;0;NA;NA;NA
X100155160_TGI_at;100155160_TGI_at;NM_201630;LRRN2;leucine rich repeat neuronal 2;0,00000000000025000000;1,497952138;4,59E-06;1,278869198;0,000162666;0,001461933;1,36528478;0,011898514;0;1;U4;U2;U1
X100155163_TGI_at;100155163_TGI_at;BC046159;PPFIBP1;PTPRF interacting protein, binding protein 1 (liprin beta 1);0,00000069800000000000;0,761400519;0,000347494;0,831546063;0,002347954;0,191451954;0,900463325;0,318230865;0;0;NA;NA;NA
X100155178_TGI_at;100155178_TGI_at;NM_003200;TCF3;transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47);0,00000009440000000000;0,830009642;0,000190009;0,87060208;0,001571754;0,450742398;0,92651099;0,587204022;0;0;NA;NA;NA
X100155201_TGI_at;100155201_TGI_at;NM_001085377;MCC;mutated in colorectal cancers;0,00000002060000000000;0,725542527;0,430941846;0,944809411;0,475496601;0,069432339;0,821550457;0,153169355;0;0;NA;NA;NA
X100155227_TGI_at;100155227_TGI_at;NM_006574;CSPG5;chondroitin sulfate proteoglycan 5 (neuroglycan C);0,00000000000114000000;1,90519569;0,002383316;1,426924608;0,008890542;0,003045158;1,51683171;0,018596182;0;1;U2;U1;U1
X100155230_TGI_at;100155230_TGI_at;BF031974;E2F3;E2F transcription factor 3;0,00000000315000000000;1,322200382;0,251157143;1,041982799;0,300140701;0,190864759;1,129483957;0,318230865;0;0;NA;NA;NA
X100155268_TGI_at;100155268_TGI_at;NM_003786;ABCC3;ATP-binding cassette, sub-family C (CFTR/MRP), member 3;0,00000000000007290000;1,893751875;0,004377271;1,24855954;0,01372368;0,252599303;1,134452024;0,387495266;0;0;NA;NA;NA
X100155280_TGI_at;100155280_TGI_at;AB209366;FUBP1;far upstream element (FUSE) binding protein 1;0,00000126000000000000;0,801309308;0,948227104;0,980428699;0,953255133;0,01262694;0,773704508;0,046447382;0;0;NA;NA;NA
X100155300_TGI_at;100155300_TGI_at;NM_175571;GIMAP8;GTPase, IMAP family member 8;0,00000000026700000000;0,72383513;0,000535197;0,829815992;0,003176686;0,552010088;0,944548384;0,680615346;0;0;NA;NA;NA
X100155314_TGI_at;100155314_TGI_at;NM_153267;MAMDC2;MAM domain containing 2;0,00000000003550000000;0,63544821;0,035793874;0,897317415;0,062902756;0,131303184;0,86060331;0,240585653;0;0;NA;NA;NA
X100155319_TGI_at;100155319_TGI_at;NM_033008;PCBP4;poly(rC) binding protein 4;0,00000010300000000000;0,801250613;0,003076272;0,868966125;0,010707153;0,431008093;0,942893644;0,568620174;0;0;NA;NA;NA
X100155339_TGI_at;100155339_TGI_at;NM_002068;GNA15;guanine nucleotide binding protein (G protein), alpha 15 (Gq class);0,00000006160000000000;1,419290011;0,47977983;1,033757606;0,521352121;0,003653668;1,286653012;0,020560753;0;0;NA;NA;NA
X100155351_TGI_at;100155351_TGI_at;AF086204;;similar to WDNM1-like protein;0,00000000000311000000;2,050971235;0,035970005;1,231808884;0,063109051;0,203149235;1,243700377;0,330514884;0;0;NA;NA;NA
X100155403_TGI_at;100155403_TGI_at;NM_020731;AHRR;aryl-hydrocarbon receptor repressor;0,00000000000000000003;6,115441698;5,03E-12;4,027508946;5,40E-09;1,68E-07;3,953901646;0,00013516;1;1;U8;U2;U3
X100155408_TGI_at;100155408_TGI_at;NM_001047434;DPH3;DPH3, KTI11 homolog (S. cerevisiae);0,00000000000777000000;1,512845643;0,000755288;1,227379742;0,004091251;0,007918414;1,240744712;0,034341403;0;1;U2;U3;U1
X100155426_TGI_at;100155426_TGI_at;AF124366;;;0,00000001230000000000;0,686429111;0,110091487;0,873447775;0,151053581;0,37483693;1,090044226;0,511473085;0;0;NA;NA;NA
X100155442_TGI_at;100155442_TGI_at;ENST00000217246;MACROD2;MACRO domain containing 2;0,00000008950000000000;1,6856768;0,102713657;1,307365137;0,143808044;2,28E-05;2,059405278;0,001749595;0;0;NA;NA;NA
X100155451_TGI_at;100155451_TGI_at;NM_003044;SLC6A12;solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12;0,00000000000000940000;2,52818432;0,000169695;1,523162511;0,001435503;0,000461729;1,931937373;0,006049403;0;1;U1;U1;U1
X100155460_TGI_at;100155460_TGI_at;NM_207103;C17orf87;chromosome 17 open reading frame 87;0,00000000000233000000;1,668552172;0,008377057;1,231430749;0,021773592;0,00017114;1,680889061;0,004028419;0;1;U1;U1;U1
X100155476_TGI_at;100155476_TGI_at;AA278408;ADRBK2;adrenergic, beta, receptor kinase 2;0,00000000000144000000;1,529068004;0,01482693;1,154404819;0,032663838;4,78E-06;1,406139701;0,000962178;0;1;U5;U1;U1
X100155483_TGI_at;100155483_TGI_at;NM_052862;RCSD1;RCSD domain containing 1;0,00000062800000000000;0,799850327;0,004961603;0,886437446;0,015057672;0,421327994;0,948936604;0,560904521;0;0;NA;NA;NA
X100155486_TGI_at;100155486_TGI_at;NM_014767;SPOCK2;sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2;0,00000000000024400000;0,721181752;0,129070511;0,898172559;0,172468597;0,587186896;0,992915165;0,708272218;0;0;NA;NA;NA
X100155493_TGI_at;100155493_TGI_at;NM_022486;SUSD1;sushi domain containing 1;0,00000000000000302000;1,614880998;9,35E-07;1,314187754;6,55E-05;0,009298025;1,272722187;0,038004115;0;1;U2;U2;U1
X100155509_TGI_at;100155509_TGI_at;NM_021813;BACH2;BTB and CNC homology 1, basic leucine zipper transcription factor 2;0,00000000129000000000;0,685699224;4,16E-05;0,764651679;0,000607007;0,523607186;0,900365062;0,657671847;0;0;NA;NA;NA
X100155516_TGI_at;100155516_TGI_at;NM_000071;CBS;cystathionine-beta-synthase;0,00000008230000000000;1,482230316;0,061663359;1,1149615;0,096335921;0,131303184;1,243135776;0,240585653;0;0;NA;NA;NA
X100155606_TGI_at;100155606_TGI_at;NM_001039131;ALOX15B;arachidonate 15-lipoxygenase, type B;0,00000000004000000000;1,821348328;0,021084349;1,229704302;0,04255157;5,65E-05;2,403462726;0,002249479;0;1;U4;U1;U1
X100155612_TGI_at;100155612_TGI_at;AW970730;ST6GALNAC1;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1;0,00000060100000000000;1,337241347;0,435129476;1,104593625;0,479460616;0,431008093;1,008672902;0,568620174;0;0;NA;NA;NA
X100155643_TGI_at;100155643_TGI_at;AK093899;PRICKLE2;prickle homolog 2 (Drosophila);0,00000110000000000000;0,757001353;0,390650172;0,959683049;0,437175522;0,37483693;0,903356178;0,511473085;0;0;NA;NA;NA
X100155646_TGI_at;100155646_TGI_at;NM_014214;IMPA2;inositol(myo)-1(or 4)-monophosphatase 2;0,00000004850000000000;1,233375754;0,024715872;1,091788374;0,047757347;0,007170261;1,273344545;0,031919548;0;1;U1;U1;U1
X100155675_TGI_at;100155675_TGI_at;NM_001860;SLC31A2;solute carrier family 31 (copper transporters), member 2;0,00000000002370000000;1,427477233;0,015276815;1,155391234;0,033381135;0,00139981;1,331281918;0,011509154;0;1;U2;U1;U1
X100155677_TGI_at;100155677_TGI_at;NM_002153;HSD17B2;hydroxysteroid (17-beta) dehydrogenase 2;0,00000039200000000000;1,639266615;0,039641612;1,286501708;0,067923932;0,750005011;1,086798503;0,835845834;0;0;NA;NA;NA
X100155678_TGI_at;100155678_TGI_at;NM_018367;PHCA;phytoceramidase, alkaline;0,00000008410000000000;1,31899997;0,015486569;1,15207459;0,033702371;0,022436456;1,342954644;0,06841315;0;0;NA;NA;NA
X100155679_TGI_at;100155679_TGI_at;NM_020685;C3orf14;chromosome 3 open reading frame 14;0,00000000013200000000;1,399656123;9,04E-05;1,199769694;0,000997879;0,926061411;0,980805958;0,959350695;0;0;NA;NA;NA
X100155726_TGI_at;100155726_TGI_at;NM_002953;RPS6KA1;ribosomal protein S6 kinase, 90kDa, polypeptide 1;0,00000000016000000000;1,311086597;0,057304522;1,084205143;0,091204066;0,000188734;1,393431875;0,004028419;0;0;NA;NA;NA
X100155727_TGI_at;100155727_TGI_at;NM_138712;PPARG;peroxisome proliferator-activated receptor gamma;0,00000000354000000000;1,546155565;0,000814161;1,394286118;0,004259805;0,000174604;1,743845759;0,004028419;0;1;U1;U1;U1
X100155740_TGI_at;100155740_TGI_at;NM_017728;TMEM104;transmembrane protein 104;0,00000000025400000000;1,442231991;0,00257274;1,170174306;0,009390646;0,004862758;1,284604528;0,024374289;0;1;U2;U1;U1
X100155785_TGI_at;100155785_TGI_at;NM_004050;BCL2L2;BCL2-like 2;0,00000000027500000000;0,826656536;0,225725769;0,939019764;0,274637279;0,819786989;0,970728189;0,887827105;0;0;NA;NA;NA
X100155821_TGI_at;100155821_TGI_at;NM_001097642;GJB1;gap junction protein, beta 1, 32kDa;0,00000000114000000000;1,742032079;0,0418679;1,253847697;0,070797609;0,000399716;1,760638555;0,005625698;0;0;NA;NA;NA
X100155842_TGI_at;100155842_TGI_at;AK056255;BCAT1;branched chain aminotransferase 1, cytosolic;0,00000000001510000000;2,215830497;0,033823235;1,305617403;0,059863968;0,18024766;1,373497668;0,304954439;0;0;NA;NA;NA
X100155879_TGI_at;100155879_TGI_at;BU741143;;;0,00000000000166000000;1,337289658;0,007002781;1,106620639;0,019143309;0,215347198;1,104604165;0,344448645;0;0;NA;NA;NA
X100155939_TGI_at;100155939_TGI_at;NM_015033;FNBP1;formin binding protein 1;0,00000003880000000000;0,808642644;0,098861292;0,947855345;0,13926134;0,287685654;0,950560069;0,426107933;0;0;NA;NA;NA
X100155950_TGI_at;100155950_TGI_at;NM_032571;EMR3;egf-like module containing, mucin-like, hormone receptor-like 3;0,00000000002990000000;1,802431868;1,43E-05;1,607841102;0,000331475;0,022436456;1,424265343;0,06841315;0;0;NA;NA;NA
X100155979_TGI_at;100155979_TGI_at;NM_020179;C11orf75;chromosome 11 open reading frame 75;0,00000000000075000000;1,590272326;0,023141098;1,115985651;0,045422509;0,012656854;1,23004873;0,046447382;0;1;U2;U1;U1
X100155989_TGI_at;100155989_TGI_at;AK056963;;;0,00000000022800000000;0,78203618;0,239165346;0,933596729;0,287837906;0,924555569;1,02413718;0,959350695;0;0;NA;NA;NA
X100156137_TGI_at;100156137_TGI_at;NM_015459;ATL3;atlastin GTPase 3;0,00000000000185000000;1,37678145;0,062244216;1,075538795;0,097084325;0,174827775;1,071481893;0,298290058;0;0;NA;NA;NA
X100156138_TGI_at;100156138_TGI_at;NM_032265;ZMYND15;zinc finger, MYND-type containing 15;0,00000000005080000000;1,630134552;0,002828009;1,255476238;0,009997133;0,000371641;1,677964727;0,00537129;0;1;U2;U1;U1
X100156210_TGI_at;100156210_TGI_at;ENST00000379459;EHD3;EH-domain containing 3;0,00000016400000000000;0,704821532;0,038000342;0,874975269;0,065911982;0,203035049;0,840126263;0,330514884;0;0;NA;NA;NA
X100156233_TGI_at;100156233_TGI_at;NM_001076552;ACSS2;acyl-CoA synthetase short-chain family member 2;0,00000000000118000000;1,449443051;0,005030005;1,151075754;0,015193728;0,00236704;1,313429334;0,016094875;0;1;U4;U1;U1
X100156250_TGI_at;100156250_TGI_at;NM_198129;LAMA3;laminin, alpha 3;0,00000000000098400000;0,691014863;0,144150051;0,874563324;0,18801927;0,599133899;1,091902545;0,718556347;0;0;NA;NA;NA
X100156251_TGI_at;100156251_TGI_at;NM_018052;VAC14;Vac14 homolog (S. cerevisiae);0,00000000549000000000;1,346487629;0,022237886;1,088587978;0,044269738;0,005143125;1,22544994;0,025423759;0;1;U4;U1;U1
X100156267_TGI_at;100156267_TGI_at;NM_054023;SCGB3A2;secretoglobin, family 3A, member 2;0,00000000000918000000;1,512314891;0,00013867;1,299909073;0,001266103;0,002093302;1,298381196;0,014968787;0;1;U1;U2;U1
X100156282_TGI_at;100156282_TGI_at;L12392;HTT;huntingtin;0,00000006000000000000;1,219826468;0,401395392;1,026917392;0,447336566;0,083615947;1,124224837;0,17510994;0;0;NA;NA;NA
X100156312_TGI_at;100156312_TGI_at;AF190725;BACE1;beta-site APP-cleaving enzyme 1;0,00000071500000000000;1,210885556;0,023141098;1,119940915;0,045422509;0,06589724;1,15317456;0,147695969;0;0;NA;NA;NA
X100156330_TGI_at;100156330_TGI_at;NM_015687;FILIP1;filamin A interacting protein 1;0,00000046500000000000;1,245834326;0,074386478;1,057220202;0,111406886;0,392990225;1,098865608;0,532042792;0;0;NA;NA;NA
X100156343_TGI_at;100156343_TGI_at;NM_024501;HOXD1;homeobox D1;0,00000000833000000000;1,769725521;0,000109657;1,526871669;0,001094198;3,38E-05;2,32374002;0,001805101;0;1;U1;U2;U1
X100156370_TGI_at;100156370_TGI_at;N49471;DAAM1;dishevelled associated activator of morphogenesis 1;0,00000000202000000000;0,773559023;5,81E-05;0,860067208;0,0007487;0,611235009;1,041255533;0,727019861;0;0;NA;NA;NA
X100156384_TGI_at;100156384_TGI_at;NM_080870;DPCR1;diffuse panbronchiolitis critical region 1;0,00000000276000000000;1,777624152;0,000124681;1,57049694;0,001194742;0,000188734;2,270488902;0,004028419;0;1;U4;U2;U1
X100156398_TGI_at;100156398_TGI_at;NM_176796;P2RY6;pyrimidinergic receptor P2Y, G-protein coupled, 6;0,00000001560000000000;1,441844655;0,047177407;1,137189193;0,077856008;0,534478464;1,06706013;0,664336324;0;0;NA;NA;NA
X100156422_TGI_at;100156422_TGI_at;NM_004231;ATP6V1F;ATPase, H+ transporting, lysosomal 14kDa, V1 subunit F;0,00000000000000101000;1,49093118;0,00478784;1,139153797;0,014585264;1,98E-05;1,350579826;0,001749595;0;1;U4;U1;U1
X100156435_TGI_at;100156435_TGI_at;NM_006665;HPSE;heparanase;0,00000027200000000000;1,510576956;0,73756481;1,034533965;0,760451498;0,927501324;1,019248098;0,959350695;0;0;NA;NA;NA
X100156442_TGI_at;100156442_TGI_at;AI131310;;;0,00000000021000000000;0,594118159;0,084147794;0,835329324;0,123108643;0,315219134;0,979871132;0,454361033;0;0;NA;NA;NA
X100156451_TGI_at;100156451_TGI_at;AK092659;SHROOM4;shroom family member 4;0,00000001750000000000;0,790594083;0,005816236;0,854348257;0,016648071;0,601955364;1,080497489;0,718556347;0;0;NA;NA;NA
X100156468_TGI_at;100156468_TGI_at;CK001662;;;0,00000002490000000000;0,774425341;0,295868283;0,95228847;0,345251077;0,849099163;1,004140779;0,906474529;0;0;NA;NA;NA
X100156510_TGI_at;100156510_TGI_at;NM_016066;GLRX2;glutaredoxin 2;0,00000000071800000000;1,284972122;0,018924824;1,09766383;0,039149364;0,010855277;1,191130639;0,041904859;0;1;U1;U1;U1
X100156651_TGI_at;100156651_TGI_at;XM_290799;ARHGAP23;Rho GTPase activating protein 23;0,00000000398000000000;0,764140912;2,96E-05;0,850611466;0,000491632;0,043948888;0,852448951;0,109380128;0;0;NA;NA;NA
X100156652_TGI_at;100156652_TGI_at;NM_002083;GPX2;glutathione peroxidase 2 (gastrointestinal);0,00000000062300000000;2,490627988;0,051135979;1,6302424;0,083153249;0,357146031;1,223334751;0,494450884;0;0;NA;NA;NA
X100156688_TGI_at;100156688_TGI_at;AK021612;MYCT1;myc target 1;0,00000030600000000000;0,781709801;0,005573674;0,872401524;0,016242271;0,759495311;0,995451233;0,842344593;0;0;NA;NA;NA
X100156693_TGI_at;100156693_TGI_at;AL833176;CHST11;carbohydrate (chondroitin 4) sulfotransferase 11;0,00000000059400000000;1,306470506;0,013452035;1,114336767;0,030302638;0,006071612;1,219872128;0,028156556;0;1;U1;U1;U1
X100156707_TGI_at;100156707_TGI_at;NM_003684;MKNK1;MAP kinase interacting serine/threonine kinase 1;0,00000028600000000000;1,213247913;0,039319131;1,070082483;0,067586966;0,018620907;1,148584804;0,060256208;0;0;NA;NA;NA
X100156711_TGI_at;100156711_TGI_at;AK128437;GALNT7;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7);0,00000000137000000000;1,369495314;0,350875674;1,039295233;0,398054311;0,197238472;1,214856826;0,324667823;0;0;NA;NA;NA
X100156712_TGI_at;100156712_TGI_at;AU148886;CLCN4;chloride channel 4;0,00000037400000000000;1,294084727;0,18294964;1,072038082;0,230691194;0,054502519;1,249964574;0,128784177;0;0;NA;NA;NA
X100156730_TGI_at;100156730_TGI_at;NM_012331;MSRA;methionine sulfoxide reductase A;0,00000000343000000000;1,262533707;0,00314995;1,134591344;0,010858063;0,010855277;1,279213051;0,041904859;0;1;U2;U1;U1
X100156780_TGI_at;100156780_TGI_at;NM_018084;CCDC88A;coiled-coil domain containing 88A;0,00000000005220000000;1,349469643;0,032536559;1,10032706;0,058433727;0,238684003;1,081327345;0,372171524;0;0;NA;NA;NA
X100156798_TGI_at;100156798_TGI_at;BX648604;;similar to phosphodiesterase 4D, cAMP specific;0,00000000000212000000;1,772651824;2,09E-08;1,800451181;4,82E-06;0,001203889;1,542426929;0,010630505;0;1;U4;U3;U1
X100156813_TGI_at;100156813_TGI_at;NM_032023;RASSF4;Ras association (RalGDS/AF-6) domain family member 4;0,00000126000000000000;1,291771974;0,297625823;1,081380733;0,347050662;0,307230301;1,120062019;0,446439703;0;0;NA;NA;NA
X100156873_TGI_at;100156873_TGI_at;NM_004454;ETV5;ets variant 5;0,00000000882000000000;0,789098255;0,005517643;0,839007196;0,016108119;0,365926162;1,138969137;0,503363219;0;0;NA;NA;NA
X100156891_TGI_at;100156891_TGI_at;NM_000337;SGCD;sarcoglycan, delta (35kDa dystrophin-associated glycoprotein);0,00000000792000000000;0,688059906;0,078967443;0,83395139;0,116641645;0,849099163;0,982908837;0,906474529;0;0;NA;NA;NA
X100156914_TGI_at;100156914_TGI_at;NM_021902;FXYD1;FXYD domain containing ion transport regulator 1;0,00000012500000000000;0,716791028;0,04728403;0,84393428;0,077952138;0,203035049;0,863349098;0,330514884;0;0;NA;NA;NA
X100156920_TGI_at;100156920_TGI_at;NM_006406;PRDX4;peroxiredoxin 4;0,00000000061700000000;1,231370533;0,132693749;1,055510515;0,176359568;0,323340368;1,074133851;0,462755775;0;0;NA;NA;NA
X100156921_TGI_at;100156921_TGI_at;NM_016121;KCTD3;potassium channel tetramerisation domain containing 3;0,00000004100000000000;0,749135226;0,705838337;0,973080284;0,732898506;0,421327994;0,921118207;0,560904521;0;0;NA;NA;NA
X100156951_TGI_at;100156951_TGI_at;AF087573;DFFA;DNA fragmentation factor, 45kDa, alpha polypeptide;0,00000030100000000000;1,240288503;0,920876849;1,007962302;0,928075698;0,131303184;1,155041536;0,240585653;0;0;NA;NA;NA
X100156974_TGI_at;100156974_TGI_at;NM_003887;ASAP2;ArfGAP with SH3 domain, ankyrin repeat and PH domain 2;0,00000000000150000000;0,780760158;0,447155122;0,969982371;0,490197605;0,01269629;0,883684156;0,046447382;0;0;NA;NA;NA
X100156986_TGI_at;100156986_TGI_at;NM_001024372;BAALC;brain and acute leukemia, cytoplasmic;0,00000003990000000000;0,630222872;0,001151774;0,788304654;0,005338446;0,064330368;0,75319567;0,144788251;0;0;NA;NA;NA
X100156994_TGI_at;100156994_TGI_at;AI809436;FBXL19;F-box and leucine-rich repeat protein 19;0,00000000002290000000;1,388204104;0,00465962;1,117753745;0,01433925;0,080474437;1,106703487;0,170587136;0;0;NA;NA;NA
X100157016_TGI_at;100157016_TGI_at;BC114506;DAPK2;death-associated protein kinase 2;0,00000076900000000000;0,788484606;0,062244216;0,86305223;0,097084325;0,303779418;1,124706242;0,443625313;0;0;NA;NA;NA
X100157057_TGI_at;100157057_TGI_at;NM_001624;AIM1;absent in melanoma 1;0,00000000020400000000;1,290493984;0,096870685;1,062806136;0,136996146;0,011420211;1,162529662;0,043251869;0;0;NA;NA;NA
X100157127_TGI_at;100157127_TGI_at;NM_000483;APOC2;apolipoprotein C-II;0,00000000805000000000;2,111293418;0,000337896;1,635223118;0,002297553;0,000987594;2,336883774;0,009357144;0;1;U1;U2;U1
X100157152_TGI_at;100157152_TGI_at;AK095050;TMEM108;transmembrane protein 108;0,00000003390000000000;0,781473998;0,644731983;0,966721457;0,677084125;0,601955364;0,9555664;0,718556347;0;0;NA;NA;NA
X100157155_TGI_at;100157155_TGI_at;NM_015493;KANK2;KN motif and ankyrin repeat domains 2;0,00000000009340000000;0,787710019;0,023490028;0,920490863;0,045939539;0,008816537;0,867798623;0,036964527;0;1;D2;D1;D1
X100157167_TGI_at;100157167_TGI_at;BC043194;;;0,00000012700000000000;0,760262892;0,428454586;0,960768645;0,473238221;0,09653965;0,802684379;0,193392487;0;0;NA;NA;NA
X100157171_TGI_at;100157171_TGI_at;NM_000136;FANCC;Fanconi anemia, complementation group C;0,00000048400000000000;0,804091375;0,000739884;0,857639783;0,004034934;0,797584764;1,022090115;0,871690639;0;0;NA;NA;NA
X100157179_TGI_at;100157179_TGI_at;ENST00000356338;MYO5A;myosin VA (heavy chain 12, myoxin);0,00000000000006220000;1,597534582;0,00155273;1,205227527;0,006643984;0,000987594;1,346729599;0,009357144;0;1;U6;U1;U1
X100157203_TGI_at;100157203_TGI_at;NM_138765;BAX;BCL2-associated X protein;0,00000000000089400000;1,431890282;0,064671204;1,107267375;0,100113011;0,010314762;1,413012597;0,040961273;0;0;NA;NA;NA
X100157226_TGI_at;100157226_TGI_at;NM_182609;ZNF677;zinc finger protein 677;0,00000001350000000000;0,684320534;0,08392924;0,891097711;0,122844659;0,009303521;0,819832407;0,038004115;0;0;NA;NA;NA
X100157240_TGI_at;100157240_TGI_at;NM_001885;CRYAB;crystallin, alpha B;0,00000000525000000000;0,744610053;0,025145164;0,841874485;0,048383799;0,01806578;0,837511155;0,05881415;0;0;NA;NA;NA
X100157242_TGI_at;100157242_TGI_at;NM_000528;MAN2B1;mannosidase, alpha, class 2B, member 1;0,00000000000017400000;1,538887544;0,003268833;1,149975374;0,011184127;0,005235058;1,2803394;0,025720413;0;1;U4;U1;U1
X100157244_TGI_at;100157244_TGI_at;NM_001098500;KIAA1217;KIAA1217;0,00000001480000000000;0,790477306;0,227763131;0,961416055;0,276581581;0,038082294;0,868044291;0,099545202;0;0;NA;NA;NA
X100157255_TGI_at;100157255_TGI_at;ENST00000333475;;similar to kinesin-like motor protein C20orf23;0,00000000873000000000;0,684855478;0,023705491;0,813994106;0,046304727;0,797584764;0,960041991;0,871690639;0;0;NA;NA;NA
X100157287_TGI_at;100157287_TGI_at;AK094744;;;0,00000026200000000000;0,812098232;0,267714477;0,935252902;0,316872479;0,940656418;1,009348181;0,965520903;0;0;NA;NA;NA
X100157299_TGI_at;100157299_TGI_at;AL050184;MAGI1;membrane associated guanylate kinase, WW and PDZ domain containing 1;0,00000004100000000000;0,826988874;0,003177763;0,894161889;0,010942233;0,979808692;1,017977254;0,987556719;0;0;NA;NA;NA
X100157315_TGI_at;100157315_TGI_at;NM_012338;TSPAN12;tetraspanin 12;0,00000104000000000000;0,727691871;0,402443599;0,947376073;0,448233158;0,704079782;1,053613306;0,801288537;0;0;NA;NA;NA
X100157333_TGI_at;100157333_TGI_at;NM_003622;PPFIBP1;PTPRF interacting protein, binding protein 1 (liprin beta 1);0,00000001460000000000;0,690208625;0,012411914;0,770958338;0,028676416;0,784830893;1,005705269;0,861549716;0;0;NA;NA;NA
X100157335_TGI_at;100157335_TGI_at;NM_152545;RASGEF1B;RasGEF domain family, member 1B;0,00000007630000000000;1,610594363;0,00061425;1,397333673;0,003505988;0,002886902;1,494410032;0,017893238;0;1;U1;U1;U1
X100157346_TGI_at;100157346_TGI_at;ENST00000320306;FAM82B;family with sequence similarity 82, member B;0,00000000136000000000;1,226689219;0,006385541;1,071774182;0,017849609;0,003371616;1,274392048;0,019650484;0;1;U2;U1;U1
X100157349_TGI_at;100157349_TGI_at;NM_207627;ABCG1;ATP-binding cassette, sub-family G (WHITE), member 1;0,00000000388000000000;1,231815809;0,021357694;1,131320954;0,042923852;0,000345371;1,389257112;0,005300617;0;1;U1;U1;U1
X100157378_TGI_at;100157378_TGI_at;NM_019593;RP5-1022P6.2;hypothetical protein KIAA1434;0,00000000087400000000;1,274225082;0,010370688;1,130748506;0,025245201;0,226311985;1,076200536;0,358253206;0;0;NA;NA;NA
X100157396_TGI_at;100157396_TGI_at;NM_152565;ATP6V0D2;ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2;0,00000000000000076400;5,889355894;4,58E-07;3,573636366;4,08E-05;5,09E-05;3,271843319;0,002079933;0;1;U2;U3;U1
X100157407_TGI_at;100157407_TGI_at;NM_178822;IGSF10;immunoglobulin superfamily, member 10;0,00000000951000000000;0,742737213;0,275895297;0,874002734;0,325003853;0,93558554;1,025692886;0,965520903;0;0;NA;NA;NA
X100157425_TGI_at;100157425_TGI_at;BC040204;;;0,00000000263000000000;0,647596446;0,108405474;0,863771579;0,149376161;0,967010726;0,951039414;0,980394958;0;0;NA;NA;NA
X100157432_TGI_at;100157432_TGI_at;NM_001040001;MLLT4;"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4";0,00000000003220000000;0,829640838;0,019451814;0,945667386;0,040085165;0,066842161;0,939132066;0,148369342;0;0;NA;NA;NA
X100157458_TGI_at;100157458_TGI_at;NM_015236;LPHN3;latrophilin 3;0,00000001520000000000;0,630950815;0,445215162;0,931718828;0,488661657;0,291649909;0,850179689;0,430200301;0;0;NA;NA;NA
X100157462_TGI_at;100157462_TGI_at;NM_032782;HAVCR2;hepatitis A virus cellular receptor 2;0,00000000000830000000;1,634278186;0,020109172;1,213559482;0,041020393;0,020928503;1,285218729;0,065424408;0;0;NA;NA;NA
X100157540_TGI_at;100157540_TGI_at;BI913098;;;0,00000000062600000000;0,646105721;0,067035975;0,816765071;0,10337653;0,823248705;1,003777487;0,88918585;0;0;NA;NA;NA
X100157542_TGI_at;100157542_TGI_at;U46837;MED21;mediator complex subunit 21;0,00000000208000000000;1,23715188;0,098435093;1,064417724;0,138721602;0,061450873;1,159488185;0,141367712;0;0;NA;NA;NA
X100157547_TGI_at;100157547_TGI_at;AK091040;AMOTL2;angiomotin like 2;0,00000034900000000000;0,812643471;0,234395156;0,934343671;0,283048178;0,672949117;0,986584036;0,774063003;0;0;NA;NA;NA
X100157572_TGI_at;100157572_TGI_at;NM_015278;SASH1;SAM and SH3 domain containing 1;0,00000000015500000000;0,770566721;0,070740399;0,91811139;0,107596181;0,927501324;1,003694447;0,959350695;0;0;NA;NA;NA
X100157584_TGI_at;100157584_TGI_at;NM_004563;PCK2;phosphoenolpyruvate carboxykinase 2 (mitochondrial);0,00000000201000000000;1,388257625;0,073315274;1,120818722;0,110338959;0,007144385;1,316345188;0,031892454;0;0;NA;NA;NA
X100157613_TGI_at;100157613_TGI_at;AF193058;EDC3;enhancer of mRNA decapping 3 homolog (S. cerevisiae);0,00000001950000000000;1,277727975;0,002293473;1,115618178;0,008696308;0,004595971;1,193267708;0,023853166;0;1;U1;U1;U1
X100157618_TGI_at;100157618_TGI_at;NM_175872;ZNF792;zinc finger protein 792;0,00000089300000000000;0,761273669;0,206591519;0,913260493;0,255938548;0,810391779;0,941365984;0,881205366;0;0;NA;NA;NA
X100157619_TGI_at;100157619_TGI_at;AK074749;RDH11;retinol dehydrogenase 11 (all-trans/9-cis/11-cis);0,00000000078800000000;1,216060765;0,505090011;0,979481222;0,544267839;0,000863569;1,279568122;0,008670668;0;0;NA;NA;NA
X100157621_TGI_at;100157621_TGI_at;BC013413;FZR1;fizzy/cell division cycle 20 related 1 (Drosophila);0,00000003480000000000;1,234370055;0,193131879;1,040378646;0,241546001;0,03644136;1,155501064;0,096439395;0;0;NA;NA;NA
X100157638_TGI_at;100157638_TGI_at;NM_003991;EDNRB;endothelin receptor type B;0,00000000000034400000;0,591948722;0,000203591;0,757553505;0,001640436;0,91436561;1,093618522;0,951873502;0;0;NA;NA;NA
X100157653_TGI_at;100157653_TGI_at;NM_015440;MTHFD1L;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like;0,00000000025800000000;1,438503402;0,002669934;1,161138704;0,009645635;0,248075799;1,08511525;0,381463883;0;0;NA;NA;NA
X100157654_TGI_at;100157654_TGI_at;BC014004;WDFY2;WD repeat and FYVE domain containing 2;0,00000000089200000000;1,218393442;0,013257079;1,079791841;0,030047513;0,875109546;1,029405014;0,925961283;0;0;NA;NA;NA
X100157672_TGI_at;100157672_TGI_at;NM_001040058;SPP1;secreted phosphoprotein 1;0,00000000599000000000;3,286599932;0,008661579;1,820599439;0,022279544;0,563622584;0,865065493;0,691231198;0;0;NA;NA;NA
X100157692_TGI_at;100157692_TGI_at;NM_006702;PNPLA6;patatin-like phospholipase domain containing 6;0,00000000055400000000;1,518113227;0,01605445;1,164477614;0,034680626;0,041415229;1,315207676;0,104282253;0;0;NA;NA;NA
X100157718_TGI_at;100157718_TGI_at;NM_015704;FAM152B;family with sequence similarity 152, member B;0,00000000000007020000;1,471691675;0,064146237;1,097252054;0,099443637;6,87E-05;1,419040534;0,002575879;0;0;NA;NA;NA
X100157730_TGI_at;100157730_TGI_at;NM_005725;TSPAN2;tetraspanin 2;0,00000005730000000000;0,693001078;0,053277656;0,839251843;0,085642836;0,131303184;0,76513508;0,240585653;0;0;NA;NA;NA
X100157741_TGI_at;100157741_TGI_at;NM_003312;TST;thiosulfate sulfurtransferase (rhodanese);0,00000001160000000000;1,221762729;0,046422148;1,109098286;0,076898291;0,015374349;1,331534138;0,052959853;0;0;NA;NA;NA
X100157800_TGI_at;100157800_TGI_at;NM_001082578;RBM9;RNA binding motif protein 9;0,00000000020700000000;0,818230816;0,166579462;0,940183337;0,212375635;0,103904525;0,918121069;0,203577073;0;0;NA;NA;NA
X100157806_TGI_at;100157806_TGI_at;NM_032152;PRAM1;PML-RARA regulated adaptor molecule 1;0,00000000000001920000;1,967020936;0,000279938;1,30047908;0,002022959;0,001055444;1,639339309;0,009719131;0;1;U2;U1;U1
X100157821_TGI_at;100157821_TGI_at;NM_178834;LAYN;layilin;0,00000101000000000000;0,77871954;0,005463048;0,856483333;0,01600673;0,00053236;0,772068114;0,006649296;0;1;D1;D1;D1
X100157831_TGI_at;100157831_TGI_at;AK023623;GLDN;gliomedin;0,00000000022800000000;1,437015091;0,763633556;1,018467185;0,784568362;0,089987178;1,219148462;0,184145191;0;0;NA;NA;NA
X100157851_TGI_at;100157851_TGI_at;BF846660;LAMC2;laminin, gamma 2;0,00000051500000000000;0,795715597;0,095757599;0,84910385;0,135719763;0,365926162;1,104050487;0,503363219;0;0;NA;NA;NA
X100157859_TGI_at;100157859_TGI_at;ENST00000389980;SPTBN1;spectrin, beta, non-erythrocytic 1;0,00000000000154000000;0,757953025;0,005190221;0,893147543;0,015488965;0,540575724;1,089076314;0,670621847;0;0;NA;NA;NA
X100157872_TGI_at;100157872_TGI_at;NM_001085384;ZNF154;zinc finger protein 154;0,00000123000000000000;0,803533337;0,095734617;0,893244657;0,135719763;0,491673531;1,054498796;0,627589621;0;0;NA;NA;NA
X100157899_TGI_at;100157899_TGI_at;NM_000218;KCNQ1;potassium voltage-gated channel, KQT-like subfamily, member 1;0,00000009490000000000;1,258499745;0,024509091;1,107454851;0,047528761;0,020928503;1,305031986;0,065424408;0;0;NA;NA;NA
X100157910_TGI_at;100157910_TGI_at;NM_153811;SLC38A6;solute carrier family 38, member 6;0,00000000000001900000;1,749654244;8,20E-06;1,312321307;0,000250205;0,032083057;1,210647219;0,088319445;0;0;NA;NA;NA
X100157914_TGI_at;100157914_TGI_at;S75295;KPNA1;karyopherin alpha 1 (importin alpha 5);0,00000001080000000000;1,206718583;0,008323605;1,086081818;0,021704675;0,647960846;1,054679676;0,755321916;0;0;NA;NA;NA
X100157920_TGI_at;100157920_TGI_at;NM_021643;TRIB2;tribbles homolog 2 (Drosophila);0,00000000008750000000;0,799344279;0,645826129;0,984648089;0,677791473;0,01554453;0,847878873;0,052959853;0;0;NA;NA;NA
X100157922_TGI_at;100157922_TGI_at;AK000276;;hypothetical protein LOC283859;0,00000000227000000000;0,677023185;0,000307111;0,801393067;0,00215178;0,077689446;0,768782975;0,166153341;0;0;NA;NA;NA
X100157939_TGI_at;100157939_TGI_at;AF075030;;;0,00000013700000000000;0,705833851;0,001815037;0,745163956;0,007499003;0,295660849;0,832366409;0,435717839;0;0;NA;NA;NA
X100157966_TGI_at;100157966_TGI_at;AL833615;;;0,00000091600000000000;0,773190414;0,001962104;0,828752909;0,007904827;0,402347064;0,909513253;0,542112532;0;0;NA;NA;NA
X100157975_TGI_at;100157975_TGI_at;AA453470;;;0,00000026800000000000;1,314737667;7,04E-06;1,256690686;0,000226851;0,938242924;1,009672242;0,965520903;0;0;NA;NA;NA
X100157979_TGI_at;100157979_TGI_at;NM_021173;POLD4;polymerase (DNA-directed), delta 4;0,00000000190000000000;1,263520271;0,227763131;1,040894118;0,276581581;0,000923705;1,265137924;0,008967168;0;0;NA;NA;NA
X100158003_TGI_at;100158003_TGI_at;AF190461;FAIM2;Fas apoptotic inhibitory molecule 2;0,00000087100000000000;1,668354868;0,236635936;1,148949567;0,28564705;0,953827391;0,993521217;0,974385319;0;0;NA;NA;NA
X100158020_TGI_at;100158020_TGI_at;BX106890;ITGA8;integrin, alpha 8;0,00000007040000000000;0,787740456;0,993206944;0,995114386;0,994132292;0,902151634;0,984025039;0,945572265;0;0;NA;NA;NA
X100158022_TGI_at;100158022_TGI_at;NM_014988;LIMCH1;LIM and calponin homology domains 1;0,00000000132000000000;0,803538998;0,075321601;0,934000786;0,112389593;0,552010088;1,075851222;0,680615346;0;0;NA;NA;NA
X100158049_TGI_at;100158049_TGI_at;AL157484;;;0,00000109000000000000;0,770090618;0,063887628;0,875564166;0,099090387;0,031930775;1,456214604;0,088319445;0;0;NA;NA;NA
X100158062_TGI_at;100158062_TGI_at;NM_003874;CD84;CD84 molecule;0,00000000037100000000;1,799524977;0,091197087;1,190199034;0,131159398;0,344081797;1,145191442;0,485966535;0;0;NA;NA;NA
X100158077_TGI_at;100158077_TGI_at;NM_001039350;DPP6;dipeptidyl-peptidase 6;0,00000000000000000200;0,212752867;0,000158506;0,564936468;0,001373293;0,339979528;0,739507562;0,480593868;0;0;NA;NA;NA
X100158134_TGI_at;100158134_TGI_at;NM_020844;C8orf79;chromosome 8 open reading frame 79;0,00000042000000000000;0,781982928;0,196359273;0,925244618;0,245011977;0,053765992;0,826524768;0,127699182;0;0;NA;NA;NA
X100158135_TGI_at;100158135_TGI_at;NM_030923;TMEM163;transmembrane protein 163;0,00000003890000000000;1,309238537;0,072666823;1,147043186;0,109697973;0,000104771;1,989507434;0,003284032;0;0;NA;NA;NA
X100158139_TGI_at;100158139_TGI_at;AK026611;SOAT1;sterol O-acyltransferase 1;0,00000000013200000000;1,663904611;0,00292393;1,21844806;0,010299264;0,241271938;1,286308809;0,374575845;0;0;NA;NA;NA
X100158195_TGI_at;100158195_TGI_at;NM_007268;VSIG4;V-set and immunoglobulin domain containing 4;0,00000000000000124000;1,832307005;0,006684985;1,288730576;0,018541916;0,000695763;1,683183377;0,007705996;0;1;U2;U1;U1
X100158212_TGI_at;100158212_TGI_at;NM_001080398;KIAA0368;KIAA0368;0,00000009960000000000;0,772060774;0,005004235;0,878710342;0,015130065;0,221636126;0,901924613;0,351888292;0;0;NA;NA;NA
X100158226_TGI_at;100158226_TGI_at;NM_001033503;SAR1B;SAR1 homolog B (S. cerevisiae);0,00000000000127000000;1,314781352;0,124698729;1,052617032;0,167529806;0,819786989;0,989934618;0,887827105;0;0;NA;NA;NA
X100158231_TGI_at;100158231_TGI_at;NM_004313;ARRB2;arrestin, beta 2;0,00000000004920000000;1,363344967;0,041724775;1,095187509;0,0706297;0,002522564;1,273679094;0,016763349;0;0;NA;NA;NA
X100158249_TGI_at;100158249_TGI_at;NM_021219;JAM2;junctional adhesion molecule 2;0,00000000248000000000;0,768288383;0,061452158;0,934512838;0,096087432;0,01929287;0,813911409;0,061810059;0;0;NA;NA;NA
X100158252_TGI_at;100158252_TGI_at;NM_014772;KIAA0427;KIAA0427;0,00000000202000000000;0,792388163;0,000352894;0,861856398;0,002369537;0,383639173;1,071266929;0,520942343;0;0;NA;NA;NA
X100158255_TGI_at;100158255_TGI_at;NM_005501;ITGA3;integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor);0,00000001850000000000;0,772960985;0,002160237;0,812548607;0,008418916;0,985987913;1,03822934;0,992454417;0;0;NA;NA;NA
X100158305_TGI_at;100158305_TGI_at;NM_000952;PTAFR;platelet-activating factor receptor;0,00000000000077700000;1,676947989;0,053277656;1,176625334;0,085642836;0,000211783;1,572516772;0,004272984;0;0;NA;NA;NA
X100158335_TGI_at;100158335_TGI_at;ENST00000293217;ACOX1;acyl-Coenzyme A oxidase 1, palmitoyl;0,00000000081400000000;1,334603603;0,00369309;1,149331786;0,012158149;0,007918414;1,240093837;0,034341403;0;1;U1;U1;U1
X100158342_TGI_at;100158342_TGI_at;ENST00000373857;PTAFR;platelet-activating factor receptor;0,00000000000047400000;1,69473698;0,002612552;1,198526207;0,009482269;2,27E-06;1,765588382;0,000730441;0;1;U5;U1;U1
X100158367_TGI_at;100158367_TGI_at;BM998468;;;0,00000014800000000000;0,738836571;0,52311882;0,951135364;0,561629566;0,005437653;0,663644631;0,026196646;0;0;NA;NA;NA
X100158420_TGI_at;100158420_TGI_at;NM_015472;WWTR1;WW domain containing transcription regulator 1;0,00000009750000000000;1,406777758;6,16E-05;1,276731195;0,000775394;0,025716846;1,2829072;0,075487609;0;0;NA;NA;NA
X100158427_TGI_at;100158427_TGI_at;NM_004591;CCL20;chemokine (C-C motif) ligand 20;0,00000080900000000000;2,87935088;0,00065342;2,446644447;0,003675346;0,000371641;3,246552055;0,00537129;0;1;U2;U3;U1
X100158502_TGI_at;100158502_TGI_at;BC020746;PNPLA4;patatin-like phospholipase domain containing 4;0,00000000000392000000;1,243259871;0,024201607;1,063802802;0,047045705;0,979808692;1,031212638;0,987556719;0;0;NA;NA;NA
X100158512_TGI_at;100158512_TGI_at;NM_024940;DOCK5;dedicator of cytokinesis 5;0,00000071800000000000;1,284664785;0,050336287;1,115289225;0,082060624;0,57904816;1,061816822;0,700552635;0;0;NA;NA;NA
X100158515_TGI_at;100158515_TGI_at;BC035691;GSR;glutathione reductase;0,00000000042000000000;1,270361258;0,003926858;1,10669402;0,012656262;0,004386492;1,177762622;0,022988073;0;1;U2;U1;U1
X100158516_TGI_at;100158516_TGI_at;BM146612;AIM1;absent in melanoma 1;0,00000011600000000000;1,219868548;0,127510055;1,090158323;0,17066649;0,009797793;1,322640423;0,039467969;0;0;NA;NA;NA
X100158532_TGI_at;100158532_TGI_at;ENST00000377922;PCDH17;protocadherin 17;0,00000000325000000000;0,674632312;3,14E-05;0,691844836;0,000508004;0,025021176;0,722119178;0,074188821;0;0;NA;NA;NA
X100158556_TGI_at;100158556_TGI_at;CB306881;KIAA1377;KIAA1377;0,00000000014600000000;0,716069461;0,000945553;0,730125067;0,004645604;0,001558392;0,718848437;0,012371173;0;1;D3;D2;D1
X100158578_TGI_at;100158578_TGI_at;NM_000875;IGF1R;insulin-like growth factor 1 receptor;0,00000000005780000000;0,767359908;0,008661579;0,897718814;0,022279544;0,118794011;0,899368142;0,224033409;0;0;NA;NA;NA
X100158631_TGI_at;100158631_TGI_at;AI221753;;;0,00000000000130000000;1,659496826;2,77E-05;1,449135855;0,000479188;0,127936269;1,168343769;0,236568327;0;0;NA;NA;NA
X100158641_TGI_at;100158641_TGI_at;AI380960;PCDH17;protocadherin 17;0,00000066100000000000;0,686567058;0,007538999;0,792844962;0,020162294;0,212463914;0,797882831;0,341531768;0;0;NA;NA;NA
X100158656_TGI_at;100158656_TGI_at;NM_139177;SLC39A11;solute carrier family 39 (metal ion transporter), member 11;0,00000000000345000000;1,359651289;0,010370688;1,104853008;0,025245201;0,01262694;1,177750359;0,046447382;0;1;U2;U1;U1
X100158670_TGI_at;100158670_TGI_at;M74777;DPP4;dipeptidyl-peptidase 4;0,00000000515000000000;1,587471426;0,01201623;1,263655598;0,027982883;0,004100912;1,910777932;0,022065509;0;1;U8;U1;U1
X100158697_TGI_at;100158697_TGI_at;NM_152605;ZNF781;zinc finger protein 781;0,00000123000000000000;0,717379012;0,043948098;0,906956455;0,073619918;0,083615947;0,771140885;0,17510994;0;0;NA;NA;NA
X100158698_TGI_at;100158698_TGI_at;NM_016242;EMCN;endomucin;0,00000000000001140000;0,628447374;0,002700098;0,82001631;0,00973047;0,154336744;0,850542926;0,270635106;0;0;NA;NA;NA
X100158699_TGI_at;100158699_TGI_at;U90920;ARHGAP29;Rho GTPase activating protein 29;0,00000001280000000000;0,716820627;0,021039396;0,880877322;0,042487451;0,118794011;0,882189924;0,224033409;0;0;NA;NA;NA
X100158717_TGI_at;100158717_TGI_at;L40377;SERPINB8;serpin peptidase inhibitor, clade B (ovalbumin), member 8;0,00000000315000000000;1,555299552;0,549465309;1,049105793;0,586399566;0,069432339;1,217609176;0,153169355;0;0;NA;NA;NA
X100158718_TGI_at;100158718_TGI_at;U51127;IRF5;interferon regulatory factor 5;0,00000058600000000000;1,601228905;0,013228583;1,285315767;0,030047513;0,144787165;1,223276936;0,25853132;0;0;NA;NA;NA
X100158735_TGI_at;100158735_TGI_at;NM_003573;LTBP4;latent transforming growth factor beta binding protein 4;0,00000000492000000000;0,674841463;0,010730868;0,824134287;0,025848719;0,036773227;0,827003432;0,096988634;0;0;NA;NA;NA
X100158754_TGI_at;100158754_TGI_at;NM_018965;TREM2;triggering receptor expressed on myeloid cells 2;0,00000000000000043900;3,344002418;1,57E-06;1,740451446;8,74E-05;2,08E-05;2,156237067;0,001749595;0;1;U8;U2;U1
X100158760_TGI_at;100158760_TGI_at;NM_000511;FUT2;fucosyltransferase 2 (secretor status included);0,00000008410000000000;1,500204181;0,493672452;1,076096589;0,533570192;0,888166261;0,744438934;0,935477078;0;0;NA;NA;NA
X100158765_TGI_at;100158765_TGI_at;AF023476;ADAM12;ADAM metallopeptidase domain 12;0,00000000306000000000;1,516568631;8,89E-06;1,572507581;0,000259388;0,184980417;1,164118666;0,311548887;0;0;NA;NA;NA
X100158789_TGI_at;100158789_TGI_at;AK122784;GLUL;glutamate-ammonia ligase (glutamine synthetase);0,00000000007230000000;1,464114307;0,030842113;1,14622435;0,056192273;0,709599351;1,020207424;0,803597578;0;0;NA;NA;NA
X100158825_TGI_at;100158825_TGI_at;BC031412;HABP2;hyaluronan binding protein 2;0,00000000000028400000;1,971145785;1,36E-05;1,497387274;0,000322623;0,0866454;1,204375478;0,179491513;0;0;NA;NA;NA
X100158839_TGI_at;100158839_TGI_at;BQ721208;HSDL2;hydroxysteroid dehydrogenase like 2;0,00000000600000000000;1,222943078;0,031946117;1,103434872;0,057746682;0,009707916;1,260579885;0,039467969;0;0;NA;NA;NA
X100158916_TGI_at;100158916_TGI_at;NM_003966;SEMA5A;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A;0,00000000000012900000;0,656323678;0,026045106;0,854835409;0,049675051;0,203149235;1,124531025;0,330514884;0;0;NA;NA;NA
X100158920_TGI_at;100158920_TGI_at;ENST00000350997;FADS1;fatty acid desaturase 1;0,00000000034800000000;1,345179569;0,086045249;1,155815039;0,125202636;0,000679589;1,536361266;0,007605257;0;0;NA;NA;NA
X100158963_TGI_at;100158963_TGI_at;NM_003504;CDC45L;CDC45 cell division cycle 45-like (S. cerevisiae);0,00000006690000000000;1,35722074;0,32032804;1,094153649;0,368984015;0,17922841;1,070260311;0,304669392;0;0;NA;NA;NA
X100158964_TGI_at;100158964_TGI_at;AB050856;B3GALNT1;beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group);0,00000000060700000000;0,698654796;0,112641765;0,888783071;0,15370212;0,512848122;0,980262515;0,646425302;0;0;NA;NA;NA
X100158968_TGI_at;100158968_TGI_at;L32786;;;0,00000000031800000000;1,224047948;0,715016295;1,009220983;0,739806587;0,050233572;1,129242575;0,121639972;0;0;NA;NA;NA
X100159021_TGI_at;100159021_TGI_at;NM_015991;C1QA;complement component 1, q subcomponent, A chain;0,00000000003440000000;1,483452281;0,113249769;1,144176085;0,154335732;0,00236704;1,582266429;0,016094875;0;0;NA;NA;NA
X100159022_TGI_at;100159022_TGI_at;NM_178564;NRBP2;nuclear receptor binding protein 2;0,00000000021900000000;0,811134047;0,407889843;0,950082184;0,453320332;0,185788694;0,916119434;0,311548887;0;0;NA;NA;NA
X100159026_TGI_at;100159026_TGI_at;X62572;FCGR2A;Fc fragment of IgG, low affinity IIa, receptor (CD32);0,00000018900000000000;1,239874671;0,109390801;1,105583989;0,150284122;0,190864759;1,188017035;0,318230865;0;0;NA;NA;NA
X100159027_TGI_at;100159027_TGI_at;BC107739;NQO1;NAD(P)H dehydrogenase, quinone 1;0,00000000000000032400;2,019275947;0,002429436;1,395066251;0,009052107;0,052890615;1,215828592;0,126177982;0;0;NA;NA;NA
X100159047_TGI_at;100159047_TGI_at;NM_001031739;ASB9;ankyrin repeat and SOCS box-containing 9;0,00000010500000000000;0,799850272;0,004765188;0,841475091;0,014571347;0,118794011;1,115366701;0,224033409;0;0;NA;NA;NA
X100159076_TGI_at;100159076_TGI_at;NM_005819;STX6;syntaxin 6;0,00000003300000000000;1,206025543;0,011610048;1,088132224;0,027277267;0,132255041;1,061849949;0,242040809;0;0;NA;NA;NA
X100159083_TGI_at;100159083_TGI_at;NM_023037;FRY;furry homolog (Drosophila);0,00000000000000101000;0,684914922;0,009079637;0,891481146;0,023054415;0,69730432;0,961817872;0,795825717;0;0;NA;NA;NA
X100159085_TGI_at;100159085_TGI_at;NM_139022;TSPAN32;tetraspanin 32;0,00000083000000000000;1,362528716;0,018998554;1,178676689;0,039276677;0,000987594;1,456768083;0,009357144;0;1;U1;U1;U1
X100159116_TGI_at;100159116_TGI_at;ENST00000325577;RAD1;RAD1 homolog (S. pombe);0,00000000007910000000;1,321248191;0,454676211;1,047073873;0,497361597;0,002131763;1,302496658;0,014968787;0;0;NA;NA;NA
X100159118_TGI_at;100159118_TGI_at;NM_033439;IL33;interleukin 33;0,00000000179000000000;0,607998212;0,160127364;0,917805932;0,205613743;0,159283623;0,825559642;0,276600817;0;0;NA;NA;NA
X100159125_TGI_at;100159125_TGI_at;NM_021149;COTL1;coactosin-like 1 (Dictyostelium);0,00000009240000000000;1,23637216;0,026274021;1,108217168;0,049929935;0,003239583;1,284064445;0,019115922;0;1;U1;U1;U1
X100159127_TGI_at;100159127_TGI_at;AB022821;MS4A4A;membrane-spanning 4-domains, subfamily A, member 4;0,00000000000036900000;1,721238357;0,000104188;1,36366531;0,00106414;0,000558686;1,665525636;0,006820628;0;1;U6;U1;U1
X100159149_TGI_at;100159149_TGI_at;BM972944;;;0,00000000000024100000;0,634745773;0,194507121;0,894910541;0,243062674;0,601955364;0,917957537;0,718556347;0;0;NA;NA;NA
X100159169_TGI_at;100159169_TGI_at;NM_022754;SFXN1;sideroflexin 1;0,00000003680000000000;1,216731993;0,526819014;0,986454736;0,565225593;0,5291358;0,946565705;0,660834037;0;0;NA;NA;NA
X100159185_TGI_at;100159185_TGI_at;CX782729;PDK3;pyruvate dehydrogenase kinase, isozyme 3;0,00000000185000000000;1,367085217;0,001930734;1,145137164;0,007817533;0,421843348;1,05278452;0,560904521;0;0;NA;NA;NA
X100159223_TGI_at;100159223_TGI_at;NM_152309;PIK3AP1;phosphoinositide-3-kinase adaptor protein 1;0,00000048000000000000;1,350644247;0,012089313;1,152394558;0,028132748;0,010855277;1,294496675;0,041904859;0;1;U2;U1;U1
X100159236_TGI_at;100159236_TGI_at;NM_183233;SLC22A18;solute carrier family 22, member 18;0,00000000343000000000;1,445174524;0,068973078;1,106603289;0,10553519;0,03650134;1,114328166;0,096439395;0;0;NA;NA;NA
X100159243_TGI_at;100159243_TGI_at;NM_004267;CHST2;carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2;0,00000000914000000000;0,713342233;0,000661123;0,802685272;0,003711391;0,257214424;0,825866576;0,391963163;0;0;NA;NA;NA
X100159248_TGI_at;100159248_TGI_at;NM_001080430;TOX3;TOX high mobility group box family member 3;0,00000006000000000000;1,513313341;0,181324495;1,179919941;0,228731447;0,91436561;0,880420997;0,951873502;0;0;NA;NA;NA
X100159288_TGI_at;100159288_TGI_at;BC028363;PIGN;phosphatidylinositol glycan anchor biosynthesis, class N;0,00000000000994000000;1,244905179;0,00024931;1,130337088;0,001890651;0,197238472;1,036319331;0,324667823;0;0;NA;NA;NA
X100159297_TGI_at;100159297_TGI_at;NM_005562;LAMC2;laminin, gamma 2;0,00000012800000000000;0,808210955;0,000614609;0,803543444;0,003505988;0,590451681;1,015977522;0,709819384;0;0;NA;NA;NA
X100159325_TGI_at;100159325_TGI_at;NM_052854;CREB3L1;cAMP responsive element binding protein 3-like 1;0,00000000433000000000;1,333808703;0,003969839;1,137731303;0,012743815;0,590451681;1,128356631;0,709819384;0;0;NA;NA;NA
X100159328_TGI_at;100159328_TGI_at;ENST00000361600;GPRASP1;G protein-coupled receptor associated sorting protein 1;0,00000015900000000000;0,75688131;0,794387335;0,993954101;0,813830382;0,064330368;0,789505826;0,144788251;0;0;NA;NA;NA
X100159348_TGI_at;100159348_TGI_at;NM_183075;CYP2U1;cytochrome P450, family 2, subfamily U, polypeptide 1;0,00000003990000000000;0,73927785;0,006385541;0,893228266;0,017849609;0,159283623;0,884513954;0,276600817;0;0;NA;NA;NA
X100159355_TGI_at;100159355_TGI_at;NM_057089;AP1S1;adaptor-related protein complex 1, sigma 1 subunit;0,00000000353000000000;1,218089932;0,312031947;1,046360086;0,361494955;0,229758073;1,140028744;0,361577279;0;0;NA;NA;NA
X100159384_TGI_at;100159384_TGI_at;BC009795;TNFSF10;tumor necrosis factor (ligand) superfamily, member 10;0,00000087100000000000;0,787200355;0,085474602;0,920864815;0,124653685;0,431008093;1,040864804;0,568620174;0;0;NA;NA;NA
X100159426_TGI_at;100159426_TGI_at;NM_005630;SLCO2A1;solute carrier organic anion transporter family, member 2A1;0,00000000010600000000;0,688884827;0,002471725;0,797532379;0,009146232;0,334904546;0,882725766;0,476134694;0;0;NA;NA;NA
X100159445_TGI_at;100159445_TGI_at;ENST00000377187;NEBL;nebulette;0,00000015300000000000;0,782097383;0,55713264;1,038519699;0,593403338;0,004862758;1,397084539;0,024374289;0;0;NA;NA;NA
X100159453_TGI_at;100159453_TGI_at;NM_013351;TBX21;T-box 21;0,00000002880000000000;0,650880146;0,714291005;0,973810503;0,739293484;0,512848122;0,969106359;0,646425302;0;0;NA;NA;NA
X100159465_TGI_at;100159465_TGI_at;BC025273;GDE1;glycerophosphodiester phosphodiesterase 1;0,00000000019300000000;1,218477203;0,852322817;1,002315104;0,86602662;0,038082294;1,202763344;0,099545202;0;0;NA;NA;NA
X100159476_TGI_at;100159476_TGI_at;NM_030775;WNT5B;wingless-type MMTV integration site family, member 5B;0,00000000792000000000;0,72955943;5,93E-05;0,739946342;0,000754915;0,00902735;0,722905182;0,037736899;0;1;D2;D2;D1
X100159498_TGI_at;100159498_TGI_at;BC010960;ATP6V1C1;ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1;0,00000000010400000000;1,349161941;0,033988394;1,08610775;0,060090287;0,034281134;1,134265908;0,09276918;0;0;NA;NA;NA
X100159520_TGI_at;100159520_TGI_at;NM_030761;WNT4;wingless-type MMTV integration site family, member 4;0,00000022700000000000;1,328371061;0,321951967;1,057009512;0,370325193;0,412325494;1,055971209;0,553027493;0;0;NA;NA;NA
X100159582_TGI_at;100159582_TGI_at;NM_199171;PMEPA1;prostate transmembrane protein, androgen induced 1;0,00000055800000000000;0,8055225;0,241162832;0,950220782;0,289809026;0,647960846;1,003368565;0,755321916;0;0;NA;NA;NA
X100159583_TGI_at;100159583_TGI_at;NM_005408;CCL13;chemokine (C-C motif) ligand 13;0,00000000271000000000;1,686338736;0,030190519;1,275240359;0,055254992;0,523607186;1,077098368;0,657671847;0;0;NA;NA;NA
X100159596_TGI_at;100159596_TGI_at;NM_001909;CTSD;cathepsin D;0,00000000000004690000;1,500086755;0,002712805;1,14859787;0,009736492;0,000203903;1,573589324;0,004159363;0;1;U2;U2;U1
X100159619_TGI_at;100159619_TGI_at;BC005339;TPMT;thiopurine S-methyltransferase;0,00000000007950000000;1,510662238;0,009104568;1,182343806;0,023054415;0,061895338;1,206216399;0,141481329;0;0;NA;NA;NA
X100159637_TGI_at;100159637_TGI_at;NM_005248;FGR;Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog;0,00000000000702000000;1,496969317;0,095086882;1,10686306;0,135006616;0,236919365;1,1177113;0,369777779;0;0;NA;NA;NA
X100159649_TGI_at;100159649_TGI_at;NM_005324;H3F3B;H3 histone, family 3B (H3.3B);0,00000000000804000000;0,777539215;0,008807054;0,898421885;0,022492182;0,221636126;0,942248341;0,351888292;0;0;NA;NA;NA
X100159669_TGI_at;100159669_TGI_at;NM_012082;ZFPM2;zinc finger protein, multitype 2;0,00000126000000000000;0,760030084;0,347540305;0,907377051;0,394826366;0,248075799;0,87199156;0,381463883;0;0;NA;NA;NA
X100159678_TGI_at;100159678_TGI_at;BC031481;ZFAND3;zinc finger, AN1-type domain 3;0,00000015200000000000;1,273080655;0,143862073;1,057227777;0,187795651;0,021425185;1,178799366;0,066397472;0;0;NA;NA;NA
X100159680_TGI_at;100159680_TGI_at;NM_005831;CALCOCO2;calcium binding and coiled-coil domain 2;0,00000000001360000000;0,780315555;4,97E-05;0,871459763;0,000681811;0,927501324;1,068156346;0,959350695;0;0;NA;NA;NA
X100159684_TGI_at;100159684_TGI_at;NM_001040429;PCDH17;protocadherin 17;0,00000004820000000000;0,653758463;0,013238052;0,812012624;0,030047513;0,024581037;0,632583331;0,072950903;0;0;NA;NA;NA
X100159699_TGI_at;100159699_TGI_at;NM_014917;NTNG1;netrin G1;0,00000000000022700000;0,616838914;0,016480721;0,820489754;0,035317396;0,315219134;0,889259797;0,454361033;0;0;NA;NA;NA
X100159792_TGI_at;100159792_TGI_at;NM_020733;HEG1;HEG homolog 1 (zebrafish);0,00000000000558000000;0,814730084;0,640628148;0,986953216;0,673432655;0,450742398;0,974589399;0,587204022;0;0;NA;NA;NA
X100159795_TGI_at;100159795_TGI_at;NM_198098;AQP1;aquaporin 1 (Colton blood group);0,00000000006990000000;0,828361697;1,32E-05;0,826927795;0,000318541;0,169104816;0,933528483;0,290015121;0;0;NA;NA;NA
X100159804_TGI_at;100159804_TGI_at;AK024350;AMOTL1;angiomotin like 1;0,00000126000000000000;0,827975644;0,054692429;0,920678661;0,087654748;0,111490212;1,145372846;0,213634335;0;0;NA;NA;NA
X100159872_TGI_at;100159872_TGI_at;AK023205;CORO1C;coronin, actin binding protein, 1C;0,00000000000008460000;1,392264416;0,005615411;1,140027844;0,016290801;0,001370872;1,307374291;0,011387427;0;1;U2;U1;U1
X100159887_TGI_at;100159887_TGI_at;NM_014737;RASSF2;Ras association (RalGDS/AF-6) domain family member 2;0,00000000032800000000;0,798662376;0,007965937;0,864621978;0,020975665;0,5291358;1,029033929;0,660834037;0;0;NA;NA;NA
X100159895_TGI_at;100159895_TGI_at;NM_138635;H2AFV;H2A histone family, member V;0,00000000029000000000;0,796260835;0,196206492;0,96209139;0,244916159;0,122857837;0,928263045;0,229149774;0;0;NA;NA;NA
X100159939_TGI_at;100159939_TGI_at;NM_080625;C20orf160;chromosome 20 open reading frame 160;0,00000009540000000000;0,697061313;0,010883635;0,832577394;0,02611664;0,157518655;0,799463545;0,275315957;0;0;NA;NA;NA
X100159943_TGI_at;100159943_TGI_at;BC004372;CD44;CD44 molecule (Indian blood group);0,00000000007220000000;1,254866975;0,018332206;1,106302259;0,038168352;0,002719171;1,195694769;0,017251748;0;1;U4;U1;U1
X100159958_TGI_at;100159958_TGI_at;NM_001098526;AMICA1;adhesion molecule, interacts with CXADR antigen 1;0,00000000000000531000;1,618423224;7,36E-07;1,39256783;5,39E-05;0,006071612;1,496398261;0,028156556;0;1;U5;U3;U1
X100160046_TGI_at;100160046_TGI_at;NM_025081;KIAA1305;KIAA1305;0,00000002670000000000;0,742976947;0,070948242;0,905923186;0,107810554;0,493698061;0,942795743;0,628679909;0;0;NA;NA;NA
X100160142_TGI_at;100160142_TGI_at;NM_014060;MCTS1;malignant T cell amplified sequence 1;0,00000000000000348000;1,310059476;0,009411023;1,073375073;0,023512966;0,245573996;1,073613486;0,379609108;0;0;NA;NA;NA
X100160148_TGI_at;100160148_TGI_at;AF052119;;;0,00000018800000000000;0,749528401;0,032139285;0,867886928;0,057998272;0,802816453;1,015677579;0,876241102;0;0;NA;NA;NA
X100160297_TGI_at;100160297_TGI_at;AB029290;MACF1;microtubule-actin crosslinking factor 1;0,00000000035300000000;0,772956149;0,028458518;0,919664808;0,052926602;0,823248705;1,026550715;0,88918585;0;0;NA;NA;NA
X100160300_TGI_at;100160300_TGI_at;NM_018342;TMEM144;transmembrane protein 144;0,00000000004050000000;1,376462935;5,07E-05;1,190345999;0,000692145;0,162295252;1,138160921;0,281073399;0;0;NA;NA;NA
X100160305_TGI_at;100160305_TGI_at;AK126830;DLEU7;deleted in lymphocytic leukemia, 7;0,00000000000010500000;2,098325984;3,06E-05;1,688323362;0,000503102;0,008356944;1,588086785;0,035724879;0;1;U2;U1;U1
X100160322_TGI_at;100160322_TGI_at;NM_133371;MYOZ3;myozenin 3;0,00000000000000118000;0,626543937;5,24E-06;0,745630334;0,000181585;0,086710607;0,826459633;0,179491513;0;0;NA;NA;NA
X100160324_TGI_at;100160324_TGI_at;NM_020689;SLC24A3;solute carrier family 24 (sodium/potassium/calcium exchanger), member 3;0,00000012600000000000;0,804563297;0,379278337;0,960453549;0,426522708;0,019518593;1,187519666;0,062162477;0;0;NA;NA;NA
X100160340_TGI_at;100160340_TGI_at;NM_000350;ABCA4;ATP-binding cassette, sub-family A (ABC1), member 4;0,00000078800000000000;1,312662647;0,003412144;1,19288828;0,01151554;0,601955364;1,05630771;0,718556347;0;0;NA;NA;NA
X100160343_TGI_at;100160343_TGI_at;NM_021978;ST14;suppression of tumorigenicity 14 (colon carcinoma);0,00000000002010000000;1,398569716;0,021790006;1,104768725;0,043566494;0,016931008;1,189613596;0,056430856;0;0;NA;NA;NA
X100160347_TGI_at;100160347_TGI_at;NM_000163;GHR;growth hormone receptor;0,00000000003220000000;0,699805725;0,001815037;0,833226106;0,007499003;0,009797793;0,758894105;0,039467969;0;1;D1;D1;D1
X100160357_TGI_at;100160357_TGI_at;NM_024575;TNFAIP8L2;tumor necrosis factor, alpha-induced protein 8-like 2;0,00000000083200000000;1,399989254;0,013228583;1,142800141;0,030047513;0,000371641;1,600794526;0,00537129;0;1;U1;U1;U1
X100160366_TGI_at;100160366_TGI_at;NM_032744;C6orf105;chromosome 6 open reading frame 105;0,00000000000000060300;2,351344718;5,98E-07;2,007173486;4,70E-05;0,000297835;2,133421884;0,004872704;0;1;U2;U2;U1
X100160385_TGI_at;100160385_TGI_at;CR749365;ZFYVE26;zinc finger, FYVE domain containing 26;0,00000000007010000000;1,313069716;0,059094048;1,082298175;0,093139209;0,00256018;1,199117491;0,01677126;0;0;NA;NA;NA
X100160387_TGI_at;100160387_TGI_at;NM_032021;TMEM133;transmembrane protein 133;0,00000000248000000000;0,757517374;0,341639607;0,97301702;0,389948125;0,110976585;0,885378993;0,212903293;0;0;NA;NA;NA
X100160409_TGI_at;100160409_TGI_at;NM_001040022;SIRPA;signal-regulatory protein alpha;0,00000000000656000000;1,260643204;0,005631195;1,111116761;0,016314727;0,000108253;1,26532933;0,003322844;0;1;U1;U1;U1
X100160416_TGI_at;100160416_TGI_at;NM_032034;SLC4A11;solute carrier family 4, sodium borate transporter, member 11;0,00000003670000000000;1,554529103;0,486864302;1,110148431;0,527449965;0,883640065;0,86982766;0,933455238;0;0;NA;NA;NA
X100160419_TGI_at;100160419_TGI_at;NM_004106;FCER1G;"Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide";0,00000000000075100000;1,289831645;0,009868546;1,090268931;0,024466402;0,002081391;1,182847952;0,014968787;0;1;U3;U1;U1
X100160420_TGI_at;100160420_TGI_at;NM_175575;WFIKKN2;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2;0,00000000000009270000;2,320680254;1,03E-06;1,718564163;6,67E-05;0,209793529;1,233987008;0,337744527;0;0;NA;NA;NA
X100160423_TGI_at;100160423_TGI_at;AI373835;;;0,00000000464000000000;0,724781239;0,227927448;0,936209333;0,276581581;0,481261259;0,930732363;0,617970134;0;0;NA;NA;NA
X100160432_TGI_at;100160432_TGI_at;NM_001115;ADCY8;adenylate cyclase 8 (brain);0,00000000000859000000;0,626576876;0,002947312;0,744249713;0,01037029;0,481261259;1,050449858;0,617970134;0;0;NA;NA;NA
X100160437_TGI_at;100160437_TGI_at;ENST00000367920;DDR2;discoidin domain receptor tyrosine kinase 2;0,00000000408000000000;0,785107186;0,391823392;0,935115458;0,43833627;0,064330368;0,827948548;0,144788251;0;0;NA;NA;NA
X100160445_TGI_at;100160445_TGI_at;NM_005950;MT1G;metallothionein 1G;0,00000000000281000000;2,905710425;1,31E-06;2,147690266;7,52E-05;0,015374349;1,905919604;0,052959853;0;0;NA;NA;NA
X100160491_TGI_at;100160491_TGI_at;NM_032812;PLXDC2;plexin domain containing 2;0,00000000000369000000;1,254502725;0,00098459;1,184496704;0,004757623;0,072102527;1,096360578;0,157336794;0;0;NA;NA;NA
X100160523_TGI_at;100160523_TGI_at;NM_001183;ATP6AP1;ATPase, H+ transporting, lysosomal accessory protein 1;0,00000000000001090000;1,270146474;0,132693749;1,043536467;0,176359568;0,021425185;1,171712706;0,066397472;0;0;NA;NA;NA
X100160528_TGI_at;100160528_TGI_at;NM_002178;IGFBP6;insulin-like growth factor binding protein 6;0,00000003880000000000;0,579458067;0,064671204;0,708628151;0,100113011;0,074854353;0,76852116;0,161916497;0;0;NA;NA;NA
X100160537_TGI_at;100160537_TGI_at;NM_004449;ERG;v-ets erythroblastosis virus E26 oncogene homolog (avian);0,00000000000290000000;0,691958233;0,000523918;0,852345885;0,003132814;0,185788694;0,908728838;0,311548887;0;0;NA;NA;NA
X100160608_TGI_at;100160608_TGI_at;AK095013;SLC8A1;solute carrier family 8 (sodium/calcium exchanger), member 1;0,00000001400000000000;1,522716554;0,002652147;1,295257023;0,00959357;0,054500465;1,237642042;0,128784177;0;0;NA;NA;NA
X100160618_TGI_at;100160618_TGI_at;BC008300;PCNXL2;pecanex-like 2 (Drosophila);0,00000002880000000000;1,403284201;0,002087431;1,239681382;0,008224681;0,660894461;0,991570636;0,764285198;0;0;NA;NA;NA
X100160626_TGI_at;100160626_TGI_at;NM_032802;;signal peptide peptidase-like 2A;0,00000000004920000000;1,290186123;0,015519588;1,120231373;0,033751438;0,059535454;1,090540918;0,137945916;0;0;NA;NA;NA
X100160629_TGI_at;100160629_TGI_at;NM_018690;;apolipoprotein B48 receptor;0,00000000002830000000;1,560056928;0,094984342;1,135421564;0,134920465;0,008241833;1,397315543;0,035370744;0;0;NA;NA;NA
X100160634_TGI_at;100160634_TGI_at;NM_005615;RNASE6;ribonuclease, RNase A family, k6;0,00000000043500000000;1,393938777;0,014318358;1,16273436;0,03180432;0,025338248;1,240796553;0,074853504;0;0;NA;NA;NA
X100160640_TGI_at;100160640_TGI_at;NM_024652;LRRK1;leucine-rich repeat kinase 1;0,00000009130000000000;1,24511463;0,021680178;1,110756784;0,043454736;0,157518655;1,078484985;0,275315957;0;0;NA;NA;NA
X100160654_TGI_at;100160654_TGI_at;ENST00000381889;KLB;klotho beta;0,00000009440000000000;2,118128414;6,07E-05;2,036284081;0,00077025;0,001284943;2,325790651;0,011043654;0;1;U1;U1;U1
X100160674_TGI_at;100160674_TGI_at;NM_000760;CSF3R;colony stimulating factor 3 receptor (granulocyte);0,00000111000000000000;1,308384153;0,163154208;1,118539038;0,208751891;0,014774182;1,346949747;0,051589587;0;0;NA;NA;NA
X100160736_TGI_at;100160736_TGI_at;BX648243;ZNF677;zinc finger protein 677;0,00000000364000000000;0,7215303;0,033062617;0,842263998;0,058873378;0,005878108;0,73752208;0,027778803;0;0;NA;NA;NA
X100160743_TGI_at;100160743_TGI_at;NM_002030;FPR3;formyl peptide receptor 3;0,00000000002830000000;1,702871843;0,000668799;1,346028098;0,003711391;0,001370872;1,741165387;0,011387427;0;1;U5;U1;U1
X100160780_TGI_at;100160780_TGI_at;NM_006846;SPINK5;serine peptidase inhibitor, Kazal type 5;0,00000000000000381000;2,712214988;9,92E-06;1,693460131;0,000268799;0,000320802;1,869029435;0,005118537;0;1;U6;U3;U1
X100160839_TGI_at;100160839_TGI_at;AK022347;;;0,00000126000000000000;0,761944945;0,096870685;0,922871459;0,136996146;0,601955364;0,900293013;0,718556347;0;0;NA;NA;NA
X100160842_TGI_at;100160842_TGI_at;ENST00000359156;CD163;CD163 molecule;0,00000000006160000000;1,558943904;0,394998562;1,039618044;0,441122787;0,16275398;1,324592161;0,281112582;0;0;NA;NA;NA
X100160861_TGI_at;100160861_TGI_at;AK222841;ABHD2;abhydrolase domain containing 2;0,00000000000020900000;1,637129462;0,022237886;1,131808677;0,044269738;0,020452962;1,225030066;0,064249412;0;0;NA;NA;NA
X100160865_TGI_at;100160865_TGI_at;NM_130446;KLHL6;kelch-like 6 (Drosophila);0,00000000189000000000;1,576108733;0,003191549;1,193941656;0,010966271;0,255009933;1,237946355;0,38934013;0;0;NA;NA;NA
X100160870_TGI_at;100160870_TGI_at;NM_001009880;C22orf9;chromosome 22 open reading frame 9;0,00000009240000000000;1,257620007;8,99E-05;1,192933933;0,000995294;0,00638893;1,16999693;0,029273149;0;1;U1;U1;U1
X100160951_TGI_at;100160951_TGI_at;NM_001080494;TTC39A;tetratricopeptide repeat domain 39A;0,00000000141000000000;1,351136113;0,843349251;1,00636827;0,857449411;0,036535061;1,401765982;0,096439395;0;0;NA;NA;NA
X100160967_TGI_at;100160967_TGI_at;NM_182961;SYNE1;spectrin repeat containing, nuclear envelope 1;0,00000000448000000000;0,79284699;0,001058284;0,875910351;0,005008588;0,107219939;0,930248207;0,208174617;0;0;NA;NA;NA
X100160973_TGI_at;100160973_TGI_at;NM_005277;GPM6A;glycoprotein M6A;0,00000000000470000000;0,594228347;0,005918957;0,812550423;0,016822575;0,059535454;1,324042318;0,137945916;0;0;NA;NA;NA
X100160987_TGI_at;100160987_TGI_at;NM_001060;TBXA2R;thromboxane A2 receptor;0,00000003540000000000;0,673467114;0,025680989;0,861949248;0,04912156;0,493698061;0,862037699;0,628679909;0;0;NA;NA;NA
X100161012_TGI_at;100161012_TGI_at;NM_000055;BCHE;butyrylcholinesterase;0,00000000000051900000;0,467911234;0,000316514;0,691901779;0,002193817;0,169527921;0,811727743;0,290015121;0;0;NA;NA;NA
X100161017_TGI_at;100161017_TGI_at;BC021107;TM9SF4;transmembrane 9 superfamily protein member 4;0,00000000648000000000;1,301588361;0,003329794;1,136089875;0,011296764;0,000612657;1,248917071;0,007180335;0;1;U1;U1;U1
X100161022_TGI_at;100161022_TGI_at;ENST00000368170;CD1C;CD1c molecule;0,00000000000136000000;1,658597475;0,052297587;1,25719887;0,084616026;0,061895338;1,38835074;0,141481329;0;0;NA;NA;NA
X100161033_TGI_at;100161033_TGI_at;DQ893158;INHBA;inhibin, beta A;0,00000000029000000000;1,664862707;0,000964889;1,546360661;0,004711873;0,06589724;1,259343091;0,147695969;0;0;NA;NA;NA
X100161037_TGI_at;100161037_TGI_at;NM_020125;SLAMF8;SLAM family member 8;0,00000000008280000000;1,997937488;0,028663655;1,230686468;0,053185353;0,021964693;1,450440955;0,067549815;0;0;NA;NA;NA
X100161038_TGI_at;100161038_TGI_at;NM_015568;PPP1R16B;protein phosphatase 1, regulatory (inhibitor) subunit 16B;0,00000001990000000000;0,71145761;0,001156139;0,807951623;0,005338446;0,348497017;1,144703015;0,486868611;0;0;NA;NA;NA
X100161060_TGI_at;100161060_TGI_at;NM_002314;LIMK1;LIM domain kinase 1;0,00000000004050000000;1,355697411;0,000158395;1,159052816;0,001373293;0,034975442;1,183744834;0,093703947;0;0;NA;NA;NA
X100161064_TGI_at;100161064_TGI_at;BU947519;MRPS33;mitochondrial ribosomal protein S33;0,00000069800000000000;0,750615948;0,490063816;0,941871651;0,530381356;0,450742398;0,889670906;0,587204022;0;0;NA;NA;NA
X100161068_TGI_at;100161068_TGI_at;NM_032333;C10orf58;chromosome 10 open reading frame 58;0,00000000000000016600;1,616467852;1,91E-07;1,258404135;2,37E-05;0,043170182;1,199864929;0,107774978;0;0;NA;NA;NA
X100161086_TGI_at;100161086_TGI_at;AW449132;CAPN8;calpain 8;0,00000065800000000000;1,536480307;0,183185043;1,169821269;0,230807425;0,003661766;1,430394445;0,020560753;0;0;NA;NA;NA
X100161149_TGI_at;100161149_TGI_at;DQ891914;GM2A;GM2 ganglioside activator;0,00000000584000000000;1,604155598;0,0056156;1,253879896;0,016290801;0,002988929;1,397923111;0,018419346;0;1;U1;U3;U1
X100161152_TGI_at;100161152_TGI_at;NM_021095;SLC5A6;solute carrier family 5 (sodium-dependent vitamin transporter), member 6;0,00000002370000000000;1,210618631;0,570051276;1,018191466;0,605961498;0,980202899;0,991608434;0,987556719;0;0;NA;NA;NA
X100161156_TGI_at;100161156_TGI_at;NM_032663;USP30;ubiquitin specific peptidase 30;0,00000000000726000000;1,345486633;0,007901575;1,121086588;0,020943071;0,010882522;1,199710022;0,041904859;0;1;U2;U1;U1
X100161167_TGI_at;100161167_TGI_at;NM_080878;ITLN2;intelectin 2;0,00000056700000000000;0,656562395;0,162700327;0,865298343;0,208419378;0,015374349;1,981624045;0,052959853;0;0;NA;NA;NA
X100161181_TGI_at;100161181_TGI_at;NM_017803;DUS2L;dihydrouridine synthase 2-like, SMM1 homolog (S. cerevisiae);0,00000091600000000000;1,23632443;0,050018567;1,073923803;0,081583928;0,184980417;1,093243994;0,311548887;0;0;NA;NA;NA
X100161196_TGI_at;100161196_TGI_at;AK074600;TMEM86A;transmembrane protein 86A;0,00000017400000000000;1,416857893;0,013889189;1,205450723;0,031000594;0,00057123;1,46430887;0,006879298;0;1;U1;U1;U1
X100161199_TGI_at;100161199_TGI_at;NM_000640;IL13RA2;interleukin 13 receptor, alpha 2;0,00000000480000000000;2,394963771;0,009388181;1,470611988;0,023512966;0,460794302;0,737795704;0,597401462;0;0;NA;NA;NA
X100161200_TGI_at;100161200_TGI_at;NM_005817;M6PRBP1;mannose-6-phosphate receptor binding protein 1;0,00000000036000000000;1,231699751;0,062481993;1,062800808;0,097378852;0,57904816;1,039028133;0,700552635;0;0;NA;NA;NA
X100161207_TGI_at;100161207_TGI_at;BC035844;;hypothetical protein LOC284242;0,00000022400000000000;1,305348642;0,003926858;1,165601383;0,012656262;0,03650134;1,262303405;0,096439395;0;0;NA;NA;NA
X100161214_TGI_at;100161214_TGI_at;NM_003313;TSTA3;tissue specific transplantation antigen P35B;0,00000023600000000000;1,240319023;0,057304522;1,076278262;0,091204066;0,039719764;1,151775707;0,101661999;0;0;NA;NA;NA
X100161215_TGI_at;100161215_TGI_at;AB037821;PCDH10;protocadherin 10;0,00000000000010900000;0,537750616;0,048777784;0,827176578;0,0799648;0,000629401;0,618286091;0,007323323;0;0;NA;NA;NA
X100161251_TGI_at;100161251_TGI_at;DA056814;GLIPR2;GLI pathogenesis-related 2;0,00000000011300000000;1,451359909;0,063070935;1,120490889;0,097870787;3,74E-05;1,384573595;0,00185207;0;0;NA;NA;NA
X100161253_TGI_at;100161253_TGI_at;NM_007047;BTN3A2;butyrophilin, subfamily 3, member A2;0,00000051500000000000;0,758684901;0,005247601;0,829687551;0,015616822;0,537464131;0,936327468;0,667275383;0;0;NA;NA;NA
X100161276_TGI_at;100161276_TGI_at;NM_017593;BMP2K;BMP2 inducible kinase;0,00000000354000000000;1,343132239;0,009868546;1,17468911;0,024466402;0,241271938;1,089112998;0,374575845;0;0;NA;NA;NA
X100161296_TGI_at;100161296_TGI_at;NM_021111;RECK;reversion-inducing-cysteine-rich protein with kazal motifs;0,00000014900000000000;0,747831189;0,262287169;0,940879198;0,311592903;0,450742398;0,944716342;0,587204022;0;0;NA;NA;NA
X100161298_TGI_at;100161298_TGI_at;BC016631;;;0,00000000000536000000;2,341733556;7,59E-06;1,880546419;0,000239953;0,00095128;1,670497099;0,009207138;0;1;U2;U3;U1
X100161303_TGI_at;100161303_TGI_at;BC062294;CISD3;CDGSH iron sulfur domain 3;0,00000000021900000000;1,375312295;0,019590297;1,123518463;0,040216259;0,140181821;1,135927698;0,252829328;0;0;NA;NA;NA
X100161343_TGI_at;100161343_TGI_at;NM_018988;GFOD1;glucose-fructose oxidoreductase domain containing 1;0,00000018100000000000;0,762679181;0,000112238;0,736027466;0,001109637;0,759495311;0,944653415;0,842344593;0;0;NA;NA;NA
X100161378_TGI_at;100161378_TGI_at;NM_001077693;;endothelial cell-specific molecule 2;0,00000001680000000000;0,822074228;0,014775974;0,894877938;0,03261847;0,635603663;0,987003555;0,747431382;0;0;NA;NA;NA
X100161393_TGI_at;100161393_TGI_at;NM_178858;SFXN2;sideroflexin 2;0,00000000003420000000;1,506687767;0,00103678;1,204295805;0,004941373;0,16275398;1,115369094;0,281112582;0;0;NA;NA;NA
X100161431_TGI_at;100161431_TGI_at;NM_002404;MFAP4;microfibrillar-associated protein 4;0,00000000534000000000;0,77741254;0,446700042;0,972528766;0,490032074;0,017393773;0,865001248;0,057734429;0;0;NA;NA;NA
X100161518_TGI_at;100161518_TGI_at;NM_000275;OCA2;oculocutaneous albinism II;0,00000051800000000000;0,680909514;0,005816236;0,790661906;0,016648071;0,010314762;0,686605912;0,040961273;0;1;D2;D2;D1
X100161520_TGI_at;100161520_TGI_at;NM_005931;MICB;MHC class I polypeptide-related sequence B;0,00000001560000000000;1,305431818;0,430572963;1,051830741;0,475252281;0,080140884;1,158637074;0,170587136;0;0;NA;NA;NA
X100161541_TGI_at;100161541_TGI_at;AK054604;TBX3;T-box 3;0,00000000353000000000;0,652651321;0,013873289;0,802317626;0,031000594;0,862086046;0,934967267;0,916392918;0;0;NA;NA;NA
X100161548_TGI_at;100161548_TGI_at;ENST00000367620;SOAT1;sterol O-acyltransferase 1;0,00000001350000000000;1,209867378;0,046430057;1,055655395;0,076898291;0,010855277;1,128932573;0,041904859;0;0;NA;NA;NA
X100161563_TGI_at;100161563_TGI_at;NM_024554;PGBD5;piggyBac transposable element derived 5;0,00000000077400000000;1,526287689;1,76E-05;1,34197477;0,000366485;0,014774182;1,377764287;0,051589587;0;0;NA;NA;NA
X100161565_TGI_at;100161565_TGI_at;ENST00000340892;TC2N;tandem C2 domains, nuclear;0,00000066400000000000;1,342163592;0,108127834;1,096737899;0,149121099;0,169527921;1,155929722;0,290015121;0;0;NA;NA;NA
X100161586_TGI_at;100161586_TGI_at;NM_005980;S100P;S100 calcium binding protein P;0,00000079000000000000;1,957856534;0,324732812;1,114443372;0,372858515;0,746919855;0,825592605;0,832983631;0;0;NA;NA;NA
X100161626_TGI_at;100161626_TGI_at;NM_001611;ACP5;acid phosphatase 5, tartrate resistant;0,00000000000000146000;2,166267868;1,96E-05;1,566159636;0,000385755;2,50E-05;2,551945012;0,001789912;0;1;U2;U2;U1
X100161633_TGI_at;100161633_TGI_at;NM_019107;C19orf10;chromosome 19 open reading frame 10;0,00000000004320000000;1,205093832;0,186363523;1,064773488;0,234445603;0,024581037;1,22662814;0,072950903;0;0;NA;NA;NA
X100161635_TGI_at;100161635_TGI_at;NM_000433;NCF2;neutrophil cytosolic factor 2;0,00000000000000113000;1,671684477;0,002857032;1,197033577;0,010085668;0,001055444;1,535711055;0,009719131;0;1;U3;U1;U1
X100161637_TGI_at;100161637_TGI_at;NM_014331;SLC7A11;solute carrier family 7, (cationic amino acid transporter, y+ system) member 11;0,00000000113000000000;1,707826428;0,007675747;1,396175476;0,020462311;0,015374349;1,359385025;0,052959853;0;0;NA;NA;NA
X100161640_TGI_at;100161640_TGI_at;AB002438;SEMA6A;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A;0,00000000010600000000;0,573080324;0,094224532;0,846200812;0,134255379;0,601955364;1,040768518;0,718556347;0;0;NA;NA;NA
X100161704_TGI_at;100161704_TGI_at;NM_020802;KIAA1377;KIAA1377;0,00000000004180000000;0,651153726;0,002507396;0,733520405;0,009235815;0,000806993;0,601142804;0,008256949;0;1;D8;D1;D1
X100161709_TGI_at;100161709_TGI_at;AK125687;TMOD3;tropomodulin 3 (ubiquitous);0,00000001810000000000;0,752441201;0,20257395;0,944724403;0,251403866;0,901252766;1,001570201;0,944937432;0;0;NA;NA;NA
X100161773_TGI_at;100161773_TGI_at;AB073669;TRPV4;transient receptor potential cation channel, subfamily V, member 4;0,00000046500000000000;1,313412272;0,277731348;1,047400005;0,326808374;0,862086046;0,979953678;0,916392918;0;0;NA;NA;NA
X100161794_TGI_at;100161794_TGI_at;NM_001451;FOXF1;forkhead box F1;0,00000000457000000000;0,764103105;0,321492384;0,932782683;0,370192909;0,242831425;0,918339665;0,376271963;0;0;NA;NA;NA
X100161809_TGI_at;100161809_TGI_at;BC005131;EIF1AD;eukaryotic translation initiation factor 1A domain containing;0,00000012000000000000;1,299845674;0,040183399;1,077644782;0,068669721;0,004654763;1,26663202;0,023927113;0;0;NA;NA;NA
X100161814_TGI_at;100161814_TGI_at;NM_015258;FKBP15;FK506 binding protein 15, 133kDa;0,00000000000051900000;1,494346512;9,71E-05;1,208284224;0,001049817;0,007537159;1,241613393;0,0330507;0;1;U4;U1;U1
X100161818_TGI_at;100161818_TGI_at;NM_178505;TMEM26;transmembrane protein 26;0,00000096100000000000;0,669770096;0,079940239;0,861150505;0,117862484;0,823248705;0,886772174;0,88918585;0;0;NA;NA;NA
X100161832_TGI_at;100161832_TGI_at;NM_003189;TAL1;T-cell acute lymphocytic leukemia 1;0,00000032600000000000;0,741778124;0,013238052;0,835798663;0,030047513;0,481261259;0,965380124;0,617970134;0;0;NA;NA;NA
X100161855_TGI_at;100161855_TGI_at;NM_014297;ETHE1;ethylmalonic encephalopathy 1;0,00000046800000000000;1,252099204;0,177645539;1,031833957;0,224530028;0,010345168;1,195544802;0,040961273;0;0;NA;NA;NA
X100161879_TGI_at;100161879_TGI_at;NM_006907;PYCR1;pyrroline-5-carboxylate reductase 1;0,00000045700000000000;1,290762738;0,131797314;1,037391553;0,175631757;0,077689446;0,807376391;0,166153341;0;0;NA;NA;NA
X100161904_TGI_at;100161904_TGI_at;AL049240;;;0,00000001180000000000;0,672418231;0,00260307;0,762952643;0,009458504;0,91436561;0,908601789;0,951873502;0;0;NA;NA;NA
X100161913_TGI_at;100161913_TGI_at;NM_021226;ARHGAP22;Rho GTPase activating protein 22;0,00000000083900000000;1,542241444;0,125625516;1,135346696;0,168634335;0,601955364;1,028123233;0,718556347;0;0;NA;NA;NA
X100161920_TGI_at;100161920_TGI_at;AK055621;;;0,00000003680000000000;0,596723199;0,101523164;0,878174865;0,142326732;0,093170847;1,339246164;0,188856657;0;0;NA;NA;NA
X100161944_TGI_at;100161944_TGI_at;NM_006750;SNTB2;syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2);0,00000082900000000000;0,830142452;0,002202001;0,904215052;0,00850965;0,402347064;1,087684022;0,542112532;0;0;NA;NA;NA
X100161992_TGI_at;100161992_TGI_at;CA433119;TRIM44;tripartite motif-containing 44;0,00000006330000000000;1,351677915;0,021362041;1,138612905;0,042923852;0,623344939;1,055987513;0,736451884;0;0;NA;NA;NA
X100162001_TGI_at;100162001_TGI_at;NM_005984;SLC25A1;"solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1";0,00000071500000000000;1,201970889;0,392976666;1,02621016;0,439169138;0,144787165;1,133973906;0,25853132;0;0;NA;NA;NA
X100162085_TGI_at;100162085_TGI_at;AK123747;ATP8B4;ATPase, class I, type 8B, member 4;0,00000000006710000000;1,555135499;0,000243791;1,34331499;0,001875273;0,440813265;1,069306756;0,5787133;0;0;NA;NA;NA
X100162087_TGI_at;100162087_TGI_at;NM_005620;S100A11;S100 calcium binding protein A11;0,00000000043300000000;1,243689897;0,017316091;1,09395585;0,036572583;0,000753789;1,207339873;0,007913552;0;1;U1;U1;U1
X100162128_TGI_at;100162128_TGI_at;NM_182811;PLCG1;phospholipase C, gamma 1;0,00000009000000000000;0,815488653;0,000271447;0,864737901;0,002002002;0,023487994;0,8640849;0,070485851;0;0;NA;NA;NA
X100162131_TGI_at;100162131_TGI_at;NM_001098506;CEACAM21;carcinoembryonic antigen-related cell adhesion molecule 21;0,00000004570000000000;1,45850132;0,098435093;1,156459517;0,138721602;0,000114023;1,542086214;0,003466937;0;0;NA;NA;NA
X100162139_TGI_at;100162139_TGI_at;ENST00000315253;DIXDC1;DIX domain containing 1;0,00000013000000000000;0,764268375;0,126263474;0,897724378;0,169279191;0,985987913;1,041507261;0,992454417;0;0;NA;NA;NA
X100162150_TGI_at;100162150_TGI_at;NM_000581;GPX1;glutathione peroxidase 1;0,00000000000000619000;1,410400938;0,086254592;1,054556342;0,125394023;0,000281133;1,382500836;0,004768908;0;0;NA;NA;NA
X100162159_TGI_at;100162159_TGI_at;NM_012193;FZD4;frizzled homolog 4 (Drosophila);0,00000003180000000000;0,759506249;4,22E-05;0,815837112;0,000609621;0,590451681;0,930393908;0,709819384;0;0;NA;NA;NA
X100162167_TGI_at;100162167_TGI_at;M18414;TRDV1;T cell receptor delta variable 1;0,00000111000000000000;0,608870009;0,023012864;0,755790213;0,045364196;0,274492264;1,166394593;0,411866186;0;0;NA;NA;NA
X100162207_TGI_at;100162207_TGI_at;NM_001064;TKT;transketolase;0,00000000000009070000;1,273924351;0,0418679;1,09183396;0,070797609;0,001221875;1,256195359;0,010701369;0;0;NA;NA;NA
X100162235_TGI_at;100162235_TGI_at;AY149920;CD109;CD109 molecule;0,00000008760000000000;1,334344406;0,000872714;1,242409117;0,004464695;0,383281963;1,07527884;0,520942343;0;0;NA;NA;NA
X100162237_TGI_at;100162237_TGI_at;NM_198281;GPRIN3;GPRIN family member 3;0,00000000111000000000;1,676902135;2,57E-06;1,534178316;0,000115604;0,274492264;1,173951299;0,411866186;0;0;NA;NA;NA
X100162261_TGI_at;100162261_TGI_at;NM_004519;KCNQ3;potassium voltage-gated channel, KQT-like subfamily, member 3;0,00000093800000000000;1,302550396;0,415517427;1,068307579;0,460685472;0,365926162;1,081983728;0,503363219;0;0;NA;NA;NA
X100162262_TGI_at;100162262_TGI_at;AF143684;MYO9B;myosin IXB;0,00000001560000000000;1,437007951;0,071750435;1,091554723;0,10872198;0,07711217;1,14513086;0,166153341;0;0;NA;NA;NA
X100162279_TGI_at;100162279_TGI_at;NM_030797;FAM49A;family with sequence similarity 49, member A;0,00000005680000000000;1,406567491;0,010557348;1,215830887;0,025602959;0,299373904;1,170138543;0,437985516;0;0;NA;NA;NA
X100162282_TGI_at;100162282_TGI_at;ENST00000342007;;;0,00000028400000000000;1,350119814;0,000144665;1,334476332;0,001291564;0,110976585;1,178429891;0,212903293;0;0;NA;NA;NA
X100162285_TGI_at;100162285_TGI_at;NM_001452;FOXF2;forkhead box F2;0,00000014100000000000;0,728707916;0,026841265;0,854949671;0,050619894;0,093170847;0,867554853;0,188856657;0;0;NA;NA;NA
X100162304_TGI_at;100162304_TGI_at;NM_017653;DYM;dymeclin;0,00000000000131000000;1,228562176;0,148985923;1,044039702;0,193465605;0,759495311;0,99424031;0,842344593;0;0;NA;NA;NA
X100162358_TGI_at;100162358_TGI_at;NM_001002236;SERPINA1;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1;0,00000000000362000000;1,214479585;0,009256664;1,122253636;0,023326213;3,28E-05;1,318980869;0,001805101;0;1;U2;U1;U1
X100162367_TGI_at;100162367_TGI_at;ENST00000320378;EMP2;epithelial membrane protein 2;0,00000000018700000000;0,811914854;0,252131554;0,929027587;0,301193476;0,14742388;1,214981819;0,262512245;0;0;NA;NA;NA
X100162375_TGI_at;100162375_TGI_at;AK128648;;;0,00000120000000000000;0,763316722;0,538062749;0,98539082;0,575755724;0,797584764;1,019288004;0,871690639;0;0;NA;NA;NA
X100162381_TGI_at;100162381_TGI_at;ENST00000367003;C1orf97;chromosome 1 open reading frame 97;0,00000000056300000000;1,265283662;0,073025136;1,092029615;0,110135711;0,141436063;1,150143615;0,254806278;0;0;NA;NA;NA
X100162384_TGI_at;100162384_TGI_at;NM_015051;TXNDC4;thioredoxin domain containing 4 (endoplasmic reticulum);0,00000010600000000000;0,824294371;0,039634827;0,910540755;0,067923932;0,357146031;1,069030377;0,494450884;0;0;NA;NA;NA
X100162421_TGI_at;100162421_TGI_at;NM_001042784;;hypothetical protein FLJ25770;0,00000061600000000000;0,824308975;0,884647971;0,977626426;0,895476487;0,000695763;0,797499513;0,007705996;0;0;NA;NA;NA
X100162439_TGI_at;100162439_TGI_at;NM_153218;C13orf31;chromosome 13 open reading frame 31;0,00000003300000000000;1,39846495;0,001887632;1,175298299;0,007662265;0,276598639;1,123387483;0,413486741;0;0;NA;NA;NA
X100162545_TGI_at;100162545_TGI_at;ENST00000382420;PLA2G4E;phospholipase A2, group IVE;0,00000000000000001280;5,874048933;1,80E-11;5,21594865;1,45E-08;2,13E-05;3,407419248;0,001749595;0;1;U7;U4;U1
X100162565_TGI_at;100162565_TGI_at;NM_032413;C15orf48;chromosome 15 open reading frame 48;0,00000003890000000000;1,814676161;0,05149324;1,298152447;0,08356632;0,26927095;1,246791338;0,405163526;0;0;NA;NA;NA
X100162588_TGI_at;100162588_TGI_at;BC073832;FAM178A;family with sequence similarity 178, member A;0,00000075100000000000;0,777215;0,82260143;0,978304775;0,838470718;0,849099163;1,038642159;0,906474529;0;0;NA;NA;NA
X100162631_TGI_at;100162631_TGI_at;BC012842;OLA1;Obg-like ATPase 1;0,00000000197000000000;1,215080283;0,001175193;1,075877361;0,005372547;0,72932161;0,965867378;0,820741462;0;0;NA;NA;NA
X100162680_TGI_at;100162680_TGI_at;AF523360;HNMT;histamine N-methyltransferase;0,00000017300000000000;1,266175027;0,00069521;1,129948048;0,003843331;0,431724615;1,081935036;0,569099564;0;0;NA;NA;NA
X100162695_TGI_at;100162695_TGI_at;ENST00000304465;SRGAP2P1;SLIT-ROBO Rho GTPase activating protein 2 pseudogene 1;0,00000009490000000000;0,809678331;0,85841668;0,976639784;0,870571731;0,026197762;0,86439176;0,076620133;0;0;NA;NA;NA
X100162704_TGI_at;100162704_TGI_at;NM_002073;GNAZ;guanine nucleotide binding protein (G protein), alpha z polypeptide;0,00000000000173000000;0,611352796;5,93E-05;0,688500323;0,000754915;0,023487994;0,780661468;0,070485851;0;0;NA;NA;NA
X100162707_TGI_at;100162707_TGI_at;NM_020665;TMEM27;transmembrane protein 27;0,00000000005570000000;1,816934037;0,000781145;1,498022983;0,004161373;0,013942384;1,601563409;0,049653374;0;1;U4;U1;U1
X100162713_TGI_at;100162713_TGI_at;BI860659;TTC39B;tetratricopeptide repeat domain 39B;0,00000000174000000000;1,374570298;0,017801931;1,154648516;0,037208576;0,028691511;1,157928528;0,082417771;0;0;NA;NA;NA
X100162729_TGI_at;100162729_TGI_at;NM_005358;LMO7;LIM domain 7;0,00000037000000000000;0,761829345;0,465205387;0,975042204;0,507396603;0,064330368;1,457513085;0,144788251;0;0;NA;NA;NA
X100162746_TGI_at;100162746_TGI_at;NM_014269;ADAM29;ADAM metallopeptidase domain 29;0,00000000748000000000;0,598320073;0,884918589;0,944886356;0,895476487;0,704079782;1,046263474;0,801288537;0;0;NA;NA;NA
X100162761_TGI_at;100162761_TGI_at;NM_175732;PTPMT1;protein tyrosine phosphatase, mitochondrial 1;0,00000000000918000000;1,365705047;0,025516694;1,102275178;0,048923441;6,48E-06;1,448872834;0,001159269;0;1;U1;U1;U1
X100162763_TGI_at;100162763_TGI_at;NM_153184;CADM2;cell adhesion molecule 2;0,00000006130000000000;0,636109119;0,020122011;0,793469916;0,041020393;0,038187481;0,737517021;0,099577872;0;0;NA;NA;NA
X100162792_TGI_at;100162792_TGI_at;ENST00000226230;TMEM97;transmembrane protein 97;0,00000001000000000000;1,403344358;0,002244503;1,318088028;0,008591489;0,000328732;1,62423895;0,005193636;0;1;U4;U1;U1
X100162796_TGI_at;100162796_TGI_at;BC025699;SMAD2;SMAD family member 2;0,00000000002710000000;1,211579233;0,16096668;1,046480772;0,206444731;0,046244403;1,113609952;0,113775352;0;0;NA;NA;NA
X100162817_TGI_at;100162817_TGI_at;AW052186;;;0,00000000097700000000;0,633877664;0,368312245;0,915029431;0,415495403;0,63704437;0,989646424;0,747431382;0;0;NA;NA;NA
X100162821_TGI_at;100162821_TGI_at;NM_022337;RAB38;RAB38, member RAS oncogene family;0,00000000469000000000;1,344634938;0,001853474;1,15861388;0,007561703;0,010882522;1,245213422;0,041904859;0;1;U3;U1;U1
X100162830_TGI_at;100162830_TGI_at;NM_002872;RAC2;ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2);0,00000019900000000000;1,299985908;0,013889189;1,153278047;0,031000594;0,039901467;1,266134456;0,101661999;0;0;NA;NA;NA
X100162901_TGI_at;100162901_TGI_at;NM_003206;TCF21;transcription factor 21;0,00000006350000000000;0,738420255;0,186744185;0,90040201;0,234741227;0,993131469;1,034802353;0,995253159;0;0;NA;NA;NA
X100162955_TGI_at;100162955_TGI_at;BX413407;NFYB;nuclear transcription factor Y, beta;0,00000093800000000000;0,819868329;0,799626751;0,985928768;0,818157783;0,402475181;0,930999946;0,542112532;0;0;NA;NA;NA
X100162968_TGI_at;100162968_TGI_at;NM_080390;TCEAL2;transcription elongation factor A (SII)-like 2;0,00000000000003490000;0,51388198;0,000486874;0,734260269;0,002960745;0,074854353;0,679604661;0,161916497;0;0;NA;NA;NA
X100162978_TGI_at;100162978_TGI_at;NM_024775;GEMIN6;gem (nuclear organelle) associated protein 6;0,00000001950000000000;1,225452307;0,040768899;1,090930737;0,06937601;0,144787165;1,094981707;0,25853132;0;0;NA;NA;NA
X100162998_TGI_at;100162998_TGI_at;NM_206943;LTBP1;latent transforming growth factor beta binding protein 1;0,00000000016000000000;0,764716612;0,088077873;0,89640536;0,127584262;0,050233572;0,83735762;0,121639972;0;0;NA;NA;NA
X100163000_TGI_at;100163000_TGI_at;NM_005994;TBX2;T-box 2;0,00000000020700000000;0,639477084;0,000101761;0,753061442;0,001063056;0,228052747;0,864504237;0,35942005;0;0;NA;NA;NA
X100163001_TGI_at;100163001_TGI_at;NM_032623;;ovary-specific acidic protein;0,00000104000000000000;0,775568213;0,141601334;0,927912785;0,185596218;0,793641573;0,993878665;0,870332355;0;0;NA;NA;NA
X100163005_TGI_at;100163005_TGI_at;BC047782;;hypothetical protein LOC100134934;0,00000041900000000000;1,230884428;0,637760213;0,980575254;0,670855472;0,001768621;1,327422416;0,013507735;0;0;NA;NA;NA
X100163006_TGI_at;100163006_TGI_at;AK091335;;;0,00000008230000000000;1,682471894;0,018355863;1,216637929;0,038168352;0,000574164;1,71006599;0,006879298;0;1;U2;U1;U1
X100163011_TGI_at;100163011_TGI_at;DB511450;PROM1;prominin 1;0,00000009420000000000;0,626247505;0,049215579;0,789328705;0,080518686;0,347587896;0,851492642;0,486868611;0;0;NA;NA;NA
X100163019_TGI_at;100163019_TGI_at;AK023074;OSBPL11;oxysterol binding protein-like 11;0,00000039000000000000;1,343585905;0,011266738;1,181241955;0,026680893;0,030713739;1,354759659;0,086003807;0;0;NA;NA;NA
X100163030_TGI_at;100163030_TGI_at;NM_177403;RAB7B;RAB7B, member RAS oncogene family;0,00000000824000000000;1,524264617;0,003896652;1,26993104;0,012604096;0,000370278;1,504601899;0,00537129;0;1;U4;U1;U1
X100163032_TGI_at;100163032_TGI_at;NM_001017535;VDR;vitamin D (1,25- dihydroxyvitamin D3) receptor;0,00000000000007840000;1,572347043;0,000128626;1,220094502;0,001204762;0,001882981;1,322612476;0,014113602;0;1;U4;U1;U1
X100163041_TGI_at;100163041_TGI_at;ENST00000266659;GLIPR1;GLI pathogenesis-related 1;0,00000011700000000000;1,299580021;0,103915228;1,119506604;0,14473586;0,37483693;1,09287323;0,511473085;0;0;NA;NA;NA
X100163104_TGI_at;100163104_TGI_at;NM_000575;IL1A;interleukin 1, alpha;0,00000000612000000000;1,91179895;0,000260942;1,750065463;0,001951317;0,000497032;2,342078038;0,006356879;0;1;U2;U2;U1
X100163107_TGI_at;100163107_TGI_at;NM_016651;DACT1;dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis);0,00000000000052700000;0,654744723;0,127510055;0,877339663;0,17066649;0,184944706;0,820065855;0,311548887;0;0;NA;NA;NA
X100163108_TGI_at;100163108_TGI_at;NM_000860;HPGD;hydroxyprostaglandin dehydrogenase 15-(NAD);0,00000001610000000000;0,638694249;0,011625652;0,79478046;0,027277267;0,849099163;1,045319;0,906474529;0;0;NA;NA;NA
X100163187_TGI_at;100163187_TGI_at;NM_018384;GIMAP5;GTPase, IMAP family member 5;0,00000000055400000000;0,760502213;0,014094273;0,879076267;0,031393119;0,312041432;0,948158595;0,452818341;0;0;NA;NA;NA
X100300004_TGI_at;100300004_TGI_at;hCT6776;RAPGEF4;Rap guanine nucleotide exchange factor (GEF) 4;0,00000011400000000000;0,691871785;0,620275428;0,958583123;0,653743527;0,797584764;1,016311581;0,871690639;0;0;NA;NA;NA
X100300028_TGI_at;100300028_TGI_at;Z70222;UFM1;ubiquitin-fold modifier 1;0,00000024500000000000;1,259281824;0,002255715;1,133065796;0,008624162;0,347587896;1,103591984;0,486868611;0;0;NA;NA;NA
X100300043_TGI_at;100300043_TGI_at;Z22968;CD163;CD163 molecule;0,00000000002250000000;1,513619841;0,396128587;1,028095839;0,441925384;0,184980417;1,254698805;0,311548887;0;0;NA;NA;NA
X100300052_TGI_at;100300052_TGI_at;Y17151;ABCC3;ATP-binding cassette, sub-family C (CFTR/MRP), member 3;0,00000000000069900000;1,766928799;0,001299028;1,244727042;0,005806891;0,241271938;1,168073375;0,374575845;0;0;NA;NA;NA
X100300055_TGI_at;100300055_TGI_at;Y13341;MATN3;matrilin 3;0,00000000039500000000;0,533861272;0,402478051;0,870803803;0,448233158;0,613556941;0,923049281;0,727019861;0;0;NA;NA;NA
X100300059_TGI_at;100300059_TGI_at;Y10745;KCNJ15;potassium inwardly-rectifying channel, subfamily J, member 15;0,00000068100000000000;1,313614968;0,010051668;1,170344853;0,024730173;0,000256336;1,742791202;0,004600156;0;1;U1;U2;U1
X100300119_TGI_at;100300119_TGI_at;XM_930559;;Similar to Lysophospholipase;0,00000064800000000000;0,730286992;0,001199051;0,772273345;0,005450693;0,927501324;0,996447429;0,959350695;0;0;NA;NA;NA
X100300140_TGI_at;100300140_TGI_at;XM_498853;;;0,00000008050000000000;1,458165528;0,250398739;1,136003833;0,299345377;0,107895631;1,461128537;0,208857428;0;0;NA;NA;NA
X100300156_TGI_at;100300156_TGI_at;XM_377032;GPRASP1;G protein-coupled receptor associated sorting protein 1;0,00000004330000000000;0,746855859;0,643657887;0,980739961;0,676176457;0,046864607;0,766021335;0,114688405;0;0;NA;NA;NA
X100300181_TGI_at;100300181_TGI_at;XM_300881;ZDHHC11;zinc finger, DHHC-type containing 11;0,00000026800000000000;0,591197438;0,003969839;0,738528389;0,012743815;0,262074839;1,242490387;0,39749045;0;0;NA;NA;NA
X100300237_TGI_at;100300237_TGI_at;XM_113636;SLC16A12;solute carrier family 16, member 12 (monocarboxylic acid transporter 12);0,00000002880000000000;0,770693892;0,011822614;0,87080945;0,027580294;0,460794302;1,013186941;0,597401462;0;0;NA;NA;NA
X100300245_TGI_at;100300245_TGI_at;XM_096424;INSC;inscuteable homolog (Drosophila);0,00000017500000000000;0,715042814;0,526819014;0,951901226;0,565225593;0,365926162;0,928413526;0,503363219;0;0;NA;NA;NA
X100300275_TGI_at;100300275_TGI_at;XM_039259;DOCK3;dedicator of cytokinesis 3;0,00000000044400000000;1,697140934;9,17E-06;1,555798044;0,000259388;0,951952506;0,99172521;0,974385319;0;0;NA;NA;NA
X100300278_TGI_at;100300278_TGI_at;XM_033379;WDFY4;WDFY family member 4;0,00000000141000000000;1,379325226;0,034484489;1,141302362;0,060900552;0,001203889;1,365782385;0,010630505;0;0;NA;NA;NA
X100300279_TGI_at;100300279_TGI_at;XM_031744;STARD9;StAR-related lipid transfer (START) domain containing 9;0,00000000000002190000;0,660296072;0,002197319;0,859998251;0,00850965;0,03650134;0,844388778;0,096439395;0;0;NA;NA;NA
X100300281_TGI_at;100300281_TGI_at;XM_031561;C15orf23;chromosome 15 open reading frame 23;0,00000028900000000000;1,368121297;0,016683338;1,141542082;0,035704116;0,177060975;1,075559763;0,301461976;0;0;NA;NA;NA
X100300282_TGI_at;100300282_TGI_at;XM_031536;TMEM97;transmembrane protein 97;0,00000000364000000000;1,326617722;0,007585089;1,163856252;0,020254136;0,000203903;1,492246123;0,004159363;0;1;U1;U1;U1
X100300290_TGI_at;100300290_TGI_at;XM_001134298;LAD1;ladinin 1;0,00000007910000000000;1,406108495;0,013463661;1,156145179;0,030302638;0,002131763;1,505517881;0,014968787;0;1;U4;U1;U1
X100300309_TGI_at;100300309_TGI_at;XM_001129769;C11orf21;chromosome 11 open reading frame 21;0,00000001150000000000;1,419845275;0,028875709;1,135437541;0,053486442;0,008356944;1,277907375;0,035724879;0;0;NA;NA;NA
X100300311_TGI_at;100300311_TGI_at;XM_001129592;FCGR2B;Fc fragment of IgG, low affinity IIb, receptor (CD32);0,00000000117000000000;1,671222339;0,003108043;1,268810365;0,010794421;0,107219939;1,240018702;0,208174617;0;0;NA;NA;NA
X100300341_TGI_at;100300341_TGI_at;X91911;GLIPR1;GLI pathogenesis-related 1;0,00000015200000000000;1,310947972;0,101523164;1,116873174;0,142326732;0,330381396;1,144548375;0,47157628;0;0;NA;NA;NA
X100300362_TGI_at;100300362_TGI_at;X74039;PLAUR;plasminogen activator, urokinase receptor;0,00000000000001530000;2,016652694;9,17E-06;1,493836356;0,000259388;0,000161447;1,556564985;0,004028419;0;1;U5;U3;U1
X100300365_TGI_at;100300365_TGI_at;X68487;ADORA2B;adenosine A2b receptor;0,00000000151000000000;1,444958427;0,09460924;1,108301171;0,134565569;0,061895338;1,186005905;0,141481329;0;0;NA;NA;NA
X100300366_TGI_at;100300366_TGI_at;X67643;HSPA4;heat shock 70kDa protein 4;0,00000000000072400000;1,28880418;0,210738343;1,06461778;0,259679814;0,030713739;1,207978505;0,086003807;0;0;NA;NA;NA
X100300377_TGI_at;100300377_TGI_at;X56807;DSC2;desmocollin 2;0,00000004200000000000;1,318353547;0,00331075;1,275225059;0,011255853;0,063921148;1,192028438;0,144788251;0;0;NA;NA;NA
X100300390_TGI_at;100300390_TGI_at;X05978;CSTA;cystatin A (stefin A);0,00000000000863000000;1,348665055;0,100343684;1,068223291;0,140918385;0,006359107;1,271337697;0,029237377;0;0;NA;NA;NA
X100300419_TGI_at;100300419_TGI_at;W28923;GNAZ;guanine nucleotide binding protein (G protein), alpha z polypeptide;0,00000000324000000000;0,793470418;0,00478784;0,901559605;0,014585264;0,144787165;0,898026773;0,25853132;0;0;NA;NA;NA
X100300422_TGI_at;100300422_TGI_at;W19346;SEMA5A;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A;0,00000000017700000000;0,724249565;0,021039396;0,829593534;0,042487451;0,940656418;0,968713132;0,965520903;0;0;NA;NA;NA
X100300494_TGI_at;100300494_TGI_at;U96721;HPS1;Hermansky-Pudlak syndrome 1;0,00000000000656000000;1,59652529;0,001248116;1,198821299;0,005610428;0,080609435;1,147731717;0,170587136;0;0;NA;NA;NA
X100300501_TGI_at;100300501_TGI_at;U90942;MYO5A;myosin VA (heavy chain 12, myoxin);0,00000000000002300000;1,65535664;0,001712667;1,200529161;0,007188327;0,010855277;1,271196991;0,041904859;0;1;U6;U1;U1
X100300502_TGI_at;100300502_TGI_at;U90920;ARHGAP29;Rho GTPase activating protein 29;0,00000000940000000000;0,708896611;0,027446409;0,904309085;0,051460022;0,110976585;0,867940591;0,212903293;0;0;NA;NA;NA
X100300504_TGI_at;100300504_TGI_at;U90236;MYO6;myosin VI;0,00000007890000000000;1,244526577;0,003786346;1,212920176;0,012414438;0,421327994;1,024638292;0,560904521;0;0;NA;NA;NA
X100300523_TGI_at;100300523_TGI_at;U66346;PDE4C;phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila);0,00000050900000000000;1,341431086;0,032139285;1,112767487;0,057998272;0,00226685;1,341622574;0,015678236;0;0;NA;NA;NA
X100300533_TGI_at;100300533_TGI_at;U59288;CDH13;cadherin 13, H-cadherin (heart);0,00000000000334000000;0,63976334;0,186948512;0,924659371;0,234814908;0,034975442;0,794662601;0,093703947;0;0;NA;NA;NA
X100300544_TGI_at;100300544_TGI_at;U50196;ADK;adenosine kinase;0,00000000104000000000;1,378729748;0,007197489;1,184138701;0,019510099;0,030011484;1,275889205;0,085222037;0;0;NA;NA;NA
X100300550_TGI_at;100300550_TGI_at;U43784;MAPKAPK3;mitogen-activated protein kinase-activated protein kinase 3;0,00000007530000000000;1,378362181;0,186948512;1,089880921;0,234814908;0,001710443;1,314567942;0,013125611;0;0;NA;NA;NA
X100300559_TGI_at;100300559_TGI_at;U38945;CDKN2A;cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4);0,00000000023300000000;1,571353184;1,75E-06;1,443716558;9,27E-05;0,107219939;1,199207031;0,208174617;0;0;NA;NA;NA
X100300560_TGI_at;100300560_TGI_at;U33837;LRP2;low density lipoprotein-related protein 2;0,00000000242000000000;1,811797049;0,011418316;1,384318861;0,026977475;0,000117389;2,254998372;0,003535926;0;1;U2;U1;U1
X100300571_TGI_at;100300571_TGI_at;U24152;PAK1;p21 protein (Cdc42/Rac)-activated kinase 1;0,00000045500000000000;1,285393012;0,47223542;1,04165825;0,514194175;0,759495311;0,98325399;0,842344593;0;0;NA;NA;NA
X100300592_TGI_at;100300592_TGI_at;U04343;CD86;CD86 molecule;0,00000000000007840000;1,748775494;0,000194337;1,33958239;0,00159156;0,003444946;1,48274136;0,019661534;0;1;U6;U1;U1
X100300599_TGI_at;100300599_TGI_at;T95917;LONP2;lon peptidase 2, peroxisomal;0,00000035200000000000;1,21737655;0,285784143;1,041952706;0,335060855;0,080609435;1,134257518;0,170587136;0;0;NA;NA;NA
X100300607_TGI_at;100300607_TGI_at;T83690;FRAS1;Fraser syndrome 1;0,00000030900000000000;0,7494254;0,462317258;0,909635139;0,504588054;0,980202899;1,059674133;0,987556719;0;0;NA;NA;NA
X100300613_TGI_at;100300613_TGI_at;T76939;NFIB;nuclear factor I/B;0,00000000002950000000;0,702186988;0,81210893;0,984832462;0,829875422;0,315016309;0,888887193;0,454361033;0;0;NA;NA;NA
X100300615_TGI_at;100300615_TGI_at;T73729;FGA;fibrinogen alpha chain;0,00000011700000000000;1,290784179;7,44E-05;1,448934255;0,000868464;0,061450873;1,15577183;0,141367712;0;0;NA;NA;NA
X100300637_TGI_at;100300637_TGI_at;S74774;FYN;FYN oncogene related to SRC, FGR, YES;0,00000042300000000000;0,817814979;0,016833096;0,884541436;0,035881658;0,738514412;1,017663799;0,827043763;0;0;NA;NA;NA
X100300658_TGI_at;100300658_TGI_at;R79897;HPGD;hydroxyprostaglandin dehydrogenase 15-(NAD);0,00000083000000000000;0,691067504;0,071793805;0,819539114;0,108736576;0,648925345;1,081090885;0,755321916;0;0;NA;NA;NA
X100300681_TGI_at;100300681_TGI_at;R49737;;;0,00000000066800000000;0,671535847;0,038540891;0,881615091;0,066524815;0,91436561;1,007926709;0,951873502;0;0;NA;NA;NA
X100300688_TGI_at;100300688_TGI_at;R42193;NDRG4;NDRG family member 4;0,00000000587000000000;0,754846695;0,000428415;0,80683024;0,002723432;0,63704437;0,939802952;0,747431382;0;0;NA;NA;NA
X100300699_TGI_at;100300699_TGI_at;R27783;LPHN2;latrophilin 2;0,00000001440000000000;0,755930399;0,000102249;0,794956955;0,001063056;0,114834098;0,861308211;0,21874131;0;0;NA;NA;NA
X100300727_TGI_at;100300727_TGI_at;NM_207582;;HERV-FRD provirus ancestral Env polyprotein;0,00000004220000000000;0,736221265;0,017801931;0,870693021;0,037208576;0,709599351;1,052263144;0,803597578;0;0;NA;NA;NA
X100300756_TGI_at;100300756_TGI_at;NM_206943;LTBP1;latent transforming growth factor beta binding protein 1;0,00000000086500000000;0,767742441;0,082917187;0,898430621;0,121694942;0,040752593;0,838605881;0,103748505;0;0;NA;NA;NA
X100300763_TGI_at;100300763_TGI_at;NM_206818;OSCAR;osteoclast associated, immunoglobulin-like receptor;0,00000000000072400000;1,898169264;0,000266578;1,363696748;0,001979679;9,98E-05;2,010378288;0,003183838;0;1;U2;U1;U1
X100300807_TGI_at;100300807_TGI_at;NM_198989;DLEU7;deleted in lymphocytic leukemia, 7;0,00000000001190000000;1,599118127;0,002042231;1,260172918;0,008096077;0,009283516;1,228723619;0,038004115;0;1;U2;U1;U1
X100300822_TGI_at;100300822_TGI_at;NM_198709;ARSB;arylsulfatase B;0,00000000098600000000;1,363962162;0,010014837;1,150456604;0,024730173;0,515344896;1,054232727;0,649064713;0;0;NA;NA;NA
X100300865_TGI_at;100300865_TGI_at;NM_197954;CLEC7A;C-type lectin domain family 7, member A;0,00000000000003240000;1,755323384;0,000138179;1,389496362;0,0012652;0,003250241;1,440540913;0,019115922;0;1;U5;U2;U1
X100300878_TGI_at;100300878_TGI_at;NM_183247;TMPRSS4;transmembrane protease, serine 4;0,00000000046800000000;2,627821136;0,175827036;1,350565272;0,222755715;0,849099163;0,847992522;0,906474529;0;0;NA;NA;NA
X100300884_TGI_at;100300884_TGI_at;NM_182945;NIN;ninein (GSK3B interacting protein);0,00000000115000000000;1,268729132;0,654148276;1,004805598;0,685632486;0,635603663;1,046840168;0,747431382;0;0;NA;NA;NA
X100300945_TGI_at;100300945_TGI_at;NM_178826;ANO4;anoctamin 4;0,00000005550000000000;0,743712239;0,001687111;0,815778471;0,007117225;0,187192252;0,938115539;0,313739277;0;0;NA;NA;NA
X100300954_TGI_at;100300954_TGI_at;NM_178564;NRBP2;nuclear receptor binding protein 2;0,00000000397000000000;0,813558649;0,155625162;0,92338523;0,200631958;0,305602819;0,957608025;0,445682301;0;0;NA;NA;NA
X100300965_TGI_at;100300965_TGI_at;NM_178273;PILRA;paired immunoglobin-like type 2 receptor alpha;0,00000000707000000000;1,372083449;0,01605445;1,163565457;0,034680626;0,010806794;1,373533721;0,041904859;0;1;U1;U1;U1
X100300990_TGI_at;100300990_TGI_at;NM_177405;CECR1;cat eye syndrome chromosome region, candidate 1;0,00000000072900000000;1,387201782;0,019215045;1,155162055;0,039673344;0,01262694;1,264846686;0,046447382;0;1;U2;U1;U1
X100301004_TGI_at;100301004_TGI_at;NM_175732;PTPMT1;protein tyrosine phosphatase, mitochondrial 1;0,00000000000000335000;1,425437404;0,004662592;1,121609513;0,01433925;3,49E-05;1,320753046;0,001805101;0;1;U3;U1;U1
X100301017_TGI_at;100301017_TGI_at;NM_174909;TMEM167A;transmembrane protein 167A;0,00000000005570000000;1,327015109;0,033579109;1,092299609;0,059497233;0,899296207;1,002631366;0,944937432;0;0;NA;NA;NA
X100301073_TGI_at;100301073_TGI_at;NM_172313;CSF3R;colony stimulating factor 3 receptor (granulocyte);0,00000054400000000000;1,32054436;0,077127246;1,113465317;0,114395359;0,007375314;1,405485396;0,032696886;0;0;NA;NA;NA
X100301074_TGI_at;100301074_TGI_at;NM_172250;MMAA;methylmalonic aciduria (cobalamin deficiency) cblA type;0,00000058600000000000;1,21644175;0,33148691;1,05210645;0,379666777;0,09653965;1,141034997;0,193392487;0;0;NA;NA;NA
X100301080_TGI_at;100301080_TGI_at;NM_172212;CSF1;colony stimulating factor 1 (macrophage);0,00000000000645000000;1,974925422;0,000125665;1,460790168;0,001194742;0,033503156;1,309009155;0,091046096;0;0;NA;NA;NA
X100301113_TGI_at;100301113_TGI_at;NM_153684;NUP50;nucleoporin 50kDa;0,00000008630000000000;1,281349677;0,000368513;1,306110663;0,002453959;0,103562613;1,134439107;0,203277894;0;0;NA;NA;NA
X100301118_TGI_at;100301118_TGI_at;NM_153366;SVEP1;sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1;0,00000000280000000000;0,696718342;0,018355863;0,840061311;0,038168352;0,373880087;0,912987999;0,511473085;0;0;NA;NA;NA
X100301122_TGI_at;100301122_TGI_at;NM_153292;NOS2;nitric oxide synthase 2, inducible;0,00000042300000000000;0,657748597;0,031293295;0,7635072;0,056725698;0,184980417;0,815697522;0,311548887;0;0;NA;NA;NA
X100301148_TGI_at;100301148_TGI_at;NM_152707;SLC25A16;"solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16";0,00000000105000000000;1,272556832;0,713221632;1,030967282;0,73842381;0,007537159;1,249801034;0,0330507;0;0;NA;NA;NA
X100301163_TGI_at;100301163_TGI_at;NM_152547;BTNL9;butyrophilin-like 9;0,00000080800000000000;0,669793789;0,003050272;0,767025871;0,010651167;0,350421333;0,871419434;0,489132939;0;0;NA;NA;NA
X100301180_TGI_at;100301180_TGI_at;NM_152406;AFAP1L1;actin filament associated protein 1-like 1;0,00000011900000000000;0,75582491;0,023705491;0,867960549;0,046304727;0,698315981;1,095001623;0,796134562;0;0;NA;NA;NA
X100301189_TGI_at;100301189_TGI_at;NM_152313;SLC36A4;solute carrier family 36 (proton/amino acid symporter), member 4;0,00000000009340000000;1,357910822;0,13333503;1,073057022;0,17692005;0,222469843;1,107696257;0,352690755;0;0;NA;NA;NA
X100301196_TGI_at;100301196_TGI_at;NM_148975;MS4A4A;membrane-spanning 4-domains, subfamily A, member 4;0,00000000000443000000;1,542537566;0,000222313;1,265753122;0,001751873;0,000558686;1,495767315;0,006820628;0;1;U6;U1;U1
X100301197_TGI_at;100301197_TGI_at;NM_148964;CTSE;cathepsin E;0,00000000288000000000;1,836337007;0,360249302;1,149874762;0,407397719;0,149505026;1,565470941;0,264174725;0;0;NA;NA;NA
X100301205_TGI_at;100301205_TGI_at;NM_147204;TRPV4;transient receptor potential cation channel, subfamily V, member 4;0,00000000000452000000;1,666887422;0,051212907;1,160598666;0,083153249;0,228052747;0,804222306;0,35942005;0;0;NA;NA;NA
X100301221_TGI_at;100301221_TGI_at;NM_145733;03/set;septin 3;0,00000035200000000000;1,481149363;0,002000343;1,258628967;0,007988979;0,119496494;1,197723779;0,225094798;0;0;NA;NA;NA
X100301228_TGI_at;100301228_TGI_at;NM_145642;APOL3;apolipoprotein L, 3;0,00000000001560000000;0,731065403;0,000154792;0,804674705;0,001355693;0,567746993;0,958543213;0,6918142;0;0;NA;NA;NA
X100301229_TGI_at;100301229_TGI_at;NM_145641;APOL3;apolipoprotein L, 3;0,00000000000733000000;0,722774491;0,000109657;0,800339638;0,001094198;0,672949117;0,964656251;0,774063003;0;0;NA;NA;NA
X100301230_TGI_at;100301230_TGI_at;NM_145640;APOL3;apolipoprotein L, 3;0,00000000001560000000;0,728868965;0,000213012;0,809565417;0,001699353;0,57904816;0,957961895;0,700552635;0;0;NA;NA;NA
X100301231_TGI_at;100301231_TGI_at;NM_145639;APOL3;apolipoprotein L, 3;0,00000000001460000000;0,72792931;0,000165838;0,801709693;0,00141401;0,440813265;0,951774619;0,5787133;0;0;NA;NA;NA
X100301248_TGI_at;100301248_TGI_at;NM_145273;CD300LG;CD300 molecule-like family member g;0,00000104000000000000;0,542961039;0,010906918;0,654678606;0,02611664;0,080140884;0,664988931;0,170587136;0;0;NA;NA;NA
X100301279_TGI_at;100301279_TGI_at;NM_144628;TBC1D20;TBC1 domain family, member 20;0,00000000000156000000;0,80605317;0,057616059;0,923878893;0,09125138;0,750005011;0,955749566;0,835845834;0;0;NA;NA;NA
X100301291_TGI_at;100301291_TGI_at;NM_139241;FGD4;FYVE, RhoGEF and PH domain containing 4;0,00000011400000000000;1,395584267;0,044206554;1,159276252;0,073860924;0,164346936;0,882556379;0,282652175;0;0;NA;NA;NA
X100301297_TGI_at;100301297_TGI_at;NM_139022;TSPAN32;tetraspanin 32;0,00000075100000000000;1,366407208;0,026048448;1,152017317;0,049675051;0,01554453;1,286248921;0,052959853;0;0;NA;NA;NA
X100301298_TGI_at;100301298_TGI_at;NM_139018;CD300LF;CD300 molecule-like family member f;0,00000000000000276000;1,791155214;0,000558438;1,338002791;0,003296419;0,010855277;1,515396014;0,041904859;0;1;U6;U1;U1
X100301315_TGI_at;100301315_TGI_at;NM_138715;MSR1;macrophage scavenger receptor 1;0,00000000004050000000;1,70988997;3,77E-05;1,453874395;0,000578467;0,00017114;1,675907779;0,004028419;0;1;U2;U1;U1
X100301331_TGI_at;100301331_TGI_at;NM_138362;FAM104B;family with sequence similarity 104, member B;0,00000073300000000000;0,830336659;0,001004664;0,824861671;0,004818499;0,069432339;0,88943639;0,153169355;0;0;NA;NA;NA
X100301334_TGI_at;100301334_TGI_at;NM_138337;CLEC12A;C-type lectin domain family 12, member A;0,00000000001890000000;1,887501603;0,008489575;1,316079869;0,02197743;0,028121921;1,57727997;0,080853658;0;0;NA;NA;NA
X100301348_TGI_at;100301348_TGI_at;NM_133484;TANK;TRAF family member-associated NFKB activator;0,00000101000000000000;1,263566061;0,003454833;1,190498917;0,011610977;0,660894461;0,988413045;0,764285198;0;0;NA;NA;NA
X100301362_TGI_at;100301362_TGI_at;NM_133169;OSCAR;osteoclast associated, immunoglobulin-like receptor;0,00000000000330000000;1,853086178;0,000278706;1,368648723;0,002018582;0,000259767;1,835511848;0,004600156;0;1;U2;U1;U1
X100301366_TGI_at;100301366_TGI_at;NM_130771;OSCAR;osteoclast associated, immunoglobulin-like receptor;0,00000000000420000000;1,851164383;0,000450954;1,358385576;0,002805841;0,000259767;1,821406959;0,004600156;0;1;U2;U1;U1
X100301367_TGI_at;100301367_TGI_at;NM_130762;MADCAM1;mucosal vascular addressin cell adhesion molecule 1;0,00000028800000000000;1,535279682;0,049321008;1,187284825;0,080650232;0,965670402;1,080160463;0,980394958;0;0;NA;NA;NA
X100301368_TGI_at;100301368_TGI_at;NM_130760;MADCAM1;mucosal vascular addressin cell adhesion molecule 1;0,00000002380000000000;1,519673572;0,05089478;1,193781117;0,082845391;0,924562456;1,084743959;0,959350695;0;0;NA;NA;NA
X100301380_TGI_at;100301380_TGI_at;NM_080718;TBX5;T-box 5;0,00000038300000000000;0,753656838;0,09349449;0,909947068;0,133569477;0,164346936;0,863324582;0,282652175;0;0;NA;NA;NA
X100301406_TGI_at;100301406_TGI_at;NM_052941;GBP4;guanylate binding protein 4;0,00000000011300000000;0,62191918;0,005857073;0,771083067;0,016676101;0,734410047;0,91246024;0,82359206;0;0;NA;NA;NA
X100301441_TGI_at;100301441_TGI_at;NM_033304;ADRA1A;adrenergic, alpha-1A-, receptor;0,00000000104000000000;0,689968026;0,014094273;0,833946632;0,031393119;0,159283623;0,893666248;0,276600817;0;0;NA;NA;NA
X100301446_TGI_at;100301446_TGI_at;NM_033222;PSIP1;PC4 and SFRS1 interacting protein 1;0,00000000047500000000;0,791335036;0,022121178;0,930753951;0,044091872;0,000661994;0,817406908;0,007434173;0;1;D1;D1;D1
X100301455_TGI_at;100301455_TGI_at;NM_033024;MACF1;microtubule-actin crosslinking factor 1;0,00000000002920000000;0,793530816;0,110978562;0,938715541;0,15207649;0,772133359;1,011535266;0,852547385;0;0;NA;NA;NA
X100301461_TGI_at;100301461_TGI_at;NM_032997;ZWINT;ZW10 interactor;0,00000001900000000000;1,452382769;0,004537508;1,230725721;0,014116205;0,045429645;1,279074018;0,112199038;0;0;NA;NA;NA
X100301485_TGI_at;100301485_TGI_at;NM_032683;;hypothetical protein MGC12972;0,00000118000000000000;1,227796384;0,754306221;0,998923788;0,775479729;0,234597793;1,083525741;0,367043051;0;0;NA;NA;NA
X100301595_TGI_at;100301595_TGI_at;NM_031459;SESN2;sestrin 2;0,00000000000039700000;1,571998225;0,021398285;1,15861013;0,042969889;0,005548396;1,299031262;0,02669027;0;1;U5;U1;U1
X100301622_TGI_at;100301622_TGI_at;NM_030789;HM13;histocompatibility (minor) 13;0,00000058600000000000;1,217965342;0,34191542;1,033818668;0,389948125;0,077689446;1,106637986;0,166153341;0;0;NA;NA;NA
X100301628_TGI_at;100301628_TGI_at;NM_030760;S1PR5;sphingosine-1-phosphate receptor 5;0,00000016000000000000;0,664631495;0,087025521;0,834976186;0,126286922;0,115439964;0,797986736;0,219635776;0;0;NA;NA;NA
X100301629_TGI_at;100301629_TGI_at;NM_030644;APOL3;apolipoprotein L, 3;0,00000000000972000000;0,725885691;9,94E-05;0,805917542;0,001053705;0,470967706;0,958437497;0,606928795;0;0;NA;NA;NA
X100301640_TGI_at;100301640_TGI_at;NM_025214;CCDC68;coiled-coil domain containing 68;0,00000011100000000000;0,700784866;0,057592601;0,85835674;0,09125138;0,734410047;1,049461101;0,82359206;0;0;NA;NA;NA
X100301645_TGI_at;100301645_TGI_at;NM_025185;TANC2;tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2;0,00000000000110000000;1,279273178;0,117215198;1,066992873;0,159000245;0,001660524;1,358299466;0,012896073;0;0;NA;NA;NA
X100301659_TGI_at;100301659_TGI_at;NM_025048;GPR110;G protein-coupled receptor 110;0,00000000000049400000;1,712306762;0,000125665;1,376798618;0,001194742;0,014643299;1,275478156;0,051467124;0;0;NA;NA;NA
X100301662_TGI_at;100301662_TGI_at;NM_025008;ADAMTSL4;ADAMTS-like 4;0,00000000046600000000;1,390078242;0,053926632;1,084936018;0,086556541;0,017119128;1,257770469;0,056940092;0;0;NA;NA;NA
X100301683_TGI_at;100301683_TGI_at;NM_024837;ATP8B4;ATPase, class I, type 8B, member 4;0,00000000000532000000;1,700773965;0,000552854;1,268188449;0,003269446;0,197238472;1,16428194;0,324667823;0;0;NA;NA;NA
X100301693_TGI_at;100301693_TGI_at;NM_024768;CCDC48;coiled-coil domain containing 48;0,00000002820000000000;0,677462565;0,00385602;0,817909945;0,012528179;0,312041432;0,8459656;0,452818341;0;0;NA;NA;NA
X100301712_TGI_at;100301712_TGI_at;NM_024587;TMEM53;transmembrane protein 53;0,00000000132000000000;1,327252718;0,242377952;1,070687004;0,290835495;0,044349835;1,234373952;0,110207801;0;0;NA;NA;NA
X100301724_TGI_at;100301724_TGI_at;NM_024334;TMEM43;transmembrane protein 43;0,00000000000424000000;0,832095601;0,00098459;0,931549397;0,004757623;0,698315981;0,985903331;0,796134562;0;0;NA;NA;NA
X100301726_TGI_at;100301726_TGI_at;NM_024318;LILRA6;leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6;0,00000008050000000000;1,566254783;0,225725769;1,126972788;0,274637279;0,00919586;1,392453971;0,038004115;0;0;NA;NA;NA
X100301739_TGI_at;100301739_TGI_at;NM_023926;ZSCAN18;zinc finger and SCAN domain containing 18;0,00000000693000000000;0,779001755;0,003433993;0,87823117;0,011577155;0,242831425;0,91901729;0,376271963;0;0;NA;NA;NA
X100301766_TGI_at;100301766_TGI_at;NM_022776;OSBPL11;oxysterol binding protein-like 11;0,00000038300000000000;1,270728549;0,004456737;1,153750035;0,013932165;0,046864607;1,24067474;0,114688405;0;0;NA;NA;NA
X100301774_TGI_at;100301774_TGI_at;NM_022736;MFSD1;major facilitator superfamily domain containing 1;0,00000000020900000000;1,239228052;0,002293473;1,087772375;0,008696308;0,003250241;1,168991418;0,019115922;0;1;U2;U1;U1
X100301776_TGI_at;100301776_TGI_at;NM_022572;PNKD;paroxysmal nonkinesigenic dyskinesia;0,00000000000262000000;1,43836141;0,01500958;1,168357053;0,032976056;0,000862533;1,387229785;0,008670668;0;1;U5;U1;U1
X100301794_TGI_at;100301794_TGI_at;NM_022059;CXCL16;chemokine (C-X-C motif) ligand 16;0,00000000000010600000;1,27358557;0,000564452;1,167211296;0,003319763;0,002861166;1,219348991;0,017893238;0;1;U2;U1;U1
X100301804_TGI_at;100301804_TGI_at;NM_021928;SPCS3;signal peptidase complex subunit 3 homolog (S. cerevisiae);0,00000000734000000000;1,325672765;0,010153099;1,156502444;0,024960671;0,315219134;1,100599285;0,454361033;0;0;NA;NA;NA
X100301807_TGI_at;100301807_TGI_at;NM_021871;FGA;fibrinogen alpha chain;0,00000000000107000000;5,774977676;8,08E-05;3,027223089;0,00091079;0,000923705;2,937749098;0,008967168;0;1;U6;U2;U1
X100301808_TGI_at;100301808_TGI_at;NM_021870;FGG;fibrinogen gamma chain;0,00000000000000492000;13,58162309;1,58E-05;3,667228266;0,000345112;5,15E-05;3,264905309;0,002079933;0;1;U8;U1;U1
X100301816_TGI_at;100301816_TGI_at;NM_021706;LAIR1;leukocyte-associated immunoglobulin-like receptor 1;0,00000000000162000000;1,599787788;0,0380271;1,168275139;0,065911982;0,012656854;1,400940561;0,046447382;0;0;NA;NA;NA
X100301817_TGI_at;100301817_TGI_at;NM_021642;FCGR2A;Fc fragment of IgG, low affinity IIa, receptor (CD32);0,00000002850000000000;1,231264809;0,029298155;1,114919292;0,054144468;0,083263264;1,206839555;0,17510994;0;0;NA;NA;NA
X100301825_TGI_at;100301825_TGI_at;NM_021159.2;RAP1GDS1;RAP1, GTP-GDP dissociation stimulator 1;0,00000000019700000000;1,228970141;0,514306248;1,01968941;0,553643633;0,200146826;1,072115493;0,328951158;0;0;NA;NA;NA
X100301855_TGI_at;100301855_TGI_at;NM_020848;KIAA1462;KIAA1462;0,00000000006360000000;0,684186373;0,007320753;0,835230411;0,019739332;0,339979528;0,898798729;0,480593868;0;0;NA;NA;NA
X100301857_TGI_at;100301857_TGI_at;NM_020828;ZFP28;zinc finger protein 28 homolog (mouse);0,00000000021200000000;0,74036288;0,038556734;0,895034702;0,066524815;0,041415229;0,809483471;0,104282253;0;0;NA;NA;NA
X100301865_TGI_at;100301865_TGI_at;NM_020777;SORCS2;sortilin-related VPS10 domain containing receptor 2;0,00000111000000000000;1,25620798;0,497295263;1,053648697;0,537305609;0,100003042;1,221032142;0,198466629;0;0;NA;NA;NA
X100301870_TGI_at;100301870_TGI_at;NM_020716;GRAMD1B;GRAM domain containing 1B;0,00000004220000000000;1,358957169;0,033345326;1,127432644;0,059245858;0,007144385;1,247592459;0,031892454;0;0;NA;NA;NA
X100301873_TGI_at;100301873_TGI_at;NM_020681;SEMA6A;sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A;0,00000000000161000000;0,683452088;0,108833569;0,907645299;0,149837929;0,810391779;1,016160422;0,881205366;0;0;NA;NA;NA
X100301892_TGI_at;100301892_TGI_at;NM_020365;EIF2B3;eukaryotic translation initiation factor 2B, subunit 3 gamma, 58kDa;0,00000000000311000000;1,215971226;0,636535271;1,013487265;0,669785563;0,043170182;1,078584861;0,107774978;0;0;NA;NA;NA
X100301962_TGI_at;100301962_TGI_at;NM_018593.2;SLC16A10;solute carrier family 16, member 10 (aromatic amino acid transporter);0,00000000177000000000;1,755776682;0,000212593;1,665234964;0,001699353;0,023487994;1,460608009;0,070485851;0;0;NA;NA;NA
X100301988_TGI_at;100301988_TGI_at;NM_018407;LAPTM4B;lysosomal protein transmembrane 4 beta;0,00000087100000000000;1,220278826;0,142312127;1,066875434;0,186224923;0,077689446;1,180248546;0,166153341;0;0;NA;NA;NA
X100301989_TGI_at;100301989_TGI_at;NM_018404;ADAP2;ArfGAP with dual PH domains 2;0,00000000063000000000;1,433913645;0,407854011;1,044733406;0,453320332;0,055034692;1,173654044;0,12937769;0;0;NA;NA;NA
X100301994_TGI_at;100301994_TGI_at;NM_018367.2;PHCA;phytoceramidase, alkaline;0,00000000734000000000;1,354089938;0,009579042;1,17774637;0,023877225;0,045429645;1,285749979;0,112199038;0;0;NA;NA;NA
X100302053_TGI_at;100302053_TGI_at;NM_017817;RAB20;RAB20, member RAS oncogene family;0,00000000025000000000;1,309496431;0,531498004;1,030654327;0,56986629;0,100003042;1,163676528;0,198466629;0;0;NA;NA;NA
X100302055_TGI_at;100302055_TGI_at;NM_017791;FLVCR2;feline leukemia virus subgroup C cellular receptor family, member 2;0,00000000040000000000;1,400689833;0,108127834;1,166235157;0,149121099;0,005235058;1,268728627;0,025720413;0;0;NA;NA;NA
X100302088_TGI_at;100302088_TGI_at;NM_017571;CCDC88A;coiled-coil domain containing 88A;0,00000000472000000000;1,316909328;0,059125914;1,114675114;0,093139209;0,215347198;1,084727069;0,344448645;0;0;NA;NA;NA
X100302089_TGI_at;100302089_TGI_at;NM_017565;FAM20A;family with sequence similarity 20, member A;0,00000000048200000000;1,455875986;0,006385541;1,1694717;0,017849609;0,003250241;1,35704276;0,019115922;0;1;U6;U1;U1
X100302099_TGI_at;100302099_TGI_at;NM_017424;CECR1;cat eye syndrome chromosome region, candidate 1;0,00000000042000000000;1,380615923;0,012410242;1,169276692;0,028676416;0,014643299;1,266577482;0,051467124;0;0;NA;NA;NA
X100302100_TGI_at;100302100_TGI_at;NM_017423;GALNT7;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7);0,00000003680000000000;1,280047537;0,00207888;1,10598642;0,008201018;0,648925345;1,063495558;0,755321916;0;0;NA;NA;NA
X100302108_TGI_at;100302108_TGI_at;NM_016827;OGG1;8-oxoguanine DNA glycosylase;0,00000004960000000000;0,791404069;0,001004664;0,857913242;0,004818499;0,81616847;0,997751188;0,885097907;0;0;NA;NA;NA
X100302109_TGI_at;100302109_TGI_at;NM_016826;OGG1;8-oxoguanine DNA glycosylase;0,00000016000000000000;0,797976835;0,000836876;0,86813798;0,004336418;0,660894461;0,921419626;0,764285198;0;0;NA;NA;NA
X100302114_TGI_at;100302114_TGI_at;NM_016610;TLR8;toll-like receptor 8;0,00000000056300000000;1,89937591;0,020822243;1,299708741;0,042154578;0,001558392;1,819181176;0,012371173;0;1;U1;U1;U1
X100302141_TGI_at;100302141_TGI_at;NM_016326;CKLF;chemokine-like factor;0,00000000132000000000;1,291423902;0,001554317;1,117380435;0,006643984;0,017971918;1,152751748;0,058805575;0;0;NA;NA;NA
X100302152_TGI_at;100302152_TGI_at;NM_016205;PDGFC;platelet derived growth factor C;0,00000000914000000000;1,251449102;0,004745963;1,110155943;0,014553986;0,209323164;1,130616703;0,337324278;0;0;NA;NA;NA
X100302154_TGI_at;100302154_TGI_at;NM_016201;AMOTL2;angiomotin like 2;0,00000059900000000000;0,782132806;0,01344048;0,885849904;0,030302638;0,154336744;1,117916508;0,270635106;0;0;NA;NA;NA
X100302162_TGI_at;100302162_TGI_at;NM_016103;SAR1B;SAR1 homolog B (S. cerevisiae);0,00000000000830000000;1,291102663;0,029927107;1,090626805;0,05498277;0,660894461;0,99750571;0,764285198;0;0;NA;NA;NA
X100302169_TGI_at;100302169_TGI_at;NM_016032;ZDHHC9;zinc finger, DHHC-type containing 9;0,00000056700000000000;1,212889752;0,549465309;1,032397818;0,586399566;0,032083057;1,157833714;0,088319445;0;0;NA;NA;NA
X100302186_TGI_at;100302186_TGI_at;NM_015851;HLA-DOA;major histocompatibility complex, class II, DO alpha;0,00000123000000000000;1,201619739;0,116554233;1,084815424;0,158236855;0,00256018;1,23634175;0,01677126;0;0;NA;NA;NA
X100302187_TGI_at;100302187_TGI_at;NM_015842;LMO7;LIM domain 7;0,00000051500000000000;0,793532963;0,48239216;1,031854421;0,524014133;0,114834098;1,301963752;0,21874131;0;0;NA;NA;NA
X100302212_TGI_at;100302212_TGI_at;NM_015488;PNKD;paroxysmal nonkinesigenic dyskinesia;0,00000000000811000000;1,430061016;0,024778326;1,157302811;0,047792068;0,001497214;1,372422841;0,012033721;0;1;U5;U1;U1
X100302221_TGI_at;100302221_TGI_at;NM_015392;NPDC1;neural proliferation, differentiation and control, 1;0,00000002510000000000;0,76959158;0,005715124;0,830722988;0,016466538;0,002151633;0,745900096;0,015075462;0;1;D2;D1;D1
X100302229_TGI_at;100302229_TGI_at;NM_015313;ARHGEF12;Rho guanine nucleotide exchange factor (GEF) 12;0,00000000001910000000;0,794441355;0,000667146;0,889206354;0,003711391;0,545460135;0,951057135;0,674086662;0;0;NA;NA;NA
X100302238_TGI_at;100302238_TGI_at;NM_015187;;KIAA0746 protein;0,00000000660000000000;1,2242134;0,028046529;1,094094828;0,052351584;0,074175285;1,193983233;0,161422649;0;0;NA;NA;NA
X100302246_TGI_at;100302246_TGI_at;NM_015030;FRYL;FRY-like;0,00000000068600000000;0,799651154;0,032873206;0,944784683;0,058795973;0,37483693;0,960545881;0,511473085;0;0;NA;NA;NA
X100302288_TGI_at;100302288_TGI_at;NM_014705;DOCK4;dedicator of cytokinesis 4;0,00000000013800000000;0,756162031;0,001850312;0,8906786;0,007561703;0,365926162;0,93242215;0,503363219;0;0;NA;NA;NA
X100302305_TGI_at;100302305_TGI_at;NM_014505.3;KCNMB4;potassium large conductance calcium-activated channel, subfamily M, beta member 4;0,00000000000206000000;0,588152506;5,38E-05;0,733134203;0,000715495;0,164346936;0,848727107;0,282652175;0;0;NA;NA;NA
X100302312_TGI_at;100302312_TGI_at;NM_014397;NEK6;NIMA (never in mitosis gene a)-related kinase 6;0,00000000000000694000;1,888961606;0,000577323;1,270606576;0,003352635;0,002409533;1,329455047;0,016145377;0;1;U6;U1;U1
X100302313_TGI_at;100302313_TGI_at;NM_014395;DAPP1;dual adaptor of phosphotyrosine and 3-phosphoinositides;0,00000000385000000000;1,352345474;0,620984743;1,008362893;0,654277158;0,209185181;1,148540955;0,337324278;0;0;NA;NA;NA
X100302319_TGI_at;100302319_TGI_at;NM_014349;APOL3;apolipoprotein L, 3;0,00000000001980000000;0,729007668;0,000162076;0,806059812;0,001397404;0,470967706;0,95264171;0,606928795;0;0;NA;NA;NA
X100302321_TGI_at;100302321_TGI_at;NM_014339;IL17RA;interleukin 17 receptor A;0,00000051800000000000;1,251554136;0,817729147;0,986392039;0,834031975;0,01554453;1,262800226;0,052959853;0;0;NA;NA;NA
X100302323_TGI_at;100302323_TGI_at;NM_014326;DAPK2;death-associated protein kinase 2;0,00000000045300000000;0,701603056;0,027837492;0,853899512;0,052102344;0,402505519;1,141835393;0,542112532;0;0;NA;NA;NA
X100302365_TGI_at;100302365_TGI_at;NM_013402;FADS1;fatty acid desaturase 1;0,00000000000122000000;1,392870388;0,022718929;1,147152453;0,045060374;0,003661766;1,363784887;0,020560753;0;1;U7;U1;U1
X100302370_TGI_at;100302370_TGI_at;NM_013372;GREM1;gremlin 1, cysteine knot superfamily, homolog (Xenopus laevis);0,00000016900000000000;1,84726919;0,031491038;1,642231393;0,056987993;0,660413637;0,982624739;0,764285198;0;0;NA;NA;NA
X100302400_TGI_at;100302400_TGI_at;NM_012331;MSRA;methionine sulfoxide reductase A;0,00000000241000000000;1,276444094;0,011443663;1,116858502;0,026977475;0,03650134;1,250640005;0,096439395;0;0;NA;NA;NA
X100302408_TGI_at;100302408_TGI_at;NM_012259;HEY2;hairy/enhancer-of-split related with YRPW motif 2;0,00000000001420000000;0,598580184;0,040183399;0,797106599;0,068669721;0,01554453;0,731646998;0,052959853;0;0;NA;NA;NA
X100302462_TGI_at;100302462_TGI_at;NM_007022;CYB561D2;cytochrome b-561 domain containing 2;0,00000000040700000000;1,271532301;0,170118588;1,049048831;0,216118333;0,024581037;1,170266806;0,072950903;0;0;NA;NA;NA
X100302488_TGI_at;100302488_TGI_at;NM_006774;INMT;indolethylamine N-methyltransferase;0,00000000160000000000;0,817898251;8,57E-05;0,812967239;0,000961872;0,209323164;0,989819884;0,337324278;0;0;NA;NA;NA
X100302489_TGI_at;100302489_TGI_at;NM_006762;LAPTM5;lysosomal multispanning membrane protein 5;0,00000000000001370000;1,340616854;0,004377271;1,102258278;0,01372368;0,000538929;1,273547505;0,006680644;0;1;U5;U1;U1
X100302520_TGI_at;100302520_TGI_at;NM_006408;AGR2;anterior gradient homolog 2 (Xenopus laevis);0,00000009590000000000;1,512482829;0,430071053;1,106022101;0,474860912;0,431008093;1,001153943;0,568620174;0;0;NA;NA;NA
X100302546_TGI_at;100302546_TGI_at;NM_006120;HLA-DMA;major histocompatibility complex, class II, DM alpha;0,00000000060700000000;1,230668791;0,004008236;1,126896412;0,012828742;0,000355178;1,287153832;0,00537129;0;1;U2;U2;U1
X100302562_TGI_at;100302562_TGI_at;NM_005994.2;TBX2;T-box 2;0,00000000009040000000;0,626503789;0,000128962;0,747253744;0,001204762;0,209185181;0,874083526;0,337324278;0;0;NA;NA;NA
X100302619_TGI_at;100302619_TGI_at;NM_005489;SH2D3C;SH2 domain containing 3C;0,00000000805000000000;0,71105934;0,003371859;0,81694776;0,011403465;0,746919855;1,0950679;0,832983631;0;0;NA;NA;NA
X100302632_TGI_at;100302632_TGI_at;NM_005373;MPL;myeloproliferative leukemia virus oncogene;0,00000003760000000000;0,731123483;0,580907236;0,951227079;0,615876323;0,303779418;0,862346215;0,443625313;0;0;NA;NA;NA
X100302686_TGI_at;100302686_TGI_at;NM_004881;TP53I3;tumor protein p53 inducible protein 3;0,00000032900000000000;1,276946229;0,051212907;1,102723211;0,083153249;0,008831116;1,31690886;0,036964527;0;0;NA;NA;NA
X100302687_TGI_at;100302687_TGI_at;NM_004874;BAG4;BCL2-associated athanogene 4;0,00000000089200000000;1,455269429;5,39E-05;1,280010384;0,000715495;0,025484686;1,207139685;0,075217163;0;0;NA;NA;NA
X100302688_TGI_at;100302688_TGI_at;NM_004867;ITM2A;integral membrane protein 2A;0,00000000000143000000;0,671911176;0,000999539;0,867460957;0,004818499;0,110976585;0,904124039;0,212903293;0;0;NA;NA;NA
X100302689_TGI_at;100302689_TGI_at;NM_004864;GDF15;growth differentiation factor 15;0,00000000000001830000;2,816043094;0,000333836;1,617078572;0,002284401;0,131303184;1,244618425;0,240585653;0;0;NA;NA;NA
X100302691_TGI_at;100302691_TGI_at;NM_004846;EIF4E2;eukaryotic translation initiation factor 4E family member 2;0,00000013000000000000;1,200775123;0,223416733;1,043288979;0,272849094;0,203149235;1,103901159;0,330514884;0;0;NA;NA;NA
X100302693_TGI_at;100302693_TGI_at;NM_004835;AGTR1;angiotensin II receptor, type 1;0,00000034600000000000;0,754371108;0,094984342;0,909765238;0,134920465;0,512848122;0,993766146;0,646425302;0;0;NA;NA;NA
X100302695_TGI_at;100302695_TGI_at;NM_004823;KCNK6;potassium channel, subfamily K, member 6;0,00000085000000000000;1,267265007;0,123158888;0,939296271;0,165737409;0,114834098;1,11766138;0,21874131;0;0;NA;NA;NA
X100302710_TGI_at;100302710_TGI_at;NM_004666;VNN1;vanin 1;0,00000002370000000000;1,87452492;0,078967443;1,230493843;0,116641645;0,709599351;1,07576315;0,803597578;0;0;NA;NA;NA
X100302713_TGI_at;100302713_TGI_at;NM_004635;MAPKAPK3;mitogen-activated protein kinase-activated protein kinase 3;0,00000000033600000000;1,303228137;0,137178612;1,089417219;0,18097694;0,001882981;1,362512862;0,014113602;0;0;NA;NA;NA
X100302720_TGI_at;100302720_TGI_at;NM_004582;RABGGTB;Rab geranylgeranyltransferase, beta subunit;0,00000001100000000000;1,224961197;0,004119392;1,086662883;0,013055233;0,679153243;1,013409473;0,780082288;0;0;NA;NA;NA
X100302737_TGI_at;100302737_TGI_at;NM_004363;CEACAM5;carcinoembryonic antigen-related cell adhesion molecule 5;0,00000001280000000000;3,452615347;2,70E-05;3,222372597;0,000475581;0,048807143;2,235229579;0,118721072;0;0;NA;NA;NA
X100302740_TGI_at;100302740_TGI_at;NM_004324;BAX;BCL2-associated X protein;0,00000000000408000000;1,435475535;0,070638801;1,108441042;0,107492378;0,014774182;1,293275004;0,051589587;0;0;NA;NA;NA
X100302750_TGI_at;100302750_TGI_at;NM_004258;IGSF2;immunoglobulin superfamily, member 2;0,00000000000000155000;2,600473662;1,51E-05;1,76232942;0,000343266;0,000185312;2,191205022;0,004028419;0;1;U1;U1;U1
X100302762_TGI_at;100302762_TGI_at;NM_004145;MYO9B;myosin IXB;0,00000000323000000000;1,346495393;0,162297341;1,061384363;0,208068548;0,431008093;1,103697467;0,568620174;0;0;NA;NA;NA
X100302763_TGI_at;100302763_TGI_at;NM_004132;HABP2;hyaluronan binding protein 2;0,00000000000000113000;3,305847113;3,53E-08;2,501505472;6,69E-06;0,001433084;1,796969515;0,011752749;0;1;U8;U3;U1
X100302772_TGI_at;100302772_TGI_at;NM_003991;EDNRB;endothelin receptor type B;0,00000000000008430000;0,584484194;0,000502021;0,771611905;0,003035671;0,980202899;1,082306991;0,987556719;0;0;NA;NA;NA
X100302774_TGI_at;100302774_TGI_at;NM_003937;KYNU;kynureninase (L-kynurenine hydrolase);0,00000000002800000000;1,935498853;0,00033996;1,389528197;0,002301874;0,002131763;1,557915974;0,014968787;0;1;U2;U1;U1
X100302790_TGI_at;100302790_TGI_at;NM_003811;TNFSF9;tumor necrosis factor (ligand) superfamily, member 9;0,00000000000000109000;1,827232711;2,58E-05;1,467982484;0,000460173;0,004342204;1,407492745;0,022867523;0;1;U4;U2;U1
X100302791_TGI_at;100302791_TGI_at;NM_003810;TNFSF10;tumor necrosis factor (ligand) superfamily, member 10;0,00000045400000000000;0,734847405;0,008179808;0,808881169;0,021433757;0,523607186;1,103363528;0,657671847;0;0;NA;NA;NA
X100302811_TGI_at;100302811_TGI_at;NM_003580;NSMAF;neutral sphingomyelinase (N-SMase) activation associated factor;0,00000000011100000000;1,218762893;0,00608885;1,124262828;0,017229467;0,31372464;1,049404249;0,454361033;0;0;NA;NA;NA
X100302850_TGI_at;100302850_TGI_at;NM_003128;SPTBN1;spectrin, beta, non-erythrocytic 1;0,00000000000143000000;0,751655151;9,99E-05;0,828098181;0,001055515;0,91436561;1,033072073;0,951873502;0;0;NA;NA;NA
X100302851_TGI_at;100302851_TGI_at;NM_003122;SPINK1;serine peptidase inhibitor, Kazal type 1;0,00000028500000000000;2,081126026;0,003898682;1,705208046;0,012604096;0,117745748;1,40776369;0,223495021;0;0;NA;NA;NA
X100302853_TGI_at;100302853_TGI_at;NM_003104;SORD;sorbitol dehydrogenase;0,00000000159000000000;1,299646036;0,87149108;1,028602886;0,882997721;0,746919855;0,956111043;0,832983631;0;0;NA;NA;NA
X100302854_TGI_at;100302854_TGI_at;NM_003101;SOAT1;sterol O-acyltransferase 1;0,00000000000012600000;1,889235479;8,01E-06;1,318558966;0,000248289;0,086710607;1,290101631;0,179491513;0;0;NA;NA;NA
X100302870_TGI_at;100302870_TGI_at;NM_002906;RDX;radixin;0,00000026200000000000;0,812135597;0,707530368;0,984007801;0,733709902;0,993400377;1,013451764;0,995253159;0;0;NA;NA;NA
X100302892_TGI_at;100302892_TGI_at;NM_002766;PRPSAP1;phosphoribosyl pyrophosphate synthetase-associated protein 1;0,00000000057100000000;0,806966487;0,001125297;0,897996067;0,005263905;0,534478464;0,933003998;0,664336324;0;0;NA;NA;NA
X100302913_TGI_at;100302913_TGI_at;NM_002543;OLR1;oxidized low density lipoprotein (lectin-like) receptor 1;0,00000000000000062700;1,513842979;0,00010576;1,269418875;0,001071898;0,000137814;1,610642751;0,003701458;0;1;U2;U2;U1
X100302920_TGI_at;100302920_TGI_at;NM_002445;MSR1;macrophage scavenger receptor 1;0,00000000000004130000;1,523023626;3,08E-05;1,275542635;0,000504257;3,58E-05;1,585734257;0,001805101;0;1;U2;U2;U1
X100302926_TGI_at;100302926_TGI_at;NM_002392;MDM2;Mdm2 p53 binding protein homolog (mouse);0,00000000159000000000;1,400377071;0,001828264;1,236258547;0,007525538;0,35549972;1,05786387;0,494450884;0;0;NA;NA;NA
X100302928_TGI_at;100302928_TGI_at;NM_002375;MAP4;microtubule-associated protein 4;0,00000000027800000000;0,831272972;6,62E-05;0,891288734;0,000812592;0,3219842;0,950461062;0,462755775;0;0;NA;NA;NA
X100302950_TGI_at;100302950_TGI_at;NM_002064;GLRX;glutaredoxin (thioltransferase);0,00000000008210000000;1,407019189;0,003819241;1,241612377;0,012480854;0,267057988;0,874599018;0,403399161;0;0;NA;NA;NA
X100302954_TGI_at;100302954_TGI_at;NM_002020;FLT4;fms-related tyrosine kinase 4;0,00000000086500000000;0,747182554;0,029725907;0,847544084;0,054809267;0,57904816;0,919955575;0,700552635;0;0;NA;NA;NA
X100302959_TGI_at;100302959_TGI_at;NM_001935;DPP4;dipeptidyl-peptidase 4;0,00000000385000000000;1,473187785;0,003454833;1,200447453;0,011610977;0,003444946;1,667013627;0,019661534;0;1;U6;U1;U1
X100302960_TGI_at;100302960_TGI_at;NM_001932;MPP3;membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3);0,00000006160000000000;0,729745088;0,053277656;0,828347936;0,085642836;0,613556941;0,941013613;0,727019861;0;0;NA;NA;NA
X100302963_TGI_at;100302963_TGI_at;NM_001910;CTSE;cathepsin E;0,00000000169000000000;1,854040917;0,335917459;1,150529828;0,384303319;0,159283623;1,55556817;0,276600817;0;0;NA;NA;NA
X100302972_TGI_at;100302972_TGI_at;NM_001860;SLC31A2;solute carrier family 31 (copper transporters), member 2;0,00000000000118000000;1,425767177;0,010717959;1,162881721;0,025848719;0,000281133;1,371309309;0,004768908;0;1;U3;U1;U1
X100302987_TGI_at;100302987_TGI_at;NM_001736;C5AR1;complement component 5a receptor 1;0,00000000000271000000;1,419210771;0,00088411;1,189296756;0,004487371;0,041415229;1,250295643;0,104282253;0;0;NA;NA;NA
X100302989_TGI_at;100302989_TGI_at;NM_001701;BAAT;bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase);0,00000013200000000000;1,340856571;0,009341024;1,175768425;0,023502047;0,726611241;1,013460899;0,817976958;0;0;NA;NA;NA
X100302990_TGI_at;100302990_TGI_at;NM_001694;ATP6V0C;ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c;0,00000000017000000000;1,246671519;0,047714643;1,062542882;0,078541519;0,002719171;1,193531532;0,017251748;0;0;NA;NA;NA
X100302991_TGI_at;100302991_TGI_at;NM_001693;ATP6V1B2;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2;0,00000000000114000000;1,264200382;0,003786346;1,114663088;0,012414438;0,002409533;1,217024829;0,016145377;0;1;U2;U1;U1
X100302995_TGI_at;100302995_TGI_at;NM_001633;AMBP;alpha-1-microglobulin/bikunin precursor;0,00000000021500000000;1,362350422;0,378013819;1,044300128;0,425397535;0,000181762;1,352371688;0,004028419;0;0;NA;NA;NA
X100303016_TGI_at;100303016_TGI_at;NM_001424;EMP2;epithelial membrane protein 2;0,00000038300000000000;0,74125524;0,317546799;0,910428456;0,36656638;0,144922405;1,243903306;0,25862952;0;0;NA;NA;NA
X100303023_TGI_at;100303023_TGI_at;NM_001360;DHCR7;7-dehydrocholesterol reductase;0,00000000013900000000;1,448135401;0,27459638;1,065844228;0,323710364;1,34E-05;1,600006289;0,00144276;0;0;NA;NA;NA
X100303025_TGI_at;100303025_TGI_at;NM_001336;CTSZ;cathepsin Z;0,00000003210000000000;1,301858808;0,372419657;1,06400329;0,419688306;0,000753789;1,39473226;0,007913552;0;0;NA;NA;NA
X100303026_TGI_at;100303026_TGI_at;NM_001332;CTNND2;catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein);0,00000000091900000000;0,604185535;0,12609829;0,835943074;0,169128085;0,849099163;1,1051912;0,906474529;0;0;NA;NA;NA
X100303033_TGI_at;100303033_TGI_at;NM_001295;CCR1;chemokine (C-C motif) receptor 1;0,00000000003120000000;1,446070149;0,003612061;1,199780221;0,011977029;0,00919586;1,40139716;0,038004115;0;1;U2;U1;U1
X100303034_TGI_at;100303034_TGI_at;NM_001290;LDB2;LIM domain binding 2;0,00000000000972000000;0,740345517;0,000286278;0,880339832;0,002059544;0,212463914;0,898593738;0,341531768;0;0;NA;NA;NA
X100303079_TGI_at;100303079_TGI_at;NM_001100912;BEND7;BEN domain containing 7;0,00000000078900000000;0,802270701;0,076428642;0,922023146;0,113673056;0,18024766;0,931496422;0,304954439;0;0;NA;NA;NA
X100303083_TGI_at;100303083_TGI_at;NM_001100812;CXCL16;chemokine (C-X-C motif) ligand 16;0,00000000000000000874;1,676257757;6,52E-05;1,328207457;0,000805535;0,000221405;1,506138918;0,004272984;0;1;U4;U2;U1
X100303100_TGI_at;100303100_TGI_at;NM_001099694;ZNF578;zinc finger protein 578;0,00000027500000000000;0,762461325;0,00077099;0,84249089;0,004127742;0,442606018;0,896633854;0,579650222;0;0;NA;NA;NA
X100303108_TGI_at;100303108_TGI_at;NM_001099280;;hypothetical protein KIAA1833;0,00000000000787000000;1,428829795;0,252851456;1,029735873;0,301829719;0,005143125;1,294364826;0,025423759;0;0;NA;NA;NA
X100303115_TGI_at;100303115_TGI_at;NM_001098825;TMEM91;transmembrane protein 91;0,00000000005420000000;1,236608003;0,026062833;1,080718097;0,049675051;0,021756187;1,173690811;0,067164932;0;0;NA;NA;NA
X100303119_TGI_at;100303119_TGI_at;NM_001098634;RBM47;RNA binding motif protein 47;0,00000029800000000000;1,216270414;0,362300012;1,041858597;0,409429501;0,140181821;1,239285058;0,252829328;0;0;NA;NA;NA
X100303128_TGI_at;100303128_TGI_at;NM_001098483;C10orf125;chromosome 10 open reading frame 125;0,00000000000052600000;1,599062509;0,005774829;1,21499541;0,016573709;0,003239583;1,488542006;0,019115922;0;1;U1;U1;U1
X100303129_TGI_at;100303129_TGI_at;NM_001098479;HLA-F;major histocompatibility complex, class I, F;0,00000027500000000000;0,811078807;0,058366931;0,928501212;0,092304523;1;0,987358444;1;0;0;NA;NA;NA
X100303188_TGI_at;100303188_TGI_at;NM_001080498;EMR4P;egf-like module containing, mucin-like, hormone receptor-like 4 pseudogene;0,00000000848000000000;1,686209956;0,000564452;1,519494409;0,003319763;0,001311767;1,591303095;0,011184726;0;1;U1;U1;U1
X100303191_TGI_at;100303191_TGI_at;NM_001080494;TTC39A;tetratricopeptide repeat domain 39A;0,00000001280000000000;1,314652202;0,920155713;0,991978116;0,927929244;0,029139344;1,387887727;0,083541684;0;0;NA;NA;NA
X100303221_TGI_at;100303221_TGI_at;NM_001079843;CASZ1;castor zinc finger 1;0,00000010100000000000;0,787328742;0,311393181;0,949096985;0,360884654;0,802816453;0,997956706;0,876241102;0;0;NA;NA;NA
X100303237_TGI_at;100303237_TGI_at;NM_001076675;ZNF626;zinc finger protein 626;0,00000001280000000000;0,720219309;0,019292443;0,860506942;0,039807646;0,209185181;0,84697609;0,337324278;0;0;NA;NA;NA
X100303239_TGI_at;100303239_TGI_at;NM_001061;TBXAS1;thromboxane A synthase 1 (platelet);0,00000000000025900000;1,485836511;0,013463661;1,120928419;0,030302638;0,000803319;1,426008245;0,008256949;0;1;U6;U1;U1
X100303247_TGI_at;100303247_TGI_at;NM_001047434;DPH3;DPH3, KTI11 homolog (S. cerevisiae);0,00000000000452000000;1,529291406;0,001004664;1,217294512;0,004818499;0,005373466;1,232912431;0,026121691;0;1;U2;U3;U1
X100303249_TGI_at;100303249_TGI_at;NM_001045556;SLA;Src-like-adaptor;0,00000089900000000000;1,250525396;0,130619943;1,077290313;0,174250032;0,81616847;0,955344546;0,885097907;0;0;NA;NA;NA
X100303266_TGI_at;100303266_TGI_at;NM_001042422;SLC16A3;solute carrier family 16, member 3 (monocarboxylic acid transporter 4);0,00000000000950000000;1,584325336;0,05251581;1,115681603;0,084820412;0,209180841;1,209455934;0,337324278;0;0;NA;NA;NA
X100303292_TGI_at;100303292_TGI_at;NM_001040003;NCF1;neutrophil cytosolic factor 1;0,00000001850000000000;1,680588117;0,005463048;1,261944673;0,01600673;0,000753789;1,783373628;0,007913552;0;1;U1;U1;U1
X100303315_TGI_at;100303315_TGI_at;NM_001037954;DIXDC1;DIX domain containing 1;0,00000002120000000000;0,772398774;0,12689158;0,920161184;0,170050546;0,248075799;0,906512765;0,381463883;0;0;NA;NA;NA
X100303342_TGI_at;100303342_TGI_at;NM_001031744;HSD17B7P2;hydroxysteroid (17-beta) dehydrogenase 7 pseudogene 2;0,00000001270000000000;1,297431873;0,73756481;1,036980892;0,760451498;0,043170182;1,249609144;0,107774978;0;0;NA;NA;NA
X100303347_TGI_at;100303347_TGI_at;NM_001031716;OBFC2A;oligonucleotide/oligosaccharide-binding fold containing 2A;0,00000012500000000000;1,307718559;0,088373832;1,124434366;0,127813203;0,613556941;0,959078301;0,727019861;0;0;NA;NA;NA
X100303349_TGI_at;100303349_TGI_at;NM_001031701;NT5DC3;"5';-nucleotidase domain containing 3";0,00000021800000000000;0,827397724;0,54929724;0,947693494;0,586399566;0,135030094;0,826843925;0,246713147;0;0;NA;NA;NA
X100303364_TGI_at;100303364_TGI_at;NM_001025368;VEGFA;vascular endothelial growth factor A;0,00000019200000000000;0,781910797;0,321951967;0,938218573;0,370325193;0,966354072;1,018041095;0,980394958;0;0;NA;NA;NA
X100303382_TGI_at;100303382_TGI_at;NM_001024074;HNMT;histamine N-methyltransferase;0,00000000000000273000;1,602281911;0,019590297;1,141829969;0,040216259;0,000923705;1,366170153;0,008967168;0;1;U2;U1;U1
X100303384_TGI_at;100303384_TGI_at;NM_001018115;FANCD2;Fanconi anemia, complementation group D2;0,00000000025600000000;1,368862972;0,0630447;1,111700368;0,097870787;0,587186896;1,063222361;0,708272218;0;0;NA;NA;NA
X100303426_TGI_at;100303426_TGI_at;NM_001012665;DYNC2LI1;dynein, cytoplasmic 2, light intermediate chain 1;0,00000000248000000000;0,776857833;0,210618902;0,956704495;0,259679814;0,019518593;0,854788689;0,062162477;0;0;NA;NA;NA
X100303445_TGI_at;100303445_TGI_at;NM_001009568;SMPDL3B;sphingomyelin phosphodiesterase, acid-like 3B;0,00000000756000000000;1,436481416;0,058350121;1,144879465;0,092304523;0,044986133;1,345287942;0,111445279;0;0;NA;NA;NA
X100303450_TGI_at;100303450_TGI_at;NM_001008707;EML1;echinoderm microtubule associated protein like 1;0,00000000707000000000;0,707201953;0,0762663;0,912708313;0,113483972;0,383877774;0,881759868;0,520942343;0;0;NA;NA;NA
X100303493_TGI_at;100303493_TGI_at;NM_001005741;GBA;"glucosidase, beta; acid (includes glucosylceramidase)";0,00000000013200000000;1,364483714;0,167985773;1,062416464;0,213745814;0,010314762;1,24198258;0,040961273;0;0;NA;NA;NA
X100303500_TGI_at;100303500_TGI_at;NM_001005377;PLAUR;plasminogen activator, urokinase receptor;0,00000000001760000000;1,746145965;0,000198758;1,446475995;0,001617667;0,004342204;1,475194074;0,022867523;0;1;U4;U3;U1
X100303505_TGI_at;100303505_TGI_at;NM_001005176;SP140;SP140 nuclear body protein;0,00000000013200000000;1,552902968;0,005517643;1,252101254;0,016108119;0,000612657;1,483648469;0,007180335;0;1;U6;U1;U1
X100303529_TGI_at;100303529_TGI_at;NM_001002275;FCGR2B;Fc fragment of IgG, low affinity IIb, receptor (CD32);0,00000000271000000000;1,496677522;0,001490572;1,274972836;0,00650083;0,164346936;1,196065378;0,282652175;0;0;NA;NA;NA
X100303531_TGI_at;100303531_TGI_at;NM_001002235;SERPINA1;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1;0,00000000000011500000;1,282130242;0,006956535;1,143081414;0,019033032;2,08E-05;1,392172272;0,001749595;0;1;U6;U1;U1
X100303536_TGI_at;100303536_TGI_at;NM_001001939;PCBD1;pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha;0,00000012600000000000;1,234523132;0,004043969;1,114780953;0,012891901;0,005356868;1,261395879;0,026121691;0;1;U1;U1;U1
X100303544_TGI_at;100303544_TGI_at;NM_001001668;ZNF470;zinc finger protein 470;0,00000111000000000000;0,782391005;0,001815037;0,839308155;0,007499003;0,35549972;0,92804867;0,494450884;0;0;NA;NA;NA
X100303556_TGI_at;100303556_TGI_at;NM_001001290;SLC2A9;solute carrier family 2 (facilitated glucose transporter), member 9;0,00000000000001780000;1,702861149;1,68E-05;1,259811352;0,000356071;0,001227552;1,326886962;0,01072195;0;1;U5;U1;U1
X100303565_TGI_at;100303565_TGI_at;NM_000923;PDE4C;phosphodiesterase 4C, cAMP-specific (phosphodiesterase E1 dunce homolog, Drosophila);0,00000000567000000000;1,797925931;0,026832411;1,270845889;0,050619894;0,013444935;1,559384145;0,048579627;0;0;NA;NA;NA
X100303585_TGI_at;100303585_TGI_at;NM_000777;CYP3A5;cytochrome P450, family 3, subfamily A, polypeptide 5;0,00000001280000000000;0,628839811;0,032598151;0,820987205;0,058433727;0,623344939;0,996707706;0,736451884;0;0;NA;NA;NA
X100303594_TGI_at;100303594_TGI_at;NM_000698;ALOX5;arachidonate 5-lipoxygenase;0,00000000000020100000;1,597734981;0,000131328;1,279116197;0,001222808;0,001370872;1,500082434;0,011387427;0;1;U2;U1;U1
X100303598_TGI_at;100303598_TGI_at;NM_000677;ADORA3;adenosine A3 receptor;0,00000001930000000000;1,624299905;0,177645539;1,202609417;0,224530028;0,029393816;1,421159972;0,083541684;0;0;NA;NA;NA
X100303608_TGI_at;100303608_TGI_at;NM_000581;GPX1;glutathione peroxidase 1;0,00000000000000807000;1,385109171;0,113249769;1,051759166;0,154335732;0,000188734;1,376556437;0,004028419;0;0;NA;NA;NA
X100303618_TGI_at;100303618_TGI_at;NM_000487;ARSA;arylsulfatase A;0,00000103000000000000;1,38632979;0,576525867;1,008094679;0,611633598;0,004862758;1,376751088;0,024374289;0;0;NA;NA;NA
X100303619_TGI_at;100303619_TGI_at;NM_000483;APOC2;apolipoprotein C-II;0,00000002380000000000;2,078287425;9,94E-05;1,737478131;0,001053705;0,001127468;2,321526175;0,010122083;0;1;U2;U2;U1
X100303621_TGI_at;100303621_TGI_at;NM_000461;THRB;thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian);0,00000000648000000000;0,80972572;0,100343684;0,939444973;0,140918385;0,267097055;0,914155382;0,403399161;0;0;NA;NA;NA
X100303628_TGI_at;100303628_TGI_at;NM_000391;TPP1;tripeptidyl peptidase I;0,00000000000019400000;1,31544039;0,026812922;1,079609431;0,050619894;0,004474434;1,167673441;0,02341088;0;0;NA;NA;NA
X100303638_TGI_at;100303638_TGI_at;NM_000271;NPC1;Niemann-Pick disease, type C1;0,00000002100000000000;1,271372972;0,005326341;1,128169715;0,015749355;9,19E-05;1,345143739;0,003022585;0;1;U4;U1;U1
X100303648_TGI_at;100303648_TGI_at;NM_000195;HPS1;Hermansky-Pudlak syndrome 1;0,00000011100000000000;1,277182015;0,059105286;1,095225923;0,093139209;0,262074839;1,136304033;0,39749045;0;0;NA;NA;NA
X100303651_TGI_at;100303651_TGI_at;NM_000167;GK;glycerol kinase;0,00000000353000000000;1,520199639;0,005183407;1,18854314;0,015488965;0,154336744;1,248646429;0,270635106;0;0;NA;NA;NA
X100303658_TGI_at;100303658_TGI_at;NM_000104;CYP1B1;cytochrome P450, family 1, subfamily B, polypeptide 1;0,00000000000000000007;4,417204418;4,16E-10;2,364306789;1,68E-07;0,001703037;1,595615973;0,013125611;0;1;U8;U4;U1
X100303659_TGI_at;100303659_TGI_at;NM_000101;CYBA;cytochrome b-245, alpha polypeptide;0,00000000001020000000;1,481213861;0,024715872;1,137895142;0,047757347;0,016349104;1,41188432;0,055233924;0;0;NA;NA;NA
X100303667_TGI_at;100303667_TGI_at;NM_000041;APOE;apolipoprotein E;0,00000000020100000000;1,992111052;0,006838796;1,277302639;0,018822749;0,005437653;1,508473619;0,026196646;0;1;U4;U1;U1
X100303679_TGI_at;100303679_TGI_at;N79400;TMEM144;transmembrane protein 144;0,00000000012800000000;1,32443977;0,000376562;1,209308021;0,002487007;0,357146031;1,151783639;0,494450884;0;0;NA;NA;NA
X100303707_TGI_at;100303707_TGI_at;N27741;PLUNC;palate, lung and nasal epithelium associated;0,00000000000049100000;15,07101819;0,001302493;3,986916114;0,005814313;0,545460135;0,827680007;0,674086662;0;0;NA;NA;NA
X100303710_TGI_at;100303710_TGI_at;N25888;GDF15;growth differentiation factor 15;0,00000000000004000000;1,985237435;0,003277374;1,313784257;0,011201461;0,003371616;1,343403304;0,019650484;0;1;U6;U1;U2
X100303728_TGI_at;100303728_TGI_at;M63014;PON1;paraoxonase 1;0,00000000908000000000;1,682787678;1,47E-05;1,719980512;0,000337712;0,002131763;1,512567148;0,014968787;0;1;U2;U3;U1
X100303745_TGI_at;100303745_TGI_at;M35296;ABL2;v-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene);0,00000036400000000000;1,450799716;0,024715872;1,216215213;0,047757347;0,441735902;0,854559507;0,579452507;0;0;NA;NA;NA
X100303749_TGI_at;100303749_TGI_at;M32373;ARSB;arylsulfatase B;0,00000000080600000000;1,504729325;0,14546655;1,113982806;0,189353268;0,007460982;1,303961524;0,032940745;0;0;NA;NA;NA
X100303750_TGI_at;100303750_TGI_at;M31158;PRKAR2B;protein kinase, cAMP-dependent, regulatory, type II, beta;0,00000007430000000000;0,759755123;0,057331504;0,926589343;0,091204066;0,660894461;0,935458977;0,764285198;0;0;NA;NA;NA
X100303754_TGI_at;100303754_TGI_at;M28253;CYP11A1;cytochrome P450, family 11, subfamily A, polypeptide 1;0,00000058600000000000;1,353771257;0,655913179;1,067305114;0,686812273;0,491673531;1,101334362;0,627589621;0;0;NA;NA;NA
X100303766_TGI_at;100303766_TGI_at;M19922;FBP1;fructose-1,6-bisphosphatase 1;0,00000000000002070000;1,707435157;3,82E-05;1,44539069;0,000578519;0,000203903;1,728382007;0,004159363;0;1;U2;U1;U1
X100303768_TGI_at;100303768_TGI_at;M18414;TRDV1;T cell receptor delta variable 1;0,00000000863000000000;0,608026711;0,028663655;0,795599123;0,053185353;0,374422782;1,06189959;0,511473085;0;0;NA;NA;NA
X100303772_TGI_at;100303772_TGI_at;M16765;APP;amyloid beta (A4) precursor protein;0,00000000000034400000;0,815664975;0,026236583;0,918369906;0,049929935;0,274492264;0,939397536;0,411866186;0;0;NA;NA;NA
X100303794_TGI_at;100303794_TGI_at;L32185;SLC11A1;solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1;0,00000000002400000000;1,832494648;0,023356949;1,23314441;0,045707011;0,007948708;1,64543846;0,034341403;0;1;U2;U1;U1
X100303796_TGI_at;100303796_TGI_at;L29376;;MHC class I mRNA fragment 3.8-1;0,00000009240000000000;0,765424113;0,268305342;0,9271408;0,317338759;1;1,021667257;1;0;0;NA;NA;NA
X100303823_TGI_at;100303823_TGI_at;J04183;LAMP2;lysosomal-associated membrane protein 2;0,00000000000454000000;1,373927213;0,000112238;1,220411434;0,001109637;0,00226685;1,349922301;0,015678236;0;1;U2;U1;U1
X100303860_TGI_at;100303860_TGI_at;H38281;SGSM1;small G protein signaling modulator 1;0,00000000067700000000;0,745157568;0,196606479;0,909780988;0,24503584;0,127027071;0,880436895;0,235834246;0;0;NA;NA;NA
X100303901_TGI_at;100303901_TGI_at;ENST00000390477;TRDV1;T cell receptor delta variable 1;0,00000051800000000000;0,592349159;0,017153183;0,759429924;0,036371519;0,276598639;1,160783864;0,413486741;0;0;NA;NA;NA
X100303953_TGI_at;100303953_TGI_at;ENST00000381323;FAM49A;family with sequence similarity 49, member A;0,00000013300000000000;1,357223347;0,010895442;1,209693197;0,02611664;0,103904525;1,202738632;0,203577073;0;0;NA;NA;NA
X100303958_TGI_at;100303958_TGI_at;ENST00000380725;CDKN1C;cyclin-dependent kinase inhibitor 1C (p57, Kip2);0,00000002140000000000;0,769355231;0,012410242;0,875918635;0,028676416;0,613556941;1,023461973;0,727019861;0;0;NA;NA;NA
X100303975_TGI_at;100303975_TGI_at;ENST00000378952;NUDT5;nudix (nucleoside diphosphate linked moiety X)-type motif 5;0,00000000000536000000;1,215372285;0,214902634;1,034461192;0,263911579;0,048205102;1,077545664;0,117790025;0;0;NA;NA;NA
X100303982_TGI_at;100303982_TGI_at;ENST00000377918;PCDH17;protocadherin 17;0,00000000805000000000;0,640319399;0,011258261;0,807886395;0,026680893;0,064330368;0,670651742;0,144788251;0;0;NA;NA;NA
X100303997_TGI_at;100303997_TGI_at;ENST00000376517;ABHD12;abhydrolase domain containing 12;0,00000000000141000000;1,52054634;0,003674662;1,144058119;0,012122249;0,002487191;1,353156168;0,016596722;0;1;U4;U1;U1
X100304013_TGI_at;100304013_TGI_at;ENST00000374690;AR;androgen receptor;0,00000000021200000000;0,744941738;0,010386329;0,843238917;0,025245201;0,072102527;0,858998739;0,157336794;0;0;NA;NA;NA
X100304015_TGI_at;100304015_TGI_at;ENST00000374536;TCEB3;transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A);0,00000000034800000000;1,273310327;0,262287169;1,053967476;0,311592903;0,010806794;1,20540468;0,041904859;0;0;NA;NA;NA
X100304017_TGI_at;100304017_TGI_at;ENST00000373857;PTAFR;platelet-activating factor receptor;0,00000000000091700000;1,724624042;0,042442521;1,183378309;0,071469302;1,19E-05;1,764664095;0,001323039;0;0;NA;NA;NA
X100304023_TGI_at;100304023_TGI_at;ENST00000373506;ZBTB8OS;zinc finger and BTB domain containing 8 opposite strand;0,00000000000141000000;1,280706632;0,075321601;1,072884728;0,112389593;0,008800507;1,180096318;0,036964527;0;0;NA;NA;NA
X100304054_TGI_at;100304054_TGI_at;ENST00000370894;FPGT;fucose-1-phosphate guanylyltransferase;0,00000016100000000000;1,256127523;6,10E-05;1,21149451;0,000770895;0,245573996;1,089264302;0,379609108;0;0;NA;NA;NA
X100304070_TGI_at;100304070_TGI_at;ENST00000370076;NTNG1;netrin G1;0,00000001650000000000;0,714207436;0,051893584;0,851621888;0,084046744;0,709599351;0,919026844;0,803597578;0;0;NA;NA;NA
X100304083_TGI_at;100304083_TGI_at;ENST00000368925;DDO;D-aspartate oxidase;0,00000000232000000000;1,452355653;0,027233712;1,204264609;0,051218159;0,023487994;1,28154031;0,070485851;0;0;NA;NA;NA
X100304085_TGI_at;100304085_TGI_at;ENST00000368682;FYN;FYN oncogene related to SRC, FGR, YES;0,00000007090000000000;0,829712204;0,001746475;0,879949694;0,007300763;0,341346989;0,944052734;0,482315364;0;0;NA;NA;NA
X100304091_TGI_at;100304091_TGI_at;ENST00000368054;CD84;CD84 molecule;0,00000000196000000000;1,677954853;0,514126673;1,07576699;0,553635238;0,041415229;1,387026886;0,104282253;0;0;NA;NA;NA
X100304094_TGI_at;100304094_TGI_at;ENST00000367649;RASAL2;RAS protein activator like 2;0,00000003120000000000;1,238985739;0,002507396;1,171884654;0,009235815;0,133199162;1,150462174;0,243505899;0;0;NA;NA;NA
X100304101_TGI_at;100304101_TGI_at;ENST00000367051;CR1;complement component (3b/4b) receptor 1 (Knops blood group);0,00000000002190000000;1,664615538;0,042887999;1,165004877;0,07214406;0,089895036;1,234826529;0,184145191;0;0;NA;NA;NA
X100304106_TGI_at;100304106_TGI_at;ENST00000366654;FAM89A;family with sequence similarity 89, member A;0,00000000001140000000;1,383373225;0,024778326;1,153407424;0,047792068;0,037400545;1,261942846;0,098562514;0;0;NA;NA;NA
X100304163_TGI_at;100304163_TGI_at;ENST00000338578;NCF1B;neutrophil cytosolic factor 1B pseudogene;0,00000001320000000000;1,659194331;0,003076272;1,28481851;0,010707153;0,000429707;1,739123389;0,005893387;0;1;U1;U1;U1
X100304179_TGI_at;100304179_TGI_at;ENST00000330964;RPS27L;ribosomal protein S27-like;0,00000000000179000000;1,337433173;0,019612282;1,132187235;0,040235763;0,002081391;1,208779021;0,014968787;0;1;U3;U1;U1
X100304234_TGI_at;100304234_TGI_at;ENST00000287497;ITGAM;integrin, alpha M (complement component 3 receptor 3 subunit);0,00000000002250000000;1,712742055;0,006722851;1,238540862;0,01856705;0,003797214;1,396815293;0,021100725;0;1;U1;U1;U1
X100304242_TGI_at;100304242_TGI_at;ENST00000270464;LILRB3;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3;0,00000000001280000000;1,605461909;0,015486569;1,164848361;0,033702371;0,049454079;1,207715007;0,12011341;0;0;NA;NA;NA
X100304269_TGI_at;100304269_TGI_at;ENST00000238918;BAI3;brain-specific angiogenesis inhibitor 3;0,00000004090000000000;0,635592794;0,0630447;0,855399821;0,097870787;0,37483693;0,883256742;0,511473085;0;0;NA;NA;NA
X100304275_TGI_at;100304275_TGI_at;ENST00000221130;GSR;glutathione reductase;0,00000000078900000000;1,264000108;0,01261405;1,094755019;0,029018619;0,00919586;1,17709395;0,038004115;0;1;U2;U1;U1
X100304293_TGI_at;100304293_TGI_at;EF553520;CD109;CD109 molecule;0,00000000027800000000;1,296627058;0,000775214;1,204617013;0,004136613;0,81616847;1,00208104;0,885097907;0;0;NA;NA;NA
X100304352_TGI_at;100304352_TGI_at;EB387542;10/set;septin 10;0,00000007660000000000;0,788242371;0,720349785;1,023603511;0,744846762;0,993400377;1,068194681;0,995253159;0;0;NA;NA;NA
X100304400_TGI_at;100304400_TGI_at;DR423676;JAM2;junctional adhesion molecule 2;0,00000000003370000000;0,728876411;0,049728695;0,948224575;0,081234456;0,022470993;0,821602699;0,068453695;0;0;NA;NA;NA
X100304425_TGI_at;100304425_TGI_at;DQ895023;ATP6V1B2;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2;0,00000000000023500000;1,396942963;0,00389894;1,204882958;0,012604096;0,001497214;1,382944375;0,012033721;0;1;U1;U1;U1
X100304426_TGI_at;100304426_TGI_at;DQ894918;TRIM38;tripartite motif-containing 38;0,00000001810000000000;1,236013122;0,000474433;1,170477031;0,002905189;0,013270593;1,192899885;0,048111498;0;1;U1;U1;U1
X100304450_TGI_at;100304450_TGI_at;DQ893132;MMP7;matrix metallopeptidase 7 (matrilysin, uterine);0,00000079000000000000;1,730809305;0,000791659;1,611918475;0,004196572;0,026555824;1,796434344;0,077596935;0;0;NA;NA;NA
X100304468_TGI_at;100304468_TGI_at;DQ892684;ITGB2;integrin, beta 2 (complement component 3 receptor 3 and 4 subunit);0,00000000296000000000;1,487919553;0,013019646;1,206364775;0,029735334;0,00236704;1,332873033;0,016094875;0;1;U5;U1;U1
X100304472_TGI_at;100304472_TGI_at;DQ892544;SPP1;secreted phosphoprotein 1;0,00000000220000000000;2,623370725;0,0169985;1,716336047;0,036091018;0,951948154;0,881325631;0,974385319;0;0;NA;NA;NA
X100304496_TGI_at;100304496_TGI_at;DQ891835;SLC7A7;solute carrier family 7 (cationic amino acid transporter, y+ system), member 7;0,00000000003160000000;1,407917193;0,0380271;1,155764712;0,065911982;0,001950454;1,484765263;0,014451293;0;0;NA;NA;NA
X100304512_TGI_at;100304512_TGI_at;DQ891071;ASAH1;N-acylsphingosine amidohydrolase (acid ceramidase) 1;0,00000063300000000000;1,273346843;0,001554317;1,243726502;0,006643984;0,002861166;1,597556285;0,017893238;0;1;U1;U1;U1
X100304519_TGI_at;100304519_TGI_at;DQ890758;AKR1B1;aldo-keto reductase family 1, member B1 (aldose reductase);0,00000000486000000000;1,339791654;0,042160976;1,126348755;0,071218463;0,000281133;1,489463349;0,004768908;0;0;NA;NA;NA
X100304521_TGI_at;100304521_TGI_at;DQ890613;CHN1;chimerin (chimaerin) 1;0,00000059900000000000;0,783025402;0,896513818;1,015440611;0,905788099;0,883640065;0,989359429;0,933455238;0;0;NA;NA;NA
X100304527_TGI_at;100304527_TGI_at;DQ836394;FLT1;fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);0,00000000353000000000;0,771046593;2,70E-05;0,772049512;0,000475581;0,251357622;0,920059812;0,386141856;0;0;NA;NA;NA
X100304571_TGI_at;100304571_TGI_at;DN990445;TCEAL2;transcription elongation factor A (SII)-like 2;0,00000000000001650000;0,519232382;0,000151437;0,683736712;0,00134088;0,295660849;0,807033437;0,435717839;0;0;NA;NA;NA
X100304596_TGI_at;100304596_TGI_at;DC353575;SPARCL1;SPARC-like 1 (hevin);0,00000003180000000000;0,815606429;0,020067257;0,898881787;0,041020393;0,054500465;0,901154917;0,128784177;0;0;NA;NA;NA
X100304610_TGI_at;100304610_TGI_at;DB571936;POLR3K;polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa;0,00000000824000000000;1,231263622;0,040588371;1,100756657;0,069251625;0,188348637;1,101994091;0,315185699;0;0;NA;NA;NA
X100304613_TGI_at;100304613_TGI_at;DB567851;RAPGEF4;Rap guanine nucleotide exchange factor (GEF) 4;0,00000045400000000000;0,683593143;0,124065523;0,8750553;0,166818182;0,980202899;0,960827011;0,987556719;0;0;NA;NA;NA
X100304614_TGI_at;100304614_TGI_at;DB567116;TMEM35;transmembrane protein 35;0,00000002780000000000;0,681549825;0,380521699;0,962582781;0,427324542;0,135687627;0,834466901;0,247213805;0;0;NA;NA;NA
X100304620_TGI_at;100304620_TGI_at;DB540400;RAPGEF4;Rap guanine nucleotide exchange factor (GEF) 4;0,00000002880000000000;0,658443535;0,087025521;0,87682979;0,126286922;0,91436561;0,969741;0,951873502;0;0;NA;NA;NA
X100304629_TGI_at;100304629_TGI_at;DB521849;MS4A14;membrane-spanning 4-domains, subfamily A, member 14;0,00000000185000000000;1,813376929;0,002468511;1,422416731;0,009146232;0,028121921;1,742107991;0,080853658;0;0;NA;NA;NA
X100304654_TGI_at;100304654_TGI_at;DB477632;;;0,00000005240000000000;1,281699799;0,560985751;1,034461783;0,596915508;0,100003042;1,12718894;0,198466629;0;0;NA;NA;NA
X100304683_TGI_at;100304683_TGI_at;DB365874;;;0,00000000006360000000;0,589087104;0,002515697;0,735756407;0,009245257;0,221636126;0,842500448;0,351888292;0;0;NA;NA;NA
X100304688_TGI_at;100304688_TGI_at;DB356727;NTNG1;netrin G1;0,00000008270000000000;0,754725621;0,057616059;0,857350192;0,09125138;0,122857837;0,8252097;0,229149774;0;0;NA;NA;NA
X100304689_TGI_at;100304689_TGI_at;DB356566;RAB23;RAB23, member RAS oncogene family;0,00000032600000000000;0,794185802;0,210734374;0,946685434;0,259679814;0,114834098;0,900412268;0,21874131;0;0;NA;NA;NA
X100304725_TGI_at;100304725_TGI_at;DB331903;BCL2L14;BCL2-like 14 (apoptosis facilitator);0,00000000039500000000;1,439768705;0,166579462;1,074117374;0,212375635;0,567746993;1,021300495;0,6918142;0;0;NA;NA;NA
X100304726_TGI_at;100304726_TGI_at;DB330556;SSR1;signal sequence receptor, alpha;0,00000020200000000000;1,212375392;0,032940498;1,078054143;0,058873378;0,980202899;1,009105963;0,987556719;0;0;NA;NA;NA
X100304734_TGI_at;100304734_TGI_at;DB325606;;;0,00000110000000000000;0,805906247;0,001273337;0,830115681;0,00570788;1;0,970636889;1;0;0;NA;NA;NA
X100304748_TGI_at;100304748_TGI_at;DB317311;GIMAP1;GTPase, IMAP family member 1;0,00000000014200000000;0,634224838;0,005857073;0,8194485;0,016676101;0,660894461;1,078371129;0,764285198;0;0;NA;NA;NA
X100304751_TGI_at;100304751_TGI_at;DB312027;SLCO1A2;solute carrier organic anion transporter family, member 1A2;0,00000015200000000000;0,504817225;0,183185043;0,807968504;0,230807425;0,149505026;1,298787946;0,264174725;0;0;NA;NA;NA
X100304772_TGI_at;100304772_TGI_at;DB299957;;;0,00000000000173000000;1,575884328;0,210741641;1,098260909;0,259679814;0,006071612;1,341078888;0,028156556;0;0;NA;NA;NA
X100304848_TGI_at;100304848_TGI_at;DA833911;SLC43A2;solute carrier family 43, member 2;0,00000002120000000000;1,341288151;0,267714477;1,045476694;0,316872479;0,002719171;1,389608598;0,017251748;0;0;NA;NA;NA
X100304875_TGI_at;100304875_TGI_at;DA765181;RBMS3;RNA binding motif, single stranded interacting protein;0,00000001420000000000;0,820300929;0,004830681;0,892521304;0,014701875;0,089895036;0,88017595;0,184145191;0;0;NA;NA;NA
X100304878_TGI_at;100304878_TGI_at;DA748162;ZNF271;zinc finger protein 271;0,00000003120000000000;1,222229996;0,655913179;1,01624393;0,686812273;0,245573996;1,051064934;0,379609108;0;0;NA;NA;NA
X100304886_TGI_at;100304886_TGI_at;DA734980;SLC13A4;solute carrier family 13 (sodium/sulfate symporters), member 4;0,00000000459000000000;1,210424615;0,002775838;1,087843943;0,009874753;0,071816378;1,109625937;0,157336794;0;0;NA;NA;NA
X100304907_TGI_at;100304907_TGI_at;DA646246;GRB2;growth factor receptor-bound protein 2;0,00000101000000000000;1,202954891;0,032598151;1,105528658;0,058433727;0,012010459;1,270787978;0,044912263;0;0;NA;NA;NA
X100304940_TGI_at;100304940_TGI_at;DA498480;CTNND2;catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein);0,00000002060000000000;0,79236981;0,252745809;0,939946565;0,301815391;0,131303184;1,103157047;0,240585653;0;0;NA;NA;NA
X100305048_TGI_at;100305048_TGI_at;D78129;SQLE;squalene epoxidase;0,00000058400000000000;1,263032927;0,441819571;1,029173287;0,485690869;0,014774182;1,251511221;0,051589587;0;0;NA;NA;NA
X100305055_TGI_at;100305055_TGI_at;D59253;NCBP2;nuclear cap binding protein subunit 2, 20kDa;0,00000000000055800000;1,431970497;0,00260307;1,138297168;0,009458504;0,015374349;1,204752475;0,052959853;0;0;NA;NA;NA
X100305058_TGI_at;100305058_TGI_at;D45917;TIMP3;TIMP metallopeptidase inhibitor 3;0,00000000033600000000;0,773988914;0,015486569;0,911446692;0,033702371;0,567746993;0,920937695;0,6918142;0;0;NA;NA;NA
X100305082_TGI_at;100305082_TGI_at;CX873518;HSDL2;hydroxysteroid dehydrogenase like 2;0,00000013700000000000;1,21531595;0,005517643;1,103416521;0,016108119;0,002302051;1,260975064;0,015887602;0;1;U1;U1;U1
X100305087_TGI_at;100305087_TGI_at;CX870374;MACF1;microtubule-actin crosslinking factor 1;0,00000000000070600000;0,825335036;0,007039731;0,932867018;0,019195477;0,967010726;0,990388594;0,980394958;0;0;NA;NA;NA
X100305096_TGI_at;100305096_TGI_at;CX865413;LDHB;lactate dehydrogenase B;0,00000000079800000000;1,214196423;0,003839642;1,142678504;0,012512807;0,029393816;1,153460446;0,083541684;0;0;NA;NA;NA
X100305107_TGI_at;100305107_TGI_at;CX782729;PDK3;pyruvate dehydrogenase kinase, isozyme 3;0,00000000002620000000;1,296512132;0,000854145;1,145213652;0,004397617;0,483056205;1,049831477;0,620027936;0;0;NA;NA;NA
X100305111_TGI_at;100305111_TGI_at;CX762683;PGD;phosphogluconate dehydrogenase;0,00000000000000008820;1,591937195;0,001219327;1,190914398;0,005518227;0,000616664;1,321160617;0,007201116;0;1;U6;U1;U1
X100305164_TGI_at;100305164_TGI_at;CR974602;UBA52;ubiquitin A-52 residue ribosomal protein fusion product 1;0,00000000863000000000;1,262192517;0,094809248;1,047858665;0,134790564;0,111490212;1,101727562;0,213634335;0;0;NA;NA;NA
X100305174_TGI_at;100305174_TGI_at;CR936625;KCNE3;potassium voltage-gated channel, Isk-related family, member 3;0,00000000457000000000;1,440382232;0,089140461;1,118788923;0,128776202;0,100003042;1,218277368;0,198466629;0;0;NA;NA;NA
X100305183_TGI_at;100305183_TGI_at;CR749546;PTPRB;protein tyrosine phosphatase, receptor type, B;0,00000000612000000000;0,702517311;0,444468355;0,932721525;0,48824864;0,460794302;1,122696608;0,597401462;0;0;NA;NA;NA
X100305202_TGI_at;100305202_TGI_at;CR741383;;;0,00000001050000000000;0,578577236;0,019215045;0,734373082;0,039673344;0,953827391;1,026861901;0,974385319;0;0;NA;NA;NA
X100305208_TGI_at;100305208_TGI_at;CR739580;LMO3;LIM domain only 3 (rhombotin-like 2);0,00000008690000000000;1,314529497;0,000190191;1,343839979;0,001571754;0,058379601;1,298702198;0,13605022;0;0;NA;NA;NA
X100305212_TGI_at;100305212_TGI_at;CR737921;ME2;malic enzyme 2, NAD(+)-dependent, mitochondrial;0,00000007230000000000;1,276375008;0,00314995;1,141093912;0,010858063;0,029200074;1,147595989;0,083541684;0;0;NA;NA;NA
X100305216_TGI_at;100305216_TGI_at;CR627469;PSMB7;proteasome (prosome, macropain) subunit, beta type, 7;0,00000000000072600000;1,334485164;0,000237679;1,173346099;0,001841444;0,000461729;1,235503555;0,006049403;0;1;U2;U1;U1
X100305221_TGI_at;100305221_TGI_at;CR627386;HEXA;hexosaminidase A (alpha polypeptide);0,00000000000007580000;1,337002001;0,00046485;1,130464793;0,002853737;0,000127227;1,331242561;0,003628771;0;1;U2;U2;U1
X100305225_TGI_at;100305225_TGI_at;CR626036;FDX1;ferredoxin 1;0,00000000227000000000;1,287909816;0,004744494;1,121019422;0,014553986;0,044986133;1,155550689;0,111445279;0;0;NA;NA;NA
X100305228_TGI_at;100305228_TGI_at;CR624148;SSR3;signal sequence receptor, gamma (translocon-associated protein gamma);0,00000000000005230000;1,284797607;0,004513052;1,084465637;0,014053687;0,234597793;1,128341307;0,367043051;0;0;NA;NA;NA
X100305235_TGI_at;100305235_TGI_at;CR618910;SAR1B;SAR1 homolog B (S. cerevisiae);0,00000000082300000000;1,273324095;0,628382811;1,009210559;0,661639269;0,303779418;1,069693902;0,443625313;0;0;NA;NA;NA
X100305236_TGI_at;100305236_TGI_at;CR618850;ITM2A;integral membrane protein 2A;0,00000000000004490000;0,611558327;0,000339491;0,825954308;0,002301874;0,185788694;0,913821188;0,311548887;0;0;NA;NA;NA
X100305266_TGI_at;100305266_TGI_at;CR602466;ARL8B;ADP-ribosylation factor-like 8B;0,00000000001090000000;1,312561118;0,005756236;1,129461257;0,016549819;0,002131763;1,240791085;0,014968787;0;1;U3;U1;U1
X100305277_TGI_at;100305277_TGI_at;CR597988;ITPR2;inositol 1,4,5-triphosphate receptor, type 2;0,00000000053900000000;1,330877909;0,000529892;1,154653962;0,003162672;0,089895036;1,154084348;0,184145191;0;0;NA;NA;NA
X100305278_TGI_at;100305278_TGI_at;CR597062;BAALC;brain and acute leukemia, cytoplasmic;0,00000073300000000000;0,623592735;0,000325348;0,724652963;0,002235816;0,025716846;0,663516253;0,075487609;0;0;NA;NA;NA
X100305282_TGI_at;100305282_TGI_at;CR594502;TIMP3;TIMP metallopeptidase inhibitor 3;0,00000000049700000000;0,784908376;0,003268833;0,890117427;0,011184127;0,781815973;1,040053973;0,860879017;0;0;NA;NA;NA
X100305294_TGI_at;100305294_TGI_at;CR542123;S100B;S100 calcium binding protein B;0,00000000000000021400;2,713741563;7,35E-05;1,558069491;0,00086144;0,567746993;1,115817824;0,6918142;0;0;NA;NA;NA
X100305300_TGI_at;100305300_TGI_at;CR533471;PXMP4;peroxisomal membrane protein 4, 24kDa;0,00000007070000000000;1,305936149;0,027446409;1,131245676;0,051460022;0,001055444;1,512000918;0,009719131;0;0;NA;NA;NA
X100305333_TGI_at;100305333_TGI_at;CN431800;INPP5A;inositol polyphosphate-5-phosphatase, 40kDa;0,00000000003020000000;0,793733352;0,075876919;0,940108695;0,113113465;0,179079095;0,941979516;0,304576213;0;0;NA;NA;NA
X100305339_TGI_at;100305339_TGI_at;CN414887;LTBP1;latent transforming growth factor beta binding protein 1;0,00000026100000000000;0,7641289;0,177645539;0,894172824;0,224530028;0,506813049;0,888482291;0,641830435;0;0;NA;NA;NA
X100305400_TGI_at;100305400_TGI_at;CN266127;LTBP4;latent transforming growth factor beta binding protein 4;0,00000007660000000000;0,75562801;0,336012024;0,913593594;0,384303319;0,910890029;1,015024812;0,951873502;0;0;NA;NA;NA
X100305401_TGI_at;100305401_TGI_at;CN265353;ITPR2;inositol 1,4,5-triphosphate receptor, type 2;0,00000000000000679000;1,542497102;6,37E-05;1,211931976;0,000795607;0,00053236;1,337629352;0,006649296;0;1;U7;U3;U1
X100305407_TGI_at;100305407_TGI_at;CK904564;SMN2;survival of motor neuron 2, centromeric;0,00000120000000000000;0,81388547;0,587781339;0,983694872;0,622140971;0,590451681;0,941206039;0,709819384;0;0;NA;NA;NA
X100305412_TGI_at;100305412_TGI_at;CK903540;;;0,00000038300000000000;1,214574852;0,010730868;1,09655764;0,025848719;0,888166261;1,01542025;0,935477078;0;0;NA;NA;NA
X100305425_TGI_at;100305425_TGI_at;CK300725;BACH2;BTB and CNC homology 1, basic leucine zipper transcription factor 2;0,00000001700000000000;0,782662415;6,78E-05;0,802397381;0,000818939;0,875109546;0,990873972;0,925961283;0;0;NA;NA;NA
X100305453_TGI_at;100305453_TGI_at;CF454950;GPM6B;glycoprotein M6B;0,00000000027500000000;0,731402947;0,005378863;0,828760499;0,015846503;0,191451954;0,896276122;0,318230865;0;0;NA;NA;NA
X100305463_TGI_at;100305463_TGI_at;CF135398;PIK3AP1;phosphoinositide-3-kinase adaptor protein 1;0,00000000164000000000;1,323737039;0,451321445;1,068721854;0,494092736;0,005746943;1,411735987;0,02719882;0;0;NA;NA;NA
X100305469_TGI_at;100305469_TGI_at;CF121667;CLCN4;chloride channel 4;0,00000064900000000000;1,278085955;0,090534847;1,075220607;0,13033267;0,056742235;1,270854105;0,133003799;0;0;NA;NA;NA
X100305489_TGI_at;100305489_TGI_at;CD677713;NFYB;nuclear transcription factor Y, beta;0,00000037300000000000;0,83198667;0,270240507;0,956913806;0,319393163;0,383385956;0,928772872;0,520942343;0;0;NA;NA;NA
X100305504_TGI_at;100305504_TGI_at;CD637344;GSTA1;glutathione S-transferase A1;0,00000007250000000000;1,290416859;0,224886342;1,060525718;0,274237109;0,635646818;1,028071633;0,747431382;0;0;NA;NA;NA
X100305523_TGI_at;100305523_TGI_at;CD517462;TXNL4B;thioredoxin-like 4B;0,00000000314000000000;1,36419799;0,016737853;1,11355701;0,035749569;0,103562613;1,150915694;0,203277894;0;0;NA;NA;NA
X100305526_TGI_at;100305526_TGI_at;CD516895;LAMB1;laminin, beta 1;0,00000000935000000000;0,746973418;0,005656966;0,826326525;0,016366609;0,041415229;0,707861809;0,104282253;0;0;NA;NA;NA
X100305543_TGI_at;100305543_TGI_at;CD367723;PAXIP1;PAX interacting (with transcription-activation domain) protein 1;0,00000000144000000000;0,803837215;0,225725769;0,971016062;0,274637279;0,734410047;1,010752066;0,82359206;0;0;NA;NA;NA
X100305548_TGI_at;100305548_TGI_at;CD365074;PRKAR1B;protein kinase, cAMP-dependent, regulatory, type I, beta;0,00000000121000000000;1,533800989;0,002721705;1,168047829;0,009743171;0,080609435;1,157199855;0,170587136;0;0;NA;NA;NA
X100305549_TGI_at;100305549_TGI_at;CD364682;GLA;galactosidase, alpha;0,00000000000002320000;1,546567442;0,00207888;1,213584171;0,008201018;0,013270593;1,246629724;0,048111498;0;1;U4;U1;U1
X100305578_TGI_at;100305578_TGI_at;CD104568;PHCA;phytoceramidase, alkaline;0,00000000094000000000;1,440693542;0,006608675;1,241631274;0,018377705;0,039719764;1,365354216;0,101661999;0;0;NA;NA;NA
X100305586_TGI_at;100305586_TGI_at;CB999589;RAPH1;Ras association (RalGDS/AF-6) and pleckstrin homology domains 1;0,00000063300000000000;0,784056961;0,413819893;0,943303862;0,459277382;0,721968894;1,100192119;0,81331903;0;0;NA;NA;NA
X100305588_TGI_at;100305588_TGI_at;CB997714;;hypothetical protein FLJ22662;0,00000000031200000000;1,508498446;0,000244575;1,385810262;0,001876818;0,004027359;1,480729939;0,021963076;0;1;U1;U1;U1
X100305591_TGI_at;100305591_TGI_at;CB995974;AVL9;AVL9 homolog (S. cerevisiase);0,00000014400000000000;1,289191017;0,029318807;1,143077926;0,054151584;0,849099163;0,972301414;0,906474529;0;0;NA;NA;NA
X100305602_TGI_at;100305602_TGI_at;CB961894;GBA;"glucosidase, beta; acid (includes glucosylceramidase)";0,00000000000040400000;1,341489474;0,003584132;1,120705891;0,011906754;0,000371641;1,274071302;0,00537129;0;1;U5;U1;U1
X100305623_TGI_at;100305623_TGI_at;CB529641;GCA;grancalcin, EF-hand calcium binding protein;0,00000036400000000000;1,283867628;0,116367346;1,098652356;0,158116339;0,107219939;1,19444361;0,208174617;0;0;NA;NA;NA
X100305629_TGI_at;100305629_TGI_at;CB321846;;;0,00000002990000000000;1,366160586;4,33E-06;1,367170471;0,000158381;0,625254079;1,015211333;0,737895971;0;0;NA;NA;NA
X100305634_TGI_at;100305634_TGI_at;CB306677;;U2-associated SR140 protein;0,00000002270000000000;0,800050014;0,090409212;0,957382187;0,13033267;0,09653965;0,916234573;0,193392487;0;0;NA;NA;NA
X100305637_TGI_at;100305637_TGI_at;CB305605;TMC5;transmembrane channel-like 5;0,00000096100000000000;1,350445214;0,294084669;1,081721054;0,343418438;0,107219939;1,173186803;0,208174617;0;0;NA;NA;NA
X100305639_TGI_at;100305639_TGI_at;CB243481;MLLT4;"myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4";0,00000000000518000000;0,829730649;0,012824514;0,940454235;0,029356114;0,057249107;0,934205447;0,133608886;0;0;NA;NA;NA
X100305642_TGI_at;100305642_TGI_at;CB241906;ST6GALNAC1;ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1;0,00000005680000000000;1,370493549;0,377446262;1,129421752;0,424907196;0,672949117;0,953245546;0,774063003;0;0;NA;NA;NA
X100305650_TGI_at;100305650_TGI_at;CB240565;GANC;"glucosidase, alpha; neutral C";0,00000006860000000000;1,305034968;0,003191549;1,169193051;0,010966271;3,88E-06;1,639732018;0,000832852;0;1;U1;U1;U4
X100305668_TGI_at;100305668_TGI_at;CB115148;ADFP;adipose differentiation-related protein;0,00000000078900000000;1,502049373;0,131819181;1,134628423;0,175631757;0,086710607;1,337508674;0,179491513;0;0;NA;NA;NA
X100305712_TGI_at;100305712_TGI_at;CA449974;DCTN5;dynactin 5 (p25);0,00000098500000000000;1,216300424;0,534259277;1,021838899;0,572096915;0,197238472;1,110686183;0,324667823;0;0;NA;NA;NA
X100305714_TGI_at;100305714_TGI_at;CA448021;;;0,00000000053800000000;0,791268848;0,015976847;0,885765809;0,034605766;0,052890615;0,894076631;0,126177982;0;0;NA;NA;NA
X100305718_TGI_at;100305718_TGI_at;CA447290;CSPP1;centrosome and spindle pole associated protein 1;0,00000000224000000000;0,742943937;0,000144442;0,769618911;0,001291564;0,122857837;0,873712887;0,229149774;0;0;NA;NA;NA
X100305722_TGI_at;100305722_TGI_at;CA446024;;;0,00000016600000000000;0,828137845;0,024416133;0,906935173;0,047377;0,421327994;1,070801838;0,560904521;0;0;NA;NA;NA
X100305736_TGI_at;100305736_TGI_at;CA438544;GAS2;growth arrest-specific 2;0,00000000011800000000;0,67755665;0,431797112;0,958424653;0,476114298;0,131303184;0,908411137;0,240585653;0;0;NA;NA;NA
X100305738_TGI_at;100305738_TGI_at;CA438250;;DKFZP564O0823 protein;0,00000041500000000000;1,276709822;0,0630447;1,119901847;0,097870787;0,000461729;1,41480714;0,006049403;0;0;NA;NA;NA
X100305778_TGI_at;100305778_TGI_at;CA420066;C14orf106;chromosome 14 open reading frame 106;0,00000005320000000000;1,355610294;1,13E-05;1,257135798;0,000291789;0,709599351;1,011824659;0,803597578;0;0;NA;NA;NA
X100305783_TGI_at;100305783_TGI_at;CA418013;EIF4E2;eukaryotic translation initiation factor 4E family member 2;0,00000000305000000000;1,301756631;0,177645539;1,060903285;0,224530028;0,011420211;1,190632634;0,043251869;0;0;NA;NA;NA
X100305811_TGI_at;100305811_TGI_at;CA312624;;;0,00000023000000000000;0,758814743;0,386718587;0,955677793;0,43337761;0,441735902;0,990230112;0,579452507;0;0;NA;NA;NA
X100305815_TGI_at;100305815_TGI_at;CA312010;DAAM1;dishevelled associated activator of morphogenesis 1;0,00000002060000000000;0,82047586;0,007965937;0,896503473;0,020975665;0,016931008;0,865924627;0,056430856;0;0;NA;NA;NA
X100305823_TGI_at;100305823_TGI_at;CA310821;TTC39B;tetratricopeptide repeat domain 39B;0,00000000000504000000;1,574164555;0,002197319;1,254808693;0,00850965;0,031382101;1,201846563;0,087495254;0;0;NA;NA;NA
X100305828_TGI_at;100305828_TGI_at;CA309888;RTN2;reticulon 2;0,00000007630000000000;1,347512421;0,151335735;1,083061279;0,195964272;0,002081391;1,444487287;0,014968787;0;0;NA;NA;NA
X100305835_TGI_at;100305835_TGI_at;CA308530;HCK;hemopoietic cell kinase;0,00000000778000000000;1,407481386;0,09460924;1,101364218;0,134565569;0,007798068;1,343576254;0,034055789;0;0;NA;NA;NA
X100305836_TGI_at;100305836_TGI_at;CA308455;HLA-DPA1;major histocompatibility complex, class II, DP alpha 1;0,00000008170000000000;1,432335338;0,007338368;1,241913972;0,01975903;0,055034692;1,25502135;0,12937769;0;0;NA;NA;NA
X100305842_TGI_at;100305842_TGI_at;CA306502;;hypothetical protein LOC150166;0,00000002650000000000;1,237220077;0,407889843;1,03061171;0,453320332;0,002220121;1,177564426;0,015454534;0;0;NA;NA;NA
X100305873_TGI_at;100305873_TGI_at;BX649155;PSIP1;PC4 and SFRS1 interacting protein 1;0,00000005100000000000;0,792328937;0,141779497;0,948870617;0,185678715;0,055034692;0,82222619;0,12937769;0;0;NA;NA;NA
X100305879_TGI_at;100305879_TGI_at;BX649137;ABCC3;ATP-binding cassette, sub-family C (CFTR/MRP), member 3;0,00000020400000000000;1,260725911;0,421889195;1,023558622;0,467267655;0,940656418;0,996877639;0,965520903;0;0;NA;NA;NA
X100305907_TGI_at;100305907_TGI_at;BX648942;PARVG;parvin, gamma;0,00000006750000000000;1,223935602;0,106876436;1,054538694;0,148028686;0,234597793;1,036125779;0,367043051;0;0;NA;NA;NA
X100305925_TGI_at;100305925_TGI_at;BX648771;PTPRB;protein tyrosine phosphatase, receptor type, B;0,00000002490000000000;0,74082343;0,011085531;0,800684628;0,026406997;0,993400377;1,125505177;0,995253159;0;0;NA;NA;NA
X100305939_TGI_at;100305939_TGI_at;BX648666;DPY19L2P1;dpy-19-like 2 pseudogene 1 (C. elegans);0,00000007450000000000;0,643284994;0,194646218;0,856663923;0,243062674;0,00919586;0,708217768;0,038004115;0;0;NA;NA;NA
X100305962_TGI_at;100305962_TGI_at;BX648496;;;0,00000000173000000000;0,729316211;0,041299878;0,888497482;0,070131458;0,613556941;0,983652561;0,727019861;0;0;NA;NA;NA
X100305970_TGI_at;100305970_TGI_at;BX648451;KIAA1217;KIAA1217;0,00000000025000000000;0,773583176;0,313100335;1,054869141;0,362602365;0,025716846;0,875001539;0,075487609;0;0;NA;NA;NA
X100305980_TGI_at;100305980_TGI_at;BX648352;DOCK5;dedicator of cytokinesis 5;0,00000007230000000000;1,23129391;0,029927107;1,083726232;0,05498277;0,470967706;1,055074141;0,606928795;0;0;NA;NA;NA
X100305988_TGI_at;100305988_TGI_at;BX648299;SLC8A1;solute carrier family 8 (sodium/calcium exchanger), member 1;0,00000063200000000000;1,233527669;0,033089721;1,106751143;0,058889107;0,135687627;1,157207041;0,247213805;0;0;NA;NA;NA
X100306045_TGI_at;100306045_TGI_at;BX647874;CCDC88A;coiled-coil domain containing 88A;0,00000000288000000000;1,341889398;6,78E-05;1,264927039;0,000818939;0,006769665;1,256089408;0,030601164;0;1;U1;U2;U1
X100306056_TGI_at;100306056_TGI_at;BX647781;C1QTNF7;C1q and tumor necrosis factor related protein 7;0,00000000279000000000;0,67111577;0,017427659;0,838338638;0,036664064;0,267057988;0,935119474;0,403399161;0;0;NA;NA;NA
X100306067_TGI_at;100306067_TGI_at;BX647704;WWC2;WW and C2 domain containing 2;0,00000087100000000000;0,759173507;0,796209286;0,984192358;0,815178694;0,149505026;1,24160829;0,264174725;0;0;NA;NA;NA
X100306142_TGI_at;100306142_TGI_at;BX641113;;;0,00000002860000000000;0,77532495;0,052581813;0,906481688;0,084820412;0,421327994;0,9356149;0,560904521;0;0;NA;NA;NA
X100306156_TGI_at;100306156_TGI_at;BX641062;GCOM1;GRINL1A complex locus;0,00000020200000000000;0,66267705;0,060668464;0,824120998;0,095249602;0,154336744;1,11271776;0,270635106;0;0;NA;NA;NA
X100306164_TGI_at;100306164_TGI_at;BX641004;SFRS11;splicing factor, arginine/serine-rich 11;0,00000101000000000000;0,824787372;0,036938569;0,933890611;0,064562368;0,357146031;0,992724333;0,494450884;0;0;NA;NA;NA
X100306213_TGI_at;100306213_TGI_at;BX538173;KLHL8;kelch-like 8 (Drosophila);0,00000000006760000000;1,267865843;7,53E-05;1,186734506;0,000869522;0,348497017;1,088572755;0,486868611;0;0;NA;NA;NA
X100306214_TGI_at;100306214_TGI_at;BX538171;ZNF660;zinc finger protein 660;0,00000000051300000000;0,777379286;0,363087998;0,958725176;0,409888833;0,221636126;0,861300046;0,351888292;0;0;NA;NA;NA
X100306223_TGI_at;100306223_TGI_at;BX538084;HLA-E;major histocompatibility complex, class I, E;0,00000000000022400000;0,804712462;8,23E-06;0,854189972;0,000250205;0,444272804;1,037156267;0,58159677;0;0;NA;NA;NA
X100306233_TGI_at;100306233_TGI_at;BX537966;TFRC;transferrin receptor (p90, CD71);0,00000000297000000000;1,398963515;3,50E-06;1,236791084;0,000137466;0,013331481;1,3046447;0,048277936;0;1;U2;U3;U1
X100306241_TGI_at;100306241_TGI_at;BX537918;SVEP1;sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1;0,00000010100000000000;0,77731855;0,151806604;0,895029726;0,196416173;0,056034188;0,871576327;0,131535461;0;0;NA;NA;NA
X100306261_TGI_at;100306261_TGI_at;BX537620;HMGCS1;3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 (soluble);0,00000031700000000000;1,552473863;0,020391221;1,280925682;0,041490471;0,017971918;1,327183069;0,058805575;0;0;NA;NA;NA
X100306307_TGI_at;100306307_TGI_at;BX500800;UACA;uveal autoantigen with coiled-coil domains and ankyrin repeats;0,00000004700000000000;0,754952088;0,138699269;0,923409243;0,182833433;0,736968995;0,950272017;0,825599955;0;0;NA;NA;NA
X100306316_TGI_at;100306316_TGI_at;BX477653;ADRBK2;adrenergic, beta, receptor kinase 2;0,00000000012800000000;1,459308546;0,003620908;1,228416973;0,01198171;0,013942384;1,359470658;0,049653374;0;1;U2;U1;U1
X100306318_TGI_at;100306318_TGI_at;BX473738;TNPO1;transportin 1;0,00000000000501000000;1,295349572;0,676544643;1,018389143;0,705664526;0,127936269;1,088602931;0,236568327;0;0;NA;NA;NA
X100306327_TGI_at;100306327_TGI_at;BX463901;GPM6B;glycoprotein M6B;0,00000001070000000000;0,716061932;0,435862119;0,92424344;0,480103763;0,315219134;0,903487464;0,454361033;0;0;NA;NA;NA
X100306328_TGI_at;100306328_TGI_at;BX463466;SNAP25;synaptosomal-associated protein, 25kDa;0,00000051200000000000;1,431005379;0,002515697;1,320839599;0,009245257;0,144787165;1,155903711;0,25853132;0;0;NA;NA;NA
X100306331_TGI_at;100306331_TGI_at;BX462887;GGA2;golgi associated, gamma adaptin ear containing, ARF binding protein 2;0,00000000017100000000;1,267230264;0,025145164;1,128587646;0,048383799;0,001600651;1,247552733;0,012613442;0;1;U1;U1;U1
X100306339_TGI_at;100306339_TGI_at;BX459360;GDAP2;ganglioside induced differentiation associated protein 2;0,00000000619000000000;1,206578617;0,000165838;1,16509515;0,00141401;0,442606018;1,025711582;0,579650222;0;0;NA;NA;NA
X100306369_TGI_at;100306369_TGI_at;BX438131;FXYD6;FXYD domain containing ion transport regulator 6;0,00000009490000000000;0,788961952;0,993206944;0,991956682;0,994132292;0,772133359;1,008645091;0,852547385;0;0;NA;NA;NA
X100306391_TGI_at;100306391_TGI_at;BX422993;CHN1;chimerin (chimaerin) 1;0,00000009120000000000;0,766085883;0,891942054;1,013600774;0,901734392;0,938242924;1,020126464;0,965520903;0;0;NA;NA;NA
X100306458_TGI_at;100306458_TGI_at;BX364902;DST;dystonin;0,00000000119000000000;0,80023017;0,019590297;0,928343834;0,040216259;0,952908828;0,990073449;0,974385319;0;0;NA;NA;NA
X100306462_TGI_at;100306462_TGI_at;BX359251;EFHD2;EF-hand domain family, member D2;0,00000026100000000000;1,41714521;0,0063625;1,177217247;0,017849609;0,000534337;1,448156326;0,006649296;0;1;U1;U1;U1
X100306471_TGI_at;100306471_TGI_at;BX353872;TTC39C;tetratricopeptide repeat domain 39C;0,00000000008770000000;1,335159989;0,050457527;1,087672177;0,082175144;0,560040474;0,981520977;0,687361176;0;0;NA;NA;NA
X100306476_TGI_at;100306476_TGI_at;BX348943;ABHD5;abhydrolase domain containing 5;0,00000000000656000000;1,414982691;0,000441341;1,168765285;0,002767398;0,011420211;1,256303238;0,043251869;0;1;U2;U1;U1
X100306496_TGI_at;100306496_TGI_at;BX336608;FAM118B;family with sequence similarity 118, member B;0,00000000079800000000;1,26308202;0,214902634;1,05824814;0,263911579;0,000577123;1,285896454;0,006889141;0;0;NA;NA;NA
X100306504_TGI_at;100306504_TGI_at;BX327952;;;0,00000000000060700000;1,771285856;5,73E-05;1,427556441;0,000744162;0,014045781;1,450457607;0,049746761;0;1;U3;U2;U1
X100306540_TGI_at;100306540_TGI_at;BX115088;TMEM47;transmembrane protein 47;0,00000000048200000000;0,666223357;0,157974138;0,916449301;0,203172645;0,348497017;0,866088456;0,486868611;0;0;NA;NA;NA
X100306552_TGI_at;100306552_TGI_at;BX109958;;;0,00000000000233000000;0,664237029;2,34E-05;0,806098205;0,000435318;0,967010726;1,004077415;0,980394958;0;0;NA;NA;NA
X100306559_TGI_at;100306559_TGI_at;BX108263;;;0,00000048000000000000;1,554141778;0,000945553;1,416149108;0,004645604;0,028121921;1,357940918;0,080853658;0;0;NA;NA;NA
X100306565_TGI_at;100306565_TGI_at;BX107193;ITPR2;inositol 1,4,5-triphosphate receptor, type 2;0,00000000003090000000;1,389977077;0,006722851;1,12463332;0,01856705;0,03059974;1,189728278;0,086003807;0;0;NA;NA;NA
X100306566_TGI_at;100306566_TGI_at;BX107168;MASP2;mannan-binding lectin serine peptidase 2;0,00000030100000000000;0,800465734;0,196606479;0,938096847;0,24503584;0,704079782;0,951991569;0,801288537;0;0;NA;NA;NA
X100306574_TGI_at;100306574_TGI_at;BX103325;;hypothetical LOC441027;0,00000000549000000000;0,748075763;0,504820029;0,97495342;0,544158847;0,000875061;0,736014028;0,008731645;0;0;NA;NA;NA
X100306622_TGI_at;100306622_TGI_at;BX090533;CTNNB1;catenin (cadherin-associated protein), beta 1, 88kDa;0,00000073200000000000;0,724624633;0,005857073;0,774883203;0,016676101;0,083615947;0,757448377;0,17510994;0;0;NA;NA;NA
X100306624_TGI_at;100306624_TGI_at;BX090437;;;0,00000111000000000000;1,329227806;0,139435432;1,080328949;0,183428734;0,832935571;1,035948972;0,897243096;0;0;NA;NA;NA
X100306694_TGI_at;100306694_TGI_at;BU740400;NFIB;nuclear factor I/B;0,00000000025500000000;0,806183572;0,515477483;0,955653782;0,554501919;0,571494922;0,989185562;0,695592196;0;0;NA;NA;NA
X100306722_TGI_at;100306722_TGI_at;BU688079;FAM171A1;family with sequence similarity 171, member A1;0,00000000068000000000;0,760979112;0,112555401;0,907773774;0,15370212;0,09653965;0,870343545;0,193392487;0;0;NA;NA;NA
X100306756_TGI_at;100306756_TGI_at;BU634330;NCK1;NCK adaptor protein 1;0,00000028200000000000;1,372995136;0,009104568;1,165623768;0,023054415;0,016931008;1,317942515;0,056430856;0;0;NA;NA;NA
X100306782_TGI_at;100306782_TGI_at;BU623004;ODZ3;odz, odd Oz/ten-m homolog 3 (Drosophila);0,00000003380000000000;1,504744514;0,000337896;1,404593211;0,002297553;0,660413637;0,947405382;0,764285198;0;0;NA;NA;NA
X100306784_TGI_at;100306784_TGI_at;BU622857;C2orf68;chromosome 2 open reading frame 68;0,00000000074200000000;0,774776676;0,208641601;0,95980202;0,257879934;0,029393816;0,836583796;0,083541684;0;0;NA;NA;NA
X100306785_TGI_at;100306785_TGI_at;BU622650;BHLHB3;basic helix-loop-helix domain containing, class B, 3;0,00000000000006060000;1,796809499;7,35E-05;1,367846426;0,00086144;0,004269773;1,343540165;0,02282169;0;1;U4;U2;U1
X100306787_TGI_at;100306787_TGI_at;BU622441;FKBP7;FK506 binding protein 7;0,00000000248000000000;0,726282533;0,037861606;0,874632857;0,065818747;0,013942384;0,76742213;0,049653374;0;0;NA;NA;NA
X100306804_TGI_at;100306804_TGI_at;BU618839;BCAT1;branched chain aminotransferase 1, cytosolic;0,00000000000000225000;2,384385658;0,002570096;1,510942038;0,009390646;0,00256018;1,683803679;0,01677126;0;1;U8;U1;U1
X100306818_TGI_at;100306818_TGI_at;BU616476;SLC31A1;solute carrier family 31 (copper transporters), member 1;0,00000000000000143000;1,699933458;0,000902448;1,249728189;0,00453758;0,000297835;1,49689182;0,004872704;0;1;U2;U1;U1
X100306858_TGI_at;100306858_TGI_at;BU539358;TBC1D30;TBC1 domain family, member 30;0,00000000612000000000;1,414431869;0,12976749;1,076591783;0,173328065;0,144787165;1,133466602;0,25853132;0;0;NA;NA;NA
X100306865_TGI_at;100306865_TGI_at;BU526830;CORO2A;coronin, actin binding protein, 2A;0,00000000566000000000;1,25520968;0,134754056;1,057059567;0,17836235;0,022801724;1,178159029;0,069330147;0;0;NA;NA;NA
X100306917_TGI_at;100306917_TGI_at;BU174390;SCD;stearoyl-CoA desaturase (delta-9-desaturase);0,00000009000000000000;1,414282844;0,005857073;1,279675444;0,016676101;0,006972738;1,978675009;0,031430956;0;1;U1;U1;U1
X100306950_TGI_at;100306950_TGI_at;BU150463;DPT;dermatopontin;0,00000000001160000000;0,58198867;0,346073239;0,830913513;0,393437055;0,597911661;0,896094492;0,71825169;0;0;NA;NA;NA
X100306959_TGI_at;100306959_TGI_at;BU145581;RP5-1022P6.2;hypothetical protein KIAA1434;0,00000000397000000000;1,321175971;0,001968862;1,206953956;0,007912272;0,077689446;1,155645965;0,166153341;0;0;NA;NA;NA
X100306975_TGI_at;100306975_TGI_at;BT019481;HUS1;HUS1 checkpoint homolog (S. pombe);0,00000000000006530000;1,324596938;0,000518817;1,160420131;0,003113871;0,00372287;1,160224852;0,020759189;0;1;U6;U1;U1
X100306983_TGI_at;100306983_TGI_at;BT007390;PTPN6;protein tyrosine phosphatase, non-receptor type 6;0,00000000006990000000;1,459158472;0,00207888;1,176941923;0,008201018;0,002687123;1,382913642;0,017251748;0;1;U1;U1;U1
X100306999_TGI_at;100306999_TGI_at;BT006704;FDFT1;farnesyl-diphosphate farnesyltransferase 1;0,00000057000000000000;1,201577963;0,024163668;1,133088762;0,047045705;0,000647022;1,279889529;0,007421185;0;1;U2;U1;U1
X100307016_TGI_at;100307016_TGI_at;BQ946293;USP14;ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase);0,00000000012900000000;1,267676078;0,012002102;1,106834383;0,027970191;0,846130083;1,005386571;0,906474529;0;0;NA;NA;NA
X100307045_TGI_at;100307045_TGI_at;BQ894504;PIK3R1;phosphoinositide-3-kinase, regulatory subunit 1 (alpha);0,00000011400000000000;0,750962576;0,906526314;0,953408115;0,915330298;0,323340368;0,895080228;0,462755775;0;0;NA;NA;NA
X100307047_TGI_at;100307047_TGI_at;BQ893766;GPM6B;glycoprotein M6B;0,00000000045300000000;0,676555481;0,673756666;0,93601739;0,702984051;0,402347064;0,93917697;0,542112532;0;0;NA;NA;NA
X100307074_TGI_at;100307074_TGI_at;BQ771727;PID1;phosphotyrosine interaction domain containing 1;0,00000000021400000000;1,423951354;8,68E-05;1,201987262;0,000964198;0,086481142;1,214320418;0,179491513;0;0;NA;NA;NA
X100307085_TGI_at;100307085_TGI_at;BQ720460;PHCA;phytoceramidase, alkaline;0,00000000000012300000;1,581523111;0,000271447;1,256403977;0,002002002;0,093210697;1,215689214;0,188856657;0;0;NA;NA;NA
X100307087_TGI_at;100307087_TGI_at;BQ719852;NDRG4;NDRG family member 4;0,00000002630000000000;0,781721069;0,003561399;0,868707954;0,011857838;0,967010726;0,974082864;0,980394958;0;0;NA;NA;NA
X100307095_TGI_at;100307095_TGI_at;BQ716144;GNG2;guanine nucleotide binding protein (G protein), gamma 2;0,00000016700000000000;0,791612089;0,468156379;1,059839149;0,510269871;0,613556941;0,965205846;0,727019861;0;0;NA;NA;NA
X100307115_TGI_at;100307115_TGI_at;BQ683561;PRPSAP1;phosphoribosyl pyrophosphate synthetase-associated protein 1;0,00000000233000000000;0,809007867;0,188851525;0,975497308;0,236928169;0,556550302;0,967236437;0,68359818;0;0;NA;NA;NA
X100307121_TGI_at;100307121_TGI_at;BQ671973;CDR2L;cerebellar degeneration-related protein 2-like;0,00000013900000000000;0,809477341;0,00385602;0,845793455;0,012528179;0,711121171;0,937921262;0,803908641;0;0;NA;NA;NA
X100307123_TGI_at;100307123_TGI_at;BQ671891;ATP6V1B2;ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2;0,00000000015000000000;1,208747197;0,003497168;1,127697413;0,011704437;0,041415229;1,147878406;0,104282253;0;0;NA;NA;NA
X100307129_TGI_at;100307129_TGI_at;BQ651417;MACF1;microtubule-actin crosslinking factor 1;0,00000000000271000000;0,759330623;0,341863119;0,942195165;0,389948125;0,784830893;1,036471481;0,861549716;0;0;NA;NA;NA
X100307130_TGI_at;100307130_TGI_at;BQ651180;APOE;apolipoprotein E;0,00000005840000000000;1,52840054;0,064671204;1,14100108;0,100113011;0,034975442;1,300977447;0,093703947;0;0;NA;NA;NA
X100307141_TGI_at;100307141_TGI_at;BQ642390;GM2A;GM2 ganglioside activator;0,00000069500000000000;1,284010779;0,257948758;1,070902336;0,306891416;0,009303521;1,282109167;0,038004115;0;0;NA;NA;NA
X100307153_TGI_at;100307153_TGI_at;BQ576195;MS4A7;membrane-spanning 4-domains, subfamily A, member 7;0,00000000079200000000;1,404621719;1,14E-06;1,318350516;6,93E-05;0,000429707;1,709428005;0,005893387;0;1;U2;U2;U1
X100307170_TGI_at;100307170_TGI_at;BQ446122;CLEC5A;C-type lectin domain family 5, member A;0,00000000000000000218;3,009244366;1,13E-05;1,77244778;0,000291789;0,06647101;1,379779467;0,148369342;0;0;NA;NA;NA
X100307171_TGI_at;100307171_TGI_at;BQ446019;;;0,00000000026700000000;0,687599085;0,033062617;0,815072198;0,058873378;0,103562613;0,874489084;0,203277894;0;0;NA;NA;NA
X100307178_TGI_at;100307178_TGI_at;BQ440490;CEP27;centrosomal protein 27kDa;0,00000034000000000000;1,223793958;0,340241109;1,066009102;0,388726371;0,071816378;1,177854794;0,157336794;0;0;NA;NA;NA
X100307185_TGI_at;100307185_TGI_at;BQ436702;KLHDC10;kelch domain containing 10;0,00000000374000000000;1,295528021;0,486864302;1,043619578;0,527449965;0,378530849;1,041053216;0,51585832;0;0;NA;NA;NA
X100307190_TGI_at;100307190_TGI_at;BQ433458;MTHFD2;methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase;0,00000000017700000000;1,539267383;0,046032072;1,160115032;0,076356855;0,875109546;1,034037146;0,925961283;0;0;NA;NA;NA
X100307199_TGI_at;100307199_TGI_at;BQ431402;PTP4A1;protein tyrosine phosphatase type IVA, member 1;0,00000001520000000000;1,512516683;0,006956535;1,253093485;0,019033032;0,064330368;1,326269585;0,144788251;0;0;NA;NA;NA
X100307210_TGI_at;100307210_TGI_at;BQ423343;PPP1R1C;protein phosphatase 1, regulatory (inhibitor) subunit 1C;0,00000000000000067900;2,257005995;8,01E-07;1,865177815;5,73E-05;3,28E-05;2,05330344;0,001805101;0;1;U8;U2;U1
X100307214_TGI_at;100307214_TGI_at;BQ422129;NQO1;NAD(P)H dehydrogenase, quinone 1;0,00000000000000068200;1,820833233;0,001817165;1,32495348;0,007499003;0,006071612;1,274456037;0,028156556;0;1;U2;U1;U1
X100307237_TGI_at;100307237_TGI_at;BQ270678;ICA1;islet cell autoantigen 1, 69kDa;0,00000044500000000000;1,356671814;0,49759612;0,912350101;0,537395825;0,746919855;0,927582692;0,832983631;0;0;NA;NA;NA
X100307259_TGI_at;100307259_TGI_at;BQ222415;;;0,00000015200000000000;1,290179567;0,626374161;1,00014627;0,659739844;0,331593893;1,088914491;0,472261209;0;0;NA;NA;NA
X100307267_TGI_at;100307267_TGI_at;BQ217349;ETV5;ets variant 5;0,00000008080000000000;0,736770987;0,028046529;0,832267654;0,052351584;0,053765992;1,323309863;0,127699182;0;0;NA;NA;NA
X100307270_TGI_at;100307270_TGI_at;BQ213325;AMOT;angiomotin;0,00000075200000000000;0,780833088;0,798808181;0,966447227;0,817579793;0,618369026;1,022220177;0,731645878;0;0;NA;NA;NA
X100307302_TGI_at;100307302_TGI_at;BQ066408;INSIG1;insulin induced gene 1;0,00000000000088500000;1,547063385;0,000889677;1,281784969;0,004487371;0,000174604;1,490644867;0,004028419;0;1;U6;U1;U1
X100307334_TGI_at;100307334_TGI_at;BQ015570;;;0,00000010800000000000;0,816269916;0,041724775;0,917672801;0,0706297;0,169527921;0,908009244;0,290015121;0;0;NA;NA;NA
X100307348_TGI_at;100307348_TGI_at;BQ011959;;;0,00000031700000000000;1,236607809;0,324732812;1,063483754;0,372858515;0,154336744;1,131158088;0,270635106;0;0;NA;NA;NA
X100307364_TGI_at;100307364_TGI_at;BQ007626;;hypothetical protein MGC3032;0,00000085000000000000;0,82956569;0,008130398;0,901530582;0,021321622;0,402347064;0,924729218;0,542112532;0;0;NA;NA;NA
X100307365_TGI_at;100307365_TGI_at;BQ007085;;;0,00000000630000000000;0,65205106;0,388663759;0,980614713;0,435254793;0,234597793;0,835163787;0,367043051;0;0;NA;NA;NA
X100307391_TGI_at;100307391_TGI_at;BP380380;UFM1;ubiquitin-fold modifier 1;0,00000019900000000000;1,265549585;0,002170078;1,131347975;0,008436864;0,3219842;1,106143015;0,462755775;0;0;NA;NA;NA
X100307439_TGI_at;100307439_TGI_at;BP215249;GPM6B;glycoprotein M6B;0,00000000057100000000;0,774227548;0,693502941;0,975431842;0,720786836;0,967010726;0,981813781;0,980394958;0;0;NA;NA;NA
X100307452_TGI_at;100307452_TGI_at;BM999412;NPC1;Niemann-Pick disease, type C1;0,00000000748000000000;1,335289808;0,212834192;1,074143476;0,261918519;0,004131968;1,441080806;0,022121815;0;0;NA;NA;NA
X100307455_TGI_at;100307455_TGI_at;BM997844;CCDC48;coiled-coil domain containing 48;0,00000001480000000000;0,697595949;0,001227302;0,798008043;0,00554005;0,168116482;0,869998716;0,288673107;0;0;NA;NA;NA
X100307462_TGI_at;100307462_TGI_at;BM993522;ATP13A4;ATPase type 13A4;0,00000000000000003180;4,912462082;2,67E-07;2,988603147;2,78E-05;3,58E-05;2,771641975;0,001805101;0;1;U7;U3;U1
X100307470_TGI_at;100307470_TGI_at;BM988557;PCYOX1;prenylcysteine oxidase 1;0,00000039200000000000;0,816628189;0,889401977;1,003922173;0,899448563;0,131303184;1,129985717;0,240585653;0;0;NA;NA;NA
X100307475_TGI_at;100307475_TGI_at;BM985119;VEGFA;vascular endothelial growth factor A;0,00000000001940000000;0,715486119;0,813780137;0,961459379;0,830529886;0,556550302;1,064703005;0,68359818;0;0;NA;NA;NA
X100307524_TGI_at;100307524_TGI_at;BM931837;;;0,00000000271000000000;1,282422387;0,160080905;1,054489463;0,205613743;0,526622464;1,025065608;0,659403342;0;0;NA;NA;NA
X100307531_TGI_at;100307531_TGI_at;BM928530;PHLDB1;pleckstrin homology-like domain, family B, member 1;0,00000000280000000000;0,728237336;0,009079637;0,860921207;0,023054415;0,965670402;1,020546146;0,980394958;0;0;NA;NA;NA
X100307543_TGI_at;100307543_TGI_at;BM922028;NLRC5;NLR family, CARD domain containing 5;0,00000010800000000000;0,760351455;0,001524272;0,82130105;0,006576612;0,234597793;0,908349315;0,367043051;0;0;NA;NA;NA
X100307544_TGI_at;100307544_TGI_at;BM921317;;;0,00000077400000000000;1,310190972;0,009014255;1,12438919;0,022966754;0,545460135;1,025000412;0,674086662;0;0;NA;NA;NA
X100307578_TGI_at;100307578_TGI_at;BM843195;G6PD;glucose-6-phosphate dehydrogenase;0,00000002470000000000;1,334499562;0,356349633;1,036956134;0,403695911;0,0064123;1,23187558;0,029273149;0;0;NA;NA;NA
X100307600_TGI_at;100307600_TGI_at;BM793951;TTC39A;tetratricopeptide repeat domain 39A;0,00000000001620000000;1,421102899;0,470625;1,049672684;0,512613847;0,000647022;1,598885605;0,007421185;0;0;NA;NA;NA
X100307627_TGI_at;100307627_TGI_at;BM728398;TCF4;transcription factor 4;0,00000000183000000000;0,801680945;0,001966437;0,87378409;0,007912272;0,020452962;0,806902204;0,064249412;0;0;NA;NA;NA
X100307673_TGI_at;100307673_TGI_at;BM684168;hCG_17324;primary ciliary dyskinesia protein 1;0,00000053100000000000;1,233161585;0,104911384;1,087912444;0,145871178;0,05081529;1,174494781;0,122313429;0;0;NA;NA;NA
X100307680_TGI_at;100307680_TGI_at;BM682615;CHDH;choline dehydrogenase;0,00000000566000000000;1,446699517;0,008347524;1,242888313;0,021714342;0,019786991;1,270537005;0,062769164;0;0;NA;NA;NA
X100307693_TGI_at;100307693_TGI_at;BM680740;;;0,00000001880000000000;0,720601543;0,255546423;0,923911215;0,304370333;0,194183373;0,875086574;0,322272406;0;0;NA;NA;NA
X100307695_TGI_at;100307695_TGI_at;BM679668;;;0,00000000000334000000;0,658800351;0,000871743;0,789300276;0,004464695;0,051573216;0,80523294;0,12395263;0;0;NA;NA;NA
X100307699_TGI_at;100307699_TGI_at;BM678635;NR2C1;nuclear receptor subfamily 2, group C, member 1;0,00000004580000000000;0,722848449;0,143339186;0,908696058;0,187416713;0,875109546;0,994582925;0,925961283;0;0;NA;NA;NA
X100307725_TGI_at;100307725_TGI_at;BM670762;01/mar;membrane-associated ring finger (C3HC4) 1;0,00000006510000000000;1,393804586;0,033155092;1,144988843;0,058972882;0,020452962;1,191932924;0,064249412;0;0;NA;NA;NA
X100307767_TGI_at;100307767_TGI_at;BM550721;CD44;CD44 molecule (Indian blood group);0,00000000019600000000;1,301597843;0,001381914;1,201740607;0,006118008;0,000923705;1,308746514;0,008967168;0;1;U1;U1;U1
X100307786_TGI_at;100307786_TGI_at;BM543893;PLAUR;plasminogen activator, urokinase receptor;0,00000000001880000000;1,505149723;0,000940185;1,229451461;0,004645604;0,006769665;1,311392884;0,030601164;0;1;U3;U2;U1
X100307792_TGI_at;100307792_TGI_at;BM541598;PHLDA1;pleckstrin homology-like domain, family A, member 1;0,00000120000000000000;1,577194507;0,000190191;1,495021227;0,001571754;0,734410047;1,040204497;0,82359206;0;0;NA;NA;NA
X100307806_TGI_at;100307806_TGI_at;BM477681;SPTBN1;spectrin, beta, non-erythrocytic 1;0,00000000020200000000;0,798728261;0,017801931;0,898459094;0,037208576;0,421843348;1,068077791;0,560904521;0;0;NA;NA;NA
X100307849_TGI_at;100307849_TGI_at;BM455533;STK39;serine threonine kinase 39 (STE20/SPS1 homolog, yeast);0,00000000486000000000;1,275581854;0,041299878;1,103382296;0,070131458;0,209185181;1,044152935;0,337324278;0;0;NA;NA;NA
X100307892_TGI_at;100307892_TGI_at;BM021385;ZNF582;zinc finger protein 582;0,00000002420000000000;0,809487945;0,000456772;0,858378661;0,002820262;0,107895631;0,869120223;0,208857428;0;0;NA;NA;NA
X100307901_TGI_at;100307901_TGI_at;BJ996964;SERPINA2;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 2;0,00000003480000000000;2,521569369;0,021357694;1,583440272;0,042923852;0,017758754;1,782937435;0,058404554;0;0;NA;NA;NA
X100307919_TGI_at;100307919_TGI_at;BI870184;SFXN4;sideroflexin 4;0,00000057200000000000;1,249161299;0,572238526;1,004990945;0,607885553;0,846130083;0,976810907;0,906474529;0;0;NA;NA;NA
X100307934_TGI_at;100307934_TGI_at;BI836843;CYBA;cytochrome b-245, alpha polypeptide;0,00000000271000000000;1,325781394;0,167622727;1,060090666;0,21345241;0,018980373;1,220966432;0,060869395;0;0;NA;NA;NA
X100307935_TGI_at;100307935_TGI_at;BI836716;CD164;CD164 molecule, sialomucin;0,00000000000014800000;1,342536393;0,000389157;1,17067196;0,00255449;0,01554453;1,170876773;0,052959853;0;0;NA;NA;NA
X100307941_TGI_at;100307941_TGI_at;BI824983;PHCA;phytoceramidase, alkaline;0,00000000000000047600;1,79274844;9,53E-05;1,338366299;0,001037829;0,005356868;1,281511316;0,026121691;0;1;U7;U1;U1
X100307943_TGI_at;100307943_TGI_at;BI823609;UBE2F;ubiquitin-conjugating enzyme E2F (putative);0,00000000000000752000;1,317174477;0,220449108;1,043800651;0,269949648;0,063921148;1,094815857;0,144788251;0;0;NA;NA;NA
X100307945_TGI_at;100307945_TGI_at;BI820698;PTPRB;protein tyrosine phosphatase, receptor type, B;0,00000000365000000000;0,738500555;0,177645539;0,909239513;0,224530028;0,883640065;1,038984192;0,933455238;0;0;NA;NA;NA
X100307990_TGI_at;100307990_TGI_at;BI597633;SIPA1L1;signal-induced proliferation-associated 1 like 1;0,00000000000301000000;0,827463924;0,119918818;0,952750129;0,162121791;0,875109546;0,983126575;0,925961283;0;0;NA;NA;NA
X100308037_TGI_at;100308037_TGI_at;BI333531;SLC36A4;solute carrier family 36 (proton/amino acid symporter), member 4;0,00000000873000000000;1,380040374;0,00106718;1,216661078;0,005021199;0,856524137;1,006600014;0,913191298;0;0;NA;NA;NA
X100308058_TGI_at;100308058_TGI_at;BI118145;SYK;spleen tyrosine kinase;0,00000000003190000000;1,332877291;0,051135979;1,087247626;0,083153249;0,001935464;1,211263507;0,014451293;0;0;NA;NA;NA
X100308061_TGI_at;100308061_TGI_at;BI093105;;;0,00000000005570000000;0,805757827;0,117881853;0,938387017;0,159782169;0,330381396;1,059073453;0,47157628;0;0;NA;NA;NA
X100308097_TGI_at;100308097_TGI_at;BG830360;ALG14;asparagine-linked glycosylation 14 homolog (S. cerevisiae);0,00000112000000000000;1,215021569;5,78E-05;1,175155781;0,0007487;0,086693301;1,097458946;0,179491513;0;0;NA;NA;NA
X100308116_TGI_at;100308116_TGI_at;BG772331;PENK;proenkephalin;0,00000002720000000000;0,667030739;0,006608675;0,83778929;0,018377705;0,901252766;0,946742111;0,944937432;0;0;NA;NA;NA
X100308117_TGI_at;100308117_TGI_at;BG771986;TXNRD1;thioredoxin reductase 1;0,00000000000432000000;1,46389551;0,035433161;1,128421251;0,062404961;0,005746943;1,369536521;0,02719882;0;0;NA;NA;NA
X100308154_TGI_at;100308154_TGI_at;BG720894;MRPS15;mitochondrial ribosomal protein S15;0,00000000000777000000;1,270403212;0,095734617;1,062677108;0,135719763;0,000753789;1,162138779;0,007913552;0;0;NA;NA;NA
X100308163_TGI_at;100308163_TGI_at;BG707766;LMCD1;LIM and cysteine-rich domains 1;0,00000000002620000000;0,690412942;0,108127834;0,906905932;0,149121099;0,571494922;1,083393766;0,695592196;0;0;NA;NA;NA
X100308195_TGI_at;100308195_TGI_at;BG680883;LAMC2;laminin, gamma 2;0,00000007660000000000;0,806970688;0,045678687;0,847672672;0,076005373;0,940656418;1,027832192;0,965520903;0;0;NA;NA;NA
X100308207_TGI_at;100308207_TGI_at;BG674475;SMARCA5;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5;0,00000016300000000000;1,228634703;0,002723735;1,086590489;0,009743171;0,041415229;1,154097666;0,104282253;0;0;NA;NA;NA
X100308209_TGI_at;100308209_TGI_at;BG656243;JAG1;jagged 1 (Alagille syndrome);0,00000003380000000000;0,829283345;0,223663452;0,935150022;0,272849094;0,033503156;0,831012922;0,091046096;0;0;NA;NA;NA
X100308226_TGI_at;100308226_TGI_at;BG616989;SERPINA1;serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1;0,00000000000050800000;1,285628139;0,00612932;1,131460855;0,01732877;9,68E-06;1,364859105;0,001248259;0;1;U6;U1;U1
X100308231_TGI_at;100308231_TGI_at;BG612208;;;0,00000000000000346000;1,656865146;0,016480721;1,150973933;0,035317396;0,001495954;1,520034243;0,012033721;0;1;U6;U1;U1
X100308233_TGI_at;100308233_TGI_at;BG610848;OPA1;optic atrophy 1 (autosomal dominant);0,00000000012000000000;1,338814432;0,005039075;1,143257774;0,015206871;0,734410047;1,019663688;0,82359206;0;0;NA;NA;NA
X100308234_TGI_at;100308234_TGI_at;BG574214;CXorf26;chromosome X open reading frame 26;0,00000000009040000000;1,263530804;0,070638801;1,058407021;0,107492378;0,004862758;1,262886348;0,024374289;0;0;NA;NA;NA
X100308259_TGI_at;100308259_TGI_at;BG548563;ANKRD29;ankyrin repeat domain 29;0,00000001400000000000;0,816231363;0,097405791;0,914016713;0,13763212;0,26927095;1,162588837;0,405163526;0;0;NA;NA;NA
X100308274_TGI_at;100308274_TGI_at;BG536877;S1PR1;sphingosine-1-phosphate receptor 1;0,00000000014100000000;0,72269179;0,026062833;0,889326647;0,049675051;0,470967706;0,934715236;0,606928795;0;0;NA;NA;NA
X100308279_TGI_at;100308279_TGI_at;BG529853;PFKFB3;6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3;0,00000058400000000000;0,7793194;0,707530368;0,944566386;0,733709902;0,685086646;1,043751621;0,784939303;0;0;NA;NA;NA
X100308321_TGI_at;100308321_TGI_at;BG426451;;;0,00000000002010000000;1,287021254;0,002764239;1,150900134;0,009844355;0,000188734;1,350707522;0,004028419;0;1;U2;U1;U1
X100308342_TGI_at;100308342_TGI_at;BG327170;AVL9;AVL9 homolog (S. cerevisiase);0,00000001070000000000;1,294123272;0,01145057;1,118682795;0,026977475;0,810391779;1,00944861;0,881205366;0;0;NA;NA;NA
X100308362_TGI_at;100308362_TGI_at;BG260295;SAR1B;SAR1 homolog B (S. cerevisiae);0,00000000000518000000;1,323353435;0,04480815;1,065892405;0,074672527;0,512848122;1,02006042;0,646425302;0;0;NA;NA;NA
X100308374_TGI_at;100308374_TGI_at;BG252150;PFKP;phosphofructokinase, platelet;0,00000068100000000000;1,311918587;0,483315019;1,045075512;0,524486298;0,843026037;1,008721557;0,905389176;0;0;NA;NA;NA
X100308385_TGI_at;100308385_TGI_at;BG218813;TYSND1;trypsin domain containing 1;0,00000085600000000000;1,201177481;0,9307231;1,001854776;0,936827155;0,154336744;1,109351028;0,270635106;0;0;NA;NA;NA
X100308387_TGI_at;100308387_TGI_at;BG218178;MMP12;matrix metallopeptidase 12 (macrophage elastase);0,00000000000018900000;3,996620197;0,000227329;2,536598786;0,001787025;0,061768971;1,621531175;0,141481329;0;0;NA;NA;NA
X100308414_TGI_at;100308414_TGI_at;BG189674;PPA2;pyrophosphatase (inorganic) 2;0,00000001230000000000;1,210263413;4,02E-05;1,116450748;0,000593747;0,266380968;1,065894405;0,403399161;0;0;NA;NA;NA
X100308497_TGI_at;100308497_TGI_at;BF963827;;;0,00000085000000000000;0,713334206;0,089140461;0,847717423;0,128776202;0,685086646;0,944433252;0,784939303;0;0;NA;NA;NA
X100308541_TGI_at;100308541_TGI_at;BF791901;TMEM38B;transmembrane protein 38B;0,00000053900000000000;1,374869504;0,068799286;1,08912281;0,10547769;0,155979894;1,177905989;0,273070722;0;0;NA;NA;NA
X100308550_TGI_at;100308550_TGI_at;BF697965;ITGAE;"integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)";0,00000000000007330000;1,449810678;2,08E-07;1,236009683;2,48E-05;0,05394607;1,185836619;0,127938325;0;0;NA;NA;NA
X100308611_TGI_at;100308611_TGI_at;BF511680;AMOTL1;angiomotin like 1;0,00000000000033800000;0,807071513;0,033062617;0,937078617;0,058873378;0,241271938;1,059056101;0,374575845;0;0;NA;NA;NA
X100308636_TGI_at;100308636_TGI_at;BF439217;CTNND2;catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein);0,00000000000918000000;0,599859286;0,208672314;0,872770971;0,257879934;0,299373904;1,125455284;0,437985516;0;0;NA;NA;NA
X100308637_TGI_at;100308637_TGI_at;BF439126;GLB1;galactosidase, beta 1;0,00000000002530000000;1,259826891;0,001551089;1,117439886;0,006643984;0,000185312;1,268943637;0,004028419;0;1;U2;U1;U1
X100308689_TGI_at;100308689_TGI_at;BF220289;GRN;granulin;0,00000000756000000000;1,398789988;0,0169985;1,198184845;0,036091018;0,001710443;1,580885861;0,013125611;0;1;U1;U1;U1
X100308704_TGI_at;100308704_TGI_at;BF195993;STX4;syntaxin 4;0,00000103000000000000;1,228192691;0,108127834;1,073071242;0,149121099;0,672949117;1,051818498;0,774063003;0;0;NA;NA;NA
X100308729_TGI_at;100308729_TGI_at;BF109150;;;0,00000093800000000000;0,747302318;0,008518256;0,837713069;0,021998668;0,992835319;1,006127593;0,995253159;0;0;NA;NA;NA
X100308731_TGI_at;100308731_TGI_at;BF087961;M6PR;mannose-6-phosphate receptor (cation dependent);0,00000076900000000000;1,270803249;0,00314995;1,1452901;0,010858063;0,122857837;1,136401722;0,229149774;0;0;NA;NA;NA
X100308757_TGI_at;100308757_TGI_at;BF033995;PLD3;phospholipase D family, member 3;0,00000001850000000000;1,295907003;0,053155532;1,123053217;0,085642836;0,001055444;1,499667332;0,009719131;0;0;NA;NA;NA
X100308761_TGI_at;100308761_TGI_at;BF026299;SLC39A11;solute carrier family 39 (metal ion transporter), member 11;0,00000005380000000000;1,222255655;0,219294675;1,048191012;0,268638061;0,013942384;1,131568493;0,049653374;0;0;NA;NA;NA
X100308770_TGI_at;100308770_TGI_at;BE965639;FCRLB;Fc receptor-like B;0,00000000014300000000;1,681881882;0,000251026;1,371910134;0,001899192;0,08994195;1,168903925;0,184145191;0;0;NA;NA;NA
X100308797_TGI_at;100308797_TGI_at;BE874245;PNPLA6;patatin-like phospholipase domain containing 6;0,00000000202000000000;1,434504325;0,040588371;1,125918936;0,069251625;0,027420742;1,299324812;0,079475766;0;0;NA;NA;NA
X100308805_TGI_at;100308805_TGI_at;BE858438;NPL;N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase);0,00000000000739000000;1,873567648;0,001147322;1,308561172;0,005335959;9,19E-05;1,633000915;0,003022585;0;1;U5;U1;U1
X100308808_TGI_at;100308808_TGI_at;BE857029;TBXAS1;thromboxane A synthase 1 (platelet);0,00000000951000000000;1,380342444;0,109686054;1,125990006;0,150625544;0,151013543;1,134236783;0,266548001;0;0;NA;NA;NA
X100308882_TGI_at;100308882_TGI_at;BE619875;LITAF;lipopolysaccharide-induced TNF factor;0,00000000076500000000;1,256753636;0,148097263;1,064073829;0,192466726;0,122857837;1,119122623;0,229149774;0;0;NA;NA;NA
X100308932_TGI_at;100308932_TGI_at;BE465341;;;0,00000000562000000000;1,321847374;0,660019158;1,029922816;0,690662905;0,348497017;0,95314591;0,486868611;0;0;NA;NA;NA
X100308999_TGI_at;100308999_TGI_at;BC150270;MYST4;MYST histone acetyltransferase (monocytic leukemia) 4;0,00000000727000000000;0,811710607;0,346073239;1,020223946;0,393437055;0,348497017;0,958951668;0,486868611;0;0;NA;NA;NA
X100309012_TGI_at;100309012_TGI_at;BC142620;TBX4;T-box 4;0,00000000518000000000;0,709810051;0,045916534;0,855639443;0,076282984;0,323340368;0,902734557;0,462755775;0;0;NA;NA;NA
X100309018_TGI_at;100309018_TGI_at;BC139913;COL13A1;collagen, type XIII, alpha 1;0,00000009960000000000;0,754298909;0,188851525;0,938556143;0,236928169;0,228052747;0,89505858;0,35942005;0;0;NA;NA;NA
X100309035_TGI_at;100309035_TGI_at;BC128418;CBX7;chromobox homolog 7;0,00000003210000000000;0,794421255;0,54929724;0,956141358;0,586399566;0,766901256;1,031047509;0,849973434;0;0;NA;NA;NA
X100309044_TGI_at;100309044_TGI_at;BC126107;TEP1;telomerase-associated protein 1;0,00000000196000000000;1,318021619;0,023141098;1,11450714;0,045422509;0,041415229;1,14977004;0,104282253;0;0;NA;NA;NA
X100309048_TGI_at;100309048_TGI_at;BC121034;TTC39C;tetratricopeptide repeat domain 39C;0,00000000000888000000;1,370384698;0,156294214;1,069712381;0,201333434;0,872642718;1,075653088;0,925961283;0;0;NA;NA;NA
X100309049_TGI_at;100309049_TGI_at;BC121003;RASGEF1B;RasGEF domain family, member 1B;0,00000008950000000000;1,557878389;0,00038123;1,432945981;0,002512687;0,004342204;1,467200342;0,022867523;0;1;U1;U1;U1
X100309076_TGI_at;100309076_TGI_at;BC112897;CLEC16A;C-type lectin domain family 16, member A;0,00000120000000000000;1,307036109;0,146498011;1,065443681;0,19061893;0,69730432;0,951123916;0,795825717;0;0;NA;NA;NA
X100309090_TGI_at;100309090_TGI_at;BC110411;;hypothetical protein MGC9913;0,00000000919000000000;0,814371668;0,004619603;0,881069267;0,014302575;0,015374349;0,808294277;0,052959853;0;0;NA;NA;NA
X100309110_TGI_at;100309110_TGI_at;BC105793;MRPS33;mitochondrial ribosomal protein S33;0,00000000007270000000;1,245719812;0,000277495;1,147871222;0,002018582;0,061895338;1,144362881;0,141481329;0;0;NA;NA;NA
X100309142_TGI_at;100309142_TGI_at;BC098380;NETO2;neuropilin (NRP) and tolloid (TLL)-like 2;0,00000001020000000000;0,655462751;0,000243791;0,71245376;0,001875273;0,174827775;0,824221574;0,298290058;0;0;NA;NA;NA
X100309159_TGI_at;100309159_TGI_at;BC094742;SLC9A7;solute carrier family 9 (sodium/hydrogen exchanger), member 7;0,00000000046800000000;1,401917685;0,012819095;1,172760714;0,029356114;0,10529688;1,224828769;0,206179735;0;0;NA;NA;NA
X100309178_TGI_at;100309178_TGI_at;BC090052;ABHD2;abhydrolase domain containing 2;0,00000000000006770000;1,71316028;0,003926858;1,181193642;0,012656262;0,002719171;1,305497777;0,017251748;0;1;U5;U1;U1
X100309188_TGI_at;100309188_TGI_at;BC084547;NCKAP1L;NCK-associated protein 1-like;0,00000000000366000000;1,514465029;0,00168003;1,201172562;0,007096641;0,000259767;1,464641965;0,004600156;0;1;U6;U1;U1
X100309210_TGI_at;100309210_TGI_at;BC071865;LOXL3;lysyl oxidase-like 3;0,00000006010000000000;1,300957183;0,007538999;1,138799875;0,020162294;0,007798068;1,221481051;0,034055789;0;1;U1;U1;U1
X100309217_TGI_at;100309217_TGI_at;BC071703;GJB2;gap junction protein, beta 2, 26kDa;0,00000008560000000000;1,851062714;0,067242194;1,370652263;0,103447061;0,829572899;1,102829771;0,894817086;0;0;NA;NA;NA
X100309229_TGI_at;100309229_TGI_at;BC070280;DHFR;dihydrofolate reductase;0,00000000001240000000;1,692698104;0,183316006;1,114223612;0,230882175;0,491673531;0,937485586;0,627589621;0;0;NA;NA;NA
X100309235_TGI_at;100309235_TGI_at;BC070107;SLC12A6;solute carrier family 12 (potassium/chloride transporters), member 6;0,00000000057100000000;1,373959757;0,001583573;1,208720345;0,006760074;0,356396596;1,063358281;0,494450884;0;0;NA;NA;NA
X100309247_TGI_at;100309247_TGI_at;BC069216;C1orf225;chromosome 1 open reading frame 225;0,00000000000122000000;0,650530196;1,94E-05;0,753686738;0,000384507;0,57904816;0,944043879;0,700552635;0;0;NA;NA;NA
X100309255_TGI_at;100309255_TGI_at;BC068553;DR1;down-regulator of transcription 1, TBP-binding (negative cofactor 2);0,00000000002320000000;1,266244575;0,005559244;1,091139148;0,016214881;0,010882522;1,156739088;0,041904859;0;1;U2;U1;U1
X100309258_TGI_at;100309258_TGI_at;BC068526;FAM3C;family with sequence similarity 3, member C;0,00000118000000000000;0,816703919;0,0688894;0,937228195;0,10547769;0,055034692;0,862639696;0,12937769;0;0;NA;NA;NA
X100309277_TGI_at;100309277_TGI_at;BC066924;TRIM27;tripartite motif-containing 27;0,00000000515000000000;1,246320982;0,831709962;0,998135149;0,846951408;0,348497017;1,068122927;0,486868611;0;0;NA;NA;NA
X100309279_TGI_at;100309279_TGI_at;BC066775;KANK3;KN motif and ankyrin repeat domains 3;0,00000000000487000000;0,673408491;7,71E-05;0,801209183;0,000883245;0,184980417;0,905011007;0,311548887;0;0;NA;NA;NA
X100309280_TGI_at;100309280_TGI_at;BC065926;REEP5;receptor accessory protein 5;0,00000000000037000000;1,279170221;0,000803306;1,143558402;0,004223584;1,23E-07;1,298871376;0,00013516;0;1;U1;U1;U1
X100309286_TGI_at;100309286_TGI_at;BC065270;APOC2;apolipoprotein C-II;0,00000001700000000000;1,774765364;0,000102249;1,491317523;0,001063056;0,002886902;1,718892179;0,017893238;0;1;U1;U2;U1
X100309287_TGI_at;100309287_TGI_at;BC065000;TCEB2;transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B);0,00000001700000000000;1,239002064;0,407854011;1,028201903;0,453320332;0,014036883;1,224254842;0,049746761;0;0;NA;NA;NA
X100309299_TGI_at;100309299_TGI_at;BC064393;FPGS;folylpolyglutamate synthase;0,00000000967000000000;1,264578221;0,693502941;1,005857888;0,720786836;0,086710607;1,103182742;0,179491513;0;0;NA;NA;NA
X100309324_TGI_at;100309324_TGI_at;BC062365;;;0,00000000001590000000;0,720342081;0,414548725;0,956184698;0,459769629;0,594725383;0,941444395;0,714690495;0;0;NA;NA;NA
X100309325_TGI_at;100309325_TGI_at;BC061924;SLC31A1;solute carrier family 31 (copper transporters), member 1;0,00000000000015100000;1,70298914;0,028875709;1,135486714;0,053486442;0,001882981;1,372851542;0,014113602;0;0;NA;NA;NA
X100309326_TGI_at;100309326_TGI_at;BC061918;;;0,00000016600000000000;0,798595488;0,813780137;0,978948679;0,830529886;0,953827391;0,998913116;0,974385319;0;0;NA;NA;NA
X100309331_TGI_at;100309331_TGI_at;BC060854;CPSF2;cleavage and polyadenylation specific factor 2, 100kDa;0,00000000030900000000;1,297263783;0,01454558;1,12490856;0,032242368;0,093285696;1,165916571;0,188856657;0;0;NA;NA;NA
X100309336_TGI_at;100309336_TGI_at;BC060770;SUSD1;sushi domain containing 1;0,00000000000001380000;1,479978629;1,80E-06;1,27386581;9,38E-05;0,002337491;1,258044257;0,016063395;0;1;U2;U3;U1
X100309338_TGI_at;100309338_TGI_at;BC059394;LYN;v-yes-1 Yamaguchi sarcoma viral related oncogene homolog;0,00000000154000000000;1,203982045;0,004765188;1,11585505;0,014571347;0,004342204;1,211194589;0,022867523;0;1;U2;U1;U1
X100309363_TGI_at;100309363_TGI_at;BC054028;CTSC;cathepsin C;0,00000003780000000000;1,261391455;0,680700863;1,017522178;0,709092518;0,074854353;1,154314909;0,161916497;0;0;NA;NA;NA
X100309366_TGI_at;100309366_TGI_at;BC053649;ZNF280D;zinc finger protein 280D;0,00000007630000000000;1,292151601;0,078004298;1,069550098;0,115483626;0,438672823;1,058843142;0,577550045;0;0;NA;NA;NA
X100309388_TGI_at;100309388_TGI_at;BC050635;CUGBP2;CUG triplet repeat, RNA binding protein 2;0,00000000001560000000;0,815141207;0,210734374;0,97341268;0,259679814;0,033503156;1,251429392;0,091046096;0;0;NA;NA;NA
X100309392_TGI_at;100309392_TGI_at;BC050439;VPS36;vacuolar protein sorting 36 homolog (S. cerevisiae);0,00000085000000000000;1,215775978;0,016268394;1,090381576;0,035002026;0,754854076;0,956823298;0,840087944;0;0;NA;NA;NA
X100309408_TGI_at;100309408_TGI_at;BC047725;MFAP4;microfibrillar-associated protein 4;0,00000002470000000000;0,748046286;0,88022223;1,008956902;0,891563874;0,043371606;0,851357061;0,10819403;0;0;NA;NA;NA
X100309429_TGI_at;100309429_TGI_at;BC046098;;CBF1 interacting corepressor;0,00000015900000000000;1,211829385;0,037693376;1,086663005;0,065561658;0,512848122;1,03296966;0,646425302;0;0;NA;NA;NA
X100309441_TGI_at;100309441_TGI_at;BC044585;ROD1;ROD1 regulator of differentiation 1 (S. pombe);0,00000002840000000000;1,335774726;0,04728403;1,131494221;0,077952138;0,463464856;1,076737906;0,599898486;0;0;NA;NA;NA
X100309471_TGI_at;100309471_TGI_at;BC042003;NPL;N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase);0,00000000001460000000;1,863917139;0,000727928;1,300393174;0,003976458;0,000127227;1,718499427;0,003628771;0;1;U5;U1;U1
X100309479_TGI_at;100309479_TGI_at;BC041570;TRPM2;transient receptor potential cation channel, subfamily M, member 2;0,00000005530000000000;1,373518816;0,109390801;1,102396994;0,150284122;0,365926162;1,076344447;0,503363219;0;0;NA;NA;NA
X100309486_TGI_at;100309486_TGI_at;BC040939;;hypothetical protein BC036928;0,00000001060000000000;0,796737319;0,087892631;0,924879813;0,127373179;0,685961904;0,954005197;0,785104835;0;0;NA;NA;NA
X100309510_TGI_at;100309510_TGI_at;BC039741;TMEM106B;transmembrane protein 106B;0,00000004700000000000;1,267822091;0,001851378;1,108556175;0,007561703;0,939476698;0,983685565;0,965520903;0;0;NA;NA;NA
X100309517_TGI_at;100309517_TGI_at;BC039435;UBE2F;ubiquitin-conjugating enzyme E2F (putative);0,00000000000290000000;1,288210147;0,105636542;1,054731636;0,146752835;0,347587896;1,037931981;0,486868611;0;0;NA;NA;NA
X100309523_TGI_at;100309523_TGI_at;BC039037;CNIH4;cornichon homolog 4 (Drosophila);0,00000006680000000000;1,260477572;0,14542493;0,929130882;0,189353268;0,819786989;1,057287065;0,887827105;0;0;NA;NA;NA
X100309531_TGI_at;100309531_TGI_at;BC038724;REEP3;receptor accessory protein 3;0,00000000001940000000;1,346980813;0,680087183;1,010743002;0,709092518;0,188348637;1,070931366;0,315185699;0;0;NA;NA;NA
X100309539_TGI_at;100309539_TGI_at;BC037857;RAD1;RAD1 homolog (S. pombe);0,00000000000982000000;1,249276252;0,052191534;1,071843587;0,084486847;0,000220177;1,241430577;0,004272984;0;0;NA;NA;NA
X100309543_TGI_at;100309543_TGI_at;BC037549;GK;glycerol kinase;0,00000000000075000000;1,932121519;0,002128386;1,333988331;0,008324987;0,000137814;1,622496553;0,003701458;0;1;U2;U1;U1
X100309555_TGI_at;100309555_TGI_at;BC036784;RASGEF1B;RasGEF domain family, member 1B;0,00000073300000000000;1,727794918;0,048564501;1,287421804;0,079696226;0,383639173;1,175498009;0,520942343;0;0;NA;NA;NA
X100309574_TGI_at;100309574_TGI_at;BC035895;OLFML1;olfactomedin-like 1;0,00000007430000000000;0,771956633;0,887373879;0,974881122;0,897679226;0,462143696;1,141026664;0,598428739;0;0;NA;NA;NA
X100309609_TGI_at;100309609_TGI_at;BC034321;ALDH5A1;aldehyde dehydrogenase 5 family, member A1;0,00000000015200000000;1,358603769;0,000749376;1,196190768;0,004066058;0,01262694;1,23527504;0,046447382;0;1;U2;U1;U1
X100309616_TGI_at;100309616_TGI_at;BC033918;INTS7;integrator complex subunit 7;0,00000008690000000000;1,210080459;0,011075532;1,077206303;0,026402691;0,034975442;1,127465013;0,093703947;0;0;NA;NA;NA
X100309636_TGI_at;100309636_TGI_at;BC033036;ANO1;anoctamin 1, calcium activated chloride channel;0,00000001380000000000;0,828255502;0,037335373;0,931971226;0,065044273;0,057249107;0,91309549;0,133608886;0;0;NA;NA;NA
X100309655_TGI_at;100309655_TGI_at;BC032541;EML1;echinoderm microtubule associated protein like 1;0,00000000122000000000;0,736048834;0,014568442;0,893434044;0,032270851;0,534478464;0,858885079;0,664336324;0;0;NA;NA;NA
X100309675_TGI_at;100309675_TGI_at;BC031412;HABP2;hyaluronan binding protein 2;0,00000000000014100000;2,106677072;1,81E-05;1,617498714;0,0003666;0,004647789;1,393659997;0,023927113;0;1;U7;U1;U1
X100309678_TGI_at;100309678_TGI_at;BC031289;EIF4E3;eukaryotic translation initiation factor 4E family member 3;0,00000000466000000000;0,780447602;0,072666823;0,928925133;0,109697973;0,716662803;1,075740387;0,809321729;0;0;NA;NA;NA
X100309687_TGI_at;100309687_TGI_at;BC030765;;hypothetical gene supported by BC030765;0,00000041800000000000;0,730116727;0,000123142;0,814892825;0,001188283;0,462143696;0,959647512;0,598428739;0;0;NA;NA;NA
X100309697_TGI_at;100309697_TGI_at;BC030130;WFS1;Wolfram syndrome 1 (wolframin);0,00000024500000000000;0,795638134;0,011826238;0,875930954;0,027580294;0,623344939;1,008869323;0,736451884;0;0;NA;NA;NA
X100309701_TGI_at;100309701_TGI_at;BC030011;SV2B;synaptic vesicle glycoprotein 2B;0,00000005040000000000;1,491701681;0,000641288;1,328217535;0,003626088;0,323340368;1,111929588;0,462755775;0;0;NA;NA;NA
X100309720_TGI_at;100309720_TGI_at;BC028692;LNPEP;leucyl/cystinyl aminopeptidase;0,00000052800000000000;1,252385519;0,137890553;1,075112685;0,181841756;0,832935571;1,076464028;0,897243096;0;0;NA;NA;NA
X100309725_TGI_at;100309725_TGI_at;BC028350;TTLL7;tubulin tyrosine ligase-like family, member 7;0,00000025800000000000;0,812197746;0,091631188;0,892406187;0,131431829;0,032083057;0,760311094;0,088319445;0;0;NA;NA;NA
X100309726_TGI_at;100309726_TGI_at;BC028284;MARCKS;myristoylated alanine-rich protein kinase C substrate;0,00000002560000000000;0,803794881;0,111850944;0,900972679;0,153149551;0,899296207;1,034782209;0,944937432;0;0;NA;NA;NA
X100309736_TGI_at;100309736_TGI_at;BC027858;CLEC10A;C-type lectin domain family 10, member A;0,00000000110000000000;1,404298744;0,008460347;1,226813416;0,021972359;0,008379773;1,324775009;0,035724879;0;1;U1;U1;U1
X100309738_TGI_at;100309738_TGI_at;BC027588;RP5-1022P6.2;hypothetical protein KIAA1434;0,00000000314000000000;1,453662892;0,003361251;1,221510928;0,011391495;0,127027071;1,15329357;0,235834246;0;0;NA;NA;NA
X100309740_TGI_at;100309740_TGI_at;BC026754;IPO7;importin 7;0,00000000475000000000;1,206593869;0,003819326;1,108431441;0,012480854;0,103562613;1,044475095;0,203277894;0;0;NA;NA;NA
X100309757_TGI_at;100309757_TGI_at;BC025968;BHLHB3;basic helix-loop-helix domain containing, class B, 3;0,00000000000001250000;2,03666901;1,52E-05;1,495819559;0,000343429;0,023889612;1,340101942;0,071425065;0;0;NA;NA;NA
X100309763_TGI_at;100309763_TGI_at;BC025373;ATP6V1D;ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D;0,00000000002710000000;1,271835814;0,033532736;1,04863062;0,059447749;0,096726246;1,067205405;0,193392487;0;0;NA;NA;NA
X100309765_TGI_at;100309765_TGI_at;BC025246;ME1;malic enzyme 1, NADP(+)-dependent, cytosolic;0,00000013300000000000;1,338554981;0,000454215;1,260343165;0,002813909;0,031930775;1,252572729;0,088319445;0;0;NA;NA;NA
X100309780_TGI_at;100309780_TGI_at;BC023542;SORT1;sortilin 1;0,00000000000000109000;1,571973087;0,047818686;1,143533989;0,078632462;4,67E-05;1,559185543;0,002060556;0;0;NA;NA;NA
X100309799_TGI_at;100309799_TGI_at;BC022330;CYCS;cytochrome c, somatic;0,00000033400000000000;1,224038172;0,344634911;1,049752453;0,39221692;0,450742398;1,060618703;0,587204022;0;0;NA;NA;NA
X100309801_TGI_at;100309801_TGI_at;BC022303;EIF4E3;eukaryotic translation initiation factor 4E family member 3;0,00000007860000000000;0,826296653;0,016737853;0,925958926;0,035749569;0,91436561;1,003344323;0,951873502;0;0;NA;NA;NA
X100309828_TGI_at;100309828_TGI_at;BC020657;GIMAP4;GTPase, IMAP family member 4;0,00000001420000000000;0,79806167;0,000197029;0,834039046;0,00160766;0,315219134;1,120796368;0,454361033;0;0;NA;NA;NA
X100309849_TGI_at;100309849_TGI_at;BC019270;CDC42EP3;CDC42 effector protein (Rho GTPase binding) 3;0,00000003970000000000;1,247804715;3,30E-05;1,187812646;0,000520792;0,772133359;0,997885947;0,852547385;0;0;NA;NA;NA
X100309853_TGI_at;100309853_TGI_at;BC018910;QPRT;quinolinate phosphoribosyltransferase;0,00000000500000000000;1,347997385;0,000319304;1,184121932;0,002208407;0,00919586;1,264285739;0,038004115;0;1;U1;U2;U1
X100309871_TGI_at;100309871_TGI_at;BC017972;SRGAP2P1;SLIT-ROBO Rho GTPase activating protein 2 pseudogene 1;0,00000000173000000000;0,757482158;0,000535197;0,869171832;0,003176686;0,012010459;0,853796289;0,044912263;0;1;D1;D1;D1
X100309875_TGI_at;100309875_TGI_at;BC017850;CCL11;chemokine (C-C motif) ligand 11;0,00000005680000000000;1,765200792;0,011826238;1,422045413;0,027580294;0,431008093;1,136828297;0,568620174;0;0;NA;NA;NA
X100309880_TGI_at;100309880_TGI_at;BC017719;FZD1;frizzled homolog 1 (Drosophila);0,00000000001940000000;0,6565906;0,194646218;0,930104525;0,243062674;0,188348637;0,874881179;0,315185699;0;0;NA;NA;NA
X100309900_TGI_at;100309900_TGI_at;BC016742;DNAJC5B;DnaJ (Hsp40) homolog, subfamily C, member 5 beta;0,00000000000003010000;2,650108223;2,17E-06;1,825440468;0,000101523;3,92E-05;1,91572442;0,001884006;0;1;U6;U2;U1
X100309917_TGI_at;100309917_TGI_at;BC015893;CALCOCO2;calcium binding and coiled-coil domain 2;0,00000000007450000000;0,784362185;3,87E-05;0,862599074;0,000583303;0,940656418;1,066293899;0,965520903;0;0;NA;NA;NA
X100309919_TGI_at;100309919_TGI_at;BC015880;STT3B;STT3, subunit of the oligosaccharyltransferase complex, homolog B (S. cerevisiae);0,00000000031800000000;1,244301527;0,006063538;1,119101286;0,01717292;0,215347198;1,066843056;0,344448645;0;0;NA;NA;NA
X100309944_TGI_at;100309944_TGI_at;BC014631;FASN;fatty acid synthase;0,00000000004290000000;1,461764121;0,005183407;1,237988571;0,015488965;2,21E-05;1,766671861;0,001749595;0;1;U4;U1;U3
X100309959_TGI_at;100309959_TGI_at;BC014223;GIT2;G protein-coupled receptor kinase interacting ArfGAP 2;0,00000001200000000000;1,213270021;0,025303994;1,100627077;0,048602367;0,057249107;1,089991227;0,133608886;0;0;NA;NA;NA
X100309964_TGI_at;100309964_TGI_at;BC014004;WDFY2;WD repeat and FYVE domain containing 2;0,00000000053700000000;1,212596717;0,016476527;1,09218753;0,035317396;0,383877774;1,064937225;0,520942343;0;0;NA;NA;NA
X100309972_TGI_at;100309972_TGI_at;BC013329;DPP4;dipeptidyl-peptidase 4;0,00000000021200000000;1,582065377;0,003329794;1,262201336;0,011296764;0,007948708;1,665073632;0,034341403;0;1;U6;U1;U1
X100309989_TGI_at;100309989_TGI_at;BC012570;PALMD;palmdelphin;0,00000000000003470000;0,682507884;0,026659915;0,87959274;0,050455025;0,09653965;0,855675751;0,193392487;0;0;NA;NA;NA
X100310034_TGI_at;100310034_TGI_at;BC010444;MATN2;matrilin 2;0,00000001320000000000;0,66775376;0,051805827;0,829812657;0,083973089;0,323340368;0,853310771;0,462755775;0;0;NA;NA;NA
X100310046_TGI_at;100310046_TGI_at;BC009968;ARAP3;ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3;0,00000059900000000000;0,754550917;0,000104664;0,813257036;0,00106414;0,734410047;0,94445854;0,82359206;0;0;NA;NA;NA
X100310047_TGI_at;100310047_TGI_at;BC009944;STX6;syntaxin 6;0,00000000000002400000;1,487304646;0,013889189;1,1321168;0,031000594;0,006670412;1,237010007;0,030279914;0;1;U5;U1;U1
X100310053_TGI_at;100310053_TGI_at;BC009795;TNFSF10;tumor necrosis factor (ligand) superfamily, member 10;0,00000045100000000000;0,778924155;0,023069632;0,879769815;0,045422509;0,365926162;1,059726221;0,503363219;0;0;NA;NA;NA
X100310068_TGI_at;100310068_TGI_at;BC009317;ACSS3;acyl-CoA synthetase short-chain family member 3;0,00000000863000000000;1,343892717;0,000271447;1,230729033;0,002002002;0,030508302;1,207911538;0,086003807;0;0;NA;NA;NA
X100310071_TGI_at;100310071_TGI_at;BC009180;MKKS;McKusick-Kaufman syndrome;0,00000010600000000000;1,212219469;0,058477116;1,074472314;0,092433421;0,679153243;1,057168881;0,780082288;0;0;NA;NA;NA
X100310084_TGI_at;100310084_TGI_at;BC008663;GNGT2;guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2;0,00000000000005220000;1,612304472;8,68E-05;1,270707732;0,000964198;8,16E-05;1,459392251;0,00282637;0;1;U4;U1;U1
X100310085_TGI_at;100310085_TGI_at;BC008650;HSD17B11;hydroxysteroid (17-beta) dehydrogenase 11;0,00000003320000000000;1,264867395;2,39E-06;1,241773738;0,000109836;0,000753789;1,341580595;0,007913552;0;1;U1;U2;U1
X100310090_TGI_at;100310090_TGI_at;BC008396;BCHE;butyrylcholinesterase;0,00000000000020500000;0,498586464;0,015276815;0,756557815;0,033381135;0,080609435;0,809734611;0,170587136;0;0;NA;NA;NA
X100310106_TGI_at;100310106_TGI_at;BC007338;CDV3;CDV3 homolog (mouse);0,00000002630000000000;1,250204788;0,279577061;1,042821547;0,328380783;0,080609435;1,168285038;0,170587136;0;0;NA;NA;NA
X100310116_TGI_at;100310116_TGI_at;BC007021;FABP3;fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor);0,00000000000127000000;3,055854647;3,39E-06;2,063546971;0,000134812;5,16E-05;2,37251423;0,002079933;0;1;U2;U1;U1
X100310125_TGI_at;100310125_TGI_at;BC006399;RTN4IP1;reticulon 4 interacting protein 1;0,00000000533000000000;1,220950965;0,010679198;1,092582875;0,025840132;0,534478464;1,046325982;0,664336324;0;0;NA;NA;NA
X100310130_TGI_at;100310130_TGI_at;BC006145;FAF2;Fas associated factor family member 2;0,00000096100000000000;1,230745833;0,116554233;1,062715609;0,158236855;0,806687836;1,033792602;0,879551723;0;0;NA;NA;NA
X100310141_TGI_at;100310141_TGI_at;BC005374;TXNDC4;thioredoxin domain containing 4 (endoplasmic reticulum);0,00000000000518000000;1,200306514;0,003998875;1,070005999;0,012811505;0,017758754;1,116026746;0,058404554;0;0;NA;NA;NA
X100310150_TGI_at;100310150_TGI_at;BC005106;C12orf32;chromosome 12 open reading frame 32;0,00000000446000000000;1,223695745;0,000435507;1,118211438;0,002760548;0,006972738;1,167402392;0,031430956;0;1;U2;U1;U1
X100310155_TGI_at;100310155_TGI_at;BC004932;TMEM204;transmembrane protein 204;0,00000002220000000000;0,684248241;0,000154792;0,791185028;0,001355693;0,357146031;0,871875099;0,494450884;0;0;NA;NA;NA
X100310176_TGI_at;100310176_TGI_at;BC003568;ADK;adenosine kinase;0,00000000037100000000;1,320722129;5,38E-05;1,195452052;0,000715495;0,005685907;1,252132925;0,027149152;0;1;U2;U2;U1
X100310184_TGI_at;100310184_TGI_at;BC003064;DAB2;disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila);0,00000000001460000000;1,442092293;0,005816236;1,208253622;0,016648071;0,005635154;1,273160854;0,026986777;0;1;U6;U1;U1
X100310209_TGI_at;100310209_TGI_at;BC001871;C20orf24;chromosome 20 open reading frame 24;0,00000000005910000000;1,253940963;0,000920468;1,122145522;0,004620326;0,038468809;1,122836062;0,100230372;0;0;NA;NA;NA
X100310212_TGI_at;100310212_TGI_at;BC001766;S100B;S100 calcium binding protein B;0,00000000000000019800;2,937131078;3,06E-05;1,600570275;0,000503102;0,69730432;1,054229408;0,795825717;0;0;NA;NA;NA
X100310222_TGI_at;100310222_TGI_at;BC001405;UPP1;uridine phosphorylase 1;0,00000000000057800000;1,701905325;0,007125287;1,22500203;0,019363238;0,131303184;1,169595797;0,240585653;0;0;NA;NA;NA
X100310224_TGI_at;100310224_TGI_at;BC001395;CIAO1;cytosolic iron-sulfur protein assembly 1 homolog (S. cerevisiae);0,00000005380000000000;1,237787416;0,28695991;1,028139995;0,336131821;0,218819432;1,074858671;0,349136153;0;0;NA;NA;NA
X100310228_TGI_at;100310228_TGI_at;BC001281;TNFRSF10B;tumor necrosis factor receptor superfamily, member 10b;0,00000000000006070000;1,773555575;0,008802152;1,192458443;0,022492182;0,005746943;1,413188956;0,02719882;0;1;U6;U1;U1
X100310230_TGI_at;100310230_TGI_at;BC001266;ST3GAL6;ST3 beta-galactoside alpha-2,3-sialyltransferase 6;0,00000012700000000000;1,279736936;0,043023798;1,091348065;0,072259354;0,072102527;1,243219576;0,157336794;0;0;NA;NA;NA
X100310254_TGI_at;100310254_TGI_at;BC000181;GPR160;G protein-coupled receptor 160;0,00000000002560000000;1,6352728;4,68E-07;1,352410495;4,08E-05;0,009707916;1,319485857;0,039467969;0;1;U3;U1;U1
X100310273_TGI_at;100310273_TGI_at;AY762103;CAV1;caveolin 1, caveolae protein, 22kDa;0,00000000000000602000;0,7538749;0,427597909;0,965378682;0,472615934;0,020452962;1,274980967;0,064249412;0;0;NA;NA;NA
X100310300_TGI_at;100310300_TGI_at;AY513278;SPARCL1;SPARC-like 1 (hevin);0,00000000000887000000;0,733064488;0,003768954;0,845557791;0,012382609;0,289772413;0,909852657;0,428607841;0;0;NA;NA;NA
X100310311_TGI_at;100310311_TGI_at;AY376900;RAP1GDS1;RAP1, GTP-GDP dissociation stimulator 1;0,00000005780000000000;1,20472598;0,092390302;1,088904742;0,13240282;0,013270593;1,178049278;0,048111498;0;0;NA;NA;NA
X100310317_TGI_at;100310317_TGI_at;AY359067;AIF1L;allograft inflammatory factor 1-like;0,00000042300000000000;0,770704001;6,68E-05;0,81740432;0,000812592;0,059535454;0,820015452;0,137945916;0;0;NA;NA;NA
X100310319_TGI_at;100310319_TGI_at;AY359019;MPZL1;myelin protein zero-like 1;0,00000010000000000000;1,277348749;0,013550757;1,125142323;0,030477382;0,534478464;1,020060981;0,664336324;0;0;NA;NA;NA
X100310323_TGI_at;100310323_TGI_at;AY358924;GRAMD1B;GRAM domain containing 1B;0,00000000000236000000;1,619960184;0,025680989;1,155567261;0,04912156;0,000923705;1,348826342;0,008967168;0;1;U5;U1;U1
X100310330_TGI_at;100310330_TGI_at;AY358559;SCPEP1;serine carboxypeptidase 1;0,00000000272000000000;1,469199615;1,76E-05;1,289509985;0,000366485;0,063309309;1,256694513;0,144202051;0;0;NA;NA;NA
X100310334_TGI_at;100310334_TGI_at;AY358312;LRRN1;leucine rich repeat neuronal 1;0,00000098500000000000;0,747065053;0,774391154;0,947522381;0,794354771;0,038082294;0,716686481;0,099545202;0;0;NA;NA;NA
X100310335_TGI_at;100310335_TGI_at;AY358278;ANGPTL1;angiopoietin-like 1;0,00000000000038300000;0,613771104;0,000289971;0,73721216;0,002072229;0,080609435;0,839421371;0,170587136;0;0;NA;NA;NA
X100310342_TGI_at;100310342_TGI_at;AY353255;CAV2;caveolin 2;0,00000000090100000000;0,804630761;0,157541305;0,947142265;0,202696856;0,767721344;1,058445971;0,850005459;0;0;NA;NA;NA
X100310343_TGI_at;100310343_TGI_at;AY351902;IQGAP2;IQ motif containing GTPase activating protein 2;0,00000020700000000000;1,328991469;0,001463504;1,210985385;0,006408795;0,046864607;1,27750701;0,114688405;0;0;NA;NA;NA
X100310400_TGI_at;100310400_TGI_at;AY077698;JAM2;junctional adhesion molecule 2;0,00000001630000000000;0,766834913;0,181073936;0,962381797;0,228504814;0,107895631;0,892779965;0,208857428;0;0;NA;NA;NA
X100310404_TGI_at;100310404_TGI_at;AY052377;ATP5S;ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B);0,00000000002010000000;1,281682481;0,103678413;1,064857863;0,14471872;0,05233147;1,12829114;0,125587736;0;0;NA;NA;NA
X100310432_TGI_at;100310432_TGI_at;AW993431;MYO5A;myosin VA (heavy chain 12, myoxin);0,00000001150000000000;1,313112446;0,00218639;1,148856635;0,008490041;0,006014229;1,216599003;0,028156556;0;1;U4;U2;U1
X100310454_TGI_at;100310454_TGI_at;AW954554;TSPAN7;tetraspanin 7;0,00000014500000000000;0,782956587;0,354940079;0,953901286;0,402240463;0,203035049;1,147846076;0,330514884;0;0;NA;NA;NA
X100310466_TGI_at;100310466_TGI_at;AW856256;MAP3K2;mitogen-activated protein kinase kinase kinase 2;0,00000000435000000000;1,289217964;0,006722851;1,111402993;0,01856705;0,613556941;0,95819046;0,727019861;0;0;NA;NA;NA
X100310515_TGI_at;100310515_TGI_at;AW513849;KCTD15;potassium channel tetramerisation domain containing 15;0,00000000450000000000;0,715512047;0,005326341;0,866091627;0,015749355;0,05081529;0,853251877;0,122313429;0;0;NA;NA;NA
X100310546_TGI_at;100310546_TGI_at;AW444881;SLC44A1;solute carrier family 44, member 1;0,00000126000000000000;0,768024217;0,929255278;1,015229744;0,9359343;0,502203015;0,967389919;0,637495201;0;0;NA;NA;NA
X100310553_TGI_at;100310553_TGI_at;AW384920;SEMA5A;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A;0,00000000030200000000;0,669828968;0,040183399;0,85522888;0,068669721;0,209185181;1,135774512;0,337324278;0;0;NA;NA;NA
X100310563_TGI_at;100310563_TGI_at;AW351717;ALOX5;arachidonate 5-lipoxygenase;0,00000000005570000000;1,663565135;0,000144211;1,388202414;0,001291564;0,000371641;1,730199673;0,00537129;0;1;U2;U1;U1
X100310570_TGI_at;100310570_TGI_at;AW316845;CTSE;cathepsin E;0,00000000146000000000;1,874992035;0,315516277;1,147236087;0,364744965;0,149505026;1,547045331;0,264174725;0;0;NA;NA;NA
X100310600_TGI_at;100310600_TGI_at;AW273796;;;0,00000000005590000000;0,646889983;0,302245553;0,934270834;0,351547245;0,161066496;1,28271576;0,279095331;0;0;NA;NA;NA
X100310611_TGI_at;100310611_TGI_at;AW262910;ADFP;adipose differentiation-related protein;0,00000034800000000000;1,504218414;0,343149257;1,088993824;0,391216858;0,846792216;0,888877592;0,906474529;0;0;NA;NA;NA
X100310689_TGI_at;100310689_TGI_at;AW070324;CDS2;CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2;0,00000004330000000000;1,257685116;0,023272111;1,124681363;0,045651866;0,004862758;1,224854755;0,024374289;0;1;U1;U1;U1
X100310696_TGI_at;100310696_TGI_at;AW027183;MYLIP;myosin regulatory light chain interacting protein;0,00000114000000000000;0,75570002;0,0762663;0,866750921;0,113483972;0,91436561;0,968761889;0,951873502;0;0;NA;NA;NA
X100310698_TGI_at;100310698_TGI_at;AW027026;EVI2A;ecotropic viral integration site 2A;0,00000003370000000000;1,438132867;0,005368356;1,12773188;0,015830021;0,004862758;1,313763933;0,024374289;0;1;U3;U1;U1
X100310715_TGI_at;100310715_TGI_at;AW003093;;;0,00000000010400000000;1,353267566;0,002060432;1,138703849;0,008158198;0,071816378;1,140447102;0,157336794;0;0;NA;NA;NA
X100310724_TGI_at;100310724_TGI_at;AV751953;WIF1;WNT inhibitory factor 1;0,00000014300000000000;0,660333745;0,002337999;0,744682832;0,008792732;0,992507023;1,039264889;0,995253159;0;0;NA;NA;NA
X100310745_TGI_at;100310745_TGI_at;AV727904;LIPA;lipase A, lysosomal acid, cholesterol esterase;0,00000000000192000000;1,878645877;0,000245369;1,396427396;0,001878441;0,000656787;1,698053768;0,007427454;0;1;U2;U1;U1
X100310750_TGI_at;100310750_TGI_at;AV724490;CD160;CD160 molecule;0,00000004640000000000;0,759377397;0,080142176;0,938037028;0,118004197;0,086710607;0,74361488;0,179491513;0;0;NA;NA;NA
X100310776_TGI_at;100310776_TGI_at;AV699259;CHURC1;churchill domain containing 1;0,00000032900000000000;1,227421414;0,884918589;0,996723779;0,895476487;0,440813265;1,09912535;0,5787133;0;0;NA;NA;NA
X100310780_TGI_at;100310780_TGI_at;AV692564;C9orf97;chromosome 9 open reading frame 97;0,00000000022300000000;0,772003866;0,016833096;0,90299862;0,035881658;0,78952051;1,005439348;0,866402657;0;0;NA;NA;NA
X100310807_TGI_at;100310807_TGI_at;AU157176;TMEM38B;transmembrane protein 38B;0,00000001860000000000;1,463180485;0,000866119;1,250361954;0,004445065;0,103904525;1,20541464;0,203577073;0;0;NA;NA;NA
X100310808_TGI_at;100310808_TGI_at;AU155388;ZNF250;zinc finger protein 250;0,00000000012900000000;0,748596021;0,012813633;0,846585879;0,029356114;1;1,044362318;1;0;0;NA;NA;NA
X100310812_TGI_at;100310812_TGI_at;AU146170;EIF3I;eukaryotic translation initiation factor 3, subunit I;0,00000009040000000000;0,756252493;0,136240309;0,91437132;0,180033832;0,149505026;0,852290189;0,264174725;0;0;NA;NA;NA
X100310835_TGI_at;100310835_TGI_at;AU119383;SENP3;SUMO1/sentrin/SMT3 specific peptidase 3;0,00000025500000000000;1,259745359;0,075195228;1,114868588;0,112389593;0,255009933;1,19458312;0,38934013;0;0;NA;NA;NA
X100310842_TGI_at;100310842_TGI_at;AU100313;KIAA0355;KIAA0355;0,00000000214000000000;0,783124947;0,034306989;0,889948236;0,060620299;0,077689446;0,867664652;0,166153341;0;0;NA;NA;NA
X100310855_TGI_at;100310855_TGI_at;AM393038;FAM49A;family with sequence similarity 49, member A;0,00000007840000000000;1,340577263;0,010730868;1,199067483;0,025848719;0,048807143;1,270837981;0,118721072;0;0;NA;NA;NA
X100310859_TGI_at;100310859_TGI_at;AM392966;CNIH4;cornichon homolog 4 (Drosophila);0,00000000001210000000;1,281989544;0,001125297;1,154701577;0,005263905;0,000875061;1,276360518;0,008731645;0;1;U3;U1;U1
X100310878_TGI_at;100310878_TGI_at;AL834530;NRBP2;nuclear receptor binding protein 2;0,00000000019500000000;0,818378647;0,736637811;0,968918698;0,760225317;0,339979528;0,922760396;0,480593868;0;0;NA;NA;NA
X100310905_TGI_at;100310905_TGI_at;AL833915;TDRD9;tudor domain containing 9;0,00000004450000000000;1,42986709;0,006838796;1,272945887;0,018822749;0,061450873;1,208480362;0,141367712;0;0;NA;NA;NA
X100310916_TGI_at;100310916_TGI_at;AL833546;PLEKHH2;pleckstrin homology domain containing, family H (with MyTH4 domain) member 2;0,00000123000000000000;0,719841996;0,408888147;0,930573087;0,454273181;0,110976585;0,816434941;0,212903293;0;0;NA;NA;NA
X100310930_TGI_at;100310930_TGI_at;AL833400;PLEKHH2;pleckstrin homology domain containing, family H (with MyTH4 domain) member 2;0,00000000635000000000;0,63829191;0,073331074;0,849902457;0,110338959;0,836152269;1,128516222;0,898605789;0;0;NA;NA;NA
X100310966_TGI_at;100310966_TGI_at;AL832991;USP47;ubiquitin specific peptidase 47;0,00000000125000000000;0,802540733;0,03023484;0,906971188;0,055304705;0,613556941;0,970088933;0,727019861;0;0;NA;NA;NA
X100310972_TGI_at;100310972_TGI_at;AL832770;MEIS1;Meis homeobox 1;0,00000000693000000000;0,754400193;0,091631188;0,918606908;0,131431829;0,016931008;0,763703499;0,056430856;0;0;NA;NA;NA
X100310990_TGI_at;100310990_TGI_at;AL832585;CHRM2;cholinergic receptor, muscarinic 2;0,00000069800000000000;0,535208813;0,074246935;0,704557776;0,111406886;0,613556941;0,953371933;0,727019861;0;0;NA;NA;NA
X100311026_TGI_at;100311026_TGI_at;AL832187;GPRASP2;G protein-coupled receptor associated sorting protein 2;0,00000087100000000000;0,814484345;0,988678483;0,994750401;0,990214652;0,203149235;0,95625769;0,330514884;0;0;NA;NA;NA
X100311056_TGI_at;100311056_TGI_at;AL831937;SETDB2;SET domain, bifurcated 2;0,00000001090000000000;1,223020618;0,018924824;1,08268835;0,039149364;0,255009933;1,101042769;0,38934013;0;0;NA;NA;NA
X100311082_TGI_at;100311082_TGI_at;AL698310;LRP2;low density lipoprotein-related protein 2;0,00000001740000000000;1,576543516;0,00527515;1,379399991;0,015684324;0,001882981;1,559768721;0,014113602;0;1;U4;U1;U1
X100311090_TGI_at;100311090_TGI_at;AL582343;KANK3;KN motif and ankyrin repeat domains 3;0,00000000000220000000;0,683051809;0,000117571;0,799789154;0,001151763;0,060804037;0,846835653;0,140481298;0;0;NA;NA;NA
X100311100_TGI_at;100311100_TGI_at;AL576132;ADFP;adipose differentiation-related protein;0,00000000002530000000;1,400811892;0,103191006;1,103852883;0,144413639;0,013942384;1,342901869;0,049653374;0;0;NA;NA;NA
X100311115_TGI_at;100311115_TGI_at;AL565381;TP53I11;tumor protein p53 inducible protein 11;0,00000009700000000000;0,760165713;0,662513641;0,996612881;0,692823317;0,307230301;1,10227816;0,446439703;0;0;NA;NA;NA
X100311162_TGI_at;100311162_TGI_at;AL532155;FAM13C1;family with sequence similarity 13, member C1;0,00000000035800000000;0,702142716;0,009327394;0,83739423;0,023486087;0,159283623;0,864090323;0,276600817;0;0;NA;NA;NA
X100311165_TGI_at;100311165_TGI_at;AL530795;TMEM33;transmembrane protein 33;0,00000000004760000000;1,448949271;0,002979003;1,207995354;0,010458963;0,003446716;1,304822981;0,019661534;0;1;U1;U1;U1
X100311191_TGI_at;100311191_TGI_at;AL515981;NCLN;nicalin homolog (zebrafish);0,00000015600000000000;1,323926985;0,200248536;1,051034236;0,249093413;0,019786991;1,207238529;0,062769164;0;0;NA;NA;NA
X100311192_TGI_at;100311192_TGI_at;AL515902;USP14;ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase);0,00000000003610000000;1,206895877;0,033823235;1,06548793;0,059863968;0,556550302;1,029700103;0,68359818;0;0;NA;NA;NA
X100311197_TGI_at;100311197_TGI_at;AL512753;CCDC50;coiled-coil domain containing 50;0,00000000011000000000;0,806176899;0,108405474;0,922195274;0,149376161;0,164346936;0,95566346;0,282652175;0;0;NA;NA;NA
X100311216_TGI_at;100311216_TGI_at;AL353952;PI4K2A;phosphatidylinositol 4-kinase type 2 alpha;0,00000000000049100000;1,516983099;0,000399069;1,171670794;0,00260892;2,43E-05;1,31380169;0,001789912;0;1;U5;U2;U1
X100311234_TGI_at;100311234_TGI_at;AL137750;ETNK1;ethanolamine kinase 1;0,00000073200000000000;1,383307888;0,001750066;1,202046419;0,007306299;1;0,954836853;1;0;0;NA;NA;NA
X100311274_TGI_at;100311274_TGI_at;AL136711;TMEM49;transmembrane protein 49;0,00000011100000000000;1,383713021;0,037278756;1,102091537;0,064980762;0,262074839;0,889235211;0,39749045;0;0;NA;NA;NA
X100311275_TGI_at;100311275_TGI_at;AL136709;ABI3;ABI family, member 3;0,00000005240000000000;1,353369685;0,031946117;1,110891154;0,057746682;0,056034188;1,195933598;0,131535461;0;0;NA;NA;NA
X100311282_TGI_at;100311282_TGI_at;AL134313;NR1D1;nuclear receptor subfamily 1, group D, member 1;0,00000106000000000000;0,818613605;0,023356949;0,904320906;0,045707011;0,512848122;0,891476414;0,646425302;0;0;NA;NA;NA
X100311283_TGI_at;100311283_TGI_at;AL133665;NFIA;nuclear factor I/A;0,00000000150000000000;0,812590135;0,96081073;1,001975387;0,965414485;0,985987913;0,960819435;0,992454417;0;0;NA;NA;NA
X100311300_TGI_at;100311300_TGI_at;AL122044;TMEM163;transmembrane protein 163;0,00000002510000000000;1,322094763;0,127072682;1,115102093;0,170222467;0,000159725;1,989946914;0,004028419;0;0;NA;NA;NA
X100311306_TGI_at;100311306_TGI_at;AL117592;EMILIN2;elastin microfibril interfacer 2;0,00000076900000000000;1,274739692;0,100048494;1,089927601;0,140626383;0,080140884;1,15278869;0,170587136;0;0;NA;NA;NA
X100311328_TGI_at;100311328_TGI_at;AL110200;;;0,00000000000268000000;1,586900596;0,000709947;1,308178606;0,003904708;0,114834098;1,179610098;0,21874131;0;0;NA;NA;NA
X100311336_TGI_at;100311336_TGI_at;AL110097;BCL2A1;BCL2-related protein A1;0,00000000000006770000;1,950777827;0,000803306;1,29943777;0,004223584;0,008831116;1,547226354;0,036964527;0;1;U2;U2;U1
X100311350_TGI_at;100311350_TGI_at;AL080130;;;0,00000001830000000000;0,826060687;0,042442521;0,874187897;0,071469302;0,940656418;0,998796058;0,965520903;0;0;NA;NA;NA
X100311352_TGI_at;100311352_TGI_at;AL079896;S100A9;S100 calcium binding protein A9;0,00000036400000000000;1,470216928;0,934407053;0,978908809;0,940241627;0,096726005;1,333754283;0,193392487;0;0;NA;NA;NA
X100311376_TGI_at;100311376_TGI_at;AL049423;;;0,00000002160000000000;0,832070509;0,140232877;0,952865;0,184252166;0,074615336;0,908324231;0,161916497;0;0;NA;NA;NA
X100311386_TGI_at;100311386_TGI_at;AL049219;RBM8A;RNA binding motif protein 8A;0,00000011400000000000;0,831278614;0,171909147;0,950951683;0,218135111;0,862086046;0,999731655;0,916392918;0;0;NA;NA;NA
X100311394_TGI_at;100311394_TGI_at;AL042986;EPB41L2;erythrocyte membrane protein band 4.1-like 2;0,00000000000334000000;0,726455969;0,000227915;0,805031986;0,001787272;0,767721344;1,01203723;0,850005459;0;0;NA;NA;NA
X100311400_TGI_at;100311400_TGI_at;AK226176;GPM6A;glycoprotein M6A;0,00000000001010000000;0,563340847;0,011065225;0,788066339;0,026402691;0,053765992;1,348401879;0,127699182;0;0;NA;NA;NA
X100311401_TGI_at;100311401_TGI_at;AK226124;CTNND2;catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein);0,00000000005240000000;0,602048631;0,107587048;0,852106182;0,148629685;0,100003042;1,237204445;0,198466629;0;0;NA;NA;NA
X100311406_TGI_at;100311406_TGI_at;AK226024;CD1C;CD1c molecule;0,00000000000382000000;1,649245726;0,070094735;1,199281671;0,106866288;0,05081529;1,443570998;0,122313429;0;0;NA;NA;NA
X100311431_TGI_at;100311431_TGI_at;AK225589;TMEM43;transmembrane protein 43;0,00000000004180000000;0,827930499;0,022121178;0,943329928;0,044091872;0,537464131;0,983986074;0,667275383;0;0;NA;NA;NA
X100311438_TGI_at;100311438_TGI_at;AK225360;SLC47A1;solute carrier family 47, member 1;0,00000000839000000000;1,590981956;0,014925456;1,300797055;0,032836003;0,000276376;1,61490022;0,004763426;0;1;U2;U1;U1
X100311449_TGI_at;100311449_TGI_at;AK225089;ACAT2;acetyl-Coenzyme A acetyltransferase 2;0,00000000062600000000;1,384411594;0,016421572;1,192971789;0,035284485;0,000461729;1,312180068;0,006049403;0;1;U2;U1;U1
X100311465_TGI_at;100311465_TGI_at;AK223091;GLB1;galactosidase, beta 1;0,00000000072400000000;1,265660497;0,000460763;1,16707013;0,002834042;0,000220177;1,310903871;0,004272984;0;1;U1;U1;U1
X100311468_TGI_at;100311468_TGI_at;AK223027;PHLDA2;pleckstrin homology-like domain, family A, member 2;0,00000098600000000000;1,623020977;0,301192721;1,144123701;0,350449148;0,103562613;1,215587877;0,203277894;0;0;NA;NA;NA
X100311473_TGI_at;100311473_TGI_at;AK222847;DPP3;dipeptidyl-peptidase 3;0,00000000042600000000;1,265965309;0,190768785;1,044699302;0,239054352;0,197238472;1,098448423;0,324667823;0;0;NA;NA;NA
X100311477_TGI_at;100311477_TGI_at;AK222762;SSR1;signal sequence receptor, alpha;0,00000000003670000000;1,30201861;0,144150051;1,061957554;0,18801927;0,299373904;1,045630316;0,437985516;0;0;NA;NA;NA
X100311503_TGI_at;100311503_TGI_at;AK130858;C1orf97;chromosome 1 open reading frame 97;0,00000000006340000000;1,333582273;0,003102284;1,135136071;0,010786043;0,074615336;1,161316076;0,161916497;0;0;NA;NA;NA
X100311521_TGI_at;100311521_TGI_at;AK129601;;organic solute transporter beta;0,00000002540000000000;0,638460769;0,017217882;0,771898255;0,036484702;0,348497017;0,904021172;0,486868611;0;0;NA;NA;NA
X100311532_TGI_at;100311532_TGI_at;AK128285;CLCN7;chloride channel 7;0,00000055800000000000;1,267955327;0,560985751;1,037284842;0,596915508;0,241271938;1,151753432;0,374575845;0;0;NA;NA;NA
X100311533_TGI_at;100311533_TGI_at;AK128280;KPNA1;karyopherin alpha 1 (importin alpha 5);0,00000025400000000000;1,218390247;0,043611789;1,088982734;0,073094538;0,901252766;1,011087638;0,944937432;0;0;NA;NA;NA
X100311535_TGI_at;100311535_TGI_at;AK128160;IGSF10;immunoglobulin superfamily, member 10;0,00000000280000000000;0,744427577;0,061206261;0,856419474;0,095994053;0,924555569;0,981479292;0,959350695;0;0;NA;NA;NA
X100311552_TGI_at;100311552_TGI_at;AK127289;SLCO2B1;solute carrier organic anion transporter family, member 2B1;0,00000000018500000000;1,236084001;0,001220756;1,125878836;0,005518227;0,014774182;1,191775397;0,051589587;0;0;NA;NA;NA
X100311556_TGI_at;100311556_TGI_at;AK127182;YARS;tyrosyl-tRNA synthetase;0,00000000888000000000;1,272535782;0,010979978;1,085382059;0,026252573;0,030713739;1,152429944;0,086003807;0;0;NA;NA;NA
X100311564_TGI_at;100311564_TGI_at;AK126729;NDRG4;NDRG family member 4;0,00000000272000000000;0,669702442;0,000607765;0,715274718;0,003485457;0,506743264;0,905836438;0,641830435;0;0;NA;NA;NA
X100311566_TGI_at;100311566_TGI_at;AK126652;EFTUD2;elongation factor Tu GTP binding domain containing 2;0,00000000530000000000;1,20635121;0,665411802;1,026239505;0,695402801;0,262074839;1,058394399;0,39749045;0;0;NA;NA;NA
X100311573_TGI_at;100311573_TGI_at;AK126232;LAMP2;lysosomal-associated membrane protein 2;0,00000000000089400000;1,441112791;3,54E-06;1,21040871;0,000137466;0,005437653;1,280755014;0,026196646;0;1;U2;U2;U1
X100311590_TGI_at;100311590_TGI_at;AK125659;TLR2;toll-like receptor 2;0,00000000397000000000;1,292047663;0,749906609;1,029767335;0,771695457;0,058379601;1,165196857;0,13605022;0;0;NA;NA;NA
X100311594_TGI_at;100311594_TGI_at;AK125555;PHLDB2;pleckstrin homology-like domain, family B, member 2;0,00000078900000000000;0,781727299;0,020415178;0,892367041;0,041513009;0,26927095;0,895540068;0,405163526;0;0;NA;NA;NA
X100311617_TGI_at;100311617_TGI_at;AK124954;MRAS;muscle RAS oncogene homolog;0,00000000026400000000;1,43420888;0,059094048;1,091925392;0,093139209;0,017758754;1,169938168;0,058404554;0;0;NA;NA;NA
X100311623_TGI_at;100311623_TGI_at;AK124696;KCNAB2;potassium voltage-gated channel, shaker-related subfamily, beta member 2;0,00000000985000000000;1,34832637;0,241760217;1,070251973;0,290202302;0,06589724;1,196636257;0,147695969;0;0;NA;NA;NA
X100311642_TGI_at;100311642_TGI_at;AK123772;SLC25A16;"solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16";0,00000000000410000000;1,331636373;0,097905729;1,100237575;0,13821733;0,006589531;1,364439495;0,030039685;0;0;NA;NA;NA
X100311652_TGI_at;100311652_TGI_at;AK123248;OSBPL6;oxysterol binding protein-like 6;0,00000038000000000000;0,699394453;0,013249583;0,784135096;0,030047513;0,000612657;0,614924001;0,007180335;0;1;D1;D1;D1
X100311654_TGI_at;100311654_TGI_at;AK123210;;;0,00000011700000000000;0,824975178;0,007445908;0,870772978;0,019965193;0,01262694;0,880764529;0,046447382;0;1;D2;D1;D1
X100311662_TGI_at;100311662_TGI_at;AK122881;PRICKLE1;prickle homolog 1 (Drosophila);0,00000020100000000000;0,754936251;0,20257395;0,906434152;0,251403866;0,784830893;0,824941619;0,861549716;0;0;NA;NA;NA
X100311695_TGI_at;100311695_TGI_at;AK097693;PLA2G5;phospholipase A2, group V;0,00000080500000000000;0,747759188;0,03123814;0,856265115;0,056657583;0,431008093;0,882700585;0,568620174;0;0;NA;NA;NA
X100311697_TGI_at;100311697_TGI_at;AK097588;ATL3;atlastin GTPase 3;0,00000000001590000000;1,314649685;0,010591601;1,113425201;0,02564743;0,18024766;1,061071337;0,304954439;0;0;NA;NA;NA
X100311703_TGI_at;100311703_TGI_at;AK097340;;RPE-spondin;0,00000000052100000000;0,697806772;0,023012864;0,831927271;0,045364196;0,116784593;0,85257456;0,221801262;0;0;NA;NA;NA
X100311726_TGI_at;100311726_TGI_at;AK096474;EGFLAM;EGF-like, fibronectin type III and laminin G domains;0,00000101000000000000;1,515467712;0,020725238;1,306827479;0,042010971;0,149505026;0,78591817;0,264174725;0;0;NA;NA;NA
X100311727_TGI_at;100311727_TGI_at;AK096416;NLN;neurolysin (metallopeptidase M3 family);0,00000014900000000000;1,411145921;0,002723735;1,251470075;0,009743171;0,378530849;1,079985528;0,51585832;0;0;NA;NA;NA
X100311731_TGI_at;100311731_TGI_at;AK096028;USHBP1;Usher syndrome 1C binding protein 1;0,00000006170000000000;0,716545584;0,001156139;0,764293215;0,005338446;0,556550302;0,96210208;0,68359818;0;0;NA;NA;NA
X100311734_TGI_at;100311734_TGI_at;AK095917;B3GALNT1;beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group);0,00000000018700000000;0,657475105;0,025892963;0,83532194;0,049468299;0,135687627;0,853983955;0,247213805;0;0;NA;NA;NA
X100311768_TGI_at;100311768_TGI_at;AK094507;ACTR8;ARP8 actin-related protein 8 homolog (yeast);0,00000000039500000000;1,275336326;0,017370431;1,077538329;0,036591438;0,63704437;1,059587241;0,747431382;0;0;NA;NA;NA
X100311794_TGI_at;100311794_TGI_at;AK093772;;hypothetical protein LOC150166;0,00000058600000000000;1,397233142;0,553292466;1,029760718;0,589897988;0,02416816;1,286067542;0,072190897;0;0;NA;NA;NA
X100311836_TGI_at;100311836_TGI_at;AK092353;PCNXL2;pecanex-like 2 (Drosophila);0,00000023000000000000;1,209779914;2,88E-05;1,219338479;0,000486822;0,411774001;0,929829338;0,552978168;0;0;NA;NA;NA
X100311855_TGI_at;100311855_TGI_at;AK091354;NRP1;neuropilin 1;0,00000004850000000000;1,259119039;4,16E-05;1,229802626;0,000607007;0,648001878;1,027100461;0,755321916;0;0;NA;NA;NA
X100311859_TGI_at;100311859_TGI_at;AK091196;ARHGAP24;Rho GTPase activating protein 24;0,00000000000228000000;0,803243469;0,016227066;0,916164152;0,034983166;0,679153243;1,030850351;0,780082288;0;0;NA;NA;NA
X100311865_TGI_at;100311865_TGI_at;AK091100;;hypothetical LOC643837;0,00000000208000000000;0,796583955;0,066711084;0,927847813;0,102974054;0,089895036;0,860681281;0,184145191;0;0;NA;NA;NA
X100311868_TGI_at;100311868_TGI_at;AK090924;COL8A2;collagen, type VIII, alpha 2;0,00000000000000200000;1,911985461;8,43E-06;1,415148103;0,000251644;0,001950454;1,444188749;0,014451293;0;1;U1;U2;U1
X100311870_TGI_at;100311870_TGI_at;AK090769;PHACTR1;phosphatase and actin regulator 1;0,00000000002900000000;1,404485066;0,066711084;1,108435215;0,102974054;5,09E-05;1,506422702;0,002079933;0;0;NA;NA;NA
X100311878_TGI_at;100311878_TGI_at;AK075533;C1QTNF3;C1q and tumor necrosis factor related protein 3;0,00000051200000000000;0,704932448;0,660019158;0,944263264;0,690662905;0,33768758;0,927742715;0,479456859;0;0;NA;NA;NA
X100311882_TGI_at;100311882_TGI_at;AK075393;CTSB;cathepsin B;0,00000000000221000000;1,210176937;0,011266738;1,065326283;0,026680893;0,023487994;1,108262255;0,070485851;0;0;NA;NA;NA
X100311890_TGI_at;100311890_TGI_at;AK075141;RNF149;ring finger protein 149;0,00000000005420000000;1,251386948;0,088394549;1,05285089;0,127813203;0,001497214;1,250211423;0,012033721;0;0;NA;NA;NA
X100311901_TGI_at;100311901_TGI_at;AK074669;SLAMF8;SLAM family member 8;0,00000000004600000000;1,926103382;0,026274021;1,244837822;0,049929935;0,014774182;1,387201014;0,051589587;0;0;NA;NA;NA
X100311911_TGI_at;100311911_TGI_at;AK074436;PCMTD2;protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2;0,00000093900000000000;0,802548886;0,055410454;0,941561209;0,08861465;0,197238472;0,904542106;0,324667823;0;0;NA;NA;NA
X100311922_TGI_at;100311922_TGI_at;AK074155;ATHL1;ATH1, acid trehalase-like 1 (yeast);0,00000120000000000000;0,710943921;0,134754056;0,869997039;0,17836235;0,197238472;0,851132998;0,324667823;0;0;NA;NA;NA
X100311929_TGI_at;100311929_TGI_at;AK074044;GIMAP6;GTPase, IMAP family member 6;0,00000000000000034600;0,623864568;0,000194337;0,783604441;0,00159156;0,979396399;0,98031261;0,987556719;0;0;NA;NA;NA
X100311932_TGI_at;100311932_TGI_at;AK058103;ADRBK2;adrenergic, beta, receptor kinase 2;0,00000000000521000000;1,504370989;0,000803306;1,241154379;0,004223584;0,003653668;1,402250048;0,020560753;0;1;U5;U1;U1
X100311938_TGI_at;100311938_TGI_at;AK057931;RSPH3;radial spoke 3 homolog (Chlamydomonas);0,00000000077400000000;1,275720881;0,036475174;1,110784885;0,063821653;0,642406094;1,046346325;0,75262626;0;0;NA;NA;NA
X100311944_TGI_at;100311944_TGI_at;AK057634;PLCB4;phospholipase C, beta 4;0,00000000000602000000;0,739882153;0,042442521;0,877764903;0,071469302;0,019518593;0,772920863;0,062162477;0;0;NA;NA;NA
X100311967_TGI_at;100311967_TGI_at;AK056411;CLSTN2;calsyntenin 2;0,00000087100000000000;0,68736417;0,08495127;0,817898349;0,124046493;0,118794011;0,788308186;0,224033409;0;0;NA;NA;NA
X100312001_TGI_at;100312001_TGI_at;AK055053;SHMT2;serine hydroxymethyltransferase 2 (mitochondrial);0,00000000657000000000;1,207035286;0,06748727;1,059312696;0,10367563;0,064698533;1,093011438;0,145515263;0;0;NA;NA;NA
X100312003_TGI_at;100312003_TGI_at;AK054932;;;0,00000000297000000000;0,819467026;0,099607341;0,943555889;0,140128529;0,122857837;0,893268684;0,229149774;0;0;NA;NA;NA
X100312009_TGI_at;100312009_TGI_at;AK054684;;;0,00000000000002650000;0,547531031;5,98E-07;0,659835113;4,70E-05;0,460794302;0,885195745;0,597401462;0;0;NA;NA;NA
X100312012_TGI_at;100312012_TGI_at;AK027899;RELT;RELT tumor necrosis factor receptor;0,00000000005220000000;1,459114365;0,009726645;1,137266604;0,024189026;0,083615947;1,204339024;0,17510994;0;0;NA;NA;NA
X100312026_TGI_at;100312026_TGI_at;AK027603;SLC35B4;solute carrier family 35, member B4;0,00000000002450000000;1,468904652;0,000964889;1,18903458;0,004711873;0,149505026;1,062461019;0,264174725;0;0;NA;NA;NA
X100312043_TGI_at;100312043_TGI_at;AK027034;IREB2;iron-responsive element binding protein 2;0,00000000061100000000;1,389710278;0,001133278;1,175597736;0,005285898;0,910890029;0,999941226;0,951873502;0;0;NA;NA;NA
X100312064_TGI_at;100312064_TGI_at;AK026329;CDCP1;CUB domain containing protein 1;0,00000000032700000000;1,421964972;0,028458518;1,13166722;0,052926602;0,038082294;1,240669208;0,099545202;0;0;NA;NA;NA
X100312066_TGI_at;100312066_TGI_at;AK026298;C15orf48;chromosome 15 open reading frame 48;0,00000002510000000000;1,842935988;0,039092624;1,36166529;0,067233473;0,140181821;1,29732481;0,252829328;0;0;NA;NA;NA
X100312070_TGI_at;100312070_TGI_at;AK026187;CDCP1;CUB domain containing protein 1;0,00000002370000000000;1,343659151;0,003518942;1,183100371;0,011765094;0,110976585;1,156024432;0,212903293;0;0;NA;NA;NA
X100312071_TGI_at;100312071_TGI_at;AK026178;SYT11;synaptotagmin XI;0,00000000070700000000;0,782676425;0,007076091;0,877896419;0,019245774;0,028121921;0,850248806;0,080853658;0;0;NA;NA;NA
X100312075_TGI_at;100312075_TGI_at;AK026006;TMEM53;transmembrane protein 53;0,00000000013200000000;1,428434026;0,133588437;1,077995932;0,177183347;0,004793639;1,363954737;0,024374289;0;0;NA;NA;NA
X100312092_TGI_at;100312092_TGI_at;AK025590;KCTD15;potassium channel tetramerisation domain containing 15;0,00000005090000000000;0,727024708;0,029725907;0,887621157;0,054809267;0,09653965;0,87374538;0,193392487;0;0;NA;NA;NA
X100312093_TGI_at;100312093_TGI_at;AK025517;PSME4;proteasome (prosome, macropain) activator subunit 4;0,00000000000370000000;1,304544819;0,008954707;1,091879911;0,022833087;0,421327994;1,059433688;0,560904521;0;0;NA;NA;NA
X100312103_TGI_at;100312103_TGI_at;AK025113;ATXN1L;ataxin 1-like;0,00000000000023500000;0,825531197;0,746222577;0,991357603;0,768640258;0,691575598;1,005059238;0,790968117;0;0;NA;NA;NA
X100312107_TGI_at;100312107_TGI_at;AK024855;CTSS;cathepsin S;0,00000001900000000000;1,302016456;0,006570358;1,091672251;0,018302734;0,000753789;1,307684201;0,007913552;0;1;U2;U1;U1
X100312120_TGI_at;100312120_TGI_at;AK024050;UBE2W;ubiquitin-conjugating enzyme E2W (putative);0,00000014800000000000;1,290847195;0,004265291;1,173974121;0,013424838;0,114834098;1,13290482;0,21874131;0;0;NA;NA;NA
X100312135_TGI_at;100312135_TGI_at;AK023583;CPSF2;cleavage and polyadenylation specific factor 2, 100kDa;0,00000021500000000000;1,280371865;0,175043344;1,073355798;0,221850058;0,504461526;1,06882408;0,639606411;0;0;NA;NA;NA
X100312142_TGI_at;100312142_TGI_at;AK023320;AKTIP;AKT interacting protein;0,00000000004290000000;0,828992008;0,009411023;0,919026693;0,023512966;0,191451954;0,944990943;0,318230865;0;0;NA;NA;NA
X100312167_TGI_at;100312167_TGI_at;AK022522;OPA1;optic atrophy 1 (autosomal dominant);0,00000060100000000000;1,251001806;0,007076091;1,104379214;0,019245774;0,685086646;0,982697658;0,784939303;0;0;NA;NA;NA
X100312174_TGI_at;100312174_TGI_at;AK022142;GAB1;GRB2-associated binding protein 1;0,00000003190000000000;0,800720922;0,541949686;0,985073061;0,579530138;0,709599351;1,086632022;0,803597578;0;0;NA;NA;NA
X100312178_TGI_at;100312178_TGI_at;AK022036;WWTR1;WW domain containing transcription regulator 1;0,00000000000113000000;1,594431384;8,08E-05;1,361452504;0,00091079;0,010330126;1,317039571;0,040961273;0;1;U2;U2;U1
X100312189_TGI_at;100312189_TGI_at;AK021577;NSUN4;NOL1/NOP2/Sun domain family, member 4;0,00000000256000000000;1,292748087;0,843349251;1,017407949;0,857449411;0,431008093;1,015308229;0,568620174;0;0;NA;NA;NA
X100312214_TGI_at;100312214_TGI_at;AK001397;PNPO;"pyridoxamine 5';-phosphate oxidase";0,00000007840000000000;1,232263655;0,248066932;1,05284686;0,297108778;0,022436456;1,217295955;0,06841315;0;0;NA;NA;NA
X100312217_TGI_at;100312217_TGI_at;AK001376;DARS2;aspartyl-tRNA synthetase 2, mitochondrial;0,00000000296000000000;1,243084402;0,072544689;1,062614958;0,109616283;0,09653965;1,089795297;0,193392487;0;0;NA;NA;NA
X100312231_TGI_at;100312231_TGI_at;AK000766;SLC25A13;solute carrier family 25, member 13 (citrin);0,00000000000003360000;1,341621956;0,023785164;1,069850808;0,046432212;0,016931008;1,133772592;0,056430856;0;0;NA;NA;NA
X100312245_TGI_at;100312245_TGI_at;AK000381;RPP25;ribonuclease P/MRP 25kDa subunit;0,00000000011000000000;1,362334416;0,01469465;1,13455251;0,032505736;0,00226685;1,231198422;0,015678236;0;1;U1;U1;U1
X100312255_TGI_at;100312255_TGI_at;AK000064;ATP6V1C1;ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1;0,00000000004180000000;1,370818648;0,089449084;1,086408301;0,129106314;0,3219842;1,042284227;0,462755775;0;0;NA;NA;NA
X100312261_TGI_at;100312261_TGI_at;AJ888380;BTK;Bruton agammaglobulinemia tyrosine kinase;0,00000000020700000000;1,403161683;0,002282119;1,22047319;0,008696308;0,008707469;1,298752928;0,036926544;0;1;U1;U2;U1
X100312265_TGI_at;100312265_TGI_at;AJ698135;PPARG;peroxisome proliferator-activated receptor gamma;0,00000000696000000000;1,592166011;0,000582616;1,497871019;0,003377284;0,00139981;1,591761014;0,011509154;0;1;U1;U1;U1
X100312275_TGI_at;100312275_TGI_at;AJ515553;AMICA1;adhesion molecule, interacts with CXADR antigen 1;0,00000000000000912000;1,602851236;1,01E-06;1,401820316;6,67E-05;0,008241833;1,440627754;0,035370744;0;1;U5;U3;U1
X100312281_TGI_at;100312281_TGI_at;AJ420562;PKIB;protein kinase (cAMP-dependent, catalytic) inhibitor beta;0,00000000000213000000;1,83635999;0,039092624;1,248153366;0,067233473;0,357146031;1,147798335;0,494450884;0;0;NA;NA;NA
X100312294_TGI_at;100312294_TGI_at;AJ299442;SIL1;SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae);0,00000004700000000000;1,261081343;0,142312127;1,034156134;0,186224923;0,038082294;1,246594642;0,099545202;0;0;NA;NA;NA
X100312301_TGI_at;100312301_TGI_at;AJ276359;MUC4;mucin 4, cell surface associated;0,00000091500000000000;1,955952772;0,264710888;1,187081847;0,314009273;0,875109546;0,849825878;0,925961283;0;0;NA;NA;NA
X100312303_TGI_at;100312303_TGI_at;AJ272206;C12orf5;chromosome 12 open reading frame 5;0,00000000000039000000;1,638299742;3,92E-05;1,328115784;0,000587416;0,003085297;1,339451166;0,018691562;0;1;U2;U2;U1
X100312304_TGI_at;100312304_TGI_at;AJ270695;BHLHB3;basic helix-loop-helix domain containing, class B, 3;0,00000000000000787000;1,870373558;2,83E-06;1,562380072;0,000115604;0,023487994;1,353082897;0,070485851;0;0;NA;NA;NA
X100312313_TGI_at;100312313_TGI_at;AJ227860;;;0,00000094500000000000;1,32811095;0,34174506;1,083385371;0,389948125;0,01554453;1,382585213;0,052959853;0;0;NA;NA;NA
X100312318_TGI_at;100312318_TGI_at;AJ133133;ENTPD1;ectonucleoside triphosphate diphosphohydrolase 1;0,00000048000000000000;1,335492956;0,094224532;1,109905818;0,134255379;0,18024766;1,17418022;0,304954439;0;0;NA;NA;NA
X100312336_TGI_at;100312336_TGI_at;AJ006268;ATP9B;ATPase, class II, type 9B;0,00000000208000000000;1,260665888;2,48E-07;1,153613187;2,75E-05;0,000987594;1,157150561;0,009357144;0;1;U1;U3;U1
X100312344_TGI_at;100312344_TGI_at;AI991581;CSNK2A2;casein kinase 2, alpha prime polypeptide;0,00000003990000000000;1,258496244;0,074246935;1,057492448;0,111406886;0,003871569;1,242018107;0,021358785;0;0;NA;NA;NA
X100312378_TGI_at;100312378_TGI_at;AI949987;MCCC2;methylcrotonoyl-Coenzyme A carboxylase 2 (beta);0,00000006680000000000;1,339773209;0,011249501;1,140756605;0,026680893;0,006071612;1,229123284;0,028156556;0;1;U2;U2;U1
X100312381_TGI_at;100312381_TGI_at;AI949138;hCG_17324;primary ciliary dyskinesia protein 1;0,00000000839000000000;1,300874688;0,015587149;1,169166839;0,033852683;0,103562613;1,118385555;0,203277894;0;0;NA;NA;NA
X100312404_TGI_at;100312404_TGI_at;AI915547;SF3B1;splicing factor 3b, subunit 1, 155kDa;0,00000000009640000000;0,808902257;0,289797435;0,969722884;0,338903168;0,00200392;0,829795443;0,01464543;0;0;NA;NA;NA
X100312431_TGI_at;100312431_TGI_at;AI862445;TNFAIP2;tumor necrosis factor, alpha-induced protein 2;0,00000000518000000000;1,319362764;0,093855869;1,109644674;0,133848436;0,009797793;1,2438306;0,039467969;0;0;NA;NA;NA
X100312458_TGI_at;100312458_TGI_at;AI822141;CCBE1;collagen and calcium binding EGF domains 1;0,00000000072900000000;0,728072785;0,007934042;0,817994625;0,020960178;0,442606018;1,11296485;0,579650222;0;0;NA;NA;NA
X100312461_TGI_at;100312461_TGI_at;AI819923;DDR2;discoidin domain receptor tyrosine kinase 2;0,00000000132000000000;0,792959465;0,290607224;0,931470724;0,339726907;0,044986133;0,828947957;0,111445279;0;0;NA;NA;NA
X100312463_TGI_at;100312463_TGI_at;AI818407;TMEM49;transmembrane protein 49;0,00000006680000000000;1,357317216;0,006722851;1,145127861;0,01856705;0,159283623;0,884731392;0,276600817;0;0;NA;NA;NA
X100312482_TGI_at;100312482_TGI_at;AI800694;SEMA5A;sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A;0,00000046800000000000;0,730989898;0,684866802;0,946531327;0,713190857;0,470967706;0,921246283;0,606928795;0;0;NA;NA;NA
X100312485_TGI_at;100312485_TGI_at;AI798990;ZEB1;zinc finger E-box binding homeobox 1;0,00000044200000000000;0,78060202;0,067242194;0,89826494;0,103447061;0,422375201;0,915276206;0,560904521;0;0;NA;NA;NA
X100312487_TGI_at;100312487_TGI_at;AI796266;;hypothetical LOC100131506;0,00000000091900000000;0,660094059;0,120572663;0,907292261;0,162664585;0,149505026;1,221068224;0,264174725;0;0;NA;NA;NA
X100312502_TGI_at;100312502_TGI_at;AI762858;;;0,00000000031800000000;1,386904351;0,016015338;1,136860037;0,034665839;0,020751701;1,236711234;0,065124373;0;0;NA;NA;NA
X100312506_TGI_at;100312506_TGI_at;AI761254;SNX24;sorting nexin 24;0,00000000000069900000;1,491530968;0,01261405;1,152495583;0,029018619;0,022801724;1,272563455;0,069330147;0;0;NA;NA;NA
X100312511_TGI_at;100312511_TGI_at;AI752658;CTSB;cathepsin B;0,00000000001490000000;1,42964353;0,055325263;1,08563326;0,088606816;0,115879498;1,114651176;0,220212042;0;0;NA;NA;NA
X100312518_TGI_at;100312518_TGI_at;AI741119;SYS1;SYS1 Golgi-localized integral membrane protein homolog (S. cerevisiae);0,00000001880000000000;1,212336266;0,911869176;1,020399102;0,919860517;9,68E-06;1,275891212;0,001248259;0;0;NA;NA;NA
X100312529_TGI_at;100312529_TGI_at;AI732388;MGAT4A;mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme A;0,00000000196000000000;1,33554607;0,144912005;1,090087336;0,188860248;0,374422782;1,024758686;0,511473085;0;0;NA;NA;NA
X100312538_TGI_at;100312538_TGI_at;AI701192;LAMC2;laminin, gamma 2;0,00000001460000000000;0,80643068;0,023141098;0,852625447;0,045422509;0,512848122;0,958832824;0,646425302;0;0;NA;NA;NA
X100312556_TGI_at;100312556_TGI_at;AI692523;SLIT2;slit homolog 2 (Drosophila);0,00000000000125000000;0,74516086;0,005756236;0,867833842;0,016549819;0,91436561;0,983743727;0,951873502;0;0;NA;NA;NA
X100312578_TGI_at;100312578_TGI_at;AI657057;GCNT1;glucosaminyl (N-acetyl) transferase 1, core 2 (beta-1,6-N-acetylglucosaminyltransferase);0,00000001150000000000;1,361161636;0,010200837;1,140741428;0,024967324;0,142561501;1,102869806;0,256260858;0;0;NA;NA;NA
X100312582_TGI_at;100312582_TGI_at;AI655572;NADK;NAD kinase;0,00000000214000000000;1,233380185;0,384655178;1,036699131;0,431365219;0,011420211;1,166061124;0,043251869;0;0;NA;NA;NA
X100312588_TGI_at;100312588_TGI_at;AI653698;NAGA;N-acetylgalactosaminidase, alpha-;0,00000000263000000000;1,273722435;0,026629163;1,086683164;0,050455025;0,000383543;1,220398026;0,005518566;0;0;NA;NA;NA
X100312602_TGI_at;100312602_TGI_at;AI640437;TMEM33;transmembrane protein 33;0,00000001070000000000;1,209596889;0,291511068;1,037517269;0,340659961;0,802835859;0,98136905;0,876241102;0;0;NA;NA;NA
X100312604_TGI_at;100312604_TGI_at;AI638649;GALNT12;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 (GalNAc-T12);0,00000000000484000000;1,716693371;4,90E-06;1,399501451;0,000171726;0,012011905;1,42175671;0,044912263;0;1;U1;U2;U1
X100312640_TGI_at;100312640_TGI_at;AI566394;GLT25D1;glycosyltransferase 25 domain containing 1;0,00000000000029900000;1,367891707;0,208514344;1,06898596;0,257879934;0,137820448;1,140685557;0,249969219;0;0;NA;NA;NA
X100312657_TGI_at;100312657_TGI_at;AI478811;MAPKSP1;MAPK scaffold protein 1;0,00000000000000026900;0,546382508;1,59E-07;0,708940781;2,13E-05;0,00919586;0,762684448;0,038004115;0;1;D6;D3;D1
X100312660_TGI_at;100312660_TGI_at;AI478154;TRIO;triple functional domain (PTPRF interacting);0,00000000061700000000;1,403966315;4,19E-06;1,241939111;0,00015806;0,043520849;1,234101072;0,108482363;0;0;NA;NA;NA
X100312686_TGI_at;100312686_TGI_at;AI418662;SOAT1;sterol O-acyltransferase 1;0,00000000000010100000;1,427252799;0,011429063;1,124592224;0,026977475;0,010314762;1,215781837;0,040961273;0;1;U2;U1;U1
X100312703_TGI_at;100312703_TGI_at;AI379524;;hypothetical LOC100190890;0,00000002180000000000;0,789915538;0,072730146;0,91310576;0,109742164;0,103562613;0,905062433;0,203277894;0;0;NA;NA;NA
X100312734_TGI_at;100312734_TGI_at;AI348152;GRK5;G protein-coupled receptor kinase 5;0,00000003190000000000;0,800890779;0,008347524;0,893377789;0,021714342;0,378530849;1,177572816;0,51585832;0;0;NA;NA;NA
X100312744_TGI_at;100312744_TGI_at;AI342698;EXOSC10;exosome component 10;0,00000013400000000000;1,315420261;0,093648156;1,106335364;0,133729732;0,422282974;1,039848667;0,560904521;0;0;NA;NA;NA
X100312776_TGI_at;100312776_TGI_at;AI283400;SPTBN1;spectrin, beta, non-erythrocytic 1;0,00000001570000000000;0,773859762;0,033532736;0,87113551;0,059447749;0,284058212;1,151491031;0,421122179;0;0;NA;NA;NA
X100312786_TGI_at;100312786_TGI_at;AI276889;NEK6;NIMA (never in mitosis gene a)-related kinase 6;0,00000000000000008470;2,034554847;2,16E-05;1,335530052;0,000410363;0,000987594;1,376574621;0,009357144;0;1;U6;U1;U1
X100312810_TGI_at;100312810_TGI_at;AI245841;ZNF330;zinc finger protein 330;0,00000002490000000000;1,204229042;0,017861791;1,111736232;0,037285332;0,046244403;1,128666458;0,113775352;0;0;NA;NA;NA
X100312811_TGI_at;100312811_TGI_at;AI244456;IGFBP5;insulin-like growth factor binding protein 5;0,00000067900000000000;0,747135952;0,107412227;0,864918064;0,148629685;0,005373466;0,748229883;0,026121691;0;0;NA;NA;NA
X100312822_TGI_at;100312822_TGI_at;AI219887;INPP5A;inositol polyphosphate-5-phosphatase, 40kDa;0,00000000003120000000;0,811403472;0,000724772;0,855533745;0,003965942;0,020928503;0,864232791;0,065424408;0;0;NA;NA;NA
X100312833_TGI_at;100312833_TGI_at;AI201749;;;0,00000000097700000000;0,683317108;0,002282119;0,767384861;0,008696308;0,093170847;0,842474524;0,188856657;0;0;NA;NA;NA
X100312841_TGI_at;100312841_TGI_at;AI188382;FLT1;fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor);0,00000000005640000000;1,390132537;0,005345586;1,134792827;0,015791772;0,03131461;1,179716215;0,087495254;0;0;NA;NA;NA
X100312842_TGI_at;100312842_TGI_at;AI188340;UACA;uveal autoantigen with coiled-coil domains and ankyrin repeats;0,00000014100000000000;0,811705939;0,058366931;0,8885053;0,092304523;0,103562613;0,872530229;0,203277894;0;0;NA;NA;NA
X100312856_TGI_at;100312856_TGI_at;AI150942;GM2A;GM2 ganglioside activator;0,00000000000000531000;1,71483858;2,72E-05;1,265343553;0,000476583;1,23E-07;1,590112493;0,00013516;0;1;U4;U2;U1
X100312858_TGI_at;100312858_TGI_at;AI147879;PCYT1A;phosphate cytidylyltransferase 1, choline, alpha;0,00000000263000000000;1,486061732;0,013669069;1,164939059;0,030722042;0,234597793;1,117355009;0,367043051;0;0;NA;NA;NA
X100312902_TGI_at;100312902_TGI_at;AI052130;TMEM45B;transmembrane protein 45B;0,00000000007430000000;1,472542992;0,151806604;1,122930387;0,196416173;0,066842161;1,200970328;0,148369342;0;0;NA;NA;NA
X100312913_TGI_at;100312913_TGI_at;AI033832;TBXAS1;thromboxane A synthase 1 (platelet);0,00000000000888000000;1,35237925;0,067309469;1,116085544;0,103451797;0,001495954;1,2985167;0,012033721;0;0;NA;NA;NA
X100312978_TGI_at;100312978_TGI_at;AF420602;BRE;brain and reproductive organ-expressed (TNFRSF1A modulator);0,00000000000206000000;1,202108881;0,002672526;1,063534904;0,009645635;0,001882981;1,121613533;0,014113602;0;1;U5;U1;U2
X100312979_TGI_at;100312979_TGI_at;AF420470;SNX13;sorting nexin 13;0,00000007860000000000;1,304477636;0,010952681;1,116064235;0,02620675;0,672949117;1,006716207;0,774063003;0;0;NA;NA;NA
X100312985_TGI_at;100312985_TGI_at;AF400595;CLEC7A;C-type lectin domain family 7, member A;0,00000007860000000000;1,380196716;0,001820382;1,324735017;0,007502673;0,061450873;1,17364884;0,141367712;0;0;NA;NA;NA
X100312992_TGI_at;100312992_TGI_at;AF378757;PLXDC2;plexin domain containing 2;0,00000000000095900000;1,276011486;0,007538999;1,132905026;0,020162294;0,234597793;1,098421848;0,367043051;0;0;NA;NA;NA
X100312994_TGI_at;100312994_TGI_at;AF368902;RGS10;regulator of G-protein signaling 10;0,00000000011700000000;1,319643735;0,020391221;1,115517148;0,041490471;0,003250241;1,215950972;0,019115922;0;1;U6;U1;U1
X100313036_TGI_at;100313036_TGI_at;AF309653;MS4A7;membrane-spanning 4-domains, subfamily A, member 7;0,00000000000918000000;1,55905862;0,000137907;1,273478516;0,0012652;3,00E-05;1,746966051;0,001805101;0;1;U6;U2;U1
X100313061_TGI_at;100313061_TGI_at;AF274957;RAB18;RAB18, member RAS oncogene family;0,00000000122000000000;1,209436283;0,210773315;1,054240868;0,259679814;0,245573996;1,0438406;0,379609108;0;0;NA;NA;NA
X100313070_TGI_at;100313070_TGI_at;AF261717;SAR1A;SAR1 homolog A (S. cerevisiae);0,00000000000045800000;1,379385957;0,000416243;1,142161137;0,002687443;0,169527921;1,102683417;0,290015121;0;0;NA;NA;NA
X100313073_TGI_at;100313073_TGI_at;AF257659;CALU;calumenin;0,00000011700000000000;1,223949218;0,257948758;1,077429618;0,306891416;0,369013827;1,124027994;0,507394012;0;0;NA;NA;NA
X100313078_TGI_at;100313078_TGI_at;AF251061;NCALD;neurocalcin delta;0,00000000002480000000;0,775797285;0,000292;0,826846723;0,002077518;0,091801748;0,879608669;0,187739235;0;0;NA;NA;NA
X100313092_TGI_at;100313092_TGI_at;AF224741;CLCN7;chloride channel 7;0,00000004580000000000;1,348854149;0,384300221;1,030471123;0,431117164;0,002131763;1,353549721;0,014968787;0;0;NA;NA;NA
X100313117_TGI_at;100313117_TGI_at;AF200193;BACE1;beta-site APP-cleaving enzyme 1;0,00000000000095900000;1,314912674;0,039634827;1,081304972;0,067923932;0,005746943;1,229565702;0,02719882;0;0;NA;NA;NA
X100313130_TGI_at;100313130_TGI_at;AF177862;HN1;hematological and neurological expressed 1;0,00000000000069900000;1,403547407;0,00077099;1,160882474;0,004127742;0,00139981;1,281631736;0,011509154;0;1;U2;U1;U1
X100313139_TGI_at;100313139_TGI_at;AF173378;MRTO4;mRNA turnover 4 homolog (S. cerevisiae);0,00000011300000000000;1,252628346;0,186322433;1,041346634;0,234445603;0,37483693;1,081449683;0,511473085;0;0;NA;NA;NA
X100313146_TGI_at;100313146_TGI_at;AF165531;GGA2;golgi associated, gamma adaptin ear containing, ARF binding protein 2;0,00000000556000000000;1,275431054;0,002202001;1,138308956;0,00850965;0,019786991;1,170559983;0,062769164;0;0;NA;NA;NA
X100313149_TGI_at;100313149_TGI_at;AF161505;STXBP6;syntaxin binding protein 6 (amisyn);0,00000001610000000000;0,77335286;0,008518256;0,850406351;0,021998668;0,672949117;1,052215973;0,774063003;0;0;NA;NA;NA
X100313150_TGI_at;100313150_TGI_at;AF161502;UBE2J1;ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast);0,00000024200000000000;1,236354838;0,163484482;1,079336291;0,208925648;0,940656418;0,986147593;0,965520903;0;0;NA;NA;NA
X100313154_TGI_at;100313154_TGI_at;AF161442;;;0,00000000011000000000;0,588830001;0,000323497;0,682512168;0,002227841;0,402347064;1,204331202;0,542112532;0;0;NA;NA;NA
X100313158_TGI_at;100313158_TGI_at;AF151858;TMED5;transmembrane emp24 protein transport domain containing 5;0,00000000005420000000;1,3569985;0,002244503;1,143604408;0,008591489;0,000495904;1,286502669;0,006356879;0;1;U2;U1;U1
X100313179_TGI_at;100313179_TGI_at;AF135593;VPS41;vacuolar protein sorting 41 homolog (S. cerevisiae);0,00000000000047500000;1,233412885;0,001679516;1,087384974;0,007096641;0,00372287;1,160470714;0,020759189;0;1;U2;U1;U1
X100313180_TGI_at;100313180_TGI_at;AF135160;MRPL42;mitochondrial ribosomal protein L42;0,00000000000151000000;1,311337586;0,092657036;1,066075364;0,132726056;0,218819432;1,056089001;0,349136153;0;0;NA;NA;NA
X100313198_TGI_at;100313198_TGI_at;AF123759;CLN8;ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation);0,00000014000000000000;1,232549325;0,816554793;0,99289057;0,833097847;0,222310311;1,108377999;0,352690755;0;0;NA;NA;NA
X100313213_TGI_at;100313213_TGI_at;AF109683;LAIR1;leukocyte-associated immunoglobulin-like receptor 1;0,00000000003900000000;1,615156723;0,080922752;1,119229201;0,119038808;0,001140766;1,362316478;0,010213021;0;0;NA;NA;NA
X100313241_TGI_at;100313241_TGI_at;AF087907;SSR3;signal sequence receptor, gamma (translocon-associated protein gamma);0,00000000000000720000;1,304216883;0,000878757;1,109006664;0,004481384;0,135687627;1,145118171;0,247213805;0;0;NA;NA;NA
X100313242_TGI_at;100313242_TGI_at;AF087891;BID;BH3 interacting domain death agonist;0,00000020700000000000;1,342084381;0,047068231;1,080521757;0,077796053;0,004525009;1,221370304;0,023637123;0;0;NA;NA;NA
X100313246_TGI_at;100313246_TGI_at;AF086914;SRPRB;signal recognition particle receptor, B subunit;0,00000002700000000000;1,266016694;0,534288462;0,99714286;0,572096915;0,26927095;1,056440491;0,405163526;0;0;NA;NA;NA
X100313249_TGI_at;100313249_TGI_at;AF086462;C10orf58;chromosome 10 open reading frame 58;0,00000000000000011000;1,578422573;5,65E-05;1,270758818;0,000739861;0,004595971;1,257240899;0,023853166;0;1;U3;U1;U1
X100313263_TGI_at;100313263_TGI_at;AF084521;ARFGEF2;ADP-ribosylation factor guanine nucleotide-exchange factor 2 (brefeldin A-inhibited);0,00000000288000000000;1,490949978;0,001020082;1,217292243;0,004877929;0,81616847;1,031108555;0,885097907;0;0;NA;NA;NA
X100313288_TGI_at;100313288_TGI_at;AF070544;SLC2A1;solute carrier family 2 (facilitated glucose transporter), member 1;0,00000013100000000000;1,45364058;0,241760217;1,104832972;0,290202302;0,452969134;0,924463176;0,589390197;0;0;NA;NA;NA
X100313315_TGI_at;100313315_TGI_at;AF052185;ATPAF2;ATP synthase mitochondrial F1 complex assembly factor 2;0,00000007190000000000;1,238825122;0,232376611;1,037898857;0,281137319;0,033503156;1,168996476;0,091046096;0;0;NA;NA;NA
X100313316_TGI_at;100313316_TGI_at;AF052183;WDR77;WD repeat domain 77;0,00000004700000000000;1,206611948;0,166579462;1,036300524;0,212375635;0,348497017;1,042046086;0,486868611;0;0;NA;NA;NA
X100313320_TGI_at;100313320_TGI_at;AF047711;RASAL2;RAS protein activator like 2;0,00000032000000000000;1,279083233;0,036986376;1,139718605;0,064575888;0,002719171;1,295655584;0,017251748;0;0;NA;NA;NA
X100313322_TGI_at;100313322_TGI_at;AF043453;SNX2;sorting nexin 2;0,00000004700000000000;1,230745031;0,012212653;1,106477676;0,028317874;0,030713739;1,191062727;0,086003807;0;0;NA;NA;NA
X100313324_TGI_at;100313324_TGI_at;AF043294;BUB1;BUB1 budding uninhibited by benzimidazoles 1 homolog (yeast);0,00000005690000000000;1,489508719;0,015037392;1,356972141;0,032986703;0,014036883;1,350862485;0,049746761;0;1;U1;U1;U1
X100313331_TGI_at;100313331_TGI_at;AF039652;RNASEH1;ribonuclease H1;0,00000000000136000000;1,293888152;0,001449038;1,120441385;0,006362738;0,021425185;1,144640673;0,066397472;0;0;NA;NA;NA
X100313336_TGI_at;100313336_TGI_at;AF035594;PRKCA;protein kinase C, alpha;0,00000026800000000000;1,346395504;0,163030456;1,074881366;0,208751891;0,004386492;1,263167907;0,022988073;0;0;NA;NA;NA
X100313338_TGI_at;100313338_TGI_at;AF035298;TJP1;tight junction protein 1 (zona occludens 1);0,00000006160000000000;0,773527755;0,32032804;0,948370477;0,368984015;0,759495311;1,055965618;0,842344593;0;0;NA;NA;NA
X100313348_TGI_at;100313348_TGI_at;AF030403;STK39;serine threonine kinase 39 (STE20/SPS1 homolog, yeast);0,00000066200000000000;1,217216227;0,013238052;1,146915266;0,030047513;0,613556941;0,982452119;0,727019861;0;0;NA;NA;NA
X100313353_TGI_at;100313353_TGI_at;AF027964;SMAD2;SMAD family member 2;0,00000000000039700000;1,206178404;0,008752772;1,068440298;0,022478234;0,000145725;1,171350605;0,003847048;0;1;U2;U1;U1
X100313360_TGI_at;100313360_TGI_at;AF025533;LILRB3;leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3;0,00000000001670000000;1,589513985;0,01454558;1,171642448;0,032242368;0,053765992;1,202173058;0,127699182;0;0;NA;NA;NA
X100313361_TGI_at;100313361_TGI_at;AF025304;EPHB2;EPH receptor B2;0,00000096100000000000;1,260196908;0,071750435;1,099579895;0,10872198;0,648925345;1,037308017;0,755321916;0;0;NA;NA;NA
X100313395_TGI_at;100313395_TGI_at;ABA11506;WFIKKN2;WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2;0,00000000000004280000;1,92902348;2,46E-05;1,434826688;0,00045337;0,402860155;1,118074385;0,542363526;0;0;NA;NA;NA
X100313419_TGI_at;100313419_TGI_at;AB209495;PTCH1;patched homolog 1 (Drosophila);0,00000000001850000000;0,673704188;0,001746334;0,824358825;0,007300763;0,004862758;0,727193381;0,024374289;0;1;D2;D1;D1
X100313450_TGI_at;100313450_TGI_at;AB096243;FDX1;ferredoxin 1;0,00000000217000000000;1,346253681;0,001166469;1,16594997;0,005372547;0,000429424;1,282463271;0,005893387;0;1;U2;U3;U1
X100313476_TGI_at;100313476_TGI_at;AB060691;B3GALNT1;beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group);0,00000000004050000000;0,678310075;0,008082051;0,8590625;0,02122938;0,177060975;0,919149614;0,301461976;0;0;NA;NA;NA
X100313485_TGI_at;100313485_TGI_at;AB052103;COLEC12;collectin sub-family member 12;0,00000001040000000000;1,217323413;0,003540992;1,165038017;0,011814966;0,041415229;1,22634423;0,104282253;0;0;NA;NA;NA
X100313510_TGI_at;100313510_TGI_at;AB036432;AGER;advanced glycosylation end product-specific receptor;0,00000000000001930000;0,729278775;0,275859331;0,902418887;0,325003853;0,108401488;1,241929204;0,209710682;0;0;NA;NA;NA
X100313516_TGI_at;100313516_TGI_at;AB030656;CORO1C;coronin, actin binding protein, 1C;0,00000000000000889000;1,428696752;0,001850312;1,199094781;0,007561703;0,000137814;1,384516802;0,003701458;0;1;U2;U1;U1
X100313527_TGI_at;100313527_TGI_at;AB028069;DBF4;DBF4 homolog (S. cerevisiae);0,00000001740000000000;1,274088927;0,10635186;1,083551531;0,147428836;0,357146031;0,934209729;0,494450884;0;0;NA;NA;NA
X100313531_TGI_at;100313531_TGI_at;AB026722;PPA2;pyrophosphatase (inorganic) 2;0,00000000335000000000;1,217587358;1,80E-05;1,129928879;0,0003666;0,074615336;1,124699023;0,161916497;0;0;NA;NA;NA
X100313532_TGI_at;100313532_TGI_at;AB026256;SLCO2B1;solute carrier organic anion transporter family, member 2B1;0,00000000000065200000;1,593835607;0,00066288;1,19407171;0,003711391;0,000518747;1,304854073;0,006582364;0;1;U4;U2;U1
X100313534_TGI_at;100313534_TGI_at;AB023213;DZIP1;DAZ interacting protein 1;0,00000007040000000000;0,795548996;0,040183399;0,865616873;0,068669721;0,004100912;0,747252557;0,022065509;0;0;NA;NA;NA
X100313536_TGI_at;100313536_TGI_at;AB022918;ST3GAL6;ST3 beta-galactoside alpha-2,3-sialyltransferase 6;0,00000079600000000000;1,267860007;0,010217779;1,163890439;0,024967324;0,135687627;1,195815326;0,247213805;0;0;NA;NA;NA
X100313551_TGI_at;100313551_TGI_at;AB017016;TPPP;tubulin polymerization promoting protein;0,00000037700000000000;0,726796952;0,025516694;0,846718416;0,048923441;0,120037886;1,329571867;0,225850617;0;0;NA;NA;NA
X100313575_TGI_at;100313575_TGI_at;AB004574;DNASE2;deoxyribonuclease II, lysosomal;0,00000000017700000000;1,352470345;0,057568311;1,165861714;0,09125138;0,003063783;1,374032272;0,018596182;0;0;NA;NA;NA
X100313579_TGI_at;100313579_TGI_at;AB002310;HUWE1;HECT, UBA and WWE domain containing 1;0,00000000000173000000;0,775373677;0,156731174;0,946667797;0,201735054;0,980202899;1,018113441;0,987556719;0;0;NA;NA;NA
X100313587_TGI_at;100313587_TGI_at;AAC24853;TMEM35;transmembrane protein 35;0,00000016500000000000;0,808377505;0,317003863;0,927127564;0,366201953;0,071816378;0,894072032;0,157336794;0;0;NA;NA;NA
X100313612_TGI_at;100313612_TGI_at;AA946673;;;0,00000000057100000000;1,376229605;0,000140883;1,229409282;0,00127906;0,035140254;1,197042481;0,094067308;0;0;NA;NA;NA
X100313615_TGI_at;100313615_TGI_at;AA937590;DAPK2;death-associated protein kinase 2;0,00000001340000000000;0,787476175;0,027837492;0,874066908;0,052102344;0,587186896;1,048078276;0,708272218;0;0;NA;NA;NA
X100313650_TGI_at;100313650_TGI_at;AA878516;PUS10;pseudouridylate synthase 10;0,00000013700000000000;1,322213518;0,01454558;1,129457079;0,032242368;0,017758754;1,299347754;0,058404554;0;0;NA;NA;NA
X100313659_TGI_at;100313659_TGI_at;AA861047;PDXK;pyridoxal (pyridoxine, vitamin B6) kinase;0,00000017300000000000;1,334841648;0,86581873;1,013085169;0,877526341;0,002131763;1,28823062;0,014968787;0;0;NA;NA;NA
X100313665_TGI_at;100313665_TGI_at;AA843508;LAPTM4B;lysosomal protein transmembrane 4 beta;0,00000038300000000000;1,217034367;0,321951967;1,047443301;0,370325193;0,103562613;1,155389675;0,203277894;0;0;NA;NA;NA
X100313672_TGI_at;100313672_TGI_at;AA830380;DTX2;deltex homolog 2 (Drosophila);0,00000001180000000000;1,356295639;0,49042762;1,0201611;0,530596918;0,149505026;1,060016338;0,264174725;0;0;NA;NA;NA
X100313673_TGI_at;100313673_TGI_at;AA827918;RASSF2;Ras association (RalGDS/AF-6) domain family member 2;0,00000000374000000000;0,792687015;0,017316091;0,872440702;0,036572583;0,526622464;1,015463262;0,659403342;0;0;NA;NA;NA
X100313689_TGI_at;100313689_TGI_at;AA807384;DNAJC18;DnaJ (Hsp40) homolog, subfamily C, member 18;0,00000000001160000000;0,73627957;0,00411516;0,85154666;0,013055233;0,470967706;0,912738107;0,606928795;0;0;NA;NA;NA
X100313691_TGI_at;100313691_TGI_at;AA806703;UBE2F;ubiquitin-conjugating enzyme E2F (putative);0,00000000129000000000;1,203220043;0,752749773;1,008119416;0,774126522;0,046864607;1,082501768;0,114688405;0;0;NA;NA;NA
X100313730_TGI_at;100313730_TGI_at;AA724878;PRPSAP1;phosphoribosyl pyrophosphate synthetase-associated protein 1;0,00000000035300000000;0,813841433;0,000376562;0,878364225;0,002487007;0,450742398;0,92911158;0,587204022;0;0;NA;NA;NA
X100313762_TGI_at;100313762_TGI_at;AA629282;;;0,00000000007290000000;1,455644541;0,000460763;1,170365401;0,002834042;0,081785093;1,146039111;0,172961519;0;0;NA;NA;NA
X100313781_TGI_at;100313781_TGI_at;AA594489;BLVRA;biliverdin reductase A;0,00000003300000000000;1,23494922;0,103915228;1,092904395;0,14473586;8,46E-05;1,391829163;0,002840678;0;0;NA;NA;NA
X100313784_TGI_at;100313784_TGI_at;AA588529;GRAMD1A;GRAM domain containing 1A;0,00000006870000000000;1,435106008;0,08006771;1,053226627;0,117996447;0,590451681;1,057289084;0,709819384;0;0;NA;NA;NA
X100313787_TGI_at;100313787_TGI_at;AA586953;GALNT6;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6);0,00000000001030000000;1,538242602;0,111951704;1,133626394;0,153149551;0,331593893;1,037874446;0,472261209;0;0;NA;NA;NA
X100313790_TGI_at;100313790_TGI_at;AA576487;YKT6;YKT6 v-SNARE homolog (S. cerevisiae);0,00000000038300000000;1,324596155;0,096240748;1,065425811;0,136284679;0,780651618;0,983147997;0,859890692;0;0;NA;NA;NA
X100313791_TGI_at;100313791_TGI_at;AA576451;SORD;sorbitol dehydrogenase;0,00000002310000000000;1,204296653;0,706670332;1,016626488;0,73352608;0,888166261;0,956777379;0,935477078;0;0;NA;NA;NA
X100313801_TGI_at;100313801_TGI_at;AA534881;BZW2;basic leucine zipper and W2 domains 2;0,00000000003730000000;1,272529957;0,007445908;1,102857915;0,019965193;0,09653965;1,186842059;0,193392487;0;0;NA;NA;NA
X100313807_TGI_at;100313807_TGI_at;AA528513;UGCGL1;UDP-glucose ceramide glucosyltransferase-like 1;0,00000000000077700000;1,490681767;0,017048765;1,111734551;0,036173911;0,383877774;1,068059457;0,520942343;0;0;NA;NA;NA
X100313816_TGI_at;100313816_TGI_at;AA502942;CTSZ;cathepsin Z;0,00000051500000000000;1,357247916;0,027026807;1,136183825;0,050939999;0,000661994;1,561877093;0,007434173;0;0;NA;NA;NA
X100313834_TGI_at;100313834_TGI_at;AA460367;CSNK1E;casein kinase 1, epsilon;0,00000000031800000000;0,75209258;0,519326176;0,952930393;0,558043125;0,797584764;0,98459098;0,871690639;0;0;NA;NA;NA
X100313844_TGI_at;100313844_TGI_at;AA448172;RPS6KB1;ribosomal protein S6 kinase, 70kDa, polypeptide 1;0,00000000000002400000;1,665754998;5,96E-06;1,333169562;0,000202133;0,022103782;1,25729637;0,067912763;0;0;NA;NA;NA
X100313851_TGI_at;100313851_TGI_at;AA437054;RERG;RAS-like, estrogen-regulated, growth inhibitor;0,00000005380000000000;0,716031695;0,726538069;1,03527758;0,750282664;0,5291358;0,979535212;0,660834037;0;0;NA;NA;NA
X100313853_TGI_at;100313853_TGI_at;AA436312;ITGAM;integrin, alpha M (complement component 3 receptor 3 subunit);0,00000001320000000000;1,340726343;0,465205387;1,030437781;0,507396603;0,002487191;1,31539995;0,016596722;0;0;NA;NA;NA
X100313861_TGI_at;100313861_TGI_at;AA421067;CCDC93;coiled-coil domain containing 93;0,00000003280000000000;1,343217675;0,015410247;1,140988629;0,0336271;0,875109546;1,010638963;0,925961283;0;0;NA;NA;NA
X100313864_TGI_at;100313864_TGI_at;AA416803;CCNYL1;cyclin Y-like 1;0,00000109000000000000;1,243936418;0,134754056;1,070972658;0,17836235;0,01718911;1,24048876;0,05711392;0;0;NA;NA;NA
X100313881_TGI_at;100313881_TGI_at;AA379112;SLAMF8;SLAM family member 8;0,00000000004320000000;1,955772207;0,028875709;1,203917713;0,053486442;0,008241833;1,412623425;0,035370744;0;0;NA;NA;NA
X100313887_TGI_at;100313887_TGI_at;AA367306;AKT3;v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma);0,00000004570000000000;0,789438747;0,060853623;0,93125528;0,095487453;0,348497017;0,937259225;0,486868611;0;0;NA;NA;NA
X100313923_TGI_at;100313923_TGI_at;AA278761;;;0,00000000208000000000;0,693427664;0,005232954;0,827192876;0,015587627;0,91436561;0,967457599;0,951873502;0;0;NA;NA;NA
X100313941_TGI_at;100313941_TGI_at;AA235608;SPTBN1;spectrin, beta, non-erythrocytic 1;0,00000021000000000000;0,764048757;0,09349449;0,890411495;0,133569477;0,127936269;1,254276807;0,236568327;0;0;NA;NA;NA
X100313979_TGI_at;100313979_TGI_at;AA148029;PODXL;podocalyxin-like;0,00000001400000000000;0,811291931;0,012212653;0,888935614;0,028317874;0,493698061;0,930183192;0,628679909;0;0;NA;NA;NA
X100313983_TGI_at;100313983_TGI_at;AA129406;GRB10;growth factor receptor-bound protein 10;0,00000013300000000000;0,805380485;0,000103702;0,837363931;0,00106414;0,660894461;1,021907104;0,764285198;0;0;NA;NA;NA
X100314005_TGI_at;100314005_TGI_at;AA069149;VPS37A;vacuolar protein sorting 37 homolog A (S. cerevisiae);0,00000022100000000000;1,325226466;0,016310406;1,119049452;0,035069006;0,203149235;1,126100422;0,330514884;0;0;NA;NA;NA
X100314016_TGI_at;100314016_TGI_at;AA043163;ELK3;ELK3, ETS-domain protein (SRF accessory protein 2);0,00000047700000000000;0,793294284;0,044078519;0,92294506;0,073761717;0,03650134;0,808390177;0,096439395;0;0;NA;NA;NA
